Citrus Sinensis ID: 018936
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 348 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | yes | no | 0.928 | 0.564 | 0.743 | 1e-136 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.712 | 0.347 | 0.707 | 1e-105 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.614 | 0.417 | 0.561 | 5e-68 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.640 | 0.429 | 0.54 | 2e-67 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.640 | 0.441 | 0.538 | 2e-67 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.614 | 0.417 | 0.555 | 1e-66 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.620 | 0.174 | 0.480 | 1e-54 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.620 | 0.144 | 0.480 | 4e-54 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.620 | 0.145 | 0.476 | 7e-54 | |
| Q14AX6 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.620 | 0.145 | 0.476 | 8e-54 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 484 bits (1246), Expect = e-136, Method: Compositional matrix adjust.
Identities = 247/332 (74%), Positives = 277/332 (83%), Gaps = 9/332 (2%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCVFGRE ++ +E+K+ + S VG SV +G + + + E +K EE
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSKASSGVVVVGESSVTKSNGVIAD--DVEKKKNEEANG 58
Query: 61 DGEKKP-RGERKRS-KSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSF 118
D E+K +G+R+RS K NPRLSN KH RGEQVAAGWP WL+ CGEALNGW+PR+AD+F
Sbjct: 59 DKERKSSKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTF 118
Query: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL+LRRLDHPNV+
Sbjct: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVV 178
Query: 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238
KLEGLVTSRMSCSLYLVF YM+HDLAGLA+SP VKF+E + VKC M QL+SGLEHC
Sbjct: 179 KLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESE-----VKCLMRQLISGLEHC 233
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 298
H+ GVLHRDIKGSNLLIDD GVLKIADFGLA+ FDPNHK PMTSRVVTLWYR PELLLGA
Sbjct: 234 HSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGA 293
Query: 299 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
TDYGVG+DLWSAGCILAELLAG+PIMPGRTEV
Sbjct: 294 TDYGVGIDLWSAGCILAELLAGRPIMPGRTEV 325
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (982), Expect = e-105, Method: Compositional matrix adjust.
Identities = 179/253 (70%), Positives = 215/253 (84%), Gaps = 5/253 (1%)
Query: 78 RLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKD 137
R+ ++ RG QV AGWP WL +V GEA+NGWIPR+ADSFEK++KIGQGTYS+VYKA+D
Sbjct: 123 RICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARD 182
Query: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197
+ T ++VALKKVRF N++P+SV+FMAREI+ILRRLDHPNV+KLEGL+TSR+S S+YL+F
Sbjct: 183 LETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFE 242
Query: 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD 257
YMEHDLAGLA++P + F+E Q +KCYM QLL GLEHCH+ GVLHRDIKGSNLL+D
Sbjct: 243 YMEHDLAGLASTPGINFSEAQ-----IKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDH 297
Query: 258 DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317
+ LKI DFGLA+F+ + K P+TSRVVTLWYRPPELLLG+TDYGV VDLWS GCILAEL
Sbjct: 298 NNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAEL 357
Query: 318 LAGKPIMPGRTEV 330
GKPIMPGRTEV
Sbjct: 358 FTGKPIMPGRTEV 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (659), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 132/235 (56%), Positives = 165/235 (70%), Gaps = 21/235 (8%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D FEK+++IG+GTY VY AK++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 169 LRRLDHPNVIKLEGLVTS--------------RMSCSLYLVFHYMEHDLAGLAASPEVKF 214
L++L H NVI L+ +VTS + +Y+VF YM+HDL GLA P ++F
Sbjct: 77 LKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 215 TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274
T PQ +KCYM QLL+GL +CH N VLHRDIKGSNLLID++G LK+ADFGLA +
Sbjct: 137 TVPQ-----IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSH 191
Query: 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+H +T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL GKPI+PG+TE
Sbjct: 192 DHTGNLTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTE 246
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 256 bits (655), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 135/250 (54%), Positives = 169/250 (67%), Gaps = 27/250 (10%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D FEK+++IG+GTY VY A++ T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 169 LRRLDHPNVIKLEGLVTS---------------RMSCSLYLVFHYMEHDLAGLAASPEVK 213
L++L H NVI+L+ +VTS + S+Y+VF YM+HDL GLA P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 214 FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273
FT PQ +KCYM QLL+GL +CH N VLHRDIKGSNLLID++G LK+ADFGLA F
Sbjct: 136 FTVPQ-----IKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 190
Query: 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333
+H +T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL GKPI+PG+ E
Sbjct: 191 NDHNGNLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQ- 249
Query: 334 FCFVLNLIFD 343
L+ IFD
Sbjct: 250 ----LSKIFD 255
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 256 bits (653), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 134/249 (53%), Positives = 169/249 (67%), Gaps = 26/249 (10%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D FEK+++IG+GTY VY AK++ TG+IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 169 LRRLDHPNVIKLEGLVTS--------------RMSCSLYLVFHYMEHDLAGLAASPEVKF 214
L++L H NVI+L+ +VTS + +Y+VF YM+HDL GLA P ++F
Sbjct: 77 LKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 215 TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274
T PQ +KCYM QLL+GL +CH N VLHRDIKGSNLLID++G LK+ADFGLA +
Sbjct: 137 TVPQ-----IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSH 191
Query: 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
+H +T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL KPI+PG+ E
Sbjct: 192 DHTGNLTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQ-- 249
Query: 335 CFVLNLIFD 343
LN IF+
Sbjct: 250 ---LNKIFE 255
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (647), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 131/236 (55%), Positives = 163/236 (69%), Gaps = 22/236 (9%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D FEK+++IG+GTY VY AK+ T +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 169 LRRLDHPNVIKLEGLVTS---------------RMSCSLYLVFHYMEHDLAGLAASPEVK 213
L++L H NVI+L+ +VTS + S+Y+VF YM+HDL GLA P ++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 214 FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273
FT PQ +KCYM QLL+GL +CH N VLHRDIKGSNLLID++G LK+ADFGLA F
Sbjct: 136 FTVPQ-----IKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 190
Query: 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+H +T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL GKPI+ G+ E
Sbjct: 191 SDHNGNLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNE 246
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (543), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 111/231 (48%), Positives = 144/231 (62%), Gaps = 15/231 (6%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I IG+GTY VYKAKD TG++VALKKVR DN E E A REI I
Sbjct: 702 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 760
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQFV 220
LR+L H +V+ ++ +VT + + YLVF YM+HDL GL S V+F+E
Sbjct: 761 LRQLIHKSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDH-- 818
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
+K +M QL+ GLE+CH LHRDIK SN+L+++ G +K+ADFGLA + P
Sbjct: 819 ---IKSFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPY 875
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331
T++V+TLWYRPPELLLG Y +D+WS GCIL EL KPI E++
Sbjct: 876 TNKVITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELA 926
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 111/231 (48%), Positives = 144/231 (62%), Gaps = 15/231 (6%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I IG+GTY VYKAKD TG++VALKKVR DN E E A REI I
Sbjct: 719 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 777
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQFV 220
LR+L H +V+ ++ +VT + + YLVF YM+HDL GL S V F+E
Sbjct: 778 LRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-- 835
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
+K +M QL+ GLE+CH LHRDIK SN+L+++ G +K+ADFGLA ++ P
Sbjct: 836 ---IKSFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPY 892
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331
T++V+TLWYRPPELLLG Y +D+WS GCIL EL KPI E++
Sbjct: 893 TNKVITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELA 943
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (537), Expect = 7e-54, Method: Compositional matrix adjust.
Identities = 110/231 (47%), Positives = 144/231 (62%), Gaps = 15/231 (6%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I IG+GTY VYKAKD TG++VALKKVR DN E E A REI I
Sbjct: 715 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 773
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQFV 220
LR+L H +V+ ++ +VT + + YLVF YM+HDL GL S V F+E
Sbjct: 774 LRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-- 831
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
+K +M QL+ GL++CH LHRDIK SN+L+++ G +K+ADFGLA ++ P
Sbjct: 832 ---IKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPY 888
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331
T++V+TLWYRPPELLLG Y +D+WS GCIL EL KPI E++
Sbjct: 889 TNKVITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELA 939
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 8e-54, Method: Compositional matrix adjust.
Identities = 110/231 (47%), Positives = 144/231 (62%), Gaps = 15/231 (6%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I IG+GTY VYKAKD TG++VALKKVR DN E E A REI I
Sbjct: 715 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 773
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQFV 220
LR+L H +V+ ++ +VT + + YLVF YM+HDL GL S V F+E
Sbjct: 774 LRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-- 831
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
+K +M QL+ GL++CH LHRDIK SN+L+++ G +K+ADFGLA ++ P
Sbjct: 832 ---IKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPY 888
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331
T++V+TLWYRPPELLLG Y +D+WS GCIL EL KPI E++
Sbjct: 889 TNKVITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELA 939
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 348 | ||||||
| 255542430 | 571 | Serine/threonine-protein kinase cdk9, pu | 0.928 | 0.565 | 0.818 | 1e-157 | |
| 356505916 | 573 | PREDICTED: probable serine/threonine-pro | 0.913 | 0.554 | 0.821 | 1e-153 | |
| 356535133 | 580 | PREDICTED: probable serine/threonine-pro | 0.931 | 0.558 | 0.776 | 1e-146 | |
| 356573056 | 572 | PREDICTED: probable serine/threonine-pro | 0.913 | 0.555 | 0.796 | 1e-146 | |
| 225451183 | 582 | PREDICTED: probable serine/threonine-pro | 0.922 | 0.551 | 0.763 | 1e-145 | |
| 147788188 | 576 | hypothetical protein VITISV_038843 [Viti | 0.922 | 0.557 | 0.760 | 1e-145 | |
| 356576745 | 580 | PREDICTED: probable serine/threonine-pro | 0.931 | 0.558 | 0.767 | 1e-144 | |
| 449435738 | 564 | PREDICTED: probable serine/threonine-pro | 0.931 | 0.574 | 0.739 | 1e-138 | |
| 7671528 | 599 | CRK1 protein [Beta vulgaris subsp. vulga | 0.928 | 0.539 | 0.721 | 1e-138 | |
| 357512159 | 569 | Cdc2-like protein kinase [Medicago trunc | 0.902 | 0.551 | 0.730 | 1e-138 |
| >gi|255542430|ref|XP_002512278.1| Serine/threonine-protein kinase cdk9, putative [Ricinus communis] gi|223548239|gb|EEF49730.1| Serine/threonine-protein kinase cdk9, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 559 bits (1440), Expect = e-157, Method: Compositional matrix adjust.
Identities = 270/330 (81%), Positives = 296/330 (89%), Gaps = 7/330 (2%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV GREVSSGIVSES+EV + SVESS + + KT VE+QN+ES+K+++
Sbjct: 1 MGCVLGREVSSGIVSESREVKHPSVESSRTLDNDSATKTDTSSFVEIQNEESQKEDKS-- 58
Query: 61 DGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEK 120
+G+KK + ER+RS+ NPRLSN PKHLRGEQVAAGWPPWL+AVCGEALNGWIPRRAD+FEK
Sbjct: 59 EGDKKSKAERRRSRPNPRLSNPPKHLRGEQVAAGWPPWLSAVCGEALNGWIPRRADTFEK 118
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IDK+G GTYSNVYKA+D+L+GKIVALKKVRFDNLEPESVKFMAREILILRRLDH NV+KL
Sbjct: 119 IDKVGSGTYSNVYKARDLLSGKIVALKKVRFDNLEPESVKFMAREILILRRLDHLNVVKL 178
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
EGLVTSRMSCSLYLVF YMEHDLAGLA SP VKFTE Q VKCYMHQLLSGLEHCHN
Sbjct: 179 EGLVTSRMSCSLYLVFEYMEHDLAGLAVSPGVKFTESQ-----VKCYMHQLLSGLEHCHN 233
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 300
GVLHRDIKGSNLLID++G+L+IADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD
Sbjct: 234 RGVLHRDIKGSNLLIDNEGILRIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 293
Query: 301 YGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
YGVGVDLWSAGCILAELLAGKPIMPGRTEV
Sbjct: 294 YGVGVDLWSAGCILAELLAGKPIMPGRTEV 323
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505916|ref|XP_003521735.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1407), Expect = e-153, Method: Compositional matrix adjust.
Identities = 271/330 (82%), Positives = 289/330 (87%), Gaps = 12/330 (3%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV REVS GI+SE KE S ES RKVG VS G+VVEVQN E +EK
Sbjct: 1 MGCVISREVSKGIISEVKEEKGLSGESK-RKVGGVSGSK--GEVVEVQNGE----KEKGG 53
Query: 61 DGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEK 120
+G ++ GER+RSK+NPRLSN PKHLRGEQVAAGWPPWLTAVCGEAL+GWIPR+AD+FEK
Sbjct: 54 EGVQRSCGERRRSKANPRLSNPPKHLRGEQVAAGWPPWLTAVCGEALSGWIPRKADTFEK 113
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IDKIGQGTYSNVYKAKDM+TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV+KL
Sbjct: 114 IDKIGQGTYSNVYKAKDMMTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVVKL 173
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
+GLVTSRMSCSLYLVF YMEHDLAGLAASP ++FTEPQ VKCYMHQLLSGLEHCHN
Sbjct: 174 QGLVTSRMSCSLYLVFDYMEHDLAGLAASPGIRFTEPQ-----VKCYMHQLLSGLEHCHN 228
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 300
VLHRDIKGSNLLID++G LKIADFGLAS FDPNHKHPMTSRVVTLWYRPPELLLGATD
Sbjct: 229 RHVLHRDIKGSNLLIDNEGTLKIADFGLASIFDPNHKHPMTSRVVTLWYRPPELLLGATD 288
Query: 301 YGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
Y VGVDLWSAGCIL ELLAGKPIMPGRTEV
Sbjct: 289 YSVGVDLWSAGCILGELLAGKPIMPGRTEV 318
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535133|ref|XP_003536103.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 524 bits (1350), Expect = e-146, Method: Compositional matrix adjust.
Identities = 257/331 (77%), Positives = 282/331 (85%), Gaps = 7/331 (2%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV REVSSGIVSE KE N SV S++KV S + + V QN E K+E
Sbjct: 1 MGCVISREVSSGIVSEVKEEKNLSV-GSNKKVDEASTSGAEENAVVAQNGEKEKEENGGG 59
Query: 61 DGE-KKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFE 119
D ++P+GER+RSK NPRLSN PKHL+GEQVAAGWPPWLTAVCGEAL+GWIPR+AD+FE
Sbjct: 60 DDRVRRPKGERRRSKPNPRLSNPPKHLQGEQVAAGWPPWLTAVCGEALSGWIPRKADTFE 119
Query: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
KIDKIGQGTYSNVYKAKD LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK
Sbjct: 120 KIDKIGQGTYSNVYKAKDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
LEGLVTSRMS SLYLVF YM HDLAGLAASP++KFTEPQ VKCY+HQLLSGLEHCH
Sbjct: 180 LEGLVTSRMSLSLYLVFDYMVHDLAGLAASPDIKFTEPQ-----VKCYIHQLLSGLEHCH 234
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 299
+ VLHRDIKGSNLLID++G+LKIADFGLASFFDPN + PMT+RVVTLWYRP ELLLGAT
Sbjct: 235 SRNVLHRDIKGSNLLIDNEGILKIADFGLASFFDPNRRQPMTNRVVTLWYRPLELLLGAT 294
Query: 300 DYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+YG +DLWS GCIL ELLAGKPI+PGRTEV
Sbjct: 295 EYGAAIDLWSVGCILGELLAGKPILPGRTEV 325
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573056|ref|XP_003554681.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1347), Expect = e-146, Method: Compositional matrix adjust.
Identities = 263/330 (79%), Positives = 283/330 (85%), Gaps = 12/330 (3%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV REVS G++S+ KE + S ES RKV VS +VVEVQN E K++
Sbjct: 1 MGCVISREVSKGVISDVKEERDLSGESK-RKVDGVSGSK--DEVVEVQNGEKEKEKGGEG 57
Query: 61 DGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEK 120
RG+R+RSK+NPRLSN PKHLR EQVAAGWPPWLTAVCGEAL GWIPR+AD+FEK
Sbjct: 58 VQ----RGKRRRSKANPRLSNPPKHLRWEQVAAGWPPWLTAVCGEALGGWIPRKADTFEK 113
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IDKIGQGTYSNVYKAKDM+TGKIVALKKVRFDN EPESVKFMAREILILRRLDHPNV+KL
Sbjct: 114 IDKIGQGTYSNVYKAKDMMTGKIVALKKVRFDNWEPESVKFMAREILILRRLDHPNVVKL 173
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
+GLVTSRMSCSLYLVF YMEHDLAGLAASP ++FTEPQ VKCYMHQLLSGLEHCHN
Sbjct: 174 QGLVTSRMSCSLYLVFDYMEHDLAGLAASPGIRFTEPQ-----VKCYMHQLLSGLEHCHN 228
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 300
VLHRDIKGSNLLID++G LKIADFGLAS FDPN+KHPMTSRVVTLWYRPPELLLGATD
Sbjct: 229 RRVLHRDIKGSNLLIDNEGTLKIADFGLASIFDPNNKHPMTSRVVTLWYRPPELLLGATD 288
Query: 301 YGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
YGVGVDLWSAGCIL ELLAGKPIMPGRTEV
Sbjct: 289 YGVGVDLWSAGCILGELLAGKPIMPGRTEV 318
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225451183|ref|XP_002273085.1| PREDICTED: probable serine/threonine-protein kinase At1g54610 [Vitis vinifera] gi|298204939|emb|CBI34246.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 258/338 (76%), Positives = 292/338 (86%), Gaps = 17/338 (5%)
Query: 1 MGCVFGREV-SSGIVSES-------KEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDES 52
MGCV GREV S+ +VSE+ KE + S +S+RK+ +V+ K+ VEV N E+
Sbjct: 1 MGCVLGREVLSNVVVSEANGAEKSIKEKRSNSSVNSNRKLDDVTKKS--DSKVEVGNGET 58
Query: 53 RKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIP 112
+K+E+ DG ++PRG++K+ +SNPRLSNLP H+RGEQVAAGWP WL+ V G ALNGWIP
Sbjct: 59 QKEEK--TDGSQRPRGDKKKLRSNPRLSNLPNHVRGEQVAAGWPSWLSDVAGPALNGWIP 116
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
RRAD+F+K+DKIGQGTYSNVYKA+DMLTGKIVALKKVRFDNLEPESVKFMAREI+ILRRL
Sbjct: 117 RRADTFQKLDKIGQGTYSNVYKARDMLTGKIVALKKVRFDNLEPESVKFMAREIVILRRL 176
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
DHPNV+KLEGLVTSR+SCSLYLVF YMEHDLAGLAASP +KFTEPQ VKCYM QLL
Sbjct: 177 DHPNVVKLEGLVTSRLSCSLYLVFEYMEHDLAGLAASPGIKFTEPQ-----VKCYMKQLL 231
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
SGLEHCHN GVLHRDIKGSNLL+D+ GVLKIADFGLA+ FDPN+KHPMTSRVVTLWYRPP
Sbjct: 232 SGLEHCHNRGVLHRDIKGSNLLLDNGGVLKIADFGLAAIFDPNYKHPMTSRVVTLWYRPP 291
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
ELLLGA DYGVGVDLWSAGCILAELLAGKPIMPGRTEV
Sbjct: 292 ELLLGANDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 329
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788188|emb|CAN73716.1| hypothetical protein VITISV_038843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1337), Expect = e-145, Method: Compositional matrix adjust.
Identities = 257/338 (76%), Positives = 292/338 (86%), Gaps = 17/338 (5%)
Query: 1 MGCVFGREV-SSGIVSES-------KEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDES 52
MGCV GREV S+ +VSE+ KE + S +S+RK+ +V+ K+ VEV N E+
Sbjct: 1 MGCVLGREVLSNVVVSEANGAEKSIKEKRSNSSVNSNRKLDDVTKKS--DSKVEVGNGET 58
Query: 53 RKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIP 112
+K+E+ DG ++PRG++K+ +SNP+LSNLP H+RGEQVAAGWP WL+ V G ALNGWIP
Sbjct: 59 QKEEK--TDGSQRPRGDKKKLRSNPKLSNLPNHVRGEQVAAGWPSWLSDVAGPALNGWIP 116
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
RRAD+F+K+DKIGQGTYSNVYKA+DMLTGKIVALKKVRFDNLEPESVKFMAREI+ILRRL
Sbjct: 117 RRADTFQKLDKIGQGTYSNVYKARDMLTGKIVALKKVRFDNLEPESVKFMAREIVILRRL 176
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
DHPNV+KLEGLVTSR+SCSLYLVF YMEHDLAGLAASP +KFTEPQ VKCYM QLL
Sbjct: 177 DHPNVVKLEGLVTSRLSCSLYLVFEYMEHDLAGLAASPGIKFTEPQ-----VKCYMKQLL 231
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
SGLEHCHN GVLHRDIKGSNLL+D+ GVLKIADFGLA+ FDPN+KHPMTSRVVTLWYRPP
Sbjct: 232 SGLEHCHNRGVLHRDIKGSNLLLDNGGVLKIADFGLAAIFDPNYKHPMTSRVVTLWYRPP 291
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
ELLLGA DYGVGVDLWSAGCILAELLAGKPIMPGRTEV
Sbjct: 292 ELLLGANDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 329
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576745|ref|XP_003556490.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1328), Expect = e-144, Method: Compositional matrix adjust.
Identities = 254/331 (76%), Positives = 282/331 (85%), Gaps = 7/331 (2%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV REVSSGIV E KE + SVES+ +KV VS ++ + VE QN E K+E
Sbjct: 1 MGCVISREVSSGIVYEVKEDKSSSVESN-KKVDQVSTGRVEENAVEAQNGEKEKEENGGG 59
Query: 61 DGE-KKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFE 119
D + ++ +GERKRSK NPRLSN KHL+GEQ+AAGWP WLTAVCGE L+GWIPR+AD+FE
Sbjct: 60 DDQVRRLKGERKRSKPNPRLSNPTKHLQGEQLAAGWPAWLTAVCGEVLSGWIPRKADTFE 119
Query: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
KIDKIGQGTYSNVYKAKD LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK
Sbjct: 120 KIDKIGQGTYSNVYKAKDTLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
LEGLVTSRMS SLYLVF YM HDLAGLAASP++KFTEPQ VKCYMHQLLSGLEHCH
Sbjct: 180 LEGLVTSRMSLSLYLVFDYMVHDLAGLAASPDIKFTEPQ-----VKCYMHQLLSGLEHCH 234
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 299
+ +LHRDIKGSNLLID++G+LKIADFGLASFFDPN + PMT+RVVTLWYRP ELLLGAT
Sbjct: 235 SQNILHRDIKGSNLLIDNEGILKIADFGLASFFDPNRRQPMTNRVVTLWYRPLELLLGAT 294
Query: 300 DYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+YG +DLWS GCIL ELLAGKPI+PGRTEV
Sbjct: 295 EYGAAIDLWSVGCILGELLAGKPILPGRTEV 325
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435738|ref|XP_004135651.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1282), Expect = e-138, Method: Compositional matrix adjust.
Identities = 247/334 (73%), Positives = 277/334 (82%), Gaps = 10/334 (2%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDE----SRKKE 56
MGC+ RE SS V + + + SR G + V+ + + V V +E ++++E
Sbjct: 1 MGCLVSREASSRSVEAPVDKGKRNQITESRVQGEI-VQEKEVERVSVNVEEHVNVNKEEE 59
Query: 57 EKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRAD 116
+K + +PR ER++S+ PR +NLP H +GEQVAAGWP WLTAVCGEALNGWIPR+AD
Sbjct: 60 QKADVVQDRPRAERRKSRKVPRPTNLPNHSQGEQVAAGWPSWLTAVCGEALNGWIPRKAD 119
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
+FEKIDKIGQGTYSNVYKAKD+LTGKIVALKKVRFDNLEPESVKFMAREILILRRL+H N
Sbjct: 120 TFEKIDKIGQGTYSNVYKAKDILTGKIVALKKVRFDNLEPESVKFMAREILILRRLNHNN 179
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
V+KLEGLVTSRMSCSLYLVF YMEHDLAGLAA+P +KFTE Q VKC+M QLLSGLE
Sbjct: 180 VVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAANPSIKFTESQ-----VKCFMQQLLSGLE 234
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
HCHN VLHRDIKGSNLLID GVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL
Sbjct: 235 HCHNRRVLHRDIKGSNLLIDSGGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 294
Query: 297 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
GATDYGVGVDLWSAGCILAELLAG+PIMPGRTEV
Sbjct: 295 GATDYGVGVDLWSAGCILAELLAGRPIMPGRTEV 328
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7671528|emb|CAB89490.1| CRK1 protein [Beta vulgaris subsp. vulgaris] gi|7688002|emb|CAB89665.1| CRK1 protein [Beta vulgaris subsp. vulgaris] | Back alignment and taxonomy information |
|---|
Score = 497 bits (1280), Expect = e-138, Method: Compositional matrix adjust.
Identities = 256/355 (72%), Positives = 286/355 (80%), Gaps = 32/355 (9%)
Query: 1 MGCVFGREV---SSGIVSESKEVSNFSVESSSRKVGNVSVKTI--------DGDVVEVQ- 48
MGCVFG+E +E N ES RKV ++ V + DG+ V+
Sbjct: 1 MGCVFGKESLAPEGRERGGRREKENLGTESG-RKV-DLPVADVVSGWDTGKDGENGGVEL 58
Query: 49 NDESRKKEEK--VVDGE-----------KKPRGERKRSKSNPRLSNLPKHLRGEQVAAGW 95
ND +K EEK DGE +KPRGER+R+K+NPRLSN PK++ GEQVAAGW
Sbjct: 59 NDGGKKDEEKNGEEDGEEKREGEGKGRSQKPRGERRRTKANPRLSNPPKNVHGEQVAAGW 118
Query: 96 PPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE 155
P WL+AV GEA++GW+PRRAD+FEKIDKIGQGTYSNVYKA+D LTGKIVALKKVRFDNLE
Sbjct: 119 PSWLSAVAGEAIDGWVPRRADTFEKIDKIGQGTYSNVYKARDSLTGKIVALKKVRFDNLE 178
Query: 156 PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT 215
PESVKFMAREILILRRLDHPNV+KLEGLVTSRMSCSLYLVF YMEHDLAGLAASP++KFT
Sbjct: 179 PESVKFMAREILILRRLDHPNVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLAASPDIKFT 238
Query: 216 EPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275
EPQ VKCYMHQL+SGLEHCHN GVLHRDIKGSNLL+D+ G+LKIADFGLA+FFDPN
Sbjct: 239 EPQ-----VKCYMHQLISGLEHCHNRGVLHRDIKGSNLLLDNGGILKIADFGLATFFDPN 293
Query: 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
KHPMTSRVVTLWYR PELLLGATDYGVG+DL SAGCILAELLAG+PIMPGRTEV
Sbjct: 294 KKHPMTSRVVTLWYRAPELLLGATDYGVGIDLRSAGCILAELLAGRPIMPGRTEV 348
|
Source: Beta vulgaris subsp. vulgaris Species: Beta vulgaris Genus: Beta Family: Amaranthaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357512159|ref|XP_003626368.1| Cdc2-like protein kinase [Medicago truncatula] gi|355501383|gb|AES82586.1| Cdc2-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 497 bits (1279), Expect = e-138, Method: Compositional matrix adjust.
Identities = 241/330 (73%), Positives = 274/330 (83%), Gaps = 16/330 (4%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKEEKVV 60
MGCV GR+ SS S + + + V+ +S + + +VVE++ND+ +K ++ V
Sbjct: 1 MGCVIGRQASSNKGSGA-QTNRIKVDEAS--AATTASNGEEKNVVEIENDQKKKSDDSV- 56
Query: 61 DGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEK 120
+RSK NPRLSN PKHLRGEQVAAGWP WLTAVCGEAL GWIPR+AD+FEK
Sbjct: 57 -------QRSRRSKPNPRLSNPPKHLRGEQVAAGWPSWLTAVCGEALTGWIPRKADTFEK 109
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IDKIGQGTYSNVYKA D +TGK+VALKKVRFDNLEPES+KFMAREI+ILRRLDHPNVIKL
Sbjct: 110 IDKIGQGTYSNVYKAIDSMTGKVVALKKVRFDNLEPESIKFMAREIIILRRLDHPNVIKL 169
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
+GLVTSRMSCSLYLVF YMEHDLAGLAASP ++FTE Q +KCYM+QLLSGLEHCHN
Sbjct: 170 QGLVTSRMSCSLYLVFDYMEHDLAGLAASPVIRFTESQ-----IKCYMNQLLSGLEHCHN 224
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 300
VLHRDIKGSNLLID++G+LKIADFGLASFFDPN+ +PMTSRVVTLWYRPPELLLGATD
Sbjct: 225 RRVLHRDIKGSNLLIDNEGILKIADFGLASFFDPNYMNPMTSRVVTLWYRPPELLLGATD 284
Query: 301 YGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
YGVG+DLWSAGCIL ELL GKPIMPGRTEV
Sbjct: 285 YGVGIDLWSAGCILGELLVGKPIMPGRTEV 314
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 348 | ||||||
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.931 | 0.565 | 0.728 | 1.4e-126 | |
| TAIR|locus:2096199 | 593 | AT3G05050 [Arabidopsis thalian | 0.931 | 0.546 | 0.672 | 1.8e-110 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.931 | 0.466 | 0.648 | 3.5e-107 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.666 | 0.4 | 0.789 | 4.9e-101 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.712 | 0.354 | 0.701 | 1e-98 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.729 | 0.358 | 0.681 | 2.2e-98 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.712 | 0.347 | 0.707 | 5.8e-98 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.709 | 0.402 | 0.714 | 5.8e-98 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.698 | 0.328 | 0.725 | 1.6e-95 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.744 | 0.402 | 0.680 | 6.1e-94 |
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1243 (442.6 bits), Expect = 1.4e-126, P = 1.4e-126
Identities = 241/331 (72%), Positives = 270/331 (81%)
Query: 1 MGCVFGREVSSGIVSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRXXXXXXX 60
MGCVFGRE ++ +E+K+ + S VG SV +G V+ ++ +
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSKASSGVVVVGESSVTKSNG-VIADDVEKKKNEEANGD 59
Query: 61 XXXXXPRGERKRS-KSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFE 119
+G+R+RS K NPRLSN KH RGEQVAAGWP WL+ CGEALNGW+PR+AD+FE
Sbjct: 60 KERKSSKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFE 119
Query: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL+LRRLDHPNV+K
Sbjct: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVK 179
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
LEGLVTSRMSCSLYLVF YM+HDLAGLA+SP VKF+E + VKC M QL+SGLEHCH
Sbjct: 180 LEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESE-----VKCLMRQLISGLEHCH 234
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 299
+ GVLHRDIKGSNLLIDD GVLKIADFGLA+ FDPNHK PMTSRVVTLWYR PELLLGAT
Sbjct: 235 SRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGAT 294
Query: 300 DYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
DYGVG+DLWSAGCILAELLAG+PIMPGRTEV
Sbjct: 295 DYGVGIDLWSAGCILAELLAGRPIMPGRTEV 325
|
|
| TAIR|locus:2096199 AT3G05050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1091 (389.1 bits), Expect = 1.8e-110, P = 1.8e-110
Identities = 228/339 (67%), Positives = 255/339 (75%)
Query: 2 GCVFGR--EVSSGIVSESKEVSNFSV---ESSSRKVGNVSVKTIDGDVV----EVQNDES 52
G V G EVS+ I S +V+N SV E++ V +G+ V +V + +
Sbjct: 12 GSVSGSRDEVSTRIESNRHQVNNVSVTKTETTESTSAVVVASASNGEEVRNHEDVVDQKK 71
Query: 53 RXXXXXXXXXXXXPRGERKRSKS-NPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWI 111
+GERKRSK +PR SN PK+L GEQVAAGWP WL+ VCGEAL+GW+
Sbjct: 72 ENGFVVTEAKERKSKGERKRSKPPDPRRSNPPKNLLGEQVAAGWPSWLSEVCGEALSGWL 131
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
PR+ADSFEKIDKIG GTYSNVYKAKD LTG IVALKKVR D E ES+KFMAREILILRR
Sbjct: 132 PRKADSFEKIDKIGSGTYSNVYKAKDSLTGNIVALKKVRCDVNERESLKFMAREILILRR 191
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
LDHPNVIKLEGLVTSRMS SLYLVF YM+HDLAGLAASPE+KFTE Q VKCYM QL
Sbjct: 192 LDHPNVIKLEGLVTSRMSSSLYLVFRYMDHDLAGLAASPEIKFTEQQ-----VKCYMKQL 246
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
LSGLEHCHN GVLHRDIKGSNLLIDD GVL+I DFGLA+FFD + + MT+RVVTLWYR
Sbjct: 247 LSGLEHCHNRGVLHRDIKGSNLLIDDGGVLRIGDFGLATFFDASKRQEMTNRVVTLWYRS 306
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
PELL G +Y VGVDLWSAGCILAELLAG+ IMPGR EV
Sbjct: 307 PELLHGVVEYSVGVDLWSAGCILAELLAGRAIMPGRNEV 345
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1060 (378.2 bits), Expect = 3.5e-107, P = 3.5e-107
Identities = 225/347 (64%), Positives = 252/347 (72%)
Query: 1 MGCVFGR----EVSSGIVSE---SKEVSNFSVE---SSSRKVGNVSVKTIDGDVVEVQ-- 48
MGCV G+ E S E SK S F V +SSR+ + +K DVV V+
Sbjct: 1 MGCVCGKPSAIEDSKDSPRERFSSKSSSEFRVSRPVASSRREEPLRIKE-RSDVVSVRPV 59
Query: 49 --NDESRXXXXXXXXXXXX--PRGERKRSKSNPRLS-NLPKHLRGEQVAAGWPPWLTAVC 103
N +S R E + S +S + K GE VAAGWPPWL +V
Sbjct: 60 LSNKQSNVSLHLRGENLSRREKRIENVAATSPLAMSITIAKATEGEYVAAGWPPWLASVA 119
Query: 104 GEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA 163
GEA+ GW+PRRADSFEK+DKIGQGTYSNVY+A+D+ KIVALKKVRFDNLEPESV+FMA
Sbjct: 120 GEAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 179
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK 223
REI ILRRLDHPN+IKLEGLVTSRMSCSLYLVF YMEHDLAGLA+ P +KF+E Q
Sbjct: 180 REIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAIKFSESQ----- 234
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 283
VKCY+ QLL GL+HCH+ GVLHRDIKGSNLLID+ GVLKIADFGLASFFDP P+TSR
Sbjct: 235 VKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQPLTSR 294
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
VVTLWYRPPELLLGAT YG VDLWSAGCILAEL AGKPIMPGRTEV
Sbjct: 295 VVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEV 341
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
Identities = 187/237 (78%), Positives = 211/237 (89%)
Query: 94 GWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN 153
GWPPWL A CG+++ PRRA ++EK++KIGQGTYSNVYKAKD+L+GKIVALKKVRFDN
Sbjct: 90 GWPPWLIAACGDSIKDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRFDN 149
Query: 154 LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK 213
LE ESVKFMAREIL+LRRL+HPNVIKL+GLVTSR+SCSLYLVF YMEHDL+GLAA+ +K
Sbjct: 150 LEAESVKFMAREILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGLK 209
Query: 214 FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273
F PQ VKC+M QLLSGLEHCH+ GVLHRDIKGSNLLID+DG+LKIADFGLA+F+D
Sbjct: 210 FDLPQ-----VKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 264
Query: 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
P K MTSRVVTLWYRPPELLLGAT YG GVDLWSAGCI+AELLAGKP+MPGRTEV
Sbjct: 265 PKQKQTMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEV 321
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 179/255 (70%), Positives = 219/255 (85%)
Query: 78 RLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKD 137
RL N+ ++L EQVAAGWP WL+ V GEA++GW+P R+D+FEK++KIGQGTYSNV++A +
Sbjct: 81 RLGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDAFEKLEKIGQGTYSNVFRAVE 140
Query: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197
TG+IVALKKVRFDN EPESVKFMAREILILRRL+HPN+IKLEGL+TS++SC++ LVF
Sbjct: 141 TETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNIIKLEGLITSKLSCNIQLVFE 200
Query: 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD 257
YMEHDL GL +SP++KFT PQ +KCYM QLLSGL+HCH+ GV+HRDIKGSNLL+ +
Sbjct: 201 YMEHDLTGLLSSPDIKFTTPQ-----IKCYMKQLLSGLDHCHSRGVMHRDIKGSNLLLSN 255
Query: 258 DGVLKIADFGLASFFDPN-HKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILA 315
+G+LK+ADFGLA+F + + HK P+TSRVVTLWYRPPELLLGATDYG VDLWS GC+ A
Sbjct: 256 EGILKVADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATDYGASVDLWSVGCVFA 315
Query: 316 ELLAGKPIMPGRTEV 330
ELL GKPI+ GRTEV
Sbjct: 316 ELLLGKPILRGRTEV 330
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 977 (349.0 bits), Expect = 2.2e-98, P = 2.2e-98
Identities = 178/261 (68%), Positives = 225/261 (86%)
Query: 72 RSKS-NPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYS 130
RS+S + RL NL K+L EQVAAGWP WL+ V GEA++GW+P R+D+FEK++KIGQGTYS
Sbjct: 84 RSESVSFRLGNLSKYLEAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAFEKLEKIGQGTYS 143
Query: 131 NVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190
+V++A++ TG+IVALKKVRFDN EPESV+FMAREILILR+L+HPN+IKLEG+VTS++SC
Sbjct: 144 SVFRARETETGRIVALKKVRFDNFEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSC 203
Query: 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKG 250
S++LVF YMEHDL GL +SP++ FT PQ +KCYM QLLSGL+HCH GV+HRDIKG
Sbjct: 204 SIHLVFEYMEHDLTGLLSSPDIDFTTPQ-----IKCYMKQLLSGLDHCHARGVMHRDIKG 258
Query: 251 SNLLIDDDGVLKIADFGLASFFDPN-HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWS 309
SNLL++++G+LK+ADFGLA+F + + +K P+TSRVVTLWYRPPELLLGAT+YG VDLWS
Sbjct: 259 SNLLVNNEGILKVADFGLANFCNASGNKQPLTSRVVTLWYRPPELLLGATEYGASVDLWS 318
Query: 310 AGCILAELLAGKPIMPGRTEV 330
GC+ AELL GKP++ GRTEV
Sbjct: 319 VGCVFAELLIGKPVLQGRTEV 339
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
Identities = 179/253 (70%), Positives = 215/253 (84%)
Query: 78 RLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKD 137
R+ ++ RG QV AGWP WL +V GEA+NGWIPR+ADSFEK++KIGQGTYS+VYKA+D
Sbjct: 123 RICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARD 182
Query: 138 MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197
+ T ++VALKKVRF N++P+SV+FMAREI+ILRRLDHPNV+KLEGL+TSR+S S+YL+F
Sbjct: 183 LETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFE 242
Query: 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD 257
YMEHDLAGLA++P + F+E Q +KCYM QLL GLEHCH+ GVLHRDIKGSNLL+D
Sbjct: 243 YMEHDLAGLASTPGINFSEAQ-----IKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDH 297
Query: 258 DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317
+ LKI DFGLA+F+ + K P+TSRVVTLWYRPPELLLG+TDYGV VDLWS GCILAEL
Sbjct: 298 NNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAEL 357
Query: 318 LAGKPIMPGRTEV 330
GKPIMPGRTEV
Sbjct: 358 FTGKPIMPGRTEV 370
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
Identities = 180/252 (71%), Positives = 214/252 (84%)
Query: 79 LSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDM 138
+SN+P+ E +AAGWP WLT+V GEA+ GW+PRRADSFEK+DKIGQGTYS VYKA+D+
Sbjct: 102 ISNVPRSAEAELIAAGWPYWLTSVAGEAIKGWVPRRADSFEKLDKIGQGTYSIVYKARDL 161
Query: 139 LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198
TGKIVA+KKVRF N++PESV+FMAREI ILR+LDHPNV+KL+ LVTS++S SL+LVF Y
Sbjct: 162 ETGKIVAMKKVRFANMDPESVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEY 221
Query: 199 MEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 258
MEHDL+GLA P VKFTEPQ +KC+M QLL GLEHCH+ G+LHRDIKGSNLL+++D
Sbjct: 222 MEHDLSGLALRPGVKFTEPQ-----IKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNND 276
Query: 259 GVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
GVLKI DFGLASF+ P+ P+TSRVVTLWYR PELLLG+T+YG +DLWS GCILAEL
Sbjct: 277 GVLKIGDFGLASFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELF 336
Query: 319 AGKPIMPGRTEV 330
KPIMPGRTEV
Sbjct: 337 VCKPIMPGRTEV 348
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 950 (339.5 bits), Expect = 1.6e-95, P = 1.6e-95
Identities = 180/248 (72%), Positives = 208/248 (83%)
Query: 83 PKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK 142
PK +QVAAGWP WL +V GE+L W PRRA++FEK++KIGQGTYS+VY+A+D+L K
Sbjct: 178 PKDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDLLHNK 237
Query: 143 IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202
IVALKKVRFD + ESVKFMAREI+++RRLDHPNV+KLEGL+T+ +S SLYLVF YM+HD
Sbjct: 238 IVALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMDHD 297
Query: 203 LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 262
L GL++ P VKFTEPQ VKCYM QLLSGLEHCH+ GVLHRDIKGSNLLID GVLK
Sbjct: 298 LLGLSSLPGVKFTEPQ-----VKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLK 352
Query: 263 IADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
IADFGLA+FFDP +TS VVTLWYRPPELLLGA+ YGVGVDLWS GCIL EL AGKP
Sbjct: 353 IADFGLATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKP 412
Query: 323 IMPGRTEV 330
I+PG+TEV
Sbjct: 413 ILPGKTEV 420
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
Identities = 181/266 (68%), Positives = 214/266 (80%)
Query: 66 PRGERKRSKSNPRLSNLPKHLRGE-QVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKI 124
P E KR S + P+ + E ++AAGWP WL +V GEAL W PRRA +FEK++KI
Sbjct: 85 PPEELKREPSVV-IPPSPETVSKEAELAAGWPAWLVSVAGEALVNWTPRRASTFEKLEKI 143
Query: 125 GQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLV 184
GQGTYS+VYKA+D+ KIVALK+VRFD + ESVKFMAREI+++RRLDHPNV+KLEGL+
Sbjct: 144 GQGTYSSVYKARDLTNNKIVALKRVRFDLSDLESVKFMAREIIVMRRLDHPNVLKLEGLI 203
Query: 185 TSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVL 244
T+ +S SLYLVF YM+HDL GLA+ P +KF+EPQ VKCYM QLLSGL HCH+ GVL
Sbjct: 204 TASVSSSLYLVFEYMDHDLVGLASIPGIKFSEPQ-----VKCYMQQLLSGLHHCHSRGVL 258
Query: 245 HRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVG 304
HRDIKGSNLLID +GVLKIADFGLA+FFDP + P+TSRVVTLWYRPPELLLGA YGVG
Sbjct: 259 HRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCVPLTSRVVTLWYRPPELLLGACHYGVG 318
Query: 305 VDLWSAGCILAELLAGKPIMPGRTEV 330
VDLWS GCIL EL +GKPI+ G+TEV
Sbjct: 319 VDLWSTGCILGELYSGKPILAGKTEV 344
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9ZVM9 | Y1461_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7439 | 0.9281 | 0.5646 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00031074001 | SubName- Full=Chromosome chr14 scaffold_54, whole genome shotgun sequence; (582 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 348 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-125 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-98 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-89 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-86 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-82 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-81 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-81 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-80 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-80 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-80 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-77 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-74 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-72 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-68 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-68 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-67 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-63 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-63 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-63 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-62 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-62 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-61 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-61 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-60 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-57 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-57 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-57 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-56 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-53 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-52 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-52 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-52 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-52 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-51 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-51 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-49 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-48 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-48 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-48 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-47 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-47 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-45 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-45 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-44 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-43 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-42 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-40 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-40 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-40 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-39 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-37 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-36 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-35 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-31 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-31 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-30 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-29 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-27 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-18 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-15 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-14 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 359 bits (925), Expect = e-125
Identities = 127/226 (56%), Positives = 165/226 (73%), Gaps = 10/226 (4%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+EKI +IG+GTY VYKA++ TG++VALKK+R +N + REI +L++L HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
++L+ +VTS+ S+Y+VF YM+HDL GL SPEVKFTE Q +KCYM QLL GL++
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ-----IKCYMKQLLEGLQY 115
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 297
H+NG+LHRDIKGSN+LI++DGVLK+ADFGLA + + T+RV+TLWYRPPELLLG
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 298 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
AT YG VD+WS GCILAEL GKPI G TE+ L IF+
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-----LEKIFE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 292 bits (750), Expect = 2e-98
Identities = 105/227 (46%), Positives = 141/227 (62%), Gaps = 15/227 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
+EK++K+G+GTY VYKA+D TG+IVALKK+R DN E E + A REI +L+ L HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPN 59
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
++KL ++ + LYLVF Y + DL + +K M+QLL GL
Sbjct: 60 IVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNL-----IKSIMYQLLRGLA 112
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+CH++ +LHRD+K N+LI+ DGVLK+ADFGLA F T VVTLWYR PE+LL
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILL 171
Query: 297 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
G+ Y VD+WS GCI AE++ GKP+ PG +E+ L IF
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-----LFKIFQ 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 270 bits (693), Expect = 1e-89
Identities = 107/229 (46%), Positives = 142/229 (62%), Gaps = 18/229 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMA-REILILRRLDH 174
+EK K+G+GTY+ VYKA+D TG+IVA+KK++ + + + F A REI +L+ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
PN+I L + + + + LVF +ME DL + + T +K YM L G
Sbjct: 62 PNIIGLLDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPAD-----IKSYMLMTLRG 114
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPPE 293
LE+ H+N +LHRD+K +NLLI DGVLK+ADFGLA F PN K MT +VVT WYR PE
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPE 172
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342
LL GA YGVGVD+WS GCI AELL P +PG +++ L IF
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-----QLGKIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 263 bits (673), Expect = 2e-86
Identities = 113/227 (49%), Positives = 152/227 (66%), Gaps = 13/227 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
FEK+++IG+GTY VY+A+D +G+IVALKKVR DN E + + + REI +L L HPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPN 67
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
+++L+ +V + S++LV Y E DLA L + F+E Q VKC M QLL GL+
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ-----VKCLMLQLLRGLQ 122
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ H N ++HRD+K SNLL+ D G LKIADFGLA + PMT +VVTLWYR PELLL
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPELLL 181
Query: 297 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
G T Y +D+W+ GCILAELLA KP++PG++E+ L+LI
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-----LDLIIQ 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 1e-82
Identities = 113/247 (45%), Positives = 145/247 (58%), Gaps = 21/247 (8%)
Query: 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA- 163
+ +EK+ KIGQGT+ V+KA+ T +IVALKKV +N E E A
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITAL 59
Query: 164 REILILRRLDHPNVIKL------EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEP 217
REI IL+ L H NV+ L + +R S YLVF + EHDLAGL ++ VKFT
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS 119
Query: 218 QFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-- 275
+ +K M LL+GL + H N +LHRD+K +N+LI DG+LK+ADFGLA F +
Sbjct: 120 E-----IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 276 -HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
+ T+RVVTLWYRPPELLLG DYG +D+W AGCI+AE+ PIM G TE
Sbjct: 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-- 232
Query: 335 CFVLNLI 341
L LI
Sbjct: 233 ---LTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 2e-81
Identities = 112/230 (48%), Positives = 145/230 (63%), Gaps = 15/230 (6%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
W R D F+ I +IG+GTY VYKA+D TG++VALKKVR DN E E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 169 LRRLDHPNVIKLEGLVTSRMSC--------SLYLVFHYMEHDLAGLAASPEVKFTEPQFV 220
LR+L+H N++ L+ +VT + + YLVF YM+HDL GL S V F+E
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-- 117
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
+K +M QLL GL +CH LHRDIK SN+L+++ G +K+ADFGLA ++ P
Sbjct: 118 ---IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
T++V+TLWYRPPELLLG YG +D+WS GCIL EL KPI E+
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 2e-81
Identities = 108/233 (46%), Positives = 149/233 (63%), Gaps = 15/233 (6%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRR 171
R D +EK+++I +GTY VY+A+D TG+IVALKK++ + E E + REI IL +
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLK 60
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
L HPN++ ++ +V +Y+V Y+EHDL L + + F + + VKC M QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE-----VKCLMLQL 115
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYR 290
LSG+ H H+N +LHRD+K SNLL+++ G+LKI DFGLA + P P T VVTLWYR
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP--LKPYTQLVVTLWYR 173
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
PELLLGA +Y +D+WS GCI AELL KP+ PG++E+ LN IF
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-----QLNKIFK 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 1e-80
Identities = 105/226 (46%), Positives = 141/226 (62%), Gaps = 13/226 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++K+ KIG+GTY VYKA+D LTG+IVA+KK++ K REI +L+ L+HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
IKL + + LYLVF +M+ DL L + E +K Y++QLL GL
Sbjct: 61 IKLLDVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESL-----IKSYLYQLLQGLAF 113
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 297
CH++G+LHRD+K NLLI+ +GVLK+ADFGLA F + P T VVT WYR PELLLG
Sbjct: 114 CHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLG 172
Query: 298 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
Y VD+WS GCI AELL+ +P+ PG++E+ L IF
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-----LFKIFR 213
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 2e-80
Identities = 110/245 (44%), Positives = 151/245 (61%), Gaps = 28/245 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+E + K+G+GT+ VYKA+ + TG++VALKK+ N E + A REI IL++L H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKH 66
Query: 175 PNVIKLEGLV------TSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYM 228
PNV+ L + + R S+Y+V YM+HDL+GL +P VK TE Q +KCYM
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ-----IKCYM 121
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD---PNHKHP------ 279
QLL G+ + H N +LHRDIK +N+LID+ G+LKIADFGLA +D PN K
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 280 -MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338
T+ VVT WYRPPELLLG Y VD+W GC+ AE+ +PI+ G++++ L
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-----L 236
Query: 339 NLIFD 343
+LIF
Sbjct: 237 HLIFK 241
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 5e-80
Identities = 98/228 (42%), Positives = 124/228 (54%), Gaps = 12/228 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ + +IG+G + V+KAKD TG+ VALKKV LE REI L+ HP V
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
+KL L LV YM DL+ + E E Q VK YM LL G+ +
Sbjct: 62 VKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQ-----VKSYMRMLLKGVAY 114
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 297
H NG++HRD+K +NLLI DGVLKIADFGLA F + +V T WYR PELL G
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 298 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPF 345
A Y GVDLW+ GCI AELL G P+ PG ++ L ++F
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-----LAIVFRTL 217
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 2e-77
Identities = 88/228 (38%), Positives = 134/228 (58%), Gaps = 13/228 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E ++K+G+G++ VY A+D TGK+VA+K ++ ++ + + + REI IL++L HPN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
++L + LYLV Y E DL L + +E + + Y+ Q+LS LE
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKK-RGRLSEDE-----ARFYLRQILSALE 111
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ H+ G++HRD+K N+L+D+DG +K+ADFGLA DP K +T+ V T Y PE+LL
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLL 169
Query: 297 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
G YG VD+WS G IL ELL GKP PG ++ F +
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF 216
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 3e-74
Identities = 105/222 (47%), Positives = 146/222 (65%), Gaps = 17/222 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
++K++KIG+GTY VYKA+D LTG+IVALKK+R + E E V A REI +L+ L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
+++L +V S LYLVF +++ DL + +SP P +K Y++QLL G+
Sbjct: 60 IVRLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPL-----IKSYLYQLLQGI 112
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM---TSRVVTLWYRPP 292
+CH++ VLHRD+K NLLID +G LK+ADFGLA F P+ T VVTLWYR P
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV----PVRTYTHEVVTLWYRAP 168
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
E+LLG+ Y VD+WS GCI AE++ +P+ PG +E+ F
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 224 bits (574), Expect = 3e-72
Identities = 90/224 (40%), Positives = 124/224 (55%), Gaps = 10/224 (4%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E + K+G G++ VYKAK TGKIVA+K ++ + + + + REI ILRRL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
++L LYLV Y E DL + +E + K Q+L GLE
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLSR-GGPLSEDE-----AKKIALQILRGLE 112
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ H+NG++HRD+K N+L+D++GV+KIADFGLA +T+ V T WY PE+LL
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLL 171
Query: 297 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340
G YG VD+WS G IL ELL GKP G + L
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL 215
|
Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 215 bits (548), Expect = 4e-68
Identities = 103/223 (46%), Positives = 142/223 (63%), Gaps = 17/223 (7%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F+K++KIG+GTY VYKA++ LTG++VALKK+R D E E V A REI +L+ L+HP
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++KL ++ + LYLVF ++ DL + ASP P +K Y+ QLL G
Sbjct: 60 NIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASPLSGIPLPL-----IKSYLFQLLQG 112
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM---TSRVVTLWYRP 291
L CH++ VLHRD+K NLLI+ +G +K+ADFGLA F P+ T VVTLWYR
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----PVRTYTHEVVTLWYRA 168
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
PE+LLG Y VD+WS GCI AE++ + + PG +E+ F
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 215 bits (551), Expect = 6e-68
Identities = 93/233 (39%), Positives = 130/233 (55%), Gaps = 20/233 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLDHP 175
+E + IG G Y V A D TG+ VA+KK+ FD+L K + REI +LR L H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI--DAKRILREIKLLRHLRHE 59
Query: 176 NVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
N+I L ++ +Y+V ME DL + SP+ T+ Y ++Q+L
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYF-----LYQIL 113
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTSRVVTLWYR 290
GL++ H+ V+HRD+K SN+L++ + LKI DFGLA DP+ +T VVT WYR
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
PELLL ++ Y +D+WS GCI AELL KP+ PGR + LNLI +
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-----LNLIVE 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 1e-67
Identities = 97/237 (40%), Positives = 138/237 (58%), Gaps = 28/237 (11%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRLD- 173
+E++ +IG+G Y VYKA+D+ TG+ VALKKVR E P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 174 --HPNVIKL----EGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKC 226
HPN+++L G T R L LVF +++ DLA L+ P+ +K
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPE-----TIKD 111
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
M QLL G++ H++ ++HRD+K N+L+ DG +KIADFGLA + +TS VVT
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVT 169
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
LWYR PE+LL ++ Y VD+WS GCI AEL +P+ G +E L+ IFD
Sbjct: 170 LWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-----LDKIFD 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-63
Identities = 87/216 (40%), Positives = 128/216 (59%), Gaps = 9/216 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +E + +G+G Y V K ++ TG+IVA+KK + + + K RE+ +LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++ L R LYLVF Y+E L L ASP P V+ Y+ QLL
Sbjct: 61 NIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASP--GGLPPD----AVRSYIWQLLQA 112
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
+ +CH++ ++HRDIK N+L+ + GVLK+ DFG A P+T V T WYR PEL
Sbjct: 113 IAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
L+G T+YG VD+W+ GCI+AELL G+P+ PG +++
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 2e-63
Identities = 99/212 (46%), Positives = 133/212 (62%), Gaps = 11/212 (5%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+EK++KIG+GTY V+KAK+ T +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N+++L ++ S L LVF Y + DL S VK +M QLL GL
Sbjct: 60 NIVRLYDVLHSDKK--LTLVFEYCDQDLKKYFDSCNGDIDPEI-----VKSFMFQLLKGL 112
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
CH++ VLHRD+K NLLI+ +G LK+ADFGLA F + ++ VVTLWYRPP++L
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVL 171
Query: 296 LGATDYGVGVDLWSAGCILAELL-AGKPIMPG 326
GA Y +D+WSAGCI AEL AG+P+ PG
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 5e-63
Identities = 97/220 (44%), Positives = 141/220 (64%), Gaps = 12/220 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
+ KI+KIG+GTY VYK ++ TG+IVA+KK+R ++ E E V A REI +L+ L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPN 60
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
++ L+ ++ LYL+F ++ DL L + P+ ++ + + V K Y++Q+L G+
Sbjct: 61 IVCLQDVLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELV----KSYLYQILQGI 114
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPEL 294
CH+ VLHRD+K NLLID+ GV+K+ADFGLA +F P + T VVTLWYR PE+
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY--THEVVTLWYRAPEV 172
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
LLG+ Y VD+WS G I AE+ KP+ G +E+ F
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-62
Identities = 92/225 (40%), Positives = 127/225 (56%), Gaps = 18/225 (8%)
Query: 118 FEKIDKIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+E IG+GTY VYKA K+ GK A+KK + D + + A REI +LR L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF-TEPQFVYLK---VKCYMHQ 230
NV+ L + S+YL+F Y EHDL + +KF + + V + VK + Q
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQI-----IKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSR--V 284
+L+G+ + H+N VLHRD+K +N+L+ + GV+KI D GLA F+ K V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
VT+WYR PELLLGA Y +D+W+ GCI AELL +PI GR
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 8e-62
Identities = 92/230 (40%), Positives = 138/230 (60%), Gaps = 18/230 (7%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMAREILILRRLDH 174
+F++++K+G+GTY+ VYK ++ TG+IVALK++ D E P + REI +++ L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKH 57
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N+++L ++ + L LVF YM+ DL + V+ VK + +QLL G
Sbjct: 58 ENIVRLHDVIHTE--NKLMLVFEYMDKDLKKYMDTHGVRGALDP---NTVKSFTYQLLKG 112
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPE 293
+ CH N VLHRD+K NLLI+ G LK+ADFGLA +F P + ++ VVTLWYR P+
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPD 170
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
+LLG+ Y +D+WS GCI+AE++ G+P+ PG L IF
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-----LLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 3e-61
Identities = 99/222 (44%), Positives = 137/222 (61%), Gaps = 11/222 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
D++EK++KIG+GTY VYKA+D TGK+VALKK R + ++ E + A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 175 -PNVIKL---EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
+++L E + SLYLVF Y++ DL S P +K +M+Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKT-IKSFMYQ 118
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASFFD-PNHKHPMTSRVVTLW 288
LL G+ HCH +GV+HRD+K NLL+D G+LKIAD GL F P + T +VTLW
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLW 176
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
YR PE+LLG+T Y VD+WS GCI AE+ +P+ PG +E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 7e-61
Identities = 92/236 (38%), Positives = 146/236 (61%), Gaps = 27/236 (11%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRL 172
+ ++++K+DK+G+G+Y+ VYK + LTG++VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDL 60
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTE--PQFVYLK-VKCYMH 229
H N++ L ++ ++ + L LVF Y++ DL ++ + + + V+ ++
Sbjct: 61 KHANIVTLHDIIHTKKT--LTLVFEYLDTDLK--------QYMDDCGGGLSMHNVRLFLF 110
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA---SFFDPNHKHPMTSRVVT 286
QLL GL +CH VLHRD+K NLLI + G LK+ADFGLA S P+ + ++ VVT
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--PSKTY--SNEVVT 166
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342
LWYRPP++LLG+T+Y +D+W GCI E+ G+P+ PG T+V L+ IF
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ----LHKIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 3e-60
Identities = 100/222 (45%), Positives = 144/222 (64%), Gaps = 12/222 (5%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
D +EK++KIG+GTY VYKA+D +T + +ALKK+R + E E V A REI +L+ + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLS 233
N+++L+ +V S LYLVF Y++ DL + +SP+ F + + +K Y++Q+L
Sbjct: 61 GNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPD--FAKNPRL---IKTYLYQILR 113
Query: 234 GLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
G+ +CH++ VLHRD+K NLLID LK+ADFGLA F + T VVTLWYR P
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAP 172
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
E+LLG+ Y VD+WS GCI AE++ KP+ PG +E+ F
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 4e-59
Identities = 92/239 (38%), Positives = 126/239 (52%), Gaps = 34/239 (14%)
Query: 118 FEKIDK-IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-----------FMA-R 164
+ + +G+GTY V KA D LTGKIVA+KKV+ + + K F R
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV 224
E+ I+ + H N++ L + + LV M DL + +++ TE Q V
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDF--INLVMDIMASDLKKVVDR-KIRLTESQ-----V 121
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS------FFDPNHKH 278
KC + Q+L+GL H +HRD+ +N+ I+ G+ KIADFGLA + D K
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 279 P-------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
MTS+VVTLWYR PELL+GA Y VD+WS GCI AELL GKP+ PG E+
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 1e-57
Identities = 76/196 (38%), Positives = 114/196 (58%), Gaps = 11/196 (5%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G+G + VY A+D TGK VA+K ++ ++ + + REI IL++L+HPN++KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 184 VTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG 242
LYLV Y E L L E K +E + + + Q+L GLE+ H+NG
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDE-----ILRILLQILEGLEYLHSNG 112
Query: 243 VLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 301
++HRD+K N+L+D D+G +K+ADFGL+ + K + + V T Y PE+LLG Y
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 302 GVGVDLWSAGCILAEL 317
D+WS G IL EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 4e-57
Identities = 94/223 (42%), Positives = 133/223 (59%), Gaps = 28/223 (12%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD---NLEPESVKFMAREILILRRL-D 173
+E + K+G+G Y V+KA D T ++VALKK+ FD N F REI+ L+ L D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGD 65
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDL-----AGLAASPEVKFTEPQFVYLKVKCYM 228
HPN++KL ++ + +YLVF YME DL A + ++ M
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYI------------M 113
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA---SFFDPNHKHP-MTSRV 284
+QLL L++ H+ V+HRD+K SN+L++ D +K+ADFGLA S + N ++P +T V
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327
T WYR PE+LLG+T Y GVD+WS GCIL E+L GKP+ PG
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 4e-57
Identities = 88/217 (40%), Positives = 134/217 (61%), Gaps = 16/217 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV--RFDNLEPESVKFMAREILILRRL-DH 174
++ I ++G GT+ +VY A++ TG++VA+KK+ +F + E E + RE+ LR+L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK-FTEPQFVYLKVKCYMHQLLS 233
PN++KL+ + R + LY VF YME +L L + K F+E ++ ++Q+L
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESV-----IRSIIYQILQ 110
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
GL H H +G HRD+K NLL+ V+KIADFGLA + + P T V T WYR PE
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPE 168
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+LL +T Y VD+W+ GCI+AEL +P+ PG +E+
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI 205
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 7e-56
Identities = 90/213 (42%), Positives = 122/213 (57%), Gaps = 14/213 (6%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALK--KVRFDNLEPESVKFMAREILILRRL-DHPNV 177
+ KIG+GT+S V KA+ TGK A+K K F +LE + REI LRRL HPN+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
++L ++ R + L LVF M+ +L L + E +VK YM+QLL L+H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPE-----KRVKSYMYQLLKSLDH 115
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 297
H NG+ HRDIK N+LI DD +LK+ADFG S K P T + T WYR PE LL
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFG--SCRGIYSKPPYTEYISTRWYRAPECLLT 172
Query: 298 ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
YG +D+W+ GC+ E+L+ P+ PG E+
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL 205
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-54
Identities = 85/223 (38%), Positives = 123/223 (55%), Gaps = 15/223 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV--RFDNLEPESVKFMAREILILRRLD 173
++ I+ IG G Y V A D +GK VA+KK+ FD P K RE+ ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFK 62
Query: 174 HPNVIKLEGLVTSRMS--CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
H N+I + ++ + +Y+V ME DL + S + TE Y +++QL
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRY-----FLYQL 116
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---HKHPMTSRVVTLW 288
L GL++ H+ V+HRD+K SNLL+++D L+I DFG+A + HK+ MT V T W
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331
YR PELLL +Y +D+WS GCI AE+L + + PG+ V
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-53
Identities = 72/211 (34%), Positives = 116/211 (54%), Gaps = 15/211 (7%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
+ + + +G+G++ +VY A D TG+++A+K V E ++ + REI IL L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH----DLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
+++ G +L + ++E+ L+ L K EP ++ Y Q+L
Sbjct: 61 IVRYYGSERDEEKNTLNI---FLEYVSGGSLSSLLKK-FGKLPEPV-----IRKYTRQIL 111
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRP 291
GL + H+NG++HRDIKG+N+L+D DGV+K+ADFG A T V T ++
Sbjct: 112 EGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE++ G +YG D+WS GC + E+ GKP
Sbjct: 172 PEVIRG-EEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-52
Identities = 91/234 (38%), Positives = 141/234 (60%), Gaps = 16/234 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ +++ K+DK+G+GTY+ VYK + LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEP--QFVYL-KVKCYMHQ 230
H N++ L ++ + S L LVF Y++ DL ++ + + + VK ++ Q
Sbjct: 63 HANIVTLHDIIHTEKS--LTLVFEYLDKDLK--------QYLDDCGNSINMHNVKLFLFQ 112
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
LL GL +CH VLHRD+K NLLI++ G LK+ADFGLA K ++ VVTLWYR
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVTLWYR 171
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
PP++LLG+TDY +D+W GCI E+ G+P+ PG T V F+ ++ P
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST-VEEQLHFIFRILGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 5e-52
Identities = 84/216 (38%), Positives = 122/216 (56%), Gaps = 10/216 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +EK+ KIG+G+Y V+K ++ TG+IVA+KK +P K REI +L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++ L + R L+LVF Y +H L L +P E +K + Q L
Sbjct: 61 NLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPE-----HLIKKIIWQTLQA 112
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
+ CH + +HRD+K N+LI G +K+ DFG A T V T WYR PEL
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPEL 171
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
L+G T YG VD+W+ GC+ AELL G+P+ PG+++V
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 5e-52
Identities = 90/226 (39%), Positives = 133/226 (58%), Gaps = 31/226 (13%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ +++ K+DK+G+GTY+ V+K + LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 174 HPNVIKLEGLV-TSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYL---------- 222
H N++ L ++ T R L LVF Y++ DL YL
Sbjct: 62 HANIVTLHDIIHTER---CLTLVFEYLDSDLKQ---------------YLDNCGNLMSMH 103
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
VK +M QLL GL +CH +LHRD+K NLLI++ G LK+ADFGLA K ++
Sbjct: 104 NVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSN 162
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328
VVTLWYRPP++LLG+T+Y +D+W GCIL E+ G+P+ PG T
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 7e-52
Identities = 88/239 (36%), Positives = 123/239 (51%), Gaps = 28/239 (11%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA----REILILR 170
++ + IG+G Y V A TG VA+KK+ P + REI ILR
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-----SPFEHQTFCQRTLREIKILR 58
Query: 171 RLDHPNVIKLEGLVTSRMSCSL---YLVFHYMEHDLAGLAASPEVKFTEPQ-FVYLKVKC 226
R H N+I + ++ S Y+V ME DL L + + Q F+Y
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY----- 113
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTSRV 284
Q+L GL++ H+ VLHRD+K SNLL++ + LKI DFGLA DP H H +T V
Sbjct: 114 ---QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
T WYR PE++L + Y +D+WS GCILAE+L+ +P+ PG+ + LNLI
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-----LNLILG 224
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-51
Identities = 87/209 (41%), Positives = 123/209 (58%), Gaps = 14/209 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLDHPNVIKLE 181
IG+G Y V AK+ T + VA+KK+ FDN K REI +LR LDH NVI ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI--DAKRTLREIKLLRHLDHENVIAIK 70
Query: 182 GLV--TSRMSCS-LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238
++ R + + +Y+V+ M+ DL + S + ++ Y +++QLL GL++
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQY-----FLYQLLRGLKYI 124
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 298
H+ VLHRD+K SNLL++ + LKI DFGLA MT VVT WYR PELLL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNC 183
Query: 299 TDYGVGVDLWSAGCILAELLAGKPIMPGR 327
++Y +D+WS GCI AELL KP+ PG+
Sbjct: 184 SEYTTAIDVWSVGCIFAELLGRKPLFPGK 212
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 8e-51
Identities = 88/221 (39%), Positives = 129/221 (58%), Gaps = 13/221 (5%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G G + V A+D LTG+ VA+KK+ P K RE+ +L+ L H N+I L +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 184 VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGV 243
S + +Y V + DL L S + E QF+ + +++Q+L GL++ H+ GV
Sbjct: 78 FISPLE-DIYFVTELLGTDLHRLLTSRPL---EKQFI----QYFLYQILRGLKYVHSAGV 129
Query: 244 LHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGV 303
+HRD+K SN+LI+++ LKI DFGLA DP MT V T +YR PE++L Y V
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 304 GVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
VD+WSAGCI AE+L GKP+ PG+ V+ F + +L+ P
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTP 225
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 166 bits (420), Expect = 6e-49
Identities = 91/220 (41%), Positives = 135/220 (61%), Gaps = 15/220 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRL 172
+ADS+EK++K+G+G+Y+ VYK K + GK+VALK +R E E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGL 60
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYL-KVKCYMHQL 231
H N++ L ++ ++ + L LVF Y+ DL + P ++ VK ++ QL
Sbjct: 61 KHANIVLLHDIIHTKET--LTLVFEYVHTDLC------QYMDKHPGGLHPENVKLFLFQL 112
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD-PNHKHPMTSRVVTLWYR 290
L GL + H +LHRD+K NLLI D G LK+ADFGLA P+H + ++ VVTLWYR
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY--SNEVVTLWYR 170
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
PP++LLG+T+Y +D+W GCI E++ G PG ++
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 1e-48
Identities = 91/219 (41%), Positives = 131/219 (59%), Gaps = 15/219 (6%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLD 173
A S+ ++K+G+G+Y+ VYK + G++VALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVY-LKVKCYMHQLL 232
H N++ L ++ ++ + L VF YM DLA P ++ V+ +M QLL
Sbjct: 62 HANIVLLHDIIHTKET--LTFVFEYMHTDLAQYMIQ------HPGGLHPYNVRLFMFQLL 113
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRP 291
GL + H +LHRD+K NLLI G LK+ADFGLA + P+ + +S VVTLWYRP
Sbjct: 114 RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY--SSEVVTLWYRP 171
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
P++LLGATDY +D+W AGCI E+L G+P PG ++V
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 1e-48
Identities = 84/215 (39%), Positives = 133/215 (61%), Gaps = 9/215 (4%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ +++ K++K+G+GTY+ V+K + LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
H N++ L +V + S L LVF Y++ DL + VK +++Q+L
Sbjct: 63 HANIVTLHDIVHTDKS--LTLVFEYLDKDLKQYMDDCGNIMS-----MHNVKIFLYQILR 115
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
GL +CH VLHRD+K NLLI++ G LK+ADFGLA K ++ VVTLWYRPP+
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPD 174
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328
+LLG+++Y +D+W GCI E+ +G+P+ PG T
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 2e-48
Identities = 90/235 (38%), Positives = 131/235 (55%), Gaps = 29/235 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G G+ V+ A D K VA+KK+ +P+SVK REI I+RRLDH N++K+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 184 VTSRMS------------CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
+ S S+Y+V YME DLA + + + +M+QL
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANV-------LEQGPLSEEHARLFMYQL 123
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPN--HKHPMTSRVVTLW 288
L GL++ H+ VLHRD+K +N+ I+ +D VLKI DFGLA DP+ HK ++ +VT W
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
YR P LLL +Y +D+W+AGCI AE+L GKP+ G E+ + LI +
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-----MQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-48
Identities = 80/215 (37%), Positives = 130/215 (60%), Gaps = 12/215 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPN 176
+E + +G+G+Y V K K TG+IVA+KK ++ + + VK +A REI +L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
++ L + R LYLVF +++H + +++ +V+ Y+ Q+L G+E
Sbjct: 62 LVNL--IEVFRRKKRLYLVFEFVDHTVLD-----DLEKYPNGLDESRVRKYLFQILRGIE 114
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD-PNHKHPMTSRVVTLWYRPPELL 295
CH++ ++HRDIK N+L+ GV+K+ DFG A P + T V T WYR PELL
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELL 172
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+G T YG VD+W+ GC++ E+L G+P+ PG +++
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-47
Identities = 77/223 (34%), Positives = 125/223 (56%), Gaps = 15/223 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ D IG+G + VYK ++ TG VA+K++ + ++ E++K + +EI +L+ L HPN+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
+K G + + S SLY++ Y E+ L + F E V Y++Q+L GL
Sbjct: 62 VKYIGSIET--SDSLYIILEYAENGSLRQII-KKFGPFPESL-----VAVYVYQVLQGLA 113
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ H GV+HRDIK +N+L DGV+K+ADFG+A+ + K + V T ++ PE++
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIE 172
Query: 297 --GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337
GA+ D+WS GC + ELL G P ++A F V
Sbjct: 173 MSGAS---TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-47
Identities = 91/234 (38%), Positives = 128/234 (54%), Gaps = 16/234 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL---DH 174
+E + +IG G Y VYKA+D +G VALK VR E RE+ +L+RL DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 175 PNVIKLEGL-VTSRM--SCSLYLVFHYMEHDL-AGLAASPEVKFTEPQFVYLKVKCYMHQ 230
PN+++L + TSR + LVF +++ DL L P P +K M Q
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPP-----PGLPAETIKDLMRQ 116
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
L GL+ H N ++HRD+K N+L+ G +K+ADFGLA + + + +T VVTLWYR
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYR 174
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
PE+LL +T Y VD+WS GCI AE+ KP+ G +E + +LI P
Sbjct: 175 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-46
Identities = 83/218 (38%), Positives = 119/218 (54%), Gaps = 19/218 (8%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLD 173
D ++ + +G G Y V A D TG+ VA+KK+ F + K RE+ +L+ +D
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMD 72
Query: 174 HPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
H NVI L + T S +YLV H M DL + K ++ +L ++
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFL-----VY 125
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 289
Q+L GL++ H+ G++HRD+K SN+ +++D LKI DFGLA D MT V T WY
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWY 181
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327
R PE++L Y VD+WS GCI+AELL GK + PG
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 9e-46
Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 13/206 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
FE ++KIG+G + VYKA+ TGK VA+K ++ + E + + EI IL++ HPN+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
+K G + L++V + L L S TE Q + +LL GLE
Sbjct: 60 VKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLE 112
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ H+NG++HRDIK +N+L+ DG +K+ DFGL++ + + V T ++ PE++
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVIN 170
Query: 297 GATDYGVGVDLWSAGCILAELLAGKP 322
G Y D+WS G EL GKP
Sbjct: 171 G-KPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E I +IG+G++ VY + GK+ LK++ N+ + + E+ IL++L+HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 178 IKL-EGLVTSRMSCSLYLVFHYMEH----DLAGL---AASPEVKFTEPQFVYLKVKCYMH 229
IK E L +V ME+ DL+ F E Q + +
Sbjct: 62 IKYYESFEE---KGKLCIV---MEYADGGDLSQKIKKQKKEGKPFPEEQILD-----WFV 110
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLW 288
QL L++ H+ +LHRDIK N+ + +G++K+ DFG++ + + VV T +
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPY 168
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
Y PEL Y D+WS GC+L EL K
Sbjct: 169 YLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 7e-45
Identities = 91/226 (40%), Positives = 123/226 (54%), Gaps = 22/226 (9%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+ FE + +G+G Y V K + T +IVA+KK + D+ E E VK RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL------AASPEVKFTEPQFVYLKVKCYM 228
N+++L+ R LYLVF Y+E ++ L PE KV+ Y+
Sbjct: 60 ENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPE-----------KVRSYI 106
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
+QL+ + CH N ++HRDIK NLLI + VLK+ DFG A T V T W
Sbjct: 107 YQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW 166
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
YR PELLLGA YG VD+WS GCIL EL G+P+ PG +E+ F
Sbjct: 167 YRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 7e-44
Identities = 87/231 (37%), Positives = 127/231 (54%), Gaps = 18/231 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLDHP 175
E IG G + V+ D GK VALKK+ F NL S K + RE+ +L H
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHD 59
Query: 176 NVIK-LEGLVTSRMSC--SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
NV+ L+ L + +Y+V M+ DL + SP+ ++ VK +++Q+L
Sbjct: 60 NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD------HVKVFLYQIL 113
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
GL++ H+ G+LHRDIK NLL++ + VLKI DFGLA +P+ MT VVT +YR P
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
E+L+G+ Y VD+WS GCI AELL + + ++ + L+LI D
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-----LDLITD 219
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-43
Identities = 87/235 (37%), Positives = 117/235 (49%), Gaps = 23/235 (9%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLT--GKIVALKKVR--FDNLEPESVKFMAREILILRRL- 172
+E I ++GQG Y V A++ T + VA+KK+ F K RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFR 59
Query: 173 DHPNVIKLEGL--VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
H N+ L + V LYL ME DL + S T+ F +++Q
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQS-----FIYQ 113
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP---MTSRVVTL 287
+L GL++ H+ VLHRD+K NLL++ D LKI DFGLA F N MT V T
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342
WYR PE++L Y +D+WS GCILAELL KP+ G+ V LN I
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ-----LNQIL 223
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 5e-43
Identities = 93/233 (39%), Positives = 132/233 (56%), Gaps = 19/233 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLEPESVKFMAREILILRRLD--- 173
+E + +IG+G Y V+KA+D+ G + VALK+VR E RE+ +LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 174 HPNVIKLEGLVT-SRM--SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
HPNV++L + T SR L LVF +++ DL K EP +K M Q
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD----KVPEPGVPTETIKDMMFQ 118
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
LL GL+ H++ V+HRD+K N+L+ G +K+ADFGLA + + + +TS VVTLWYR
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYR 176
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V L I D
Sbjct: 177 APEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-----LGKILD 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 6e-42
Identities = 77/228 (33%), Positives = 112/228 (49%), Gaps = 17/228 (7%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHP 175
S+ + K+G+G++ VY A+D K+VALK + + + V+ REI IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 176 -NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++KL SLYLV Y++ L + + + + Q+LS
Sbjct: 58 PNIVKLYDFFQD--EGSLYLVMEYVDGGS--LEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 235 LEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPN-----HKHPMTSRVVTLW 288
LE+ H+ G++HRDIK N+L+D D V+K+ DFGLA ++ V T
Sbjct: 114 LEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 289 YRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
Y PE+LLG + D+WS G L ELL G P G SAT
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS 221
|
Length = 384 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 84/221 (38%), Positives = 122/221 (55%), Gaps = 19/221 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+P R + + ++G G Y +V A D TG+ VA+KK+ K RE+ +L+
Sbjct: 13 LPER---YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK 69
Query: 171 RLDHPNVIKLEGLVTSRMSC----SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKC 226
+ H NVI L + TS +S YLV YM+ DL + P +E + YL
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYL---- 122
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
++Q+L GL++ H+ G++HRD+K NL +++D LKI DFGLA D MT VVT
Sbjct: 123 -VYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVT 177
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327
WYR PE++L Y VD+WS GCI+AE+L GK + G+
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 3e-40
Identities = 88/219 (40%), Positives = 121/219 (55%), Gaps = 17/219 (7%)
Query: 123 KIGQGTYSNVYKAK--DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
K+G+GTY +VYKAK D + ALK++ + + REI +LR L HPNVI L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISL 63
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK---VKCYMHQLLSGLEH 237
+ + S ++L+F Y EHDL + + V L VK ++Q+L G+ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 238 CHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYR 290
H N VLHRD+K +N+L+ + G +KIAD G A F+ K P+ VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVVTFWYR 182
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
PELLLGA Y +D+W+ GCI AELL +PI R E
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-40
Identities = 72/208 (34%), Positives = 118/208 (56%), Gaps = 16/208 (7%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+KIG GT+ VY A ++ TG+++A+K++R + +P+++K +A E+ +L L HPN++K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
G+ R V+ +ME+ G L E + V ++ Y QLL GL + H+
Sbjct: 66 GVEVHREK-----VYIFMEYCSGGTLEELLEHGRILDEHV---IRVYTLQLLEGLAYLHS 117
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL----WYRPPELLL 296
+G++HRDIK +N+ +D +GV+K+ DFG A N+ M V +L Y PE++
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 297 GATDYGVG--VDLWSAGCILAELLAGKP 322
G G G D+WS GC++ E+ GK
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 82/217 (37%), Positives = 126/217 (58%), Gaps = 20/217 (9%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLDHPNVIKLE 181
IG+G+Y V A D TG+ VA+KK+ F+++ ++ + + REI +LR L HP++++++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHPDIVEIK 65
Query: 182 GLV---TSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
++ + R +Y+VF ME DL + A+ ++ QF +++QLL L++
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF-------FLYQLLRALKY 118
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA--SFFDPNHKHPMTSRVVTLWYRPPELL 295
H V HRD+K N+L + D LKI DFGLA +F D T V T WYR PE L
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 177
Query: 296 LGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
G+ + Y +D+WS GCI AE+L GKP+ PG+ V
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-40
Identities = 74/208 (35%), Positives = 110/208 (52%), Gaps = 17/208 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ ++KIG+G VYKA D TGK VA+KK+R E + EILI++ HPN+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNI 77
Query: 178 IKLEG--LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
+ LV L++V YM+ L + V+ EPQ Y+ ++L G
Sbjct: 78 VDYYDSYLV---GDE-LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-----CREVLQG 128
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
LE+ H+ V+HRDIK N+L+ DG +K+ADFG A+ S V T ++ PE+
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSVVGTPYWMAPEV 187
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKP 322
+ DYG VD+WS G + E+ G+P
Sbjct: 188 IKR-KDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 9e-40
Identities = 77/233 (33%), Positives = 111/233 (47%), Gaps = 39/233 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV--RFDNLEPESVKFMAREILILRRLD 173
D F+ IG+G++S V AK+ T K A+K + R E + VK++ E +L RL+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLN 59
Query: 174 -HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC---YM 228
HP +IKL T + +LY V Y + +L ++ + L KC Y
Sbjct: 60 GHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQY-----IRK----YGSLDEKCTRFYA 108
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK----------- 277
++L LE+ H+ G++HRD+K N+L+D D +KI DFG A DPN
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 278 ----HPMTSR----VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
R V T Y PELL G DLW+ GCI+ ++L GKP
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 88/219 (40%), Positives = 121/219 (55%), Gaps = 17/219 (7%)
Query: 123 KIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
K+G+GTY +VYKA KD K ALK++ + + REI +LR L HPNVI L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIAL 63
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAA---SPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
+ + S ++L+F Y EHDL + + + Q VK ++Q+L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 238 CHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYR 290
H N VLHRD+K +N+L+ + G +KIAD G A F+ K P+ VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVVTFWYR 182
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
PELLLGA Y +D+W+ GCI AELL +PI R E
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 3e-38
Identities = 82/226 (36%), Positives = 119/226 (52%), Gaps = 15/226 (6%)
Query: 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR 164
+ LN I + ++ + +G G Y +V A D TG VA+KK+ K R
Sbjct: 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFV 220
E+ +L+ + H NVI L + T S +YLV H M DL + ++ QF+
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
++Q+L GL++ H+ ++HRD+K SNL +++D LKI DFGLA D M
Sbjct: 126 -------IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----M 174
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326
T V T WYR PE++L Y VD+WS GCI+AELL G+ + PG
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 9e-38
Identities = 74/208 (35%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
E++ +GQG+ VYK + TGKI ALKK+ D + E K + RE+ LR + P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
V+K G + +V YM+ LA L K EP Y+ Q+L G
Sbjct: 60 YVVKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYI-----ARQILKG 111
Query: 235 LEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
L++ H ++HRDIK SNLLI+ G +KIADFG++ + T V T+ Y PE
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPE 170
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGK 321
+ G + Y D+WS G L E GK
Sbjct: 171 RIQGES-YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 72/222 (32%), Positives = 118/222 (53%), Gaps = 28/222 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN---LEPESVKFMAREILILRRLDHPNVIKL 180
+G G++ +VY+ ++ G A+K+V + E+VK + +EI +L +L HPN+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQFVYLKVKCYMHQLLSGLEH 237
G T R +LY+ ++E G A K F EP ++ Y Q+L GLE+
Sbjct: 68 LG--TEREEDNLYI---FLELVPGGSLAKLLKKYGSFPEPV-----IRLYTRQILLGLEY 117
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT-----SRVVTLWYRPP 292
H+ +HRDIKG+N+L+D +GV+K+ADFG+A K + S + ++ P
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAP 170
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
E++ YG+ D+WS GC + E+ GKP V+A F
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 3e-37
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G++ V + TGK+ A+K ++ ++ + V+ E IL R++HP ++KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 183 LVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
+ LYLV Y +L S E +F+E + + Y +++ L
Sbjct: 59 ------HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEER-----ARFYAAEIVLAL 106
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
E+ H+ G+++RD+K N+L+D DG +K+ DFGLA + + T Y PE+L
Sbjct: 107 EYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVL 165
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKP 322
LG YG VD WS G +L E+L GKP
Sbjct: 166 LGK-GYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-36
Identities = 82/215 (38%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D + + ++G G Y V A D TG VA+KK+ K RE+ +L+ + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 176 NVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
NVI L + T +S YLV +M DL L K +E + +L ++Q+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFL-----VYQM 127
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
L GL++ H G++HRD+K NL +++D LKI DFGLA D MT VVT WYR
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRA 183
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326
PE++L Y VD+WS GCI+AE+L GKP+ G
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 72/214 (33%), Positives = 113/214 (52%), Gaps = 16/214 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E ++ IG+G++ V K + GKI+ K++ + N+ + + + E+ ILR L HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGL--AASPEVKFTEPQFVYLKVKCYMHQLLSG 234
++ + R + +LY+V Y E DLA L E K+ E +F+ ++ + QLL
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRI---LTQLLLA 117
Query: 235 LEHCHN-----NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLW 288
L CHN N VLHRD+K +N+ +D + +K+ DFGLA H V T +
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPY 175
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
Y PE L + Y D+WS GC++ EL A P
Sbjct: 176 YMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 1e-35
Identities = 80/222 (36%), Positives = 120/222 (54%), Gaps = 22/222 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+P R ++ + +G G Y +V A D + VA+KK+ F +L + RE+ +
Sbjct: 13 VPER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY--RELRL 67
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV 224
L+ + H NVI L + T S +YLV + M DL + ++ QF+
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL---- 123
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
++QLL GL++ H+ G++HRD+K SN+ +++D L+I DFGLA D MT V
Sbjct: 124 ---IYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYV 176
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326
T WYR PE++L Y VD+WS GCI+AELL GK + PG
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 77/228 (33%), Positives = 123/228 (53%), Gaps = 32/228 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ +R ++ + IG G V A D +TG+ VA+KK+ F N K RE+++
Sbjct: 14 VLKR---YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVL 68
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV 224
++ ++H N+I L + T + S +YLV M+ +L + ++ + YL
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERMSYL-- 123
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-----SFFDPNHKHP 279
++Q+L G++H H+ G++HRD+K SN+++ D LKI DFGLA SF
Sbjct: 124 ---LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM------- 173
Query: 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327
MT VVT +YR PE++LG Y VD+WS GCI+ E++ G + PG
Sbjct: 174 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 37/224 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +E I +IG GTY +VYKA+D+ TG++VA+K ++ + + + + +EI +L+ HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHP 60
Query: 176 NVIKLEGLVTSR------MSC----SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVK 225
N++ G R M SL ++ L +E Q Y+
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL-----------SELQIAYV--- 106
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR-- 283
C + L GL + H G +HRDIKG+N+L+ +DG +K+ADFG+++ + R
Sbjct: 107 C--RETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKRKS 160
Query: 284 -VVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIM 324
+ T ++ PE+ Y D+W+ G EL +P M
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 69/208 (33%), Positives = 113/208 (54%), Gaps = 17/208 (8%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKV--------RFDNLEPESVKFMAREILILRRLDHP 175
IG+GTY VY A ++ TG+++A+K+V R D+ + + VK + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N+++ G T+ S++L Y+ G +F E V+ + Q+L GL
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQL-----VRFFTEQVLEGL 121
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP--NHKHPMTSRVVTLWYRPPE 293
+ H+ G+LHRD+K NLL+D DG+ KI+DFG++ D ++ M+ + W P
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGK 321
+ + Y VD+WS GC++ E+ AG+
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 74/210 (35%), Positives = 113/210 (53%), Gaps = 16/210 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
+F+ KIG+G +S VYKA +L G++VALKKV+ F+ ++ ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 175 PNVIK-LEGLVTSRMSCSLYLVFHYMEH-DLAGL---AASPEVKFTEPQFVYLKVKCYMH 229
PNVIK L + + L +V + DL+ + + E + Y
Sbjct: 62 PNVIKYLASFIENNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERT-----IWKYFV 113
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 289
QL S LEH H+ ++HRDIK +N+ I GV+K+ D GL FF + S V T +Y
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYY 172
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLA 319
PE + Y D+WS GC+L E+ A
Sbjct: 173 MSPERIHE-NGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK---FMAREILILRRLDHPNVIKL 180
I +G Y V+ AK TG I A+K ++ ++ ++ R+IL + P V+KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS--QAQSPYVVKL 58
Query: 181 -EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238
+ +LYLV Y+ DLA L + E + Y+ +++ LE+
Sbjct: 59 YYSFQGKK---NLYLVMEYLPGGDLASLLENVGS-LDEDV-----ARIYIAEIVLALEYL 109
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-------TSRVV-TLWYR 290
H+NG++HRD+K N+LID +G LK+ DFGL S + R+V T Y
Sbjct: 110 HSNGIIHRDLKPDNILIDSNGHLKLTDFGL-SKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE++LG + VD WS GCIL E L G P
Sbjct: 169 APEVILG-QGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 5e-31
Identities = 67/215 (31%), Positives = 115/215 (53%), Gaps = 32/215 (14%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRF----DNLEPESVKFMAREILILRRLDHPNVIK 179
+G G +S+ Y+A+D+ TG ++A+K+V + + + E V+ + +EI ++ RL+HP++I+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
+ G +L++ + +AG + S + F + Y QLL GL + H
Sbjct: 68 MLGATCEDSHFNLFVEW------MAGGSVSHLLSKYGA-FKEAVIINYTEQLLRGLSYLH 120
Query: 240 NNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVV-----------TL 287
N ++HRD+KG+NLLID G L+IADFG A+ + ++ T+
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA--------RLAAKGTGAGEFQGQLLGTI 172
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
+ PE+L G YG D+WS GC++ E+ KP
Sbjct: 173 AFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-31
Identities = 75/213 (35%), Positives = 114/213 (53%), Gaps = 15/213 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++++ IG G V A D + G VA+KK+ K RE+++L+ ++H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 178 IKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
I L + T + S +YLV M+ A L ++ + YL ++Q+L
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIHMELDHERMSYL-----LYQMLC 134
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
G++H H+ G++HRD+K SN+++ D LKI DFGLA N MT VVT +YR PE
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYRAPE 192
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326
++LG Y VD+WS GCI+ EL+ G I G
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 70/217 (32%), Positives = 115/217 (52%), Gaps = 15/217 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ + IG G V A D + + VA+KK+ K RE+++++ ++H N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 178 IKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
I L + T + S +Y+V M+ A L +++ + YL ++Q+L
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYL-----LYQMLC 137
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
G++H H+ G++HRD+K SN+++ D LKI DFGLA MT VVT +YR PE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE 195
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
++LG Y VD+WS GCI+ E++ G + PG +
Sbjct: 196 VILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 72/214 (33%), Positives = 115/214 (53%), Gaps = 15/214 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ + IG G V A D + + VA+KK+ K RE+++++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 178 IKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
I L + T + S +YLV M+ A L +++ + YL ++Q+L
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYL-----LYQMLC 130
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
G++H H+ G++HRD+K SN+++ D LKI DFGLA MT VVT +YR PE
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE 188
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327
++LG Y VD+WS GCI+ E++ K + PGR
Sbjct: 189 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGR 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKK-VRFDNLEPESVKFMAREILILRRLDHPN 176
FE + IG+G + V + T K+ A+K + +E SV+ + E IL+ L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAG---LAASPEVKFTEPQFVYLKVKCYMHQLLS 233
++ L + + ++YLV + L G S +VKF+E Q VK ++ +++
Sbjct: 62 LVNLW--YSFQDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQ-----VKFWICEIVL 111
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
LE+ H+ G++HRDIK N+L+D+ G + I DF +A+ P+ TS T Y PE
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPE 169
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGK 321
+L Y V VD WS G E L GK
Sbjct: 170 VLCRQ-GYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMAREILILRRLD 173
D +E I+ IG G + VY A + + VA+K++ +LE SV + +E+ + + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKV--KCY 227
HPNV+K L+LV Y+ D+ +K + P+ +
Sbjct: 58 HPNVVKYYTSFVVGDE--LWLVMPYLSGGSLLDI--------MKSSYPRGGLDEAIIATV 107
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL-ASFFDP--NHKHPMTSRV 284
+ ++L GLE+ H+NG +HRDIK N+L+ +DG +KIADFG+ AS D + + V
Sbjct: 108 LKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T + PE++ Y D+WS G EL G
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES---VKFMAREILILRRLDHPNVIKL 180
+GQG + VY D+ TG+ +A+K+V FD PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
G + + S++ ME+ + G + ++K + K Y Q+L G+E+ H+
Sbjct: 70 YGCLRDDETLSIF-----MEY-MPGGSVKDQLKAYGALTETVTRK-YTRQILEGVEYLHS 122
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGA 298
N ++HRDIKG+N+L D G +K+ DFG + + V T ++ PE++ G
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 299 TDYGVGVDLWSAGCILAELLAGKP 322
YG D+WS GC + E+L KP
Sbjct: 183 G-YGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 68/209 (32%), Positives = 117/209 (55%), Gaps = 16/209 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ F+ ++K+G+G+Y +VYKA TG++VA+K V + E ++ + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 176 NVIKLEGLVTSRMSCS-LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
++K G S + L++V ME+ AG + S +K T ++ ++Q L G
Sbjct: 59 YIVKYYG---SYFKNTDLWIV---MEYCGAG-SVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS-FFDPNHKHPMTSRVVTLWYRPPE 293
LE+ H+N +HRDIK N+L++++G K+ADFG++ D K + + T ++ PE
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPE 169
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKP 322
++ Y D+WS G E+ GKP
Sbjct: 170 VIQE-IGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 23/213 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ F ++ IG+G++ VYKA D T ++VA+K + + E E ++ + +EI L + P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQFVYLKVKCYMHQLL 232
+ K G L+++ ME+ G + +K E + + ++L
Sbjct: 60 YITKYYGSFLKG--SKLWII---MEY-CGGGSCLDLLKPGKLDETY-----IAFILREVL 108
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWY 289
GLE+ H G +HRDIK +N+L+ ++G +K+ADFG++ M+ R V T ++
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSG----QLTSTMSKRNTFVGTPFW 164
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE++ + Y D+WS G EL G+P
Sbjct: 165 MAPEVIKQ-SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-D 173
FE ++ IG+GTY VYKA+ TG++VA+K + ++ + + + E ILR+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSN 61
Query: 174 HPNVIKLEGLVTSRMSCS----LYLVFHYMEH----DLA-GLAASPEVKFTEPQFVYLKV 224
HPN+ G + L+LV DL GL + + E Y+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYI-- 118
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR- 283
+ + L GL + H N V+HRDIKG N+L+ + +K+ DFG+++ D + R
Sbjct: 119 ---LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD----STLGRRN 171
Query: 284 --VVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKP 322
+ T ++ PE++ Y D+WS G EL GKP
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 67/227 (29%), Positives = 120/227 (52%), Gaps = 28/227 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-------VKFMAREILILRRLDHPN 176
IG G++ +VY + +G+++A+K+V ++ S + +AREI +L+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQFVYLKVKCYMHQLLS 233
+++ G S + + +L ++E+ G A+ F E V+ ++ Q+L
Sbjct: 68 IVQYLG---SSLD-ADHLNI-FLEYVPGGSVAALLNNYGAFEETL-----VRNFVRQILK 117
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN------HKHPMTSRVVTL 287
GL + HN G++HRDIKG+N+L+D+ G +KI+DFG++ + N + + +
Sbjct: 118 GLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
W P ++ T Y D+WS GC++ E+L GK P T++ A F
Sbjct: 178 WMAPE--VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
E K+G+G + VYK T VA+K ++ E E +F+ E I+++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
HPN+++L G+ T LY+V YM DL K T + Q+
Sbjct: 60 HPNIVRLLGVCTQGEP--LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQ-----MALQIA 112
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT--SRVVTLWYR 290
G+E+ + +HRD+ N L+ ++ V+KI+DFGL+ + + ++ W
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM- 171
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELL 318
PE L + D+WS G +L E+
Sbjct: 172 APESLKDGK-FTSKSDVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 119 EKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
K+G+G + VYK K VA+K ++ D E + +F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
PNV+KL G+ T LY+V YME DL K + + + Q+
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLS-----FALQIAR 113
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL-WYRPP 292
G+E+ + +HRD+ N L+ ++ V+KI+DFGL+ + + + + W P
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-AP 172
Query: 293 ELLLGATDYGVGVDLWSAGCILAELL 318
E L + D+WS G +L E+
Sbjct: 173 ESLKEGK-FTSKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKI-----VALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
K+G+G + VYK L GK VA+K ++ D E E F+ +E ++++L HPN
Sbjct: 1 KKLGEGAFGEVYKG--KLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPN 57
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAG--LAASPEVKFTEPQFVYLKVK-CYMHQLL 232
V++L G+ T LYLV YME DL + P E + LK + Q+
Sbjct: 58 VVRLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLWYR 290
G+E+ + +HRD+ N L+ +D V+KI+DFGL+ + + + ++ W
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174
Query: 291 PPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
PE L + D+WS G +L E+ L P
Sbjct: 175 APESLKDGI-FTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 119 EKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
K+G+G + VYK VA+K ++ D E + +F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVKCYMHQLL 232
PN++KL G+ T L +V YM DL L + + + + + Q+
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLS-----FALQIA 113
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL-WYRP 291
G+E+ + +HRD+ N L+ ++ V+KI+DFGL+ + + + + + W
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-A 172
Query: 292 PELLLGATDYGVGVDLWSAGCILAELL 318
PE L + D+WS G +L E+
Sbjct: 173 PESLKEGK-FTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 71/209 (33%), Positives = 111/209 (53%), Gaps = 17/209 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
F + +IG G++ VY A+D+ T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
I+ +G + +LV ME+ L + EV Q V + C H L GL
Sbjct: 77 TIEYKGCYLREHTA--WLV---MEYCLGSASDILEVHKKPLQEVEIAAIC--HGALQGLA 129
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ H++ +HRDIK N+L+ + G +K+ADFG AS P + S V T ++ PE++L
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVIL 184
Query: 297 GATD---YGVGVDLWSAGCILAELLAGKP 322
A D Y VD+WS G EL KP
Sbjct: 185 -AMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 76/222 (34%), Positives = 115/222 (51%), Gaps = 33/222 (14%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
IG G++ VY+A + T + VA+KKV D ++ RE+LI++ L+H N+I L+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDY 127
Query: 184 VTS----RMSCSLYL----------VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
+ + +++L V YM+H A P VK Y +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP----------LFLVKLYSY 177
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVVTLW 288
QL L + H+ + HRD+K NLLID + LK+ DFG A + S + + +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRF 235
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
YR PEL+LGAT+Y +DLWS GCI+AE++ G PI G++ V
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 69/213 (32%), Positives = 113/213 (53%), Gaps = 18/213 (8%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-FMAREILILR 170
P++ + + +KIGQG VY A D+ TG+ VA+K++ NL+ + K + EIL++R
Sbjct: 17 PKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMR 71
Query: 171 RLDHPNVIKLEGLVTSRMSC-SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
HPN++ + S + L++V Y LAG + + V TE ++
Sbjct: 72 ENKHPNIVNY---LDSYLVGDELWVVMEY----LAGGSLTDVV--TETCMDEGQIAAVCR 122
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 289
+ L LE H+N V+HRDIK N+L+ DG +K+ DFG + P ++ V T ++
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYW 181
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE++ YG VD+WS G + E++ G+P
Sbjct: 182 MAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 11/213 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F+ + K+G+G+Y +VYK K + + ALK+V ++ + + EI IL ++HPN+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLA-ASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
I + L +V Y L+ A + K ++ QLL GL+
Sbjct: 62 ISYKE--AFLDGNKLCIVMEYA--PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELL 295
H +LHRD+K +N+L+ + ++KI D G++ K M + T Y PE+
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328
G Y D+WS GC+L E+ P R+
Sbjct: 174 KG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-26
Identities = 74/202 (36%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDHPNVIKLE 181
KIG+G +S VY+A +L G VALKKV+ FD ++ ++ +EI +L++L+HPNVIK
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLA-ASPEVKFTEPQFVYLKVKC---YMHQLLSGLEH 237
++ L +LA S +K + Q + K Y QL S LEH
Sbjct: 69 ASFIEDNELNIVL-------ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 297
H+ V+HRDIK +N+ I GV+K+ D GL FF + S V T +Y PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIH 179
Query: 298 ATDYGVGVDLWSAGCILAELLA 319
Y D+WS GC+L E+ A
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 33/213 (15%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G+GTY VY A+D+ T +A+K++ + V+ + EI + L H N+++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 184 VTSRMSCSLYLVFH-YMEH----DLAGLAASP--EVKFTEPQFVYLKVKCYMHQLLSGLE 236
S S F +ME L+ L S +K E ++ Y Q+L GL+
Sbjct: 73 -----SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-----YTKQILEGLK 122
Query: 237 HCHNNGVLHRDIKGSNLLIDD-DGVLKIADFG----LASFFDPNHKHPMTSRVV-TLWYR 290
+ H+N ++HRDIKG N+L++ GV+KI+DFG LA +P T TL Y
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI------NPCTETFTGTLQYM 176
Query: 291 PPELL-LGATDYGVGVDLWSAGCILAELLAGKP 322
PE++ G YG D+WS GC + E+ GKP
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 72/203 (35%), Positives = 112/203 (55%), Gaps = 16/203 (7%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDHPNVIK-L 180
KIG+G +S VY+A +L K VALKKV+ F+ ++ ++ + +EI +L++L+HPNVIK L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC---YMHQLLSGLE 236
+ + L +V + DL+ + +K+ + Q + + Y QL S +E
Sbjct: 69 DSFIEDN---ELNIVLELADAGDLSQM-----IKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
H H+ V+HRDIK +N+ I GV+K+ D GL FF + S V T +Y PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RI 178
Query: 297 GATDYGVGVDLWSAGCILAELLA 319
Y D+WS GC+L E+ A
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 80/243 (32%), Positives = 109/243 (44%), Gaps = 51/243 (20%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
D FE I IG+G + V+ +D TG++ A+K +R D ++ + + E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 175 PNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCY 227
P ++KL S LYLV YM DL L +V F E + Y
Sbjct: 61 PWIVKLY--------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEET-----ARFY 106
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD-------------- 273
+ +L+ L+ H G +HRDIK N+LID DG +K+ADFGL +
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 274 -----------PNHKHPMT---SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 319
+HK S V T Y PE+L G T YG+ D WS G IL E+L
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLY 225
Query: 320 GKP 322
G P
Sbjct: 226 GFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 19/220 (8%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR---EILILRRLDHPNVIKL 180
+GQG + VY D+ TG+ +A K+V+FD PE+ K ++ EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK----FTEPQFVYLKVKCYMHQLLSGLE 236
G + R +L + YM G + ++K TE + Y Q+L G+
Sbjct: 70 YGCLRDRAEKTLTIFMEYM----PGGSVKDQLKAYGALTESV-----TRKYTRQILEGMS 120
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPEL 294
+ H+N ++HRDIKG+N+L D G +K+ DFG + R V T ++ PE+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
+ G YG D+WS GC + E+L KP ++A F
Sbjct: 181 ISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 4e-24
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 35/219 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
D FE I +G G++ V + +GK ALK + ++ + V+ + E IL+ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYME-------HDLAGLAASPEVKFTEPQFVYLKVKCY 227
P ++ L G + + +LYLV Y+ +G +F EP + Y
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPV-----ARFY 106
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 287
Q++ LE+ H+ +++RD+K NLL+D DG +KI DFG A R TL
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--------RTYTL 158
Query: 288 W----YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
Y PE++L YG VD W+ G ++ E+LAG P
Sbjct: 159 CGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-24
Identities = 68/225 (30%), Positives = 117/225 (52%), Gaps = 15/225 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
F + +IG G++ VY A+D+ T ++VA+KK+ + + E + + +E+ L+R+ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
I+ +G + L ME+ L +AS ++ + +++ H L GL
Sbjct: 87 SIEYKGCYLREHTAWLV-----MEYCLG--SASDLLEVHKKPLQEVEIAAITHGALQGLA 139
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ H++ ++HRDIK N+L+ + G +K+ADFG AS P + S V T ++ PE++L
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-----SFVGTPYWMAPEVIL 194
Query: 297 GATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339
+ Y VD+WS G EL KP + +SA + N
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 239
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 88/294 (29%), Positives = 125/294 (42%), Gaps = 61/294 (20%)
Query: 64 KKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAV-----CGEALNGWIPRRADSF 118
+ R + P L+ LP R +A P + + +G P A S
Sbjct: 15 TARHTTKSRPRRRPDLT-LPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSL 73
Query: 119 ---EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
E++++IG G VYK TG++ ALK V + N E + + REI ILR ++HP
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVRRQICREIEILRDVNHP 132
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYM------------EHDLAGLAASPEVKFTEPQFVYLK 223
NV+K + + + ++ +M E LA +A
Sbjct: 133 NVVKCHDMFDH--NGEIQVLLEFMDGGSLEGTHIADEQFLADVA---------------- 174
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG----LASFFDPNHKHP 279
Q+LSG+ + H ++HRDIK SNLLI+ +KIADFG LA D P
Sbjct: 175 -----RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-----P 224
Query: 280 MTSRVVTLWYRPPE-----LLLGATDYGVGVDLWSAGCILAELLAGK-PIMPGR 327
S V T+ Y PE L GA D G D+WS G + E G+ P GR
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-23
Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 27/215 (12%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--- 174
+++++ IG+G Y VY+ K + TG++VALK + D + + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 175 PNVIKLEG--LVTSRMSCSLYLVFHYMEHDLAG-----LAASPEVKFTEPQFVYLKVKCY 227
PN+ K G L R L+++ ME+ G + A P E Y+ V
Sbjct: 62 PNITKYYGSYLKGPR----LWII---MEYAEGGSVRTLMKAGP---IAEK---YISV--I 106
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 287
+ ++L L++ H GV+HRDIK +N+L+ + G +K+ DFG+A+ + N T V T
Sbjct: 107 IREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTP 165
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
++ PE++ Y D+WS G + E+ G P
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 64/225 (28%), Positives = 114/225 (50%), Gaps = 15/225 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
F + +IG G++ VY A+D+ ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
I+ G + L ME+ L +AS ++ + +++ H L GL
Sbjct: 77 TIQYRGCYLREHTAWLV-----MEYCLG--SASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ H++ ++HRD+K N+L+ + G++K+ DFG AS P + V T ++ PE++L
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----XFVGTPYWMAPEVIL 184
Query: 297 GATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339
+ Y VD+WS G EL KP + +SA + N
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-23
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES---VKFMAREILILRRLDHPNVIKL 180
+GQG + VY D TG+ +A+K+V+FD PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKC---YMHQLLSGLEH 237
G + M +L + +MEH G +K + L Y Q+L G+ +
Sbjct: 70 YGCLRDPMERTLSI---FMEHMPGG-----SIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN--HKHPMTSRVVTLWYRPPELL 295
H+N ++HRDIKG+N+L D G +K+ DFG + M S T ++ PE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKP 322
G YG D+WS GC + E+L KP
Sbjct: 182 SG-EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 7e-23
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D E + ++G G V K TGKI+A+K +R + + K + RE+ IL + + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAA-SPEVKFTEPQFVYLKVKCYMHQLLSG 234
++ G + + + + YM D L EV+ P+ + K+ +L G
Sbjct: 60 YIVGFYGAFYN--NGDISICMEYM--DGGSLDKILKEVQGRIPERILGKI---AVAVLKG 112
Query: 235 LEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFG--------LASFFDPNHKHPMTSRVV 285
L + H ++HRD+K SN+L++ G +K+ DFG LA F V
Sbjct: 113 LTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-----------VG 161
Query: 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK-PIMP 325
T Y PE + G DY V D+WS G L EL G+ P P
Sbjct: 162 TSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-23
Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 14/223 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-FMAREILILRRLDHPN 176
+ + +KIGQG VY A D+ TG+ VA++++ NL+ + K + EIL++R +PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPN 78
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
++ L + + L++V Y LAG + + V TE ++ + L LE
Sbjct: 79 IVNY--LDSYLVGDELWVVMEY----LAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
H+N V+HRDIK N+L+ DG +K+ DFG + P + ++ V T ++ PE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVT 189
Query: 297 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339
YG VD+WS G + E++ G+P + A + N
Sbjct: 190 RKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 8e-23
Identities = 75/240 (31%), Positives = 118/240 (49%), Gaps = 24/240 (10%)
Query: 112 PRRADSFEKID---------KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKF 161
P AD F K D +IG G++ VY A + T ++VA+KK+ + + E +
Sbjct: 8 PEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD 67
Query: 162 MAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVY 221
+ +E+ L++L HPN I+ +G + +LV ME+ L + EV Q V
Sbjct: 68 IIKEVKFLQQLKHPNTIEYKGCYLKEHTA--WLV---MEYCLGSASDLLEVHKKPLQEV- 121
Query: 222 LKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 281
++ H L GL + H++ ++HRDIK N+L+ + G +K+ADFG AS P
Sbjct: 122 -EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK-----SSPAN 175
Query: 282 SRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339
S V T ++ PE++L + Y VD+WS G EL KP + +SA + N
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 235
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-23
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
D +E I ++G G + VYKA+ TG A K ++ ++ E E FM EI IL H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKH 61
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
PN++ L L+++ + + L + E TEPQ Y+ Q+L
Sbjct: 62 PNIVGL--YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV-----CRQMLE 114
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWYR 290
L H++ V+HRD+K N+L+ DG +K+ADFG+++ +K + R + T ++
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA----KNKSTLQKRDTFIGTPYWM 170
Query: 291 PPELLLGATD----YGVGVDLWSAGCILAELLAGKP 322
PE++ T Y D+WS G L EL +P
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 27/210 (12%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRRLDHPN 176
+ I +G + +VY AK TG A+K ++ ++ + +VK R I++++ + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAIMMIQG-ESPY 58
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEP---QFVYLKVKCYMHQLL 232
V KL S+ LYLV Y+ D A L +K + K Y+ +++
Sbjct: 59 VAKLYYSFQSKDY--LYLVMEYLNGGDCASL-----IKTLGGLPEDWA----KQYIAEVV 107
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
G+E H G++HRDIK NLLID G LK+ DFGL+ N K V T Y P
Sbjct: 108 LGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF-----VGTPDYLAP 162
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKP 322
E +LG D + D WS GC++ E L G P
Sbjct: 163 ETILGVGDDKMS-DWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 14/223 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-FMAREILILRRLDHPN 176
+ + +KIGQG VY A D+ TG+ VA+K++ NL+ + K + EIL++R +PN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPN 77
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
++ L + + L++V Y LAG + + V TE ++ + L L+
Sbjct: 78 IVNY--LDSYLVGDELWVVMEY----LAGGSLTDVV--TETCMDEGQIAAVCRECLQALD 129
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
H+N V+HRDIK N+L+ DG +K+ DFG + P + ++ V T ++ PE++
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVT 188
Query: 297 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339
YG VD+WS G + E++ G+P + A + N
Sbjct: 189 RKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+E I KIG+G++ +Y AK + +K++ + + + +E+++L ++ HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYME-HDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
+ + + + L++V Y + DL + V F+E Q + + Q+ GL
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL-----SWFVQISLGL 114
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
+H H+ +LHRDIK N+ + +G V K+ DFG+A + + + T V T +Y PE+
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEI 173
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGK 321
Y D+WS GC+L EL K
Sbjct: 174 CQNRP-YNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-22
Identities = 60/212 (28%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDH 174
+ FE I +IG GTY +VYKA+++ TG++ A+K ++ LEP E + +EI++++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKH 65
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++ G R L++ + G + ++ ++ + L G
Sbjct: 66 SNIVAYFGSYLRRDK--LWICMEF-----CGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
L + H+ G +HRDIKG+N+L+ D+G +K+ADFG+++ S + T ++ PE+
Sbjct: 119 LYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEV 177
Query: 295 --LLGATDYGVGVDLWSAGCILAELLAGKPIM 324
+ Y D+W+ G EL +P M
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-22
Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 14/223 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK-FMAREILILRRLDHPN 176
+ + +KIGQG V+ A D+ TG+ VA+K++ NL+ + K + EIL+++ L +PN
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPN 77
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
++ L + + L++V Y LAG + + V TE ++ + L LE
Sbjct: 78 IVNF--LDSFLVGDELFVVMEY----LAGGSLTDVV--TETCMDEAQIAAVCRECLQALE 129
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
H N V+HRDIK N+L+ DG +K+ DFG + P + ++ V T ++ PE++
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVT 188
Query: 297 GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339
YG VD+WS G + E++ G+P + A + N
Sbjct: 189 RKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 120 KIDKIGQGTYSNVYKAK-DML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
I ++G+G + V + D L TG+ VA+K + E F REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF-EREIEILRTLDHE 66
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N++K +G+ SL L+ ME+ +G + ++ Q ++ + Q+ G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLI---MEYLPSG-SLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-----KHPMTSRVVTLWYR 290
++ + +HRD+ N+L++ + ++KI+DFGLA + K P S + WY
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY- 179
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELL 318
PE L + D+WS G L EL
Sbjct: 180 APECLRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 8e-22
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
KIG+G+ V A D TG+ VA+KK+ D + + + + E++I+R HPN++++
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 183 --LVTSRMSCSLYLVFHYMEHDLAGLAAS---PEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
LV L++V ++E G A + + E Q + + L L
Sbjct: 84 SYLVGDE----LWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLAV-----LKALSF 130
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD---PNHKHPMTSRVVTLWYRPPEL 294
H GV+HRDIK ++L+ DG +K++DFG + P K S V T ++ PE
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK----SLVGTPYWMAPE- 185
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKP 322
++ YG VD+WS G ++ E++ G+P
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-22
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHPNVIKLEG 182
+G+G + V + TGK+ A KK+ L+ + MA E IL ++ ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 183 LVTSRMSCSLYLV--------FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
++ L + +H G F E + ++ Y Q++ G
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--------FPEARAIF-----YAAQIICG 107
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
LEH H +++RD+K N+L+DD G ++I+D GLA + R T Y PE+
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEV 165
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGK 321
L G Y VD ++ GC L E++AG+
Sbjct: 166 LQGEV-YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 118 FEKIDKIGQGTY--SNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ I +G+G + + +Y+ + +V K+V L + + EI+IL L HP
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-----LAASPEVKFTEPQFVYLKVKCYMHQ 230
N+I + + ME+ G + F E ++ Y+ Q
Sbjct: 60 NIIAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQ 109
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWY 289
++S + + H G+LHRDIK N+ + G++K+ DFG++ ++ M VV T +Y
Sbjct: 110 IVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYY 167
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELL 318
PEL G Y D+W+ GC+L ELL
Sbjct: 168 MSPELCQGV-KYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
FE ++KIG+G++ V+K ++ A+K++ + + E +L +LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 178 IK-LEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
I+ E + L +V Y E H L L E Q + Q+L
Sbjct: 62 IRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFI-----QIL 111
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
GL H H+ +LHRDIK NL +D +KI D G+A N T V T +Y P
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSP 170
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGK 321
E L Y D+W+ G +L E GK
Sbjct: 171 E-LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-21
Identities = 67/222 (30%), Positives = 114/222 (51%), Gaps = 22/222 (9%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-----LEPESVKFMAREILILRRLDHPNVI 178
+G+G Y VY G+++A+K+V D E E K + E+ +L+ L H N++
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEK-LQEEVDLLKSLKHVNIV 65
Query: 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTE-PQFVYLKVKCYMHQLLSGLEH 237
+ G T ++ + +ME G +S +F P+ V+ K Y Q+L G+ +
Sbjct: 66 QYLG--TCLDDNTISI---FMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAY 117
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-----DPNHKHPMTSRVVTLWYRPP 292
HNN V+HRDIKG+N+++ +G++K+ DFG A H + + S T ++ P
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
E ++ + YG D+WS GC + E+ GKP + ++A F
Sbjct: 178 E-VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-21
Identities = 71/232 (30%), Positives = 105/232 (45%), Gaps = 17/232 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
F+ +G+G + V ++ TG I A+K ++ L E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
P + +L + +LYLV Y DL L E +F E + Y+ +L+
Sbjct: 61 PWIPQL--QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-----AQFYLAELVL 113
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
+ H G +HRDIK N+LID G +K+ADFG A+ N V T Y PE
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 294 LLL-----GATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVSATFCFVLN 339
+L G YGV D WS G I E++ G+ P G + T+ ++N
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG--TSAKTYNNIMN 223
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 70/217 (32%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
F+ + ++GQG Y V+ AK TG+IVALK+++ L V+ + E IL
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAG-----LAASPEVKFTEPQFVYLKVKCYMHQL 231
++KL L + LYL ME+ G L + +F YM ++
Sbjct: 63 LVKL--LYAFQDDEYLYLA---MEYVPGGDFRTLLNNLGVLSEDHARF-------YMAEM 110
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
++ H G +HRD+K N LID G +K+ DFGL+ + + S V + Y
Sbjct: 111 FEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMA 166
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328
PE+L G Y VD WS GC+L E L G P G T
Sbjct: 167 PEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-21
Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 23/224 (10%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILR 170
P +D++E I+ IG+GTY V+K + G A+K + +++ E + E IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILK 69
Query: 171 RL-DHPNVIKLEGLVTSRMSCS---LYLVFHYME----HDLAGLAASPEVKFTEPQFVYL 222
L DHPNV+K G+ + + L+LV DL + EP Y+
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
+H+ L GL+H H N +HRD+KG+N+L+ +G +K+ DFG+++ + + +
Sbjct: 130 -----LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNT 183
Query: 283 RVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKP 322
V T ++ PE++ + Y D+WS G EL G P
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-21
Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPN 176
+E I ++G GTY +VYKA+++ TG++ A+K ++ LEP + + +EI +++ H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCN 67
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
++ G SR L++ Y G + ++ L++ + L GL
Sbjct: 68 IVAYFGSYLSREK--LWICMEY-----CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ H+ G +HRDIKG+N+L+ D+G +K+ADFG+A+ S + T ++ PE+
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-RKSFIGTPYWMAPEVAA 179
Query: 297 GATDYGVG--VDLWSAGCILAELLAGKPIM 324
+ G D+W+ G EL +P M
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 9e-21
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 39/221 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRF-DNLEPESVKFMAREILILRRLDH 174
D E+I +G GT+ V+ +D ++ ALK + + + + + + E +L+ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVK--------- 225
P +I+L T LY++ Y E+ F YL+
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEY--------VPGGEL------FSYLRNSGRFSNSTGL 104
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y +++ LE+ H+ +++RD+K N+L+D +G +K+ DFG A + R
Sbjct: 105 FYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK--------KLRDRTW 156
Query: 286 TLW----YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
TL Y PE ++ + + VD W+ G ++ E+L G P
Sbjct: 157 TLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F K+++IG+G++ V+K D T ++VA+K + + E E ++ + +EI +L + D P V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 178 IKLEGLVTSRMSCSLYLVFHYME--HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
K G + L+++ Y+ L L A P F ++ + ++L GL
Sbjct: 65 TKYYG--SYLKGTKLWIIMEYLGGGSALDLLRAGP--------FDEFQIATMLKEILKGL 114
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
++ H+ +HRDIK +N+L+ + G +K+ADFG+A T W P +
Sbjct: 115 DYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE--V 172
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKP 322
+ + Y D+WS G EL G+P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+ K+ KIG+G++ K GK +K++ + P+ + +E+ +L + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DL-AGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
++ + + + +LY+V Y E DL + A V F E Q + V Q+ L
Sbjct: 62 VQYQE--SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV-----QICLAL 114
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
+H H+ +LHRDIK N+ + DG +K+ DFG+A + + T + T +Y PE+
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEIC 173
Query: 296 LGATDYGVGVDLWSAGCILAELLAGK 321
Y D+W+ GC+L E+ K
Sbjct: 174 ENRP-YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F K+++IG+G++ VYK D T ++VA+K + + E E ++ + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
+ G + L+++ Y L G +A +K + Y + + ++L GL++
Sbjct: 65 TRYYG--SYLKGTKLWIIMEY----LGGGSALDLLKPGPLEETY--IATILREILKGLDY 116
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG 297
H+ +HRDIK +N+L+ + G +K+ADFG+A T W P +
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 298 ATDYGVGVDLWSAGCILAELLAGKP 322
A D+ D+WS G EL G+P
Sbjct: 177 AYDF--KADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-20
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 15/207 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F K++KIG+G++ V+K D T K+VA+K + + E E ++ + +EI +L + D P V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEP-QFVYLKVKCYMHQLLSGLE 236
K G + L+++ Y L + EP ++ + ++L GL+
Sbjct: 65 TKYYG--SYLKDTKLWIIMEY-------LGGGSALDLLEPGPLDETQIATILREILKGLD 115
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPELL 295
+ H+ +HRDIK +N+L+ + G +K+ADFG+A D K + V T ++ PE +
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-V 172
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKP 322
+ + Y D+WS G EL G+P
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 76/254 (29%), Positives = 107/254 (42%), Gaps = 64/254 (25%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
D FE I IG+G + V + TG I A+KK+R + LE E V + E IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 175 PNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTE--PQFVYLKVK 225
P V+K + S LYL+ Y+ D+ L + FTE +F
Sbjct: 61 PWVVK--------LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETRF------ 105
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH--------- 276
Y+ + + ++ H G +HRDIK NLL+D G +K++DFGL + +H
Sbjct: 106 -YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 277 -----------KHPMTS-RVVTLW----------------YRPPELLLGATDYGVGVDLW 308
PM+S R W Y PE+ L T Y D W
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWW 223
Query: 309 SAGCILAELLAGKP 322
S G I+ E+L G P
Sbjct: 224 SLGVIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 31/241 (12%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL--- 167
+ D++E I+ IG+GTY VYK + G + A+K L+P + + EI
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI-----LDP--ISDVDEEIEAEY 69
Query: 168 -ILRRL-DHPNVIKLEGLVTSRMSCS---LYLVFHY-----MEHDLAGLAASPEVKFTEP 217
IL+ L +HPNV+K G+ L+LV + + GL + + E
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEA 128
Query: 218 QFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277
Y+ ++ L GL+H HNN ++HRD+KG+N+L+ +G +K+ DFG+++
Sbjct: 129 MISYI-----LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 278 HPMTSRVVTLWYRPPELLLGATDYGVG----VDLWSAGCILAELLAGKPIMPGRTEVSAT 333
TS V T ++ PE++ Y D+WS G EL G P + V
Sbjct: 184 RRNTS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242
Query: 334 F 334
F
Sbjct: 243 F 243
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 7e-20
Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 47/231 (20%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++ ++G+G +V K + TG I ALK + D P+ K + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVK-----CYMHQ 230
++K G S S+ + Y E S + +Y KVK
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCE------GGSLDS-------IYKKVKKRGGRIGEKV 106
Query: 231 L-------LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG--------LASFFDPN 275
L L GL + H+ ++HRDIK SN+L+ G +K+ DFG LA F
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF--- 163
Query: 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK-PIMP 325
T +Y PE + G Y + D+WS G L E+ + P P
Sbjct: 164 --------TGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 9e-20
Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 35/212 (16%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVR----FDNLEPESVKFMAREILILRRLDHPNVIK 179
+G G + V K + ALK V+ + + E + E IL +HP ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 180 LEGLVTSRMSCSLYLVFHYME--------HDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
L T + +Y++ Y D GL +F Y+ +
Sbjct: 58 L--YRTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARF------------YIACV 102
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYR 290
+ E+ HN G+++RD+K NLL+D +G +K+ DFG A K T T Y
Sbjct: 103 VLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYV 159
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE++L Y VD WS G +L ELL G+P
Sbjct: 160 APEIILN-KGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-19
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES---VKFMAREILILRRLDHPNVIKL 180
+G+G + VY D TG+ +A+K+V FD E+ V + EI +L+ L H +++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK----FTEPQFVYLKVKCYMHQLLSGLE 236
G + L + YM G + ++K TE + Y Q+L G+
Sbjct: 70 YGCLRDPEEKKLSIFVEYM----PGGSIKDQLKAYGALTENV-----TRRYTRQILQGVS 120
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPEL 294
+ H+N ++HRDIKG+N+L D G +K+ DFG + + V T ++ PE+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKP 322
+ G YG D+WS C + E+L KP
Sbjct: 181 ISG-EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 35/226 (15%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLE--------PESVKFMAREIL 167
+ ++ +G G + VYK + G ++ALK++ N +S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 168 ILR-RLDHPNVIK-----LEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVK---FTEP 217
I++ +L HPN+++ LE LY+V +E L S + K FTE
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEN-------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113
Query: 218 QFVYLKVKCYMHQLLSGLEHCHNNG-VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276
+ + V Q++ L + H ++HRD+ +N+++ +D + I DFGLA P
Sbjct: 114 RIWNIFV-----QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES 168
Query: 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
K +TS V T+ Y PE++ YG D+W+ GCIL ++ +P
Sbjct: 169 K--LTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 24/226 (10%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
W IPR +S + K+G G + V+ T K VA+K ++ + PE+ +E I
Sbjct: 1 WEIPR--ESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQI 54
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQFVYLKVKC 226
+++L H +++L + + +Y+V YM L L + K PQ V +
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---- 108
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
Q+ G+ + + +HRD+ N+L+ ++ V KIADFGLA + +
Sbjct: 109 -AAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP 167
Query: 287 LWYRPPELLLGATDYG---VGVDLWSAGCILAELLA-GKPIMPGRT 328
+ + PE A +YG + D+WS G +L E++ G+ PG T
Sbjct: 168 IKWTAPE----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 69/221 (31%), Positives = 109/221 (49%), Gaps = 33/221 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +E I ++G G + VYKA++ TG + A K + D E ++ EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCDHP 62
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASP-----EVKFTEPQFVYLKVKCYMHQ 230
N++KL L +L+++ + AG A E TEPQ ++V C Q
Sbjct: 63 NIVKL--LDAFYYENNLWILIEF----CAGGAVDAVMLELERPLTEPQ---IRVVC--KQ 111
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT-----SRVV 285
L L + H N ++HRD+K N+L DG +K+ADFG+++ K+ T S +
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIG 165
Query: 286 TLWYRPPELLLGATD----YGVGVDLWSAGCILAELLAGKP 322
T ++ PE+++ T Y D+WS G L E+ +P
Sbjct: 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 55/212 (25%), Positives = 108/212 (50%), Gaps = 18/212 (8%)
Query: 117 SFEKIDK-IGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRL 172
S KI++ IG G + V + + L GK VA+K ++ E + F++ E I+ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQF 62
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
DHPN+I LEG+VT S + ++ +ME+ A ++ + QF +++ + +
Sbjct: 63 DHPNIIHLEGVVTK--SRPVMIITEFMENG----ALDSFLRQNDGQFTVIQLVGMLRGIA 116
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-----DPNHKHPMTSRVVTL 287
+G+++ +HRD+ N+L++ + V K++DFGL+ F DP + + ++
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLA 319
W P + + D+WS G ++ E+++
Sbjct: 177 WTAPEAIAY--RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-18
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 22/220 (10%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A FE ++ +G GTY VYK + + TG++ A+K + E E +K +EI +L++ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 175 -PNVIKLEGLVTSR----MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYM- 228
N+ G + M L+LV ME AG + + +K T+ + + Y+
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLV---MEFCGAG-SVTDLIKNTKGNTLKEEWIAYIC 117
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
++L GL H H + V+HRDIKG N+L+ ++ +K+ DFG+++ D T + T +
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 176
Query: 289 YRPPELLLGATD------YGVGVDLWSAGCILAELLAGKP 322
+ PE++ A D Y DLWS G E+ G P
Sbjct: 177 WMAPEVI--ACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-18
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F +G+G + V + TGK+ A KK+ ++ + MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF-----TEPQFVYLKVKCYMHQ 230
V+ L ++ + L L L ++KF P F + Y +
Sbjct: 61 FVVSLAYAYETKDALCLVLT----------LMNGGDLKFHIYNMGNPGFDEERAVFYAAE 110
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
+ GLE H +++RD+K N+L+DD G ++I+D GLA + RV T+ Y
Sbjct: 111 ITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGYM 168
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
PE ++ Y D W GC++ E++ GK R E
Sbjct: 169 APE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-18
Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 18/203 (8%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
KIG+G+ V A + TGK VA+KK+ D + + + + E++I+R H NV+ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG 242
+ + L++V ++E G A + V T + C +L L + HN G
Sbjct: 87 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIATVCL--SVLRALSYLHNQG 138
Query: 243 VLHRDIKGSNLLIDDDGVLKIADFGLASFFD---PNHKHPMTSRVVTLWYRPPELLLGAT 299
V+HRDIK ++L+ DG +K++DFG + P K S V T ++ PE ++
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK----SLVGTPYWMAPE-VISRL 193
Query: 300 DYGVGVDLWSAGCILAELLAGKP 322
YG VD+WS G ++ E++ G+P
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
IG+GT+ VY+ + T +I A+K + + + + + V E IL R + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 183 LVTSRMSCS-LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
L S + S LYLV YM E +F+E + K Y+ +L+ LEH H
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----RAKFYIAELVLALEHLHKY 115
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGAT 299
+++RD+K N+L+D G + + DFGL+ N T+ T Y PE+LL
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 300 DYGVGVDLWSAGCILAELLAG 320
Y VD WS G ++ E+ G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F + +G+G + V + TGK+ A K++ ++ + MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF-----TEPQFVYLKVKCYMHQ 230
V+ L ++ + L L + ++KF P F + Y +
Sbjct: 61 FVVNLAYAYETKDALCLVLT----------IMNGGDLKFHIYNMGNPGFEEERALFYAAE 110
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
+L GLE H ++RD+K N+L+DD G ++I+D GLA + RV T+ Y
Sbjct: 111 ILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYM 168
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
PE +L Y + D W GC++ E++ G+ GR E
Sbjct: 169 APE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +E I ++G G + VYKAK+ TG + A K + + E E +M EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIEILATCNHP 69
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASP-----EVKFTEPQFVYLKVKCYMHQ 230
++KL G + + F G A + TEPQ ++V C Q
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEF------CPGGAVDAIMLELDRGLTEPQ---IQVIC--RQ 118
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK--HPMTSRVVTLW 288
+L L++ H+ ++HRD+K N+L+ DG +K+ADFG+++ N K S + T +
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPY 175
Query: 289 YRPPELLLGAT----DYGVGVDLWSAGCILAELLAGKP 322
+ PE+++ T Y D+WS G L E+ +P
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-17
Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 30/241 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF--MAREILILRRLD 173
D E +D++G+G Y +VYK TG +A+K++R LE + KF + E+ IL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR---LELDESKFNQIIMELDILHKAV 57
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
P ++ G + ++Y+ YM+ L L A P+ V ++ + + L
Sbjct: 58 SPYIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL-----ASFFDPNHKHPMTSRVVTL 287
L+ HN ++HRD+K +N+L++ +G +K+ DFG+ AS N +
Sbjct: 116 KFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--------IGCQ 165
Query: 288 WYRPPELL--LGATD---YGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342
Y PE + G Y V D+WS G + E+ G+ P E A L+ I
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR--YPYPPETYANIFAQLSAIV 223
Query: 343 D 343
D
Sbjct: 224 D 224
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRL-DHPNVIK 179
IG+G + VY + TGK+ A+K K R + E++ R +L L D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 180 LE-GLVTSRMSCSLY-------LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
+ T C + L +H +H G+ + E++F Y ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQH---GVFSEKEMRF------------YATEI 106
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
+ GLEH HN V++RD+K +N+L+D+ G ++I+D GLA F H + V T Y
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMA 163
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAG 320
PE+L T Y D +S GC+L +LL G
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES---VKFMAREILILRRLDH 174
+ + +G+G++ + + + + A+K++R P+S V+ +E ++L ++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKH 57
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVK-FTEPQFVYLKVKCYMHQLL 232
PN++ + + LY+V Y + DL K F E + + Q+
Sbjct: 58 PNIVAFKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTIL-----QWFVQMC 110
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT---SRVVTLWY 289
G++H H VLHRDIK N+ + +G +K+ DFG A P + V T +Y
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL----TSPGAYACTYVGTPYY 166
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAEL 317
PPE+ Y D+WS GCIL EL
Sbjct: 167 VPPEIWENMP-YNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRL 172
+A+ F+ I IG+G + V + + ++ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 173 DHPNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
+ +++L + LY+V YM DL L ++ ++ +F
Sbjct: 101 NSEWIVQLH--------YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF------ 146
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y +++ L+ H+ G +HRD+K N+L+D G LK+ADFG D N + V
Sbjct: 147 -YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205
Query: 286 TLWYRPPELLL---GATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L G YG D WS G L E+L G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 120 KIDK-IGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
KI+K IG G + V + L GK VA+K ++ E + F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N+I LEG+VT S + +V YME+ + ++ + QF +++ + + SG+
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENG----SLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRVVTLWYRPPE 293
++ + G +HRD+ N+L++ + V K++DFGL+ DP + + + + PE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 294 LLLGATDYGVGVDLWSAGCILAELLA 319
+ + D+WS G ++ E+++
Sbjct: 180 -AIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 30/209 (14%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRL-DHPNVIK 179
IG+G + VY + TGK+ A+K K R + E++ R +L L D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 180 LEGLVTS--RMSCSLYLV------FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
+ + ++S L L+ +H +H G+ + E++F Y ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEAEMRF------------YAAEI 106
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
+ GLEH HN V++RD+K +N+L+D+ G ++I+D GLA F H + V T Y
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMA 163
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAG 320
PE+L Y D +S GC+L +LL G
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S + I K+G G + V+ K VA+K ++ + PES E I++
Sbjct: 3 IPR--ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQFVYLKVKCYM 228
+L H +++L +V+ +Y+V YM L L P V +
Sbjct: 57 KLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA---- 109
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-HKHPMTSRVVTL 287
Q+ +G+ + +HRD++ +N+L+ D V KIADFGLA + N + ++
Sbjct: 110 -QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK 168
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 326
W P L G + + D+WS G +L EL+ G+ PG
Sbjct: 169 WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 60/201 (29%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
KIG+G+ V A +GK+VA+KK+ D + + + + E++I+R H NV+++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG 242
+ + L++V ++E G A + V T + C +L L H G
Sbjct: 85 --SYLVGDELWVVMEFLE----GGALTDIVTHTRMNEEQIAAVCL--AVLKALSVLHAQG 136
Query: 243 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATDY 301
V+HRDIK ++L+ DG +K++DFG + + + P +V T ++ PE L+ Y
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPE-LISRLPY 193
Query: 302 GVGVDLWSAGCILAELLAGKP 322
G VD+WS G ++ E++ G+P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 120 KIDK-IGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
I+K IG G + V + + L GK VA+K ++ + + + + F+ E I+ + DHP
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHP 65
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N+I+LEG+VT + ++ YME+ L + KFT Q V + + + SG
Sbjct: 66 NIIRLEGVVTKSRP--VMIITEYMENGSLDKFLRENDGKFTVGQLVGM-----LRGIASG 118
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLWYRPP 292
+++ +HRD+ N+L++ + V K++DFGL+ + + T ++ W P
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLA 319
+ + D+WS G ++ E+++
Sbjct: 179 AIAYRK--FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR----FDNLEPESVKFMAREILILRRLD 173
F + +G+G + V A+ TG++ A+K ++ E ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG---LAASPEVKFTEPQFVYLKVKCYMHQ 230
HP ++ L + V ME+ G + +V F+EP+ V+ Y
Sbjct: 61 HPFLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDV-FSEPRAVF-----YAAC 109
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM--TSRVVTLW 288
++ GL++ H N +++RD+K NLL+D +G +KIADFGL K M R T
Sbjct: 110 VVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFC 162
Query: 289 YRP----PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
P PE+L T Y VD W G ++ E+L G+ PG E
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 46/219 (21%)
Query: 125 GQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG-- 182
++ K K T +VA+KK+ D+ E +K + +EI+ R+L HPN++
Sbjct: 11 EDLMIVHLAKHKP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 183 -------LVTSRM---SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCY-MHQL 231
+V+ M SC L H+ E GL PE+ + + +
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPE----GL---PEL-----------AIAFILKDV 110
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFD------PNHKHPMTSRV 284
L+ L++ H+ G +HR +K S++L+ DG + ++ + S H P +S
Sbjct: 111 LNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 285 VTLWYRPPEL---LLGATDYGVGVDLWSAGCILAELLAG 320
W P L L G Y D++S G EL G
Sbjct: 171 NLPWLSPEVLQQNLQG---YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 22/220 (10%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A FE ++ +G GTY VYK + + TG++ A+K + E E +K EI +L++ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 175 -PNVIKLEGLVTSRMSC----SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYM- 228
N+ G + L+LV ME AG + + VK T+ + Y+
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLV---MEFCGAG-SVTDLVKNTKGNALKEDWIAYIC 127
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
++L GL H H + V+HRDIKG N+L+ ++ +K+ DFG+++ D T + T +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 186
Query: 289 YRPPELLLGATD------YGVGVDLWSAGCILAELLAGKP 322
+ PE++ A D Y D+WS G E+ G P
Sbjct: 187 WMAPEVI--ACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 18/218 (8%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
E KIG+G+ V A++ +G+ VA+K + D + + + + E++I+R H NV
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
+++ + + L+++ +++ S + + E Q + +L L +
Sbjct: 81 VEM--YKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQ-----IATVCESVLQALCY 132
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD---PNHKHPMTSRVVTLWYRPPEL 294
H+ GV+HRDIK ++L+ DG +K++DFG + P K S V T ++ PE
Sbjct: 133 LHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK----SLVGTPYWMAPE- 187
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332
++ T YG VD+WS G ++ E++ G+P + V A
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 118 FEKIDKIGQGTYSNV----YKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+KI +G+G + V Y + TG++VA+K ++ + ++ +EI IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAAS-PEVKFTEPQFVYLKVKCYMHQLL 232
H N++K +G + + L L+ Y+ L L P+ K Q + + Q+
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLL-----FAQQIC 117
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLWY 289
G+ + H+ +HRD+ N+L+D+D ++KI DFGLA H++ WY
Sbjct: 118 EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELL 318
L + D+WS G L ELL
Sbjct: 178 AVE--CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G++ V A+ T ++ A+K ++ D ++ + V+ E +L D P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP------ 61
Query: 183 LVTSRMSC-----SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
+T SC LY V Y+ KF EPQ V+ Y ++ GL
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-----YAAEISVGLFF 116
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELL 295
H G+++RD+K N+++D +G +KIADFG+ + +T+R T Y PE +
Sbjct: 117 LHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE-I 172
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+ YG VD W+ G +L E+LAG+P G E
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+EKI +G+G + V+ + K+V +K++ + + + E +L+ L HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 178 IK-LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
I+ E + +L +V Y G A K + + Q+L L
Sbjct: 62 IEYYENFL---EDKALMIVMEYAP---GGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 237 HCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
H H +LHRD+K N+L+D V+KI DFG++ + K + V T Y PEL
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELC 173
Query: 296 LGATDYGVGVDLWSAGCILAELLAGK 321
G Y D+W+ GC+L EL + K
Sbjct: 174 EGKP-YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLE- 181
+G+GT+ V ++ TGK A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
T C V Y S E F+E + + Y +++S L + H+
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALGYLHSC 114
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 301
V++RD+K NL++D DG +KI DFGL + M + T Y PE +L DY
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-VLEDNDY 172
Query: 302 GVGVDLWSAGCILAELLAGK 321
G VD W G ++ E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+KIG+G + +VYK + VA+K R KF+ +E IL++ DHPN++KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL---SGLEHC 238
G+ + +Y+V + + F + L VK + L +G+E+
Sbjct: 59 GVCVQKQP--IYIVMELV-------PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN--HKHPMTSRVVTLWYRPPELLL 296
+ +HRD+ N L+ ++ VLKI+DFG++ + ++ W P L
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 297 GATDYGVGVDLWSAGCILAELLAG 320
G Y D+WS G +L E +
Sbjct: 170 GR--YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F + +G+G + V + TGK+ A KK+ ++ + MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 176 NVIKLEGLVTSRMSCSLYLV--------FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCY 227
V+ L ++ + L L FH AG F E + V+ Y
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--------FEEGRAVF-----Y 107
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 287
++ GLE H +++RD+K N+L+DD G ++I+D GLA + RV T+
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTV 165
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 321
Y PE++ Y D W+ GC+L E++AG+
Sbjct: 166 GYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-16
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
W R D K K+G G Y VY+ VA+K ++ D +E V+ +E ++
Sbjct: 1 WEMERTDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVM 56
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQFVYLKVKCY 227
+ + HPN+++L G+ T Y++ +M + L L + +Y+
Sbjct: 57 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT--- 111
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVT 286
Q+ S +E+ +HRD+ N L+ ++ ++K+ADFGL+ + ++
Sbjct: 112 --QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 169
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAEL 317
W P L + + D+W+ G +L E+
Sbjct: 170 KWTAPES--LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREILILRRLDHPNVIKLEG 182
IG+G++ V + + T +I ALK +R ++ S V E +L +++ P ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 183 LVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
S LYLV FH+++ E +F + + Y +LL
Sbjct: 61 SFQSPEK--LYLVLAFINGGELFHHLQR--------------EGRFDLSRARFYTAELLC 104
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRP 291
LE+ H V++RD+K N+L+D G + + DFGL N K + T Y
Sbjct: 105 ALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEYLA 161
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PELLLG Y VD W+ G +L E+L G P
Sbjct: 162 PELLLG-HGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 51/225 (22%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPN 176
FE + +G G++ V AK TG+ A+K ++ L+ + V+ +A+E IL L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 177 VIKLEGLVTSRMSCS------LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK------- 223
++ M CS +Y + ++ + G E+ F +L+
Sbjct: 80 IVN--------MMCSFQDENRVYFLLEFV---VGG-----EL------FTHLRKAGRFPN 117
Query: 224 --VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 281
K Y +L+ E+ H+ +++RD+K NLL+D+ G +K+ DFG A +
Sbjct: 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVP 169
Query: 282 SRVVTLW----YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
R TL Y PE ++ + +G VD W+ G +L E +AG P
Sbjct: 170 DRTFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR + E K+GQG + V+ T + VA+K ++ + PE+ +E +++
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQFVYLKVKCYM 228
+L H +++L +V+ +Y+V YM L L PQ V +
Sbjct: 57 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA---- 109
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-HKHPMTSRVVTL 287
Q+ SG+ + +HRD++ +N+L+ ++ V K+ADFGLA + N + ++
Sbjct: 110 -QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 168
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 326
W P L G + + D+WS G +L EL G+ PG
Sbjct: 169 WTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 24/224 (10%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+PR ++ + + K+G G + V+ K VA+K ++ ++ PE+ F+A E +++
Sbjct: 3 VPR--ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPE-VKFTEPQFVYLKVKCYM 228
+L HP +++L +VT +Y++ YME+ L +PE +K T + + +
Sbjct: 57 QLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA---- 109
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
Q+ G+ +HRD++ +N+L+ + KIADFGLA + N +
Sbjct: 110 -QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK 168
Query: 289 YRPPELLLGATDYG---VGVDLWSAGCILAELLA-GKPIMPGRT 328
+ PE A +YG + D+WS G +L E++ G+ PG T
Sbjct: 169 WTAPE----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 6/109 (5%)
Query: 213 KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272
FTE + V+ Y+ +++ L+H H G+++RDIK N+L+D +G + + DFGL+ F
Sbjct: 101 HFTESE-----VRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155
Query: 273 DPNHKHPMTSRVVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELLAG 320
+ S T+ Y PE++ G + + VD WS G + ELL G
Sbjct: 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRL 172
+A+ +E + IG+G + V + T K+ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
+ P V++L + LY+V YM DL L ++ +V +F Y ++
Sbjct: 101 NSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF-------YTAEV 151
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
+ L+ H+ G +HRD+K N+L+D G LK+ADFG + + V T Y
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 292 PELLL---GATDYGVGVDLWSAGCILAELLAG 320
PE+L G YG D WS G L E+L G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+ +G G VYKA +LT +I+A+K + D + E K + E+ IL + D P +I
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 182 G--LVTSRMS-CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238
G V +R+S C+ +M+ S +V P+ V ++ ++ GL +
Sbjct: 66 GAFFVENRISICT-----EFMD------GGSLDVYRKIPEHVLGRIAV---AVVKGLTYL 111
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 298
+ +LHRD+K SN+L++ G +K+ DFG+++ + V T Y PE + G
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISG- 167
Query: 299 TDYGVGVDLWSAGCILAELLAGK 321
YG+ D+WS G EL G+
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 124 IGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+GQG++ V+ + + G++ A+K ++ L+ E IL ++HP ++KL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
+ LYL+ ++ S EV FTE VK Y+ +L L+H H+
Sbjct: 64 H--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALALDHLHS 116
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 300
G+++RD+K N+L+D++G +K+ DFGL S +H+ S T+ Y PE ++
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 174
Query: 301 YGVGVDLWSAGCILAELLAG 320
+ D WS G ++ E+L G
Sbjct: 175 HTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 37/98 (37%), Positives = 57/98 (58%)
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
+V+ Y +++ LEH H G+++RDIK N+L+D +G + + DFGL+ F K S
Sbjct: 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 320
T+ Y PE++ G +G VD WS G ++ ELL G
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLE- 181
+G+GT+ V ++ TG+ A+K +R + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
T C V Y S E FTE + + Y +++S LE+ H+
Sbjct: 63 AFQTHDRLC---FVMEYANGGELFFHLSRERVFTEE-----RARFYGAEIVSALEYLHSR 114
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 301
V++RDIK NL++D DG +KI DFGL + M + T Y PE +L DY
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPE-VLEDNDY 172
Query: 302 GVGVDLWSAGCILAELLAGK 321
G VD W G ++ E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 71/233 (30%), Positives = 106/233 (45%), Gaps = 33/233 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
+ FE I I G Y VY + T + A+KK+ NL + + V F+ R+IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDILTFA- 58
Query: 172 LDHPNVIKLEG-LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMH 229
++P V+ + T R C +V Y+E D A L +K V + + Y
Sbjct: 59 -ENPFVVSMFCSFETKRHLC---MVMEYVEGGDCATL-----LKNIGALPVDM-ARMYFA 108
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS-------------FFDPNH 276
+ + LE+ HN G++HRD+K NLLI G +K+ DFGL+ + +
Sbjct: 109 ETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 277 KHPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328
+ + +V T Y PE++L YG VD W+ G IL E L G G T
Sbjct: 169 REFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 47/226 (20%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMARE--ILILRRLDHPNVIKL 180
+G+G++ V A+ T ++ A+K ++ D L+ + V+ E +L L HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHP----- 56
Query: 181 EGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
+T SC L+ V Y M H +F EP+ + Y
Sbjct: 57 --FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR------SGRFDEPRARF-----YAA 103
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW- 288
+++ GL+ H G+++RD+K N+L+D +G +KIADFG+ K + V T
Sbjct: 104 EIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTF 156
Query: 289 -----YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
Y PE+L YG VD W+ G +L E+LAG+ G E
Sbjct: 157 CGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 121 IDKIGQGTYSNVYKAK-DML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
I ++G+G + +V + D L TG++VA+KK++ E ++ REI IL+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDN 66
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
++K +G+ S +L LV Y+ + L + + + Y Q+ G+
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL-----YASQICKGM 121
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-----KHPMTSRVVTLWYR 290
E+ + +HRD+ N+L++ + +KI DFGL + + P S + WY
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWYA 179
Query: 291 PPELLLGATDYGVGVDLWSAGCILAEL 317
P L + + V D+WS G +L EL
Sbjct: 180 PES--LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRL 172
+A+ ++ + IG+G + V + + K+ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
+ P V++L + LY+V YM DL L ++ +V +F Y ++
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF-------YTAEV 151
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
+ L+ H+ G++HRD+K N+L+D G LK+ADFG D + V T Y
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
Query: 292 PELLL---GATDYGVGVDLWSAGCILAELLAG 320
PE+L G YG D WS G L E+L G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 53/173 (30%), Positives = 82/173 (47%), Gaps = 37/173 (21%)
Query: 163 AREILILRRLDHPNVIKLEGLVT-SRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVY 221
A E ILR ++HP++I+L+G T ++ +C L+ + DL + Y
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDL---------------YCY 172
Query: 222 LKVK-----CYM----HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF- 271
L K C + +L +++ H N ++HRDIK N+ I+ G + + DFG A F
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP 232
Query: 272 --FDPNHKHPMTSRVVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELLAGK 321
+ N + + T PELL A D YG VD+WSAG +L E+
Sbjct: 233 VDINANKYYGWAGTIAT---NAPELL--ARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKK-VRFDNLEPESVKFMAREILILRRLDH 174
+ E + +IG GT VYK + TG ++A+K+ R N E M ++ +L+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTE---PQFVYLKVKCYMHQL 231
P ++K G + VF ME L +K + P+ + K+ + +
Sbjct: 74 PYIVKCYGYFITDSD-----VFICME--LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
L L+ H GV+HRD+K SN+L+D G +K+ DFG++ + ++ Y
Sbjct: 127 LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA--YMA 182
Query: 292 PELLLGAT---DYGVGVDLWSAGCILAELLAGK 321
PE + Y + D+WS G L EL G+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 71/249 (28%), Positives = 100/249 (40%), Gaps = 53/249 (21%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDHPN 176
F KI IG G + V + + T + A+K +R D L + E IL D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
V+KL + + +LY V Y+ D+ L + F E + Y+ +L +
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDL-----ARFYIAELTCAI 114
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH------------------- 276
E H G +HRDIK N+LID DG +K+ DFGL + F H
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 277 -------KHPMT----------------SRVVTLWYRPPELLLGATDYGVGVDLWSAGCI 313
+ + S V T Y PE+LL T Y D WS G I
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVI 233
Query: 314 LAELLAGKP 322
L E+L G+P
Sbjct: 234 LYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 34/218 (15%)
Query: 118 FEKIDKIGQGTYSNV----YKAKDMLTGKIVALKKVRFDNLEPES----VKFMAREILIL 169
++I +G+G + V Y + TG+ VA+K +L+PES + + +EI IL
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPESGGNHIADLKKEIEIL 60
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQ---FVYLKVKC 226
R L H N++K +G+ T + L+ ++ S +K P+ + LK +
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFL--------PSGSLKEYLPRNKNKINLKQQL 112
Query: 227 -YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-----KHPM 280
Y Q+ G+++ + +HRD+ N+L++ + +KI DFGL + + K +
Sbjct: 113 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
S V WY PE L+ + Y + D+WS G L ELL
Sbjct: 173 DSPV--FWY-APECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G++ V A+ T ++ A+K ++ D ++ + V+ E +L P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP------ 61
Query: 183 LVTSRMSC-----SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
+T SC LY V Y+ KF EP V+ Y ++ GL
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-----YAAEIAIGLFF 116
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELL 295
H+ G+++RD+K N+++D +G +KIADFG+ N T+R T Y PE++
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYIAPEII 173
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
YG VD W+ G +L E+LAG+P G E
Sbjct: 174 A-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 117 SFEKIDKIGQGTYSNVY---KAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRR 171
+FE + +G G Y V+ K +GK+ A+K ++ + + ++ + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 172 LDH-PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
+ P ++ L + L+L+ Y+ S +F E + V+ Y +
Sbjct: 61 IRQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQE-----VQIYSGE 113
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
++ LEH H G+++RDIK N+L+D +G + + DFGL+ F + S T+ Y
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 291 PPELLLGA-TDYGVGVDLWSAGCILAELLAG 320
P+++ G + VD WS G ++ ELL G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 15/214 (7%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
F K+G G + V++ VA+K ++ D+L + +E+ L+RL H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHL 64
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVK-FTEPQFVYLKVKCYMHQLLSGL 235
I L + + +Y++ ME L SPE + + + Q+ G+
Sbjct: 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC-----QVAEGM 117
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
+ +HRD+ N+L+ +D V K+ADFGLA + ++ W P
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 296 LGATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 328
G + D+WS G +L E+ G+ PG
Sbjct: 178 HGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMN 209
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ D FEKI ++G G V+K +G I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
P ++ G S S+ MEH D L + P+ + KV + + L
Sbjct: 62 SPYIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 116
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
+ L H ++HRD+K SN+L++ G +K+ DFG++ + + S V T Y P
Sbjct: 117 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 171
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGK-PIMP 325
E L G T Y V D+WS G L E+ G+ PI P
Sbjct: 172 ERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 14/157 (8%)
Query: 165 EILILRRLDHPNVIKL-EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK 223
E ++L+ ++HP+VI++ + LV+ ++C +V + DL Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQ----- 158
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 283
Q+L GL + H ++HRD+K N+ I+D + I D G A F P
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLG 215
Query: 284 VV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 319
+ T+ PE+L Y D+WSAG +L E+LA
Sbjct: 216 LAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVK--FMAREILILRRLDHPNVIKL 180
+G+G++ V+ A+ T + A+K ++ D L + V+ + + +L L +HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
T + +L+ V Y+ DL S KF P+ + Y +++ GL+ H
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATF-----YAAEIICGLQFLH 113
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW------YRPPE 293
+ G+++RD+K N+L+D DG +KIADFG+ K M T Y PE
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMC-------KENMLGDAKTCTFCGTPDYIAPE 166
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+LLG Y VD WS G +L E+L G+ G E
Sbjct: 167 ILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 4/159 (2%)
Query: 161 FMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFV 220
+ EIL L RL+H N++K+E ++ R + Y++ + DL + + +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
+ + M QLL +E+ H+ ++HRDIK N+ ++ DG + + DFG A F+ +
Sbjct: 267 K-QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 319
V T+ PE+L G Y D+WS G IL ++L+
Sbjct: 326 YGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 39/236 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDH 174
F+KI +G+G V+ + TGK+ ALK + + + ++ VK + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHY-MEHDL-AGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
P + L + + L LV Y +L L P +E + Y ++L
Sbjct: 61 PFLPTLYA--SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV-----ARFYAAEVL 113
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA----------------SFFDPNH 276
LE+ H G+++RD+K N+L+ + G + ++DF L+ +
Sbjct: 114 LALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 277 KHPMTSRVV------------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 320
+ T Y PE++ G +G VD W+ G +L E+L G
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAK--DMLTGK---IVALKKVRFDNLEPESVKFMAREILI 168
+ D+ ++G+G + V+ + + +VA+K ++ + ++ K RE +
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAEL 61
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL--AASPEVKF----------- 214
L H N++K G+ T +VF YMEH DL + P+ F
Sbjct: 62 LTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 215 TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFD 273
T Q + + V Q+ SG+ + + +HRD+ N L+ D V+KI DFG++ +
Sbjct: 120 TLSQLLQIAV-----QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174
Query: 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317
++ ++ + + PPE ++ + D+WS G +L E+
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 17/199 (8%)
Query: 140 TGKIVALKKVRFDNLEPE-SVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198
TG VA+K +R D E E RE + RL HPN++ L L+F
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFAV 57
Query: 199 MEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 258
E+ + G EV + + M Q+L L HN G++HRD+K N+++
Sbjct: 58 FEY-VPGRTLR-EVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 259 GV---LKIADFGLASFFDPNHKH-----PMTSRVV-TLWYRPPELLLGATDYGVGVDLWS 309
GV K+ DFG+ + T+ V+ T Y PE L G DL++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYA 174
Query: 310 AGCILAELLAGKPIMPGRT 328
G I E L G+ ++ G +
Sbjct: 175 WGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +IG G + V+ L + VA+K +R + E E ++ +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFI---EEAQVMMKLSHP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
+++L G+ T R + LVF +MEH L+ + KF++ + + C + G
Sbjct: 60 KLVQLYGVCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGM---CL--DVCEG 112
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF-FDPNHKHPMTSRVVTLWYRPPE 293
+ + ++ V+HRD+ N L+ ++ V+K++DFG+ F D + ++ W P
Sbjct: 113 MAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEV 172
Query: 294 LLLGATDYGVGVDLWSAGCILAELLA 319
Y D+WS G ++ E+ +
Sbjct: 173 FSFS--KYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 123 KIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
++G+G++ VY KD ++ LK++ L P +E +L +LDHP ++K
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 180 LEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238
R + ++ Y E DL E+K T +V + QLL G+ +
Sbjct: 67 FHASFLERDA--FCIITEYCEGRDLD--CKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 298
H +LHRD+K N+ + ++ +LKI DFG++ T+ T +Y PE L
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE-ALKH 179
Query: 299 TDYGVGVDLWSAGCILAEL 317
Y D+WS GCIL E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
W I R S + + K+G G + V++ T VA+K ++ ++P+ F+ E I
Sbjct: 1 WEIDRT--SIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQI 54
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQFVYLKVKC 226
+++L HP +I+L + T + +Y+V M++ L L PQ + +
Sbjct: 55 MKKLRHPKLIQLYAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA-- 110
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
Q+ SG+ + +HRD+ N+L+ ++ + K+ADFGLA +
Sbjct: 111 ---QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 328
+ + PE L + + D+WS G +L E++ G+ PG T
Sbjct: 168 IKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 66/247 (26%), Positives = 104/247 (42%), Gaps = 56/247 (22%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
R + +E I KIG G + V+ K T + K + + L+ + E+ ++R L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCY------ 227
H N+++ ++ + LY++ + D L+ + + KCY
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFC--DAGDLSRNIQ-------------KCYKMFGKI 115
Query: 228 --------MHQLLSGLEHCHN-----NG--VLHRDIKGSNLL-----------------I 255
QLL L +CHN NG VLHRD+K N+ +
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 256 DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCIL 314
+ + KI DFGL+ + + S V T +Y PELLL T Y D+W+ GCI+
Sbjct: 176 NGRPIAKIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 315 AELLAGK 321
EL +GK
Sbjct: 234 YELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
+ ++G G + V+ K GKI VA+K +R + + F+ E ++ +L HPN+++
Sbjct: 9 LKELGSGQFGVVHLGK--WRGKIDVAIKMIREGAMSEDD--FI-EEAKVMMKLSHPNLVQ 63
Query: 180 LEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
L G+ T + +++V YM + L L TE +L C + +E+
Sbjct: 64 LYGVCTKQRP--IFIVTEYMANGCLLNYLRERKGKLGTE----WLLDMC--SDVCEAMEY 115
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF-FDPNHKHPMTSRVVTLWYRPPELLL 296
+NG +HRD+ N L+ +D V+K++DFGLA + D + ++ W PPE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKW-APPEVFD 174
Query: 297 GATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 328
+ + D+WS G ++ E+ + GK +
Sbjct: 175 -YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 76/272 (27%), Positives = 113/272 (41%), Gaps = 52/272 (19%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
D FE + IG+G + V + TG I A+K +R D LE E V + E IL D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPE-VKFTEPQFVYLKVKCYMHQLL 232
V+K+ + + +LYL+ ++ D+ L + + QF Y+ + +
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-------YIAETV 111
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL------------------------ 268
++ H G +HRDIK NLL+D G +K++DFGL
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 269 ----------ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
A + N + S V T Y PE+ + T Y D WS G I+ E+L
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEML 230
Query: 319 AGKPIMPGRTEVSATFCFVLN----LIFDPFV 346
G P T T+ V+N L+F P V
Sbjct: 231 IGYPPFCSETP-QETYRKVMNWKETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 7e-14
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEG 182
+G+GT+ V ++ +GK A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG 242
+ + L V Y+ S E F+E + + Y +++S L++ H+
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED-----RTRFYGAEIVSALDYLHSGK 115
Query: 243 VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYG 302
+++RD+K NL++D DG +KI DFGL M + T Y PE +L DYG
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPE-VLEDNDYG 173
Query: 303 VGVDLWSAGCILAELLAGK 321
VD W G ++ E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLE 181
IG+G++ V AK GK A+K ++ + + E MA ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
+ + + LY V Y+ E F EP + + Y ++ S L + H+
Sbjct: 63 --YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSL 115
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 301
+++RD+K N+L+D G + + DFGL H ++ T Y PE+L Y
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR-KQPY 173
Query: 302 GVGVDLWSAGCILAELLAGKP 322
VD W G +L E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 20/220 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR + + K+GQG + V+ T K VA+K ++ + PE+ +E I++
Sbjct: 3 IPRESLRLDV--KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYM-EHDLAGLAASPEVKFTE-PQFVYLKVKCYM 228
+L H ++ L +V+ +Y+V +M + L + K+ + PQ V +
Sbjct: 57 KLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA---- 109
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-HKHPMTSRVVTL 287
Q+ G+ + +HRD++ +N+L+ D+ V KIADFGLA + N + ++
Sbjct: 110 -QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK 168
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 326
W P L G + + D+WS G +L EL+ G+ PG
Sbjct: 169 WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 74/271 (27%), Positives = 115/271 (42%), Gaps = 50/271 (18%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRLDH 174
+ FE + IG+G + V + TG + A+K +R D LE E V + E IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
V+K+ +++ LYL+ ++ D+ L + E + + Y+ + +
Sbjct: 61 LWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEE------ETQFYIAETVL 112
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS----------FFDPNHKHPM--- 280
++ H G +HRDIK NLL+D G +K++DFGL + + + NH P
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 281 -----TSRVVTLWYR----------------PPELLLGATDYGVGVDLWSAGCILAELLA 319
+ R W R PE+ + T Y D WS G I+ E+L
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLI 231
Query: 320 GKPIMPGRTEVSATFCFVLN----LIFDPFV 346
G P T T+ V+N LIF P V
Sbjct: 232 GYPPFCSETP-QETYKKVMNWKETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR-EILILRRLDHPNVIKLE- 181
+G+G + V + TGK+ A KK+ L+ +S + MA E IL +++ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 182 --------GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
LV S M+ L +H GL +V Y Q+
Sbjct: 61 AFESKTHLCLVMSLMNGG-DLKYHIYNVGERGLEME-------------RVIHYSAQITC 106
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
G+ H H+ +++RD+K N+L+DD G +++D GLA + +T R T Y PE
Sbjct: 107 GILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPE 164
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGK 321
+L Y VD ++ GC + E++AG+
Sbjct: 165 ILKEEP-YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 15/224 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ D FE+I ++G G V K + +G I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
P ++ G S S+ MEH D L + P+ + KV + + L
Sbjct: 62 SPYIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGL 116
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
+ L H ++HRD+K SN+L++ G +K+ DFG++ + + S V T Y P
Sbjct: 117 AYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 171
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGK-PI-MPGRTEVSATF 334
E L G T Y V D+WS G L EL G+ PI P E+ A F
Sbjct: 172 ERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH- 174
D E I+++G+G Y V K + + TG I+A+K++R + + K + ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDC 59
Query: 175 PNVIKLEGLVTSR---------MSCSLYLVF-HYMEHDLAGLAASPEVKFTEPQFVYLKV 224
P + G + M SL + + L T P+ + K+
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGL-----------TIPEDILGKI 108
Query: 225 KCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTS 282
++ LE+ H+ V+HRD+K SN+LI+ +G +K+ DFG++ + D K T
Sbjct: 109 AV---SIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---TI 162
Query: 283 RVVTLWYRPPELLLGATD---YGVGVDLWSAGCILAELLAGK 321
Y PE + + Y V D+WS G + EL G+
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVK--FMAREILILRRLDHPNVIKL 180
+G+G++ V A+ T ++ A+K ++ D L+ + V + IL L HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHP----- 56
Query: 181 EGLVTSRMSC-----SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
+T+ C L+ V Y+ KF EP + + Y ++ L
Sbjct: 57 --FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP-----RSRFYAAEVTLAL 109
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW------Y 289
H +GV++RD+K N+L+D +G K+ADFG+ K + + V T Y
Sbjct: 110 MFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMC-------KEGILNGVTTTTFCGTPDY 162
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE +L +YG VD W+ G ++ E++AG+P
Sbjct: 163 IAPE-ILQELEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 9/109 (8%)
Query: 214 FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFF 272
F EP+ + Y Q++SGLEH H +++RD+K N+L+D+DG ++I+D GLA
Sbjct: 94 FPEPRACF-----YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK 148
Query: 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 321
D K T + PELL G +Y VD ++ G L E++A +
Sbjct: 149 DGQSK--TKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 121 IDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
++++G+G + VYK + + L+ VA+K ++ +N EP+ + +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 176 NVIKLEGLVT-SRMSCSLYLVFHYMEH-DL----------AGLAASPEVKFTEPQFVYLK 223
N++ L G+ T + +C L F Y+ H DL + + A + +
Sbjct: 69 NIVCLLGVCTKEQPTCML---FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL------ASFFDPNHK 277
Q+ +G+E+ ++ +HRD+ N L+ + +KI+DFGL A ++ K
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317
+ R W P +L G + D+WS G +L E+
Sbjct: 186 SLLPVR----WMPPEAILYGK--FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 30/206 (14%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
+G+G+Y V + GK +KK+ N K +E +L +L HPN+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI------ 61
Query: 184 VTSRMS-----CSLYLVFHYME-----HDLAGLAAS--PEVKFTEPQFVYLKVKCYMHQL 231
V R S LY+V + E H L PE + E + Q+
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE----------WFVQI 111
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
L++ H +LHRD+K N+ + ++K+ D G+A + N ++ + T +Y
Sbjct: 112 AMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMS 170
Query: 292 PELLLGATDYGVGVDLWSAGCILAEL 317
PE L Y D+W+ GC + E+
Sbjct: 171 PE-LFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 73/255 (28%), Positives = 103/255 (40%), Gaps = 61/255 (23%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRF-DNLEPESVKFMAREILILRRLDHPN 176
F KI +G G + V A+ + T + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTE--PQFVYLKVKCYMHQLLS 233
V++L + + +LY V Y+ D+ L + F E +F Y+ +L
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARF-------YIAELTC 112
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK---------------- 277
+E H G +HRDIK N+LID DG +K+ DFGL + F H
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 278 -----------------HPMTSR-------------VVTLWYRPPELLLGATDYGVGVDL 307
P+ R V T Y PE+LL T Y D
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDW 231
Query: 308 WSAGCILAELLAGKP 322
WS G IL E+L G+P
Sbjct: 232 WSVGVILYEMLVGQP 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 74/262 (28%), Positives = 103/262 (39%), Gaps = 59/262 (22%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRF-DNLEPESVKFMAREILILRRLDHPN 176
F KI +G G + V A + T + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 177 VIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
V+KL + + LY V Y+ D+ L EV F + + Y+ +L +
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMEV------FPEVLARFYIAELTLAI 114
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF----------DPNHKHPMTSRVV 285
E H G +HRDIK N+LID DG +K+ DFGL + F +H +
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 286 TLW------------------------------------YRPPELLLGATDYGVGVDLWS 309
LW Y PE+LL Y D WS
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWS 233
Query: 310 AGCILAELLAGKP--IMPGRTE 329
G IL E+L G+P + P TE
Sbjct: 234 VGVILFEMLVGQPPFLAPTPTE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 45/201 (22%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
IG G + V++ + G+ VA+K ++ E + F++ E I+ + H N+I+L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
EG+VT ++ YME+ A ++ + +F ++ + + +G+++ +
Sbjct: 72 EGVVTKFKP--AMIITEYMENG----ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRVVTLWYRPPELLLGA 298
+HRD+ N+L++ + K++DFGL+ DP + + + + + PE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAY 184
Query: 299 TDYGVGVDLWSAGCILAELLA 319
+ D+WS G ++ E+++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 165 EILILRRLDHPNVIKLEGL-VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK 223
E +LRRL HP V+ L + V ++C LV DL + Q
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQ----- 261
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 283
V QLLS +++ H G++HRDIK N+L++ + + DFG A F + P
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 284 VV-TLWYRPPELLLGATDYGVGVDLWSAGCILAE 316
+ T+ PE+L G Y VD+WSAG ++ E
Sbjct: 322 IAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 124 IGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G + V+K L K VA+K + D + +KF++ E IL++ DHPN++KL G
Sbjct: 3 LGKGNFGEVFKGT--LKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIG 59
Query: 183 LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
+ T R +Y+V + D + + Q V + +G+ + +
Sbjct: 60 VCTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDA-----AAGMAYLESK 112
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-HKHPMTSRVVTLWYRPPELLLGATD 300
+HRD+ N L+ ++ VLKI+DFG++ D + ++ W P L G
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR-- 170
Query: 301 YGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332
Y D+WS G +L E + G PG T A
Sbjct: 171 YSSESDVWSYGILLWETFSLGVCPYPGMTNQQA 203
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK----KVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
IG+G++ V AK L GK A+K K+ + E + + MA ++L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
L + + + LY V ++ E F EP + + Y ++ S L + H
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLH 113
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 299
+ +++RD+K N+L+D G + + DFGL T+ T Y PE++
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIR-KQ 171
Query: 300 DYGVGVDLWSAGCILAELLAGKP 322
Y VD W G +L E+L G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 124 IGQGTYSNVYKAKDML---TGKIVA---LKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+G+G Y V++ + + TGKI A LKK + ++ A E IL + HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPFI 62
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKC-YMHQLLSGLE 236
+ L + + LYL+ Y+ + E F E C Y+ ++ LE
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFME------DTACFYLSEISLALE 114
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA--SFFDPNHKHPMTSRVVTLWYRPPEL 294
H H G+++RD+K N+L+D G +K+ DFGL S + H T+ Y PE+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCG---TIEYMAPEI 171
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKP 322
L+ + +G VD WS G ++ ++L G P
Sbjct: 172 LM-RSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+ IG+G + V + + TG+ VA+K ++ D + F+ E ++ +L H N+++L
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCD---VTAQAFLE-ETAVMTKLHHKNLVRLL 65
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAG-----LAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236
G++ + LY+V ME G L + Q + + + G+E
Sbjct: 66 GVI---LHNGLYIV---MELMSKGNLVNFLRTRGRALVSVIQLLQFSL-----DVAEGME 114
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
+ + ++HRD+ N+L+ +DGV K++DFGLA S++ W P L
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKWTAPEALKH 171
Query: 297 GATDYGVGVDLWSAGCILAELLA 319
+ D+WS G +L E+ +
Sbjct: 172 K--KFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 64/255 (25%), Positives = 105/255 (41%), Gaps = 57/255 (22%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
+ F + IG+G + V + TGKI A+K + + + + + + E +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
P V+ L + + + LYL+ ++ DL + + F+E + YM + +
Sbjct: 61 PWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDV-----TRFYMAECVL 112
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH--------------KHP 279
+E H G +HRDIK N+LID G +K++DFGL++ F H K+
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 280 MTSR----VVTLW----------------------------YRPPELLLGATDYGVGVDL 307
+ +R V ++ Y PE+ L YG D
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDW 231
Query: 308 WSAGCILAELLAGKP 322
WS G I+ E L G P
Sbjct: 232 WSLGAIMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE-SVKFMAREILILRRLDHPNVIKL 180
++IG+G + V+ + VA+K R + L P+ KF+ +E IL++ HPN+++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFL-QEARILKQYSHPNIVRL 58
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCY---MHQLLSGLEH 237
G+ T + +Y+V ++ + F + LKVK + +G+E+
Sbjct: 59 IGVCTQKQP--IYIVMELVQ-------GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS---RVVTLWYRPPEL 294
+ +HRD+ N L+ + VLKI+DFG+ S + + + T ++ W P L
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGM-SREEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 295 LLGATDYGVGVDLWSAGCILAE 316
G Y D+WS G +L E
Sbjct: 169 NYGR--YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 24/224 (10%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR + EK K+G G + V+ A K VA+K ++ ++ SV+ E +++
Sbjct: 3 IPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQFVYLKVKCYM 228
L H ++KL +VT +Y++ +M L L + K P+ +
Sbjct: 57 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA---- 109
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
Q+ G+ +HRD++ +N+L+ V KIADFGLA + N +
Sbjct: 110 -QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 168
Query: 289 YRPPELLLGATDYG---VGVDLWSAGCILAELLA-GKPIMPGRT 328
+ PE A ++G + D+WS G +L E++ G+ PG +
Sbjct: 169 WTAPE----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 54/235 (22%), Positives = 102/235 (43%), Gaps = 37/235 (15%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAK--DMLTGK---IVALKKVRFDNLEPESVKFMAREI 166
PR ++ E + IGQG + V++A+ +L + +VA+K ++ + F RE
Sbjct: 3 PR--NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 59
Query: 167 LILRRLDHPNVIKLEGL-VTSRMSCSLYLVFHYME--------------------HDLAG 205
++ DHPN++KL G+ + C L+F YM H +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 206 LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265
+ C Q+ +G+ + +HRD+ N L+ ++ V+KIAD
Sbjct: 117 ARKCGLNP---LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 173
Query: 266 FGLA-SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 319
FGL+ + + ++ + + + + PPE + Y D+W+ G +L E+ +
Sbjct: 174 FGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S + + K+G G + V+ + K VA+K ++ + SV+ E +++
Sbjct: 3 IPR--ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMK 56
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQFVYLKVKCYM 228
L H +++L +VT +Y++ YM L L + K P+ +
Sbjct: 57 TLQHDKLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA---- 110
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
Q+ G+ + +HRD++ +N+L+ + + KIADFGLA + N +
Sbjct: 111 -QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK 169
Query: 289 YRPPELLLGATDYG---VGVDLWSAGCILAELLA-GKPIMPGRT 328
+ PE A ++G + D+WS G +L E++ GK PG +
Sbjct: 170 WTAPE----AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+ IG+G + +V G+ VA+K ++ D+ ++ F+A E ++ L HPN++
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 179 KLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPE----VKFTEPQFVYLKVKCYMHQLLS 233
+L G+V LY+V YM L S + F +
Sbjct: 64 QLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--------DVCE 113
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
G+E+ +HRD+ N+L+ +D V K++DFGLA + ++ W P
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEA 170
Query: 294 LLLGATDYGVGVDLWSAGCILAELLA 319
L + D+WS G +L E+ +
Sbjct: 171 LREK--KFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLE 181
IG+G++ V AK G A+K ++ + + E MA ++L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
+ + + LY V Y+ E F EP + + Y ++ S + + H+
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSL 115
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATD 300
+++RD+K N+L+D G + + DFGL + TS T Y PE +L
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE-VLRKEP 172
Query: 301 YGVGVDLWSAGCILAELLAGKP 322
Y VD W G +L E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVK--FMAREILILRRLDHPNVIKL 180
+G+G++ V A+ T + A+K ++ D LE + V+ + R +L L +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
T + L+ V Y+ +F E + + Y +++ GL+ H
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-----RARFYAAEIICGLQFLHK 114
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 300
G+++RD+K N+L+D DG +KIADFG+ + N + ++ T Y PE+L G
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYIAPEILKGQK- 172
Query: 301 YGVGVDLWSAGCILAELLAGKPIMPGRTE 329
Y VD WS G +L E+L G+ G E
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-12
Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLE 181
IG+G+Y+ V + T +I A+K V+ + + + E + ++ E + + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
+ L+ V Y+ + K E + Y ++ L + H
Sbjct: 63 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHER 115
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATD 300
G+++RD+K N+L+D +G +K+ D+G+ + TS T Y PE+L G D
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRG-ED 172
Query: 301 YGVGVDLWSAGCILAELLAGK 321
YG VD W+ G ++ E++AG+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 38/105 (36%), Positives = 59/105 (56%), Gaps = 6/105 (5%)
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA--SFFDPNHKHPMTSRV 284
Y +++ GL+ H+ G+++RD+K N+++D DG +KIADFG+ + F N ++
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFC 157
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
T Y PE+L G Y VD WS G +L E+L G+ G E
Sbjct: 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 14/185 (7%)
Query: 143 IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH- 201
+VA+K +R D + F+ +EI I+ RL +PN+I+L G+ S L ++ YME+
Sbjct: 46 LVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENG 102
Query: 202 DLAGLAASPEV--KFTE----PQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI 255
DL + E+ FT P + Q+ SG+++ + +HRD+ N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 256 DDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCI 313
+ +KIADFG++ + + R V W +LLG + D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVT 220
Query: 314 LAELL 318
L E+
Sbjct: 221 LWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDHPNVIKLEG 182
+G+G++ V A+ T ++ A+K ++ D ++ + V+ E +L P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP------ 61
Query: 183 LVTSRMSC-----SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
+T SC LY V Y+ +F EP V+ Y ++ GL
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-----YAAEIAIGLFF 116
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELL 295
H+ G+++RD+K N+++D +G +KIADFG+ N +T++ T Y PE +
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPE-I 172
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+ YG VD W+ G +L E+LAG+ G E
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 122 DKIGQGTYSNVYKAK-DMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
K+G G++ V + + GK+ VA+K ++ D L F+ +E I+ LDH N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE-VKFTEPQFVYLKVKC-YMHQLLSGLE 236
+L G+V ++ L +V +LA L + + ++ + C Y Q+ +G+
Sbjct: 60 RLYGVV---LTHPLMMVT-----ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLWYRPPEL 294
+ + +HRD+ N+L+ D +KI DFGL N H + V + PE
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 295 L-----LGATD-YGVGVDLW 308
L A+D + GV LW
Sbjct: 172 LRTRTFSHASDVWMFGVTLW 191
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 19/219 (8%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDHP 175
+F +G+G + V + TGK+ A KK+ ++ + MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF-----TEPQFVYLKVKCYMHQ 230
V+ L +L LV M ++KF P F + Y +
Sbjct: 61 FVVSLA--YAYETKDALCLVLTIMN--------GGDLKFHIYNMGNPGFDEQRAIFYAAE 110
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
L GLE +++RD+K N+L+DD G ++I+D GLA + RV T+ Y
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYM 168
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
PE++ Y D W GC++ E++ G+ R E
Sbjct: 169 APEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 123 KIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+IG+G ++VY A+ TG +V ++ +N E +K + E+++ HPN++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK-VKCYMHQLLSGLEHCH 239
+ T+ L+++ +M + +A+ +K P+ + + + L GL + H
Sbjct: 65 WTVFTT--GSWLWVISPFMAYG----SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH 118
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFG-LASFFDPNHKH------PMTSRVVTLWYRPP 292
NG +HR+IK S++LI DG++ ++ L S K P S V W P
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGK-PIM 324
L Y V D++S G EL G+ P
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK--FMAREILILRRLDHP 175
++ I IG+G VY A D + + VALKK+R D E +K F+ RE I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLK--VKCYM---H 229
++ + + + +Y Y+E + L L S K + + + K V ++ H
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA----------SFFDPNHKHP 279
++ + +E+ H+ GVLHRD+K N+L+ G + I D+G A D + ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 280 MTSR-------VVTLWYRPPELLLGA-----TD-YGVGVDLW 308
S V T Y PE LLG TD Y +GV L+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILY 222
|
Length = 932 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D FEK+ ++G G V K +G I+A K + + ++P + RE+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSP 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH------DLAGLAAS--PEVKFTEPQFVYLKVKCY 227
++ G S S+ MEH D A PE + L+ Y
Sbjct: 60 YIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 287
+ + ++HRD+K SN+L++ G +K+ DFG++ S V T
Sbjct: 115 LREKHK---------IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTR 162
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGK-PIMP 325
Y PE L G T Y V D+WS G L E+ G+ PI P
Sbjct: 163 SYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 13/155 (8%)
Query: 123 KIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
IG+G + +VY+ KI VA+K + KF+ E I+R+ DHP+++K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVK 71
Query: 180 LEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238
L G++T +++V ME L L + +V L + Y QL + L +
Sbjct: 72 LIGVITEN---PVWIV---MELAPLGELRSYLQVNKYSLDLASLILYSY--QLSTALAYL 123
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273
+ +HRDI N+L+ +K+ DFGL+ + +
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMARE--ILILRRLDHPNVIKL 180
+G+G++ V A+ +G++ A+K ++ D L+ + V+ E IL L R +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
+ L+ V ++ +F E + + Y ++ S L H+
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEITSALMFLHD 114
Query: 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGAT 299
G+++RD+K N+L+D +G K+ADFG+ + TS T Y PE +L
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPE-ILQEM 171
Query: 300 DYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
YG VD W+ G +L E+L G E
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEG 182
+G+GT+ V K+ TG+ A+K ++ + + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN- 241
+ + L V Y S E F+E + + Y +++S L++ H+
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALDYLHSEK 115
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY 301
V++RD+K NL++D DG +KI DFGL M + T Y PE +L DY
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-VLEDNDY 173
Query: 302 GVGVDLWSAGCILAELLAGK 321
G VD W G ++ E++ G+
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLE 181
IG+G++ V A+ K A+K ++ + + E M+ ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
+ + + LY V Y+ E F EP + + Y ++ S L + H+
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSL 115
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGAT 299
+++RD+K N+L+D G + + DFGL N +H T+ T Y PE +L
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPE-VLHKQ 171
Query: 300 DYGVGVDLWSAGCILAELLAGKP 322
Y VD W G +L E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 124 IGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
+G+G + +V + + D K VA+K ++ D ++ E ++ DHPNV+K
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 180 LEGLVTSRMSC-----SLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYL-KVKCYMHQLL 232
L G V S ++ +M+H DL + P+ + L + +M +
Sbjct: 66 LIG-VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIA 123
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
G+E+ N +HRD+ N ++ +D + +ADFGL+
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 44/226 (19%)
Query: 114 RADSFEKIDKIGQGTYSNV----YKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
+ + F I +G G++ V YK +D I +K + ++ + V + E IL
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKIL 85
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK------ 223
++HP + L G + + LYLV ++ + G +F F +L+
Sbjct: 86 NYINHPFCVNLYG--SFKDESYLYLVLEFV---IGG-------EF----FTFLRRNKRFP 129
Query: 224 --VKC-YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
V C Y Q++ E+ + +++RD+K NLL+D DG +K+ DFG A D
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------- 182
Query: 281 TSRVVTLWYRP----PELLLGATDYGVGVDLWSAGCILAELLAGKP 322
+R TL P PE+LL +G D W+ G + E+L G P
Sbjct: 183 -TRTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 44/164 (26%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLK 223
E ++ +L H +++L G+ T + +Y+V YM + L +F Q + +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM- 105
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF-FDPNHKHPMTS 282
C + G+ + + +HRD+ N L+DD G +K++DFGL+ + D + + S
Sbjct: 106 --CK--DVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMP 325
+ W PPE+LL + + D+W+ G ++ E+ + GK MP
Sbjct: 162 KFPVRW-SPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 124 IGQGTYSNVYKAK---DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+G+G + +V +A+ + + + VA+K ++ D ++ RE ++ DHPNVIKL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 181 EGL-VTSRMSCSL---YLVFHYMEH-DL-AGLAASP--EVKFTEPQFVYLKVKCYMHQLL 232
G+ + SR L ++ +M+H DL L S E FT P ++ +M +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR---FMIDIA 123
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRVVTLWYR 290
SG+E+ + +HRD+ N +++++ + +ADFGL+ + ++ S++ W
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELL 318
L Y D+W+ G + E++
Sbjct: 184 LES--LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-11
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+ ++G G + V+ K K VA+K + + E F+ E ++ +L HP +++L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQL 64
Query: 181 EGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
G+ T + LY+V +ME+ L + K ++ + + C + G+E+
Sbjct: 65 YGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSM---C--QDVCEGMEYLE 117
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASF-FDPNHKHPMTSRVVTLWYRPPELLLGA 298
N +HRD+ N L+ GV+K++DFG+ + D + ++ W PPE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPEVFN-F 175
Query: 299 TDYGVGVDLWSAGCILAELLA-GKPIMP 325
+ Y D+WS G ++ E+ GK MP
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLD-HPNVIKLE 181
IG+G+Y+ V + +I A+K V+ + + + E + ++ E + + +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
+ + L+LV Y+ + K E + Y ++ L H
Sbjct: 63 SCFQT--TSRLFLVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYAAEICIALNFLHER 115
Query: 242 GVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPELLLGATD 300
G+++RD+K N+L+D DG +K+ D+G+ P ++ T Y PE+L G +
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRG-EE 172
Query: 301 YGVGVDLWSAGCILAELLAGK 321
YG VD W+ G ++ E++AG+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 39/235 (16%)
Query: 112 PRRADSFEKIDKIGQGTYSNVY--KAKDMLTGK--------------IVALKKVRFDNLE 155
PR+ +F+ +K+G+G + V+ +A+ M +VA+K +R D +
Sbjct: 3 PRKRLTFK--EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 156 PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME----------HDLAG 205
F+ +EI I+ RL PN+I+L L S L ++ YME H+
Sbjct: 61 NARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 206 LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265
A +V Y + Q+ SG+++ + +HRD+ N L+ + +KIAD
Sbjct: 118 AAEKADVVTIS----YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIAD 173
Query: 266 FGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
FG++ + + R V W +LLG + D+W+ G L E+L
Sbjct: 174 FGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 53/226 (23%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGKI---VALKKVRFDNLEPESVKFMAR 164
W R + I ++GQG++ VY+ AK ++ G+ VA+K V + E ++F+
Sbjct: 1 WELPR-EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN- 58
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAAS--PEVKFTEPQFV- 220
E +++ + +V++L G+V+ +V M DL S PE +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 221 -YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKH 278
K ++ G+ + +HRD+ N ++ +D +KI DFG+ ++ ++
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 279 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
++ + + PE L + D+WS G +L E+ LA +P
Sbjct: 177 KGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 121 IDKIGQGTYSNVYKAKDMLTG-----KIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
++++G+ + VYK T + VA+K ++ D E + E ++ RL HP
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH--------------DLAGLAASPEVKFT--EPQF 219
N++ L G+VT S+ +F Y H D+ VK T F
Sbjct: 69 NIVCLLGVVTKEQPLSM--IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 220 VYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL-ASFFDPNHKH 278
V++ + Q+ +G+E ++ V+H+D+ N+L+ D +KI+D GL + ++
Sbjct: 127 VHI-----VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 279 PMTSRVVTL-WYRPPELLLGATDYGVGVDLWSAGCILAELLA 319
M + ++ + W P ++ G + + D+WS G +L E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLE 181
IG+G+Y+ V + T +I A+K ++ + + + E + ++ E + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 182 GL--VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
SR L+ V ++ + K E + Y ++ L H
Sbjct: 63 SCFQTESR----LFFVIEFVSGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNFLH 113
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPPELLLGA 298
G+++RD+K N+L+D +G +K+ D+G+ + TS T Y PE+L G
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRG- 170
Query: 299 TDYGVGVDLWSAGCILAELLAGK 321
DYG VD W+ G ++ E++AG+
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 118 FEKIDKIGQGTYSNVYKA---KDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLD 173
EKI +G G + VYK + KI VA+K +R + P++ K + E ++ +D
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVD 67
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
HP+V++L G+ +S + L+ M V+ + + + Q+
Sbjct: 68 HPHVVRLLGIC---LSSQVQLITQLMPLG----CLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVVTLWYRP 291
G+ + ++HRD+ N+L+ +KI DFGLA D + K +V W
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 292 PELLLGATDYGVGVDLWSAGCILAELL 318
+L Y D+WS G + EL+
Sbjct: 181 ESILHR--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 122 DKIGQGTYSNVYKA---KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNV 177
D IG+G + V KA KD L A+K+++ + + + A E+ +L +L HPN+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMD-AAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYM---HQLLS 233
I L G R LYL Y H +L V T+P F QLL
Sbjct: 71 INLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 234 -------GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
G+++ +HRD+ N+L+ ++ V KIADFGL+ + K M R+
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPV 187
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
W L + Y D+WS G +L E+ L G P
Sbjct: 188 RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 29/212 (13%)
Query: 124 IGQGTYSNVYKAK-DMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+G G + +V K M +GK VA+K ++ K RE ++ +LDHP +++L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF--TEPQFVYLKVKCYMHQLLSG---L 235
G+ LV ME LA L P +K+ + +K HQ+ G L
Sbjct: 62 IGVCKGEPLM---LV---ME--LAPLG--PLLKYLKKRREIPVSDLKELAHQVAMGMAYL 111
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---HKHPMTSRVVTLWYRPP 292
E H +HRD+ N+L+ + KI+DFG++ ++ R WY P
Sbjct: 112 ESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLA--GKP 322
+ G D+WS G L E + KP
Sbjct: 169 CINYGKFSS--KSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
R + E I +G G +V K K + TG ++A KKV + K + RE+ I+
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
P ++ G + + + + +M D L + P + K+ + + L+
Sbjct: 62 SPYIVSFYGAFLNENNICMCM--EFM--DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLT 117
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-----SFFDPNHKHPMTSRVVTLW 288
L + H ++HRDIK SN+L++ G +K+ DFG++ S D + V T
Sbjct: 118 YLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--------TFVGTST 167
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGK 321
Y PE + G Y V D+WS G + EL GK
Sbjct: 168 YMSPERIQGG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 32/222 (14%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A+ + + +IG+G + V K +G I+A+K++R E E + + +++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
P ++K G + C ++ M+ L ++VY +K + + + G
Sbjct: 63 PYIVKFYGALFREGDC--WICMELMDISLDKFY----------KYVYEVLKSVIPEEILG 110
Query: 235 ---------LEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
L + ++HRD+K SN+L+D +G +K+ DFG++ ++
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-----QLVDSIAKT 165
Query: 285 VTLWYRP---PELLL--GATDYGVGVDLWSAGCILAELLAGK 321
RP PE + Y V D+WS G L E+ GK
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDH 174
D FE I IG+G + V K T +I A+K + +++ L+ E +L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVF-HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
+ L + LYLV +Y+ DL L + E + E + Y+ +++
Sbjct: 61 QWITTLH--YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM-----ARFYIAEMVL 113
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRP 291
+ H +HRDIK N+L+D +G +++ADFG S N + S V T Y
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 292 PELLLGATD----YGVGVDLWSAGCILAELLAGK 321
PE+L D YG D WS G + E+L G+
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 6/113 (5%)
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSR 283
CY Q+ G+E + +HRD+ N+L+ ++ V+KI DFGLA + DP++ +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335
+ W P + Y + D+WS G +L E+ + G PG ++ FC
Sbjct: 243 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPG-VKIDEEFC 292
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 117 SFEKIDKIGQGTYSNVYKAK-----DMLTGKIV---ALKKVRFDNLEPESVKFMAREILI 168
+ ++I +G+G + V+ AK + +V AL+K + +NL+ E RE+ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE----FRRELDM 61
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME-HDLAG--LAASPEVKFTEPQFVYLKVK 225
R+L H NV++L GL R + Y++ Y + DL A + + +P + K K
Sbjct: 62 FRKLSHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 226 CYM-HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
+ Q+ G++H N +HRD+ N L+ +K++ L+ + + + + +
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317
+ L + PE + D+ D+WS G ++ E+
Sbjct: 180 IPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSR 283
CY Q+ G+E + +HRD+ N+L+ ++ V+KI DFGLA + DP++ ++R
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335
+ W P + Y D+WS G +L E+ + G PG +++ FC
Sbjct: 238 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPG-VQINEEFC 287
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 48/221 (21%), Positives = 106/221 (47%), Gaps = 31/221 (14%)
Query: 121 IDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
++++G+ + +YK L G ++VA+K ++ D P+ +E ++ L HPN
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPN 68
Query: 177 VIKLEGLVTSRMSCSLYLVFHYME-------------HDLAGLAASPE--VK--FTEPQF 219
++ L G+VT + ++F Y+ H G ++ + VK F
Sbjct: 69 IVCLLGVVTQEQP--VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 220 VYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKH 278
+++ + Q+ +G+E+ ++ +H+D+ N+LI + +KI+D GL+ + ++
Sbjct: 127 LHIAI-----QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 279 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 319
++ + + PPE ++ + D+WS G +L E+ +
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 49/172 (28%), Positives = 72/172 (41%), Gaps = 36/172 (20%)
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK 223
REI IL+ + H +I L + R ++ +V + DL F Y+
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCDL---------------FTYVD 177
Query: 224 VKCYM---------HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274
+ +LL L + H G++HRD+K N+ +D+ + DFG A D
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD- 236
Query: 275 NHKHPMTSR----VVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELLAGK 321
HP T + TL PELL A D Y D+WSAG +L E+
Sbjct: 237 --AHPDTPQCYGWSGTLETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGKI---VALKKV-RFDNLEPESVKFMAREILILRRLDHPNVIK 179
IG+G + VY + + A+K + R +LE V+ +E +I++ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNVLS 60
Query: 180 LEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238
L G+ L +V YM+H DL S T + + Q+ G+E+
Sbjct: 61 LLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-----QVAKGMEYL 114
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLA------SFFDP-NHKHPMTSRVVTLWYRP 291
+ +HRD+ N ++D+ +K+ADFGLA ++ NH +++ W
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG---AKLPVKWMAL 171
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLA-GKPIMP 325
L + D+WS G +L EL+ G P P
Sbjct: 172 ES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 120 KIDKI-GQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
KI++I G G + + + L K VA+ +R + + F+A E L L + DH
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHS 66
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N+++LEG++T ++ +V YM + A ++ E Q V ++ + L SG+
Sbjct: 67 NIVRLEGVITR--GNTMMIVTEYMSNG----ALDSFLRKHEGQLVAGQLMGMLPGLASGM 120
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-----HPMTSRVVTLWYR 290
++ G +H+ + +L++ D V KI+ F K M+ + LW
Sbjct: 121 KYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL----QEDKSEAIYTTMSGKSPVLWAA 176
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLA 319
P + + D+WS G ++ E+++
Sbjct: 177 PEAIQYH--HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 13/212 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDH 174
+ FE + IG+G + V K K+ A+K + +++ L+ E +L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVF-HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
+ L + +LYLV +Y+ DL L + E + E + Y+ +++
Sbjct: 61 QWITTLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-----ARFYLAEMVI 113
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
++ H +HRDIK N+L+D +G +++ADFG + + V T Y PE
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 294 LLLGATD----YGVGVDLWSAGCILAELLAGK 321
+L D YG D WS G + E+L G+
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 124 IGQGTYSNVYKAK----DMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRL-DHPNV 177
+G+G + V KA+ D VA+K ++ D E + ++ E+ +++ + H N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNI 78
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DL---------AGLAASPEVKFT-EPQFVYLKVKC 226
I L G+ T LY+V Y H +L G ASP+ E +
Sbjct: 79 INLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH----KHPMTS 282
+ +Q+ G+E + +HRD+ N+L+ +D V+KIADFGLA D +H +
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNG 194
Query: 283 RVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAEL--LAGKPIMPG 326
R+ W P L D Y D+WS G +L E+ L G P PG
Sbjct: 195 RLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 13/212 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPESVKFMAREILILRRLDH 174
D FE + IG+G + V K TG++ A+K + +++ L+ E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVF-HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
+ L + LYLV +Y+ DL L + E + E + Y+ +++
Sbjct: 61 RWITNLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFEDRLPEDM-----ARFYLAEMVL 113
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
++ H G +HRDIK N+L+D +G +++ADFG + V T Y PE
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
Query: 294 LLLGATD----YGVGVDLWSAGCILAELLAGK 321
+L D YG D WS G + E+L G+
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 23/226 (10%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-----ESVKFMAREI 166
PR SF K +G G + V +A K A+ KV L+P E M+ E+
Sbjct: 33 PRNNLSFGKT--LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-EL 89
Query: 167 LILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKV 224
I+ L +H N++ L G T + + ++ Y + DL F +
Sbjct: 90 KIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLT----LEDL 143
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTS 282
+ +Q+ G+ + +HRD+ N+L+ ++KI DFGLA D N+ +
Sbjct: 144 LSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPG 326
R+ W P + Y D+WS G +L E+ L P PG
Sbjct: 204 RLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNP-YPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 29/226 (12%)
Query: 124 IGQGTYSNVYKAKDMLTGK-------IVALKKVRFDNLEPESVKFMAREILILRRLD-HP 175
+G+G + V +A+ K VA+K ++ DN + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELMKLIGKHK 78
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYM------EHDLAGLAASPEVKF-----TEPQFVYLKV 224
N+I L G+ T LY++ Y E A P+ F E Q + +
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS-- 282
+Q+ G+E+ + +HRD+ N+L+ +D V+KIADFGLA + TS
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPG 326
R+ W P L Y D+WS G ++ E+ L G P PG
Sbjct: 197 RLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 123 KIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
++G G + V K K + K VA+K ++ DN +P + RE ++++LD+P ++++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKC---YMHQLLSGLEH 237
G+ + S LV ME LA L P KF + + ++ K +HQ+ G+++
Sbjct: 62 IGICEAE---SWMLV---ME--LAELG--PLNKFLQ-KNKHVTEKNITELVHQVSMGMKY 110
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPN-HKHPMTSRVVTLWYRPPEL 294
+HRD+ N+L+ KI+DFGL+ D N +K + WY P
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE-- 168
Query: 295 LLGATDYGVGVDLWSAGCILAE 316
+ + D+WS G ++ E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 33/228 (14%)
Query: 124 IGQGTYSNVYKAKDMLTGK-------IVALKKVRFDNLEPESVKFMAREILILRRL-DHP 175
+G+G + V A+ + K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYM------EHDLA----GLAASPEV-KFTEPQFVYLKV 224
N+I L G T LY++ Y E+ A G+ S ++ + + Q + +
Sbjct: 82 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN----HKHPM 280
+Q+ G+E+ + +HRD+ N+L+ ++ V+KIADFGLA D N +K
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPG 326
R+ W P L Y D+WS G ++ E+ L G P PG
Sbjct: 198 NGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 131 NVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG-------- 182
NV K + +L VA+K +R D + F+ +E+ IL RL PN+I+L G
Sbjct: 40 NVRKGRPLL----VAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVDEDPL 94
Query: 183 -LVTSRMSC---SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238
++T M + +L H+++ + P Y + Q+ SG+++
Sbjct: 95 CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLL 296
+ +HRD+ N L+ ++ +KIADFG++ + + R V W +L+
Sbjct: 155 SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM 214
Query: 297 GATDYGVGVDLWSAGCILAELL 318
G + D+W+ G L E+L
Sbjct: 215 G--KFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 50/218 (22%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 123 KIGQGTYSNVYKA--------KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
++G+G + V+ A +D + +VA+K ++ + + K RE +L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKI---LVAVKTLK--DASDNARKDFHREAELLTNLQH 66
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DL----------AGLAA--SPEVKFTEPQFVY 221
+++K G+ L +VF YM+H DL A L A + + T+ Q ++
Sbjct: 67 EHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 222 LKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPM 280
+ Q+ +G+ + + +HRD+ N L+ ++ ++KI DFG++ + ++
Sbjct: 125 IA-----QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
++ + + PPE ++ + D+WS G +L E+
Sbjct: 180 GHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 122 DKIGQGTYSNVYKA---KD--MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHP 175
D IG+G + V +A KD + I LK+ +N + A E+ +L +L HP
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD----FAGELEVLCKLGHHP 63
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVY---LKVKCYMHQL 231
N+I L G +R LY+ Y + +L V T+P F QL
Sbjct: 64 NIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 232 L-------SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
L +G+++ +HRD+ N+L+ ++ KIADFGL+ + K M R+
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-GRL 180
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
W L + Y D+WS G +L E+ L G P
Sbjct: 181 PVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGL 183
IG+G + +V G VA+K ++ D + F+A E ++ +L H N+++L G+
Sbjct: 14 IGKGEFGDVMLGD--YRGNKVAVKCIKND---ATAQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 184 VTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQ-FVYLKVKCYMH---QLLSGLEHCH 239
+ LY+V YM A V + + L C + + +E+
Sbjct: 68 IVEEKG-GLYIVTEYM-------AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 299
N +HRD+ N+L+ +D V K++DFGL T ++ W P L
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--EK 174
Query: 300 DYGVGVDLWSAGCILAEL 317
+ D+WS G +L E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 9/130 (6%)
Query: 144 VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-D 202
VA+K +R D + F+ +E+ IL RL PN+ +L G+ T L ++ YME+ D
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENGD 105
Query: 203 LAGL--AASPEVKFTEPQFVYLKVKCYMH---QLLSGLEHCHNNGVLHRDIKGSNLLIDD 257
L E L ++ Q+ SG+ + + +HRD+ N L+
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 258 DGVLKIADFG 267
+ +KIADFG
Sbjct: 166 NYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 39/109 (35%), Positives = 55/109 (50%), Gaps = 12/109 (11%)
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH----KHP 279
V C +Q+ G+E+ + +HRD+ N+L+ +D V+KIADFGLA D +H K
Sbjct: 143 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKT 199
Query: 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPG 326
R+ W P L Y D+WS G +L E+ L G P PG
Sbjct: 200 TNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 34/231 (14%)
Query: 124 IGQGTYSNVYKAKDM-LTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+G+G + V KA L G+ VA+K ++ +N ++ + E +L++++HP+VI
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 179 KLEGLVTSRMSCSLYLVFHYMEHD----------------LAGLAASPEVKFTEPQFVYL 222
KL G + L L+ Y ++ L P L
Sbjct: 67 KLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 223 KVK---CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHK 277
+ + Q+ G+++ ++HRD+ N+L+ + +KI+DFGL+ + + ++
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPG 326
R+ W L Y D+WS G +L E+ L G P PG
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 123 KIGQGTYSNVYKAK--DMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++G+G + V+ A+ ++L + +VA+K ++ + E F RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTVLQHQHI 69
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHD---------------LAGLAASPEVKFTEPQFVYL 222
++ G+ T L +VF YM H LAG + T Q + +
Sbjct: 70 VRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMT 281
Q+ SG+ + + +HRD+ N L+ V+KI DFG++ + ++
Sbjct: 128 AS-----QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 282 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
++ + + PPE +L + D+WS G +L E+
Sbjct: 183 RTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 38/118 (32%), Positives = 56/118 (47%), Gaps = 7/118 (5%)
Query: 213 KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272
K E Q + + +Q+ G+E+ + +HRD+ N+L+ +D V+KIADFGLA
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 273 D--PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPG 326
+K R+ W P L Y D+WS G +L E+ L G P PG
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSR 283
Y Q+ G+E + +HRD+ N+L+ ++ V+KI DFGLA + DP++ +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVSATFC 335
+ W P + Y D+WS G +L E+ L P PG ++ FC
Sbjct: 237 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASP-YPG-VQIDEEFC 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 47/217 (21%), Positives = 86/217 (39%), Gaps = 29/217 (13%)
Query: 126 QGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+GT+ ++ + V +K V+ D+ V + +E +L L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 182 GLVTSR----MSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQFVYLKVKCYMHQLLSG 234
+ Y+ + ++ L + Q V++ + Q+ G
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI-----QIACG 129
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP--- 291
+ + H GV+H+DI N +ID++ +KI D L+ P H + RP
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE----NRPVKW 185
Query: 292 --PELLLGATDYGVGVDLWSAGCILAEL--LAGKPIM 324
E L+ +Y D+WS G +L EL L P +
Sbjct: 186 MALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 124 IGQGTYSNVYK--AKDML---TGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+G G + VY+ A D+L +G I VA+K +R + E +F+ E ++ +HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHD--LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
+KL G+ ++ Y++ ME L+ L + +F P ++ + G
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 236 EHCHNNGVLHRDIKGSNLLI-----DDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWY 289
+ +HRD+ N L+ D D V+KI DFGLA + ++ ++ + +
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 328
PE LL + D+WS G ++ E+L G+ P
Sbjct: 180 MAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKA----KDMLTGKI-VALKKVRFDNLEPESVKFMARE 165
+PR DS + +G G + VY+ +D ++ VA+K + E + F+ E
Sbjct: 3 VPR--DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-ME 59
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLK- 223
LI+ + +H N+++L G+ R+ +++ M DL + P + +K
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLP--RFILLELMAGGDLKSFLRENRPRPERPSSLTMKD 117
Query: 224 -VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLA------SFFD 273
+ C + G ++ N +HRDI N L+ G V KIADFG+A S++
Sbjct: 118 LLFCAR-DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 328
+ + + + PPE L + D+WS G +L E+ + G PGRT
Sbjct: 177 KGGRAMLPIK-----WMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-08
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 18/150 (12%)
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT---EPQFVYLKVKCYMHQL 231
PN++ L + S S VF ++H G S KF E VK + ++
Sbjct: 45 PNMVCLHKYIVSEDS-----VFLVLQHAEGGKLWSHISKFLNIPEEC-----VKRWAAEM 94
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
+ L+ H G++ RD+ +N+L+DD G +++ F S + + + Y
Sbjct: 95 VVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCA 150
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGK 321
PE + G ++ D WS G IL ELL GK
Sbjct: 151 PE-VGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 8e-08
Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 122 DKIGQGTYSNVYKA---KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNV 177
D IG+G + V KA KD L ++ A K + + + A E+ +L +L HPN+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGL--RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVY---LKVKCYMHQLL- 232
I L G R LYL Y H +L V T+P F QLL
Sbjct: 59 INLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 233 ------SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
G+++ +HRD+ N+L+ ++ V KIADFGL+ + K M R+
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPV 175
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
W L + Y D+WS G +L E+ L G P
Sbjct: 176 RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 123 KIGQGTYSNVYKA--------KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
++G+G + V+ A KD + +VA+K ++ L K RE +L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKM---LVAVKALKDPTLAAR--KDFQREAELLTNLQH 66
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL--AASPEVK-FTEPQFVYLKVKCYMHQ 230
+++K G+ L +VF YM+H DL A P+ + Q K + + Q
Sbjct: 67 EHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 231 LL-------SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTS 282
+L SG+ + + +HRD+ N L+ + ++KI DFG++ + ++
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
++ + + PPE ++ + D+WS G IL E+
Sbjct: 185 TMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 24/46 (52%), Positives = 31/46 (67%)
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+K M Q+L+GL H G++HRDIK NLL+ DG +KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 14/211 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILR 170
+ K+ +G G + V+K + G KI K D ++ + + +L +
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
LDH +++L G+ SL LV +PQ ++ + Q
Sbjct: 65 SLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQ----RLLNWCVQ 117
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT--LW 288
+ G+ + + ++HR++ N+L+ D +++IADFG+A P+ K S T W
Sbjct: 118 IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLA 319
+L G Y D+WS G + E+++
Sbjct: 178 MALESILFGR--YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 38/120 (31%), Positives = 61/120 (50%), Gaps = 7/120 (5%)
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTL 287
+Q++ L+ H+ ++HRD+K +N+ + G++K+ DFG + + D +S T
Sbjct: 176 YQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIM-PGRTEVSATFCFVLNLIFDPF 345
+Y PE L Y D+WS G IL ELL +P P + E+ VL +DPF
Sbjct: 236 YYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ---VLYGKYDPF 291
|
Length = 478 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 12/168 (7%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPES-VKFMAREILIL 169
+ +++ +G G + VYK + G+ V + K+ + P++ V+FM E LI+
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIM 63
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
+DHP++++L G+ +S ++ LV M H L E K + L +
Sbjct: 64 ASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGCL-LDYVHEHKDNIGSQLLLN---WCV 116
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277
Q+ G+ + ++HRD+ N+L+ +KI DFGLA + + K
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 122 DKIGQGTYSNVY--KAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179
D+IG G + V +A ++ V +K++R E + F+ +E+ R L+HPNV++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 180 LEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQ-FVYLKVKCYMHQLLSGLE 236
G S LV + DL L ++ + Q V ++ C ++ SGL
Sbjct: 60 CLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC---EVASGLL 114
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA------SFFDPNHKHPMTSRVVTLWYR 290
H +H D+ N + D +KI D+GLA ++ H V L +
Sbjct: 115 WLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH-----AVPLRWL 169
Query: 291 PPELL------LGATDYGVGVDLWSAGCILAEL--LAGKP 322
PEL+ L D ++WS G + EL A +P
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 32/215 (14%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTG---KI-VALKKVRFDNLEPESVKFMAREILILRRLD 173
F+KI +G G + VYK + G KI VA+K++R + P++ K + E ++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 67
Query: 174 HPNVIKLEG--------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVK 225
+P+V +L G L+T M L + D G YL
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-------------YLLNW 114
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK--HPMTSR 283
C Q+ G+ + ++HRD+ N+L+ +KI DFGLA + K H +
Sbjct: 115 CV--QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
V W +L Y D+WS G + EL+
Sbjct: 173 VPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 123 KIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
++G G + V K + K VA+K ++ +N E M RE I+ +LD+P ++++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF---TEPQFVYLKVKCYMHQLLSGLEH 237
G+ + +L LV ME G P KF + + V MHQ+ G+++
Sbjct: 61 IGVCEAE---ALMLV---MEMASGG----PLNKFLSGKKDEITVSNVVELMHQVSMGMKY 110
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF---DPNHKHPMTSRVVTLWYRPPEL 294
+HRD+ N+L+ + KI+DFGL+ D +K + WY P +
Sbjct: 111 LEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 295 LLGATDYGVGVDLWSAGCILAELLA--GKP 322
+ D+WS G + E + KP
Sbjct: 171 NF--RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 46/218 (21%)
Query: 120 KIDK-IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI---------- 168
KIDK IG G + VY+ + I + +NLE E+ + E L+
Sbjct: 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET---IVMETLVYNNIYDIDKI 71
Query: 169 -----LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK 223
+ +DH + K G S C +Y F +E L + + F +
Sbjct: 72 ALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEK----LVENTKEIFK-------R 119
Query: 224 VKCY--------MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275
+KC M +L+ LE+ H +G+ H DIK N+++D + I D+G+AS F +
Sbjct: 120 IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
Query: 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCI 313
KH S+ +R T Y G+D + C+
Sbjct: 180 GKHIEYSKEQKDLHR-------GTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRV 284
+ Q+ G++ + +HRD+ N+L+ D V KI DFGLA D N+ +R+
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 326
W P + Y V D+WS G +L E+ + GK PG
Sbjct: 277 PVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 16/100 (16%)
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF------DPNHKHPMTSR 283
Q+L + H H+ ++HRDIK +N+L+ +G++K+ DFG + + D T
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 284 VVT--LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 321
V +W R P Y D++S G +L ELL K
Sbjct: 211 YVAPEIWRRKP--------YSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFM--AREILILRRLDH 174
F + I +G + VY + K+ A+K V+ D + V + R+ L L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--S 63
Query: 175 PNVIKLEGLVTSRMSCS-LYLVFHYM-EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
P ++ L S S + +YLV Y+ D+ L F E V Y+ ++
Sbjct: 64 PFIVHL---YYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVK-----YISEVA 114
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
L++ H +G++HRD+K N+LI ++G +K+ DFGL+
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 46/190 (24%), Positives = 77/190 (40%), Gaps = 16/190 (8%)
Query: 140 TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199
TG+ V ++++ + E V F+ E+ + + +HPN++ + L++V +M
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSFM 81
Query: 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 259
+ G A L + + +L L++ H+ G +HR +K S++LI DG
Sbjct: 82 AY---GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 138
Query: 260 VLKIADFGLASFFD---------PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSA 310
K+ GL S H P S V W P L Y D++S
Sbjct: 139 --KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 311 GCILAELLAG 320
G EL G
Sbjct: 197 GITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 48/215 (22%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 124 IGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+G+G + +V + + I VA+K ++ ++ E + ++ DHPNV++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 182 GLVTSRMSCSLY----LVFHYMEH-DLAGLAASPEVKFTEPQFV--YLKVKCYMHQLLSG 234
G+ + Y ++ +M+H DL + PQ++ + VK +M + SG
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC-PQYLPTQMLVK-FMTDIASG 124
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRVVTLWYRPP 292
+E+ + +HRD+ N +++++ + +ADFGL+ + ++ +++ W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 326
L Y D+WS G + E+ G+ PG
Sbjct: 185 S--LADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 6/110 (5%)
Query: 217 PQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDP 274
P Y+ + + +Q+ +G+E + +HRD+ N+LI + ++KI DFGLA D
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS 293
Query: 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
N+ ++ + W P + Y D+WS G +L E+ L G P
Sbjct: 294 NYISKGSTFLPLKWMAPESIF--NNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 22/167 (13%)
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYL-KVKCY 227
R L HPN+++ G + LVF Y E DL + + Q + L ++ C
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC- 106
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVT 286
++ +G+ H H + LH D+ N + D +K+ D+G+ S + ++ + V
Sbjct: 107 --EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 287 LWYRPPEL-------LLGA--TDYGVGVDLWSAGCILAELL--AGKP 322
L + PEL L+ A T ++W+ G L EL A +P
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPS---NVWALGVTLWELFENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 118 FEKIDKIGQGTYSNVYK---AKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+K+ +G G + VYK D KI KV +N P++ K + E ++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
P V +L G+ ++ ++ LV M + V+ + + + + Q+ G
Sbjct: 69 PYVCRLLGIC---LTSTVQLVTQLMPYG----CLLDYVRENKDRIGSQDLLNWCVQIAKG 121
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK--HPMTSRVVTLWYRPP 292
+ + ++HRD+ N+L+ +KI DFGLA D + H +V W
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 293 ELLLGATDYGVGVDLWSAGCILAELL 318
+L + D+WS G + EL+
Sbjct: 182 SIL--HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 49/184 (26%), Positives = 75/184 (40%), Gaps = 36/184 (19%)
Query: 114 RADSFEKIDKIGQGTYSNVYKA----KDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
+ D F K+G+G + VYKA K LKK ++ A EI +
Sbjct: 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT---------EYGAVEIWMN 180
Query: 170 RRLDH--PNVIK-----LEGLVTSRMSCSLYLVFHYM-EHDLAGLAASPEVKFTEPQFVY 221
R+ PN V+S+ +LV+ Y E LA L S E + ++
Sbjct: 181 ERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLL 240
Query: 222 LKV--------------KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADF 266
KV + M Q+L L+ H+ G++HRD+K N++ + G KI D
Sbjct: 241 GKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 267 GLAS 270
G A+
Sbjct: 301 GAAA 304
|
Length = 566 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 6/111 (5%)
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS--FFDPNHKHPMTSRV 284
+ +Q+ G+E + +HRD+ N+L+ ++KI DFGLA D N+ ++ +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334
W P + Y D+WS G +L E+ + G PG V +TF
Sbjct: 302 PVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI-VDSTF 349
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 119 EKID---KIGQGTYSNVYK--AKDMLTGKI---VALKKVRFDNLEPESVKFMAREILILR 170
EKI ++GQG++ VY+ A+D++ G+ VA+K V E ++F+ E +++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMK 64
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-----LAGLAASPEVKFTEPQFVYLKVK 225
+V++L G+V S+ +L +V M H L L E P ++
Sbjct: 65 GFTCHHVVRLLGVV-SKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRV 284
++ G+ + + +HRD+ N ++ D +KI DFG+ ++ ++ +
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
+ + + PE L + D+WS G +L E+ LA +P
Sbjct: 183 LPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 21/95 (22%)
Query: 243 VLHRDIKGSNLLID----------------DDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
++H D+K N+L++ D ++I D G + +H T+ V T
Sbjct: 253 LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC----DERHSRTAIVST 308
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 321
YR PE++LG + D+WS GCI+ EL GK
Sbjct: 309 RHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 53/212 (25%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 123 KIGQGTYSNVYK--AKDMLTGKI---VALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++GQG++ VY+ AK ++ + VA+K V E ++F+ E +++ + +V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 71
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAAS--PEVKFTEPQFV-YLKVKCYMH-QLLS 233
++L G+V S+ +L ++ DL S PE++ Q LK M ++
Sbjct: 72 VRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPP 292
G+ + + N +HRD+ N ++ +D +KI DFG+ ++ ++ ++ + + P
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 293 ELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
E L + D+WS G +L E+ LA +P
Sbjct: 191 ESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 5/103 (4%)
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRV 284
+ +Q+ G+ + +HRD+ N+L+ + KI DFGLA D N+ +R+
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPG 326
W P + Y D+WS G +L E+ + G PG
Sbjct: 279 PVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 26/212 (12%)
Query: 123 KIGQGTYSNVY--KAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+IG G + V + T V +K++R E +KF+ E R L H N+++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE-EAQPYRSLQHSNLLQC 60
Query: 181 EGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
G T L + F + DL G L + + + P L+ ++ GL H H
Sbjct: 61 LGQCTEVTPYLLVMEFCPL-GDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLH 117
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLAS-------FFDPNHKHPMTSRVVTLWYRPP 292
N +H D+ N L+ D +KI D+GL+ + P+ V L + P
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW------VPLRWIAP 171
Query: 293 ELL------LGATDYGVGVDLWSAGCILAELL 318
EL+ L D ++WS G + EL
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 32/202 (15%)
Query: 127 GTYSNVY--KAKD---MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
G + V K K + KI+ K F+ +EP + M D+PN IKL
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKN--FNAIEPMVHQLMK---------DNPNFIKLY 75
Query: 182 GLVTSRMSCSLYLVFHYM-EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240
VT+ L+ Y+ + DL L E K +E +VK + QL+ L H
Sbjct: 76 YSVTT--LKGHVLIMDYIKDGDLFDLLKK-EGKLSEA-----EVKKIIRQLVEALNDLHK 127
Query: 241 NGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT 299
+ ++H DIK N+L D + + D+GL + TL Y PE + G
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGH- 181
Query: 300 DYGVGVDLWSAGCILAELLAGK 321
+Y V D W+ G + ELL GK
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 9e-04
Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 11/114 (9%)
Query: 162 MAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVY 221
RE+ IL+ L + + L + YL+ ++E G + +
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE----GETLDEVSEEEKEDIA- 92
Query: 222 LKVKCYMHQLLSGLEHCHNNGVL-HRDIKGSNLLIDDDGVLKIADFGLASFFDP 274
++ + +L H VL H D+ N+L+DD +L I D+ A + P
Sbjct: 93 EQLAELLAKL-----HQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 124 IGQGTYSNVYK------AKDMLTGKIVALKKVRFDNLEPESVKFMA--REILILRRLDHP 175
+GQGT++N+YK + + G + V L + +A ++ +L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV-LGSDHRDSLAFFETASLMSQLSHK 61
Query: 176 NVIKLEGLVTSRMSCSLY-LVFHYMEHDLAGLAASPEVKF--TEPQFVYLKVKCY-MHQL 231
+++KL G+ +V Y++ P F E V L K QL
Sbjct: 62 HLVKLYGV----CVRDENIMVEEYVKF-------GPLDVFLHREKNNVSLHWKLDVAKQL 110
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGV-------LKIADFGLASFFDPNHKHPMTSRV 284
S L + + ++H ++ G N+L+ G+ +K++D G+ P RV
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI-----PITVLSREERV 165
Query: 285 VTLWYRPPELL-LGATDYGVGVDLWSAGCILAELLAGKPI 323
+ + PE + G + D WS G L E+ +
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 25/94 (26%), Positives = 36/94 (38%), Gaps = 15/94 (15%)
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
Q L L H N+L+ DG+LK+ G +F P SR +
Sbjct: 24 LQCLGALRELHRQAKSG------NILLTWDGLLKL--DGSVAFKTPE-----QSRPDPYF 70
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE++ G Y D++S G L E L +
Sbjct: 71 -MAPEVIQG-QSYTEKADIYSLGITLYEALDYEL 102
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.004
Identities = 12/33 (36%), Positives = 19/33 (57%), Gaps = 1/33 (3%)
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271
H G++H D+ SN+++ + I DFGL F
Sbjct: 109 HKAGIVHGDLTTSNIILSGGRIYFI-DFGLGEF 140
|
Length = 204 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 348 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.69 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.67 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.64 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.31 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.3 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.21 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.04 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.95 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.7 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.68 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.68 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.56 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.52 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.46 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.31 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.3 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.29 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.1 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.9 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.68 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.58 | |
| PLN02236 | 344 | choline kinase | 96.46 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.35 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.29 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.21 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.99 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.94 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.62 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.31 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.27 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.74 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.7 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.6 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.07 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.06 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-60 Score=436.08 Aligned_cols=256 Identities=70% Similarity=1.157 Sum_probs=240.5
Q ss_pred CCCCCCCCCcccccccCCCchhhhhhhccccCcccCCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChH
Q 018936 78 RLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE 157 (348)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~ 157 (348)
+..+.++....+..+++||.|+...+++.+..|.+...+.|+.+++||+|.||.||+|++..+|+.||+|+++.++..+.
T Consensus 79 ~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~ 158 (560)
T KOG0600|consen 79 RPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG 158 (560)
T ss_pred CCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc
Confidence 34445555666889999999999999999999999999999999999999999999999999999999999999987777
Q ss_pred HHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHH
Q 018936 158 SVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237 (348)
Q Consensus 158 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~ 237 (348)
......+||.+|++|+||||++|.+....+..+.+|||||||+++|.+++......|++++ +++||+||+.||+|
T Consensus 159 ~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~q-----IKc~mkQLl~Gl~~ 233 (560)
T KOG0600|consen 159 FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQ-----IKCYMKQLLEGLEY 233 (560)
T ss_pred chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHH-----HHHHHHHHHHHHHH
Confidence 7888899999999999999999999999987788999999999999999999888887777 99999999999999
Q ss_pred HHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHH
Q 018936 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317 (348)
Q Consensus 238 LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el 317 (348)
+|++||+|||||.+|||||.+|.+||+|||||+++........++.+.|.||+|||+++|...|+.++|+||.||+|.||
T Consensus 234 cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El 313 (560)
T KOG0600|consen 234 CHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAEL 313 (560)
T ss_pred HhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHH
Confidence 99999999999999999999999999999999999888777789999999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHH
Q 018936 318 LAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 318 ltG~~pf~~~~~~~~~~~~i~ 338 (348)
++|++.|+|.++.+++-.|..
T Consensus 314 ~~gkPI~~G~tEveQl~kIfk 334 (560)
T KOG0600|consen 314 FLGKPILQGRTEVEQLHKIFK 334 (560)
T ss_pred HcCCCCcCCccHHHHHHHHHH
Confidence 999999999999999988764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=370.79 Aligned_cols=217 Identities=30% Similarity=0.490 Sum_probs=191.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++++.||+|+||+||+++.+.+++.||+|++++... .....+....|..+|.+++||+||+++-.|++ ...+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeEE
Confidence 3789999999999999999999999999999999988766 33457778899999999999999999666655 66799
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||+||+.|+.+.....+++.+.+.. ++.|+++|+.||.|||++|||||||||+|||||.+|+++|+||||++..-
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~-----arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDR-----ARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhH-----HHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999977777777776665554 89999999999999999999999999999999999999999999999653
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
.. ...+.+++||+.|||||++.+. .|+..+||||||+++|||++|.+||.+.+......+|+...
T Consensus 177 ~~-~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 177 KD-GDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK 241 (357)
T ss_pred cC-CCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence 33 2335668999999999999886 59999999999999999999999999999888888887766
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=364.03 Aligned_cols=213 Identities=31% Similarity=0.532 Sum_probs=184.9
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
....+|.+.++||+|+||+||+|+++.++..||||.+.+..+.+...+.+..|+.+|+.++|||||+++++++.+ ..+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~~i 84 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--DFI 84 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--CeE
Confidence 344789999999999999999999999999999999999888888889999999999999999999999999884 569
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC------CcEEEEee
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD------GVLKIADF 266 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~------~~~kl~DF 266 (348)
|||||||.++.+..+...... +.+.+++.++.||+.||++||+++||||||||.||||+.+ -.+||+||
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~-----l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGR-----LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 999999996555555444443 4445599999999999999999999999999999999865 46899999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
|+|+.+.+.. ...+.+|++-|||||++... .|+.|+|+||+|+++|+|++|++||...+..+-...
T Consensus 160 GfAR~L~~~~--~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~ 225 (429)
T KOG0595|consen 160 GFARFLQPGS--MAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY 225 (429)
T ss_pred chhhhCCchh--HHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence 9999997443 35678999999999988754 499999999999999999999999998776555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=351.62 Aligned_cols=217 Identities=39% Similarity=0.692 Sum_probs=192.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|+.+.++|+|+||+||+|+++.+|+.||||++.-+.-++...+--.+|+++|+.++|||+|.++++|..+ ..++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk--rklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK--RKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc--ceeEEE
Confidence 579999999999999999999999999999999977666667677778999999999999999999999774 459999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++...+..+....... +...++.++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..
T Consensus 80 FE~~dhTvL~eLe~~p~G~-----~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGV-----PSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred eeecchHHHHHHHhccCCC-----CHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9999998887776544333 3344899999999999999999999999999999999999999999999998864
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
.....+..+-|.||+|||.+.|..+|+..+||||+||++.||++|.+.|+|.++.++++.|....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktL 218 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTL 218 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHH
Confidence 23335677889999999999998889999999999999999999999999999999999887653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=342.61 Aligned_cols=220 Identities=26% Similarity=0.447 Sum_probs=197.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++++.||.|+||.|.+++++.+|..||+|++.+... .-.+.+...+|..+|+.+.||+++++.+.|.+ ...+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLYM 121 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEEE
Confidence 789999999999999999999999999999999987765 44567788899999999999999999877766 567999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+..+.+...+++++. ++.|++||+.||+|||+++|++|||||+|||+|.+|++||+|||.|+....
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~-----arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPH-----ARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchh-----HHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999887777777777777766 899999999999999999999999999999999999999999999998743
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCcCc
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFVF 347 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~~~ 347 (348)
. +-+.||||.|+|||.+.+. +|+.++|||||||++|||+.|.+||-..+....+.+|+.....-|-.|
T Consensus 197 r----T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~f 264 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYF 264 (355)
T ss_pred c----EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCccc
Confidence 3 5678999999999988874 599999999999999999999999999999999989998877776543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=366.62 Aligned_cols=221 Identities=29% Similarity=0.482 Sum_probs=195.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.+|...+.||+|||+.||.+++..+|+.||+|++.+..+ .+...+.+.+||++.+.|+|||||+++++|++. ..+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs--~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS--NNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC--CceEE
Confidence 569999999999999999999999999999999988655 556678899999999999999999999999995 45999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|+|+|....+..+......++++. ++.+++||+.||.|||+++|+|||||..|+|++++.++||+|||||..+..
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpE-----ary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPE-----ARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHH-----HHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999766655555555555554 999999999999999999999999999999999999999999999998864
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCc
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPF 345 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~ 345 (348)
.. +...+.||||.|+|||++.. ..++..+||||+||+||.|+.|+|||...+-.+.+.+|..+....|-
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~ 239 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS 239 (592)
T ss_pred cc-cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc
Confidence 42 33567899999999998885 45999999999999999999999999999999999999888776664
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=343.44 Aligned_cols=222 Identities=45% Similarity=0.740 Sum_probs=195.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.+.|+.++.|++|.||.||+|+++.+++.||+|+++.+.-...---.-.+||++|.+.+|||||.+..+........+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 36899999999999999999999999999999999876422111122456999999999999999999988777777999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||||++++..++..-.. .+....+++++.|++.||.|||.+.|+||||||+|+|+.+.|.+||+|||||+.+..
T Consensus 155 VMe~~EhDLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eHHHHHhhHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999999998888765443 344445999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
. ....+..+.|.+|+|||.+++...|+.++|+||+||++.||++++|.|+|.++.+++.+|+.-+-.
T Consensus 230 p-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt 296 (419)
T KOG0663|consen 230 P-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT 296 (419)
T ss_pred C-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence 4 445778889999999999999999999999999999999999999999999999999999876543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=330.13 Aligned_cols=216 Identities=44% Similarity=0.794 Sum_probs=191.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|..+++||+|.||.||+|++..+|+.||||+++..+..+...-...+|+..|+.++||||+.++++|-...+ +.+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~--l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN--LSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc--eEEE
Confidence 57999999999999999999999999999999999877654444456679999999999999999999988554 8999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+|||+.++..........+... .++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.+.
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa-----~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPA-----DIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred EEeccccHHHHhcccccccCHH-----HHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9999999998888776655444 49999999999999999999999999999999999999999999999998755
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
... .+..+.|.+|+|||.+.|+..|+..+|+||.||++.||+-|.|.|+|.++.+++-.|+.-
T Consensus 155 ~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~ 217 (318)
T KOG0659|consen 155 NRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA 217 (318)
T ss_pred Ccc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH
Confidence 443 233377999999999999999999999999999999999999999999999988777653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=351.54 Aligned_cols=215 Identities=30% Similarity=0.436 Sum_probs=175.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh-----HHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||++.++.... .......+|+++|++|+|||||+++++|+..
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-- 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-- 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence 367889999999999999999999999999999998765421 2233467999999999999999999999884
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC---CcEEEEee
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADF 266 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kl~DF 266 (348)
...||||||++++.+....-......+.. -+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+||
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~-----~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDL-----GKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccch-----hHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence 45799999999755444433344443333 57789999999999999999999999999999866 68999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCc--ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
|+|+..+.. ..+.+.|||+.|.|||++.+. ..+..++|+||+||+||-+++|.+||.+......+...|.
T Consensus 324 GlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL 395 (475)
T ss_pred chhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence 999988643 347788999999999998642 3344589999999999999999999988766554444443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=355.15 Aligned_cols=219 Identities=33% Similarity=0.462 Sum_probs=188.3
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
..++|+++.+||+|+||.||+|+.+.||..||+|+++++.+ ...+.+.++.|..+|...++|+||+|+-.|.+ ..++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCee
Confidence 34899999999999999999999999999999999998876 55678889999999999999999999766665 6679
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
||||||++|+-...+......+++.. ++.|+++++.|++.||+.|+|||||||+|+|||..|++||+||||+.-+
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~-----arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDW-----ARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHH-----HHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999877766666655555544 8999999999999999999999999999999999999999999999543
Q ss_pred CC---------------C-------CCC------------------------CcccccccCcccccccccCcccCCcccc
Q 018936 273 DP---------------N-------HKH------------------------PMTSRVVTLWYRPPELLLGATDYGVGVD 306 (348)
Q Consensus 273 ~~---------------~-------~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~D 306 (348)
.. . ... ...+.+|||.|+|||++++.. |+..+|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cD 370 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECD 370 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCcccc
Confidence 21 0 000 012347899999999999865 999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 307 LWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 307 vwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
||||||++||||.|.|||.+.+..+...+|+.-.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999999999999999999888888887655
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=340.31 Aligned_cols=227 Identities=29% Similarity=0.478 Sum_probs=190.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+|+++++||+|+||.||++++..+|..+|.|.+.....+....+.+..|+.+|+.|+|||||++++.-..+....+++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 57999999999999999999999999999999999888888889999999999999999999999884444445568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN--NG--VLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~--ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
||+++.+.+..+.... +.....+++..+|.++.|++.||.++|+ .. |+||||||.||+|+.+|.+||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~-K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHF-KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHH-HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999875544443221 1122356666799999999999999999 44 99999999999999999999999999999
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCcC
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFV 346 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~~ 346 (348)
+.... ....+.+|||.||+||.+.+.+ |+.+|||||+||++|||+.-++||.|. +.-++.+-|.+.=..|++
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCCCCCCc
Confidence 86543 3467789999999999998755 999999999999999999999999998 455555555555555554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=355.40 Aligned_cols=215 Identities=40% Similarity=0.690 Sum_probs=190.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 193 (348)
+++|.++++||.|.||.||+|+.+.+|..||||.++..-..-+..- -.+|+..|++|+ ||||+++.+++.+... .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 4789999999999999999999999999999999976544322232 346999999998 9999999999988654 799
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||||++.+..++..+...+ ++..++.||.||+.||+|+|.+|+.|||+||||||+..+..+||+|||||+...
T Consensus 87 fVfE~Md~NLYqLmK~R~r~f-----se~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLF-----SESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcC-----CHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 999999999999998875544 445599999999999999999999999999999999999999999999999875
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.. .+.+..+.|.||+|||+++....|+.++|+|++||+++|+.+-++.|+|.++.++.++|..
T Consensus 162 Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~ 224 (538)
T KOG0661|consen 162 SK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE 224 (538)
T ss_pred cC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence 43 3467788899999999999888899999999999999999999999999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=338.85 Aligned_cols=201 Identities=32% Similarity=0.484 Sum_probs=179.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++.+.++.||+|..|+||+++++.+++.+|+|.+. .+.++...+++.+|++++++.+|||||.+||.|..... .++++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEee
Confidence 57889999999999999999999999999999994 45577888899999999999999999999999998654 69999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+++.++......++.+++. +..++.++++||.|||+ ++||||||||+|||++..|.+||+|||.++.+..
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~-----L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPV-----LGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHH-----HHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 99999877776666555555544 77789999999999996 8999999999999999999999999999998754
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
. ...+++||..|||||.+.+.. |+.++||||||++++|+.+|+.||...
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred h---hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCc
Confidence 4 457889999999999999865 999999999999999999999999775
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=354.67 Aligned_cols=225 Identities=26% Similarity=0.390 Sum_probs=197.1
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCc
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 190 (348)
...++|.++++||+|+||+|+++..+.+++.||||.++++.+ ..+..+....|..++... +||++++++..|.. ..
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~ 442 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KE 442 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--CC
Confidence 345899999999999999999999999999999999999876 677788899999999887 59999999888876 56
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
++|+||||+.|+.. ....... .+++.+++.|++.|+.||.|||++||||||||.+|||+|.+|++||+||||++
T Consensus 443 ~l~fvmey~~Ggdm-~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDL-MHHIHTD-----VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred eEEEEEEecCCCcE-EEEEecc-----cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence 79999999998763 2222223 45566699999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCcCc
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFVF 347 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~~~ 347 (348)
..-. ....+.+++|||.|+|||++.+.. |+.++|||||||+||||+.|+.||+|.++.+.-.+|+.....-|.++
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~l 591 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 591 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 7532 233578899999999999888754 99999999999999999999999999999888889998888888765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=347.63 Aligned_cols=223 Identities=33% Similarity=0.471 Sum_probs=186.8
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCce
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 191 (348)
..++|...+.||.|+|++|++|+++.+++.||||++.+.-+ .+...+-+..|.++|..| .||.|++|+..|.+ ...
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~s 148 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EES 148 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccc
Confidence 34789999999999999999999999999999999877655 444566677899999999 89999999777766 455
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|+|+||++++.+..+....+.+. +.-.+.|++||+.||+|||++|||||||||+|||||+|+++||+|||.|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfd-----e~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFD-----ETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcch-----HHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999998654444444445444 444899999999999999999999999999999999999999999999998
Q ss_pred cCCCCCC------------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 272 FDPNHKH------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 272 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
+.+.... ...+++||..|++||++... ..++.+|+|+|||++|+|+.|.+||.+.++.-..++|+.-
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 8643221 12558999999999988764 4889999999999999999999999999998888887765
Q ss_pred hccCC
Q 018936 340 LIFDP 344 (348)
Q Consensus 340 ~~~~p 344 (348)
...-|
T Consensus 303 ~y~fp 307 (604)
T KOG0592|consen 303 DYEFP 307 (604)
T ss_pred cccCC
Confidence 54433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=327.11 Aligned_cols=223 Identities=44% Similarity=0.747 Sum_probs=190.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeecc----Cc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN-VIKLEGLVTSRM----SC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~----~~ 190 (348)
..|+.+++||+|.||+||+|+.+.+|+.||+|+++.+.-.+..-....+|+.+|+.++|+| ||++++++.... ..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 5699999999999999999999999999999999876543223334567999999999999 999999997743 23
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++||||++.++..++....... ...+...++.++.||+.||+|||+++|+||||||.||||+++|.+||+|||+|+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 689999999999888876544211 122335589999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
..... ....++.++|.+|+|||++.+...|+..+|+||+||++.||+++++.|++.++.+++..|...+-
T Consensus 169 a~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG 238 (323)
T KOG0594|consen 169 AFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG 238 (323)
T ss_pred HhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC
Confidence 76532 23356778899999999999998899999999999999999999999999999999999887553
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=326.89 Aligned_cols=215 Identities=40% Similarity=0.676 Sum_probs=181.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc---eE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC---SL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---~~ 192 (348)
-.|.-.+.+|+|+||.||+|....+++.||||.+..+.. .-.+|+++|+.++|||||+|..+|...... +.
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 358899999999999999999999999999999864432 223599999999999999999888765444 55
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC-CcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~ 271 (348)
.+|||||+..+...+... ......++...++.++.||+.||.|||+.||+||||||.|+|+|.+ |.+||+|||.|+.
T Consensus 98 nlVleymP~tL~~~~r~~--~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHY--TRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHhchHHHHHHHHHH--hhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 689999999888777641 1111244455588899999999999999999999999999999965 9999999999999
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
+..+.. ..+...|..|+|||.+.|...|+.+.||||.||++.||+-|++.|+|.+..+++..|+.-.
T Consensus 176 L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 176 LVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred eccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 865543 3666778899999999999999999999999999999999999999999988888776543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=333.92 Aligned_cols=223 Identities=31% Similarity=0.449 Sum_probs=187.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcE-EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~-vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
+.+.+.+.||+|+||+||+|. ..|+. ||+|++..........+.|.+|+.+|++++|||||+++|++..... .+.+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEE
Confidence 456777789999999999997 45666 9999998766655557889999999999999999999999987542 5899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCCEEECCCC-cEEEEeeCCcccc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG-VLHRDIKGSNLLIDDDG-VLKIADFGLASFF 272 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDikp~NIll~~~~-~~kl~DFGla~~~ 272 (348)
|||||+++.+..+.... ....++...+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 99999986665555442 2335666668899999999999999999 99999999999999998 9999999999877
Q ss_pred CCCCCCCcccccccCcccccccccC-cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCc
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPF 345 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~ 345 (348)
.... ...+...||+.|||||++.+ ...|+.|+||||||+++|||+||+.||.+.........++.+...+++
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI 267 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 5432 23455789999999999984 245999999999999999999999999999997777777777666654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.05 Aligned_cols=226 Identities=32% Similarity=0.496 Sum_probs=191.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC------------hHHHHHHHHHHHHHHhcCCCceeeeec
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE------------PESVKFMAREILILRRLDHPNVIKLEG 182 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~l~~ 182 (348)
.++|++.+.||+|.||+|-+|++..+++.||||++.+..+. -...+...+|+.+|++++|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 48899999999999999999999999999999998764321 112467889999999999999999999
Q ss_pred eEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEE
Q 018936 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 183 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 262 (348)
+..+.....+|||+|||..+........ .+.+.+.+++.|+++++.||+|||.+|||||||||+|+||+++|++|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9998888899999999986654433221 12377778999999999999999999999999999999999999999
Q ss_pred EEeeCCccccCCC----CCCCcccccccCcccccccccC---cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 263 IADFGLASFFDPN----HKHPMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 263 l~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
|+|||.+..+..+ ........+|||.|+|||...+ ....+.+.||||+||+||-|+.|+.||.+..+.+...+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999999877332 2223455789999999999876 23356789999999999999999999999999999999
Q ss_pred HHHHhccCCc
Q 018936 336 FVLNLIFDPF 345 (348)
Q Consensus 336 ~i~~~~~~p~ 345 (348)
|+++-+..|.
T Consensus 331 Ivn~pL~fP~ 340 (576)
T KOG0585|consen 331 IVNDPLEFPE 340 (576)
T ss_pred HhcCcccCCC
Confidence 9988777664
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=320.88 Aligned_cols=224 Identities=25% Similarity=0.309 Sum_probs=189.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++++.||+|.-|+||+++...++..+|+|++.+..+ ......+...|.+||+.++||.++.||+.|+. ..+.|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeE
Confidence 4789999999999999999999999999999999988766 34556677889999999999999999999987 56799
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++||||.|+.+..+.+. .+...+++..++.|+++++.||+|||..|||+|||||+||||.++|++.|+||.|+....
T Consensus 154 l~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999987655444432 233366666799999999999999999999999999999999999999999999874331
Q ss_pred C---------------------------------C-C---------------------CCCcccccccCcccccccccCc
Q 018936 274 P---------------------------------N-H---------------------KHPMTSRVVTLWYRPPELLLGA 298 (348)
Q Consensus 274 ~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~ 298 (348)
. . . .....+++||..|+|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 0123456889999999999986
Q ss_pred ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 299 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 299 ~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
. .+.++|||+|||++|||+.|..||.|.++.+...+|+.....-|
T Consensus 311 G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp 355 (459)
T KOG0610|consen 311 G-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP 355 (459)
T ss_pred C-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC
Confidence 5 89999999999999999999999999999999999987655444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.71 Aligned_cols=223 Identities=30% Similarity=0.490 Sum_probs=188.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 190 (348)
...|.+.+.||+|+||+|++|++..+|..||+|++...... ....+.+.+|+.+++.++ ||||++++.++... .
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~--~ 93 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP--T 93 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--C
Confidence 36899999999999999999999999999999977664221 134556778999999999 99999999999874 4
Q ss_pred eEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC-CcEEEEeeCC
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGL 268 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kl~DFGl 268 (348)
.+|+||||+.+ .+++.... .+++.+ ..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E-----~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKE-----DEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCCh-----HHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 49999999987 67776665 555555 3488899999999999999999999999999999999 9999999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccCcc-cCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCcC
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFV 346 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~~ 346 (348)
+.... .......+.+||+.|+|||++.+.. .-+.++||||+||+||.|++|+.||...+.......|......-|-+
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~ 245 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY 245 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC
Confidence 99874 2334467889999999999998865 34589999999999999999999999988777777766665555544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=335.97 Aligned_cols=212 Identities=33% Similarity=0.537 Sum_probs=185.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|-+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+...+.+.+|+++++.++|||||.+++.|+. ...+++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 67999999999999999999999999999999999888777778889999999999999999999999987 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
.||+.+++...+. .+..+++. .++.++.|++.||.|||+++|.|||+||.|||++.+|++|++|||+|+....
T Consensus 80 te~a~g~L~~il~-~d~~lpEe-----~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 80 TEYAVGDLFTILE-QDGKLPEE-----QVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred ehhhhhhHHHHHH-hccCCCHH-----HHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9999997776664 34444444 4899999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.....++..|||-|||||.+.+ .+|+..+|+||+||++|||++|+|||-...-.+....|+
T Consensus 153 ~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~ 213 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL 213 (808)
T ss_pred CceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh
Confidence 3445677789999999998886 559999999999999999999999997765443333333
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=315.79 Aligned_cols=218 Identities=40% Similarity=0.634 Sum_probs=188.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee---ccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS---RMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~~~ 192 (348)
..|..++.||+|+||.|..+.+..+|..||||++...-......++-.+|+.+|++++|+||+.+.+++.. +.-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45777899999999999999999999999999986433345566777889999999999999999998865 234568
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+|+|+|+.+|...+.... .+....++.++.||+.||.|+|+.+|+||||||+|+|++.+..+||+|||||+..
T Consensus 102 YiV~elMetDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred EEehhHHhhHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 9999999999888776543 2555668999999999999999999999999999999999999999999999988
Q ss_pred CCC-CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 273 DPN-HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 273 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
... ....++..+.|.+|.|||++.....|+.+.||||+||++.||++|++.|+|.+..++...|+.-
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 543 1223466778999999999988888999999999999999999999999999999888776643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=319.04 Aligned_cols=220 Identities=27% Similarity=0.471 Sum_probs=194.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.+|++.+.||+|.||+|-+|+....|+.||||.++++.+ +++..-.+.+|++||+.|+||||++++.+|++. ..+.+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk--dKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK--DKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC--ceEEE
Confidence 689999999999999999999889999999999999877 556677889999999999999999999999884 45999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||..++.+..+..... .+++...+.|++||..|+.|+|.++++|||||.+|||+|.++++||+||||+..+..
T Consensus 131 vMEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999998765555544444 455566999999999999999999999999999999999999999999999998854
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
. ...+++||++-|.+||++.|.++-++.+|-|||||+||.|+.|..||+|.+......+|-.....+|
T Consensus 206 ~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP 273 (668)
T KOG0611|consen 206 K--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP 273 (668)
T ss_pred c--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC
Confidence 4 3478899999999999999988778999999999999999999999999988777777777766665
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=299.08 Aligned_cols=221 Identities=32% Similarity=0.460 Sum_probs=190.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|.||.||+|+.+.++..||+|++-++.+ ......++.+|+++.+.|+||||++++++|.+.. ..|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK--RIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc--eeE
Confidence 3789999999999999999999999999999999987765 3344567889999999999999999999999854 499
Q ss_pred EEEeeccc-ChhhhhcC-CCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 194 LVFHYMEH-DLAGLAAS-PEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|++||... .+...+.. ....+.+.. ...|+.|++.||.|+|..+|+||||||+|+|++.++.+||+|||-+..
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~-----~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQR-----AATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccc-----hhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 99999975 44444442 333344443 778999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCcC
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFV 346 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~~ 346 (348)
... ....+.+||..|++||+..+.. ++..+|+|++|++.||++.|.+||...+..+.+.+|....+.+|-.
T Consensus 174 ~p~---~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~ 244 (281)
T KOG0580|consen 174 APS---NKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPST 244 (281)
T ss_pred cCC---CCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcc
Confidence 642 2346789999999999888754 8999999999999999999999999999888888998888888743
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=317.18 Aligned_cols=221 Identities=29% Similarity=0.453 Sum_probs=180.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.++...+.||+|+||.||++.+..+|...|||.+...+... .+.+.+|+.+|++++|||||+++|.........+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45888899999999999999998889999999987663222 6778999999999999999999997544333468999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-CCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~~ 274 (348)
|||+.++.+..+...... .+++..++.+.+||+.||.|||++|||||||||+|||++. ++.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999997655555443331 2444559999999999999999999999999999999999 79999999999998763
Q ss_pred --CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHHHhcc
Q 018936 275 --NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG-RTEVSATFCFVLNLIF 342 (348)
Q Consensus 275 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~-~~~~~~~~~~i~~~~~ 342 (348)
..........||+.|||||++.......+++|||||||++.||+||++||.. ....+..+.+......
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL 241 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC
Confidence 2333455678999999999998532234599999999999999999999988 5666666676665533
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=327.42 Aligned_cols=211 Identities=25% Similarity=0.437 Sum_probs=173.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.+++++.||+|-||+||+|+.. ....||+|.++..... .+.|.+|+++|++|+|+|||+++|++..+. .+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEE
Confidence 56889999999999999999853 3348999999865443 345778999999999999999999998855 49999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||.. +|+.++...... .+...+...++.||++|++||+++++|||||.+.||||+++..+||+|||||+....
T Consensus 280 tE~m~~GsLl~yLr~~~~~----~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGG----LLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhhcCCC----ccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 999985 566666652222 333444788999999999999999999999999999999999999999999996554
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
+.........-...|.|||.+.-.. ++.+||||||||+||||+| |+.||++.++.+....+-
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le 418 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE 418 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 4433333334477899999887654 9999999999999999999 999999999877665543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=323.94 Aligned_cols=215 Identities=27% Similarity=0.402 Sum_probs=175.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||+|++..+++.||+|+++.... .......+.+|+.++..++||||+++++.+.+ ...+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 469999999999999999999999999999999976432 23445677889999999999999999998877 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........ .++...++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 79 v~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEcCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999998754443333222 344555888999999999999999999999999999999999999999999976532
Q ss_pred CCC----------------------------------CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC
Q 018936 275 NHK----------------------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 320 (348)
Q Consensus 275 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG 320 (348)
... ......+||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhC
Confidence 110 001245789999999998764 489999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHH
Q 018936 321 KPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 321 ~~pf~~~~~~~~~~~~i~ 338 (348)
++||.+.+..+....++.
T Consensus 233 ~~Pf~~~~~~~~~~~i~~ 250 (363)
T cd05628 233 YPPFCSETPQETYKKVMN 250 (363)
T ss_pred CCCCCCCCHHHHHHHHHc
Confidence 999988776665555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=310.53 Aligned_cols=221 Identities=24% Similarity=0.411 Sum_probs=186.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++..+||.|..++||+|+...++..||||++..+..+.+ .+.+.+|+..|+.++||||++++..|..+ ..+|+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~--~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD--SELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec--ceeEE
Confidence 3789999999999999999999999999999999988876655 78899999999999999999999999884 45999
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||.||.++ +++.+.... .. -+.+..+..+++++++||.|||.+|.||||||+.||||+.+|.+||+|||.+..+.
T Consensus 102 VmpfMa~GS~ldIik~~~-~~---Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYY-PD---GLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHc-cc---cccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999864 444444321 11 25556688899999999999999999999999999999999999999999887764
Q ss_pred CCCCC---CcccccccCccccccc-ccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 274 PNHKH---PMTSRVVTLWYRPPEL-LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 274 ~~~~~---~~~~~~gt~~y~aPE~-~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
.+... ....++||+.|||||+ ......|+.|+||||||++..||.+|..||.....+..+..-+.+...
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 43322 1245689999999999 455567999999999999999999999999988887777666665543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=308.59 Aligned_cols=214 Identities=40% Similarity=0.702 Sum_probs=180.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|++..........+.+.+|+++++.++||||+++++++... ...|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEEEE
Confidence 469999999999999999999999999999999976654445566788899999999999999999998764 568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++++..+..... .+....++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 79 FEYVEKNMLELLEEMPN-----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred EecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99999887766543322 2444557889999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.........+|+.|+|||++.+.. ++.++|+|||||++|+|++|++||++.+..+....+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214 (287)
T ss_pred ccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 333334457899999999987654 8999999999999999999999999988766655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=308.58 Aligned_cols=214 Identities=40% Similarity=0.751 Sum_probs=177.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||.|+||.||+|++..++..||+|.++..... .....+.+|+.+++.++||||+++++++... ...+++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEEE
Confidence 6799999999999999999999999999999998754322 2234567899999999999999999998764 468999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++++...+..... .++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 82 FEYLDSDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred EeCCCcCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99999877766543322 2344457889999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
. .......+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+....++.
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 218 (288)
T cd07871 157 T-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218 (288)
T ss_pred C-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 1223456799999999987656689999999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=310.43 Aligned_cols=210 Identities=40% Similarity=0.740 Sum_probs=174.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|+++..... .....+.+|+++++.++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 81 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTLV 81 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEEEE
Confidence 7899999999999999999999889999999998754422 2233466799999999999999999998764 469999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++++...+...... +....++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 82 FEYVHTDLCQYMDKHPGG-----LHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EECCCcCHHHHHHhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 999998887776543332 334457889999999999999999999999999999999999999999999765322
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
. .......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+..+.....
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 214 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL 214 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence 1 223445679999999998776668899999999999999999999998876544333
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=324.13 Aligned_cols=214 Identities=31% Similarity=0.576 Sum_probs=186.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C-----CceeeeeceEeeccCc
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-H-----PNVIKLEGLVTSRMSC 190 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~ 190 (348)
+|.+++.||+|.||.|.+|.+..+++.||||+++.. .....+-..|+.+|..|+ | -|+|+++++|..+ .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--N 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--c
Confidence 689999999999999999999999999999999754 344555667999999997 4 5799999999985 5
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC--cEEEEeeCC
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG--VLKIADFGL 268 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kl~DFGl 268 (348)
++|||+|.++.+|.+++...... .++...++.++.||+.||.+||+.||||+|||||||||.+.+ .+||+|||.
T Consensus 262 HlciVfELL~~NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 69999999999999888765432 366667999999999999999999999999999999997543 799999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
|...... ..+.+.+..|+|||+++|.+ |+.+.|||||||++.||++|.|+|+|.++.++..+|+.-.-.+|
T Consensus 338 Sc~~~q~----vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 338 SCFESQR----VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred ccccCCc----ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 9976433 23667788899999999966 99999999999999999999999999999999999998776665
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=320.92 Aligned_cols=206 Identities=27% Similarity=0.396 Sum_probs=168.6
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
.++++|...+.||+|+||.||+|.. .+|..||||.+....... ..+|.+|++++.+++|||+|+|+|||.+... ..
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~ 147 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HR 147 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eE
Confidence 3458899999999999999999984 667999999876554332 3449999999999999999999999987543 58
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG---VLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
+||+|||..+.+.......... .++|.+...|+.++|.||+|||+.. ||||||||+|||||+++++||+|||+|
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa 224 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLA 224 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCc
Confidence 9999999975554444332211 5678888999999999999999863 999999999999999999999999999
Q ss_pred cccCCCCCCCcccc-cccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 270 SFFDPNHKHPMTSR-VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 270 ~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
+.......+ .... .||.+|+|||++... ..+.++|||||||+|+||+||+++....
T Consensus 225 ~~~~~~~~~-~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 225 KLGPEGDTS-VSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCCccccc-eeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCC
Confidence 766431111 1222 899999999988753 4899999999999999999999988754
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=322.17 Aligned_cols=213 Identities=31% Similarity=0.423 Sum_probs=173.6
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+++++.++||||+++++++.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 58999999999999999999999999999999976543 34456678899999999999999999999886 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+..+..... .++...++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+++.+...
T Consensus 80 ~E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 80 MDYIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99998754433332222 2445557889999999999999999999999999999999999999999998643210
Q ss_pred CC----------------------------------------------CCcccccccCcccccccccCcccCCccccHHH
Q 018936 276 HK----------------------------------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWS 309 (348)
Q Consensus 276 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwS 309 (348)
.. ......+||+.|+|||++.+. .++.++||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwS 233 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWS 233 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceee
Confidence 00 001235789999999988764 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 310 AGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 310 lGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
|||++|||++|++||...+..+....++
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~ 261 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVI 261 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 9999999999999998877666555554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=323.74 Aligned_cols=220 Identities=29% Similarity=0.425 Sum_probs=188.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.-|++.+.||.|+.|.|.+|++..||+..|||++.+. .........+.+|+-+|+.+.|||++++++++++ ..++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEE
Confidence 4589999999999999999999999999999999876 4455556678899999999999999999999988 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|.||++++.+..+....+.+.+. .+..+++||+.|+.|+|..+|+||||||+|+|||..++|||+|||+|..-.+
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~-----eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPER-----EAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCH-----HHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999875554444445555444 4888999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
+. -..+.||++.|.|||++.|.++-+.++||||.||+||.|+||+.||++.+-+..+.++....+.-|
T Consensus 165 gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP 232 (786)
T KOG0588|consen 165 GK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP 232 (786)
T ss_pred Cc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC
Confidence 43 356779999999999999988778999999999999999999999998777666666666555544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=319.44 Aligned_cols=213 Identities=28% Similarity=0.514 Sum_probs=185.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
..|....+||+|+.|.||.++...+++.||||.+.+.. +...+.+.+|+.+|+..+|+|||.+++.|... ..+|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEE
Confidence 57889999999999999999999999999999997765 34466788999999999999999999888764 459999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||||+++.+....... .+.+.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+...
T Consensus 349 MEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999987655544332 3555568999999999999999999999999999999999999999999999988655
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
.. ...+.+||+.|||||++... .|++++||||||++++||+-|++||-..+...+++.|..+-
T Consensus 423 ~~-KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng 485 (550)
T KOG0578|consen 423 QS-KRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 485 (550)
T ss_pred cC-ccccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC
Confidence 43 35677899999999988764 59999999999999999999999999888888888887653
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=319.59 Aligned_cols=213 Identities=31% Similarity=0.460 Sum_probs=173.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+++++.++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 469999999999999999999999999999999976432 33445667889999999999999999998887 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........ .++...++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.+..
T Consensus 79 v~E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EECCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999998755444333222 345555888999999999999999999999999999999999999999999976532
Q ss_pred CCCC-------------------------------------CcccccccCcccccccccCcccCCccccHHHHHHHHHHH
Q 018936 275 NHKH-------------------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317 (348)
Q Consensus 275 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el 317 (348)
.... ...+.+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el 232 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEM 232 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHh
Confidence 1110 01134689999999988764 489999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHH
Q 018936 318 LAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 318 ltG~~pf~~~~~~~~~~~~ 336 (348)
++|++||.+.+..+....+
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i 251 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKI 251 (364)
T ss_pred hcCCCCCCCCCHHHHHHHH
Confidence 9999999887765544444
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=321.56 Aligned_cols=214 Identities=29% Similarity=0.419 Sum_probs=171.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++++.||+|+||.||++++..+|+.||||++.+... .....+.+.+|+++++.++||||+++++++.+ ....|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 369999999999999999999999999999999875432 33445678889999999999999999999876 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........ .+....++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+..
T Consensus 79 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999997644433332222 234455788999999999999999999999999999999999999999999964321
Q ss_pred CCC-------------C---------------------------------CcccccccCcccccccccCcccCCccccHH
Q 018936 275 NHK-------------H---------------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLW 308 (348)
Q Consensus 275 ~~~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw 308 (348)
... . .....+||+.|+|||++.+. .++.++|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 232 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWW 232 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeE
Confidence 000 0 00124689999999988764 489999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 309 SAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 309 SlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
||||++|||++|++||.+.+..+....++
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999998877655444443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=321.08 Aligned_cols=213 Identities=31% Similarity=0.431 Sum_probs=172.1
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+++++.++||||+++++.+.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 59999999999999999999999999999999875432 23445678889999999999999999999887 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+........ .++...++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 80 MDYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99998754433332222 2344457889999999999999999999999999999999999999999998543110
Q ss_pred C----------------------------------------------CCCcccccccCcccccccccCcccCCccccHHH
Q 018936 276 H----------------------------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWS 309 (348)
Q Consensus 276 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwS 309 (348)
. .......+||+.|+|||++.+. .++.++||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwS 233 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS 233 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEe
Confidence 0 0001234689999999988764 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 310 AGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 310 lGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
|||++|||++|++||.+.+..+....++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999998877665555554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=308.56 Aligned_cols=212 Identities=23% Similarity=0.364 Sum_probs=173.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+..... .....+.+.+|+++++.++||||+++++++.+ ....|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 369999999999999999999988999999999875433 22345567889999999999999999988876 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|||+.++.+........ .+....+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 79 LMEYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999998654433322222 234445778899999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++..
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 213 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213 (291)
T ss_pred C----cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 2 2345689999999988764 4889999999999999999999999887765555555443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=314.12 Aligned_cols=211 Identities=26% Similarity=0.381 Sum_probs=174.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++... ...|+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEEE
Confidence 689999999999999999999999999999999976432 223456788899999999999999999998774 56999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|||+.++.+......... ++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 96 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGR-----FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEcCCCCChHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999987544333322222 33444777899999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
. .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 171 ~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 229 (329)
T PTZ00263 171 R----TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229 (329)
T ss_pred C----cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 2 23457899999999887654 88999999999999999999999988776555544443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=299.06 Aligned_cols=222 Identities=26% Similarity=0.392 Sum_probs=188.2
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
.+++|..++.||+|.||+|-+++.+.+|+.||+|+++++.+ ..+....-..|-++|+..+||++..+.-.|.. +..+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceE
Confidence 46899999999999999999999999999999999988765 55667777789999999999999988666655 5569
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++||||..++.+.+.......+++ .+.+.|-.+|+.||.|||+++||+||||.+|.|+|.+|++||+||||++.-
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE-----~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSE-----DRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccc-----hhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999998877666665544444 448889999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
- .....+.++||||.|+|||++.. .+|+.++|||.+||++|||++|+.||.+.+.....-.|+...+..|
T Consensus 319 I-~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 319 I-KYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP 388 (516)
T ss_pred c-cccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC
Confidence 3 22334678899999999998876 5699999999999999999999999988776554445666665555
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=319.93 Aligned_cols=214 Identities=31% Similarity=0.422 Sum_probs=171.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+++|+.++||||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEE
Confidence 369999999999999999999999999999999865432 22345667889999999999999999998876 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........ .++...++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|..+..
T Consensus 79 v~E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999998754443333222 234445778899999999999999999999999999999999999999999853310
Q ss_pred CC------------------------------------------CCCcccccccCcccccccccCcccCCccccHHHHHH
Q 018936 275 NH------------------------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGC 312 (348)
Q Consensus 275 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv 312 (348)
.. .......+||+.|+|||++.+. .++.++|||||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGv 232 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGV 232 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccc
Confidence 00 0011234789999999988764 4899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 313 ILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 313 ~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
++|||++|+.||.+.+..+....+.
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i~ 257 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKVI 257 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHHh
Confidence 9999999999998877655544443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=316.74 Aligned_cols=215 Identities=27% Similarity=0.392 Sum_probs=175.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||++++..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLY 119 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999999875332 23345567789999999999999999998876 45699
Q ss_pred EEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+||||++++ +...+... .++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999864 44443221 2344457888999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCcccccccccCc---ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
............||+.|+|||++.+. ..++.++|+||+||++|+|++|++||.+.+.......++.
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 54333223456789999999988643 2377899999999999999999999988776665555554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=308.65 Aligned_cols=211 Identities=35% Similarity=0.574 Sum_probs=171.8
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc---CceEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSLY 193 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~~ 193 (348)
+|++.+.||+|+||.||+|++..+|..||||.+............+.+|+++++.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 489999999999999999999999999999998654333334456788999999999999999999875432 23589
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++|||+++++...+.... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999987776654321 34455588899999999999999999999999999999999999999999998653
Q ss_pred CCCC--CCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 274 PNHK--HPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 274 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
.... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~ 217 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 2211 112345789999999987642 35889999999999999999999999887765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=312.62 Aligned_cols=212 Identities=25% Similarity=0.359 Sum_probs=173.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC-cEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g-~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
++|++.+.||+|+||.||+|++..++ ..||+|.+..... .....+.+.+|+.+++.++||||+++++++... ...|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~ 107 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYLY 107 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEEE
Confidence 68999999999999999999865554 6899999875432 334456778899999999999999999999774 5699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++|||+.++.+........ .++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999997654443333322 24445578899999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+.......+...
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 243 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence 32 23457899999999987644 889999999999999999999999987765555555443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=310.36 Aligned_cols=207 Identities=27% Similarity=0.377 Sum_probs=167.6
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecc
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 200 (348)
+.||+|+||.||+|++..+|+.||+|+++.... .......+.+|++++++++||||+++++++.. ....|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 469999999999999999999999999976432 33445567789999999999999999998876 456999999998
Q ss_pred cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCc
Q 018936 201 HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280 (348)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 280 (348)
++.+........ .+.+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 79 GGELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 765443333322 33455578889999999999999999999999999999999999999999998543221 223
Q ss_pred ccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
...+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (323)
T ss_pred cceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 455789999999988764 48999999999999999999999998866544444443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=312.56 Aligned_cols=214 Identities=36% Similarity=0.575 Sum_probs=177.7
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc---CceEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSLY 193 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~~ 193 (348)
+|++.+.||+|+||.||++++..+|+.||+|.+............+.+|+++++.++||||+++++++.... ....|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 488999999999999999999899999999998654333344567788999999999999999999987643 12689
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+++||+.+++........ .+....++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 999999987776654321 34555688899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
...........+|+.|+|||.+.+...++.++||||+||++|||++|++||.+.+..+....+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 217 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 443333445567899999999887666889999999999999999999999988776554443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=294.96 Aligned_cols=216 Identities=28% Similarity=0.421 Sum_probs=183.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|++.++||+|.|++||++.+..+|+.+|+|++..........+.+.+|+.|.+.|+|||||++.+.+.. ..+.|||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~ylv 88 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 88 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEEE
Confidence 68999999999999999999999999999999987766666677889999999999999999999887765 4578999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC---CcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~~ 272 (348)
+|+|+++.+..-.-... .+++.-+-.+++||+.||.|+|.+||||||+||+|+++... .-+||+|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVARE-----FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999865443322222 34455577899999999999999999999999999999633 45899999999998
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
+ .......++|||.|||||++... +|+..+|||+.||+||-|+.|++||.+.+......+|+....
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y 229 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY 229 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc
Confidence 7 23346778999999999988765 499999999999999999999999999888777777776543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=310.31 Aligned_cols=205 Identities=32% Similarity=0.471 Sum_probs=171.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+++.||+|+++.... .......+.+|++++..++||||+++++++.. ....|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEE
Confidence 369999999999999999999988999999999976533 22345567889999999999999999998876 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+..+..... .+....++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999998754444433222 234445788999999999999999999999999999999999999999999986643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 206 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206 (333)
T ss_pred ----ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence 23456789999999998775 589999999999999999999999988665443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=313.74 Aligned_cols=215 Identities=27% Similarity=0.359 Sum_probs=174.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.. ...+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEE
Confidence 3789999999999999999999999999999999865332 23344567789999999999999999998876 45699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||++++.+..+.... .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999865443333221 23444477789999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcc---cCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGAT---DYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
...........||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+.+.......++
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 260 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 43333334567899999999886432 37889999999999999999999998877655444444
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=299.55 Aligned_cols=217 Identities=40% Similarity=0.679 Sum_probs=174.8
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEee---cc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTS---RM 188 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---~~ 188 (348)
++|++.+.||+|+||+||+|++.. ++..||+|.++...........+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999754 468899999876544333334455677777765 69999999998853 23
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...++++|||+++++...+.... ...++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 45689999999987776664322 12345556888999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
++..... .......||+.|+|||.+.+. .++.++|||||||++|||++|++||.+.+..+....++..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~ 224 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 224 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH
Confidence 9876433 223455789999999988764 4889999999999999999999999998887777776643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=314.65 Aligned_cols=214 Identities=29% Similarity=0.409 Sum_probs=173.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||++++..+++.||+|+++.... .......+.+|+.++..++||||+++++.+.+ ...+|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 469999999999999999999999999999999975432 33445678889999999999999999998876 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........ .++...++.++.|++.||+|||+.||+||||||+|||++.+++++|+|||++..+..
T Consensus 79 v~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999998754433332222 344555888999999999999999999999999999999999999999999875532
Q ss_pred CCC----------------------------------CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC
Q 018936 275 NHK----------------------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 320 (348)
Q Consensus 275 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG 320 (348)
... ......+||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccC
Confidence 110 011245789999999988764 489999999999999999999
Q ss_pred CCCCCCCChhHHHHHHH
Q 018936 321 KPIMPGRTEVSATFCFV 337 (348)
Q Consensus 321 ~~pf~~~~~~~~~~~~i 337 (348)
++||.+.+..+....++
T Consensus 233 ~~Pf~~~~~~~~~~~i~ 249 (360)
T cd05627 233 YPPFCSETPQETYRKVM 249 (360)
T ss_pred CCCCCCCCHHHHHHHHH
Confidence 99998877655544444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=298.94 Aligned_cols=205 Identities=26% Similarity=0.436 Sum_probs=167.7
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.|+..+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++|+||+++++++... ...+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence 388899999999999999999999999999998765432 22334567899999999999999999888764 469999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+........ ...++...+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99998754433221111 113445557888999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
. ......||..|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 2 12445789999999998765 489999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=307.92 Aligned_cols=208 Identities=35% Similarity=0.578 Sum_probs=174.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC----ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~ 191 (348)
++|++.+.||+|+||.||++++..+|..||+|.+............+.+|+.+++.++||||+++++++..... ..
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 68999999999999999999999999999999987654444556677789999999999999999998865432 35
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|++|||+++++...... .+....+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 101 VYLVMELMDANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eEEEEeCCCcCHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 799999999877665432 233445778899999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
..... ......+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 173 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 173 ACTNF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred cccCc--cCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 53322 23445789999999998775 48999999999999999999999999887655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=313.37 Aligned_cols=215 Identities=26% Similarity=0.368 Sum_probs=174.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||++++..++..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+ ....|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~~ 119 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYLY 119 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEEE
Confidence 4789999999999999999999999999999999975432 22344567789999999999999999988876 45699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||++++.+..+.... .++...+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999865443333221 23344477789999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCc---ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
...........||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+.......++
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 4333233456789999999988643 237889999999999999999999998877655555544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=305.60 Aligned_cols=207 Identities=28% Similarity=0.399 Sum_probs=167.9
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecc
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 200 (348)
+.||+|+||.||++++..+|..||+|+++.... .......+.+|+++++.++||||+++++++... ...|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCCC
Confidence 469999999999999999999999999976432 234455677899999999999999999988764 46999999998
Q ss_pred cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCc
Q 018936 201 HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280 (348)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 280 (348)
++.+........ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 79 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 765543333222 34455588899999999999999999999999999999999999999999987542221 123
Q ss_pred ccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
....||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208 (323)
T ss_pred ccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 345789999999988764 48999999999999999999999998776655444444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=316.52 Aligned_cols=213 Identities=34% Similarity=0.550 Sum_probs=173.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec------cC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR------MS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 189 (348)
.+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 67999999999999999999998999999999885432 2234699999999999999998887432 22
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-cEEEEeeCC
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGL 268 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kl~DFGl 268 (348)
..+++||||+++++...+.... .....++...++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 3578999999987765543211 0112345556888999999999999999999999999999999665 799999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
|+.+..... .....+|+.|+|||++.+...++.++|||||||++|||++|.+||.+.+..+...+++.
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 987643322 34457799999999987766689999999999999999999999999888777777654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.61 Aligned_cols=214 Identities=34% Similarity=0.511 Sum_probs=176.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||+|++..+|+.||+|+++.... .......+.+|++++..++||||+++++++.+ ....|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 369999999999999999999998999999999976543 22445678889999999999999999998876 456999
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+.++ +...+... . .++...++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~-~-----~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK-D-----VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEcCCCCCCHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 99999764 44443322 2 34455588899999999999999999999999999999999999999999998765
Q ss_pred CCC----------------------------CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 274 PNH----------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 274 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCC
Confidence 432 1123345689999999998775 48999999999999999999999998
Q ss_pred CCChhHHHHHHHH
Q 018936 326 GRTEVSATFCFVL 338 (348)
Q Consensus 326 ~~~~~~~~~~~i~ 338 (348)
+.+..+....++.
T Consensus 232 ~~~~~~~~~~i~~ 244 (350)
T cd05573 232 SDTLQETYNKIIN 244 (350)
T ss_pred CCCHHHHHHHHhc
Confidence 8876555555444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=305.60 Aligned_cols=215 Identities=26% Similarity=0.363 Sum_probs=173.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||++++..+++.||+|++.+... .....+.+.+|+.++..++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 469999999999999999999999999999999875322 33345567889999999999999999998876 456999
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+.++ +...+..... .++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 79 v~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred EEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 99999764 4444432222 24445578899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
...........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....++
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 433322333568999999998863 2347889999999999999999999998766554444443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=305.75 Aligned_cols=205 Identities=26% Similarity=0.388 Sum_probs=166.8
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecc
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 200 (348)
+.||+|+||.||++++..+|+.||+|++..... .......+.+|+++++.++||||+++++++.. ....|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 469999999999999999999999999976533 33445677889999999999999999988876 456999999998
Q ss_pred cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCc
Q 018936 201 HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280 (348)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 280 (348)
++.+........ .+....++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 79 ~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 79 GGELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 765543333222 34455578899999999999999999999999999999999999999999998643221 223
Q ss_pred ccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 153 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred ccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 445789999999988764 489999999999999999999999987665444333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=303.35 Aligned_cols=205 Identities=28% Similarity=0.429 Sum_probs=166.6
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccC
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
||+|+||.||+|++..+++.||+|.++.... .......+.+|+++++.++||||+++++++.. ....|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999875432 33445667789999999999999999988876 45689999999875
Q ss_pred hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCccc
Q 018936 203 LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282 (348)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 282 (348)
.+........ .+....+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 79 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 79 ELFHHLQREG-----RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 4433333222 24445578889999999999999999999999999999999999999999998643222 22345
Q ss_pred ccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++
T Consensus 153 ~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 153 FCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred ccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 5789999999988764 48999999999999999999999998876655444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=303.12 Aligned_cols=212 Identities=25% Similarity=0.377 Sum_probs=170.7
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHH---HhcCCCceeeeeceEeeccCceEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILIL---RRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
|++++.||+|+||.||+|++..+|+.||||.++.... .....+.+.+|++++ +.++||||+++++++.. ....|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 6789999999999999999999999999999975432 223345566676655 56789999999999876 45699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||++++.+...... ..+....+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 79 lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999987655443322 134555688899999999999999999999999999999999999999999987543
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
... .......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+....+...
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~ 216 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 222 223456789999999988764 4889999999999999999999999988766655555443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.59 Aligned_cols=213 Identities=25% Similarity=0.356 Sum_probs=170.3
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
+|++.+.||+|+||.||+|++..+++.||+|.+++... .....+....|..++..+ .||+|+++++++.. ...+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 48899999999999999999999999999999976432 223344566688888877 58999999988876 356999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........ .+....+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 v~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999998654433332222 234445788999999999999999999999999999999999999999999986432
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~ 215 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 21 123455789999999988764 489999999999999999999999998776655555443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=306.36 Aligned_cols=215 Identities=26% Similarity=0.340 Sum_probs=173.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||++++..+++.||+|.+..... .......+.+|+.++..++|+||+++++++.. ....|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999865322 23345567789999999999999999998876 456999
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+.++ +...+..... .++...++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 79 v~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 99999865 4444432222 23444577889999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCc----ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
...........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+...+++
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH
Confidence 4333223345789999999987642 347889999999999999999999998876655544444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.20 Aligned_cols=212 Identities=26% Similarity=0.379 Sum_probs=169.4
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCC-ceeeeeceEeeccCceEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHP-NVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~~l 194 (348)
+|++++.||+|+||.||+|++..+++.||+|+++.... .....+.+..|++++..++|+ +|+++++++... ..+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 48999999999999999999989999999999976432 234456677899999999765 578888888763 46999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+......... +....+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 v~E~~~~g~L~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGK-----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEcCCCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999987544433332222 33445788899999999999999999999999999999999999999999875422
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.. .......||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+....+.
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 21 1233457899999999987644 8899999999999999999999998877655544443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.93 Aligned_cols=214 Identities=34% Similarity=0.525 Sum_probs=183.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 193 (348)
..|++.+.||+|.||.||+++++.+|+.+|+|.+.+.... ....+.+.+|+.+|+++. |||||++++.|++.. .++
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~~~ 112 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--SVY 112 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--eEE
Confidence 5799999999999999999999999999999999887653 335678899999999998 999999999999854 699
Q ss_pred EEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC----CcEEEEeeCC
Q 018936 194 LVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD----GVLKIADFGL 268 (348)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~----~~~kl~DFGl 268 (348)
+|||++.++ +++.+... .+++..+..++.||+.|+.|||+.||+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999964 44444433 15566688899999999999999999999999999999733 4799999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
+..... .......+||+.|+|||++... .|+..+|+||+|+++|.|++|.+||.+.++.....++.....
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC
Confidence 999876 3446778999999999988754 499999999999999999999999999998877776665543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.76 Aligned_cols=224 Identities=25% Similarity=0.454 Sum_probs=190.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|..++++|+|+||.+++++++.+++.|++|.+..............+|+.++++++|||||.+.+.|..+ ++.+++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 3689999999999999999999999999999999998887666666777899999999999999999999874 456999
Q ss_pred EEeecccChhhh-hcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGL-AASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|+|++|+.+.. +..+. ...+++.++..|+.||+.|+.|||++.|+|||||+.|||++.++.+||+|||+|+.++
T Consensus 82 vm~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEeecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999855444 33333 1245566699999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCcC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFV 346 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~~ 346 (348)
+.. ....+.+||+.|++||.+.+. +|+.|+|+|||||++|||++-+++|.+.+ ...+..-+...+..|+.
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-m~~Li~ki~~~~~~Plp 227 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASN-MSELILKINRGLYSPLP 227 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccc-hHHHHHHHhhccCCCCC
Confidence 654 235678999999999988875 49999999999999999999999998865 55555555555566653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.62 Aligned_cols=212 Identities=32% Similarity=0.559 Sum_probs=176.6
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----Cc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SC 190 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 190 (348)
.++|++.+.||+|+||.||++++..+++.||+|.+............+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 37899999999999999999999889999999998765444555667778999999999999999999886432 23
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
..|++|||+++++...... .+....+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~lv~e~~~~~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcccHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 5799999999887665532 23444577889999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
...... ......+|..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....++
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (355)
T cd07874 168 TAGTSF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_pred cCCCcc--ccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 654332 23455789999999988764 48999999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=306.98 Aligned_cols=195 Identities=27% Similarity=0.380 Sum_probs=164.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
..+|++++.||+|+||.||+|++..+++.||+|... ...+.+|+++++.++||||+++++++.. ....++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEE
Confidence 367999999999999999999999999999999643 2345689999999999999999999876 456899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
++|++.+++...+.... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 161 v~e~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 161 ILPRYKTDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99999887776654321 234555788999999999999999999999999999999999999999999976433
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 322333456789999999988764 489999999999999999999987754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=304.92 Aligned_cols=211 Identities=31% Similarity=0.566 Sum_probs=176.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----Cce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 191 (348)
++|++.+.||+|+||.||++++..+++.||||.+............+.+|+.+++.++||||+++++++.... ...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 6899999999999999999999999999999998765444455566778999999999999999999875432 235
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|+||||+++++...... .+....+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 104 VYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred EEEEEeCCCCCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 799999999887765532 233445778899999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
..... ......+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 238 (364)
T cd07875 176 AGTSF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238 (364)
T ss_pred cCCCC--cccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 64322 23445789999999998774 48999999999999999999999999988766555544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.86 Aligned_cols=216 Identities=25% Similarity=0.339 Sum_probs=173.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.++||+|+||.||++++..+++.||+|++.+... .......+.+|+.++..++|+||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 369999999999999999999999999999999864322 23334557789999999999999999998876 456999
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+.+ .+...+..... .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999976 44444433222 23444578899999999999999999999999999999999999999999997654
Q ss_pred CCCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
...........||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+....++.
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~ 222 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence 333322334578999999998862 33478899999999999999999999988776665555543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=296.99 Aligned_cols=213 Identities=39% Similarity=0.747 Sum_probs=175.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..++..||+|.++..... .....+.+|++++++++||||+++++++... ...+++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEEE
Confidence 6799999999999999999999899999999998765432 2233466799999999999999999998774 458999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++++......... .+....++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 83 FEYLDKDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred EeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 99999887776644322 2344457788999999999999999999999999999999999999999999765332
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.. ......+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+....++
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 21 12334678999999988765568899999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.57 Aligned_cols=205 Identities=28% Similarity=0.452 Sum_probs=166.0
Q ss_pred CceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCc
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 190 (348)
+|++.+.||+|+||.||++++. .++..||+|++..... .....+.+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4899999999999999999863 4789999999875432 223355677899999999 59999999988876 45
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
..+++|||+.++.+........ .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 6899999998754433322222 24445588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..............||+.|+|||++.+...++.++|||||||++|||++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 7644433334456789999999998765557889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=333.89 Aligned_cols=223 Identities=26% Similarity=0.338 Sum_probs=190.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|.+++.||+|+||.|.+++++.+++.||+|++.+-.. .......|..|..+|..-+.+.|++++-.|.+ ..++|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceE
Confidence 3789999999999999999999999999999999876332 34556789999999999999999999877776 56799
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||||+|+-+-.+......++ +..++.|+++|+.||+.||+.|+|||||||+|||||..|++||+|||.+-.++
T Consensus 152 lVMdY~pGGDlltLlSk~~~~p-----E~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLP-----EDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEEecccCchHHHHHhhcCCCh-----HHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 9999998754443333332444 44489999999999999999999999999999999999999999999999888
Q ss_pred CCCCCCcccccccCccccccccc----CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH--hccCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN--LIFDP 344 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~--~~~~p 344 (348)
.+..-.....+|||.|++||++. +...|++..||||+||++|||+.|..||...+-++.+-+|+.. .+..|
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 66665567779999999999884 2245899999999999999999999999999999999999877 44444
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.23 Aligned_cols=211 Identities=26% Similarity=0.380 Sum_probs=168.9
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||.||+|++..+++.||+|+++.... .....+.+..|.+++..+ +||||+++++++... ...|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 469999999999999989999999999876432 234455667788888866 899999999999874 4589999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+......... +.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 ~~~~L~~~l~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 79 NGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 87544433332222 3444577889999999999999999999999999999999999999999998643222 12
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05591 153 TTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213 (321)
T ss_pred ccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 3445689999999988764 489999999999999999999999998887666655554433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=300.15 Aligned_cols=206 Identities=27% Similarity=0.417 Sum_probs=163.8
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||+||+|++..+++.||+|.++.... .....+....|..++..+ +||||+++++++.. ....|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999976432 223344455677777654 89999999988876 45699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+........ .++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 ~gg~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 79 NGGDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 8755444333222 23444578889999999999999999999999999999999999999999998653222 22
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i 208 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208 (316)
T ss_pred cccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 34557899999999887654 899999999999999999999999987765444443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=300.97 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=168.3
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||.||+|+++.+++.||+|+++.... .....+.+..|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999875432 233455667788888876 79999999999876 45689999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+......... +....+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 ~~g~L~~~i~~~~~-----l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 79 NGGDLMFHIQKSRR-----FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred CCchHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 87555433332222 3445578889999999999999999999999999999999999999999988643222 22
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 212 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212 (320)
T ss_pred ccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 3445789999999988764 48899999999999999999999999887766555554433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=306.09 Aligned_cols=214 Identities=31% Similarity=0.431 Sum_probs=173.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||++++..+|+.||+|+++.... .....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 369999999999999999999999999999999986543 33456678889999999999999999988876 456999
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||++++ +...+..... .+....++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+.
T Consensus 79 v~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred EECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 99999764 4444433222 34445577889999999999999999999999999999999999999999998775
Q ss_pred CCCCCCcccccccCcccccccccC-----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
...........||+.|+|||++.. ...++.++|||||||++|+|++|+.||...+.......+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i 221 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH
Confidence 443322334468999999998763 334788999999999999999999999876655444443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=296.80 Aligned_cols=216 Identities=27% Similarity=0.406 Sum_probs=186.6
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
..+|..+.+||+|+||+|.++..+.+.+.||||+++++.+ +.+..+.-..|-++|... +-|.+++++.+|.. ...+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhhe
Confidence 3679999999999999999999999999999999988765 555566666788888766 56889999998876 3459
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+||||+.++-+.+..++.+++.++. +..|+++|+.||-+||++||++||||.+|||++.+|++||+|||+++.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~-----AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPV-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCch-----hhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999988888888888888887 7779999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
--. ...+.+++|||.|+|||++. .++|+..+||||+||+||||+.|++||.|.++.+....|...
T Consensus 501 i~~-~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 501 IFD-GVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred ccC-CcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence 222 23356789999999999776 456999999999999999999999999999987766666544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=305.44 Aligned_cols=208 Identities=27% Similarity=0.473 Sum_probs=178.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
..|+.++.||+|+||.||+|.+..+++.||+|++..+... ...+++++|+.+|..++++||.+++|.+.. ...++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHH
Confidence 4688889999999999999999999999999999877644 456788999999999999999999999988 4559999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+.++....+......+.+.. +..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+...
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~-----i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFE-----IAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHhcCcchhhhhccCCCCccce-----eeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999865554444443333333 5557899999999999999999999999999999999999999999988755
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
.... .+++||+.|||||++.+ ..|+.++||||||++.+||++|.||+...+.+..+
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl 220 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL 220 (467)
T ss_pred hhcc-ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE
Confidence 5443 78899999999999985 45999999999999999999999999887765433
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=299.73 Aligned_cols=213 Identities=26% Similarity=0.382 Sum_probs=170.1
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 194 (348)
+|+..+.||+|+||.||+|++..+|+.||+|++..... .....+.+..|+.++..+. |++|+++++++... ..+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 47889999999999999999999999999999876432 2334456777889998886 56788888888764 46999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........ .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 v~Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999998754443333222 244455888999999999999999999999999999999999999999999986432
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.. .......||+.|+|||++.+. .++.++|+||+||++|+|++|++||.+.+.......++.
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 21 122345689999999988764 489999999999999999999999998776555555444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=300.75 Aligned_cols=212 Identities=28% Similarity=0.458 Sum_probs=180.1
Q ss_pred ccCCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHH-HHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 111 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
.+...+.|+.-++||+||||.||-++...||+.||+|.+.+..+.... ...-.+|..+|++++.++||.+--.|+. .
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--k 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET--K 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--C
Confidence 455578899999999999999999999999999999988665542222 2234579999999999999999656655 4
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
..+++|+..|.|+-+.+.....+ ++.+++.+++.|+++|+.||++||+.+||+||+||+|||+|+.|+++|+|+|||
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred CceEEEEEeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 56999999999987777665443 356777779999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
..+..+.. ...++||.+|||||++.+.. |+...|||||||++|||+.|+.||.+..+.
T Consensus 335 vei~~g~~--~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 335 VEIPEGKP--IRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred EecCCCCc--cccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 98865543 45669999999999998866 999999999999999999999999776544
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=301.28 Aligned_cols=211 Identities=35% Similarity=0.581 Sum_probs=175.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----Cce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 191 (348)
++|++.+.||+|+||+||+|.+..++..||+|.+............+.+|+++++.++||||+++++++.... ...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 6899999999999999999999999999999998754433344556778999999999999999999875422 245
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|++++++++.+....... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~~~~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLMGADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred EEEEeecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 7899999987776554321 345556888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+...++.
T Consensus 168 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07878 168 ADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229 (343)
T ss_pred cCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 6432 3445789999999998775568899999999999999999999998877665555443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.57 Aligned_cols=206 Identities=27% Similarity=0.381 Sum_probs=166.2
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecc
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 200 (348)
+.||+|+||.||++++..+|..||+|+++.... .......+.+|+++++.++||||+++++++.. ....|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 469999999999999999999999999976433 23345566789999999999999999988876 456999999998
Q ss_pred cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 201 HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
++.+........ .++...++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 79 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 765544333222 34455588899999999999997 799999999999999999999999999987643222 12
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i 208 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208 (325)
T ss_pred cccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence 3345789999999988764 4899999999999999999999999877654443333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.97 Aligned_cols=215 Identities=39% Similarity=0.666 Sum_probs=172.4
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEeec---cCc
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTSR---MSC 190 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~---~~~ 190 (348)
+|++.+.||+|+||+||+|++..+|+.||+|.++.............+|+++++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999876543322233345577776665 799999999987642 235
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
..+++|||+.+++...+..... ..++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 6899999999877666543221 234556688899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
...... ......+|..|+|||++.+.. ++.++||||+||++|+|++|++||.+....+....++.
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 764322 223456789999999887644 89999999999999999999999988877665555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=266.39 Aligned_cols=216 Identities=42% Similarity=0.725 Sum_probs=187.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
..|.-.++||+|.||+||+|++..+++.||+|.++.+..++..-..-.+|+-+|+.++|+|||+++++... ...+-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 45777899999999999999999999999999999877655444556679999999999999999998866 4458999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+|||+..+..++...++.+ ....++.+|.|++.||.++|++++.|||+||.|.||+.+|.+|++|||+++.++..
T Consensus 80 fe~cdqdlkkyfdslng~~-----d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDL-----DPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHHhhHHHHHHHHhcCCcC-----CHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9999998888776655543 33448999999999999999999999999999999999999999999999988644
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~ 339 (348)
.. .....+.|.+|.+|.++.|.+-|+...|+||.||++.|+.. |++.|+|.+..+++.+|+.-
T Consensus 155 vr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~ 218 (292)
T KOG0662|consen 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_pred eE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH
Confidence 32 23445679999999999998889999999999999999986 99999999999999888754
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=299.10 Aligned_cols=209 Identities=26% Similarity=0.440 Sum_probs=165.3
Q ss_pred eeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 121 IDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++.||+|+||.||++++. .+++.||+|+++.... .......+.+|+++|+.++||||+++++++... ...|++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEE
Confidence 367999999999999863 4688999999875432 223345567899999999999999999998774 468999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+.++.+......... +....+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 79 LEYLSGGELFMHLEREGI-----FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred EeCCCCchHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999987544433332222 333447778999999999999999999999999999999999999999999754322
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~ 214 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214 (323)
T ss_pred CC-cccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 21 23345789999999988764 478999999999999999999999988776554444443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=299.48 Aligned_cols=207 Identities=25% Similarity=0.378 Sum_probs=162.1
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHH-HHHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREI-LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||.||+|++..+|+.||+|++..... .......+..|+ .+++.++||||+++++++.. ....|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999875432 222233344454 46788999999999988876 45699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+........ .+....++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 79 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 79 NGGELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 8755443332222 2344457788999999999999999999999999999999999999999998754222 122
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.....||+.|+|||.+.+. .++.++|||||||++|||++|++||.+.+.......++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209 (321)
T ss_pred cccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence 3445789999999988764 48999999999999999999999998876544444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=298.77 Aligned_cols=215 Identities=24% Similarity=0.390 Sum_probs=166.1
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.++||+|+||.||+|++. .++..||+|+++... .......+.+|+.+++.+ +||||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence 78999999999999999999742 345789999986432 334456688899999999 899999999988653 3
Q ss_pred ceEEEEEeecccChh-hhhcCCCCc-------------------------------------------------------
Q 018936 190 CSLYLVFHYMEHDLA-GLAASPEVK------------------------------------------------------- 213 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~-~~~~~~~~~------------------------------------------------------- 213 (348)
..++++|||++++.+ ..+......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 458999999986544 333221100
Q ss_pred -CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCC-CcccccccCcccc
Q 018936 214 -FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRP 291 (348)
Q Consensus 214 -~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~a 291 (348)
.....+....+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ ......++..|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 00123455567889999999999999999999999999999999999999999999865332211 1223345678999
Q ss_pred cccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 292 PELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 292 PE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
||++.+.. ++.++|||||||++|||++ |..||.+....+..
T Consensus 245 PE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~ 286 (338)
T cd05102 245 PESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286 (338)
T ss_pred cHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 99887644 8999999999999999997 99999886544333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=299.04 Aligned_cols=208 Identities=25% Similarity=0.369 Sum_probs=162.9
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHH-HHHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREI-LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||+||+|++..+++.||+|++..... .......+..|. .+++.++||||+++++++... ...|++|||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeCC
Confidence 469999999999999999999999999875432 112222333344 456789999999999888764 5689999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+......... +....++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 79 ~~~~L~~~~~~~~~-----~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~ 152 (325)
T cd05602 79 NGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT 152 (325)
T ss_pred CCCcHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence 87554444333222 334447778999999999999999999999999999999999999999999754322 122
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210 (325)
T ss_pred cccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 3455789999999988764 489999999999999999999999998776655555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=282.67 Aligned_cols=214 Identities=30% Similarity=0.432 Sum_probs=178.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL------EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 188 (348)
+.|...+.||+|..++|.++.++.+|+.+|+|++..... .....+.-.+|+.+|+++ .||+|+++.++++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 468888999999999999999999999999999865432 223455566799999988 79999999999987
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
+..+++|+|.|..+.+........ .+++...+.+|+|++.|++|||.++||||||||+|||++++.++||+|||.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence 567999999998655544444444 345555899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCccccccccc-----CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLL-----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
|+.+.++.. ....||||+|+|||.+. +.+.|+..+|+|++||++|.|+.|.+||......-.+..|+.
T Consensus 170 a~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 170 ACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred eeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 999876654 57789999999999873 446688999999999999999999999987665544444443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=293.66 Aligned_cols=204 Identities=41% Similarity=0.664 Sum_probs=164.6
Q ss_pred eeeeccCCceEEEEEEEc--cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEee
Q 018936 121 IDKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
.++||+|+||+||+|+++ .++..||+|.+..... ...+.+|++++++++||||+++++++........|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 368999999999999865 4678999999865432 2345679999999999999999999877666778999999
Q ss_pred cccChhhhhcCCCCc---CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----CCCCcEEEEeeCCccc
Q 018936 199 MEHDLAGLAASPEVK---FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASF 271 (348)
Q Consensus 199 ~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll----~~~~~~kl~DFGla~~ 271 (348)
+++++.......... .....++...++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 998876665432111 111245666788999999999999999999999999999999 4567899999999987
Q ss_pred cCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 272 FDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 272 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
...... .......+|+.|+|||++.+...++.++|+||+||++|+|++|++||.+..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 653321 123455789999999998876668999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=298.65 Aligned_cols=207 Identities=26% Similarity=0.383 Sum_probs=162.8
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREIL-ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||+||+|++..+|+.||+|++..... .......+..|.. +++.++||||+++++.+.. ....|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 469999999999999999999999999875432 2222334444544 5678999999999988876 45689999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+........ .+....++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 79 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 79 NGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 8755443333222 3444557788999999999999999999999999999999999999999998754222 222
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 209 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209 (323)
T ss_pred cccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 3455789999999988764 48999999999999999999999998876555444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=288.96 Aligned_cols=201 Identities=28% Similarity=0.402 Sum_probs=162.7
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccC
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
||+|+||+||++++..+|+.||+|.+...... ....+.+..|+++++.++||||+++.+++..+ ...|++|||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCCC
Confidence 79999999999999999999999998754432 22345667899999999999999998888764 4589999999875
Q ss_pred hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCccc
Q 018936 203 LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282 (348)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 282 (348)
.+........ .....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........ ....
T Consensus 79 ~L~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 79 DLRYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred CHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 5543321111 1122455666888999999999999999999999999999999999999999999987654322 2334
Q ss_pred ccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
..||+.|+|||.+.+. .++.++|+||||+++|+|++|+.||.....
T Consensus 157 ~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 157 YAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred cCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 5689999999998875 488999999999999999999999977554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=295.85 Aligned_cols=205 Identities=25% Similarity=0.397 Sum_probs=162.9
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||.||+|++..+|..||+|.++.... ..........|..++..+ +||||+++++++.. ....|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 469999999999999999999999999976432 123344566688888754 89999999999877 45699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
.++.+........ .+....+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++...... ..
T Consensus 79 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 79 NGGDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 8754433332222 23444577889999999999999999999999999999999999999999987542221 22
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~ 207 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207 (316)
T ss_pred eeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 3456789999999998764 489999999999999999999999988766444333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=298.99 Aligned_cols=207 Identities=26% Similarity=0.370 Sum_probs=163.3
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREIL-ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||+||+|++..+|+.||+|++..... .......+..|.. +++.++||||+++++++.. ....|++|||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 469999999999999999999999999875432 2223344445554 5677999999999988876 45689999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
.++.+........ .++...++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 79 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 79 NGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 8765443333322 3445558889999999999999999999999999999999999999999998754322 122
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~ 209 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209 (325)
T ss_pred cccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence 34557899999999887644 8899999999999999999999998876555444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=287.27 Aligned_cols=216 Identities=43% Similarity=0.736 Sum_probs=178.9
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|++|.||+|++..++..||+|.++.........+.+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 4889999999999999999998899999999987655444445667889999999999999999999987 44689999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+++++...+..... ...+....++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 79 EFLSMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred ecCCCCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 9999877666543221 1245556688899999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.......+++.|+|||.+.+...++.++|+||||+++|+|+||++||.+.++.+..+.++.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~ 216 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFR 216 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 1223345688999999887655578899999999999999999999998887776666544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=308.99 Aligned_cols=220 Identities=23% Similarity=0.323 Sum_probs=178.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC-----
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----- 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 189 (348)
.++|++.+.||+|+||+||+|++..+|+.||||.+............+.+|+.++..++|+||+++++.+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 378999999999999999999999999999999998776666667778899999999999999999877654221
Q ss_pred -ceEEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 190 -CSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 190 -~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
..+++||||+.++ +...+.... .....+....+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~--~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRA--KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 2478999999864 444433211 111245566688899999999999999999999999999999999999999999
Q ss_pred CccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 268 LASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 268 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
+++.+..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+....++
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 9987643222 2234457899999999887644 8999999999999999999999998876554444443
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=297.96 Aligned_cols=217 Identities=28% Similarity=0.491 Sum_probs=189.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.-|.+.+.||+|-|++|-+|++..+|..||||++.+..++......+.+|+++|+.++|||||+||.+... +..+||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEEE
Confidence 46999999999999999999999999999999999988877777788889999999999999999998866 5669999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC-CCCcEEEEeeCCccccC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFD 273 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~kl~DFGla~~~~ 273 (348)
+|.-++ ++.+++......+.+ ...+.|++||+.|+.|+|+..+|||||||+|+.+- .-|.+||+|||++..+.
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E-----~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNE-----DLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhhccccH-----HHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999886 777777665554444 34888999999999999999999999999999875 56899999999999887
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
++.. .++.||+..|-|||+++|..+-.+++|||||||+||.|++|++||..-++.+.+-.|+-...
T Consensus 171 PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY 236 (864)
T KOG4717|consen 171 PGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY 236 (864)
T ss_pred Ccch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc
Confidence 7654 67889999999999999876445799999999999999999999998888777766654443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=287.46 Aligned_cols=206 Identities=27% Similarity=0.435 Sum_probs=168.1
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.|++.+.||+|+||.||++.+..++..||+|.+...... ......+.+|+++++.++||||+++++.+..+ ...+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence 388999999999999999999889999999998764432 22334567899999999999999999988764 469999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+........ ...++...+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99998755443322111 113455568889999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
.. .....|++.|+|||++.+. .++.++|+||+|+++|+|++|+.||.+.+..
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~ 207 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchh
Confidence 21 2345789999999998764 4889999999999999999999999886653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=289.67 Aligned_cols=213 Identities=41% Similarity=0.763 Sum_probs=174.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||.|+||.||+|++..++..||+|.++..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEEE
Confidence 36899999999999999999999889999999998755432 2234566799999999999999999998764 46899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|||+++.+...+...... +....++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 82 v~e~~~~~l~~~l~~~~~~-----~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 82 VFEYLDKDLKQYLDDCGNS-----INMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred EEeccccCHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 9999998777766543322 33445788899999999999999999999999999999999999999999976532
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
... ......+++.|+|||.+.+...++.++||||||+++|+|++|++||.+.+..+....+
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 157 PTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred CCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 221 1233456889999998876666888999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.59 Aligned_cols=196 Identities=23% Similarity=0.435 Sum_probs=161.1
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||.||+|++..+++.||+|+++.... .....+.+.+|..++..+ +||||+++++++... ..+|++|||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999986543 234456678899999988 799999999998774 5699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+........ .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 79 ~~g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 79 SGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 8754433332222 3455558889999999999999999999999999999999999999999999753221 122
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
.....||+.|+|||++.+. .++.++|+|||||++|+|++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCccc
Confidence 3445789999999998764 488999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=306.81 Aligned_cols=213 Identities=31% Similarity=0.524 Sum_probs=184.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
..|+-++.||.|+||.||-|++..+.+.||||.+..+.. ..+...++..|+..|+.++|||++.+.|+|..+ ...||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHH
Confidence 468999999999999999999999999999999987765 445677888999999999999999999999874 34799
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||||-|+..+++..... .+-+..|..+..+.+.||+|||+++.||||||+.|||+++.|.+||+|||.|....+
T Consensus 104 VMEYClGSAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 104 VMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHHhccHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 999999876666554333 333445777899999999999999999999999999999999999999999987655
Q ss_pred CCCCCcccccccCccccccccc--CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
. .+++|||.|||||+++ +...|+-++||||||++..||.-.+||+-+.+.+++++-|..|.
T Consensus 179 A-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe 241 (948)
T KOG0577|consen 179 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 241 (948)
T ss_pred h-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC
Confidence 4 5789999999999985 44569999999999999999999999998888888888887663
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=292.86 Aligned_cols=205 Identities=27% Similarity=0.437 Sum_probs=162.2
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHh-cCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRR-LDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||+||+|++..+++.||+|.++.... ..........|..+++. ++||||+++++++... ..+|++|||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 469999999999999999999999999976432 12234455667888876 4999999999998774 4699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+........ .+....+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 79 NGGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 8654433332222 23344477789999999999999999999999999999999999999999997542221 12
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred eeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 3455789999999988764 489999999999999999999999988765444333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=293.93 Aligned_cols=206 Identities=26% Similarity=0.405 Sum_probs=165.7
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||+||+|++..+++.||+|++++... .....+.+.+|+++++.+ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 469999999999999989999999999976532 233455677889999888 799999999998764 4699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
.++.+........ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++...... ..
T Consensus 79 ~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 79 NGGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 8755443333322 34455578899999999999999999999999999999999999999999997532221 22
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
....+||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i 208 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208 (318)
T ss_pred ccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 33456899999999987654 899999999999999999999999877654444333
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=297.99 Aligned_cols=208 Identities=26% Similarity=0.421 Sum_probs=167.2
Q ss_pred eeeccCCceEEEEEEEc---cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEee
Q 018936 122 DKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
+.||+|+||.||++++. .+|+.||+|++............+.+|++++++++||||+++++++.. ....|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 67999999999999863 578999999997654433344556789999999999999999999876 4568999999
Q ss_pred cccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCC
Q 018936 199 MEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 278 (348)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 278 (348)
++++.+........ .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 80 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 98644333322222 34555688899999999999999999999999999999999999999999998654321 2
Q ss_pred CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 279 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~ 212 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212 (318)
T ss_pred ceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 23456789999999988764 478999999999999999999999988776555554443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=301.85 Aligned_cols=208 Identities=23% Similarity=0.346 Sum_probs=166.9
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC------CceeeeeceEeec
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH------PNVIKLEGLVTSR 187 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~ 187 (348)
..++|++.+.||+|+||+||+|++..+++.||||+++... ........|+++++.++| ++++++++++...
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3478999999999999999999998999999999986432 223345567777777755 4588888888654
Q ss_pred cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCC-------
Q 018936 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDG------- 259 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~------- 259 (348)
...+++||+++++.+...+... . .+....++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 204 -~~~~~iv~~~~g~~l~~~l~~~-~-----~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 -TGHMCIVMPKYGPCLLDWIMKH-G-----PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred -CceEEEEEeccCCCHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 4568999999988877766432 1 34445578899999999999998 5999999999999998765
Q ss_pred ---------cEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 260 ---------VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 260 ---------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
.+||+|||++.... ......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.++.
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886432 2234567899999999988754 899999999999999999999999988876
Q ss_pred HHHHHH
Q 018936 331 SATFCF 336 (348)
Q Consensus 331 ~~~~~~ 336 (348)
+....+
T Consensus 352 ~~~~~i 357 (467)
T PTZ00284 352 EHLHLM 357 (467)
T ss_pred HHHHHH
Confidence 555443
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=296.35 Aligned_cols=195 Identities=25% Similarity=0.454 Sum_probs=160.4
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||.||+|++..+++.||+|++++... .....+.+.+|+.++..+ +||||+++++++.. ....|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999986533 334455677888888876 89999999999877 45699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+........ .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 ~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 79 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 8765543333222 34455588899999999999999999999999999999999999999999997643221 12
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCc
Confidence 3445789999999988764 48999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=291.45 Aligned_cols=202 Identities=27% Similarity=0.408 Sum_probs=169.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||++++..+|..||+|.+.... .....+.+.+|+++|+.++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEEE
Confidence 78999999999999999999999999999999987543 344566788999999999999999999998774 468999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++.+..+..... .++...+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred eecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99998754443333222 244555788999999999999986 699999999999999999999999999986643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.. .....||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+.
T Consensus 157 ~~---~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 157 SM---ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred cc---cccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22 23456899999999987654 89999999999999999999999977654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=305.29 Aligned_cols=216 Identities=22% Similarity=0.317 Sum_probs=172.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT-GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
..|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||++++++... ...|+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEE
Confidence 4599999999999999999998777 7889999765432 34455677899999999999999999999874 56999
Q ss_pred EEeecccChh-hhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLA-GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||++++.+ ..+... .. ....+....+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 143 v~E~~~gg~L~~~l~~~-~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQR-LK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEECCCCCCHHHHHHHH-Hh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999986544 332211 00 11134455578899999999999999999999999999999999999999999998765
Q ss_pred CCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 274 PNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 274 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++.
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~ 285 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285 (478)
T ss_pred CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 3322 123455789999999988764 489999999999999999999999988776555555443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=286.94 Aligned_cols=204 Identities=46% Similarity=0.760 Sum_probs=169.5
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|+||.||+|++..+|+.||+|.++...........+.+|+++++.++||||+++++++.+. ...++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence 48899999999999999999999999999999976544444445677899999999999999999998764 4689999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+++++...+..... .++...++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 79 e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 79 EYCDQDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred ecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 9999888776654332 24455588899999999999999999999999999999999999999999998664332
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCC-CCCC
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM-PGRT 328 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf-~~~~ 328 (348)
. ......+++.|+|||.+.+...++.++|+|||||++|+|++|..|| .+.+
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~ 205 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence 2 2234466889999998877655789999999999999999988775 4444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.66 Aligned_cols=212 Identities=43% Similarity=0.666 Sum_probs=176.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
..|+.+..||+|.||.||+|....++ ..+|||.++-+.........-.+|+.+++.++|||++.|..+|... ...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 56999999999999999999644443 3789999876543333334456799999999999999999988764 456
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC----CcEEEEeeC
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD----GVLKIADFG 267 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~----~~~kl~DFG 267 (348)
++|++||.++++............ .+++...++.+++||+.|+.|||++-|+||||||.|||+..+ |.+||+|||
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999999999887765443333 477777899999999999999999999999999999999877 899999999
Q ss_pred CccccCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 268 LASFFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 268 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
+++.+...-.. .....+.|++|+|||.++|...|+++.|+|+.||++.||+|-+|.|.+..+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 99988643221 234567799999999999999999999999999999999999999977543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=318.62 Aligned_cols=222 Identities=27% Similarity=0.431 Sum_probs=179.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++++.||+|+||+||+|++..++..||+|.+............+..|+.+++.++|||||+++++|.......+|+
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 47899999999999999999999999999999999877666666778889999999999999999999987766678999
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCCEEECC---------
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-------GVLHRDIKGSNLLIDD--------- 257 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-------~ivHrDikp~NIll~~--------- 257 (348)
||||+++ .|...+..... ....+++..++.++.||+.||.|||+. +||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999986 44444432110 012355666889999999999999985 4999999999999964
Q ss_pred --------CCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 258 --------DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 258 --------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.+.+||+|||++..+.... ......||+.|+|||++.+. ..++.++|||||||+||+|++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2358999999998764322 23445789999999988642 347889999999999999999999998777
Q ss_pred hhHHHHHHHHHh
Q 018936 329 EVSATFCFVLNL 340 (348)
Q Consensus 329 ~~~~~~~~i~~~ 340 (348)
........+...
T Consensus 248 ~~~qli~~lk~~ 259 (1021)
T PTZ00266 248 NFSQLISELKRG 259 (1021)
T ss_pred cHHHHHHHHhcC
Confidence 666665555443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=293.74 Aligned_cols=196 Identities=24% Similarity=0.435 Sum_probs=161.3
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||+||+|++..+++.||+|+++.... .....+.+.+|+.++.++ +||||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 469999999999999999999999999986543 234456678899999888 699999999988764 5699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+........ .++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 ~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 79 NGGDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 8755443332222 34555588899999999999999999999999999999999999999999997532221 22
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCc
Confidence 3456789999999998764 489999999999999999999999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=282.78 Aligned_cols=215 Identities=37% Similarity=0.680 Sum_probs=178.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+..........+.+.+|+++++.++|||++++++++.. ....+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 46999999999999999999998899999999987554333334567789999999999999999999877 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++++........ .+.+..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 79 FEYCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred EeccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99999887776654332 2445558889999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.. ......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.++.+..+.+..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 21 122345688899999987655578899999999999999999999999887776665543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=291.02 Aligned_cols=199 Identities=30% Similarity=0.445 Sum_probs=163.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|+..++||+|+||.||+|++..+|+.||||++.... .......+.+|+++++.++|+||+++++++.. ...+|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEE
Confidence 467999999999999999999998999999999986543 33445678899999999999999999999876 456899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|||++++.+.... ......+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 150 v~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 150 LLEFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EEecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999876443211 122334677899999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
.. .......||..|+|||++.. ....+.++|||||||++|||++|+.||..
T Consensus 221 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 221 TM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 22 22344578999999998742 12245689999999999999999999974
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=301.32 Aligned_cols=224 Identities=30% Similarity=0.499 Sum_probs=195.4
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
....|.+...||+|.|++|.+|++..+|..||||.+.+...+......+.+|+++|+.++|||||+++.+.+.+ ..+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--ATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--ceeE
Confidence 34679999999999999999999999999999999999888877777799999999999999999999998874 4599
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||..++....+.....+..+ ..++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+.
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e-----~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKE-----KEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEeccCchhHHHHHhcccchh-----hhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 99999987555555545544444 3377889999999999999999999999999999999999999999999987
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCcC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFV 346 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~~ 346 (348)
.. ....+.+|++.|.|||++.+...-++.+|+||+|+++|-|+.|..||.+.+-.+...+.+...+.-|+.
T Consensus 207 ~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ 277 (596)
T KOG0586|consen 207 YG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY 277 (596)
T ss_pred cc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce
Confidence 44 346788999999999999998877899999999999999999999999988777777777766666654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=287.66 Aligned_cols=217 Identities=49% Similarity=0.823 Sum_probs=179.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|.+..+|+.||+|.++...........+.+|+.+++.++|+||+++++++........++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 68999999999999999999999999999999987654433333345679999999999999999999877655678999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++.+...+..... .+....++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 87 ~e~~~~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 87 MEYCEQDLASLLDNMPT-----PFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999877666554322 3455568889999999999999999999999999999999999999999999876533
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
. .......+++.|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..+....+..
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 1223334578899999987655688999999999999999999999998887766555554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.30 Aligned_cols=204 Identities=28% Similarity=0.406 Sum_probs=161.4
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc---CCCceeeeeceEeeccCceEEEEEeec
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL---DHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
||+|+||+||+|++..+|+.||+|++..... ..........|.+++... +||||+++++.+.. ....|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 7999999999999999999999999865432 222333455577777665 79999999988876 45699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
.++.+........ .++...++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ..
T Consensus 79 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 79 SGGELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred CCChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 8754433333222 34455588899999999999999999999999999999999999999999997643222 22
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
.....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~ 208 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN 208 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH
Confidence 34557899999999987655688999999999999999999999988665443333
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=287.96 Aligned_cols=203 Identities=42% Similarity=0.674 Sum_probs=163.2
Q ss_pred eeeccCCceEEEEEEEcc--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDML--TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
.+||+|+||.||+|++.. ++..||+|.+..... ...+.+|+++++.++||||+++++++........++++||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 689999999999998643 568999998864432 23466799999999999999999998766667789999999
Q ss_pred ccChhhhhcCCCC---cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----CCCCcEEEEeeCCcccc
Q 018936 200 EHDLAGLAASPEV---KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFF 272 (348)
Q Consensus 200 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll----~~~~~~kl~DFGla~~~ 272 (348)
++++...+..... ......++...++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9887766542211 1112245666688899999999999999999999999999999 56679999999999876
Q ss_pred CCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 273 DPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 273 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..... .......+|+.|+|||++.+...++.++|||||||++|||+||++||....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 53322 123345679999999998775568899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=281.68 Aligned_cols=216 Identities=44% Similarity=0.816 Sum_probs=178.3
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|+..+.||.|++|.||+|++..+|+.||||.+..........+.+.+|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4899999999999999999998899999999987655444445568889999999999999999999876 44689999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+.+++......... ..+....+..++.|++.||+|||+.+++||||+|+||+++.++.+||+|||++.......
T Consensus 79 e~~~~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLHQDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccccCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 9998776665543221 134555688899999999999999999999999999999999999999999998664332
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
. ......+++.|+|||.+.+...++.++|+||||+++|+|+||+.||.+.++.+...+++..
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 216 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 216 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 1 1233456888999998876555688999999999999999999999998887777766643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=280.59 Aligned_cols=206 Identities=41% Similarity=0.721 Sum_probs=169.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+|+++++.++|+||+++++++.. ....|++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv 81 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTFV 81 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEEE
Confidence 6799999999999999999999889999999998654332 223345679999999999999999999876 4468999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||+.++++......... +....++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 82 FEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EecccCCHHHHHHhCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 999988877765443222 233346778999999999999999999999999999999999999999999765322
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
. .......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+....
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~ 210 (291)
T cd07870 157 S-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210 (291)
T ss_pred C-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH
Confidence 2 11233456889999998876555788999999999999999999999876654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=279.76 Aligned_cols=215 Identities=43% Similarity=0.720 Sum_probs=180.1
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|+||.||+|++..+|..||+|.+..........+.+.+|+.+++.++||||+++++++.. ....|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4899999999999999999998899999999998766545556678899999999999999999999877 45689999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+.+++...+..... .+....++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 79 EYMPSDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred cccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9996676665543332 34555688899999999999999999999999999999999999999999998775443
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
........++..|+|||.+.+...++.++||||+|+++|+|++|++||.+.++.+...+++.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR 215 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence 22234456789999999887655578999999999999999999999988887666555543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=276.11 Aligned_cols=214 Identities=29% Similarity=0.486 Sum_probs=172.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeE
Confidence 4699999999999999999999889999999998765432 22345688899999999999999999999874 479
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++++||+++..+........ .++...++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++..
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999998654433222221 2344557788999999999999999999999999999999999999999999866
Q ss_pred CCCCCCCc--ccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 273 DPNHKHPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 273 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
........ ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+......++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 220 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 220 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh
Confidence 43222111 2345788899999987754 8899999999999999999999998766655554443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=279.92 Aligned_cols=215 Identities=38% Similarity=0.735 Sum_probs=181.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+.+|+++++.++|+||+++++++.. ....+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 36999999999999999999998899999999987655455556778899999999999999999999977 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||++++++......... +....+..++.||+.||.|||+.+++|+||+|+||++++++.+||+|||++......
T Consensus 79 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 79 FEYVERTLLELLEASPGG-----LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred EecCCCCHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999998877665443322 344557888999999999999999999999999999999999999999999887654
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.........++..|+|||++.+...++.++|+||||+++|+|++|++||.+.+..+..+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 215 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 43234455678899999998876468899999999999999999999999887766655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=279.12 Aligned_cols=207 Identities=27% Similarity=0.455 Sum_probs=168.5
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
|+..+.||.|+||+||++++..+++.||+|.+....... .....+.+|+++++.++|+||+.+.+.+..+ ...+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEEE
Confidence 788899999999999999999999999999987654322 2344567899999999999999998888764 4689999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+.+..+........ ...++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9998754443322111 1135556688899999999999999999999999999999999999999999997653222
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+..+...
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~ 209 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209 (285)
T ss_pred --cccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 123457899999999987644 89999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=293.50 Aligned_cols=202 Identities=23% Similarity=0.400 Sum_probs=169.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.+.+...||+|.||+||+|++ .| .||||++......++..+.|++|+.++++-+|.||+-++|++.... +.+|
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~w--hG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIi 465 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRW--HG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAII 465 (678)
T ss_pred HHhhccceeccccccceeeccc--cc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeee
Confidence 6788999999999999999985 33 5999999999888999999999999999999999999999998743 4899
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC-
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP- 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~- 274 (348)
..+|++..+..+.. ..+..+...+.+.|++||+.|+.|||.++|||||||..||++.+++.+||+||||+..-..
T Consensus 466 TqwCeGsSLY~hlH----v~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLH----VQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred ehhccCchhhhhcc----chhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 99999865544432 2234566667889999999999999999999999999999999999999999999964321
Q ss_pred CCCCCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
..........|...|||||++.. ..+|++.+||||||+++|||+||..||...
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~ 596 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ 596 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence 22222334456778999999853 356899999999999999999999999843
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=282.51 Aligned_cols=219 Identities=48% Similarity=0.854 Sum_probs=178.3
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc-----
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----- 188 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 188 (348)
..++|++.+.||+|+||.||+|.+..+|+.||+|.++...........+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 347899999999999999999999889999999999765443344456778999999999999999999886543
Q ss_pred ---CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEe
Q 018936 189 ---SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265 (348)
Q Consensus 189 ---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~D 265 (348)
....++++||+++.+......... .+....++.++.||+.||.|||+.||+||||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLV-----HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 336899999999877776654322 344455888999999999999999999999999999999999999999
Q ss_pred eCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 266 FGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 266 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
||++...............++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+....+.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999987654332222334557789999988665557889999999999999999999998776655444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=279.15 Aligned_cols=197 Identities=28% Similarity=0.407 Sum_probs=158.6
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccC
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
||+|+||.||++++..+|+.||+|.+....... ........|+++++.++||||+++++++.. ....|++|||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 799999999999999999999999986543321 223345569999999999999999988876 45699999999875
Q ss_pred hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCccc
Q 018936 203 LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282 (348)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 282 (348)
.+........ ...+....+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....... ....
T Consensus 79 ~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 79 DLKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred CHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 4433322111 1124445577789999999999999999999999999999999999999999998764332 1234
Q ss_pred ccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..++..|+|||++.+.. ++.++|+||+||++|+|++|+.||....
T Consensus 154 ~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 154 RAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred cCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 56899999999887755 8999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.00 Aligned_cols=212 Identities=27% Similarity=0.339 Sum_probs=168.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.++||+|+||.||+|++..+|+.||+|+++.... .....+.+.+|+++++.++||||+++++++.+ ....|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 579999999999999999999999999999999875433 23445678889999999999999999998876 446899
Q ss_pred EEeecccChhhhhcCC---CCcCC---cchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 195 VFHYMEHDLAGLAASP---EVKFT---EPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~---~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
+|||++++.+..+... ..... ....+...+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999987544332211 00111 11233445677899999999999999999999999999999999999999999
Q ss_pred ccccCCCC-----------------CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 269 ASFFDPNH-----------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 269 a~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
++...... .......+||+.|+|||++.+.. ++.++|||||||++|||+||+.||......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 98762110 00112346899999999887654 899999999999999999999999775543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=280.35 Aligned_cols=211 Identities=41% Similarity=0.792 Sum_probs=171.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|++|.||+|++..+++.||+|.+...... .....+.+|+++++.++||||+++++++.. ....++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEEE
Confidence 6799999999999999999999889999999998754322 222345679999999999999999999876 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+.+++......... .+....++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~e~~~~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 82 FEYLDTDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 99999877665543322 3344558889999999999999999999999999999999999999999998764322
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
.. ......++..|+|||.+.+...++.++||||+|+++|+|++|++||.+.........
T Consensus 157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~ 215 (291)
T cd07844 157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH 215 (291)
T ss_pred Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence 11 112234678899999887655588899999999999999999999987764433333
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=280.86 Aligned_cols=214 Identities=36% Similarity=0.704 Sum_probs=177.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+++++.++||||+++++++.. ....|++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 36999999999999999999998889999999986654444445667889999999999999999999876 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||++++.+..+..... .+....+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 79 FEFVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred EecCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999877665543322 2345558889999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
. .......++..|+|||++.+...++.++||||||+++|+|++|++||.+....+....+.
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 2 223345678899999988765557889999999999999999999998877666555544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=299.25 Aligned_cols=195 Identities=26% Similarity=0.430 Sum_probs=163.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+...-++-||.|+.|.||+|+ ..++.||||+++ +.-..+|.-|++|+||||+.+.|+|.. ...++|+
T Consensus 124 e~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~---------elkETdIKHLRkLkH~NII~FkGVCtq--sPcyCIi 190 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGR--LHNETVAVKKVR---------ELKETDIKHLRKLKHPNIITFKGVCTQ--SPCYCII 190 (904)
T ss_pred HHhhhhhhhccCcccceeeee--ccCceehhHHHh---------hhhhhhHHHHHhccCcceeeEeeeecC--CceeEEe
Confidence 445667889999999999997 577899999874 112357889999999999999999987 4458999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||||..+-+...+...... .......|.++|+.|++|||.++|||||||.-||||..+..+||+|||.++.+...
T Consensus 191 MEfCa~GqL~~VLka~~~i-----tp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPI-----TPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eeccccccHHHHHhccCcc-----CHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999977666555443332 22336779999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
....+++||..|||||++...+ .+.|+|||||||+||||+||..||...+-..
T Consensus 266 --STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssA 318 (904)
T KOG4721|consen 266 --STKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA 318 (904)
T ss_pred --hhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchhe
Confidence 4467889999999999998754 9999999999999999999999997755443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=279.80 Aligned_cols=207 Identities=18% Similarity=0.219 Sum_probs=167.3
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEee--ccCceEEEEEee
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTS--RMSCSLYLVFHY 198 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~~~lv~e~ 198 (348)
..||+|++|.||+|.. +|+.||||.++.... .....+.+.+|+.+|++++||||++++|++.+ .....++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999984 789999999876543 23335678899999999999999999999876 445678999999
Q ss_pred cccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 199 MEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
++++.+........ .+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-- 176 (283)
T PHA02988 104 CTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176 (283)
T ss_pred CCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence 99865444433322 344455778899999999999984 9999999999999999999999999999865432
Q ss_pred CCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 278 HPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.....++..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....++..
T Consensus 177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~ 237 (283)
T PHA02988 177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK 237 (283)
T ss_pred --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 1344678899999988652 35899999999999999999999999988766555544433
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=286.48 Aligned_cols=202 Identities=26% Similarity=0.415 Sum_probs=167.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.++||+|+||.||++++..++..+|+|.+.... .....+.+.+|+++++.++||||+++++++... ...+++
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEEE
Confidence 68999999999999999999999999999999987543 344566788999999999999999999999874 469999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.++.+..+..... .+....+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99998644433322222 234455778899999999999985 799999999999999999999999999976533
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.. .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||.....
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred hc---cccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 21 2344688999999988764 488999999999999999999999976554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=281.01 Aligned_cols=216 Identities=47% Similarity=0.823 Sum_probs=179.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||.|+||.||+|++..+++.+|+|.++...........+.+|+++++.++||||+++++++........|++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57999999999999999999998899999999997665444444456789999999999999999999877645779999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||+++.+...+..... .+....++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEHDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCcCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99999877666544322 3455568889999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.. ......+++.|+|||.+.+...++.++|+||||+++|+|++|++||...+..+....++
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 21 12334568889999988765557889999999999999999999999887766555544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=277.70 Aligned_cols=211 Identities=19% Similarity=0.272 Sum_probs=166.8
Q ss_pred CCceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCc
Confidence 57999999999999999999764 346789999987543 334456688899999999999999999998763 468
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++||||++++.+..+..... ..++...++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999865554433211 13455568889999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
............++..|+|||.+.+. .++.++|||||||++|||++ |+.||.+.+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~ 219 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK 219 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 32221111222346789999988764 48999999999999999875 999998877654433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=282.41 Aligned_cols=219 Identities=44% Similarity=0.809 Sum_probs=178.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc------
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM------ 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 188 (348)
.++|++.+.||+|+||.||+|++..+++.||+|.+............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 37899999999999999999999999999999998765443333345678999999999999999998875533
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...++++++|++..+......... .++...++.++.||+.||+|||+.||+||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSV-----KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 235799999999877776654332 345556888999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCC----------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 269 ASFFDPNHKH----------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 269 a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
+......... ..+...+++.|+|||.+.+...++.++||||||+++|+|++|++||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9866432211 112335688899999887655588999999999999999999999998887766555443
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.05 Aligned_cols=204 Identities=33% Similarity=0.521 Sum_probs=168.9
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----CceE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCSL 192 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~ 192 (348)
.+...+.||+|+||.||+++++.+|+.||||.++... .....+...+|+++|++++|||||++.++-+... ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3566788999999999999999999999999987643 3344677788999999999999999988766655 4556
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC--CCCc--EEEEeeC
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDGV--LKIADFG 267 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~--~~~~--~kl~DFG 267 (348)
.++||||.+ ++...+..+.... -+++..+..++.++..||.|||++||+||||||.||++- ++|. -||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~---GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAY---GLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCccccc---CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 899999986 4555555444332 344555777899999999999999999999999999985 4443 5999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
.|+.++.+. ...+.+||..|++||++.....|+..+|.|||||++|+++||..||.-
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 999986554 578899999999999887545699999999999999999999999943
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=292.16 Aligned_cols=220 Identities=23% Similarity=0.327 Sum_probs=169.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++... +..||+|.++... .....+.+.+|+++++.+ +||||+++++++...
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 6899999999999999999986443 3579999986543 334456788899999999 899999999998774
Q ss_pred ceEEEEEeecccCh-hhhhcCCCC--------------------------------------------------------
Q 018936 190 CSLYLVFHYMEHDL-AGLAASPEV-------------------------------------------------------- 212 (348)
Q Consensus 190 ~~~~lv~e~~~~~l-~~~~~~~~~-------------------------------------------------------- 212 (348)
...+++|||+.++. ...+.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 45899999998643 333221100
Q ss_pred --------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC-cccc
Q 018936 213 --------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP-MTSR 283 (348)
Q Consensus 213 --------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 283 (348)
......+....+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++......... ....
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 0001134556688899999999999999999999999999999999999999999998654332111 1122
Q ss_pred cccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 018936 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 284 ~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~ 339 (348)
.++..|+|||++.+. .++.++|||||||++|+|++ |+.||...........++..
T Consensus 275 ~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~ 330 (374)
T cd05106 275 RLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR 330 (374)
T ss_pred CCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc
Confidence 346679999988764 48999999999999999997 99999887655555555443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=281.63 Aligned_cols=212 Identities=24% Similarity=0.368 Sum_probs=164.4
Q ss_pred CCceeeeeeccCCceEEEEEEEcc----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceee
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML----------------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~----------------~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 179 (348)
++|++.++||+|+||.||+|++.. ++..||+|.+.... .......+.+|++++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 689999999999999999997532 34579999986543 3445667889999999999999999
Q ss_pred eeceEeeccCceEEEEEeecccC-hhhhhcCCCCc-------------CCcchhhHHHHHHHHHHHHHHHHHHHHCCcee
Q 018936 180 LEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVK-------------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLH 245 (348)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 245 (348)
+++++... ...+++|||+.++ +...+...... .....+++..+..++.||+.||.|||+.||+|
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 84 LLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999874 4589999999764 44433221110 01123455567889999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh--CCC
Q 018936 246 RDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--GKP 322 (348)
Q Consensus 246 rDikp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt--G~~ 322 (348)
|||||+|||++.++.+||+|||+++....... .......++..|+|||++.+. .++.++||||||+++|||++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999986543321 112233457889999988764 48999999999999999987 567
Q ss_pred CCCCCChhH
Q 018936 323 IMPGRTEVS 331 (348)
Q Consensus 323 pf~~~~~~~ 331 (348)
||.+.+..+
T Consensus 241 p~~~~~~~~ 249 (304)
T cd05096 241 PYGELTDEQ 249 (304)
T ss_pred CCCcCCHHH
Confidence 887765443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=273.98 Aligned_cols=211 Identities=29% Similarity=0.459 Sum_probs=169.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
.+|++.+.||+|+||.||+|++..+|..||+|.+..... .....+.+.+|+.++++++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999989999999999865432 23345678889999999999999999998876555678
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+++|||+++..+......... +....+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA-----LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 999999986544333222222 333446778999999999999999999999999999999999999999999865
Q ss_pred CCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 273 DPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 273 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 42211 112334578899999988764 488999999999999999999999976554433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.47 Aligned_cols=210 Identities=33% Similarity=0.579 Sum_probs=174.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----Cce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 191 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++.... ...
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 6799999999999999999999999999999998654444445566778999999999999999999886432 235
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|+||||+.+.+...+... +....+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 96 VYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred EEEEEeccCCCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 7999999998777655321 33445777899999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
...... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 168 AGTSFM--MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229 (353)
T ss_pred CCCCCC--CCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 643322 2344678899999988764 4899999999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=274.67 Aligned_cols=202 Identities=33% Similarity=0.525 Sum_probs=169.6
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEe
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 197 (348)
|++.+.||+|+||+||++++..+++.||+|.+..............+|+.++++++||||+++++++.. ....+++|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 788999999999999999999999999999998776544444444569999999999999999999987 456889999
Q ss_pred eccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 198 YMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 198 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
++++ .+...+. . ...+....+..++.||+.||.+||+.||+|+||||+||+++.++.++|+|||++.... ..
T Consensus 79 ~~~~~~L~~~l~-~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~ 151 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-K-----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-EN 151 (260)
T ss_dssp EETTEBHHHHHH-H-----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-ST
T ss_pred cccccccccccc-c-----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cc
Confidence 9998 5555554 1 1234555688899999999999999999999999999999999999999999998642 22
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
........++..|+|||.+.....++.++|+||+|+++|+|++|..||....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~ 203 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN 203 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2234556779999999998733458899999999999999999999998873
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=277.58 Aligned_cols=216 Identities=44% Similarity=0.763 Sum_probs=176.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|++|.||+|++..+|+.||+|.+..........+.+.+|+++++.++||||+++++++... ...|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEE
Confidence 579999999999999999999988999999999876554444456677899999999999999999998764 569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-CCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~~ 274 (348)
|||+++.+.......... ......++.++.||+.||+|||+.+++||||+|+||+++. ++.+||+|||++.....
T Consensus 80 ~e~~~~~l~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDF----AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred EecccccHHHHHHhCCCC----CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 999988776665432211 2234447788999999999999999999999999999985 56799999999986543
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.. .......+++.|+|||.+.+...++.++||||+|+++|+|+||++||...+..+...+++.
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~ 218 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR 218 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 22 1123345688999999887655578899999999999999999999998887776666543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=307.67 Aligned_cols=220 Identities=25% Similarity=0.438 Sum_probs=179.3
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
.+.+..+.||+|+||+||+|+.. .+...||||.++.. ...+...+|++|+++|..++|||||+|+|+|.....
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P- 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDP- 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe-
Confidence 56788899999999999999743 23468999998644 345567889999999999999999999999988544
Q ss_pred eEEEEEeeccc-ChhhhhcCCCC----cCC----cchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcE
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEV----KFT----EPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 261 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~----~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~ 261 (348)
++||+|||.. +|..++....- ... .+.+...+...++.||+.|+.||-++.+|||||.+.|.||.++..+
T Consensus 564 -~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 564 -LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred -eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 9999999985 55555543211 101 2346777788999999999999999999999999999999999999
Q ss_pred EEEeeCCccccCCCCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 018936 262 KIADFGLASFFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 262 kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~ 339 (348)
||+||||++..-...... .........|||||.++-.+ |+.+||||||||+|||+++ |+.||.|.++.+...+|-..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 999999999764433332 22455688999999998644 9999999999999999998 99999999988777766543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=270.87 Aligned_cols=214 Identities=27% Similarity=0.439 Sum_probs=176.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|++|.||+|++..+++.|++|.+..........+.+.+|+++++.++||||+++++++... ...|++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 48889999999999999999999999999999987666666677888999999999999999999998764 5689999
Q ss_pred eeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 197 HYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 197 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||+.+ .+...+.... ...+....+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 79 EYAENGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EeCCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99976 4444433211 123445557788999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
... .....+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||...++.+....+..
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08529 155 TNF-ANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215 (256)
T ss_pred cch-hhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 221 23346788999999887654 88999999999999999999999988776554444443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=278.29 Aligned_cols=204 Identities=27% Similarity=0.447 Sum_probs=166.3
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.|+..+.||+|+||.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+.+++.+... ...+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEE
Confidence 378889999999999999999999999999998765432 23344567899999999999999999888764 469999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+.++.+........ ...++...+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 79 LTLMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99998654433321111 113455568889999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.. .....|+..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||.+..
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 22 23457899999999987654 8999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.09 Aligned_cols=219 Identities=27% Similarity=0.389 Sum_probs=177.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc---E-EEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---I-VALKKVRFD-NLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~---~-vAvK~i~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++-.+.++||+|+||.||+|+.+..+. . ||+|..+.+ ....+....+.+|+++|+.++|||||+++|+...+.+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P- 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP- 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-
Confidence 556677999999999999998765432 3 899998753 3567788889999999999999999999999988655
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
+++|||+|.++.+..+...... .++......++.+.+.||+|||+++++||||.++|+|++.++.+||+||||++
T Consensus 236 -l~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 -LMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred -cEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999998555444443322 34455577899999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhcc
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
.-.. .............|+|||.+... -|+.++|||||||++||+++ |..||++....+...+|+.+...
T Consensus 311 ~~~~-~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r 381 (474)
T KOG0194|consen 311 AGSQ-YVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR 381 (474)
T ss_pred CCcc-eeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence 6531 11111112346789999998876 49999999999999999999 89999999998888888665443
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=277.59 Aligned_cols=209 Identities=30% Similarity=0.476 Sum_probs=171.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+.+|++++++++||||+++++++... ...|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEE
Confidence 369999999999999999999988999999999875433 234456788899999999999999999998774 46899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+++ .+...+... . .++...+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~-~-----~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 79 VMEYVPGGELFSHLRKS-G-----RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEecCCCCCHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 9999965 444444322 2 34455577889999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.. .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......++
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 211 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211 (290)
T ss_pred CC----CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 33 2344678999999988764 47889999999999999999999998766444333433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=287.97 Aligned_cols=197 Identities=25% Similarity=0.345 Sum_probs=163.4
Q ss_pred CCceeeeeeccCCceEEEEEEEc--cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.+|++++.||+|+||.||++... .++..||+|.+... ....+|+++|+.++||||+++++++... ...|
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~ 162 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK--STVC 162 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC--CEEE
Confidence 57999999999999999999753 35678999987532 1245799999999999999999988764 4689
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++|+++.+++...+.. .. .++...++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 163 lv~e~~~~~l~~~l~~-~~-----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 163 MVMPKYKCDLFTYVDR-SG-----PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EEehhcCCCHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9999999887776632 11 34555688899999999999999999999999999999999999999999998765
Q ss_pred CCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 274 PNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 274 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 43222 223457899999999887644 8999999999999999999999997654
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=277.40 Aligned_cols=221 Identities=43% Similarity=0.743 Sum_probs=177.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccC---ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMS---CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~---~~ 191 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.++...........+.+|+.+++.++ ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3699999999999999999999899999999998765433334456778999999995 6999999998865332 34
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-CCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kl~DFGla~ 270 (348)
.|++|||+++++...+...... ....++...++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCcCHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7999999998877765433211 1224566668889999999999999999999999999999998 8899999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
....... ......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||.+.++.+....++.
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 160 AFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred ecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 6543221 122335688899999887655578999999999999999999999999888777666554
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.50 Aligned_cols=217 Identities=24% Similarity=0.438 Sum_probs=183.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
.++|.++++||+|+|++|.+++.+.+.+.||+|+++++-. ..+..+..+.|-.+.... +||++|-++.+|.. .+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence 4789999999999999999999999999999999988755 345567777888877765 89999999999977 4559
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|.||++++-+.+..++..++ ++..++.|..+|..||.|||+.||++||||.+|+|+|..|++||+|+|+++.-
T Consensus 327 ffvieyv~ggdlmfhmqrqrkl-----peeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKL-----PEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEecCcceeeehhhhhcC-----cHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999987666655554444 44458899999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCC-------CCCChhHHHHHHHHHh
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM-------PGRTEVSATFCFVLNL 340 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf-------~~~~~~~~~~~~i~~~ 340 (348)
-.. ...+.+++|||.|.|||.+.|. .|+..+|||+|||+++||+.|+.|| +..+..+-+++++++.
T Consensus 402 l~~-gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek 474 (593)
T KOG0695|consen 402 LGP-GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK 474 (593)
T ss_pred CCC-CcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence 322 2346788999999999988875 4999999999999999999999999 3344556777887764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.68 Aligned_cols=215 Identities=23% Similarity=0.344 Sum_probs=184.6
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
...+++++..||-||||.|-+++...+...+|+|++++..+ +..+.+.+..|.++|...+.|+||++|-.|.+ ..++
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~kyv 495 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKYV 495 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chhh
Confidence 34678899999999999999998655555699999988765 55667788899999999999999999888876 5679
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
||+||.|-++.+.......+.|.+.. .+.++..++.|++|||++|||+|||||+|.+++.+|-+||.|||+|+.+
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~t-----arF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYT-----ARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccch-----hhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 99999887665555555556555544 7888999999999999999999999999999999999999999999998
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
..+.. +-+++||+.|.|||+++... .+.++|.||||+++|||++|.|||.+.+.+..+-.|+.
T Consensus 571 ~~g~K--TwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk 633 (732)
T KOG0614|consen 571 GSGRK--TWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK 633 (732)
T ss_pred ccCCc--eeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence 76544 56789999999999998754 88999999999999999999999999998877666654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=275.01 Aligned_cols=216 Identities=48% Similarity=0.793 Sum_probs=181.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec------cC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR------MS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 189 (348)
+.|+.+.+||+|.||.||+|+.+.+|+.||+|++-.++-....-..-.+|+.+|..++|+|++.++++|... ..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 568889999999999999999999999999998755432222223345699999999999999999887432 23
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
..+|+||.++++++.+++.....++. ...++.+|.++..||.|+|...|+|||+||+|+||+.+|.+||+|||++
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~s-----ls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFS-----LSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCcccccc-----HHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 46899999999999999887766543 3448999999999999999999999999999999999999999999999
Q ss_pred cccCCC---CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 270 SFFDPN---HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 270 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
+.+... .....+.++.|.+|++||.++|...|+++.|+|..||++.||.+|.+.|.+.++..++..|
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 766322 1223456677999999999999999999999999999999999999999999987766543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=275.30 Aligned_cols=194 Identities=27% Similarity=0.415 Sum_probs=164.8
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|+||.||+|++..+++.||+|.+.... .......+.+|++++++++||||+++++++..+ ...+++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEE
Confidence 5889999999999999999999999999999987543 234456688899999999999999999999874 4588999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||++++.+.... .++...+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 79 EFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred ecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 999986654332 23344577889999999999999999999999999999999999999999998664322
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
.....+|..|+|||.+.+. .++.++|+||||+++|+|++|+.||..
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ---ccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2345788999999988764 488999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=274.43 Aligned_cols=213 Identities=56% Similarity=0.971 Sum_probs=176.7
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEe
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 197 (348)
|++.+.||.|+||.||+|++..+|+.+|+|.+............+.+|+++++.++|||++++++++........++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999999888999999999876433344556778999999999999999999987753467999999
Q ss_pred ecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
|+++++......... .+....++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDHDLTGLLDSPEV-----KFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccccHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 999877766654332 344555888999999999999999999999999999999999999999999987754432
Q ss_pred CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
.......++..|+|||.+.+...++.++||||||+++|+|++|+.||...+.......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~ 213 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 2234445688899999877655578999999999999999999999988776544433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=278.62 Aligned_cols=211 Identities=49% Similarity=0.813 Sum_probs=172.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc------
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM------ 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 188 (348)
.++|++.+.||+|+||.||+|++..+++.||+|.+............+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46899999999999999999999999999999998755433333345567999999999999999999876532
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
....+++|||+++.+...+..... .++...++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 245699999999877776654332 244555888999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCC---CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 269 ASFFDPNHKH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 269 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
+......... ......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9876432221 1223456888999998876555788999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.16 Aligned_cols=216 Identities=40% Similarity=0.677 Sum_probs=177.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|.+..+|..+|+|.+............+.+|+.+++++ +||||+++++++........|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 689999999999999999999888899999998865433334445677899999999 9999999999987655567899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+++++....... .+.+..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 87 VFEYMETDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EecccccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9999998776655432 223444677899999999999999999999999999999999999999999987643
Q ss_pred CCC----CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 275 NHK----HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 275 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
... .......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+....+...+++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~ 227 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 322 1223456789999999887655578899999999999999999999998877665555433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.51 Aligned_cols=220 Identities=21% Similarity=0.330 Sum_probs=169.6
Q ss_pred CCceeeeeeccCCceEEEEEEE-----ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++ ..++..||+|+++.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 5799999999999999999964 34567899999865432 23456688899999999 899999999998774
Q ss_pred ceEEEEEeecccC-hhhhhcCCCCcC------------------------------------------------------
Q 018936 190 CSLYLVFHYMEHD-LAGLAASPEVKF------------------------------------------------------ 214 (348)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~~~~~~------------------------------------------------------ 214 (348)
...+++|||++++ +...+......+
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 4589999999864 433332211000
Q ss_pred ---------------CcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 215 ---------------TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 215 ---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
....+....+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 01134556678899999999999999999999999999999999999999999998764332211
Q ss_pred -cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 018936 280 -MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 280 -~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~ 339 (348)
.....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+........+.+.+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 332 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE 332 (375)
T ss_pred ccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh
Confidence 12233466799999887654 8999999999999999998 89999887655555555544
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=271.15 Aligned_cols=213 Identities=28% Similarity=0.462 Sum_probs=171.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN---LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
.+|++.+.||+|+||.||+|++..++..||+|.+.... ........+.+|+++++.++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46999999999999999999999999999999886432 123455678899999999999999999999877656678
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
++++||+.+. +...+.. .. .+....++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~-----~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YG-----ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 9999999864 4444332 21 233444778899999999999999999999999999999999999999999986
Q ss_pred cCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 272 FDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 272 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
...... .......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 220 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK 220 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH
Confidence 643211 1123345788999999887644 78999999999999999999999987665544443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=268.60 Aligned_cols=216 Identities=22% Similarity=0.395 Sum_probs=174.9
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
.|++.+.||+|++|.||++++..+++.||+|.+..........+.+.+|+++++.++|||++++.+.+... ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999988999999999976655555566788899999999999999998877542 34689999
Q ss_pred eecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 197 HYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 197 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||+++. +...+.... ...++...++.++.|++.||++||+.|++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999864 444443211 113455568889999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
. .......+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...+..+..+.++..
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 217 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG 217 (257)
T ss_pred C-CccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 2 223344678899999988765 4888999999999999999999999887765555554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=283.25 Aligned_cols=216 Identities=36% Similarity=0.622 Sum_probs=176.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--cCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~ 193 (348)
++|++.+.||+|+||.||+|.+..+|..||+|.+............+.+|+.+++.++||||+++++++... .....|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 679999999999999999999999999999999876543334456677899999999999999999987643 235689
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++|||+++++...+.... .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEehhhhhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 999999887766654321 24555688899999999999999999999999999999999999999999998764
Q ss_pred CCCCC---CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 274 PNHKH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
..... ......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+.......++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL 225 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHH
Confidence 32221 12344678899999988665558899999999999999999999998877655444333
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=279.52 Aligned_cols=212 Identities=42% Similarity=0.652 Sum_probs=172.6
Q ss_pred CceeeeeeccCCceEEEEEEEcc--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDML--TGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~--~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.|++.+.||+|+||.||+|++.. ++..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+......+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999887 799999999876431 122345567799999999999999999999886557799
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC----CCcEEEEeeCCc
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD----DGVLKIADFGLA 269 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~----~~~~kl~DFGla 269 (348)
+||||+++++.......... ....++...++.++.||+.||+|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCcCHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999998777655432211 1124555668889999999999999999999999999999999 899999999999
Q ss_pred cccCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 270 SFFDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 270 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
........ .......+++.|+|||.+.+...++.++|+||||+++|+|++|++||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 87643322 1123346788999999887755688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=282.04 Aligned_cols=208 Identities=38% Similarity=0.660 Sum_probs=170.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc---CceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~ 192 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++.... ....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 689999999999999999999999999999999864322 234456778999999999999999998875432 2457
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+++||+++.+....... .++...++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMETDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999998776655432 3445558889999999999999999999999999999999999999999999876
Q ss_pred CCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 273 DPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 273 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
...... ......+++.|+|||.+.+...++.++||||+|+++|+|++|++||.+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~ 217 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 432221 12334678999999987665558899999999999999999999998766544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.25 Aligned_cols=194 Identities=26% Similarity=0.329 Sum_probs=162.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
...|.+.+.||+|+||.||+|++..+++.||||... ...+.+|+++|++++|||||++++++... ...++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEE
Confidence 357999999999999999999999999999999642 12345799999999999999999988763 45899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|+++.+.+...+..... .+.+..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 238 v~e~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEEccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 999998887776654322 345566888999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 275 NHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 275 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
.... ......||..|+|||++.+.. ++.++|||||||++|||++|..|+
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCc
Confidence 3222 123456899999999987754 899999999999999999987654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=275.34 Aligned_cols=213 Identities=23% Similarity=0.416 Sum_probs=168.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG-----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--Q 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--C
Confidence 57999999999999999999875554 689999986443 344566788999999999999999999998764 4
Q ss_pred eEEEEEeecccC-hhhhhcCCCCcCCc-----------chhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEVKFTE-----------PQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 258 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~ 258 (348)
..+++|||++++ +...+... ..... ..++...+..++.|++.||.|||+.|++||||||+||+++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRN-SPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhc-CCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 589999999864 44443321 11111 345566688899999999999999999999999999999999
Q ss_pred CcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 259 GVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 259 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
+.++|+|||+++....... .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+..
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999986533221 1223345678899999887644 8999999999999999998 99999887654433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=272.42 Aligned_cols=210 Identities=40% Similarity=0.640 Sum_probs=171.3
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
|++.+.||+|+||.||+|++..++..||+|.++.......... ..+|+.++.++. |||++++++++.+......++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~-~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVN-NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhh-HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 6788999999999999999989999999999875433333333 346888999885 99999999999876446789999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+++++...+..... .+.+..+..++.||+.||.|||+.|++||||+|+||+++. +.+||+|||++.......
T Consensus 80 e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 80 ELMDMNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred ecCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9999887776654332 3455568889999999999999999999999999999999 999999999998764332
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
. .....++..|+|||.+.+...++.++|+|||||++|||++|.+||++.+..+...++
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 2 233457889999998765455788999999999999999999999988766554444
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=273.75 Aligned_cols=205 Identities=28% Similarity=0.476 Sum_probs=166.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++... ...|+|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~iv 84 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWIC 84 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEEE
Confidence 579999999999999999999989999999999865432 2345677899999999999999999998764 468999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+........ .++...+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99998754443332222 2344557888999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
.. ......+++.|+|||.+.. ...++.++|+||||+++|+|++|++||......
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 21 1234467889999998742 234678999999999999999999999655433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=275.38 Aligned_cols=212 Identities=46% Similarity=0.772 Sum_probs=174.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
+|++.+.||+|+||.||+|.+..+|+.||+|.++..... ......+..|+++++.++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488899999999999999999889999999999766543 3334556789999999999999999999987 45689
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||+.+.+...+..... .+....+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 79 lv~e~~~~~L~~~i~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSI-----VLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred EEEcccCCCHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999996666665543321 34455588899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
.... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.++.+....+
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~ 215 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence 4322 1233456788999998866555788999999999999999999999887766554444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=273.05 Aligned_cols=210 Identities=28% Similarity=0.466 Sum_probs=169.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|.++.... .....+.+|+.+++.++||||+++++.+... ...|++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEE
Confidence 579999999999999999999989999999999876532 2345577899999999999999999988764 568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+........ .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99998754443332222 2445558889999999999999999999999999999999999999999999766432
Q ss_pred CCCCcccccccCccccccccc--CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
. .......|++.|+|||++. ....++.++|+|||||++|+|++|.+||...........
T Consensus 160 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~ 220 (267)
T cd06645 160 I-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred c-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh
Confidence 2 1223456899999999874 223478899999999999999999999866554443333
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=270.49 Aligned_cols=212 Identities=29% Similarity=0.506 Sum_probs=170.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
.+|+..+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+++++.++||||+++++++........
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 469999999999999999999989999999999875432 22345678889999999999999999999877556678
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
++++||+++. +...+.. ... +....++.++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~-----l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGA-----LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 9999999864 4444332 222 33444677899999999999999999999999999999999999999999986
Q ss_pred cCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 272 FDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 272 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
....... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~ 219 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH
Confidence 5432111 11234578899999988764 48899999999999999999999997765444333
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=268.22 Aligned_cols=212 Identities=29% Similarity=0.496 Sum_probs=173.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||.|+||.||+|.+..++..+|+|.+..... ...+.+.+|+++++.++||||+++++++.. ...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 679999999999999999999988899999999876542 245678899999999999999999998877 4469999
Q ss_pred EeecccChhhhhcCCC-CcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPE-VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++.+..+.... . .+....+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999875554443322 2 344555888999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCc--ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|++||.+.+.......+.
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 221 12344678889999988654 247889999999999999999999998877555544443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=271.06 Aligned_cols=214 Identities=20% Similarity=0.307 Sum_probs=165.9
Q ss_pred ceeeeeeccCCceEEEEEEEccCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----cCce
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGK--IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~ 191 (348)
|.+.+.||+|+||.||+|++..++. .||+|.++.........+.+.+|+++++.++||||+++++++... ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999876665 699999876655556677888899999999999999999876432 1235
Q ss_pred EEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++|||+.++ +...+...........++...+..++.||+.||+|||+.+|+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 68999999864 44433222211122245666688899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 271 FFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 271 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
......... .....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 223 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 764332111 1122356789999988764 48899999999999999999 8999987665443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=269.97 Aligned_cols=215 Identities=20% Similarity=0.289 Sum_probs=167.2
Q ss_pred ceeeeeeccCCceEEEEEEEccC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----Cc
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SC 190 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 190 (348)
|++.+.||+|+||.||+|....+ +..||+|.++.........+.+.+|++.++.++||||+++++++.... ..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999986543 478999999876555556677889999999999999999999875432 23
Q ss_pred eEEEEEeecccChh-hhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 191 SLYLVFHYMEHDLA-GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 191 ~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
..++++||+.++.+ ..+...........++...+..++.|++.||.|||+.+++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 47899999986443 33322221112234556668889999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 270 SFFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 270 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
+......... .....++..|+|||.+.+. .++.++||||||+++|||++ |.+||.+..+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~ 225 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 8764332211 1222346789999987654 48899999999999999999 99999876654433
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=271.87 Aligned_cols=214 Identities=41% Similarity=0.783 Sum_probs=175.5
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||.|++|.||+|++..+|..||+|.++..... ...+.+.+|+++++.++||||+++++++... ...+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence 489999999999999999999889999999998765432 2345566799999999999999999999874 4589999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+++++......... ...+....+..++.||+.||.|||+.|++||||||+||++++++.++|+|||++.......
T Consensus 78 e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 78 EYMDKDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred ecCCccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9999877776543321 1235556688899999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
. ......++..|++||.+.+...++.++|+||||+++|+|++|++||.+.+..+....++
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 2 12334568889999988765557889999999999999999999998877665544443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=278.62 Aligned_cols=205 Identities=25% Similarity=0.407 Sum_probs=163.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKI----VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
.+|++.+.||+|+||.||+|++..++.. ||+|.++... .....+.+.+|+.+++.++||||++++|++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---C
Confidence 6799999999999999999987666654 8999986432 334456788899999999999999999998753 3
Q ss_pred EEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++++|+.++ +.+.+..... .+....+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 67889998764 4444443222 23444577889999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 271 FFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 271 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
......... .....++..|+|||.+.+. .++.++||||||+++|||++ |+.||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 775432221 1222346789999988764 48899999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.27 Aligned_cols=212 Identities=26% Similarity=0.451 Sum_probs=175.9
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|+..+.||.|+||.||.+++..+++.+++|.+............+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 4899999999999999999999999999999987766656666778899999999999999999999987 45699999
Q ss_pred eeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 197 HYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 197 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||+++ .+...+.... ...++...+..++.|++.||.|||+.|++|+||+|+||++++++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 79 EYANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EecCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99986 4444443221 123445557889999999999999999999999999999999999999999999876443
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
.. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+....+
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 32 234456789999999887654 788999999999999999999999886655544444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=279.47 Aligned_cols=211 Identities=36% Similarity=0.598 Sum_probs=172.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----Cc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SC 190 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 190 (348)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|++++++++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 37899999999999999999999899999999998754433334556778999999999999999999876432 23
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
..|++++++.+.+....... .+....++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~~lv~~~~~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 47889998877665544321 24445578899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
..... .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+.......+
T Consensus 169 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 169 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred ccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 65322 234467889999998876555888999999999999999999999887765544443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=271.76 Aligned_cols=214 Identities=46% Similarity=0.829 Sum_probs=175.9
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEe
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 197 (348)
|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+++++.++|||++++++++... ...|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEe
Confidence 6788999999999999999988999999999876654444445677899999999999999999998764 56999999
Q ss_pred ecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
|++..+...+..... ..+....+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++........
T Consensus 79 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLDLDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccCcCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 998776665543221 2345556888999999999999999999999999999999999999999999976543221
Q ss_pred CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
......+++.|+|||++.+...++.++|+||||+++|+|++|++||.+.+.....+.++.
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 214 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 122335688899999887655578899999999999999999999998887766666544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=282.51 Aligned_cols=210 Identities=29% Similarity=0.462 Sum_probs=175.2
Q ss_pred ccCCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 111 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
+......|+++++||+||.+.||++.. .+.+.||+|.+.....+....+-+.+|+..|.+| .|.+||+|++|-.. .
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d 432 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--D 432 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--C
Confidence 444456899999999999999999984 6667899998877777888899999999999999 68999999998766 5
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
.++||||||-+.+|...+.........- .++.|..|++.|+.++|.+||||.||||.|+|+- .|.+||+|||+|
T Consensus 433 ~~lYmvmE~Gd~DL~kiL~k~~~~~~~~-----~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA 506 (677)
T KOG0596|consen 433 GYLYMVMECGDIDLNKILKKKKSIDPDW-----FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIA 506 (677)
T ss_pred ceEEEEeecccccHHHHHHhccCCCchH-----HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechh
Confidence 6799999999999988877654432211 3788899999999999999999999999999994 679999999999
Q ss_pred cccCCCCCC-CcccccccCcccccccccCcc----------cCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 270 SFFDPNHKH-PMTSRVVTLWYRPPELLLGAT----------DYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 270 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.....+... ...+.+||+.||+||.+.... ..+.++|||||||+||+|+.|++||..-.+
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 988765433 344568999999999885321 256789999999999999999999965443
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=270.87 Aligned_cols=205 Identities=25% Similarity=0.397 Sum_probs=163.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHH-HHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI-LRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||++++..+|..||+|.++......... .+..|+.. ++.++||||+++++++... ...|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEE
Confidence 46999999999999999999999999999999987654433333 34445554 6677999999999998764 45899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+++.+...+..... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 78 v~e~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EhhhhcccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999876655433211 112456666889999999999999997 99999999999999999999999999998764
Q ss_pred CCCCCCcccccccCcccccccccCc---ccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
.... .....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 156 DSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 3221 2334678889999987542 33688999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=275.24 Aligned_cols=201 Identities=26% Similarity=0.396 Sum_probs=166.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||++++..++..+|+|.+.... .......+.+|++++++++||||+++++++.. ....+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 36999999999999999999999999999999886432 34455678889999999999999999999977 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++.+..+..... .++...+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++.....
T Consensus 78 ~ey~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 78 MEHMDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred eeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99998754444433222 23445578899999999999997 5999999999999999999999999999876533
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.. .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 153 SM---ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred cc---cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 22 2345678999999987664 48899999999999999999999997655
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=269.57 Aligned_cols=207 Identities=33% Similarity=0.502 Sum_probs=167.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..++..||+|.+..... .......+.+|+++++.++||||+++++++... ...++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEE
Confidence 579999999999999999999989999999998865432 445566788899999999999999999998774 46899
Q ss_pred EEeecccChh-hhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLA-GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++||++++.+ ....... .....++...+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 80 VLELADAGDLSQMIKYFK--KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCcHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 9999987443 3332111 111234555578899999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 3221 12234578889999988764 47889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=292.77 Aligned_cols=214 Identities=30% Similarity=0.418 Sum_probs=176.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.-|..++.||-|+||+|-+++...+...||+|.+++... ........+.|..||...+.+.||+|+-.|.++. .+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEE
Confidence 468899999999999999999888999999999987653 5566778889999999999999999977777654 4999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||+|+.|+....++.+.+- |.+..++.|++++..|+++.|..|+|||||||+|||||.+|+|||+||||+.-+.-
T Consensus 707 VMdYIPGGDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEeccCCccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccccee
Confidence 9999998655555444443 44455899999999999999999999999999999999999999999999954310
Q ss_pred --------CCCC---------------------------------CcccccccCcccccccccCcccCCccccHHHHHHH
Q 018936 275 --------NHKH---------------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCI 313 (348)
Q Consensus 275 --------~~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~ 313 (348)
...| .....+||+.|+|||++... .|+.-.||||.||+
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVI 860 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHH
Confidence 0000 01234789999999999864 49999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHH
Q 018936 314 LAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 314 l~elltG~~pf~~~~~~~~~~~~i 337 (348)
||||+.|++||-..+..+..++++
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~ 884 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVI 884 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeee
Confidence 999999999998777666655554
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.81 Aligned_cols=205 Identities=26% Similarity=0.420 Sum_probs=158.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC-cEEEEEEe--------------ec-CCCChHHHHHHHHHHHHHHhcCCCceee
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKV--------------RF-DNLEPESVKFMAREILILRRLDHPNVIK 179 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g-~~vAvK~i--------------~~-~~~~~~~~~~~~~E~~~l~~l~hpniv~ 179 (348)
++|+++++||+|+||+||+|..+... ..++.|.+ .+ ..........+.+|+++|++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 67999999999999999998754322 22222211 00 0112234556788999999999999999
Q ss_pred eeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC
Q 018936 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 259 (348)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 259 (348)
+++++... ...|++++++.+.+...+......... ......++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 228 l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~-~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 228 IEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKD-RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred EeEEEEEC--CeeEEEEeccccCHHHHHhhccccccc-cccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999874 458999999988877766544332222 122344677899999999999999999999999999999999
Q ss_pred cEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 260 VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 260 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
.+||+|||+++.+............||..|+|||++.+. .++.++|||||||++|||++|..++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999987754433333456789999999998765 4899999999999999999987543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=283.83 Aligned_cols=193 Identities=25% Similarity=0.348 Sum_probs=160.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+|++++.||+|+||.||+|++..++..||+|+..... ...|+.+++.++||||+++++++... ...++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeC--CeeEEE
Confidence 57999999999999999999998899999999754221 23589999999999999999998874 458999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
++++.+.+...+..... .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEccCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99999888777654333 3445558889999999999999999999999999999999999999999999754322
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCC
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPG 326 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~ 326 (348)
. ......||+.|+|||++.+.. ++.++|||||||++|||+++ .++|..
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred c--ccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccC
Confidence 1 123456899999999987754 89999999999999999985 445543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=280.68 Aligned_cols=218 Identities=23% Similarity=0.366 Sum_probs=167.6
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++. .+++.||+|+++... .....+.+.+|++++.++ +||||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 68999999999999999999743 345789999986443 333455677899999999 899999999987653 3
Q ss_pred ceEEEEEeecccChhhhhcCCCCc--------------------------------------------------------
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVK-------------------------------------------------------- 213 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~-------------------------------------------------------- 213 (348)
..++++|||+.++.+.........
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 468899999987544333211000
Q ss_pred CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC-cccccccCccccc
Q 018936 214 FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP-MTSRVVTLWYRPP 292 (348)
Q Consensus 214 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aP 292 (348)
.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....... .....++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 001245666788899999999999999999999999999999999999999999998764332221 2233456789999
Q ss_pred ccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 293 ELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 293 E~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
|++.+.. ++.++|||||||++|||++ |..||.+....+.....
T Consensus 245 E~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~ 288 (337)
T cd05054 245 ESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288 (337)
T ss_pred HHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH
Confidence 9887754 8999999999999999998 99999875544443333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=274.91 Aligned_cols=216 Identities=28% Similarity=0.369 Sum_probs=174.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+++++.++||||+++++.+.. ....|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 36999999999999999999998889999999997765432 355678889999999999999999998876 456899
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+.+. +...+.... ...++...++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 79 VMDYCPGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEecCCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999874 444433211 1234555678889999999999999999999999999999999999999999987653
Q ss_pred CCCCC----------------------------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 274 PNHKH----------------------------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 274 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
..... ......||..|+|||++.+.. ++.++||||||+++|+|++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCC
Confidence 22110 111346788999999887654 7899999999999999999999998
Q ss_pred CCChhHHHHHHHH
Q 018936 326 GRTEVSATFCFVL 338 (348)
Q Consensus 326 ~~~~~~~~~~~i~ 338 (348)
+.+..+....++.
T Consensus 234 ~~~~~~~~~~~~~ 246 (316)
T cd05574 234 GSNRDETFSNILK 246 (316)
T ss_pred CCchHHHHHHHhc
Confidence 8776655555543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=273.66 Aligned_cols=216 Identities=28% Similarity=0.356 Sum_probs=171.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||++++..+++.||+|.+..... .....+.+.+|+++++.++||||+++++.+.. ....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 369999999999999999999999999999999876543 22345677789999999999999999998876 456899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|||+++..+........ .+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++....
T Consensus 79 v~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 79 VMEYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999998754443332222 234445777899999999999999999999999999999999999999999874211
Q ss_pred CCC--------------CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 275 NHK--------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 275 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+...++...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~ 231 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 100 001123567889999988764 4889999999999999999999999887665555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=268.88 Aligned_cols=210 Identities=24% Similarity=0.439 Sum_probs=167.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.++||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+++++.++||||+++++++... ...+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEEE
Confidence 7899999999999999999985 566789999876433 2356788899999999999999999888764 458999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.+ .+...+.... ...+....+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 80 TEYMAKGSLLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EecCCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999975 4544443221 11334445778899999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
..........++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.+.+..+....+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217 (261)
T ss_pred CceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 3222223334567899999887644 8889999999999999998 99999887655444333
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=267.46 Aligned_cols=210 Identities=21% Similarity=0.389 Sum_probs=166.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+++. .++..+|+|.+...... .+.+.+|++++++++||||+++++++... ...+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~-~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEe-ccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEE
Confidence 5799999999999999999986 45668999987644332 34577899999999999999999998764 458999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++ +...+..... .++...+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 9999864 4444332221 244555788999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
..........++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~ 215 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215 (256)
T ss_pred CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 222212223346679999988754 48899999999999999999 999998877665554443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=272.33 Aligned_cols=218 Identities=23% Similarity=0.357 Sum_probs=171.3
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|.+.+.||+|+||.||+|++. .++..||+|.++... ..+..+.+.+|+++++.++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--D 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--C
Confidence 57999999999999999999864 335789999986543 333456788999999999999999999998874 5
Q ss_pred eEEEEEeecccChhhhhcCCCC---------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcE
Q 018936 191 SLYLVFHYMEHDLAGLAASPEV---------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 261 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~ 261 (348)
..+++|||++++.+........ ......+....+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 6899999998654433322211 1122345566688899999999999999999999999999999999999
Q ss_pred EEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 262 KIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 262 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
+|+|||++........ .......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999986533221 1122334578899999887654 8999999999999999998 999998776655444444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=278.46 Aligned_cols=211 Identities=21% Similarity=0.314 Sum_probs=165.9
Q ss_pred eeeeeccC--CceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEe
Q 018936 120 KIDKIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 120 ~~~~LG~G--~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 197 (348)
++++||+| +|++||++++..+|+.||+|.+..........+.+.+|+++++.++||||+++++++..+ ...++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 56789999 788999999999999999999977655556667788899999999999999999999774 46899999
Q ss_pred ecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
|++++.+..+..... ...++...++.++.||+.||+|||+++|+||||||+|||++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 998754443332111 11244556888999999999999999999999999999999999999999987654321111
Q ss_pred C------CcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 278 H------PMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 278 ~------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
. ......++..|+|||++.+. ..++.++|||||||++|||++|+.||...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 221 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 221 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence 0 01123457779999998653 3488999999999999999999999987665443333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=293.50 Aligned_cols=214 Identities=24% Similarity=0.385 Sum_probs=180.8
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+...+||+|+|-+||+|.+..+|-.||.-.++.+.. .+...++|..|+.+|+.|+||||++++..+.+..+..+.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 3455789999999999999999999999877666554 45567899999999999999999999999988777788999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCCEEECC-CCcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN--GVLHRDIKGSNLLIDD-DGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~NIll~~-~~~~kl~DFGla~~~ 272 (348)
.|.+..+.+..+.....+..- ..++.|++||++||.|||++ .|+|||||.+||+|+. .|.+||+|+|||...
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~-----kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNI-----KAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eecccCCcHHHHHHHhccCCH-----HHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999987666665554443333 34899999999999999999 6999999999999984 589999999999988
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
+... ..+..|||.|||||++.. .|+..+||||||++++||+|+..||..=++..+.|+-|..-+
T Consensus 197 r~s~---aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi 260 (632)
T KOG0584|consen 197 RKSH---AKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI 260 (632)
T ss_pred hccc---cceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC
Confidence 6544 345799999999998873 499999999999999999999999988777777776665443
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=268.81 Aligned_cols=211 Identities=22% Similarity=0.410 Sum_probs=167.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+|++.+.||+|+||.||+|.+..++..||+|.+..+. ...+.+.+|+++++.++||||+++++++... ..++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEE
Confidence 46999999999999999999998899999999986432 2345678899999999999999999988764 458999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++ +...+.... ...+....+..++.|++.||+|||+.|++||||||+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999764 444433221 12344555778899999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
..........++..|+|||.+.+. .++.++||||||+++|||++ |..||++.+. +..+..+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~ 218 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELL 218 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH
Confidence 332222223346679999988764 48899999999999999998 9999987654 3333333
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=251.48 Aligned_cols=221 Identities=24% Similarity=0.341 Sum_probs=173.5
Q ss_pred ccCCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 111 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
+....++...+..||+|+||.|-+.++..+|...|+|.++..-. .+..+++.+|+++..+. ..|++|.++|.....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-- 117 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-- 117 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--
Confidence 34445778888999999999999999999999999999975543 44556677788887665 899999999977664
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...++.||.|+.++..+...-.. .....++.-+-.++..++.||.|||++ .++|||+||+||||+.+|++|+||||.
T Consensus 118 gdvwIcME~M~tSldkfy~~v~~--~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 118 GDVWICMELMDTSLDKFYRKVLK--KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred ccEEEeHHHhhhhHHHHHHHHHh--cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 34899999999888766543111 112334444777899999999999987 899999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccC---cccCCccccHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHH
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLG---ATDYGVGVDLWSAGCILAELLAGKPIMPG-RTEVSATFCFVL 338 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwSlGv~l~elltG~~pf~~-~~~~~~~~~~i~ 338 (348)
+-.+..+-. .+-..|-..|+|||.+.. ...|+.++||||||+++.||.+++.||+. .++.+++.+++.
T Consensus 196 sG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 196 SGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 987743322 122356667999998853 23589999999999999999999999965 455666666654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=278.22 Aligned_cols=208 Identities=40% Similarity=0.642 Sum_probs=171.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc---CceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~ 192 (348)
++|++.+.||+|+||+||+|++..++..||||.+............+.+|+.+++.++||||+++++++.... ....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999999999999999998754333334456678999999999999999999876432 2458
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+++||+++.+...+... . .+....+..++.||+.||.|||+.+++||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~~~L~~~~~~~-~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMDTDLHQIIRSS-Q-----TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCCCCHHHHHhcC-C-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 999999998776665432 2 3445558889999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
.... .......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 215 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV 215 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH
Confidence 4332 22334467889999998875445889999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=263.76 Aligned_cols=222 Identities=24% Similarity=0.369 Sum_probs=176.1
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
..++.+.+..||.|.-|+|++++.+.+|...|||.++... +.+..+++...+.++... +.|+||+.+|+|..... +
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V 166 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--V 166 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--H
Confidence 4567888999999999999999999999999999997655 344556666677776665 58999999999988544 7
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
++.||.|......++..-... +++..+-.+...+++||.||.++ +|+|||+||+|||+|+.|++||+|||++-.
T Consensus 167 ~IcMelMs~C~ekLlkrik~p-----iPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGP-----IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCC-----chHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 888999887665555544333 44444666778899999999975 999999999999999999999999999988
Q ss_pred cCCCCCCCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCCcC
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFV 346 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p~~ 346 (348)
+-.... .+...|-+.|||||.+.- ...|+.++||||||++++||.||+.||.+-+..-.....+++ -++|++
T Consensus 242 lvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L 315 (391)
T KOG0983|consen 242 LVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLL 315 (391)
T ss_pred eecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCC
Confidence 754433 355678889999999852 355889999999999999999999999996655455555555 333543
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=271.77 Aligned_cols=207 Identities=28% Similarity=0.512 Sum_probs=169.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+.. ....|+|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEe
Confidence 6899999999999999999999899999999998765433 24567889999999999999999998876 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+.++.+..+.... .+....+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ecccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999875443333211 2334457789999999999999999999999999999999999999999998865433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
.. ......+++.|+|||.+.+. .++.++|+|||||++|+|++|++||...+......
T Consensus 170 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 170 QS-KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred cc-ccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 21 12334678899999988764 47899999999999999999999998776544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=266.09 Aligned_cols=211 Identities=23% Similarity=0.385 Sum_probs=167.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|.+ .++..||+|.++.... ..+.+.+|++++++++||||+++++++... ...+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLW-NNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEe-cCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeee
Confidence 5799999999999999999986 4567899999875432 245577899999999999999999988764 458999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.+ .+...+.... ...++...+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999965 5555443322 12345556888999999999999999999999999999999999999999999987753
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
...........+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+.......+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218 (261)
T ss_pred CcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 322212222234579999988764 48899999999999999999 999998877655444443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=271.28 Aligned_cols=205 Identities=26% Similarity=0.422 Sum_probs=167.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|+++++||.|+||.||+|++..++..||+|.+... .....+.+.+|+.+++.++||||+++++.+..+ ...|++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEEE
Confidence 6799999999999999999999899999999998654 344566788899999999999999999988764 468999
Q ss_pred EeecccChhhhhc-CCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAA-SPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++.+.... .... .+....+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999986554432 2222 244455888999999999999999999999999999999999999999999876432
Q ss_pred CCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
.. .......+++.|+|||++.+ ...++.++|+|||||++|+|++|++||...+..
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 221 (292)
T cd06644 163 TL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 221 (292)
T ss_pred cc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH
Confidence 21 11234457889999998752 234678999999999999999999999765543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=272.13 Aligned_cols=205 Identities=31% Similarity=0.531 Sum_probs=170.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
..|+..+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+++++.++||||+++.+++... ...|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeEEE
Confidence 569999999999999999999988999999999865433 344456788899999999999999999999874 45899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|+||+.+.+......... .+....+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 93 VMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EHHhhCCCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999999887766543222 244555788899999999999999999999999999999999999999999876543
Q ss_pred CCCCCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
. ....+++.|+|||.+.+ ...++.++||||||+++|+|++|++||.+.+....
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~ 222 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence 2 23457888999998742 24478899999999999999999999987665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=270.76 Aligned_cols=209 Identities=27% Similarity=0.517 Sum_probs=172.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ....|++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 579999999999999999999989999999999875433 234567889999999999999999999876 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||+.++.+....... .+.+..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 95 MEYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEecCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999876555443321 2445568889999999999999999999999999999999999999999998876433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
.. ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+....+
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~ 227 (296)
T cd06655 169 QS-KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (296)
T ss_pred cc-cCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22 12334678899999988764 4889999999999999999999999887765554444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=285.25 Aligned_cols=199 Identities=26% Similarity=0.422 Sum_probs=172.7
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeeccc
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 201 (348)
+.||+|.||+||-|++..+|+.||||++.+-.......+.+++|+.||+.+.||.||.+.-.|+. ...+++|||-+.+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhcc
Confidence 78999999999999999999999999998877766666889999999999999999999888876 4559999999999
Q ss_pred ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC---CcEEEEeeCCccccCCCCCC
Q 018936 202 DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASFFDPNHKH 278 (348)
Q Consensus 202 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~~~~~~~~ 278 (348)
+++......+.. .+++...+.++.||+.||.|||-++|||+||||+|||+... ..+||+|||.|+...+...
T Consensus 648 DMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred hHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 988877765433 44555577789999999999999999999999999999754 3799999999999865433
Q ss_pred CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 279 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
..+.+||+.|+|||++... .|+..-|+||.||++|--++|..||+...+
T Consensus 723 -RrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred -hhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccc
Confidence 4677899999999998864 599999999999999999999999966544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=276.59 Aligned_cols=213 Identities=37% Similarity=0.622 Sum_probs=174.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC----c
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----C 190 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 190 (348)
.++|++.+.||+|+||.||++.+..+|..||+|.+..........+.+.+|+++++.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 368999999999999999999998999999999986543334445567789999999999999999998865432 3
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.++++|+|+++.+....... .++...++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 46899999977666555321 34455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
..... .....+++.|+|||.+.+...++.++|+||||+++|+|++|++||.+.+......+++.
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07880 167 QTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230 (343)
T ss_pred ccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 65432 23445688999999887644578899999999999999999999998776655555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.25 Aligned_cols=219 Identities=18% Similarity=0.276 Sum_probs=166.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
.++|++.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 378999999999999999999754 2356899998854332 23345678899999999999999999988663
Q ss_pred ceEEEEEeecccC-hhhhhcCCCCcC----CcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEE
Q 018936 190 CSLYLVFHYMEHD-LAGLAASPEVKF----TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 264 (348)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~ 264 (348)
...+++|||+.++ +...+....... .........+..++.|++.||.|||+.|++||||||+||++++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 4589999999864 443332211111 01223455577889999999999999999999999999999999999999
Q ss_pred eeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 265 DFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 265 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
|||++......... ......+++.|+|||++.+.. ++.++|+||||+++|||++ |..||.+.+..+....++
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999765332211 112234577899999887644 8999999999999999999 789998876654443333
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=268.98 Aligned_cols=213 Identities=26% Similarity=0.404 Sum_probs=171.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+-|++.+.||.|+||.||+|++..++..+++|.+... .....+.+.+|+++++.++||||+++++++..+ ...|++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEE
Confidence 3478899999999999999999889999999998543 234566788899999999999999999988774 568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||++++.+....... ...+.+..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 81 IEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 9999876654433211 113455568889999999999999999999999999999999999999999999765322
Q ss_pred CCCCcccccccCccccccccc----CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
. .......+++.|+|||++. ....++.++|+|||||++|+|++|++||...+..+....+.
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 221 (282)
T cd06643 157 I-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221 (282)
T ss_pred c-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh
Confidence 1 2223456789999999874 22347789999999999999999999998776655544443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=283.04 Aligned_cols=220 Identities=21% Similarity=0.320 Sum_probs=168.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++... +..||||+++... .....+.+.+|+++++++. ||||+++++++...
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-- 113 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-- 113 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--
Confidence 6899999999999999999986432 3479999986543 3344567888999999996 99999999999764
Q ss_pred ceEEEEEeecccChh-hhhcCCCCc-------------------------------------------------------
Q 018936 190 CSLYLVFHYMEHDLA-GLAASPEVK------------------------------------------------------- 213 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~-~~~~~~~~~------------------------------------------------------- 213 (348)
...|+||||++++.+ ..+......
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 458999999986433 322211000
Q ss_pred -----------------------------------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC
Q 018936 214 -----------------------------------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 258 (348)
Q Consensus 214 -----------------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~ 258 (348)
.....++...+..++.||+.||.|||+.+|+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 001124556678899999999999999999999999999999999
Q ss_pred CcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 259 GVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 259 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
+.+||+|||+++........ ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||......+..+..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999999876432221 122334678899999887644 8999999999999999997 99999876554444444
Q ss_pred HHH
Q 018936 337 VLN 339 (348)
Q Consensus 337 i~~ 339 (348)
+..
T Consensus 353 ~~~ 355 (400)
T cd05105 353 IKS 355 (400)
T ss_pred Hhc
Confidence 433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.45 Aligned_cols=211 Identities=21% Similarity=0.380 Sum_probs=165.4
Q ss_pred CCceeeeeeccCCceEEEEEEEc----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||+||+|++. .++..||+|.+.... .......+.+|+++++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence 67999999999999999999853 456789999986433 334456788899999999999999999988764 45
Q ss_pred EEEEEeecccC-hhhhhcCCCC-----------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC
Q 018936 192 LYLVFHYMEHD-LAGLAASPEV-----------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 259 (348)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~-----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 259 (348)
.|++|||+.++ +...+..... ......++...+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 89999999864 4433321110 00112345566778899999999999999999999999999999999
Q ss_pred cEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 260 VLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 260 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
.+||+|||+++....... .......++..|+|||++.+.. ++.++|+||||+++|||++ |.+||.+.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999987643221 1123334567899999887644 8899999999999999998 99999876643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=294.03 Aligned_cols=207 Identities=24% Similarity=0.366 Sum_probs=166.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeece-Eeec---c-
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGL-VTSR---M- 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~-~~~~---~- 188 (348)
..++++.+.|.+|||+.||+|++...|..||+|++-.. ++.....+.+|+++|+.|+ |||||.+++. ...+ .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 36799999999999999999998777799999998654 6777889999999999996 9999999983 3222 1
Q ss_pred CceEEEEEeecc-cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEECCCCcEEEEe
Q 018936 189 SCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIAD 265 (348)
Q Consensus 189 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kl~D 265 (348)
...++|.||||. +++.+++..+... .+.+..+..|+.|++.|+.+||.+. |||||||-|||||..+|+.||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 245789999999 5888887643211 2445559999999999999999996 99999999999999999999999
Q ss_pred eCCccccCCCC-CCC-------cccccccCccccccccc--CcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 266 FGLASFFDPNH-KHP-------MTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 266 FGla~~~~~~~-~~~-------~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
||.|.---... ... .....-|+-|+|||++. +..++++|+|||+|||+||-|+....||...
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 99986431111 100 00112388999999874 3455899999999999999999999999765
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=268.29 Aligned_cols=215 Identities=22% Similarity=0.280 Sum_probs=159.7
Q ss_pred eeeccCCceEEEEEEEcc--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDML--TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
++||+|+||+||+|+... ....+|+|.+.... .......+.+|+++++.++||||+++++.+... ...|++|||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEeC
Confidence 369999999999996432 34578888875433 334455677899999999999999999988764 4589999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC-C
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-H 278 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-~ 278 (348)
+++.+..+................+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 875444333222111112233445778899999999999999999999999999999999999999999875432211 1
Q ss_pred CcccccccCcccccccccC------cccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 018936 279 PMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~ 339 (348)
......++..|+|||++.. ...++.++|||||||++|||++ |..||....+.+...+++..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc
Confidence 1123345677999998642 2346789999999999999999 88999887766655555443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=276.93 Aligned_cols=205 Identities=26% Similarity=0.487 Sum_probs=172.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+-|.++.+||+|+||.||++.++.+|+.+|||.+..+ ...+.+.+|+.+|+.++.|++|++||.+... .-+++|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEee
Confidence 4689999999999999999999999999999998653 3466778899999999999999999987663 449999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+. +..+.+..+.. .+.+..+..+++..++||+|||...-+|||||+.|||++.+|++||+|||.|-.+..
T Consensus 107 MEYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred hhhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 999985 45555544444 444555788899999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
. -....+..||+.|||||++.. ..|+.++||||||++..||.-|++||...+.+.+.
T Consensus 182 T-MAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI 238 (502)
T KOG0574|consen 182 T-MAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI 238 (502)
T ss_pred h-HHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccccccee
Confidence 2 222456789999999999875 34999999999999999999999999776665443
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.14 Aligned_cols=209 Identities=25% Similarity=0.403 Sum_probs=170.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||.|+||.||++++..++..||+|.+... .....+.+.+|++++++++||||+++++.+.. ....|++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEE
Confidence 6799999999999999999998889999999998654 34455678889999999999999999999876 4468999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+..+..... ..+....++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 81 IEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred eeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99998855544432211 13445558889999999999999999999999999999999999999999998765432
Q ss_pred CCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
.. ......+++.|+|||.+.. ...++.++|+||||+++|+|++|++||.+.+..+..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~ 217 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL 217 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH
Confidence 22 1234467889999998742 234677999999999999999999999877654433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=264.44 Aligned_cols=210 Identities=25% Similarity=0.449 Sum_probs=170.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||.|+||.||++++..+++.||+|.++.... ....+.+.+|+.+++.++||||+++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48899999999999999999999999999999875433 3345677889999999999999999999876 45699999
Q ss_pred eecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 197 HYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 197 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||++++ +......... ..++...+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++......
T Consensus 78 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 78 EYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999864 4444332111 12344557888999999999999999999999999999999999999999999866432
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
.. ......+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...+.......
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 154 GA-YACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred cc-ccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 21 12345678899999988764 488999999999999999999999987665444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=264.85 Aligned_cols=208 Identities=32% Similarity=0.547 Sum_probs=173.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||.|+||.||++.+..++..||+|.+..........+.+.+|+++++.++||||+++++++........+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48899999999999999999999999999999987666666677888999999999999999999988766667789999
Q ss_pred eecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 197 HYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH-----NNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 197 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-----~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
||+++. +...+.... .....++...++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCK--KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence 999864 433332210 11123455568889999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
....... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 159 ILGHDSS-FAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cccCCcc-cccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 7754332 123446789999999887644 8889999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=267.28 Aligned_cols=205 Identities=26% Similarity=0.479 Sum_probs=170.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||.|+||.||+|++..+++.||+|.+..... ......+.+|+++++.++||||+++++++... ...|++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEE
Confidence 368999999999999999999989999999999876542 33455678899999999999999999988774 569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||+.++.+....... .+....+..++.|++.||.|||+.+++||||+|+||++++++.++|+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 78 MEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999875444333222 3445558889999999999999999999999999999999999999999999877543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
. .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|++||.+.+...
T Consensus 152 ~-~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~ 205 (274)
T cd06609 152 M-SKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMR 205 (274)
T ss_pred c-cccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHH
Confidence 2 2233446788899999887655 8999999999999999999999997765443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=267.46 Aligned_cols=210 Identities=26% Similarity=0.485 Sum_probs=167.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecc----Cc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM----SC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~----~~ 190 (348)
+.|++.+.||+|+||.||+|++..+++.||+|.+.... .....+.+|+.+++++ +||||+++++++.... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 67999999999999999999998999999999987543 2234577899999998 7999999999987542 24
Q ss_pred eEEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
..|++|||+.++ +...+.... ...+.+..+..++.|++.||+|||+.+|+||||||+||++++++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 689999999874 444333211 113445557888999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
........ ......|+..|+|||++.+ ...++.++|+|||||++|+|++|+.||.........
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~ 225 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 87643222 2344568899999998753 224788999999999999999999999765544333
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=265.64 Aligned_cols=211 Identities=30% Similarity=0.556 Sum_probs=168.5
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-------hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-------PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
|.+...||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|++++++++||||+++++++... .
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--D 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--C
Confidence 67788999999999999998888999999988654332 12345678899999999999999999998774 4
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
..++++||+++..+........ .++...+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||+++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 6899999998754433332222 23444577889999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC-----CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 271 FFDPNHKH-----PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 271 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+......++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 224 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI 224 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH
Confidence 77532111 11233578899999988764 4788999999999999999999999887665554443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=266.74 Aligned_cols=203 Identities=27% Similarity=0.396 Sum_probs=163.6
Q ss_pred ceee-eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEE
Q 018936 118 FEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 118 y~~~-~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv 195 (348)
|++. +.||+|+|+.|--+....+|..||||++.+.. .....++.+|++++... .|+||++|+++|+++. .+|||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLV 154 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLV 154 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEE
Confidence 4433 57999999999999999999999999998764 34466778899999998 6999999999999854 49999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc---EEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kl~DFGla~~~ 272 (348)
||-|.++.+.........|+ +..+..+.++|+.||.|||.+||.||||||+|||-..... +||+||.|..-.
T Consensus 155 fEKm~GGplLshI~~~~~F~-----E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFN-----EREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EecccCchHHHHHHHhhhcc-----HHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99998765544444444444 4447888999999999999999999999999999986654 799999988654
Q ss_pred CCC------CCCCcccccccCccccccccc----CcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 273 DPN------HKHPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 273 ~~~------~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
... ......+.+|+..|||||+.. ....|+.+.|.|||||+||-|++|.+||.|.-.
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 321 112234557888999999863 234588999999999999999999999977543
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=264.62 Aligned_cols=211 Identities=27% Similarity=0.429 Sum_probs=171.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||.|+||+||+|....++..+|+|.+....... ..+.+.+|+++++.++|+||+++++.+.. ....|++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 46999999999999999999988899999999987554433 56778899999999999999999998876 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+|++++..+......... ...+.+..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999987544333221111 113445557889999999999999999999999999999999999999999999876543
Q ss_pred CCC---CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 276 HKH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 276 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
... ......++..|+|||++.....++.++|+||||+++|+|++|+.||...+...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 214 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence 222 12334678899999988765458899999999999999999999997765543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=269.45 Aligned_cols=217 Identities=21% Similarity=0.346 Sum_probs=168.7
Q ss_pred CCceeeeeeccCCceEEEEEEE-----ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|.+.+.||+|+||+||++.+ ..++..+|+|.+... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 6799999999999999999975 234567999987643 34456678899999999999999999999876 45
Q ss_pred eEEEEEeecccChh-hhhcCCCC-------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEE
Q 018936 191 SLYLVFHYMEHDLA-GLAASPEV-------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 191 ~~~lv~e~~~~~l~-~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 262 (348)
..+++|||++++.+ ..+..... ......+++..+..++.||+.||+|||+.|++||||||+||++++++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 68999999986443 33322110 01112366667888999999999999999999999999999999999999
Q ss_pred EEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 263 IADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 263 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
|+|||++......... ......++..|+|||++.+. .++.++|+||||+++|+|++ |.+||.+....+....+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999865432211 11223457789999988764 48899999999999999998 999998776555444443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=276.02 Aligned_cols=210 Identities=38% Similarity=0.630 Sum_probs=170.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC----ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~ 191 (348)
++|.+.+.||+|+||.||+|++..+|+.||+|.+............+.+|+.+++.++||||+++++++..... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 67999999999999999999998899999999987544333344567789999999999999999998865321 34
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|++++|+...+..... . .++...+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~~---~-----~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIMG---H-----PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHHc---C-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 68999999865544321 1 234455778899999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.... .....++..|+|||.+.+...++.++|+|||||++|||++|+.||.+.+.......++
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~ 228 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5322 2344668889999988765558889999999999999999999999877655544433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=271.94 Aligned_cols=211 Identities=27% Similarity=0.390 Sum_probs=163.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~--vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 191 (348)
.++|++.+.||+|+||.||+|++..++.. +|+|.++. .........+.+|++++.++ +||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CC
Confidence 37899999999999999999998777764 57776543 22344556788899999999 899999999998764 45
Q ss_pred EEEEEeecccC-hhhhhcCCCCc----------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc
Q 018936 192 LYLVFHYMEHD-LAGLAASPEVK----------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 260 (348)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~ 260 (348)
.|++|||++++ +...+...... .....+....++.++.||+.||+|||+.|++||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 89999999864 44444322110 01124566678889999999999999999999999999999999999
Q ss_pred EEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 261 LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 261 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
+||+|||++........ .....++..|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 99999999864321111 1112335679999987654 48899999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=270.30 Aligned_cols=207 Identities=21% Similarity=0.199 Sum_probs=153.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccC---CcEEEEEEeecCCCCh--HH-------HHHHHHHHHHHHhcCCCceeeeece
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEP--ES-------VKFMAREILILRRLDHPNVIKLEGL 183 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~---g~~vAvK~i~~~~~~~--~~-------~~~~~~E~~~l~~l~hpniv~l~~~ 183 (348)
++|++.+.||+|+||.||+|++..+ +..+|+|......... +. ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 6899999999999999999998776 6677887644332110 00 0111223344566789999999987
Q ss_pred EeeccC--ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcE
Q 018936 184 VTSRMS--CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 261 (348)
Q Consensus 184 ~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~ 261 (348)
...... ...+++++++...+....... .. .....++.++.|++.||+|||+.+|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKRI-KC-----KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHhh-cc-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 654322 244677887766554443321 11 2233477899999999999999999999999999999999999
Q ss_pred EEEeeCCccccCCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 262 KIADFGLASFFDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 262 kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
+|+|||+|+.+...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999999876432211 122346899999999887654 89999999999999999999999988743
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=266.64 Aligned_cols=207 Identities=35% Similarity=0.528 Sum_probs=168.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||++++..++..||||.+..... .....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEE
Confidence 569999999999999999999989999999998865433 334456788899999999999999999998774 46899
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+++. +...+.... .....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 80 VLELADAGDLSRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCCHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999874 433332111 112245556688899999999999999999999999999999999999999999988764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+..
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 3322 12344678899999988664 38889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=264.63 Aligned_cols=209 Identities=21% Similarity=0.375 Sum_probs=164.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++. .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++... ...+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEE
Confidence 57999999999999999999863 4556999988654332 34578899999999999999999998764 458999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.++ +...+..... .+.+..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++....
T Consensus 78 ~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 9999764 4444332221 344555888999999999999999999999999999999999999999999986643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
..........++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||...+..+....+
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 3222122234567799999887644 8899999999999999999 99999876654443333
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=264.18 Aligned_cols=209 Identities=22% Similarity=0.377 Sum_probs=165.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||+||+|++..+ ...||+|.++... .......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--Cce
Confidence 6799999999999999999987544 4589999886543 334456678899999999999999999988764 458
Q ss_pred EEEEeecccChh-hhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLA-GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+++|||+.++.+ ..+..... .++...+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||++..
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999987544 43332222 344556888999999999999999999999999999999999999999999998
Q ss_pred cCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 272 FDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 272 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~ 218 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH
Confidence 7522111 11122346789999988764 48899999999999999998 99999776654433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=265.64 Aligned_cols=218 Identities=28% Similarity=0.444 Sum_probs=171.8
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecc----
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM---- 188 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~---- 188 (348)
..++|++.+.||+|++|.||+|++..+++.+++|.+.... ...+.+.+|+++++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4488999999999999999999998889999999987543 2345688899999999 7999999999987643
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...+|++|||+++..+........ .....+....++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 456899999999754433322111 0012344555888999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
+........ ......++..|+|||++.. ...++.++|+||||+++|+|++|++||..........++
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 230 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence 986543222 2234467889999998753 234678999999999999999999999876554444443
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=264.76 Aligned_cols=200 Identities=23% Similarity=0.349 Sum_probs=158.7
Q ss_pred eeccCCceEEEEEEE--ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecc
Q 018936 123 KIGQGTYSNVYKAKD--MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (348)
Q Consensus 123 ~LG~G~~g~Vy~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 200 (348)
+||+|+||.||+|.+ ..++..+|+|+++.........+.+.+|+.+++.++||||+++++++.. ...+++|||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 689999999999964 4567899999987665555567788899999999999999999998754 24689999998
Q ss_pred cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC-
Q 018936 201 HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP- 279 (348)
Q Consensus 201 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~- 279 (348)
++.+........ .++...+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++..........
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 79 LGPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 654433332222 23445578889999999999999999999999999999999999999999998764332211
Q ss_pred -cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 280 -MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 280 -~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
.....++..|+|||.+... .++.++|+||||+++|||++ |++||.+.+..+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 206 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206 (257)
T ss_pred ecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1122335789999987653 48889999999999999998 999998765543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=262.63 Aligned_cols=206 Identities=35% Similarity=0.551 Sum_probs=168.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .....+.+.+|++++++++|+|++++++++... ...++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 579999999999999999999988999999999875433 334467788999999999999999999998774 46899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+++ .+...+.... .....++...+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 80 VLELADAGDLSRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCCHHHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999986 4444332211 111234556688899999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
.... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 3322 12334678889999988764 4889999999999999999999999554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=262.62 Aligned_cols=201 Identities=23% Similarity=0.395 Sum_probs=159.3
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeeccc
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 201 (348)
+.||+|+||.||+|++..+++.||+|.+... ...+....+.+|+++++.++||||+++++++... ...++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeeccC
Confidence 4699999999999999889999999987543 3345566788999999999999999999998764 458999999987
Q ss_pred Chhh-hhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCc
Q 018936 202 DLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280 (348)
Q Consensus 202 ~l~~-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 280 (348)
+.+. .+..... .+.+..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...........
T Consensus 78 ~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 78 GDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred CcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 5443 3332221 244555788999999999999999999999999999999999999999999986543211111
Q ss_pred -ccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 281 -TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 281 -~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
.....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~ 204 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204 (252)
T ss_pred CCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHH
Confidence 1112245699999887644 8899999999999999998 999997766543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=261.56 Aligned_cols=205 Identities=31% Similarity=0.550 Sum_probs=169.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+.+|+++++.++|+||+++++++.. ....++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 4889999999999999999988899999999998776555567888999999999999999999998766 45689999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+++..+........ .+....+..++.|++.||.|||+.||+|+||+|+||++++++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 79 EYCSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred ecCCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9998655444433222 23344477889999999999999999999999999999999999999999998765433
Q ss_pred CCCcc---cccccCcccccccccCcc--cCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 277 KHPMT---SRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 277 ~~~~~---~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..... ...++..|+|||++.+.. .++.++|+||||+++|+|++|+.||.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 22111 345688999999886532 37789999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=272.77 Aligned_cols=215 Identities=37% Similarity=0.555 Sum_probs=171.8
Q ss_pred CceeeeeeccCCceEEEEEEEccC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec--cCce
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLT--GKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR--MSCS 191 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~ 191 (348)
+|++.+.||+|+||.||++++..+ +..||+|.+..........+.+.+|+++++++ +||||+++++.+... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999998877 89999999865433333455677899999999 599999998875432 2345
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|++++++++++...+.... .+....++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++.
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEecccCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 78999999987776664321 344555888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCC---CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 272 FDPNHKH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 272 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
+...... ......+|..|+|||.+.+...++.++|+||+|+++|+|++|++||.+.+..+...+++
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~ 223 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL 223 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHH
Confidence 6432211 12344679999999988765558899999999999999999999998876554444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=290.82 Aligned_cols=213 Identities=24% Similarity=0.378 Sum_probs=178.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|.++..||.|+||+||+|.++.++-.-|.|+|... ..+..+++.-|++||..++||+||+|++.|... +.+++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEE
Confidence 5689999999999999999999988888888987543 456788888999999999999999999988774 449999
Q ss_pred EeecccChhhhhcC-CCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAAS-PEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
.|||+|+..+.... ... .+.+.++..+++|++.||.|||+++|||||||+.|||++.+|.++|+|||.+.....
T Consensus 108 iEFC~GGAVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EeecCCchHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 99999876554432 223 334445888999999999999999999999999999999999999999999876542
Q ss_pred CCCCCcccccccCccccccccc----CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
......++.|||.|||||+++ ...+|+.++||||||++|.||.-+.||-...+.+..+.+|..
T Consensus 183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK 249 (1187)
T KOG0579|consen 183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 249 (1187)
T ss_pred -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh
Confidence 233356789999999999874 235699999999999999999999999988887776666543
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=267.12 Aligned_cols=206 Identities=24% Similarity=0.441 Sum_probs=166.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++++.||+|+||.||++++..+|..||+|.++.. ........+.+|++++++++||||+++++.+.. ....|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 3689999999999999999999889999999998654 334445678889999999999999999998877 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++..+..+..... ....+....+..++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 78 MEYMDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EeecCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99998755544433211 01234555688899999999999997 5999999999999999999999999999976532
Q ss_pred CCCCCcccccccCcccccccccCcc-----cCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.. .....+++.|+|||.+.+.. .++.++|+|||||++|+|++|+.||.....
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 156 SL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred Cc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 22 23345788899999875422 357899999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=266.30 Aligned_cols=204 Identities=24% Similarity=0.381 Sum_probs=162.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||+||+|++..+|. .||+|.++... .......+.+|+.+++.+.||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---T 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---C
Confidence 679999999999999999999877776 48999886543 334456788899999999999999999988652 3
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++++|+++ .+...+..... .++...+..++.||+.||.|||+.+|+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 6789999975 44444433222 34445578889999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCCh
Q 018936 271 FFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329 (348)
Q Consensus 271 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~ 329 (348)
........ ......+++.|+|||.+.+. .++.++|||||||++|||++ |.+||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 77533221 11222346789999988764 48899999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=269.52 Aligned_cols=216 Identities=22% Similarity=0.365 Sum_probs=166.8
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
.+|++.++||+|+||.||+|++.. ++..||+|.++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--
Confidence 568999999999999999998653 35789999986443 3344567888999999999999999999987753
Q ss_pred eEEEEEeecccChh-hhhcCCC----------CcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC
Q 018936 191 SLYLVFHYMEHDLA-GLAASPE----------VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 259 (348)
Q Consensus 191 ~~~lv~e~~~~~l~-~~~~~~~----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 259 (348)
..+++++|+.+..+ ..+.... .......+....+..++.|++.||.|||+.||+||||||+||++++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 48999999976433 3332110 000112355566788999999999999999999999999999999999
Q ss_pred cEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018936 260 VLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335 (348)
Q Consensus 260 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~ 335 (348)
.+||+|||+++....... .......+++.|+|||++.+.. ++.++||||||+++|||++ |..||.+....+....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999886643221 1123334577899999887644 8899999999999999998 8999987665443333
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=271.56 Aligned_cols=202 Identities=28% Similarity=0.510 Sum_probs=167.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+|++.+.||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.. ....|++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv 94 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 94 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEe
Confidence 6899999999999999999999899999999998754432 34567889999999999999999999876 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++..+....... .+....+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 95 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999875444433221 2344457788999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+.
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 169 QS-KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred cc-CcCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 22 12334678899999988764 478999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=266.03 Aligned_cols=214 Identities=20% Similarity=0.294 Sum_probs=167.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 82 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--Q 82 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--C
Confidence 6899999999999999999987543 3789999985443 333445677899999999999999999998774 4
Q ss_pred eEEEEEeeccc-ChhhhhcCCCCc----CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEe
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEVK----FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~D 265 (348)
..+++|||+++ .+...+...... .....+.+..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 58999999975 444443321110 0112344556788899999999999999999999999999999999999999
Q ss_pred eCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 266 FGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 266 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
||+++....... .......++..|+|||.+.+.. ++.++|+|||||++|||++ |++||.+.+..+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 231 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHH
Confidence 999986543221 1223345678899999886544 8899999999999999998 99999877654433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=253.82 Aligned_cols=208 Identities=25% Similarity=0.371 Sum_probs=168.0
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee---ccC
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS---RMS 189 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~ 189 (348)
...++|++.+.||+|||+.||++++..++..||+|++.... .+..+...+|++.-++++|||+++++++... +..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34479999999999999999999999999999999998766 4456677889999999999999999887643 234
Q ss_pred ceEEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEECCCCcEEEEee
Q 018936 190 CSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADF 266 (348)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kl~DF 266 (348)
...|++++|...+ +++...... .....+++.++..|+.+|+.||.+||+.. +.||||||.|||+.+++.++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 5689999988754 666554322 22335667778999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCC--------CcccccccCccccccccc--CcccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 267 GLASFFDPNHKH--------PMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 267 Gla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
|.+......-.. .......|..|.|||.+. .....+.++|||||||+||+|+.|..||
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPf 241 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPF 241 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcc
Confidence 999876422111 011123488899999874 2234788999999999999999999999
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=264.44 Aligned_cols=207 Identities=24% Similarity=0.401 Sum_probs=163.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.++||+|+||.||+|++..+ ..||+|.++..... .+.+.+|+++++.++||||+++++.+.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEE
Confidence 6799999999999999999987544 56999998754332 3467889999999999999999987643 347899
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.+ .+...+..... ..++...+..++.|++.||+|||+.+++||||||+||++++++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999986 44444432111 1234455788899999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
..........++..|+|||++.+.. ++.++|+||||+++|+|++ |++||.+....+...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~ 214 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 214 (262)
T ss_pred cccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH
Confidence 3322222334567899999876544 8899999999999999999 899998876554433
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=273.74 Aligned_cols=216 Identities=39% Similarity=0.635 Sum_probs=178.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc---CceEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSLY 193 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~~ 193 (348)
+|++.+.||+|++|.||+|++..+++.||+|.+..........+.+.+|+.+++.++||||+++.+++.... ....|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 489999999999999999998888999999998754433445667888999999999999999999887643 23589
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++|+|+++++...+.... .+....+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999999987666554322 34455578899999999999999999999999999999999999999999998775
Q ss_pred CCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 274 PNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 274 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.... .......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..+....++.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE 221 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 4321 1233456788999999988764688999999999999999999999999887665544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=264.12 Aligned_cols=206 Identities=22% Similarity=0.378 Sum_probs=162.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+|++.+.||+|+||.||++++. ++..+|+|.+...... .+.+.+|+++++.++||||+++++++... ...|++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEE
Confidence 46899999999999999999874 5678999998654332 34567799999999999999999988764 458999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++ +...+..... .+....+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 78 TEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred EecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence 9999764 4444432222 344555888999999999999999999999999999999999999999999986643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
..........++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...++.+..
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211 (256)
T ss_pred ccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence 222111222234579999988764 48899999999999999999 89999876654443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=271.06 Aligned_cols=203 Identities=40% Similarity=0.680 Sum_probs=168.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||.|+||.||+|++..++..||+|.+..........+.+.+|+++++.++||||+++.+++... ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEE
Confidence 4789999999999999999999999999999998865444344456677899999999999999999988653 335789
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
++||+++.+....... .+....+..++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||++.....
T Consensus 88 v~e~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 88 VTELLGTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EeehhccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 9999987766554322 233344677899999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
. .....++..|+|||.+.+...++.++|+||||+++|+|++|++||++...
T Consensus 161 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 161 Q----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred C----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 23345688899999876645588999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=263.28 Aligned_cols=212 Identities=26% Similarity=0.454 Sum_probs=169.1
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
+|++.+.||.|+||.||+|.+ .+|+.+|+|.+..... .......+.+|+++++.++|+||+++.+++... ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeE
Confidence 478889999999999999985 6889999999875432 223346688899999999999999999998774 579
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++++||+.+..+........ .++...+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999998755444433222 2344557788999999999999999999999999999999999999999999865
Q ss_pred CCCC-----CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 273 DPNH-----KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 273 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.... ........++..|+|||++.+.. ++.++|+||||+++|+|++|+.||...+..+....+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 221 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh
Confidence 3211 11123345788999999887644 7899999999999999999999998776655444433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.06 Aligned_cols=219 Identities=24% Similarity=0.450 Sum_probs=173.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccC-C----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLT-G----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-g----~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
...-++.+.||+|.||.||.|.-... | ..||+|.++... ..+....|.+|..+|++++|||||+++|++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-- 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-- 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--
Confidence 36788899999999999999985433 2 249999886543 456677788899999999999999999999884
Q ss_pred ceEEEEEeeccc-ChhhhhcCCC-CcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPE-VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
...++++|||++ +|+.++.... ..+....+.-.....++.||++|+.||+++++|||||.+.|+||++...+||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 448999999986 5666655431 22223345555678899999999999999999999999999999999999999999
Q ss_pred Ccccc-CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 268 LASFF-DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 268 la~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
||+.+ +...............|||||.+.... ++.|+|||||||+|||++| |.+||++.++.+...-.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~ 918 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL 918 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence 99944 222221112224467899999998744 9999999999999999999 999999999876655443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=301.19 Aligned_cols=202 Identities=30% Similarity=0.500 Sum_probs=165.3
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec-----
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----- 187 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 187 (348)
+..++|+.+..||+||||.||+++++-+|..||||+|.... .......+.+|+..|++|+|||||+++..+...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34678999999999999999999999999999999998765 556677788999999999999999987521000
Q ss_pred --------------------------------------------------------------------------------
Q 018936 188 -------------------------------------------------------------------------------- 187 (348)
Q Consensus 188 -------------------------------------------------------------------------------- 187 (348)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred --------------------------------cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHH
Q 018936 188 --------------------------------MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235 (348)
Q Consensus 188 --------------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL 235 (348)
....+|+-||||+..++......+.... .....+.+++||+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHH
Confidence 0024688889998888777766554432 1223778899999999
Q ss_pred HHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC-----------------CCCCCCcccccccCcccccccccCc
Q 018936 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD-----------------PNHKHPMTSRVVTLWYRPPELLLGA 298 (348)
Q Consensus 236 ~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~ 298 (348)
.|+|++|||||||||.||++++++.+||+|||+|.... .......++.+||.-|+|||++.+.
T Consensus 711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999999999999999999998721 1112245677899999999988765
Q ss_pred c--cCCccccHHHHHHHHHHHHh
Q 018936 299 T--DYGVGVDLWSAGCILAELLA 319 (348)
Q Consensus 299 ~--~~~~~~DvwSlGv~l~ellt 319 (348)
. .|+.|+|+|||||+++||+.
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc
Confidence 5 59999999999999999985
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=275.49 Aligned_cols=213 Identities=40% Similarity=0.685 Sum_probs=172.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC------
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS------ 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 189 (348)
.+|++.+.||.|+||.||+|++..+|..||+|.+..... ...+.+.+|+++++.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 679999999999999999999999999999999866543 334567789999999999999999887755322
Q ss_pred ------ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC-CCCcEE
Q 018936 190 ------CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLK 262 (348)
Q Consensus 190 ------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~k 262 (348)
...|+++||+++++...+... .+....++.++.||+.||.|||+.||+||||||+||+++ +++.++
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEE
Confidence 247899999998766554321 244555888999999999999999999999999999997 456789
Q ss_pred EEeeCCccccCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 263 IADFGLASFFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 263 l~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
|+|||++..+...... ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+....++
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999876432221 11223568889999987655558889999999999999999999998887766655544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=263.61 Aligned_cols=205 Identities=24% Similarity=0.473 Sum_probs=164.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.++||+|+||.||+|.. .+++.||+|.+...... .+.+.+|++++++++||||+++++++.. ...+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEE
Confidence 6899999999999999999985 56789999998754433 3467789999999999999999988743 347999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.+ .+......... ..+....+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999976 45444432211 1344555788899999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
..........++..|+|||.+.+. .++.++|+||||+++|+|++ |++||.+.+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 212 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212 (260)
T ss_pred CCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 322222333456789999987654 38889999999999999999 9999987765443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=263.25 Aligned_cols=209 Identities=25% Similarity=0.425 Sum_probs=165.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.++||+|+||.||+|.+ .++..+|+|.+...... .+.+.+|+.++++++|||++++++++.. ...|++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEe-cCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence 6799999999999999999986 46678999998765433 3457889999999999999999988743 347899
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.+ .+........ ...++...+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999986 4444433211 11345556888999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
..........++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.+..+....+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216 (260)
T ss_pred cccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 322222233456679999987654 48899999999999999999 99999887665544433
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=268.74 Aligned_cols=211 Identities=25% Similarity=0.346 Sum_probs=162.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK--IVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||.||+|++..++. .+++|.++.. ......+.+.+|+++++++ +||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccc
Confidence 679999999999999999999876664 4688877532 2334456688899999999 799999999988764 458
Q ss_pred EEEEeeccc-ChhhhhcCCCCc----------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcE
Q 018936 193 YLVFHYMEH-DLAGLAASPEVK----------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 261 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~ 261 (348)
|+++||+++ .+...+...... .....+....++.++.||+.||+|||+.||+||||||+|||+++++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999986 444444321100 011235566688899999999999999999999999999999999999
Q ss_pred EEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 262 KIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 262 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
||+|||++........ ......+..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999875322111 1111225579999988764 48899999999999999998 9999987765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=267.10 Aligned_cols=203 Identities=25% Similarity=0.385 Sum_probs=161.5
Q ss_pred CCc-eeeeeeccCCceEEEEEE----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSF-EKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y-~~~~~LG~G~~g~Vy~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++| ++.+.||+|+||+||++. ...++..||+|.++... .....+.+.+|++++++++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 999999999999998764 33578899999986543 233456677899999999999999999988776566
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
..+++|||+.++.+....... .++...++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccc
Confidence 789999999875444333221 24555688899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCC--cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 271 FFDPNHKHP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 271 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
......... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 764332111 1122346679999988764 488999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=261.02 Aligned_cols=214 Identities=25% Similarity=0.481 Sum_probs=173.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|+||.||++++..+|+.||+|.+............+.+|+.+++.++||||+++.+++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 4899999999999999999998999999999987665555556678889999999999999999999876 45689999
Q ss_pred eeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 197 HYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 197 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||+.+ .+......... ..++...+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 79 DYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred ecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99976 44444332111 12344557888999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.. ......+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||......+....++.
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~ 215 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc
Confidence 21 122345788899999887644 78899999999999999999999987666555544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=266.50 Aligned_cols=212 Identities=48% Similarity=0.848 Sum_probs=177.4
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEe
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 197 (348)
|++.+.||+|++|.||+|.+..+++.+|+|.+............+.+|+++++.++||||+++++++... ...++++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 5678899999999999999988999999999876655544566788899999999999999999998764 56899999
Q ss_pred ecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
|+++.+...+..... .++...+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 79 FMDTDLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred ccCCCHHHHHHhhcc-----cCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 999887776654332 34455588899999999999999999999999999999999999999999998775443
Q ss_pred CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.......++..|+|||.+.+...++.++|+||||+++|+|++|+.||++.+..+....+.
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 122334578889999988775458899999999999999999999999888766555443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=264.40 Aligned_cols=203 Identities=32% Similarity=0.469 Sum_probs=169.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+|++.+.||.|+||.||+|++..++..||+|.+..... .....+.+.+|++++++++||||+++++++.. ....+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 48999999999999999999988999999999976543 22456778899999999999999999988866 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||+.+..+........ .+....+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 79 VDLLLGGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred EeCCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99998754444333222 3444558889999999999999999999999999999999999999999999876443
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
. ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred c--cccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 2 123456788899999887644 88999999999999999999999987663
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=265.73 Aligned_cols=216 Identities=28% Similarity=0.461 Sum_probs=168.5
Q ss_pred cCCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee---c
Q 018936 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS---R 187 (348)
Q Consensus 112 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---~ 187 (348)
+...++|++.+.||+|+||.||++++..+++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 344588999999999999999999999999999999875432 2234577899999999 79999999998743 2
Q ss_pred cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
.....+++|||++++.+........ .....+....++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 3456899999998754433221110 111234555578899999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
++........ ......|++.|+|||++.. ...++.++||||+||++|+|++|+.||........
T Consensus 170 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 170 VSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred ceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 9987643221 2233468899999998753 13378899999999999999999999977654433
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=265.69 Aligned_cols=205 Identities=22% Similarity=0.372 Sum_probs=162.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||+||+|.+..++. .+++|.+... ........+..|+.++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Cc
Confidence 679999999999999999999877776 4777776432 223344567778889999999999999998753 33
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.++++||+.+ .+...+..... .+++..+..++.||+.||.|||+.+++||||||+||++++++.+||+|||+++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 6788999875 45544433222 34455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 271 FFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 271 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
......... .....++..|+|||.+.+.. ++.++||||||+++|||++ |+.||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 764332221 22334577899999887644 8999999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=259.55 Aligned_cols=211 Identities=27% Similarity=0.435 Sum_probs=172.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|+||.||++.+..+++.+|+|.+............+.+|+++++.++||||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4899999999999999999998999999999998766655667788899999999999999999998876 45689999
Q ss_pred eecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC-CcEEEEeeCCccccCC
Q 018936 197 HYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASFFDP 274 (348)
Q Consensus 197 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~~~~ 274 (348)
||+++. +...+.... ...++...+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 79 EYAPGGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred ecCCCCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999874 444443221 1134555588899999999999999999999999999999855 4689999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+.......+
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 213 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI 213 (256)
T ss_pred Ccc--ccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH
Confidence 321 2334678899999988764 3788999999999999999999999887654444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=264.05 Aligned_cols=217 Identities=28% Similarity=0.464 Sum_probs=169.7
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecc---C
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM---S 189 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~---~ 189 (348)
..++|++.+.||+|+||.||++.+..+++.+|+|.+.... ...+.+.+|+.+++++ +|||++++++++.... .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 3478999999999999999999998999999999986432 2234567799999998 8999999999986532 2
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
...|+++||++++.+........ .....+.+..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 46899999998754433221110 11123455568889999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccCcc----cCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLGAT----DYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
......... .....++..|+|||.+.... .++.++|+|||||++|+|++|++||...+..+....
T Consensus 176 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~ 244 (291)
T cd06639 176 AQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244 (291)
T ss_pred hhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence 876433221 22346788899999875432 257899999999999999999999987765554444
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=274.07 Aligned_cols=214 Identities=24% Similarity=0.398 Sum_probs=164.0
Q ss_pred CCceeeeeeccCCceEEEEEEE-----ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||+||+|++ ..+++.||||.++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 6799999999999999999974 35678999999875432 33455677899999999 689999999988654 3
Q ss_pred ceEEEEEeecccChhh-hhcCCCCc-------------------------------------------------------
Q 018936 190 CSLYLVFHYMEHDLAG-LAASPEVK------------------------------------------------------- 213 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~-~~~~~~~~------------------------------------------------------- 213 (348)
...+++|||++++.+. .+......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4578999999864443 33211100
Q ss_pred ------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCC-Cccccccc
Q 018936 214 ------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVT 286 (348)
Q Consensus 214 ------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt 286 (348)
.....+....+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......... ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 00112455567789999999999999999999999999999999999999999999865322211 11223346
Q ss_pred CcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
+.|+|||.+.+. .++.++|+||||+++|+|++ |..||........
T Consensus 245 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 290 (343)
T cd05103 245 LKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290 (343)
T ss_pred cceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH
Confidence 779999988764 48899999999999999997 9999987654333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=260.19 Aligned_cols=210 Identities=30% Similarity=0.534 Sum_probs=169.6
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
+|+..+.||+|+||+||+|.+..++..|++|.+..... .++..+.+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEE
Confidence 37778999999999999999888999999999876442 234566788999999999999999999988764 4689
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+++||+++..+..+..... .+....+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEEEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999998744433332222 23444577889999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
... ......++..|+|||.+.....++.++|+||||+++|+|++|+.||......+....
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~ 213 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK 213 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH
Confidence 332 223456788999999876543478899999999999999999999977665444444
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=264.55 Aligned_cols=213 Identities=24% Similarity=0.383 Sum_probs=165.3
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 82 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--L 82 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence 679999999999999999999876 67889999875433 233445678899999999999999999988764 3
Q ss_pred eEEEEEeeccc-ChhhhhcCCCC-cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC---cEEEEe
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEV-KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIAD 265 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~---~~kl~D 265 (348)
..+++|||+.+ .+...+..... ......+.+..+..++.||+.||+|||+.+++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 47899999976 44444432211 11122456666888999999999999999999999999999998654 699999
Q ss_pred eCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 266 FGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 266 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
||+++........ .......+..|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999876322111 111223356799999987654 8999999999999999997 9999988765443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=263.08 Aligned_cols=211 Identities=32% Similarity=0.559 Sum_probs=167.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC--------ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--------EPESVKFMAREILILRRLDHPNVIKLEGLVTSRM 188 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 188 (348)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++.... .....+.+.+|+++++.++|||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 47888999999999999999888999999998864321 112245678899999999999999999988764
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...++||||+.++.+........ .+....++.++.||+.||.|||+.+++||||+|+||+++.++.++|+|||+
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 81 -EYLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred -CceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 56899999998754443333322 234445778899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCC-CcccccccCcccccccccCcc-cCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 269 ASFFDPNHKH-PMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 269 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
+......... ......++..|+|||.+.+.. .++.++|+||||+++|+|++|..||......+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 222 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF 222 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH
Confidence 9865432211 123345788999999876533 47889999999999999999999997655544433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=267.50 Aligned_cols=211 Identities=31% Similarity=0.524 Sum_probs=172.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
..|+..+.||+|+||.||++++..++..||+|.+..... .......+.+|+++++.++|||++++++++... ...++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEE
Confidence 458999999999999999999988999999999876533 334456788899999999999999999998774 45899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|||+.+.+......... .+.+..+..++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 103 VMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEeCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 999999877666543322 234455778899999999999999999999999999999999999999999875532
Q ss_pred CCCCCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
. ....+++.|+|||++.+ ...++.++|+|||||++|+|++|++||.+.........+..
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 238 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 2 33467888999998742 23478899999999999999999999977665555554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=266.59 Aligned_cols=213 Identities=22% Similarity=0.336 Sum_probs=167.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC----------------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceee
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG----------------KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g----------------~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 179 (348)
++|++.+.||+|+||.||+|++...+ ..||+|.+.... .....+.+.+|+++++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 67999999999999999999876533 568999986543 3345677889999999999999999
Q ss_pred eeceEeeccCceEEEEEeecccChhhhhcCCCCc------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 018936 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNL 253 (348)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI 253 (348)
+++++... ...++++|++.++.+..+...... .....++...++.++.|++.||.|||+.||+||||||+||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99998774 468999999986443333222221 1112456666888999999999999999999999999999
Q ss_pred EECCCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh--CCCCCCCCChh
Q 018936 254 LIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--GKPIMPGRTEV 330 (348)
Q Consensus 254 ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt--G~~pf~~~~~~ 330 (348)
+++.++.++|+|||++........ .......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999986543321 122334557789999988764 38899999999999999998 77888776654
Q ss_pred HH
Q 018936 331 SA 332 (348)
Q Consensus 331 ~~ 332 (348)
+.
T Consensus 241 ~~ 242 (296)
T cd05051 241 QV 242 (296)
T ss_pred HH
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=263.02 Aligned_cols=208 Identities=23% Similarity=0.265 Sum_probs=156.6
Q ss_pred eeeccCCceEEEEEEEc--cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||+|+||.||+|... .++..+|+|.++..... .....+.+|+.+++.++||||+++++++... ...++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEECC
Confidence 36999999999999754 34568999988655432 3344677899999999999999999988764 4589999999
Q ss_pred ccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCC
Q 018936 200 EHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 278 (348)
Q Consensus 200 ~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 278 (348)
+++ +...+.... ...........+..++.|++.||+|||+.+++||||||+||+++.+++++|+|||++.........
T Consensus 78 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 78 PLGDLKGYLRSCR-KAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCcHHHHHHHhh-hcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 864 444433211 111112233446678999999999999999999999999999999999999999999754322111
Q ss_pred -CcccccccCcccccccccCc------ccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 279 -PMTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 279 -~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
......++..|+|||++.+. ..++.++|+||||+++|||++ |+.||...++.+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 219 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence 11234567889999987532 125789999999999999996 99999877655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=262.66 Aligned_cols=207 Identities=25% Similarity=0.453 Sum_probs=164.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||.||+|++..++. .+|+|.++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Ccc
Confidence 579999999999999999998765443 79999886543 334456788899999999999999999998764 458
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|++|||++++ +...+..... .++...+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999865 4444432221 345556788999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCc--ccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 272 FDPNHKHPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 272 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
......... ....++..|+|||.+.+. .++.++|+||||+++|++++ |..||......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~ 217 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH
Confidence 653322111 112235679999988764 48999999999999999887 999998766543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=273.24 Aligned_cols=213 Identities=38% Similarity=0.626 Sum_probs=175.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC----c
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----C 190 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 190 (348)
.++|++.+.||+|++|.||+|++..+++.||+|.+..........+.+.+|+.+++.++||||+++.+++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 368999999999999999999998899999999986544334445667789999999999999999887755322 3
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
..+++++|+++.+....... .+....++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 58999999988776665431 34455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
..... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.+....+...+++.
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 76432 23446788899999876544578899999999999999999999998877665555443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=262.87 Aligned_cols=204 Identities=33% Similarity=0.574 Sum_probs=164.9
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
+|+..+.||+|+||.||++.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 47888999999999999999999999999999875432 12245678899999999999999999999876 4468
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-cEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~ 271 (348)
++++||+.+..+........ .++...+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++..
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEEEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999998754443332222 234455788899999999999999999999999999998776 599999999987
Q ss_pred cCCCCCC---CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 272 FDPNHKH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 272 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 6533111 11234578899999988764 48899999999999999999999996544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=277.03 Aligned_cols=220 Identities=23% Similarity=0.368 Sum_probs=169.6
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 189 (348)
++|.+.+.||+|+||.||+|++. .++..||+|+++.... ....+.+.+|+++|.++. ||||+++++++...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-- 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-- 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence 57899999999999999999853 3456899999975432 333456888999999997 99999999998774
Q ss_pred ceEEEEEeecccC-hhhhhcCCCCc-------------------------------------------------------
Q 018936 190 CSLYLVFHYMEHD-LAGLAASPEVK------------------------------------------------------- 213 (348)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~~~~~------------------------------------------------------- 213 (348)
...++||||+.++ +...+......
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 4589999999864 33333211000
Q ss_pred -------------------------------------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 214 -------------------------------------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 214 -------------------------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
.....+.+..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 0012344556778999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 257 DDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
+++.+||+|||+++....... .......++..|+|||.+.+.. ++.++||||||+++|||++ |..||......+...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999986532221 1122345678899999887644 8899999999999999998 899998877666555
Q ss_pred HHHHH
Q 018936 335 CFVLN 339 (348)
Q Consensus 335 ~~i~~ 339 (348)
..+..
T Consensus 353 ~~~~~ 357 (401)
T cd05107 353 NAIKR 357 (401)
T ss_pred HHHHc
Confidence 55444
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=260.38 Aligned_cols=208 Identities=25% Similarity=0.397 Sum_probs=164.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++...||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+++++.++|||++++++++.. ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEE
Confidence 5799999999999999999986444 5699998765432 23567789999999999999999988753 347899
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.+ .+...+..... ..+....+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999986 55555533211 1244555778899999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~ 335 (348)
..........++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.+....+....
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 215 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ 215 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 3222222334567899999876544 8899999999999999999 9999988776554433
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=251.56 Aligned_cols=210 Identities=31% Similarity=0.612 Sum_probs=179.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+++|+|.|+.||.|.+..+++.++||+++ +-..+.+.+|+.+|..|+ ||||++++++..+.......|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 78999999999999999999998999999999986 455778999999999997 999999999998887778899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC-CcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~~~ 273 (348)
++||++..-...+. +.++...++.++.|+++||.|+|+.||+|||+||.|++||.. -.++|+|+|||.++.
T Consensus 113 iFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred HhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999874443332 134445589999999999999999999999999999999954 579999999999986
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHHHh
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPI-MPGRTEVSATFCFVLNL 340 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~p-f~~~~~~~~~~~~i~~~ 340 (348)
++.. ..-++-+..|--||.+...+.|+..-|+|||||++..|+..+.| |.|.++.+++.+|...+
T Consensus 185 p~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 185 PGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred CCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 6543 23344566789999999888899999999999999999997655 68999999998887544
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.72 Aligned_cols=211 Identities=20% Similarity=0.376 Sum_probs=166.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|+..+.||+|+||.||+|++..++. .+|+|.++... .....+.+.+|+++++.++||||+++.+++... ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCc
Confidence 679999999999999999999866554 79999886543 234456788899999999999999999998764 458
Q ss_pred EEEEeecccChhhhhc-CCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLAGLAA-SPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|++|||++++.+.... .... .++...+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 9999999875544333 2222 344455788899999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcc--cccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018936 272 FDPNHKHPMT--SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335 (348)
Q Consensus 272 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~ 335 (348)
.......... ....++.|+|||++.+. .++.++||||||+++|||++ |+.||...+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~ 222 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA 222 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence 6432221111 11234579999988764 48899999999999999998 9999987765443333
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=263.67 Aligned_cols=206 Identities=26% Similarity=0.381 Sum_probs=167.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|...+.||.|++|.||++.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++.......+|++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 368999999999999999999988999999999875432 3445678889999999999999999999877666678999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+......... ....++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999986443322111000 1123445557889999999999999999999999999999999999999999998765322
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
. .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 159 ~---~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 L---AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred c---cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2 1234568889999988764 4889999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=262.67 Aligned_cols=211 Identities=24% Similarity=0.376 Sum_probs=169.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+|++.+.||.|+||.||+|++.. +..+|+|.+.... ......+.+|+++++.++||||+++++++... ...+++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 80 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYII 80 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEEE
Confidence 679999999999999999999866 8899999986543 22355678899999999999999999988764 458999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ .+......... ..+....+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 999987 45444433221 1344555788999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+..+....+.
T Consensus 157 ~~~~-~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05148 157 DVYL-SSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218 (261)
T ss_pred cccc-ccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 3221 2233456789999988764 48899999999999999998 899998877655444443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=264.45 Aligned_cols=202 Identities=27% Similarity=0.448 Sum_probs=160.5
Q ss_pred CCceeeeeeccCCceEEEEEE----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||.||++. +..++..||+|.+... .....+.+.+|+++++.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 579999999999999999997 3457889999997643 2344567889999999999999999999876555567
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
+++++||+++ .+...+..... .+....+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 8999999976 45444432221 24445578889999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCc--ccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 271 FFDPNHKHPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 271 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
.......... ....++..|+|||.+.+.. ++.++|+||||+++|||++|..|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCC
Confidence 7643322111 1112344599999887644 8899999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=263.20 Aligned_cols=196 Identities=28% Similarity=0.437 Sum_probs=153.6
Q ss_pred eeccCCceEEEEEEEccCCcEEEEEEeecCCCChH-HHHHHHHHHHHHH---hcCCCceeeeeceEeeccCceEEEEEee
Q 018936 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE-SVKFMAREILILR---RLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~E~~~l~---~l~hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
.||+|+||.||++.+..+++.||+|.+........ ......+|..+++ ..+||||+.+++++... ...++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 48999999999999988999999999876543222 1222334444333 34799999998888763 458999999
Q ss_pred cccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCC
Q 018936 199 MEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 278 (348)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 278 (348)
+.++.+........ .+.+..+..++.|++.||.|||+.+|+||||||+|||+++++.++|+|||++.......
T Consensus 79 ~~~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 79 MNGGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 98765544433222 34555588899999999999999999999999999999999999999999997654322
Q ss_pred CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 279 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.....++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 2234689999999988644457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=259.69 Aligned_cols=211 Identities=23% Similarity=0.390 Sum_probs=168.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|.+ .++..||+|.+...... .+.+.+|+++++.++||||+++++++... ...+++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 79 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIYIV 79 (261)
T ss_pred hheeeeeeeccCcceEEEEEEE-cCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceEEE
Confidence 7899999999999999999986 45688999998754432 35678899999999999999999988763 458999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++. +........ ...+....+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 80 TEYMSKGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EeccCCCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999864 444443321 12345556788999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
..........++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+..+....+.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 221111222345679999988764 48899999999999999999 999998877655444443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=260.11 Aligned_cols=204 Identities=28% Similarity=0.499 Sum_probs=168.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||.|+||.||+|++..+++.||+|.+.... ..+.+.+|+++++.++||||+++++++... ...|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEE
Confidence 67999999999999999999988889999999986432 266788999999999999999999998874 568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||+.+..+........ ..++...++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 77 MEYCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EecCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99998754443322111 23455568889999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|++||.......
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred cc-ccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 21 12334578899999988765 48899999999999999999999997655433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=262.91 Aligned_cols=196 Identities=27% Similarity=0.421 Sum_probs=155.4
Q ss_pred eeccCCceEEEEEEEccCCcEEEEEEeecCCCCh-HHHHHHHHHH---HHHHhcCCCceeeeeceEeeccCceEEEEEee
Q 018936 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREI---LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~E~---~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
.||+|+||.||++++..+++.||+|.+....... ........|. ..++...||||+.+++++... ...++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 4899999999999998899999999987654321 1112233343 344456899999999888764 468999999
Q ss_pred cccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCC
Q 018936 199 MEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 278 (348)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 278 (348)
+.++.+........ .+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~~g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 79 MNGGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 98765544433222 35556688899999999999999999999999999999999999999999997654322
Q ss_pred CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 279 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.....|+..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 2334689999999998755458899999999999999999999997763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.23 Aligned_cols=215 Identities=40% Similarity=0.673 Sum_probs=172.0
Q ss_pred CCcee-eeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChH------------HHHHHHHHHHHHHhcCCCceeeeec
Q 018936 116 DSFEK-IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE------------SVKFMAREILILRRLDHPNVIKLEG 182 (348)
Q Consensus 116 ~~y~~-~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~------------~~~~~~~E~~~l~~l~hpniv~l~~ 182 (348)
++|.. .+.||.|+||+||+|++..+++.||+|.++....... ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56764 4779999999999999988999999999875433210 0124668999999999999999999
Q ss_pred eEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEE
Q 018936 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 183 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 262 (348)
++... ...+++|||+++.+...+... . .++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++
T Consensus 88 ~~~~~--~~~~lv~e~~~~~l~~~l~~~-~-----~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEG--DFINLVMDIMASDLKKVVDRK-I-----RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecC--CcEEEEEeccccCHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 98764 568999999998777665432 1 244555888999999999999999999999999999999999999
Q ss_pred EEeeCCccccCCC-------------CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 263 IADFGLASFFDPN-------------HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 263 l~DFGla~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
|+|||++...... .........+++.|+|||.+.+...++.++|+||||+++|+|++|.+||.+.++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999876411 011122334688899999987655578899999999999999999999998887
Q ss_pred hHHHHHHHH
Q 018936 330 VSATFCFVL 338 (348)
Q Consensus 330 ~~~~~~~i~ 338 (348)
.+....++.
T Consensus 240 ~~~~~~i~~ 248 (335)
T PTZ00024 240 IDQLGRIFE 248 (335)
T ss_pred HHHHHHHHH
Confidence 666554443
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=265.86 Aligned_cols=213 Identities=21% Similarity=0.347 Sum_probs=167.2
Q ss_pred CCceeeeeeccCCceEEEEEEE-----ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|.+.+.||+|+||.||++.+ ..++..||+|.++... .....+.+.+|+++++++ +||||+++++++...
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 6899999999999999999975 2345689999886543 234456788899999999 799999999988764
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...|++|||+.+ .+...+...... .+....+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRES----FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 458999999986 444444322211 245556888999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 269 ASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 269 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
++........ ......++..|+|||.+.+.. ++.++||||+||++|+|++ |..||.+....+.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~ 256 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL 256 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH
Confidence 9866432211 112234577899999887654 8899999999999999998 99999876654444333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=265.06 Aligned_cols=211 Identities=22% Similarity=0.357 Sum_probs=165.2
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
.+|.+.+.||+|+||.||+|++. .++..+++|.+.... ....+.+.+|++++++++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG--D 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--C
Confidence 56999999999999999999753 345678999875432 33345688899999999999999999998764 4
Q ss_pred eEEEEEeecccC-hhhhhcCCCC----------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEV----------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 259 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 259 (348)
..+++|||++++ +...+..... ......+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 589999999764 4443322111 01122356666888999999999999999999999999999999999
Q ss_pred cEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 260 VLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 260 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
.++|+|||++........ .......++..|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999986543221 1122345578899999887644 8899999999999999999 999997766544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=265.06 Aligned_cols=212 Identities=26% Similarity=0.424 Sum_probs=165.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 188 (348)
.++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE- 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-
Confidence 36899999999999999999987543 37899999875432 33455688899999999 899999999988764
Q ss_pred CceEEEEEeecccC-hhhhhcCCC----------CcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC
Q 018936 189 SCSLYLVFHYMEHD-LAGLAASPE----------VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD 257 (348)
Q Consensus 189 ~~~~~lv~e~~~~~-l~~~~~~~~----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~ 257 (348)
...+++|||+.++ +...+.... .......+....+..++.||+.||.|||+.+|+||||||+||+++.
T Consensus 89 -~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 89 -GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 4589999999764 433332211 0012235666678889999999999999999999999999999999
Q ss_pred CCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 258 DGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 258 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
++.+||+|||+++........ ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999999876432211 11222346779999987664 48899999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.12 Aligned_cols=210 Identities=24% Similarity=0.369 Sum_probs=164.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh-cCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR-LDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++.+-+..||.|+||+|++..++.+|+..|||.++..+...+ ..++..|.+...+ -+.||||+++|.+-.++. .|+
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWi 140 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWI 140 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eee
Confidence 567788899999999999999999999999999998776444 4456667766554 589999999998877544 789
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
.||.|+.++..++..-. ......+++..+-.+..-.+.||+||.+. .|||||+||+|||++..|.+||+|||++-.+.
T Consensus 141 CMELMd~SlDklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eHHHHhhhHHHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99999988776654311 11111233333444555678999999965 89999999999999999999999999998774
Q ss_pred CCCCCCcccccccCcccccccccCcc-cCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
.+. ..+...|-..|||||.+.... .|+.+||+||||++|||+.||+.||++=+..-
T Consensus 220 ~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf 276 (361)
T KOG1006|consen 220 DSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF 276 (361)
T ss_pred HHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH
Confidence 332 234456777799999996443 38999999999999999999999998755433
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=268.23 Aligned_cols=206 Identities=26% Similarity=0.443 Sum_probs=167.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
..|.....||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++... ...|++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEE
Confidence 346667789999999999999988999999999865432 2345677899999999999999999998773 568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||++++.+...... ..+....+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 97 ~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 97 MEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred EecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 999987555444322 12445558889999999999999999999999999999999999999999999765433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
.. ......++..|+|||++.+.. ++.++|+||||+++|+|++|+.||...+..+..
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 226 (297)
T cd06659 171 VP-KRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226 (297)
T ss_pred cc-cccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 223456789999999887644 889999999999999999999999776654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.30 Aligned_cols=211 Identities=24% Similarity=0.459 Sum_probs=165.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||.||+|++..++. .||+|.+... ........+..|+.+++.++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--Cce
Confidence 468999999999999999999876664 6999998643 2344567788999999999999999999988664 458
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+++|||++++.+....... ...++...++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 81 MIITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999875444333221 113455568889999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCc-cccc---ccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 273 DPNHKHPM-TSRV---VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 273 ~~~~~~~~-~~~~---gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
........ .... .+..|+|||.+.+. .++.++||||||+++|||++ |..||......+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~ 222 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN 222 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 43322111 1111 24579999988764 48899999999999999986 999998766554333
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=267.55 Aligned_cols=206 Identities=27% Similarity=0.463 Sum_probs=167.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+.. ....|++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEE
Confidence 45666788999999999999998899999999986433 3445668889999999999999999998876 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+..+.... .+....+..++.||+.||.|||+.+|+||||||+||+++.++.++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 98 MEFLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EeCCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 9999876554443221 2344557889999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
.. ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||.+.+..+..
T Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 227 (292)
T cd06658 172 VP-KRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227 (292)
T ss_pred cc-cCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 22345678999999988664 4889999999999999999999999876654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=261.90 Aligned_cols=204 Identities=27% Similarity=0.494 Sum_probs=167.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
..|+..+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEE
Confidence 458899999999999999999988999999999875433 3445678889999999999999999999887 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+...... . .+....+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~i~~-~-----~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 81 MEYLGGGSALDLLRA-G-----PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EecCCCCcHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999987544333322 1 2344457788999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
. .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..
T Consensus 155 ~-~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06640 155 Q-IKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPM 207 (277)
T ss_pred c-cccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChH
Confidence 2 122334678889999988764 4889999999999999999999999766543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=261.42 Aligned_cols=214 Identities=41% Similarity=0.692 Sum_probs=171.9
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEeeccC---ce
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTSRMS---CS 191 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~---~~ 191 (348)
|++.+.||+|+||.||+|++..+++.||+|.++...........+.+|+.+++++ +|||++++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999988899999999976544333344566788877766 59999999999876432 34
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.+++|||+.+.+...+..... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999998877665543221 1345566888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
...... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|++||.+.++.+....+..
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence 643321 23345688899999887654 88999999999999999999999998887665555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=266.48 Aligned_cols=212 Identities=24% Similarity=0.411 Sum_probs=166.2
Q ss_pred CCceeeeeeccCCceEEEEEEEc-------cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-------LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 187 (348)
++|.+.+.||+|+||.||+|+.. .++..||+|.+... ........+.+|+.+++.+ +||||+++++++...
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 68999999999999999999742 23457999988643 2334456788899999999 899999999998774
Q ss_pred cCceEEEEEeecccC-hhhhhcCCCC----------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 188 MSCSLYLVFHYMEHD-LAGLAASPEV----------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~-l~~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
...|++|||+.++ +...+..... ......++...+..++.||+.||.|||++||+||||||+||+++
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 94 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 4589999999864 4444332110 11223566667888999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 257 DDGVLKIADFGLASFFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
.++.+||+|||+++......... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999998764332221 2223456789999988764 48899999999999999998 889998766443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=284.55 Aligned_cols=212 Identities=23% Similarity=0.359 Sum_probs=173.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccC-C--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT-G--KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-g--~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++.++.++||+|.||+|++|.+... | -.||||+++...... ..++|.+|+.+|.+|+|||+++|||++.++. +
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp---~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP---A 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch---h
Confidence 5678889999999999999987643 3 369999998776654 6788999999999999999999999998742 7
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.||||.+.. +|++.+.. . ....+....+..|+.||+.|+.||.++++|||||...|+|+-....+||+||||.+.
T Consensus 186 mMV~ELaplGSLldrLrk-a---~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK-A---KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hHHhhhcccchHHHHHhh-c---cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 899999986 45544443 1 222445555778999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCcc--cccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 272 FDPNHKHPMT--SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 272 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
+..+...... .....+.|+|||.+.-.+ ++.++|||+|||++|||+| |+.||.|......+.+|
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i 328 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI 328 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence 8766543311 223477899999887544 9999999999999999999 89999998876555443
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=265.50 Aligned_cols=203 Identities=27% Similarity=0.497 Sum_probs=166.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|+..+.||.|+||.||+|.+..++..||+|.+...... ...+.+.+|++++++++||||+++++++.. ....|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEE
Confidence 4588899999999999999998889999999998654433 345678899999999999999999999876 4468999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||++++.+...... . .+....++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~-~-----~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 81 MEYLGGGSALDLLKP-G-----PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEccCCCcHHHHhhc-C-----CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999987544433322 1 2344557888999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.. ......++..|+|||++.+. .++.++|+||||+++|||++|+.||.....
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 155 QI-KRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred ch-hhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 21 12234578889999988764 488899999999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=266.17 Aligned_cols=207 Identities=23% Similarity=0.347 Sum_probs=165.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 194 (348)
++|+..+.||+|+||.||++++..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++... ...++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEE
Confidence 5688889999999999999999999999999998765433 44556788999999996 99999999988764 45789
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+...+......... .....++...+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~e~~~~~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccCCHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999988765443321100 0112355556888999999999999975 99999999999999999999999999998654
Q ss_pred CCCCCCcccccccCcccccccccCc--ccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.... .....+++.|+|||++.+. ..++.++||||||+++|+|++|+.||....
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 160 DSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred cCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 3221 2334678899999998764 358899999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=263.46 Aligned_cols=205 Identities=26% Similarity=0.449 Sum_probs=163.1
Q ss_pred CceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCc
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 190 (348)
+|++.+.||.|+||.||++++. .+|..||+|.++.... .....+.+.+|+++++.+ +||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 4889999999999999999864 4789999999875432 223345677899999999 699999999888764 4
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
..|+++||+++..+........ .+....+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 6899999998643333322222 23445577788899999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..............++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 7654333333345678999999987642 246789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=308.72 Aligned_cols=208 Identities=30% Similarity=0.537 Sum_probs=174.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.-+++....||.|.||.||-|.+..+|...|+|.++.............+|..++..++|||+|+++|+-.++.. ++|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--v~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--VYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH--HHH
Confidence 356788899999999999999999999999999998877666667778889999999999999999999887654 889
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
.||||+++.+..+...... ..+.-.+.|..|++.|++|||++|||||||||+||+++.+|.+|++|||.|.....
T Consensus 1312 FMEyC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999998666555443322 22333667899999999999999999999999999999999999999999998865
Q ss_pred CCC---CCcccccccCcccccccccCcc--cCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 275 NHK---HPMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 275 ~~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
+.. ......+||+.|||||++.+.. +..-+.||||+||+..||+||+.||...++
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 421 2245668999999999998653 345689999999999999999999966553
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=263.04 Aligned_cols=217 Identities=24% Similarity=0.360 Sum_probs=168.0
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
.+|...++||+|+||.||+++.. .++..+|+|.+... .....+.+.+|+++++.++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence 57899999999999999999642 35678999987543 344566788999999999999999999988764 4
Q ss_pred eEEEEEeecccC-hhhhhcCCCC---------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEV---------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 260 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~ 260 (348)
..+++|||+.++ +...+..... ......+....+..++.||+.||+|||+.|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 589999999864 4333322110 111124566678889999999999999999999999999999999999
Q ss_pred EEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 261 LKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 261 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
+||+|||++......... ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 999999999765332211 112233467899999887644 8999999999999999998 999998776655544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=263.38 Aligned_cols=212 Identities=19% Similarity=0.303 Sum_probs=162.0
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||.||+|..+. .+..||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 82 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--Q 82 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--C
Confidence 789999999999999999997542 345899998764432 23344577899999999999999999988764 4
Q ss_pred eEEEEEeecccC-hhhhhcCCCCc----CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEe
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEVK----FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~D 265 (348)
..|++|||+.++ +...+...... ..........+..++.||+.||.|||+++|+||||||+||+++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 589999999864 44444321110 0012233445777899999999999999999999999999999999999999
Q ss_pred eCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 266 FGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 266 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
||+++....... .......++..|+|||.+.+. .++.++|+|||||++|||++ |..||.+.+..+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~ 229 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999986533221 111223446789999988764 48899999999999999999 789998766443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=266.28 Aligned_cols=202 Identities=25% Similarity=0.371 Sum_probs=168.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||++++..+|+.||+|++.... .....+.+.+|+++++.++||||+++++++... ..+++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEE
Confidence 68999999999999999999998899999999986543 234456788899999999999999999998874 569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++.+........ .+....+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99998765544433222 24455578899999999999997 5999999999999999999999999999875432
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.. .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||.....
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred hc---cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 21 2345678999999988764 488999999999999999999999976544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=258.15 Aligned_cols=203 Identities=33% Similarity=0.473 Sum_probs=169.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||.|++|.||+|++..+++.||+|.+...... .....+.+|++.+.+++||||+++++++... ...+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEE
Confidence 3689999999999999999999889999999998765432 4466788999999999999999999998774 569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+||+++..+........ .++...+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 78 LEYMDGGSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999544433332222 34455578899999999999999 9999999999999999999999999999987654
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 3322 2244578889999988765 48889999999999999999999997775
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=261.98 Aligned_cols=203 Identities=28% Similarity=0.541 Sum_probs=167.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeccCceEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~ 193 (348)
.|+..+.||+|+||.||+|.+..++..||+|.++... .....+.+.+|+.+++.++ |||++++++++.. ....+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 4888999999999999999998999999999986543 2334566778999999996 9999999998876 45689
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++|||+.+..+....... .+....+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999875443333221 34455578889999999999999999999999999999999999999999998775
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
..... .....|+..|+|||.+.+...++.++|+||||+++|+|++|+.||.+...
T Consensus 153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 153 QNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred CCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 44322 23446888999999887655578899999999999999999999976554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=258.31 Aligned_cols=205 Identities=25% Similarity=0.436 Sum_probs=164.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||++.+ ..+..+|+|.+... ....+.+.+|+++++.++|+||+++++++.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYII 78 (260)
T ss_pred cceeEEeEecCccceEEEEEEe-cCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEE
Confidence 6899999999999999999985 45677999987643 2335668889999999999999999988865 347999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ .+...+..... .......+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999975 55555443211 1334455778899999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
..........++..|+|||++.+. .++.++|+||||+++|+|++ |+.||.+.+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~ 212 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 212 (260)
T ss_pred CCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 322222233456779999988764 48889999999999999999 9999988665443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=266.13 Aligned_cols=217 Identities=25% Similarity=0.410 Sum_probs=166.8
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 187 (348)
++|.+.+.||+|+||.||++++.. ++..+|+|.+.... .......+.+|+++++.+ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 679999999999999999998543 23579999987543 233455677899999999 899999999998774
Q ss_pred cCceEEEEEeeccc-ChhhhhcCCCC----------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 188 MSCSLYLVFHYMEH-DLAGLAASPEV----------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
...|++|||+.+ .+...+..... ......++...+..++.|++.||+|||+.|++||||||+||+++
T Consensus 97 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 97 --GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 458999999986 44444432211 11233466677888999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 257 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
.++.+||+|||++......... ......++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+... +..+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~ 252 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELF 252 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHH
Confidence 9999999999999865432111 11122335679999988764 48899999999999999998 8999976553 3444
Q ss_pred HHH
Q 018936 335 CFV 337 (348)
Q Consensus 335 ~~i 337 (348)
..+
T Consensus 253 ~~~ 255 (307)
T cd05098 253 KLL 255 (307)
T ss_pred HHH
Confidence 333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=258.28 Aligned_cols=199 Identities=23% Similarity=0.331 Sum_probs=156.1
Q ss_pred eeccCCceEEEEEEEc--cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecc
Q 018936 123 KIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME 200 (348)
Q Consensus 123 ~LG~G~~g~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~ 200 (348)
.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999999764 345679999886543 34445678899999999999999999998754 35799999998
Q ss_pred cChhh-hhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 201 HDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 201 ~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
++.+. .+..... .++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 78 ~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 78 GGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 65444 3332222 34555688899999999999999999999999999999999999999999998664332211
Q ss_pred c--ccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 280 M--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 280 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
. ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+....+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 206 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206 (257)
T ss_pred eccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 1 112235689999987754 38889999999999999996 999998766543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=258.80 Aligned_cols=205 Identities=26% Similarity=0.389 Sum_probs=163.5
Q ss_pred eeeccCCceEEEEEEEcc-CC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEee
Q 018936 122 DKIGQGTYSNVYKAKDML-TG--KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~-~g--~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
+.||+|++|.||+|.+.. ++ ..||+|.+...... ...+.+.+|++++++++||||+++++++.. ...++++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 468999999999998755 33 36999998766544 556778899999999999999999998876 568999999
Q ss_pred ccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 199 MEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 199 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
+++ .+...+..... ..+....++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 77 APLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred cCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 975 45544433221 2345566888999999999999999999999999999999999999999999987754222
Q ss_pred C--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018936 278 H--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335 (348)
Q Consensus 278 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~ 335 (348)
. ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||...+..+....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 212 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212 (257)
T ss_pred ceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 1 112234678899999876644 8899999999999999999 9999987766554433
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=263.82 Aligned_cols=210 Identities=30% Similarity=0.505 Sum_probs=172.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
+.|...++||+|+||.||+|++..+|..||+|.+..... .......+.+|+++++.++|||++++++++.+. ...|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEE
Confidence 457888899999999999999989999999999876543 334445678899999999999999999998874 56899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|||+.+.+...+..... .+....+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 v~e~~~~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 99 VMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 999998877766654332 244455778899999999999999999999999999999999999999999865322
Q ss_pred CCCCCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.....++..|+|||.+.+ ...++.++|+||||+++|+|++|.+||...+.......+.
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 233 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 234567889999998742 2347889999999999999999999998776655555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=265.52 Aligned_cols=211 Identities=25% Similarity=0.412 Sum_probs=164.4
Q ss_pred CCceeeeeeccCCceEEEEEEEc-------cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-------LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 187 (348)
++|.+.+.||+|+||.||+|++. .+...+|+|.++... .......+.+|+++++.+ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 68999999999999999999753 234579999886443 334456688899999999 699999999988764
Q ss_pred cCceEEEEEeecccC-hhhhhcCCC----------CcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 188 MSCSLYLVFHYMEHD-LAGLAASPE----------VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~-l~~~~~~~~----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
...|++|||+.++ +...+.... .......+....+..++.||+.||.|||++|++||||||+|||++
T Consensus 91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 4589999999864 444433211 111233466667888999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 257 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
.++.+||+|||+++........ ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999876432211 11122235679999988764 48899999999999999999 89999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=284.83 Aligned_cols=199 Identities=31% Similarity=0.500 Sum_probs=164.2
Q ss_pred eeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccC
Q 018936 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
+||+|.||+||-|++..+....|||.+.... ....+-+..|+...+.|+|.|||+++|.+.. +.++-+.||-++|+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 6999999999999999999999999986433 3445668889999999999999999999866 45677889988875
Q ss_pred hh-hhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC-CCCcEEEEeeCCccccCCCCCCCc
Q 018936 203 LA-GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPM 280 (348)
Q Consensus 203 l~-~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~ 280 (348)
.+ .++....+.+.. .+.++-.|.+||+.||.|||++.|||||||-+|+||+ -.|.+||+|||.++.+..- ...+
T Consensus 658 SLSsLLrskWGPlKD---NEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~T 733 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKD---NESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCT 733 (1226)
T ss_pred cHHHHHHhccCCCcc---chhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Cccc
Confidence 44 444444444422 2334777899999999999999999999999999997 5689999999999987533 3345
Q ss_pred ccccccCccccccccc-CcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 281 TSRVVTLWYRPPELLL-GATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 281 ~~~~gt~~y~aPE~~~-~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.++.||.-|||||++. |...|+.++|||||||++.||.||+|||.....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 6778999999999985 455699999999999999999999999965443
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=262.08 Aligned_cols=198 Identities=29% Similarity=0.463 Sum_probs=159.8
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccC
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
||+|+||+||+|.+..+|+.||+|.+...... ......+.+|+++++.++||||+++++++... ...|++|||+++.
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCCC
Confidence 69999999999999899999999998764432 22344566799999999999999999988764 4689999999864
Q ss_pred hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCccc
Q 018936 203 LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282 (348)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 282 (348)
.+......... ..++...+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... .....
T Consensus 79 ~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 79 DLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred cHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 44333222111 23455668888999999999999999999999999999999999999999999866432 12234
Q ss_pred ccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
..++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.....
T Consensus 154 ~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 154 RAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred ccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 45688899999887655 88899999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=260.52 Aligned_cols=206 Identities=27% Similarity=0.423 Sum_probs=164.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
.+|++.+.||+|+||+||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cc
Confidence 679999999999999999999776665 68999876543 34455678889999999999999999998876 45
Q ss_pred EEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.++++||+.++ +...+..... .++...+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 89999999764 4444433222 24455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCc-ccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 271 FFDPNHKHPM-TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 271 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
.......... ....++..|+|||.+... .++.++|+||||+++|||++ |+.||.+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 219 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 7753322111 112235679999987653 48899999999999999999 999998866443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=263.03 Aligned_cols=209 Identities=22% Similarity=0.345 Sum_probs=162.1
Q ss_pred CceeeeeeccCCceEEEEEEEcc-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
+|++.+.||+|+||.||+|++.. ....+|+|.+.... .....+.+.+|+++++.++||||+++++.+... ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CC
Confidence 47889999999999999998643 23578888876443 334456788899999999999999999988764 44
Q ss_pred EEEEEeecccChhhhhcCCCC-------------------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 018936 192 LYLVFHYMEHDLAGLAASPEV-------------------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSN 252 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~N 252 (348)
.++++||+.++.+..+..... ......+....+..++.|++.||.|||+.+|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 899999998644433322110 0111235566788899999999999999999999999999
Q ss_pred EEECCCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCCh
Q 018936 253 LLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329 (348)
Q Consensus 253 Ill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~ 329 (348)
||+++++.+||+|||+++........ ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999865332211 11223456789999988764 48899999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=261.99 Aligned_cols=209 Identities=26% Similarity=0.476 Sum_probs=166.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec----cCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR----MSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~----~~~ 190 (348)
+.|++.+.||.|+||.||+|++..+++.||+|.+.... .....+..|+.+++++ +||||+++++++... ...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 67999999999999999999999999999999986432 3345677899999998 799999999988542 245
Q ss_pred eEEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
..|++|||++++ +......... ..+....+..++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 789999999874 4444332111 12334457778999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
........ ......+++.|+|||.+.. ...++.++|+|||||++|+|++|.+||........
T Consensus 169 ~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 169 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred hhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 86543221 2234567899999998752 23478899999999999999999999976554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=264.53 Aligned_cols=212 Identities=23% Similarity=0.350 Sum_probs=163.8
Q ss_pred CCceeeeeeccCCceEEEEEEEcc----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceee
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML----------------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK 179 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~----------------~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 179 (348)
++|++.+.||+|+||.||++++.. ++..||+|.++... .......+.+|+++++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 34579999986442 3444567888999999999999999
Q ss_pred eeceEeeccCceEEEEEeeccc-ChhhhhcCCCCc-----CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 018936 180 LEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVK-----FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNL 253 (348)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI 253 (348)
+++++... ...+++|||+.+ .+...+...... .....++...+..++.||+.||+|||+.|++||||||+||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99998774 458999999986 444443322111 1112355566888999999999999999999999999999
Q ss_pred EECCCCcEEEEeeCCccccCCCCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh--CCCCCCCCChh
Q 018936 254 LIDDDGVLKIADFGLASFFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--GKPIMPGRTEV 330 (348)
Q Consensus 254 ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt--G~~pf~~~~~~ 330 (348)
|++.++.++|+|||+++.+....... .....+++.|+|||...+.. ++.++|+|||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998654332111 12233467899999876644 8999999999999999998 77899766544
Q ss_pred H
Q 018936 331 S 331 (348)
Q Consensus 331 ~ 331 (348)
+
T Consensus 241 ~ 241 (296)
T cd05095 241 Q 241 (296)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=256.10 Aligned_cols=202 Identities=26% Similarity=0.403 Sum_probs=159.1
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeeccc
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 201 (348)
+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+++++.++||||+++++++... ...+++|||+++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECCCC
Confidence 3699999999999985 578899999876443 334455688899999999999999999998764 458999999986
Q ss_pred Chh-hhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCc
Q 018936 202 DLA-GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280 (348)
Q Consensus 202 ~l~-~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 280 (348)
+.+ ........ .+....+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...........
T Consensus 77 ~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 77 GDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccC
Confidence 544 33332221 234455778899999999999999999999999999999999999999999976543322222
Q ss_pred ccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
....++..|+|||++.+. .++.++|+||||+++|+|++ |..||.+.+.....
T Consensus 152 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~ 204 (250)
T cd05085 152 GLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR 204 (250)
T ss_pred CCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 223346779999988654 48889999999999999998 99999877654433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=259.38 Aligned_cols=209 Identities=22% Similarity=0.375 Sum_probs=165.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---Cc
Confidence 5799999999999999999986543 3478999875432 345566788999999999999999999988653 36
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|++|||+.++ +...+..... .+....+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeee
Confidence 8999999864 4444432211 345556788899999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
.............++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 219 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219 (270)
T ss_pred cccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 644322222223345679999987654 48899999999999999996 999998877655443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=261.52 Aligned_cols=213 Identities=47% Similarity=0.827 Sum_probs=176.2
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEe
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 197 (348)
|+..+.||+|+||.||+|++..+++.||+|.+..........+.+.+|+.+++.++|||++++++++... ...++++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 6678899999999999999988999999999976543344455677899999999999999999998774 56999999
Q ss_pred ecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
|+++++...+..... .+....+..++.|++.||.|||+.||+||||+|+||++++++.++|+|||++........
T Consensus 79 ~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 79 YCDMDLKKYLDKRPG-----PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred CcCcCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 999877776654322 344555888999999999999999999999999999999999999999999987643322
Q ss_pred CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
......++..|+|||.+.+...++.++|+||||+++|||++|++||.+.+..+....+..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 223344577899999887654588999999999999999999999998887666555543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=261.16 Aligned_cols=213 Identities=21% Similarity=0.296 Sum_probs=167.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEcc----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDML----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.. .......+.+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 3789999999999999999999765 258899998753 33455567788899999999999999999987654 34
Q ss_pred eEEEEEeecccC-hhhhhcCCCCc--CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEVK--FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
..+++++|+.++ +...+...... .....+....+..++.||+.||+|||+.+++||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 578999998754 44433221110 011345666688899999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 268 LASFFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 268 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
+++.+.....+. .....++..|+|||++.+.. ++.++||||||+++|++++ |+.||...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 226 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPF 226 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHH
Confidence 998664332211 12234567799999887644 8899999999999999999 99999876543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=257.57 Aligned_cols=198 Identities=22% Similarity=0.350 Sum_probs=157.5
Q ss_pred eeeccCCceEEEEEEEccCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEee
Q 018936 122 DKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
++||+|+||.||+|....++ ..+|+|.+...... ...+.+.+|+++++.++||||+++++++.. ...+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 47999999999999765544 78999998765443 445678889999999999999999998753 347999999
Q ss_pred ccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 199 MEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 199 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
+.+ .+...+... . .+.+..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~-~-----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 77 APLGPLLKYLKKR-R-----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCCcHHHHHHhC-C-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 976 455444332 2 344555888999999999999999999999999999999999999999999987654332
Q ss_pred CCccc--ccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 278 HPMTS--RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 278 ~~~~~--~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
..... ..++..|+|||.+.+.. ++.++|+||||+++|+|++ |.+||...+..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred ccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 21111 12245799999887644 8999999999999999998 99999876654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=254.32 Aligned_cols=212 Identities=34% Similarity=0.580 Sum_probs=176.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|++|.||++++..+++.||+|.+..........+.+.+|++++++++|||++++++++... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 48899999999999999999888999999999987766556677899999999999999999999988763 5689999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
+|+++..+........ .++...+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 79 EYAENGSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred ecCCCCcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9998754443332222 34555578899999999999999999999999999999999999999999998775443
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.. .....++..|+|||...+.. ++.++|+||+|+++|+|++|+.||...+.....+++.
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 22 23446788999999877654 7889999999999999999999998777655555543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=263.85 Aligned_cols=212 Identities=23% Similarity=0.350 Sum_probs=163.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccC--------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeee
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT--------------GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~--------------g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 181 (348)
++|++.+.||+|+||.||++++..+ ...||+|.++... .....+.+.+|++++++++|||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 6799999999999999999986432 2358999986543 344566788999999999999999999
Q ss_pred ceEeeccCceEEEEEeecccC-hhhhhcCCCC------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q 018936 182 GLVTSRMSCSLYLVFHYMEHD-LAGLAASPEV------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLL 254 (348)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIl 254 (348)
+++... ...+++|||+.+. +...+..... ......+....+..++.|++.||.|||+.|++||||||+||+
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 998764 4589999999864 4333322110 001123455567888999999999999999999999999999
Q ss_pred ECCCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh--CCCCCCCCChhH
Q 018936 255 IDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--GKPIMPGRTEVS 331 (348)
Q Consensus 255 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt--G~~pf~~~~~~~ 331 (348)
+++++.+||+|||++........ .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999986533221 1122234467899999887644 8999999999999999998 678887766543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=260.06 Aligned_cols=212 Identities=38% Similarity=0.684 Sum_probs=173.6
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
|++.+.||+|++|+||+|+...+++.||||.+....... ......+|+..+++++ ||||+++++++.. ....+++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 678899999999999999988889999999986543322 2233456899999999 9999999999877 45689999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+++.+...+.... ...+....+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 78 EYMEGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred ecCCCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 999877776665433 1234555688899999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
. .....++..|+|||.+.+...++.++|+||||+++|+|++|++||++.+..+..+.+..
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~ 213 (283)
T cd07830 154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213 (283)
T ss_pred C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH
Confidence 2 23446788899999886655578999999999999999999999999887776665543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=263.79 Aligned_cols=203 Identities=23% Similarity=0.377 Sum_probs=161.9
Q ss_pred CCceeeeeeccCCceEEEEEEE----ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKD----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
..|++++.||+|+||.||+++. ..++..||+|.++... .....+.+.+|+++++.++||||+++.+++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4589999999999999999973 4568899999986543 3344567889999999999999999999987765567
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.+++|||+++..+..+..... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 899999997654443322211 1345555788999999999999999999999999999999999999999999987
Q ss_pred cCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 272 FDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 272 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
+...... ......++..|+|||.+.+. .++.++|+||||+++|+|++++.|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCC
Confidence 6433211 11233456779999988764 4889999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=258.73 Aligned_cols=213 Identities=21% Similarity=0.324 Sum_probs=163.6
Q ss_pred ceeeeeeccCCceEEEEEEEcc---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC----c
Q 018936 118 FEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----C 190 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 190 (348)
|.+.+.||+|+||.||+|.... ++..||||.+..........+.+.+|+++++.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5678899999999999998543 57899999997665555567778899999999999999999998765321 2
Q ss_pred eEEEEEeecccChh-hhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 191 SLYLVFHYMEHDLA-GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 191 ~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
..+++++|+.++.+ ..+...........++...+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 34788888875443 33322111111123455667889999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 270 SFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 270 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
+........ ......+++.|++||.+.+. .++.++||||||+++|+|++ |++||.+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence 876432211 11223346779999987764 37889999999999999999 899998766543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=256.09 Aligned_cols=207 Identities=29% Similarity=0.460 Sum_probs=165.9
Q ss_pred eeeccCCceEEEEEEEccC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEee
Q 018936 122 DKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|++.++.++|+||+++++++.. ....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 4699999999999998765 8899999987654333 46778899999999999999999999887 4568999999
Q ss_pred ccc-ChhhhhcCCCCc---CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 199 MEH-DLAGLAASPEVK---FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 199 ~~~-~l~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+.+ .+...+...... .....+++..++.++.|++.||+|||+++++||||||+||+++.++.++|+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 965 555544332100 0123456666889999999999999999999999999999999999999999999987754
Q ss_pred CCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 275 NHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 275 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
... .......+++.|+|||.+.+. .++.++|+||+|+++|+|++ |+.||......+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 216 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 321 122344568889999988765 48899999999999999999 6999988755433
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=267.24 Aligned_cols=212 Identities=25% Similarity=0.409 Sum_probs=165.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT-------GKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 187 (348)
.+|++.+.||+|+||.||+|++... +..||+|.++.. ......+.+.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 5799999999999999999986432 237899987643 3334466788899999999 899999999998764
Q ss_pred cCceEEEEEeecccC-hhhhhcCCC----------CcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 188 MSCSLYLVFHYMEHD-LAGLAASPE----------VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~-l~~~~~~~~----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
...++++||+.++ +...+.... ....+..+....+..++.||+.||.|||++||+||||||+|||++
T Consensus 91 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 91 --GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 4589999999864 444433211 012334566667888999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 257 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
.++.+||+|||+++........ ......++..|+|||++.+.. ++.++||||||+++|||++ |..||.+.+..+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999876432211 112223356799999887644 8899999999999999998 899998866444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.19 Aligned_cols=210 Identities=29% Similarity=0.436 Sum_probs=162.7
Q ss_pred eeeeeeccCCceEEEEEEEc----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 119 EKIDKIGQGTYSNVYKAKDM----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++.+.||.|.||.||+|... ..+..|+||.++. ....+..+.+.+|++.+++++||||++++|++... ...++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc--ccccc
Confidence 46789999999999999976 3467899999854 33445577889999999999999999999999853 34899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
|+||+.+ .+...+... ....++...+..++.||+.||.|||+.+++|+||+++||+++.++.+||+|||++....
T Consensus 79 v~e~~~~g~L~~~L~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSK----NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEE--TTEBHHHHHHHT----CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccccc----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999985 555555443 11234555688899999999999999999999999999999999999999999998773
Q ss_pred CCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 274 PNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 274 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
.... ...........|+|||.+.+.. ++.++||||||+++|||++ |+.||.+.+..+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~ 218 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL 218 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred ccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence 2211 1122234577899999887654 8999999999999999999 78999888665544444
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=262.96 Aligned_cols=203 Identities=29% Similarity=0.516 Sum_probs=166.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++... ...|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVG--DELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEEEE
Confidence 689999999999999999999888999999999864432 2345678899999999999999999998774 458999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
+||++++.+..+.... .+....+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 95 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999875444333221 2334457788999999999999999999999999999999999999999998766433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..
T Consensus 169 ~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~ 221 (293)
T cd06647 169 QS-KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (293)
T ss_pred cc-ccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 22 12334678889999988664 4888999999999999999999999776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=267.14 Aligned_cols=212 Identities=23% Similarity=0.343 Sum_probs=164.4
Q ss_pred eeeccC--CceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G--~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
..||+| +||+||++++..+|+.||+|++..........+.+.+|+.+++.++||||++++++|... ...++++||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEecc
Confidence 456776 999999999999999999999887665556677889999999999999999999999874 4589999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
.++.+..+..... ...++...+..++.||+.||+|||+.||+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 8644333322211 1134555578899999999999999999999999999999999999999998654332111100
Q ss_pred ------cccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 280 ------MTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 280 ------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.....++..|+|||++.+. ..++.++|+|||||++|+|++|+.||.+....+.....+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 224 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK 224 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc
Confidence 0112245679999998653 3478899999999999999999999988776655544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=262.66 Aligned_cols=223 Identities=37% Similarity=0.580 Sum_probs=182.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC---ce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS---CS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~ 191 (348)
..+.+..+.||.|+||+||-+++..+|+.||+|++..-.-.-...+.+.+|+.+|...+|.|++..+++..-... ..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 346777899999999999999999999999999875432233345567789999999999999998876543221 12
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|++.|.|..++........ .++...++.++.||+.||.|||+.+|.||||||.|.|++.|..+||+|||+|+.
T Consensus 132 iYV~TELmQSDLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHHhhhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccc
Confidence 57788888877776654432 344445888999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
........++..+.|..|.|||.++|...|+.++||||.||++.||+-.+..|..-+..+++.. |.+.+.-|
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l-ItdLLGTP 277 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM-IIDLLGTP 277 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH-HHHHhCCC
Confidence 7766666677778899999999999998899999999999999999999999988887766554 44555444
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=258.08 Aligned_cols=205 Identities=28% Similarity=0.497 Sum_probs=167.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+-|+..+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEE
Confidence 348889999999999999999888999999998865433 2345678889999999999999999999877 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+....... .+....+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 81 MEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEeCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 9999875444433221 2345557889999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
.. ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+...
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 208 (277)
T cd06641 155 QI-KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMK 208 (277)
T ss_pred hh-hhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHH
Confidence 21 12334678889999988654 47889999999999999999999997765443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=259.45 Aligned_cols=200 Identities=29% Similarity=0.448 Sum_probs=166.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|+..+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+++++.++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEE
Confidence 358889999999999999999988999999999876543 34556788899999999999999999988774 569999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||+++ .+...+..... .++...+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 78 MEYMDGGSLDKILKEVQG-----RIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEecCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999995 55444433222 34455577899999999999999 999999999999999999999999999987664
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
.... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 153 ~~~~---~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 153 NSLA---KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HHHh---hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 3222 125678899999988765 4889999999999999999999999665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=255.60 Aligned_cols=208 Identities=27% Similarity=0.504 Sum_probs=168.8
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|+||.||++.+..+|..||+|.+..........+.+.+|+++++.++||||+++++.+.. ....++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4889999999999999999999999999999987755444456678889999999999999999998876 45689999
Q ss_pred eeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-cEEEEeeCCccccCC
Q 018936 197 HYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDP 274 (348)
Q Consensus 197 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~ 274 (348)
||+.+ .+...+..... ..+.+..+..++.|++.||.|||+.+++|+||||+||++++++ .++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 79 EYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred ecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99976 44444332111 1245556888999999999999999999999999999999886 469999999987653
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
... ......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+.
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 210 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL 210 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 322 223345788999999877644 88999999999999999999999987654433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=256.02 Aligned_cols=195 Identities=28% Similarity=0.430 Sum_probs=160.9
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccC
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
||.|+||.||+|++..+++.||+|.+..... .....+.+.+|+++++.++||||+++++.+.+. ...|+++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCCC
Confidence 7999999999999988899999999976543 334456788999999999999999999988764 4589999999864
Q ss_pred hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCccc
Q 018936 203 LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282 (348)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 282 (348)
.+........ .++...+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 79 ~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 79 ELWTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred cHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 4433332222 24445577889999999999999999999999999999999999999999998765432 1233
Q ss_pred ccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 283 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||....
T Consensus 152 ~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 4678899999987654 48899999999999999999999997766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=255.12 Aligned_cols=204 Identities=24% Similarity=0.436 Sum_probs=162.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
.+|++.+.||+|+||.||++.+. ++..+|+|.+...... .+.+.+|+++++.++|||++++++++... ...+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEE
Confidence 57999999999999999999864 5778999988654433 34577899999999999999999988764 458999
Q ss_pred EeecccChhhhhcC-CCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAAS-PEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.++.+..... ... .+....++.++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99998754443332 222 234445788899999999999999999999999999999999999999999986543
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
..........++..|+|||.+.+. .++.++|+||||+++|||++ |+.||......+
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209 (256)
T ss_pred CcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 222112223346789999988764 48889999999999999998 999997766443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=262.84 Aligned_cols=204 Identities=24% Similarity=0.390 Sum_probs=161.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|+..+.||+|+||.||+|++..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---C
Confidence 679999999999999999999877776 47888875433 333344678899999999999999999988653 3
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++++|+.+ .+......... .+....+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred ceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 5788999985 45554433221 23444577889999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCCh
Q 018936 271 FFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329 (348)
Q Consensus 271 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~ 329 (348)
........ ......++..|+|||.+.+.. ++.++||||||+++|||++ |..||.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 76433221 122234567899999887644 8899999999999999997 9999977653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=258.67 Aligned_cols=212 Identities=21% Similarity=0.391 Sum_probs=165.8
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||.||+|+.+. +.+.||+|.+.... .....+.+.+|++++++++||||+++++++.+. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--E 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--C
Confidence 579999999999999999998653 34689999875432 233466788899999999999999999988763 4
Q ss_pred eEEEEEeeccc-ChhhhhcCCCCcC---CcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEee
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEVKF---TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DF 266 (348)
..+++|||+++ .+...+....... ....+....+..++.||+.||.|||+.+|+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 58999999986 4444443222110 1113556668889999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
|++...............++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~ 226 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence 998765332222233445677899999887643 7889999999999999999 888997665543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=259.59 Aligned_cols=212 Identities=35% Similarity=0.519 Sum_probs=172.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 193 (348)
++|++.+.||+|+||.||++++..+|+.||+|++..... .....+.+.+|++++++++ ||||+++++++.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 369999999999999999999988999999999876443 3344567788999999998 9999999998876 34689
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++||++++ ++...+... . .++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~l~~~-~-----~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 79 FVLEYAPNGELLQYIRKY-G-----SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EEEcCCCCCcHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999955 554444332 2 3455558889999999999999999999999999999999999999999999876
Q ss_pred CCCCC-------------------CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 273 DPNHK-------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 273 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
..... .......++..|+|||.+.+.. ++.++|+||||+++|++++|+.||...++....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 231 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 54322 1122345688999999877643 888999999999999999999999887754443
Q ss_pred HHH
Q 018936 334 FCF 336 (348)
Q Consensus 334 ~~~ 336 (348)
..+
T Consensus 232 ~~~ 234 (280)
T cd05581 232 QKI 234 (280)
T ss_pred HHH
Confidence 333
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=255.49 Aligned_cols=203 Identities=31% Similarity=0.400 Sum_probs=159.1
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHH-HhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILIL-RRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.||.|+||.||+|.+..+|+.||+|.++..... ......+..|..++ ...+|||++++++++.. ....|+++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5699999999999999889999999998755432 22223344455444 44589999999999876 45699999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCC
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 279 (348)
+++.+..+..... .++...+..++.||+.||.|||+.+++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 80 NGGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 8755444433222 234445778999999999999999999999999999999999999999999876432
Q ss_pred cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 280 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 206 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206 (260)
T ss_pred cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 12345788899999987754 8899999999999999999999998776654444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=257.54 Aligned_cols=204 Identities=28% Similarity=0.413 Sum_probs=156.2
Q ss_pred eeeccCCceEEEEEEEccCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEEEEee
Q 018936 122 DKIGQGTYSNVYKAKDMLTGK--IVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
+.||+|+||.||+|++..++. .+|+|.++.. ......+.+.+|+++++++ +||||+++++++... ...|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEe
Confidence 368999999999999877775 4688877532 2334456788899999999 899999999998774 458999999
Q ss_pred ccc-ChhhhhcCCCC----------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 199 MEH-DLAGLAASPEV----------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 199 ~~~-~l~~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
+.+ .+...+..... ......+....+..++.|++.||+|||+.|++||||||+||++++++.+||+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 976 44444332210 0011235566688899999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
++........ ......+..|+|||++.+. .++.++|+||||+++|||++ |..||.+.+..+
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~ 219 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHH
Confidence 9864321111 1112235679999987654 48899999999999999997 999997765443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=255.63 Aligned_cols=199 Identities=24% Similarity=0.413 Sum_probs=159.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.+++.++|+|++++++++... ....|++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEE
Confidence 6799999999999999999974 58889999886432 245678899999999999999999876543 3458999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+||+++ .+...+..... ..+....+..++.||+.||+|||++|++||||||+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999986 45554433221 1244455778899999999999999999999999999999999999999999986533
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
.. ....++..|+|||++.+. .++.++||||||+++|+|++ |+.||...+..
T Consensus 155 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~ 206 (256)
T cd05082 155 TQ----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred cC----CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 22 223345679999987654 48899999999999999998 99999775543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=255.43 Aligned_cols=207 Identities=28% Similarity=0.499 Sum_probs=171.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|+||.||++++..+++.+|+|.+............+.+|+++++.++||||+++.+++... ...|+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 48899999999999999999989999999999987665555667778899999999999999999988774 5689999
Q ss_pred eecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 197 HYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 197 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||+++. +...+.... .....+....+..++.|++.||+|||+.|++|+||+|+||++++++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 79 EYAPFGDLSKAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hhcCCCCHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999764 433332211 11123455568889999999999999999999999999999999999999999999877543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
. .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred C---cccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 2234578899999988764 48889999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=255.72 Aligned_cols=213 Identities=19% Similarity=0.279 Sum_probs=157.8
Q ss_pred eeeccCCceEEEEEEEccC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLT--GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
++||+|+||+||+++...+ ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+... ...|++|||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEecC
Confidence 3699999999999975332 23566776654332 33456788899999999999999999998764 4589999999
Q ss_pred ccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC-CC
Q 018936 200 EHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN-HK 277 (348)
Q Consensus 200 ~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~-~~ 277 (348)
+++ +...+...... ........++.++.||+.||+|||+.+++||||||+|||++.++.++|+|||++...... ..
T Consensus 78 ~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 78 ELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 864 44444322111 112344457788999999999999999999999999999999999999999998643211 11
Q ss_pred CCcccccccCcccccccccCc------ccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 018936 278 HPMTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~ 339 (348)
.......++..|+|||++... ..++.++||||||+++|||++ |.+||...++.+....++..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 224 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh
Confidence 122344678899999987431 235679999999999999997 67899877766655555444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=263.15 Aligned_cols=208 Identities=29% Similarity=0.531 Sum_probs=170.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
+.|+..+.||+|+||.||+|++..++..+|+|.+..... .......+.+|+++++.++|||++++++++... ...++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEE
Confidence 568889999999999999999988999999999875432 334455677899999999999999999998774 56899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+.+.+......... .+....+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 93 VMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEccCCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 999998877665543322 234555788899999999999999999999999999999999999999999986643
Q ss_pred CCCCCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
. ....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 225 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH
Confidence 2 23457888999998752 23478899999999999999999999977655444443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=260.51 Aligned_cols=212 Identities=25% Similarity=0.443 Sum_probs=165.6
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--~ 81 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG--K 81 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--C
Confidence 68999999999999999999864 257899999986433 334456788899999999999999999988764 4
Q ss_pred eEEEEEeeccc-ChhhhhcCCCC----------------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEV----------------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNL 253 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~----------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI 253 (348)
..+++|||+++ .+...+..... ......+....+..++.||+.||.|||+.+++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 58999999986 44444432111 01112355666888999999999999999999999999999
Q ss_pred EECCCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 254 LIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 254 ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
+++.++.++|+|||++........ ........+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999886533221 111222346679999988764 48999999999999999998 888997665433
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=254.54 Aligned_cols=205 Identities=29% Similarity=0.453 Sum_probs=161.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.+.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+++++.++|+||+++++++.. ....+++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEE
Confidence 45556678999999999999988899999999886543 3345678899999999999999999999876 4568999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-CCcEEEEeeCCccccC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFD 273 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~ 273 (348)
+||+.+. +...+....... ......+..++.||+.||+|||+.||+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPL---KDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccC---CCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999864 444443221111 1133446778999999999999999999999999999986 6799999999998664
Q ss_pred CCCCCCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.... ......+++.|+|||.+.+. ..++.++|+||||+++|+|++|++||....
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 3222 12334578899999987542 337889999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=254.00 Aligned_cols=207 Identities=28% Similarity=0.455 Sum_probs=164.9
Q ss_pred ceeeeeeccCCceEEEEEEEccCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
|++.+.||.|+||.||++++..++ ..||+|.++.... ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeE
Confidence 456789999999999999987766 8999999865433 22566788899999999999999999988774 4689
Q ss_pred EEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|||+.++ +...+...... .+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++...
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999864 44443322111 1555668889999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
............+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |++||...+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~ 213 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV 213 (258)
T ss_pred ccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 5432221112236788999998855 348899999999999999998 8999987655443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=256.61 Aligned_cols=203 Identities=23% Similarity=0.309 Sum_probs=161.4
Q ss_pred CCCceee-eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh-cCCCceeeeeceEeec--cCc
Q 018936 115 ADSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR-LDHPNVIKLEGLVTSR--MSC 190 (348)
Q Consensus 115 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~--~~~ 190 (348)
+++|++. ++||-|-.|+|..+.++.+|+.+|+|++... ..-++|++..-. -.|||||+++++|++. ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4677776 5799999999999999999999999998522 234467776544 4799999999998653 344
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---CCcEEEEeeC
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFG 267 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kl~DFG 267 (348)
.+.+|||.|+|+.+.......+. ..+.+..+..+++||..|+.|||+.+|.||||||+|+|.+. |..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 57899999998654443332222 23455558889999999999999999999999999999974 4579999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
+|+..... ....+.+.|+.|.|||++-. ..|+...|+||+||++|-|++|.+||...+..
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ 269 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence 99987543 23567788999999997654 45999999999999999999999999765543
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=253.57 Aligned_cols=198 Identities=26% Similarity=0.428 Sum_probs=162.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||.|+||.||+|.. .|+.||+|.++.... ..+.+.+|+.+++.++|+||+++++++.. ....+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEE
Confidence 6799999999999999999984 588999999865432 45678889999999999999999999876 4568999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ .+...+..... ..+.+..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999986 55554433221 1345556888999999999999999999999999999999999999999999987632
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCCh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~ 329 (348)
.. .....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+.
T Consensus 155 ~~----~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 155 GQ----DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred cc----ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 22 123346679999988754 48889999999999999997 9999977654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=251.87 Aligned_cols=200 Identities=26% Similarity=0.420 Sum_probs=158.4
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeeccc
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~ 201 (348)
++||.|+||.||++.+.. ++.||+|.+...... .....+.+|+++++.++||||+++++++... ...+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence 469999999999999766 999999998755433 4556788899999999999999999988764 458999999976
Q ss_pred C-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCc
Q 018936 202 D-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280 (348)
Q Consensus 202 ~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 280 (348)
. +...+..... .+....+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++...........
T Consensus 77 ~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 77 GSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence 4 4444332222 234445777899999999999999999999999999999999999999999986542221111
Q ss_pred -ccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 281 -TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 281 -~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
.....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||.......
T Consensus 152 ~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~ 203 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203 (251)
T ss_pred cccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHH
Confidence 112235679999988764 48899999999999999999 899997766543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=248.67 Aligned_cols=206 Identities=34% Similarity=0.592 Sum_probs=170.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|+..+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+++++.++|||++++++.+... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence 48889999999999999999888899999999875443 3566788899999999999999999988774 5589999
Q ss_pred eeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 197 HYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 197 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||+++ .+...+.... ..+....+..++.|++.||.+||+.|++||||+|+||++++++.++|+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 77 EFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred ecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99995 4444443322 23455557889999999999999999999999999999999999999999999877543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
.. .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+...
T Consensus 152 ~~--~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 207 (253)
T cd05122 152 KA--RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207 (253)
T ss_pred cc--ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 32 34456788999999887644 7889999999999999999999998775444333
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=255.34 Aligned_cols=194 Identities=19% Similarity=0.271 Sum_probs=151.4
Q ss_pred eeeccCCceEEEEEEEccC------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 122 DKIGQGTYSNVYKAKDMLT------------GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~------------g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
+.||+|+||.||+|+...+ ...||+|.+.... ......+.+|+.+++.++||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 3689999999999974322 2358888865432 33455677899999999999999999998764
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc-------EE
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV-------LK 262 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~-------~k 262 (348)
...+++|||++++.+........ ..+....+..++.||+.||+|||+.+|+||||||+|||++.++. ++
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 45789999999766554443211 12444557889999999999999999999999999999987664 89
Q ss_pred EEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHH-hCCCCCCCCC
Q 018936 263 IADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL-AGKPIMPGRT 328 (348)
Q Consensus 263 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell-tG~~pf~~~~ 328 (348)
++|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|+.||.+..
T Consensus 153 l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 153 LSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred eCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999998755322 23456788999998865556889999999999999998 5899987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=250.59 Aligned_cols=208 Identities=29% Similarity=0.514 Sum_probs=172.7
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|++.+.||+|+||.||++.+..+++.||+|.+............+.+|+++++.++|||++++.+.+... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 48899999999999999999988999999999987666556677788999999999999999999988764 6689999
Q ss_pred eeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 197 HYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 197 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|++++ .+...+..... ....++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 79 EYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99986 44444433210 1124556668889999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
. .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||...+..
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 209 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLL 209 (258)
T ss_pred c-ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence 2 1223446788999999877644 888999999999999999999999776543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=254.31 Aligned_cols=204 Identities=32% Similarity=0.456 Sum_probs=163.1
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccC
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
||.|+||.||++++..+|+.||+|.+..... .....+.+.+|++++++++||||+++++.+.. ....|+++||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999988899999999876543 23456678889999999999999999988876 45689999999864
Q ss_pred hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC-----
Q 018936 203 LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK----- 277 (348)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~----- 277 (348)
.+........ .++...+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 79 DLASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 4333322211 344555888999999999999999999999999999999999999999999876533211
Q ss_pred --CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 278 --HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 278 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
.......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 212 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN 212 (265)
T ss_pred ccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1223345688899999887654 78899999999999999999999987665444333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=258.10 Aligned_cols=203 Identities=25% Similarity=0.385 Sum_probs=163.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||+|.+..+++.||||.++...... ....+..|+.++.++ .||||+++++++... ...|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEE
Confidence 478999999999999999999998889999999997654333 334455577766666 599999999999774 4599
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|||+++.+......... .++...+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++..+
T Consensus 91 ~v~e~~~~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELMSTCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeeccCcCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9999998766655543222 34445577899999999999997 59999999999999999999999999999866
Q ss_pred CCCCCCCcccccccCcccccccccCc---ccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGA---TDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
..... .....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 43222 2333567889999988643 23778999999999999999999999663
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.19 Aligned_cols=148 Identities=26% Similarity=0.422 Sum_probs=124.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.++||+|+||.||+|++..+++.||||+++.... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 3689999999999999999999988999999999976543 44456778889999999999999999988766 45699
Q ss_pred EEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 194 LVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
+||||+.++ +..++. ... .+....++.++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~-~~~-----~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLH-IYG-----YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHH-hcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999764 444432 222 23344578899999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=255.75 Aligned_cols=204 Identities=27% Similarity=0.477 Sum_probs=165.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
.|...+.||+|++|.||++.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 4666789999999999999988899999999886432 2334567889999999999999999998876 45689999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+.+..+...... . .+....+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~-~-----~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 96 EFLEGGALTDIVTH-T-----RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred eccCCCCHHHHHHh-C-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99976444433322 1 23445578899999999999999999999999999999999999999999987654322
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~ 223 (285)
T cd06648 170 P-RRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223 (285)
T ss_pred c-ccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 1 12334678999999988764 488999999999999999999999977654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=253.44 Aligned_cols=199 Identities=24% Similarity=0.479 Sum_probs=160.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||++. .+++.||+|.++... ..+.+.+|+.+++.++|||++++++++... ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEE
Confidence 579999999999999999986 578899999986432 235678899999999999999999988653 36899
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+.+ .+...+..... ..+....+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 77 MELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred EECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 999986 55555433221 1344555778899999999999999999999999999999999999999999976532
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
. ......+..|+|||.+.+. .++.++|+||||+++|+|++ |++||...+..+.
T Consensus 153 ~----~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 206 (254)
T cd05083 153 G----VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV 206 (254)
T ss_pred c----CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence 2 1222335679999988654 48899999999999999998 9999987765443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=281.69 Aligned_cols=220 Identities=22% Similarity=0.399 Sum_probs=181.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
+...+.++||.|-||.|++|+.+..| ..||||.++... .+.+..+|..|+.||.+.+||||++|.|++.... .+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~--Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK--PV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc--ee
Confidence 56788999999999999999988766 479999997554 4445666888999999999999999999998744 48
Q ss_pred EEEEeecccChhh-hhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.++.|||+.+.++ ++...++ ++..+++..+++.|+.|+.||-+.++|||||.+.|||++.+-.+|++||||++.
T Consensus 706 MIiTEyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 9999999975554 4444444 455566888999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCcccccc--cCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhccCC
Q 018936 272 FDPNHKHPMTSRVV--TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 272 ~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
+..+.....++.-| ...|.|||.+.-++ ++.++||||+|++|||.++ |..||...++.+-...|-...=++|
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence 86555333344333 67899999987544 9999999999999999887 9999999999877666655554443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=255.59 Aligned_cols=210 Identities=32% Similarity=0.563 Sum_probs=171.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.+.|+..+.||+|++|.||+|.+..++..||+|.+..... ..+.+.+|+++++.++|+|++++++++... ...|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEE
Confidence 3679999999999999999999888899999999876543 455677899999999999999999998874 56899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++||+++ .+...+.... ..+....+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999995 5554444322 134445578889999999999999999999999999999999999999999987654
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
.... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+
T Consensus 168 ~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~ 228 (286)
T cd06614 168 KEKS-KRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228 (286)
T ss_pred cchh-hhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3221 12334568889999988764 4889999999999999999999999876655444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=259.64 Aligned_cols=210 Identities=23% Similarity=0.297 Sum_probs=160.5
Q ss_pred eeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
+.+.+|.| |.||.+++..+++.||+|++..........+.+.+|+++++.++||||+++++++... ...+++|||+
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~ 81 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLM 81 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEecc
Confidence 33344444 5556666567999999999987655566677899999999999999999999998774 4589999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC--
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-- 277 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-- 277 (348)
+++.+..+...... ..++...+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 87544433322111 1244555778899999999999999999999999999999999999999999876532211
Q ss_pred ----CCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 278 ----HPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 278 ----~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
.......++..|+|||++.+. ..++.++|+|||||++|+|++|+.||............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~ 222 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111233457789999988653 34788999999999999999999999887665544433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=255.70 Aligned_cols=195 Identities=21% Similarity=0.289 Sum_probs=151.0
Q ss_pred eeccCCceEEEEEEEccC------------------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCcee
Q 018936 123 KIGQGTYSNVYKAKDMLT------------------------GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178 (348)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~------------------------g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv 178 (348)
.||+|+||.||+|....+ ...||+|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974322 2358889875432 23345677899999999999999
Q ss_pred eeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC
Q 018936 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 258 (348)
Q Consensus 179 ~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~ 258 (348)
++++++... ...++||||++++.+........ ..++...+..++.||+.||+|||+.+|+||||||+|||++..
T Consensus 80 ~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeC--CceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence 999998774 45899999999876655443211 123444477889999999999999999999999999999764
Q ss_pred C-------cEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHH-hCCCCCCCCChh
Q 018936 259 G-------VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL-AGKPIMPGRTEV 330 (348)
Q Consensus 259 ~-------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell-tG~~pf~~~~~~ 330 (348)
+ .+|++|||++...... ....++..|+|||.+.+...++.++|+||||+++|||+ +|+.||.+.+..
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred CcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 4 3899999998644221 22356778999998876555889999999999999995 699999776543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=252.15 Aligned_cols=201 Identities=26% Similarity=0.394 Sum_probs=152.2
Q ss_pred eeeccCCceEEEEEEEcc---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEee
Q 018936 122 DKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
+.||+|+||.||+|.+.. ++..||+|.+... ......+.+.+|+.+++.++||||+++++++... ....++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 468999999999998643 3457999987532 2334466788899999999999999999977543 3357899999
Q ss_pred cccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 199 MEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 199 ~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
+.++ +...+...... .....+..++.||+.||+|||+.+++||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 79 MKHGDLRNFIRSETHN-----PTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCCHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9864 44443322211 22233667889999999999999999999999999999999999999999986532211
Q ss_pred ---CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 278 ---HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 278 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
.......++..|+|||.+.+. .++.++||||||+++|||++ |.+||...+..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~ 209 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF 209 (262)
T ss_pred eeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 111223456789999988764 48899999999999999999 57778765543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=248.23 Aligned_cols=206 Identities=32% Similarity=0.548 Sum_probs=170.8
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+|+..+.||+|++|.||+|.+..++..|++|.+..........+.+.+|++++++++||||+++++.+........++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47889999999999999999988999999999877665556677889999999999999999999988775336789999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+++..+........ .+....+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9996544433332222 34455578899999999999999999999999999999999999999999998775443
Q ss_pred CC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 277 KH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 277 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.. ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 123346788999999887644 8889999999999999999999997765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=256.97 Aligned_cols=205 Identities=25% Similarity=0.417 Sum_probs=164.9
Q ss_pred CCceeeeeeccCCceEEEEEEEc----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
.+|++.+.||+|+||.||+|+.. .++..||+|.+...... ...+.+.+|+++++.++||||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 56889999999999999999854 34789999998755433 35667889999999999999999999987766667
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++|||+++ .+...+..... .+....+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 8999999976 44444432221 34555578899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCC--cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 271 FFDPNHKHP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 271 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
......... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccc
Confidence 775322211 1122345669999988765 4889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=253.08 Aligned_cols=192 Identities=22% Similarity=0.320 Sum_probs=152.6
Q ss_pred eeeccCCceEEEEEEEccCC----------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 122 DKIGQGTYSNVYKAKDMLTG----------KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g----------~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
+.||+|+||.||+|.+..++ ..+++|.+..... ....+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 46999999999999987666 3578887654321 15667889999999999999999998876 23
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-------cEEEE
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-------VLKIA 264 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-------~~kl~ 264 (348)
.+++|||+.++.+......... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeC
Confidence 6899999987655444332221 344455778899999999999999999999999999999887 79999
Q ss_pred eeCCccccCCCCCCCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 018936 265 DFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLA-GKPIMPGRT 328 (348)
Q Consensus 265 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~ 328 (348)
|||++..... .....++..|+|||++.+. ..++.++|+||||+++|+|++ |..||...+
T Consensus 151 Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 151 DPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred CCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 9999986543 1233456779999998765 358889999999999999999 688886664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=252.82 Aligned_cols=193 Identities=28% Similarity=0.425 Sum_probs=153.7
Q ss_pred CCceeeeee--ccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKI--GQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~L--G~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
+.|++.+.+ |+|+||.||++++..++..+|+|.+........ |+.....+ +||||+++++.+... ...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~--~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTL--KGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecC--Cee
Confidence 456676666 999999999999999999999999875433221 22222222 799999999998774 469
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-cEEEEeeCCcc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLAS 270 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kl~DFGla~ 270 (348)
|+||||+++ .+...+... . .+.+..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE-G-----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999976 454444332 2 344555888999999999999999999999999999999988 99999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
..... ....++..|+|||++.+.. ++.++|+||+|+++|+|++|+.||....+
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 66422 2335788999999887644 88999999999999999999999976544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=270.52 Aligned_cols=207 Identities=25% Similarity=0.356 Sum_probs=168.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+...+.++||+|-||.|.+++ ...+..||+|+++.... ......|.+|+.+|.+|+||||++++|+|..+.. ++++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP--icmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP--LCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc--hHHH
Confidence 568889999999999999998 35579999999976543 3446778899999999999999999999988655 8999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|||+. ++..++....... ........++.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+-.
T Consensus 614 ~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence 999986 4545544332221 11222455899999999999999999999999999999999999999999997655
Q ss_pred CCCCCc-ccccccCcccccccccCcccCCccccHHHHHHHHHHHHh--CCCCCCCCChhH
Q 018936 275 NHKHPM-TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA--GKPIMPGRTEVS 331 (348)
Q Consensus 275 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt--G~~pf~~~~~~~ 331 (348)
+..+.. ...+....|||||.++-.+ ++.++|+|+||+++||+++ ...||...++.+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 544433 3445688999999987644 9999999999999999764 789998877643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=266.77 Aligned_cols=206 Identities=27% Similarity=0.447 Sum_probs=170.6
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh-----HHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
.++|-++..||+|||+.||+|.+....+.||+|+-..+..+. ...+...+|..|.+.|+||-||+++++|.-+ .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-t 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-T 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-c
Confidence 467999999999999999999999999999999876554332 2344566799999999999999999999775 3
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCCEEECC---CCcEEEE
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN--GVLHRDIKGSNLLIDD---DGVLKIA 264 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~NIll~~---~~~~kl~ 264 (348)
..++-|+||+++..++++..+... +++..++.++.||+.||.||.+. .|||-||||.|||+.. -|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 458899999999888888776654 44455999999999999999987 6999999999999953 4789999
Q ss_pred eeCCccccCCCCCC------CcccccccCccccccccc-C--cccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 265 DFGLASFFDPNHKH------PMTSRVVTLWYRPPELLL-G--ATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 265 DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~-~--~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
||||++.++..... -+....||.||++||.+. + -+..+.++||||+||++|+++.|+.||-.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 99999998643222 234457899999999875 3 24467899999999999999999999943
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=255.51 Aligned_cols=203 Identities=26% Similarity=0.461 Sum_probs=161.3
Q ss_pred CceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCc
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 190 (348)
+|++.+.||+|+||.||++++. .++..||+|.++.... .....+.+.+|++++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4889999999999999999853 4678999999875432 223345677899999999 69999999988876 45
Q ss_pred eEEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
..++||||+.++ +...+. ... .+....++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~-~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 79 KLHLILDYVNGGELFTHLY-QRE-----HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEEEecCCCCcHHHHHh-hcC-----CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 689999999864 443332 222 2444557888999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccCcc-cCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
...............++..|+|||.+.+.. .++.++|+||||+++|+|++|..||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 876443322223346788999999876532 3678999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=256.15 Aligned_cols=201 Identities=27% Similarity=0.461 Sum_probs=163.9
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEe
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 197 (348)
|....+||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....+++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEe
Confidence 444578999999999999998999999999875432 3345668889999999999999999999877 456999999
Q ss_pred ecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC
Q 018936 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277 (348)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 277 (348)
|+++..+....... .+....++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~- 170 (292)
T cd06657 98 FLEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 170 (292)
T ss_pred cCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-
Confidence 99876554443221 23445578889999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
.......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+....
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~ 222 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222 (292)
T ss_pred ccccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 122345678899999987654 4788999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=252.87 Aligned_cols=210 Identities=27% Similarity=0.487 Sum_probs=165.0
Q ss_pred CceeeeeeccCCceEEEEEEEcc-CCcEEEEEEeecCC--------CChHHHHHHHHHHHHHHh-cCCCceeeeeceEee
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDN--------LEPESVKFMAREILILRR-LDHPNVIKLEGLVTS 186 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~-~g~~vAvK~i~~~~--------~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 186 (348)
+|++.+.||+|+||.||+|++.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38889999999999999999877 67899999886432 122344556778888875 799999999999876
Q ss_pred ccCceEEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEE
Q 018936 187 RMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIA 264 (348)
Q Consensus 187 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~ 264 (348)
....+++|||+++. +...+... ......++...++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSL--KEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHH--HhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence 45689999999864 43333210 0111234555688899999999999996 689999999999999999999999
Q ss_pred eeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 265 DFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 265 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
|||++....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|++||.........
T Consensus 157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~ 222 (269)
T cd08528 157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222 (269)
T ss_pred cccceeeccccc--ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHH
Confidence 999998764432 234556788999999887644 889999999999999999999999776544433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=253.99 Aligned_cols=195 Identities=18% Similarity=0.268 Sum_probs=151.5
Q ss_pred eeeccCCceEEEEEEEccCCc-------EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 122 DKIGQGTYSNVYKAKDMLTGK-------IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~-------~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
+.||+|+||.||+|.+..++. .||+|.+.... ....+.+..|+.+++.++||||+++++++... ...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEE
Confidence 369999999999998765443 48888875332 33455677899999999999999999998774 34789
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc--------EEEEee
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--------LKIADF 266 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--------~kl~DF 266 (348)
+|||++++.+......... .+....+..++.||+.||+|||+.||+||||||+||+++.++. ++++||
T Consensus 77 v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEecCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999987544443322211 2344447778999999999999999999999999999987765 699999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCCCh
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTE 329 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~~~ 329 (348)
|++...... ....+++.|+|||.+.+...++.++|+||||+++|+|++| .+||...+.
T Consensus 153 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 153 GISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred ccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 998755321 2345688899999987655578899999999999999998 567665544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=253.17 Aligned_cols=208 Identities=25% Similarity=0.416 Sum_probs=159.7
Q ss_pred eeeccCCceEEEEEEEccCC------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 122 DKIGQGTYSNVYKAKDMLTG------KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g------~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.||+|+||.||+|++.... ..+|+|.+.... .......+.+|+++++.++||||+++++++... ...+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEEE
Confidence 36999999999999875443 689999876432 223455677899999999999999999998764 458999
Q ss_pred Eeeccc-ChhhhhcCCCC-cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-----cEEEEeeCC
Q 018936 196 FHYMEH-DLAGLAASPEV-KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGL 268 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-----~~kl~DFGl 268 (348)
|||+++ .+...+..... ......+....+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999986 44444432211 11222345566788999999999999999999999999999999877 899999999
Q ss_pred ccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 269 ASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 269 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
+........ .......++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||+..++.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~ 223 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH
Confidence 976532211 1122334567899999887644 8999999999999999998 99999877655433
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=269.68 Aligned_cols=203 Identities=26% Similarity=0.445 Sum_probs=170.8
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC--C----hHHHHHHHHHHHHHHhcC---CCceeeeece
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--E----PESVKFMAREILILRRLD---HPNVIKLEGL 183 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~--~----~~~~~~~~~E~~~l~~l~---hpniv~l~~~ 183 (348)
....+|..++.||.|+||.|++|.++.+...|+||.+.++.. + ....-.+-.|+.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 334679999999999999999999999999999999987654 1 111223446999999997 9999999999
Q ss_pred EeeccCceEEEEEeeccc--ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcE
Q 018936 184 VTSRMSCSLYLVFHYMEH--DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 261 (348)
Q Consensus 184 ~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~ 261 (348)
|++ +.++||+||.-.. +|+++.... +.+.+...+.+++|++.|+++||++||||||||-+|+.++.+|-+
T Consensus 638 FEd--dd~yyl~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~ 709 (772)
T KOG1152|consen 638 FED--DDYYYLETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFV 709 (772)
T ss_pred eec--CCeeEEEecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeE
Confidence 998 4569999998765 344444322 245555688899999999999999999999999999999999999
Q ss_pred EEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 262 KIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 262 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
||+|||.|.....+. ...++||.+|.|||++.|..+.+..-|||++|++||.++....||.+
T Consensus 710 klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999998876544 46788999999999999888788899999999999999999999854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=268.98 Aligned_cols=198 Identities=26% Similarity=0.430 Sum_probs=163.7
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
..+.|.+...+|.|+|+.|-.+.+..+++..++|++..... +-.+|+.++... +||||+++.+.+.+ ....
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYED--GKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecC--Ccee
Confidence 35789999999999999999999999999999999976521 223467666655 89999999999987 4569
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE-CCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI-DDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll-~~~~~~kl~DFGla~~ 271 (348)
|+|||.+.+..+........ .+. ..+..|++||+.|+.|||++|+|||||||+|||+ +..++++|+|||.++.
T Consensus 392 ~~v~e~l~g~ell~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP-----EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeeehhccccHHHHHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999999865544433221 222 3467799999999999999999999999999999 6899999999999998
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
.... ..+.+.|..|.|||++.. ..|++++||||||++||+|++|+.||......
T Consensus 466 ~~~~----~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 466 LERS----CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred Cchh----hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 7654 344567899999998874 56999999999999999999999999776654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=256.27 Aligned_cols=216 Identities=26% Similarity=0.463 Sum_probs=176.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--Cc----eeeeeceEeecc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PN----VIKLEGLVTSRM 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h--pn----iv~l~~~~~~~~ 188 (348)
.++|.+++.||+|.||.|-.+.+..++..||||+++.-. ...+.-.-|+++|+++.+ |+ +|++.++|..+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr- 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR- 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc-
Confidence 478999999999999999999999999999999986432 334445569999999932 22 78888888774
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-----------
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD----------- 257 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~----------- 257 (348)
.+.++|+|.++.++.+++..... ..++...++.+.+|++.++++||+.+++|-||||+|||+..
T Consensus 164 -ghiCivfellG~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 -GHICIVFELLGLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred -CceEEEEeccChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 45999999999888888875432 25566669999999999999999999999999999999832
Q ss_pred ---------CCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 258 ---------DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 258 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
+..++|+|||.|....+.. ...+.|..|.|||++++-. ++.+.||||+||+|+|+.+|...|.+..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCC
Confidence 2368999999999765443 4567799999999999865 9999999999999999999999999999
Q ss_pred hhHHHHHHHHHhccCCcC
Q 018936 329 EVSATFCFVLNLIFDPFV 346 (348)
Q Consensus 329 ~~~~~~~~i~~~~~~p~~ 346 (348)
+.+.+ .++.. +.+|+.
T Consensus 314 n~EHL-aMMer-IlGp~P 329 (415)
T KOG0671|consen 314 NLEHL-AMMER-ILGPIP 329 (415)
T ss_pred cHHHH-HHHHH-hhCCCc
Confidence 88777 44433 333654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=244.30 Aligned_cols=203 Identities=31% Similarity=0.507 Sum_probs=164.4
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeeccc-
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH- 201 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~- 201 (348)
||+|+||.||++.+..+++.||+|.+..... .....+.+.+|+++++.++||||+++++.+.. ....+++|||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 7999999999999888899999999876644 23356678889999999999999999988876 4568999999954
Q ss_pred ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcc
Q 018936 202 DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 281 (348)
Q Consensus 202 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 281 (348)
.+...+... . .+....+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 79 ~L~~~l~~~-~-----~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 151 (250)
T cd05123 79 ELFSHLSKE-G-----RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTN 151 (250)
T ss_pred cHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-Cccc
Confidence 554444322 1 23445578889999999999999999999999999999999999999999998764432 1234
Q ss_pred cccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 282 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
...++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 205 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205 (250)
T ss_pred CCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 456788899999887644 788999999999999999999999777653333333
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=270.62 Aligned_cols=220 Identities=29% Similarity=0.477 Sum_probs=183.6
Q ss_pred cCCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec---
Q 018936 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR--- 187 (348)
Q Consensus 112 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--- 187 (348)
+...+-|++.+.||.|.||.||+++++.+|+..|+|++.... +..+.+..|.++|+.+ .|||++.++|+|...
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 344578999999999999999999999999999999987654 3344566689999887 799999999998643
Q ss_pred cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
....+|||||||.++....+..... ...+.+..+..++..++.||.+||...++|||||-.|||++.++.+||+|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 3567999999999865555443332 3355666688899999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCc----ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
++..++.. .....+..||+.|||||++... ..|+..+|+||||++..||.-|.+|+-....+..+|+|..
T Consensus 169 vSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR 242 (953)
T KOG0587|consen 169 VSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 242 (953)
T ss_pred eeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC
Confidence 99988644 4446777899999999998532 3467799999999999999999999999998888877643
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=264.27 Aligned_cols=205 Identities=23% Similarity=0.390 Sum_probs=165.2
Q ss_pred CceeeeeeccCCceEEEEEEEcc--CC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDML--TG--KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~--~g--~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
...+.+.||.|.||.||+|.-.. .| --||||..+.+. ..+..+.|..|.-+|+.++||||++++|+|.+.. .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P---~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP---M 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc---e
Confidence 34455789999999999997432 22 368999886544 4455788999999999999999999999998753 8
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+|||.+..+.+..+...+. ..++..+...|+.||..||.|||+.++|||||...|||+...-.+||+||||++.+
T Consensus 466 WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999998655544443322 24555557779999999999999999999999999999999999999999999998
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChh
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~ 330 (348)
........+.......|||||.+.-+. ++.++|||.|||++||+++ |..||.+..+.
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred cccchhhccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 755444444444578899999876443 8999999999999999987 99999886654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=263.44 Aligned_cols=212 Identities=22% Similarity=0.413 Sum_probs=175.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
+.....+||-|.||.||.|.++.-.-.||||.++-+. -..+.|..|..+|+.++|||+|+|+|+|..+.. +||+.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP--FYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP--FYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC--eEEEE
Confidence 4777899999999999999999888999999986443 346788899999999999999999999998655 99999
Q ss_pred eeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 197 HYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 197 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||.. .|++++..-+.. .....-+..++.||..|++||..+++|||||...|.|+.++..+|++||||++++..+
T Consensus 343 EfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99985 566666543221 3344446778899999999999999999999999999999999999999999999766
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~ 339 (348)
...........+.|.|||-+.- ..++.|+|||+|||+|||+.| |-.||+|.+ .++.+-.+.+
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGid-lSqVY~LLEk 481 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYGLLEK 481 (1157)
T ss_pred ceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHhc
Confidence 5433333344778999997753 448889999999999999998 999999965 5666665554
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=243.45 Aligned_cols=213 Identities=27% Similarity=0.420 Sum_probs=163.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecC---CCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD---NLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
+|.+.+.||+|+||.||++++..++..+++|.++.. .........+..|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceE
Confidence 488999999999999999998877777777765432 22333344566799999999999999999988764 4589
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+++||+.+..+....... ......+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++....
T Consensus 79 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 79 IITEYCEGRDLDCKLEEL-KHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEEEeCCCCCHHHHHHHH-hhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999875444332211 011124555668889999999999999999999999999999975 579999999998764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
.... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+....+...+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~ 216 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR 216 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 3321 12334578889999988654 478899999999999999999999977655443333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=259.14 Aligned_cols=222 Identities=33% Similarity=0.543 Sum_probs=184.0
Q ss_pred chhhhhhhccccCcccCCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---
Q 018936 97 PWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD--- 173 (348)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~--- 173 (348)
.||....|+.++ ++|.+....|+|-|++|..|.+...|+.||||+|+.+.. ..+.=+.|+++|++|.
T Consensus 420 GYYrv~igE~LD-------~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD 489 (752)
T KOG0670|consen 420 GYYRVRIGELLD-------SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDAD 489 (752)
T ss_pred ceEEEehhhhhc-------ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccC
Confidence 477777888877 689999999999999999999999999999999986543 3344557999999995
Q ss_pred ---CCceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 018936 174 ---HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKG 250 (348)
Q Consensus 174 ---hpniv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp 250 (348)
--++++|+-.|.. ..++|||||.+...|...+....... .+....++.|+.|++.||..|..+||+|.||||
T Consensus 490 ~Edk~Hclrl~r~F~h--knHLClVFE~LslNLRevLKKyG~nv---GL~ikaVRsYaqQLflALklLK~c~vlHaDIKP 564 (752)
T KOG0670|consen 490 PEDKFHCLRLFRHFKH--KNHLCLVFEPLSLNLREVLKKYGRNV---GLHIKAVRSYAQQLFLALKLLKKCGVLHADIKP 564 (752)
T ss_pred chhhhHHHHHHHHhhh--cceeEEEehhhhchHHHHHHHhCccc---ceeehHHHHHHHHHHHHHHHHHhcCeeecccCc
Confidence 3578888777766 45699999999888877775433222 233445899999999999999999999999999
Q ss_pred CCEEECCCC-cEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 251 SNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 251 ~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
+|||+++.. .+||||||.|.....+. .+++..+..|.|||+++|.+ |+...|+||+||+||||.||+..|+|.++
T Consensus 565 DNiLVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 565 DNILVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cceEeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCc
Confidence 999999664 68999999998875443 46666777899999999965 99999999999999999999999999998
Q ss_pred hHHHHHHH
Q 018936 330 VSATFCFV 337 (348)
Q Consensus 330 ~~~~~~~i 337 (348)
-..+.-++
T Consensus 641 N~MLrl~m 648 (752)
T KOG0670|consen 641 NQMLRLFM 648 (752)
T ss_pred HHHHHHHH
Confidence 77665544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=264.44 Aligned_cols=205 Identities=24% Similarity=0.308 Sum_probs=141.5
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccC----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEe----
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLT----GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVT---- 185 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---- 185 (348)
..++|++.+.||+|+||.||+|++..+ +..||+|.+..... .+.... +.+....+.++..+...+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~--e~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMN--ERVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHH--HHHHhhchhhHHHHHHhhhcccc
Confidence 457899999999999999999999888 89999998753221 111111 1222233333333322211
Q ss_pred eccCceEEEEEeecccC-hhhhhcCCCCcC--------------CcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 018936 186 SRMSCSLYLVFHYMEHD-LAGLAASPEVKF--------------TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKG 250 (348)
Q Consensus 186 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~--------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp 250 (348)
.......+++++|++++ +...+....... .........+..++.||+.||.|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 12345689999999875 444433221110 001112334667899999999999999999999999
Q ss_pred CCEEECC-CCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcc---------------------cCCccccHH
Q 018936 251 SNLLIDD-DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT---------------------DYGVGVDLW 308 (348)
Q Consensus 251 ~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Dvw 308 (348)
+|||++. ++.+||+|||+|+.+............+++.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999985 579999999999876544444445668899999999764221 133467999
Q ss_pred HHHHHHHHHHhCCCCC
Q 018936 309 SAGCILAELLAGKPIM 324 (348)
Q Consensus 309 SlGv~l~elltG~~pf 324 (348)
||||++|||+++..++
T Consensus 364 SlGviL~el~~~~~~~ 379 (566)
T PLN03225 364 SAGLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHHHhCcCCC
Confidence 9999999999966543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=249.70 Aligned_cols=196 Identities=25% Similarity=0.386 Sum_probs=157.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeecc--Cce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR--LDHPNVIKLEGLVTSRM--SCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~--~~~ 191 (348)
...++.+.||+|.||.||+|+ .+++.||||++.. +..+.+.+|.+|.+. ++|+||++++++-.... ...
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 467888999999999999997 5679999999863 556778888888774 58999999988754322 336
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCCEEECCCCcEE
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN---------GVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---------~ivHrDikp~NIll~~~~~~k 262 (348)
++||++|.+.+.+..+...+ ..++.....++..++.||+|||+. .|+|||||..||||..|+++.
T Consensus 283 ywLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 89999999865554444333 455666888999999999999974 599999999999999999999
Q ss_pred EEeeCCccccCCCCCC-CcccccccCcccccccccCcccCC-----ccccHHHHHHHHHHHHhCCCCC
Q 018936 263 IADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYG-----VGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 263 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwSlGv~l~elltG~~pf 324 (348)
|+|||||..+.++... .+...+||..|||||++.|...+. .+.||||+|.+||||++....+
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 9999999988755432 234478999999999998765444 3689999999999999975433
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=237.94 Aligned_cols=180 Identities=27% Similarity=0.351 Sum_probs=144.6
Q ss_pred CCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccC-hhh
Q 018936 127 GTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAG 205 (348)
Q Consensus 127 G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~-l~~ 205 (348)
|.+|.||++++..+++.||+|.++... ...+|...+....||||+++++++... ...+++|||++++ +..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCHHH
Confidence 899999999999999999999987542 122355555566799999999998764 5689999999864 444
Q ss_pred hhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccc
Q 018936 206 LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285 (348)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 285 (348)
.+... . .++...+..++.|++.||+|||+.||+||||||+||+++.++.++++|||++...... .....+
T Consensus 75 ~l~~~-~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~ 144 (237)
T cd05576 75 HISKF-L-----NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAV 144 (237)
T ss_pred HHHHh-c-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCc
Confidence 43322 1 2445558889999999999999999999999999999999999999999988765432 223345
Q ss_pred cCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 286 t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
+..|+|||.+.+. .++.++|+||+|+++|+|++|+.||..
T Consensus 145 ~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 145 ENMYCAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CccccCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 6779999987654 478899999999999999999987753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=229.02 Aligned_cols=215 Identities=37% Similarity=0.574 Sum_probs=171.5
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEe
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 197 (348)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++... ...++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEe
Confidence 56788999999999999998888999999998765433 2467788899999999999999999988764 45899999
Q ss_pred eccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 198 YMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 198 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
++++ .+.......... .....+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 78 YCEGGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred ccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9988 555444332211 3445578889999999999999999999999999999999999999999998775432
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHHHh
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG-RTEVSATFCFVLNL 340 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~-~~~~~~~~~~i~~~ 340 (348)
........++..|++||.+.+...++.++|+|+||+++|+|++|+.||.. ........+.+..-
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 11223456788899999874444577899999999999999999999977 45554555555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=238.59 Aligned_cols=212 Identities=33% Similarity=0.577 Sum_probs=179.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC----ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~ 191 (348)
.+|.-++.+|.|.- .|-.+-+...+++||+|.+...........+..+|..++..+.|+||++++.+|.-+.. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57889999999999 77788888899999999876553344445566789999999999999999999865321 24
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|+|||+|..++...... .+.-.++..++.|++.|+.|||+.||+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILM--------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhhHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 799999999887766552 233445888999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.+.. -..+..+.|..|.|||++.+.. |.+.+||||+||++.||++|+..|+|.+..++..+++.-
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~ 232 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ 232 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence 6544 3467788899999999999876 999999999999999999999999999988887777643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=261.88 Aligned_cols=205 Identities=25% Similarity=0.371 Sum_probs=166.6
Q ss_pred CceeeeeeccCCceEEEEEEEccCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
..+..++||.|+||+||+|.+...|+ +||+|++.... .......+..|+-+|.+++|||+++|+|++... .+
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hH
Confidence 46677899999999999999887765 78999886544 344456678899999999999999999998763 27
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.||++||+. .|+++.......+ -......|..||++|+.|||++++|||||.+.||||....++||.|||+++.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~i-----gsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNI-----GSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccc-----cHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 889999986 5566655443333 3334788999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCccc-ccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 272 FDPNHKHPMTS-RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 272 ~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
+.......... -...+.|||-|.+.... |+.++|||||||++||++| |..|+.+....+
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 87665443222 22367799999887644 9999999999999999999 999998876543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=251.28 Aligned_cols=213 Identities=26% Similarity=0.374 Sum_probs=149.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEEc----------------cCCcEEEEEEeecCCCCh------------HHHHHHHHH
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDM----------------LTGKIVALKKVRFDNLEP------------ESVKFMARE 165 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~----------------~~g~~vAvK~i~~~~~~~------------~~~~~~~~E 165 (348)
..++|++.++||+|+||+||+|... ..++.||||.+....... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3578999999999999999999642 345689999986432110 011223346
Q ss_pred HHHHHhcCCCce-----eeeeceEeec------cCceEEEEEeecccChhhhhcCCC-Cc------------------CC
Q 018936 166 ILILRRLDHPNV-----IKLEGLVTSR------MSCSLYLVFHYMEHDLAGLAASPE-VK------------------FT 215 (348)
Q Consensus 166 ~~~l~~l~hpni-----v~l~~~~~~~------~~~~~~lv~e~~~~~l~~~~~~~~-~~------------------~~ 215 (348)
+.++.+++|.++ ++++++|... .....++|+||++++.+..+.... .. ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778877654 6677777532 123579999999875443332211 10 11
Q ss_pred cchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccc
Q 018936 216 EPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295 (348)
Q Consensus 216 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 295 (348)
...+....++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++...............+|+.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 12234455788999999999999999999999999999999999999999999976543322212223448899999987
Q ss_pred cCccc-------------------CC--ccccHHHHHHHHHHHHhCCC-CCCC
Q 018936 296 LGATD-------------------YG--VGVDLWSAGCILAELLAGKP-IMPG 326 (348)
Q Consensus 296 ~~~~~-------------------~~--~~~DvwSlGv~l~elltG~~-pf~~ 326 (348)
..... |+ .+.|+||+||++|+|++|.. ||.+
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 53210 11 24799999999999999875 7754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=276.50 Aligned_cols=187 Identities=24% Similarity=0.345 Sum_probs=150.8
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
.|...+.||+|+||.||+|++..+|..||+|.+...... ...|++.+++++|||||+++|++... ...|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEE
Confidence 466778999999999999998889999999988643211 12468899999999999999999774 4589999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH---NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||++++.+..+.. .+.+..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 763 Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 763 EYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred eCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 9998755444332 1344557889999999999999 6699999999999999999888875 77655432
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
.. ....+|+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 834 ~~-----~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 834 TD-----TKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred cC-----CCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 11 233678999999988764 489999999999999999999999853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=256.65 Aligned_cols=218 Identities=27% Similarity=0.419 Sum_probs=169.1
Q ss_pred CCceeeeeeccCCceEEEEEEEc---c----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM---L----TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~----~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 187 (348)
++.++.+.||+|.||.|++|... . ....||||.++..... ...+.+..|+++|+.+ +||||+.++|++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 44577779999999999999733 1 1457999998765544 6677889999999998 69999999999988
Q ss_pred cCceEEEEEeeccc-ChhhhhcCCC--C------cCCcc--hhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 188 MSCSLYLVFHYMEH-DLAGLAASPE--V------KFTEP--QFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~--~------~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
....+++.||+.. .+..++.... . ..... .+.......++.||+.|++||++.++|||||.+.|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 4569999999986 4555444333 0 11111 266777899999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCCCCccccc--ccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 257 DDGVLKIADFGLASFFDPNHKHPMTSRV--VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
.+..+||+|||+|+.............. -...|||||.+.. ..|+.++|||||||+||||+| |..||++....+..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 9999999999999965333222112112 3456999999887 459999999999999999999 99999986533444
Q ss_pred HHHH
Q 018936 334 FCFV 337 (348)
Q Consensus 334 ~~~i 337 (348)
+..+
T Consensus 532 ~~~l 535 (609)
T KOG0200|consen 532 LEFL 535 (609)
T ss_pred HHHH
Confidence 4433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=235.42 Aligned_cols=133 Identities=26% Similarity=0.369 Sum_probs=112.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----C---CceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-----H---PNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~~~ 187 (348)
.+|-+.++||.|-|++||+|.+..+.+.||+|+.+.. +...+.-..||++|+.++ | .+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 6899999999999999999999999999999998743 234445567999999883 3 4599999999764
Q ss_pred c--CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEE
Q 018936 188 M--SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLI 255 (348)
Q Consensus 188 ~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll 255 (348)
+ +.+++||+|+++..|+.++.....+ -++...++.|++||+.||.|||.. ||||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 3 4578999999999999888765433 455566999999999999999965 99999999999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=234.00 Aligned_cols=190 Identities=27% Similarity=0.384 Sum_probs=147.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeec--cCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR--LDHPNVIKLEGLVTSR--MSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~--~~~~ 191 (348)
.+.++.+.||+|.||.||+|+ ..|+.||||++.... .....+|.++.+. |+|+||+.+++.-... .-..
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeecc--ccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 578999999999999999997 689999999985321 2234456666664 5999999998765332 2357
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEECCCCcEE
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN--------GVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDikp~NIll~~~~~~k 262 (348)
++||.+|-+. +|.+++... .+.......++..++.||++||.. .|.|||||..|||+..++.+.
T Consensus 284 LwLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 8999999986 555555432 333444777899999999999964 499999999999999999999
Q ss_pred EEeeCCccccCCCCC---CCcccccccCcccccccccCcccC-----CccccHHHHHHHHHHHHh
Q 018936 263 IADFGLASFFDPNHK---HPMTSRVVTLWYRPPELLLGATDY-----GVGVDLWSAGCILAELLA 319 (348)
Q Consensus 263 l~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwSlGv~l~ellt 319 (348)
|+|+|||........ ......+||..|||||++...... -..+||||||.++||++.
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 999999987654432 235667999999999988643211 136899999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=219.45 Aligned_cols=198 Identities=41% Similarity=0.706 Sum_probs=160.3
Q ss_pred CceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeeccc-Chhhh
Q 018936 128 TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL 206 (348)
Q Consensus 128 ~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~-~l~~~ 206 (348)
+||.||+|.+..+|+.+|+|++........ .+.+.+|++.+++++|+||+++++++... ...++++|++++ .+...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 589999999988899999999876543322 57788999999999999999999998774 568999999998 55544
Q ss_pred hcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCccccccc
Q 018936 207 AASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286 (348)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 286 (348)
..... . +....+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... ......++
T Consensus 78 ~~~~~-~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 78 LKKRG-R-----LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred HHhcc-C-----CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 43221 1 4445578899999999999999999999999999999999999999999998775432 23445678
Q ss_pred CcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
..|++||.+.+. .++.++|+||||+++|+|++|..||....+.+.....+
T Consensus 150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~ 199 (244)
T smart00220 150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI 199 (244)
T ss_pred cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 889999988754 47889999999999999999999998744444444433
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=251.07 Aligned_cols=200 Identities=28% Similarity=0.419 Sum_probs=159.4
Q ss_pred CCceeeeeeccCCceE-EEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSN-VYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~-Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 193 (348)
.-|...+.+|.|+.|+ ||+|. ..|+.||||.+- .+..+...+|+..|+.. +|||||++ ||.++.....|
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRy--yc~E~d~qF~Y 579 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGV--YEGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRY--YCSEQDRQFLY 579 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEe--eCCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEE--EeeccCCceEE
Confidence 4567778899999885 79997 788999999875 34456678899999988 79999999 55555677899
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---C--CcEEEEeeCC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---D--GVLKIADFGL 268 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~--~~~kl~DFGl 268 (348)
+..|.|...|.++......... .......+..+.|++.||++||+.+||||||||.||||+. + ..++|+|||+
T Consensus 580 IalELC~~sL~dlie~~~~d~~--~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 580 IALELCACSLQDLIESSGLDVE--MQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred EEehHhhhhHHHHHhccccchh--hcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 9999999999888876411111 1111335667899999999999999999999999999985 3 4689999999
Q ss_pred ccccCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCC
Q 018936 269 ASFFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGR 327 (348)
Q Consensus 269 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~ 327 (348)
++.+..+... ......||-+|+|||++.... -+.++||||+||++|+.++| ..||-..
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCch
Confidence 9998765432 244567899999999987654 46699999999999999995 8999543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=243.86 Aligned_cols=219 Identities=28% Similarity=0.450 Sum_probs=185.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|+++..+|.|.||.||+++++.+++..|+|+++.... +...-+..|+-+++..+|||||.++|-+..+.. ++++
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dk--lwic 90 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK--LWIC 90 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcC--cEEE
Confidence 789999999999999999999999999999999987653 335557789999999999999999998876544 8999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+.......+ .+.+.++....++.+.||+|||+.|-+|||||-.|||+++.|.+|+.|||.+..+...
T Consensus 91 MEycgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEecCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999877766655444 4445557778899999999999999999999999999999999999999999877533
Q ss_pred CCCCcccccccCccccccccc--CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 276 HKHPMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
.....++.||+.|||||+.. ....|+..+|+|++|++..|+---++|......+..++.+-....++|
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 22356789999999999852 334589999999999999999999999988888888887766655554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=222.61 Aligned_cols=165 Identities=22% Similarity=0.249 Sum_probs=127.5
Q ss_pred CCCCceeeeeeccCCceEEEEEEEcc-CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCceee-eeceEeecc
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIK-LEGLVTSRM 188 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-~g~~vAvK~i~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~ 188 (348)
..+.|.+.+.||+|+||+||+|++.. +++.||||++..... .....+.+.+|+++|+.++|+|++. +++.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 44789999999999999999998776 678889998753311 2334667899999999999999985 4331
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCCEEECCCCcEEEEeeC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDI-KGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDi-kp~NIll~~~~~~kl~DFG 267 (348)
...|+||||+++..+.... . . . ...++.|++.||.|||+.||+|||| ||+|||++.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~~~-~-----~-~-----~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR-P-----H-G-----DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC-c-----c-c-----hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 2379999999876554221 0 0 0 1346889999999999999999999 9999999999999999999
Q ss_pred CccccCCCCCC-------CcccccccCccccccccc
Q 018936 268 LASFFDPNHKH-------PMTSRVVTLWYRPPELLL 296 (348)
Q Consensus 268 la~~~~~~~~~-------~~~~~~gt~~y~aPE~~~ 296 (348)
+|+.+...... ..+...+++.|+|||.+.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99976533211 123456788899999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=225.41 Aligned_cols=206 Identities=33% Similarity=0.529 Sum_probs=163.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEcc---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 190 (348)
.+.|..+++||.|.|++||++.+.. ....||+|.+.... ....+.+|+++|..+ .+.||+.+.+++.. +.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd 108 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN--ND 108 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc--CC
Confidence 3679999999999999999998777 67899999886543 234578899999999 68999999998877 45
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC-CCCcEEEEeeCCc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLA 269 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~kl~DFGla 269 (348)
...+|+||+++.-...+.. .+....++.|++.++.||.++|.+|||||||||+|+|.+ ..+.-.|+|||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 5999999999865544432 223344888999999999999999999999999999998 4577899999999
Q ss_pred cccCCC-------------------------------------------CCCCcccccccCcccccccccCcccCCcccc
Q 018936 270 SFFDPN-------------------------------------------HKHPMTSRVVTLWYRPPELLLGATDYGVGVD 306 (348)
Q Consensus 270 ~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 306 (348)
...+.. .......+.||++|.|||++..++.-++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 722100 0000112468999999999998888889999
Q ss_pred HHHHHHHHHHHHhCCCCC-CCCChhHHHH
Q 018936 307 LWSAGCILAELLAGKPIM-PGRTEVSATF 334 (348)
Q Consensus 307 vwSlGv~l~elltG~~pf-~~~~~~~~~~ 334 (348)
|||.||+++-+++++.|| ...++.+...
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ 289 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALA 289 (418)
T ss_pred eeeccceeehhhccccccccCccccchHH
Confidence 999999999999999887 3444444333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-26 Score=195.61 Aligned_cols=185 Identities=39% Similarity=0.656 Sum_probs=150.2
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeeccc-C
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-D 202 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~-~ 202 (348)
||.|++|.||+++...+++.+++|.+....... ..+.+.+|++.++.++|++++++++++... ...++++|++++ .
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 689999999999987779999999987554322 356788899999999999999999988764 568999999994 5
Q ss_pred hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-CCcEEEEeeCCccccCCCCCCCcc
Q 018936 203 LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKHPMT 281 (348)
Q Consensus 203 l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~ 281 (348)
+........ .......++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 78 l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 78 LKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 555443321 13444557889999999999999999999999999999999 89999999999987654321 123
Q ss_pred cccccCcccccccccCcccCCccccHHHHHHHHHHH
Q 018936 282 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317 (348)
Q Consensus 282 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el 317 (348)
...+...|++||.+.....++.++|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 345678899999886643578899999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=208.76 Aligned_cols=200 Identities=23% Similarity=0.247 Sum_probs=151.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
+.|.+.+.||+|.||.+-+++++.+...+++|.+.... ....+|.+|..---.| .|.||+.-+++.-. ....+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-TSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhh-cCceEEE
Confidence 68999999999999999999999999999999986543 4456677787655555 68999987664322 2457889
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC--CCCcEEEEeeCCcccc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFF 272 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~--~~~~~kl~DFGla~~~ 272 (348)
++||++.+.+....... .+.+...+.++.|++.|+.|+|+.++||||||.+||||- +..++||+|||+.+..
T Consensus 100 ~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999864443322221 233344677899999999999999999999999999995 3348999999998865
Q ss_pred CCCCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
+... ...-.+..|.+||.... .-...+.+|+|.||+++|.++||.+||....-
T Consensus 174 g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 174 GTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred Ccee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 4321 11223556999997642 22356789999999999999999999974333
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-25 Score=207.42 Aligned_cols=205 Identities=27% Similarity=0.298 Sum_probs=161.1
Q ss_pred CceeeeeeccCCceEEEEEEEccCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC----CceeeeeceEeeccCce
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLEPESVKFMAREILILRRLDH----PNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~~~~~~~~ 191 (348)
+|++.++||+|+||.||++.+..++ ..+|+|........... .+..|+.++..+.. +++..+++... ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 7999999999999999999986664 67899987654322211 46678888888863 57778776664 23567
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC-----CcEEEEee
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-----GVLKIADF 266 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-----~~~kl~DF 266 (348)
.|+||+.++.+|.++..... ...++..++..++.|++.+|.+||+.|++||||||+|+++... ..+.|.||
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEeccCccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 89999999999888775433 2356666688999999999999999999999999999999865 46999999
Q ss_pred CCccccC---CCC---CCC---cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 267 GLASFFD---PNH---KHP---MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 267 Gla~~~~---~~~---~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
|+++... ... ... ...+.||..|+++....+.. .+.+.|+||++.++.+++.|..||.+...
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 9998322 111 111 23356999999999888754 89999999999999999999999977663
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=189.05 Aligned_cols=205 Identities=24% Similarity=0.301 Sum_probs=161.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH-PNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~l 194 (348)
..|.++++||+|+||.+|+|....+|..||||.-+.....+ ++..|..+-+.|++ ..|+.+..+..+ ..+-.+
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvl 88 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVL 88 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccc--ccccee
Confidence 67999999999999999999999999999999765433332 45668888888865 556666655554 445789
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC---CcEEEEeeCCccc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASF 271 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~ 271 (348)
||+.++.++.+++. +++..++..++...+-|++.-++|+|.++++||||||+|+|+.-+ ..+.++|||||+.
T Consensus 89 VMdLLGPsLEdLfn-----fC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 89 VMDLLGPSLEDLFN-----FCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeccCccHHHHHH-----HHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 99999998877764 445566667788899999999999999999999999999999744 4689999999998
Q ss_pred cCCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 272 FDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 272 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
+...... ......||..|.+--...+.. -+.+.|+-|+|.+|.+..-|..||.+....+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 7533221 123446888898876665533 57789999999999999999999998765443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=203.45 Aligned_cols=215 Identities=21% Similarity=0.293 Sum_probs=167.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
.++++....+-+|.||.||.|.+... .+.|-+|.++ +...+-+...+..|.-.+..+.|||+.++.+++... .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-Y 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-c
Confidence 46789999999999999999965433 3456778774 444566778888999999999999999999988764 3
Q ss_pred ceEEEEEeecccChhhhhcC---CCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEee
Q 018936 190 CSLYLVFHYMEHDLAGLAAS---PEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DF 266 (348)
...++++.+++-+.+..+.. .............++..++.|++.|++|||++||||.||.+.|.+|++.-.+||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 45677888887544433322 111222235556667888999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCCCcccc-cccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 267 GLASFFDPNHKHPMTSR-VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
.|++.+-+...+..... --...||+||.+.... |+.++|+|||||+||||+| |+.|+-..+..+.
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 99998765544433222 1256799999988754 9999999999999999999 9999977665443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-23 Score=191.22 Aligned_cols=215 Identities=35% Similarity=0.534 Sum_probs=169.1
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChH-HHHHHHHHHHHHHhcCCC-ceeeeeceEeeccCceEEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE-SVKFMAREILILRRLDHP-NVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~~lv 195 (348)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+.+.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 778899999999999999875 7899999876654432 567788899999999988 79999998854 3347999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-cEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~ 274 (348)
++++.+..+.......... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||+++....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred EecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999875555332222100 1344455888999999999999999999999999999999988 799999999986654
Q ss_pred CCCC-----CcccccccCcccccccccCc--ccCCccccHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHHH
Q 018936 275 NHKH-----PMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTE---VSATFCFVLN 339 (348)
Q Consensus 275 ~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~elltG~~pf~~~~~---~~~~~~~i~~ 339 (348)
.... ......+|..|+|||.+.+. ..++...|+||+|++++++++|..||..... .......+..
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 3322 24566889999999998763 4588899999999999999999999877764 3444444433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=230.33 Aligned_cols=150 Identities=16% Similarity=0.206 Sum_probs=109.4
Q ss_pred hcCC-CceeeeeceEeec-----cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCce
Q 018936 171 RLDH-PNVIKLEGLVTSR-----MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVL 244 (348)
Q Consensus 171 ~l~h-pniv~l~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 244 (348)
.++| +||++++++|... ....+++++|+++.+|...+.... ..+....++.++.||+.||+|||++||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4455 5777777776211 123467889999888887775432 2355566889999999999999999999
Q ss_pred ecCCCCCCEEECCC-------------------CcEEEEeeCCccccCCCCC---------------CCcccccccCccc
Q 018936 245 HRDIKGSNLLIDDD-------------------GVLKIADFGLASFFDPNHK---------------HPMTSRVVTLWYR 290 (348)
Q Consensus 245 HrDikp~NIll~~~-------------------~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~y~ 290 (348)
||||||+||||+.. +.+|++|||+++....... ......+||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4456666666653211000 0011235788999
Q ss_pred ccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 291 aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
|||++.+.. |+.++|||||||+||||++|.+|+..
T Consensus 183 APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 183 SPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ChhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999988754 89999999999999999999998864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=187.43 Aligned_cols=201 Identities=22% Similarity=0.272 Sum_probs=160.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
-+|++.++||+|+||+.+.|++..++++||||.-....- .-++..|...-+.| ..+.|.+.+-+ .+.+-+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYF--GQEGKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeee--ccccchhhh
Confidence 369999999999999999999999999999997543322 23455577777766 56888887433 333455679
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-----cEEEEeeCCc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGLA 269 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-----~~kl~DFGla 269 (348)
|+|.++.+|.+++.. +...++..++..++.|++.-++|+|++.+|+|||||+|+||...+ .+-|+|||+|
T Consensus 102 VidLLGPSLEDLFD~-----CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDL-----CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhCcCHHHHHHH-----hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999999888776643 334566677889999999999999999999999999999997543 5899999999
Q ss_pred cccCCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 270 SFFDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 270 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
+.+...... ...+..||..||+-...+|.. -+.+.|+-|||-++++.+-|..||.|..
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 987533221 234567899999998888865 6889999999999999999999997754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=179.72 Aligned_cols=192 Identities=17% Similarity=0.144 Sum_probs=140.5
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 194 (348)
+.+...|++|+||+||++. ..+..++.+.+...... .-....+.+|+++|++|. |+++++++++ ...++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~l 75 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHL 75 (218)
T ss_pred cccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEE
Confidence 3456789999999999886 47788887777554431 112335788999999995 5889998775 22699
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDI-KGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDi-kp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|+|+.+..+..... .. ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|....
T Consensus 76 vmeyI~G~~L~~~~~------~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPP------RG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhh------hh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 999998865532210 00 1236789999999999999999999 7999999999999999999998654
Q ss_pred CCCCC----C--------cccccccCcccccccccCcccCC-ccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 274 PNHKH----P--------MTSRVVTLWYRPPELLLGATDYG-VGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 274 ~~~~~----~--------~~~~~gt~~y~aPE~~~~~~~~~-~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
..... . ..-...++.|++|+...--...+ ...+|++-|..+|.++|++.|+.+.++
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 32210 0 01123578888888653222233 567999999999999999999876554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=185.07 Aligned_cols=173 Identities=14% Similarity=0.155 Sum_probs=129.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh-HHHHH------HHHHHHHHHhcCCCceeeeeceEeecc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKF------MAREILILRRLDHPNVIKLEGLVTSRM 188 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~------~~~E~~~l~~l~hpniv~l~~~~~~~~ 188 (348)
++|+..+.||.|+||.||++.. ++..+|+|.++...... ..... +.+|++.+.++.||+|..+.+++....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 6899999999999999999754 57789999997654322 22222 578999999999999999988866432
Q ss_pred ------CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEE
Q 018936 189 ------SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 189 ------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 262 (348)
....+++|||++|..+.... ... ...+.+++.+|..||+.|++|||+||+||+++.+| ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~---------~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP----EIS---------EDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh----hcc---------HHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 23578999999985443331 111 12356999999999999999999999999999988 99
Q ss_pred EEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHH
Q 018936 263 IADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318 (348)
Q Consensus 263 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ell 318 (348)
|+|||.......... .. .+++. ..|+.++|+||||+++....
T Consensus 175 liDfg~~~~~~e~~a---~d----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKA---KD----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhh---HH----------HHHHH-hHhcccccccceeEeehHHH
Confidence 999998875532211 00 02232 33778999999999887543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=182.81 Aligned_cols=141 Identities=22% Similarity=0.234 Sum_probs=104.0
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHH------------------------HHHHHHHHHHHHhcCCCc
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES------------------------VKFMAREILILRRLDHPN 176 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~------------------------~~~~~~E~~~l~~l~hpn 176 (348)
...||+|+||.||+|.+. +|+.||||+++........ .....+|++++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999975 8999999999765321111 122345999999998877
Q ss_pred eeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCCEEE
Q 018936 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC-HNNGVLHRDIKGSNLLI 255 (348)
Q Consensus 177 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~ivHrDikp~NIll 255 (348)
+.....+... . .++||||++++.+........ .++...+..++.|++.+|.+| |+.||+||||||+|||+
T Consensus 81 v~~p~~~~~~--~--~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILLK--S--HVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEec--C--CEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 6443222111 1 389999999754322211112 344455888999999999999 79999999999999999
Q ss_pred CCCCcEEEEeeCCcccc
Q 018936 256 DDDGVLKIADFGLASFF 272 (348)
Q Consensus 256 ~~~~~~kl~DFGla~~~ 272 (348)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=176.96 Aligned_cols=142 Identities=23% Similarity=0.265 Sum_probs=106.7
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHHhcCCCc
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP------------------------ESVKFMAREILILRRLDHPN 176 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~------------------------~~~~~~~~E~~~l~~l~hpn 176 (348)
...||+|++|.||+|++. +|+.||||+++...... .....+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999975 89999999998653210 01223467899999999998
Q ss_pred eeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEE
Q 018936 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLI 255 (348)
Q Consensus 177 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll 255 (348)
+.....+... ..|+||||+++........... ..+...+..++.|++.+|.+||+ .||+||||||+|||+
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE
Confidence 7554333322 1489999998762211111111 22334477889999999999999 999999999999999
Q ss_pred CCCCcEEEEeeCCccccC
Q 018936 256 DDDGVLKIADFGLASFFD 273 (348)
Q Consensus 256 ~~~~~~kl~DFGla~~~~ 273 (348)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 8 8899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-24 Score=206.69 Aligned_cols=189 Identities=30% Similarity=0.434 Sum_probs=152.1
Q ss_pred eeccCCceEEEEEEE---ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEEEEee
Q 018936 123 KIGQGTYSNVYKAKD---MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 123 ~LG~G~~g~Vy~~~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~ 198 (348)
.+|+|+||.|++++. ...|..+|+|.+++.............|..++..++ ||.+|++.-.+..+ ...++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhh
Confidence 379999999998752 245678999998775543222224556888999887 99999998777764 458999999
Q ss_pred cccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCC
Q 018936 199 MEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 278 (348)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 278 (348)
..++.+........ .+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 79 ~rgg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cccchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 88755544433332 4555557889999999999999999999999999999999999999999999976433221
Q ss_pred CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 279 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 279 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
+||..|||||++.+ ...++|+||||++++||+||..||.+
T Consensus 154 -----cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch
Confidence 89999999998873 67799999999999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=167.66 Aligned_cols=106 Identities=28% Similarity=0.396 Sum_probs=88.6
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCc
Q 018936 219 FVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 298 (348)
Q Consensus 219 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 298 (348)
+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||+++...... ..||+.|+|||++.+.
T Consensus 14 l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y~aPE~~~~~ 79 (176)
T smart00750 14 LNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYFMAPEVIQGQ 79 (176)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc------CCCcccccChHHhcCC
Confidence 455568999999999999999998 999999999999999 99998764322 2578999999998775
Q ss_pred ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 299 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 299 ~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
. ++.++|||||||++|||++|+.||............+..
T Consensus 80 ~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 119 (176)
T smart00750 80 S-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119 (176)
T ss_pred C-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH
Confidence 4 899999999999999999999999876655544444433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-23 Score=201.81 Aligned_cols=203 Identities=31% Similarity=0.438 Sum_probs=154.7
Q ss_pred eeeeeeccCCceEEEEEEEccCCcEEEEEEeec----CCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRF----DNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~----~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.....+|.|++|.|+.+........++.|..+. ..........+..|.-+-..+.|||++..+..+.+... .+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--ILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc--chh
Confidence 466789999999999988777777677775542 11112222225567777778899999887766655333 334
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
.|||++.++....... . .+....+.++++|++.|+.|||+.||.|||+|++|++++.+|.+||+|||.+..+.-
T Consensus 399 ~mE~~~~Dlf~~~~~~-~-----~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 399 SMEYCPYDLFSLVMSN-G-----KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hhhcccHHHHHHHhcc-c-----ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 4999998555554432 2 233344888999999999999999999999999999999999999999999988764
Q ss_pred CCC---CCcccccccCcccccccccCcccCC-ccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 275 NHK---HPMTSRVVTLWYRPPELLLGATDYG-VGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 275 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
... ......+|+..|+|||.+.+.. |. ...||||.|++++.|++|+.||..-...
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~-ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKE-YDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccc-cCcchhhhhhccceEEEEecCCCcccccccc
Confidence 443 4566778999999999988765 55 4799999999999999999999654433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=171.51 Aligned_cols=208 Identities=22% Similarity=0.313 Sum_probs=133.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCC-----------Cceeeeece
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH-----------PNVIKLEGL 183 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~h-----------pniv~l~~~ 183 (348)
..+...+.||.|+++.||.+++..+|+.+|+|+...... .....+.+++|.-....+.+ ..++.+ +.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~ 90 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DL 90 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EE
Confidence 357888999999999999999999999999999866553 23356677777655555432 122221 11
Q ss_pred E---------eecc-Cc-----eEEEEEeecccChhhhhcCCCCc-CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecC
Q 018936 184 V---------TSRM-SC-----SLYLVFHYMEHDLAGLAASPEVK-FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRD 247 (348)
Q Consensus 184 ~---------~~~~-~~-----~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 247 (348)
. .... .. ..+++|+-+.+++......-... .............+..|++..+++||+.|+||+|
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 1 1111 11 13678888887776554310000 0022333443445568999999999999999999
Q ss_pred CCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCc-------ccCCccccHHHHHHHHHHHHhC
Q 018936 248 IKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA-------TDYGVGVDLWSAGCILAELLAG 320 (348)
Q Consensus 248 ikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwSlGv~l~elltG 320 (348)
|+|+|++++.+|.++|+||+.....+.... ....+..|.+||..... ..++.+.|.|+||+++|.|.+|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999998776543211 13345678999965321 2477899999999999999999
Q ss_pred CCCCCCCC
Q 018936 321 KPIMPGRT 328 (348)
Q Consensus 321 ~~pf~~~~ 328 (348)
+.||....
T Consensus 247 ~lPf~~~~ 254 (288)
T PF14531_consen 247 RLPFGLSS 254 (288)
T ss_dssp S-STCCCG
T ss_pred cCCCCCCC
Confidence 99996543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=166.00 Aligned_cols=146 Identities=24% Similarity=0.190 Sum_probs=109.2
Q ss_pred CCceeeeeeccCCceEEEEEE-EccCCcEEEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAK-DMLTGKIVALKKVRFDNLEP----------------------ESVKFMAREILILRRL 172 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~-~~~~g~~vAvK~i~~~~~~~----------------------~~~~~~~~E~~~l~~l 172 (348)
..|++.+.||+|+||.||+|. +..+|+.||+|+++...... .....+.+|+.+++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358999999999999999998 66899999999987643210 0123456899999999
Q ss_pred CCCc--eeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC-ceecCCC
Q 018936 173 DHPN--VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG-VLHRDIK 249 (348)
Q Consensus 173 ~hpn--iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDik 249 (348)
.+.. +++++++ . ..++||||+++..+........ ......+..++.||+.+|.+||+.| |+|||||
T Consensus 108 ~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 108 YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 7633 3344332 1 2489999999854433221111 2223346778999999999999999 9999999
Q ss_pred CCCEEECCCCcEEEEeeCCccccC
Q 018936 250 GSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 250 p~NIll~~~~~~kl~DFGla~~~~ 273 (348)
|+||+++ ++.++|+|||++....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999988653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=160.49 Aligned_cols=138 Identities=18% Similarity=0.199 Sum_probs=101.6
Q ss_pred eeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-----CCCceeeeeceEeeccC-ce-
Q 018936 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-----DHPNVIKLEGLVTSRMS-CS- 191 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~~-~~- 191 (348)
.-.+.||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ +||||++++|++++..+ ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 4457899999999996 5566655 69988764322 345688999999999 67999999999988643 23
Q ss_pred EEEEEeecc---cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCCEEECC----CCcEEE
Q 018936 192 LYLVFHYME---HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL-EHCHNNGVLHRDIKGSNLLIDD----DGVLKI 263 (348)
Q Consensus 192 ~~lv~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL-~~LH~~~ivHrDikp~NIll~~----~~~~kl 263 (348)
+.+|+||.+ +.+...+... .+.+ . ..++.|++.++ +|||+++|+||||||+|||++. ++.++|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~--~~~e-----~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC--RYEE-----D--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc--cccH-----h--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 337899954 3555555332 2221 1 24578888888 9999999999999999999974 347999
Q ss_pred EeeCCcc
Q 018936 264 ADFGLAS 270 (348)
Q Consensus 264 ~DFGla~ 270 (348)
+||+.+.
T Consensus 151 iDg~G~~ 157 (210)
T PRK10345 151 CDNIGES 157 (210)
T ss_pred EECCCCc
Confidence 9955443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=192.23 Aligned_cols=180 Identities=32% Similarity=0.407 Sum_probs=130.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|..++.|-.|+||.||.++++.+.+.+|+|+ .++++ +.+ +++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-------ilR--nilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-------ILR--NILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch-------hhh--ccccccCCccee-----------------
Confidence 689999999999999999999999999999953 32221 111 133334444444
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
++....+.. .+. ++ .+++.+++|||+.||+|||+||+|.+|+.-|++|++|||+++.....
T Consensus 136 -----gDc~tllk~-~g~-----lP--------vdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----GDCATLLKN-IGP-----LP--------VDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----chhhhhccc-CCC-----Cc--------chhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 111111111 011 11 13488999999999999999999999999999999999999764211
Q ss_pred --------C----CC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 276 --------H----KH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 276 --------~----~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
. .+ .....+||+.|.|||++... .|+..+|||++|+++||.+-|..||.+.+..+..-++|...+
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 0 01 12234889999999999864 499999999999999999999999999886555556655554
Q ss_pred c
Q 018936 342 F 342 (348)
Q Consensus 342 ~ 342 (348)
.
T Consensus 276 ~ 276 (1205)
T KOG0606|consen 276 E 276 (1205)
T ss_pred c
Confidence 4
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-19 Score=153.60 Aligned_cols=140 Identities=24% Similarity=0.220 Sum_probs=106.2
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh--------------------HHHHHHHHHHHHHHhcCCCc
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP--------------------ESVKFMAREILILRRLDHPN 176 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~--------------------~~~~~~~~E~~~l~~l~hpn 176 (348)
.|.+.+.||+|+||.||++.+ .+|+.||||+++.+.... ........|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 488889999999999999986 589999999977543110 01123567888999998874
Q ss_pred --eeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q 018936 177 --VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLL 254 (348)
Q Consensus 177 --iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIl 254 (348)
++..++ .+..+++|||+++..+...... .....++.+++.++.++|+.||+||||||+||+
T Consensus 95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPID------WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNIL 157 (198)
T ss_pred CCCCceee------cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEE
Confidence 344432 1335899999998654432210 114557889999999999999999999999999
Q ss_pred ECCCCcEEEEeeCCccccCC
Q 018936 255 IDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 255 l~~~~~~kl~DFGla~~~~~ 274 (348)
+++++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=164.38 Aligned_cols=150 Identities=26% Similarity=0.389 Sum_probs=111.3
Q ss_pred CCCceeeeeceEeec-------------------------cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHH
Q 018936 173 DHPNVIKLEGLVTSR-------------------------MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCY 227 (348)
Q Consensus 173 ~hpniv~l~~~~~~~-------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 227 (348)
+|||||++.++|.+. .+..+|+||....+.+..++..+. .+....+.+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-------CchHHHHHH
Confidence 599999999887542 234689999999888888776543 233346668
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCCEEEC--CCC--cEEEEeeCCccccCCC-----CCCCcccccccCcccccccccCc
Q 018936 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDG--VLKIADFGLASFFDPN-----HKHPMTSRVVTLWYRPPELLLGA 298 (348)
Q Consensus 228 ~~qi~~aL~~LH~~~ivHrDikp~NIll~--~~~--~~kl~DFGla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~ 298 (348)
+.|+++|+.|||.+||.|||+|.+|||+. +|+ .+.|+|||.+--.+.. .........|.-..||||+....
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999999999999999999995 333 5789999987543321 11112333456668999987543
Q ss_pred ccCC-----ccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 299 TDYG-----VGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 299 ~~~~-----~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
+... .++|.|+.|.+.||++....||.+..+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe 462 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE 462 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch
Confidence 2211 378999999999999999999977444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=182.75 Aligned_cols=193 Identities=24% Similarity=0.308 Sum_probs=142.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeccCce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~ 191 (348)
...|.+.+.||+|+||+||+|.+. +|+.||+|+-+..+.++-.. =.+++.+|+ -+.|..+...+.. ...
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~-~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~--~~~ 768 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHS-NGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVF--QNA 768 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecC-CCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHcc--CCc
Confidence 467999999999999999999974 49999999877666543221 233444454 2334444333333 233
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-------CCcEEE
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-------DGVLKI 263 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-------~~~~kl 263 (348)
-++|++|.+. .++++.. ... .+.+..+..++.|++..+++||..+|||+||||+|.||.. ..-++|
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~-----~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNK-----VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc-cCC-----CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 6889999986 4555444 332 3444447788999999999999999999999999999952 235999
Q ss_pred EeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCC
Q 018936 264 ADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322 (348)
Q Consensus 264 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~ 322 (348)
+|||-+..+.--.. ......++|-.+-.+|+..|+. +++.+|.|.++.+++-|+.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 99999976532111 2345667799999999888765 9999999999999999999973
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-20 Score=184.43 Aligned_cols=197 Identities=27% Similarity=0.425 Sum_probs=144.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
+|...+.||++.|=+|.+|++ ..|. |+||++-+..- .-....+...|++ ...++|||++.+.-+... ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 578889999999999999985 5555 99999866542 2222333444555 566799999998665444 334688
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc--
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-- 272 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~-- 272 (348)
|-+|..+.|.+.+..+. -+.....+-++.||+.||..+|..||+|+|||.+||||+.-+-+.|+||-.-+..
T Consensus 99 vRqyvkhnLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHHhhhhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC
Confidence 88888888877665432 3334445668899999999999999999999999999999999999999876542
Q ss_pred CCCCCCCcccc----cccCcccccccccCcc---------c-CCccccHHHHHHHHHHHHh-CCCCC
Q 018936 273 DPNHKHPMTSR----VVTLWYRPPELLLGAT---------D-YGVGVDLWSAGCILAELLA-GKPIM 324 (348)
Q Consensus 273 ~~~~~~~~~~~----~gt~~y~aPE~~~~~~---------~-~~~~~DvwSlGv~l~ellt-G~~pf 324 (348)
..++....+-+ ..-..|+|||.+.... . .+++.||||+||++.||++ |+|||
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 22222111111 1133599999985421 1 4678999999999999998 89999
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-20 Score=176.72 Aligned_cols=114 Identities=37% Similarity=0.539 Sum_probs=88.7
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC-----CCCcccccccCcccccccccCc
Q 018936 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-----KHPMTSRVVTLWYRPPELLLGA 298 (348)
Q Consensus 224 ~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~ 298 (348)
...++.|++.|+.| +|.+|||+||.||+...+..+||.|||+........ ....+...||.+||+||++.+.
T Consensus 361 ~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~ 437 (516)
T KOG1033|consen 361 MLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ 437 (516)
T ss_pred HHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhh
Confidence 45688999999999 999999999999999999999999999998765443 2234556889999999999985
Q ss_pred ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 299 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 299 ~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
+|+.++||||||++|+|++. +|....+....+..+.+-+++|
T Consensus 438 -~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 438 -QYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPP 479 (516)
T ss_pred -hhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCCh
Confidence 49999999999999999997 2222233334444444444443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=150.75 Aligned_cols=137 Identities=19% Similarity=0.229 Sum_probs=105.9
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP------ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.||+|++|.||+|.+ +|..+++|......... .....+.+|++++..+.|++++....++... ...+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEE
Confidence 5799999999999985 77889999865433211 1234577899999999999987766565543 347899
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|||+++..+........ . ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++...
T Consensus 78 ~e~~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEeCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99998754443322110 1 3667899999999999999999999999999999 789999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=147.02 Aligned_cols=134 Identities=19% Similarity=0.241 Sum_probs=100.6
Q ss_pred eeccCCceEEEEEEEccCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP------ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
.||+|+||.||+|. .+|..|++|......... ...+.+.+|++++..++|+++.....++... ...+++|
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEE
Confidence 38999999999998 577899999865432211 1235677899999999988765443344332 3368999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||+++..+....... . ..++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++....
T Consensus 77 e~~~g~~l~~~~~~~------~------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 77 EYIEGKPLKDVIEEG------N------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred EEECCccHHHHHhhc------H------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999875443332111 0 05688999999999999999999999999999 8899999999988643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-19 Score=152.61 Aligned_cols=222 Identities=16% Similarity=0.217 Sum_probs=165.5
Q ss_pred cccCcccCCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEe
Q 018936 106 ALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVT 185 (348)
Q Consensus 106 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 185 (348)
.++.+......+..+..+|.+.-.|..|+|++ +|..+++|++...........+|..|.-.|+-..||||+.++|.|.
T Consensus 180 tlsr~~gid~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn 257 (448)
T KOG0195|consen 180 TLSRYTGIDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN 257 (448)
T ss_pred ccccccCcchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc
Confidence 34444444556777888999999999999984 5667788988877776667778888999999999999999999998
Q ss_pred eccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEECCCCcEEE
Q 018936 186 SRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKI 263 (348)
Q Consensus 186 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kl 263 (348)
... .+.++..||+.+.+.........+ .....++..++.+|+.|++|||+.. |.---|....++||++.+.+|
T Consensus 258 spp--nlv~isq~mp~gslynvlhe~t~v---vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltari 332 (448)
T KOG0195|consen 258 SPP--NLVIISQYMPFGSLYNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARI 332 (448)
T ss_pred CCC--CceEeeeeccchHHHHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhe
Confidence 754 488999999865444433322111 2222347789999999999999983 444568889999999988877
Q ss_pred E--eeCCccccCCCCCCCcccccccCcccccccccCcccC--CccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 264 A--DFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDY--GVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 264 ~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
+ |--++. ........+.|++||.+...+.- -.+.|+|||.+++|||.|...||....+++--.+|.++
T Consensus 333 smad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale 404 (448)
T KOG0195|consen 333 SMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE 404 (448)
T ss_pred ecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc
Confidence 5 222111 11233458889999988754321 24789999999999999999999999998888888776
Q ss_pred hcc
Q 018936 340 LIF 342 (348)
Q Consensus 340 ~~~ 342 (348)
-+.
T Consensus 405 glr 407 (448)
T KOG0195|consen 405 GLR 407 (448)
T ss_pred ccc
Confidence 543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.4e-18 Score=166.43 Aligned_cols=140 Identities=17% Similarity=0.177 Sum_probs=105.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-C-----hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-E-----PESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
..|...+.||+|+||+||+|.. .+..+++|....... . ....+.+.+|+++++.++|++++....++...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~--~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEY--LGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEee--cCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 3456789999999999999975 334455554322211 1 12245678899999999999998876665553
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
...+++|||+++..+..... ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 34689999998754433221 145678999999999999999999999999999 6789999999999
Q ss_pred cccC
Q 018936 270 SFFD 273 (348)
Q Consensus 270 ~~~~ 273 (348)
+...
T Consensus 475 ~~~~ 478 (535)
T PRK09605 475 KYSD 478 (535)
T ss_pred ccCC
Confidence 8754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.3e-18 Score=143.71 Aligned_cols=139 Identities=27% Similarity=0.291 Sum_probs=96.1
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHH----------------------HHHHHHHHHhcCCCc--
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF----------------------MAREILILRRLDHPN-- 176 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~----------------------~~~E~~~l~~l~hpn-- 176 (348)
.+.||+|+||.||+|.+. +|+.||||+++........... ...|.+.+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999964 8999999998764332111111 134556666664433
Q ss_pred eeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEE
Q 018936 177 VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLI 255 (348)
Q Consensus 177 iv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll 255 (348)
+.+.+++ ...+++|||++++............. ..+..++.+++.++.++|. .+|+||||||+||++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~------~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL------EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhc------ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 3333332 12589999999732111000000000 2367789999999999999 999999999999999
Q ss_pred CCCCcEEEEeeCCccccC
Q 018936 256 DDDGVLKIADFGLASFFD 273 (348)
Q Consensus 256 ~~~~~~kl~DFGla~~~~ 273 (348)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-16 Score=141.39 Aligned_cols=138 Identities=18% Similarity=0.217 Sum_probs=100.6
Q ss_pred eeec-cCCceEEEEEEEccCCcEEEEEEeecCCC-----------ChHHHHHHHHHHHHHHhcCCCce--eeeeceEeec
Q 018936 122 DKIG-QGTYSNVYKAKDMLTGKIVALKKVRFDNL-----------EPESVKFMAREILILRRLDHPNV--IKLEGLVTSR 187 (348)
Q Consensus 122 ~~LG-~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-----------~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~ 187 (348)
..|| .||.|+||.++. .+..++||.+..... .......+.+|++++..++|++| ++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 889999999874 478899998854321 11234567789999999998885 6666665443
Q ss_pred cCc--eEEEEEeeccc--ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEE
Q 018936 188 MSC--SLYLVFHYMEH--DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKI 263 (348)
Q Consensus 188 ~~~--~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl 263 (348)
... ..++++|++++ .+...+... .+ +. ..+.||+.+|.+||+.||+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l-----~~----~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PL-----SE----EQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CC-----CH----HHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEE
Confidence 222 23599999986 344433221 11 11 12568999999999999999999999999999899999
Q ss_pred EeeCCcccc
Q 018936 264 ADFGLASFF 272 (348)
Q Consensus 264 ~DFGla~~~ 272 (348)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.4e-18 Score=168.02 Aligned_cols=209 Identities=30% Similarity=0.420 Sum_probs=159.2
Q ss_pred CCceeeeeeccCCceEEEEEEEc-cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 193 (348)
..|.+.+.||+|+|+.|-..... .+...+|+|.+..........+....|..+-+.+. |+|++.+++.... ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccccc
Confidence 56888899999999999888753 33456677766544333444555666888888886 9999999887766 44578
Q ss_pred EEEeecccChhhhhc-CCCC-cCCcchhhHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCEEECCCC-cEEEEeeCCc
Q 018936 194 LVFHYMEHDLAGLAA-SPEV-KFTEPQFVYLKVKCYMHQLLSGLEHCH-NNGVLHRDIKGSNLLIDDDG-VLKIADFGLA 269 (348)
Q Consensus 194 lv~e~~~~~l~~~~~-~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~NIll~~~~-~~kl~DFGla 269 (348)
+.++|..++.+.... .... ...... ...++.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+|
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~-----~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSS-----ASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccCCccCCCCcc-----hhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence 888987664433333 2222 222222 6678999999999999 99999999999999999999 9999999999
Q ss_pred cccCC--CCCCCcccccc-cCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 270 SFFDP--NHKHPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 270 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
..+.. +........+| ++.|+|||...+.....+..|+||.|+++.-+++|..|+.......
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 88755 33333445678 9999999988875556789999999999999999999986655443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.7e-16 Score=126.14 Aligned_cols=133 Identities=23% Similarity=0.204 Sum_probs=105.1
Q ss_pred eeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeeccCceEEEEEe
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~lv~e 197 (348)
+++.||.|.++.||++.. ++..+++|....... ...+.+|+.+++.++| .++++++++...+ ...++++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEE
Confidence 457899999999999985 347899998754432 4567789999999977 4888887776653 45899999
Q ss_pred ecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 198 YMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN---GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+.+...... .......++.+++.+|.+||.. +++|+|++|+||+++.++.++++|||++...
T Consensus 74 ~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 74 WIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 9987543321 1222555788999999999985 6999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-14 Score=137.93 Aligned_cols=155 Identities=28% Similarity=0.458 Sum_probs=117.5
Q ss_pred HHhcCCCceeeeeceEeeccCceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCc-eec
Q 018936 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGV-LHR 246 (348)
Q Consensus 169 l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i-vHr 246 (348)
|+.+.|.|+.+++|.+.+. ...+++.+|+.. ++.+.+..... .+.+.-...++++|+.||+|||+-.| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~-----~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDI-----KLDYFFILSFIRDISKGLAYLHNSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhcccc-----CccHHHHHHHHHHHHHHHHHHhcCcceeee
Confidence 4578999999999999886 558899999985 45555444332 33444467789999999999998865 999
Q ss_pred CCCCCCEEECCCCcEEEEeeCCccccCCCC-CCCcccccccCcccccccccCcc--c----CCccccHHHHHHHHHHHHh
Q 018936 247 DIKGSNLLIDDDGVLKIADFGLASFFDPNH-KHPMTSRVVTLWYRPPELLLGAT--D----YGVGVDLWSAGCILAELLA 319 (348)
Q Consensus 247 Dikp~NIll~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~----~~~~~DvwSlGv~l~ellt 319 (348)
.+++.|.+++..+.+||+|||+........ ........-..-|.|||.+.+.. . .+.+.|+||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 999999999999999999999988764210 01111112345599999886531 1 3567999999999999999
Q ss_pred CCCCCCCCChh
Q 018936 320 GKPIMPGRTEV 330 (348)
Q Consensus 320 G~~pf~~~~~~ 330 (348)
.+.||......
T Consensus 154 r~~~~~~~~~~ 164 (484)
T KOG1023|consen 154 RSGPFDLRNLV 164 (484)
T ss_pred ccCcccccccc
Confidence 99999774433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.1e-14 Score=140.08 Aligned_cols=150 Identities=19% Similarity=0.222 Sum_probs=94.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC----------------------------h----HHHHHH-
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE----------------------------P----ESVKFM- 162 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~----------------------------~----~~~~~~- 162 (348)
..|.. +.||+|++|.||+|+...+|+.||||++++.... . +..+.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 7999999999999998777999999999754210 0 111122
Q ss_pred -----HHHHHHHHhcC----CCceeeeeceEeeccCceEEEEEeecccChhhhhc-CCCCcCCcchhhHHHHHHHHHHHH
Q 018936 163 -----AREILILRRLD----HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAA-SPEVKFTEPQFVYLKVKCYMHQLL 232 (348)
Q Consensus 163 -----~~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~qi~ 232 (348)
.+|+..+.+++ +.+.+.+-.++.+ -.+..+|||||++|.-..... ..........+....+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 23333333332 2222322222222 133468999999985443221 111111222344444555666655
Q ss_pred HHHHHHHHCCceecCCCCCCEEECCCC----cEEEEeeCCccccCC
Q 018936 233 SGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADFGLASFFDP 274 (348)
Q Consensus 233 ~aL~~LH~~~ivHrDikp~NIll~~~~----~~kl~DFGla~~~~~ 274 (348)
..|++|+|++|.||+++.++ .++++|||++..++.
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999888 999999999987754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.4e-13 Score=132.40 Aligned_cols=143 Identities=19% Similarity=0.230 Sum_probs=92.6
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHH--------------------------------H------HHHH
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES--------------------------------V------KFMA 163 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~--------------------------------~------~~~~ 163 (348)
+.||.|++|.||+|+. .+|+.||||+.+......-. . -++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999985 68999999998654211000 0 0233
Q ss_pred HHHHHHHhcC----CCceeeeeceEeeccCceEEEEEeecccChhhhhcCC-CCcCCcchhhHHHHHHHHHHHHH-HHHH
Q 018936 164 REILILRRLD----HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASP-EVKFTEPQFVYLKVKCYMHQLLS-GLEH 237 (348)
Q Consensus 164 ~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~-aL~~ 237 (348)
+|...+.+++ |.+-+.+-.++... .+..++||||+++..+...... .... . ...++.+++. .+..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~---~-----~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL---D-----RKALAENLARSFLNQ 272 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC---C-----HHHHHHHHHHHHHHH
Confidence 4555555542 22223322233221 2346899999987543322111 0000 0 2234555554 4778
Q ss_pred HHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 238 LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
+|..|++|+|++|.||+++.++.++++|||++..+.+
T Consensus 273 l~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 273 VLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.5e-13 Score=113.82 Aligned_cols=139 Identities=19% Similarity=0.169 Sum_probs=95.6
Q ss_pred eeeccCCceEEEEEEEcc------CCcEEEEEEeecCCC--------------------ChHHHHHHH----HHHHHHHh
Q 018936 122 DKIGQGTYSNVYKAKDML------TGKIVALKKVRFDNL--------------------EPESVKFMA----REILILRR 171 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~------~g~~vAvK~i~~~~~--------------------~~~~~~~~~----~E~~~l~~ 171 (348)
..||.|.-+.||.|.... .+..+|||+.+.+.. .......+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997532 357999998755311 011122333 79999999
Q ss_pred cCC--CceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHH-HHCCceecCC
Q 018936 172 LDH--PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC-HNNGVLHRDI 248 (348)
Q Consensus 172 l~h--pniv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~ivHrDi 248 (348)
+.. -++++.+++ ...++||||+++............. .......+..|++.+|..| |+.||||+||
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~-----~~~~~~~i~~~i~~~l~~l~H~~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKL-----NDEEMKNAYYQVLSMMKQLYKECNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhcccc-----CHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 853 456666553 1258999999864221111111111 1222455678999999999 8999999999
Q ss_pred CCCCEEECCCCcEEEEeeCCcccc
Q 018936 249 KGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 249 kp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++.|||++ ++.+.|+|||.+...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999996 568999999988765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.7e-13 Score=110.31 Aligned_cols=128 Identities=17% Similarity=0.177 Sum_probs=92.7
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeccCceEEEEEeec
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~lv~e~~ 199 (348)
++.|+.|.++.||+++. .+..|++|....... ....+.+|+.+++.+.+.++ ++++..... ..++|||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEEEEec
Confidence 46789999999999984 478899998654321 12235678999998865554 445443321 247999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGV-----LHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i-----vHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
++...... .. . ....+.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 74 ~G~~l~~~-----~~---~-----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE-----DF---S-----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc-----cc---c-----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98543221 00 0 12346799999999999985 9999999999998 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.4e-12 Score=123.53 Aligned_cols=169 Identities=20% Similarity=0.309 Sum_probs=123.2
Q ss_pred EEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCc
Q 018936 134 KAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVK 213 (348)
Q Consensus 134 ~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~ 213 (348)
.|..+.++.+|.|...+.++. ...+...+-++.|+.++||||+++++.++... ..|+|.|.+..-- ..+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~Pl~-~~lk----- 99 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVRPLE-TVLK----- 99 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeeccccHH-HHHH-----
Confidence 455578889999998876553 44556777889999999999999999887744 6999999876421 1111
Q ss_pred CCcchhhHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccccCccccc
Q 018936 214 FTEPQFVYLKVKCYMHQLLSGLEHCH-NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292 (348)
Q Consensus 214 ~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 292 (348)
.+....+..-+.||+.||.||| ..+++|++|.-..|+|+..|+.||++|-++........ ......--..|..|
T Consensus 100 ----~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P 174 (690)
T KOG1243|consen 100 ----ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDP 174 (690)
T ss_pred ----HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccCh
Confidence 1112335556899999999998 56899999999999999999999999999876543221 11111222336777
Q ss_pred ccccCcccCCccccHHHHHHHHHHHHhC
Q 018936 293 ELLLGATDYGVGVDLWSAGCILAELLAG 320 (348)
Q Consensus 293 E~~~~~~~~~~~~DvwSlGv~l~elltG 320 (348)
+.+... ....|.|.||+++++++.|
T Consensus 175 ~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 175 EEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 754321 1357999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-13 Score=130.58 Aligned_cols=202 Identities=23% Similarity=0.307 Sum_probs=152.5
Q ss_pred CCceeeeeecc--CCceEEEEEEE--ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQ--GTYSNVYKAKD--MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~--G~~g~Vy~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 190 (348)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+.....+.....-.+|....+.+ .|+|.++.+..++. ..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CC
Confidence 56788899999 99999999987 78899999997433222222222333466666666 59999997666665 45
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCCEEECCC-CcEEEEe
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS----GLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIAD 265 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~----aL~~LH~~~ivHrDikp~NIll~~~-~~~kl~D 265 (348)
..|+-.|.++..+..........++... ++....+... ||.++|+.+++|-|+||.||++..+ ..++++|
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~-----l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNL-----LWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchh-----hhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence 6899999999777776655444344433 6666777777 9999999999999999999999999 7899999
Q ss_pred eCCccccCCCCCCC----cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 266 FGLASFFDPNHKHP----MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 266 FGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
||+...+....... ..+..+...|++||...+. ++.+.|+|++|.+..+..++..+...
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccC
Confidence 99999886554221 1122566779999987763 78899999999999999988765533
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.4e-13 Score=138.37 Aligned_cols=223 Identities=24% Similarity=0.236 Sum_probs=156.1
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
..+.+.+.+.+-+|+++.++.+.-..+|...++|....... .....+....+-+++-..++|.++...--+.- ....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCCc
Confidence 34789999999999999999998777787777776554332 22233444445555555567777765333222 3347
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+|+++|.++..+............ ...+.++..+..++++||+..+.|||++|.|+++..+++.++.|||+....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~sa-----epaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSA-----EPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCccc-----ccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccc
Confidence 899999876333322222221111 125667788899999999999999999999999999999999999844322
Q ss_pred CC------C------------------------CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCC
Q 018936 273 DP------N------------------------HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322 (348)
Q Consensus 273 ~~------~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~ 322 (348)
.- . .........+|+.|.+||...+.. .+..+|||++|++++|.++|.+
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCC
Confidence 10 0 000122346799999999988765 7888999999999999999999
Q ss_pred CCCCCChhHHHHHHHHHhccCC
Q 018936 323 IMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 323 pf~~~~~~~~~~~~i~~~~~~p 344 (348)
||...+.......|+...+--|
T Consensus 1034 p~na~tpq~~f~ni~~~~~~~p 1055 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDIPWP 1055 (1205)
T ss_pred CCCCcchhhhhhccccCCCCCC
Confidence 9999887666656555554443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-10 Score=96.73 Aligned_cols=134 Identities=22% Similarity=0.253 Sum_probs=91.7
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEe-ecCCCChH-----HHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKV-RFDNLEPE-----SVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i-~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
..+++|+-+.+|.+.. -|..+++|.= ++.-..++ ..+...+|+.++.+++--.|...+=++.+. ....++
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--DNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCEEE
Confidence 3578999999999953 4556777752 22222222 234456788999888644432222133332 236799
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|||+++.++....... .-.++..+-.-+.-||..||||+||.++||++..++ +.++||||+...
T Consensus 78 me~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 78 MEYIEGELLKDALEEA------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEEeCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998776443221 123577888889999999999999999999997654 999999999854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8e-12 Score=119.65 Aligned_cols=200 Identities=22% Similarity=0.214 Sum_probs=138.7
Q ss_pred CCCCceeeeeeccCCceEEEEEEEc-cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCce
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 191 (348)
...+|..+..||.|.|+.|+..... .++..|++|.+............-..|+.+...+ .|.+++.....+..- ..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--RQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--cc
Confidence 3567999999999999999987644 6788999998865544333333334566666666 577887765544332 23
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC-CcEEEEeeCCcc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kl~DFGla~ 270 (348)
.|+-.||+++....+...-. ..+.....+....|++.++.++|+..++|+|+||+||++..+ +..++.|||++.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 56888899775444433111 122333367789999999999999999999999999999876 788999999987
Q ss_pred ccCCCCCCCcccccccCccc-ccccccCcccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 271 FFDPNHKHPMTSRVVTLWYR-PPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
.+.-.. ......-++. .+|.+.....+..+.|++|||..+.+.++|.+.-
T Consensus 416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 432110 1111222334 2444544445788999999999999999987643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2e-10 Score=95.03 Aligned_cols=145 Identities=18% Similarity=0.252 Sum_probs=99.3
Q ss_pred eeeeeccCCceEEEEEEEccCCcEEEEEEe-ecC----CC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKV-RFD----NL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i-~~~----~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.+..|-+|+-+.|+++. ..|+.+.||.- .+. .+ .+-...+..+|++.|.++.--.|.--.=++.+. ..-.
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQ 86 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCe
Confidence 56788999999999996 78888888852 111 11 122345667899999988543332222244442 2357
Q ss_pred EEEeeccc--ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC---cEEEEeeCC
Q 018936 194 LVFHYMEH--DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGL 268 (348)
Q Consensus 194 lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~---~~kl~DFGl 268 (348)
++|||+++ ...+++........++ .....++++|-..+.-||..+|+|+||..+||++..++ .+.++|||+
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d----~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESED----EGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccc----hhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecc
Confidence 88999988 4445444332222221 12356788999999999999999999999999997655 468999999
Q ss_pred cccc
Q 018936 269 ASFF 272 (348)
Q Consensus 269 a~~~ 272 (348)
+...
T Consensus 163 s~~s 166 (229)
T KOG3087|consen 163 SSVS 166 (229)
T ss_pred hhcc
Confidence 8653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.1e-10 Score=95.20 Aligned_cols=127 Identities=25% Similarity=0.298 Sum_probs=80.4
Q ss_pred EEEEEEEccCCcEEEEEEeecCCC------------------------ChHHHHHHHHHHHHHHhcCCC--ceeeeeceE
Q 018936 131 NVYKAKDMLTGKIVALKKVRFDNL------------------------EPESVKFMAREILILRRLDHP--NVIKLEGLV 184 (348)
Q Consensus 131 ~Vy~~~~~~~g~~vAvK~i~~~~~------------------------~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~ 184 (348)
.||.|.. .+|..+|+|+.+.... .........+|.+.|.++..- ++++++++-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899985 7889999999765310 111234566799999999765 466665432
Q ss_pred eeccCceEEEEEeecc--cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCCEEECCCCcE
Q 018936 185 TSRMSCSLYLVFHYME--HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH-CHNNGVLHRDIKGSNLLIDDDGVL 261 (348)
Q Consensus 185 ~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~-LH~~~ivHrDikp~NIll~~~~~~ 261 (348)
. .++||||++ +..+..+...... ... ...++.+++..+.. +|..||||+||.+.|||++++ .+
T Consensus 80 ----~--~~ivME~I~~~G~~~~~l~~~~~~--~~~-----~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----R--NVIVMEYIGEDGVPLPRLKDVDLS--PEE-----PKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----T--TEEEEE--EETTEEGGCHHHCGGG--GST-----HHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CE
T ss_pred ----C--CEEEEEecCCCccchhhHHhcccc--chh-----HHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eE
Confidence 1 479999999 5433332221110 111 44567778875555 579999999999999999887 99
Q ss_pred EEEeeCCcccc
Q 018936 262 KIADFGLASFF 272 (348)
Q Consensus 262 kl~DFGla~~~ 272 (348)
.|+|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.4e-10 Score=103.91 Aligned_cols=175 Identities=20% Similarity=0.240 Sum_probs=128.9
Q ss_pred CceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--cCceEEEEEeeccc--Ch
Q 018936 128 TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLYLVFHYMEH--DL 203 (348)
Q Consensus 128 ~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~lv~e~~~~--~l 203 (348)
--.+.|++....+|..|++|++.-..... ......-+++++++.|+|+|++.++|... ....+++|++|.++ .|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 44678999999999999999984332211 11122358899999999999999888632 23468999999986 34
Q ss_pred hhhhcCCCC---------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 204 AGLAASPEV---------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 204 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
.+.+..... .......++..+|.|+.|+..||.++|+.|+..+-|.|.+||++.+.+++|+..|....+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 443322211 11234556677999999999999999999999999999999999999999988887776654
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPI 323 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~p 323 (348)
+.. |.+.+. .+-|.=.||.+++.|.||..-
T Consensus 446 d~~---------------~~le~~----Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLESQ----QQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhHH----hhhhHHHHHHHHHHHhhcccc
Confidence 321 113222 267999999999999999644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.6e-10 Score=96.31 Aligned_cols=143 Identities=20% Similarity=0.240 Sum_probs=93.2
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC--ceeeeeceEeecc-CceEEEEEee
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP--NVIKLEGLVTSRM-SCSLYLVFHY 198 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~-~~~~~lv~e~ 198 (348)
+.|+.|..+.||+++. .+|..+++|........ .....+.+|+++++.+.+. ++++++.+..... ....+++|+|
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 5789999999999985 44689999987543321 1244577899999999763 4566665554321 1246899999
Q ss_pred cccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 018936 199 MEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-------------------------------------- 240 (348)
Q Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-------------------------------------- 240 (348)
+++..+...... ..+.......++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 82 VDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred eCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 987543322110 011111233344455555555542
Q ss_pred ------------------CCceecCCCCCCEEECC--CCcEEEEeeCCcccc
Q 018936 241 ------------------NGVLHRDIKGSNLLIDD--DGVLKIADFGLASFF 272 (348)
Q Consensus 241 ------------------~~ivHrDikp~NIll~~--~~~~kl~DFGla~~~ 272 (348)
..++|+|+.|.||+++. ++.+.|+||+.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 24799999999999998 667899999988743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-08 Score=91.64 Aligned_cols=134 Identities=19% Similarity=0.148 Sum_probs=87.4
Q ss_pred EEEEEEEccCCcEEEEEEeecCCCChHHHH----------HHHHHHHHHHhcCCCce--eeeeceEeecc---CceEEEE
Q 018936 131 NVYKAKDMLTGKIVALKKVRFDNLEPESVK----------FMAREILILRRLDHPNV--IKLEGLVTSRM---SCSLYLV 195 (348)
Q Consensus 131 ~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~----------~~~~E~~~l~~l~hpni--v~l~~~~~~~~---~~~~~lv 195 (348)
.|++.. ..|+.|.||........ ...+ ...+|...+.++..-+| +..+++.+... ...-++|
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 355654 56788999976332211 1111 25678888888854443 34455554322 2236899
Q ss_pred EeecccC--hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-------CCcEEEEee
Q 018936 196 FHYMEHD--LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-------DGVLKIADF 266 (348)
Q Consensus 196 ~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-------~~~~kl~DF 266 (348)
+|++++. +........ . ..........++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||
T Consensus 114 te~l~~~~sL~~~~~~~~-~---~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA-T---NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EeeCCCCccHHHHHHhhc-c---cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 9999874 444432110 0 11122235678899999999999999999999999999975 468999999
Q ss_pred CCccc
Q 018936 267 GLASF 271 (348)
Q Consensus 267 Gla~~ 271 (348)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.9e-10 Score=98.26 Aligned_cols=156 Identities=17% Similarity=0.193 Sum_probs=107.2
Q ss_pred HHHHHhcCCCceeeeeceEeeccC---ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-
Q 018936 166 ILILRRLDHPNVIKLEGLVTSRMS---CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN- 241 (348)
Q Consensus 166 ~~~l~~l~hpniv~l~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~- 241 (348)
...|-.+.|-|||+++.|+.+... ....++.|||..+.+...+... +.....+....++.|+.||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt-~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRT-KKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHH-HHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 344556789999999998866432 3467888999865444333222 22333556667899999999999999998
Q ss_pred -CceecCCCCCCEEECCCCcEEEEeeCCcccc---CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHH
Q 018936 242 -GVLHRDIKGSNLLIDDDGVLKIADFGLASFF---DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317 (348)
Q Consensus 242 -~ivHrDikp~NIll~~~~~~kl~DFGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el 317 (348)
.|+|+++...-|++..+|.+|+.----...- +...........+-++|.|||.=.. ...+-++|||+||+..++|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHH
Confidence 5999999999999999999988522211110 0000111122345778999996433 2356689999999999999
Q ss_pred HhCCCC
Q 018936 318 LAGKPI 323 (348)
Q Consensus 318 ltG~~p 323 (348)
..|..-
T Consensus 276 ailEiq 281 (458)
T KOG1266|consen 276 AILEIQ 281 (458)
T ss_pred HHheec
Confidence 888643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2e-08 Score=88.46 Aligned_cols=139 Identities=25% Similarity=0.242 Sum_probs=97.7
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC------------------C--hHHHHHHHHHHHHHHhcCCC-
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL------------------E--PESVKFMAREILILRRLDHP- 175 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~------------------~--~~~~~~~~~E~~~l~~l~hp- 175 (348)
-..+.++||-|.-+.||.|.+ ..|.++|||.-+.... . ......-.+|.++|..|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 356778999999999999985 6899999997544211 0 11233456789999998654
Q ss_pred -ceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEE
Q 018936 176 -NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLL 254 (348)
Q Consensus 176 -niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIl 254 (348)
.+++.+++ +...+|||++++-.+..... .... ...++..|+.-+.-+-..||||+|+.+=||+
T Consensus 171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r~-----~~en-----~~~il~~il~~~~~~~~~GiVHGDlSefNIl 234 (304)
T COG0478 171 VKVPKPIAW------NRHAVVMEYIEGVELYRLRL-----DVEN-----PDEILDKILEEVRKAYRRGIVHGDLSEFNIL 234 (304)
T ss_pred CCCCCcccc------ccceeeeehcccceeecccC-----cccC-----HHHHHHHHHHHHHHHHHcCccccCCchheEE
Confidence 67776553 33579999999854432221 1111 2233445555555555889999999999999
Q ss_pred ECCCCcEEEEeeCCcccc
Q 018936 255 IDDDGVLKIADFGLASFF 272 (348)
Q Consensus 255 l~~~~~~kl~DFGla~~~ 272 (348)
+++||.+.++||--+...
T Consensus 235 V~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EecCCCEEEEeCcccccC
Confidence 999999999999877643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.5e-08 Score=90.71 Aligned_cols=199 Identities=15% Similarity=0.143 Sum_probs=126.8
Q ss_pred eeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeece-----EeeccCceE
Q 018936 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGL-----VTSRMSCSL 192 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-----~~~~~~~~~ 192 (348)
...+.||+|+-+.+|-.-. -+. .+.|+...... ....+ .+..|... .||-+-.=+.+ +-.+.+...
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Ppp--a~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPP--AAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecch--hhc-hhheeecCCCc--hHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 3457899999999996642 222 34487754332 11111 23344444 56644320100 011122235
Q ss_pred EEEEeeccc--ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 193 YLVFHYMEH--DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 193 ~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
-+.|+.+.+ ....++.-...+..-+...+.-..+.++.++.+.+.||+.|.+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 677777765 333333333333334455555577789999999999999999999999999999999999999866443
Q ss_pred ccCCCCCCCcccccccCccccccccc-C---cccCCccccHHHHHHHHHHHHhC-CCCCCCC
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLL-G---ATDYGVGVDLWSAGCILAELLAG-KPIMPGR 327 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~~~DvwSlGv~l~elltG-~~pf~~~ 327 (348)
.-..+. .....+|...|.+||.-. + ...-+...|.|.||+++++++.| +.||.|.
T Consensus 166 i~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 322221 123457888999999643 1 12245689999999999999986 9999763
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.9e-08 Score=83.46 Aligned_cols=107 Identities=22% Similarity=0.258 Sum_probs=75.5
Q ss_pred HHHHHHHHHHHhcCCCc--eeeeeceEeeccC--ceEEEEEeeccc--ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHH
Q 018936 160 KFMAREILILRRLDHPN--VIKLEGLVTSRMS--CSLYLVFHYMEH--DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233 (348)
Q Consensus 160 ~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~--~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 233 (348)
....+|...+..|..-. +++.+++.+.+.. ...++++|++++ ++......... ........++.+++.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLRALAR 129 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHHHHHH
Confidence 34667888877775433 3455566554322 234899999987 34444432111 111225667899999
Q ss_pred HHHHHHHCCceecCCCCCCEEECCCC---cEEEEeeCCcccc
Q 018936 234 GLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFF 272 (348)
Q Consensus 234 aL~~LH~~~ivHrDikp~NIll~~~~---~~kl~DFGla~~~ 272 (348)
.+.-||..||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 130 ~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.9e-08 Score=94.09 Aligned_cols=143 Identities=25% Similarity=0.383 Sum_probs=87.4
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh----------------------------HHHH----------HHH
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----------------------------ESVK----------FMA 163 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~----------------------------~~~~----------~~~ 163 (348)
..|+.++-|.||+|+. .+|+.||||+.+.+-... +..+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6899999999999995 679999999987642100 0000 122
Q ss_pred HHHHHHHhcC-----CCceeeeeceEeeccCceEEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHH
Q 018936 164 REILILRRLD-----HPNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237 (348)
Q Consensus 164 ~E~~~l~~l~-----hpniv~l~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~ 237 (348)
+|...+.+++ .|++. +=.++.+ -.+...|+|||++|- +.+.............+...-+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~-VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~----- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVY-VPKVYWE-YTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL----- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeE-eceeehh-ccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 3333333331 22221 1112211 134468999999983 222211111222223344444444555554
Q ss_pred HHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 238 LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
..|++|.|..|.||+++.+|.+.+.|||+...+++
T Consensus 283 --~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 --RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 47999999999999999999999999999987754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.1e-07 Score=78.83 Aligned_cols=139 Identities=22% Similarity=0.258 Sum_probs=91.2
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCC--------------------h--HHHHHHHHHHHHHHhcC--CCce
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--------------------P--ESVKFMAREILILRRLD--HPNV 177 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~--------------------~--~~~~~~~~E~~~l~~l~--hpni 177 (348)
-.|.+|.-+.||+|.. .++..+|+|+++.+... . .......+|...|+++. +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677888889999974 77899999998653211 1 11112335666777663 3333
Q ss_pred eeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEEC
Q 018936 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLID 256 (348)
Q Consensus 178 v~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~ 256 (348)
++-+++.. ..|+|||++......= .+............+..+++..+.-|-. .++||+||..=|||+.
T Consensus 133 P~Pi~~~~------nVLvMEfIg~~g~pAP-----~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 133 PEPIAFRN------NVLVMEFIGDDGLPAP-----RLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred CCceeecC------CeEEEEeccCCCCCCC-----CcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 44444321 4799999986521111 1111111111355567788888888777 8999999999999998
Q ss_pred CCCcEEEEeeCCccccC
Q 018936 257 DDGVLKIADFGLASFFD 273 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~ 273 (348)
++.+.|+|||-|....
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 8899999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.1e-07 Score=77.11 Aligned_cols=140 Identities=15% Similarity=0.166 Sum_probs=93.8
Q ss_pred ccCCceEEEEEEEccCCcEEEEEEeecCC---CC-hHHHHHHHHHHHHHHhcCCCc--eeeeeceEe-e--ccCceEEEE
Q 018936 125 GQGTYSNVYKAKDMLTGKIVALKKVRFDN---LE-PESVKFMAREILILRRLDHPN--VIKLEGLVT-S--RMSCSLYLV 195 (348)
Q Consensus 125 G~G~~g~Vy~~~~~~~g~~vAvK~i~~~~---~~-~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~-~--~~~~~~~lv 195 (348)
|+||-+.|+... ..|+.+-+|.-.... .. +.-...+.+|...|..+..-+ +++.. ++. . ...-.-+||
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 568888999875 455578888754211 11 223456788999999885433 44444 222 1 112235789
Q ss_pred Eeeccc--ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc--EEEEeeCCccc
Q 018936 196 FHYMEH--DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--LKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kl~DFGla~~ 271 (348)
+|-+++ ++...+...... ..+......++.+++..+.-||..|+.|+|+-+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~----~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS----PYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC----CcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998884 555544332111 1122224567889999999999999999999999999986666 99999987764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.64 E-value=1e-06 Score=76.09 Aligned_cols=140 Identities=18% Similarity=0.227 Sum_probs=88.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHH-HHH------HHHHHHHHHhcC---CCceeeeeceEe
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKF------MAREILILRRLD---HPNVIKLEGLVT 185 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~-~~~------~~~E~~~l~~l~---hpniv~l~~~~~ 185 (348)
++|+..+.+-......|.+.. .+|..+.+|..+......+. ... ..+++..+.+++ --....++.+.+
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 679999999988888888775 67889999987654321111 110 123333344442 222233222222
Q ss_pred ec---cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEE
Q 018936 186 SR---MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 186 ~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 262 (348)
.. .....+|+|||++|--+..... .. . .....|..++.-||+.|++|+|..|.|++++++ .++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~-----e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----ID-----E----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cC-----H----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEE
Confidence 21 1234568999999853322111 00 0 134567788999999999999999999999855 499
Q ss_pred EEeeCCccc
Q 018936 263 IADFGLASF 271 (348)
Q Consensus 263 l~DFGla~~ 271 (348)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.6e-08 Score=97.38 Aligned_cols=98 Identities=23% Similarity=0.429 Sum_probs=76.1
Q ss_pred HHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCc-------cc-ccccCcccccccccCccc
Q 018936 230 QLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-------TS-RVVTLWYRPPELLLGATD 300 (348)
Q Consensus 230 qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-------~~-~~gt~~y~aPE~~~~~~~ 300 (348)
+++.||.|+|.. ++||+.|.|++|.++.++..||+.|+.+....+...... .. ..-...|.|||++.+. .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 455999999976 899999999999999999999999999876654222110 00 1125679999998874 4
Q ss_pred CCccccHHHHHHHHHHHH-hCCCCCCCCC
Q 018936 301 YGVGVDLWSAGCILAELL-AGKPIMPGRT 328 (348)
Q Consensus 301 ~~~~~DvwSlGv~l~ell-tG~~pf~~~~ 328 (348)
.+.++|+||+|+++|.+. .|+..+.+.+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~ 214 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANG 214 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccC
Confidence 788999999999999998 5666665543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.3e-06 Score=69.35 Aligned_cols=129 Identities=25% Similarity=0.331 Sum_probs=91.2
Q ss_pred CCceeeeeeccCCc-eEEEEEEEccCCcEEEEEEeec---CCC-------Ch---------HHHHHHHHHHHHHHhcC--
Q 018936 116 DSFEKIDKIGQGTY-SNVYKAKDMLTGKIVALKKVRF---DNL-------EP---------ESVKFMAREILILRRLD-- 173 (348)
Q Consensus 116 ~~y~~~~~LG~G~~-g~Vy~~~~~~~g~~vAvK~i~~---~~~-------~~---------~~~~~~~~E~~~l~~l~-- 173 (348)
.+++.++.||.|.- |.||+++ -+|+.||+|.++. ... .. ...+-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999997 6788999999332 110 00 22345677888777764
Q ss_pred -CCce--eeeeceEeec----------------cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHH
Q 018936 174 -HPNV--IKLEGLVTSR----------------MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234 (348)
Q Consensus 174 -hpni--v~l~~~~~~~----------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 234 (348)
+.++ |+++||..-. ......||.||+.... .+ ...-+.+|+.-
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~---------~~~~~~~~~~d 176 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL---------QIRDIPQMLRD 176 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc---------chhHHHHHHHH
Confidence 4566 8999987322 1223456777765432 00 11125678888
Q ss_pred HHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 235 L~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
|..+|..||+-+|+++.|.. .-||+|||.+
T Consensus 177 l~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999999976 4589999964
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.5e-06 Score=84.59 Aligned_cols=140 Identities=20% Similarity=0.247 Sum_probs=84.6
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-----------------------------hHHHHH------HHHHH
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-----------------------------PESVKF------MAREI 166 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-----------------------------~~~~~~------~~~E~ 166 (348)
+.||.-+.|.||+|+. .+|+.||||+-+.+-.. ++..+. |.+|.
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5799999999999995 66999999997653211 011111 22333
Q ss_pred HHHHhc----CCCc------eeeeeceEeeccCceEEEEEeecccC---hhhhhcCCCCcCCcchhhHHHHHHHHHHHHH
Q 018936 167 LILRRL----DHPN------VIKLEGLVTSRMSCSLYLVFHYMEHD---LAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233 (348)
Q Consensus 167 ~~l~~l----~hpn------iv~l~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 233 (348)
+...+. .|-+ |++++ .+ ......|+||||+|. ..+.+... ......+.......++.||+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy---~~-~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY---WD-LSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIF- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh---hh-cCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHH-
Confidence 333222 3444 33332 21 133579999999972 22222222 22222222222333444444
Q ss_pred HHHHHHHCCceecCCCCCCEEECC----CCcEEEEeeCCccccCCC
Q 018936 234 GLEHCHNNGVLHRDIKGSNLLIDD----DGVLKIADFGLASFFDPN 275 (348)
Q Consensus 234 aL~~LH~~~ivHrDikp~NIll~~----~~~~kl~DFGla~~~~~~ 275 (348)
..|++|+|-.|.||+++. ++.+.+.|||+...+...
T Consensus 319 ------~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 ------KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ------hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 468999999999999983 678999999999876433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1e-07 Score=92.55 Aligned_cols=186 Identities=16% Similarity=0.107 Sum_probs=129.0
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeeccCceEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN-VIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~~lv 195 (348)
-+.....+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++ ..+...+.++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~--d~~~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE--DYDGEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc--cCCcccccchh
Confidence 3566678899999999999865554444 5655321 22344889999999999 343333 33345667888
Q ss_pred EeecccC--hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 196 FHYMEHD--LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 196 ~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++++.++ ........ +-.+...+.....+.-+.+|++||+.--+||| ||+..+ +..+..||+.+..+.
T Consensus 313 ~~i~s~~rs~~~~~~~s-----e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVS-----EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhcCCccccccCChh-----hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC
Confidence 9988765 21111111 11222233444566678999999998779999 777654 688999999998775
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
... ...+..+++.++|||+..... +..+.|.|++|+-..+|.-|-+|-.
T Consensus 383 ~~~--~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 383 RTM--KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccc--ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCC
Confidence 543 345667899999999877644 8889999999987777777777653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.1e-05 Score=71.07 Aligned_cols=140 Identities=16% Similarity=0.163 Sum_probs=79.7
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.+++... .....++|+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 57899999999974 24467888865322 2334677999998885433 3555555544 33467899999
Q ss_pred ccCh-hh-hhc-------------------CCCCcCCcchhhHH--HHHHHHH-------HHHH-HHHHHHHC----Cce
Q 018936 200 EHDL-AG-LAA-------------------SPEVKFTEPQFVYL--KVKCYMH-------QLLS-GLEHCHNN----GVL 244 (348)
Q Consensus 200 ~~~l-~~-~~~-------------------~~~~~~~~~~~~~~--~~~~~~~-------qi~~-aL~~LH~~----~iv 244 (348)
+|.. .. ... ..........+... .+...+. .+.. ...+|... .++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8841 10 000 00010111111100 0100000 1111 12223222 478
Q ss_pred ecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 245 HRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 245 HrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+|+.|.||++++++ +.|+||+.+..-
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 999999999999888 999999988643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-05 Score=70.29 Aligned_cols=145 Identities=22% Similarity=0.304 Sum_probs=80.2
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC--ceeeeeceEeec-cCceEEEEEe
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP--NVIKLEGLVTSR-MSCSLYLVFH 197 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~-~~~~~~lv~e 197 (348)
++.|+.|..+.||++.. .+ ..+++|..... .....+.+|..+++.+... .+.+++...... .....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~-~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTT-DD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEE-TT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEE-CC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 46799999999999985 33 58999986432 3456777899998888533 355666544332 2334789999
Q ss_pred ecccChhhh-----------------h---cCCCCcCC-cchhh----H--HHHHHH------------HHHHHH-HHHH
Q 018936 198 YMEHDLAGL-----------------A---ASPEVKFT-EPQFV----Y--LKVKCY------------MHQLLS-GLEH 237 (348)
Q Consensus 198 ~~~~~l~~~-----------------~---~~~~~~~~-~~~~~----~--~~~~~~------------~~qi~~-aL~~ 237 (348)
++++..... + ........ ..... . ...... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998743333 0 00000000 00000 0 000000 111222 3334
Q ss_pred HHH-------CCceecCCCCCCEEEC-CCCcEEEEeeCCccc
Q 018936 238 CHN-------NGVLHRDIKGSNLLID-DDGVLKIADFGLASF 271 (348)
Q Consensus 238 LH~-------~~ivHrDikp~NIll~-~~~~~kl~DFGla~~ 271 (348)
+++ ..++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 442 3599999999999999 666678999997754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.2e-05 Score=66.78 Aligned_cols=132 Identities=21% Similarity=0.234 Sum_probs=89.9
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeccCceEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~lv 195 (348)
..+..+.||+|.+|.||+|. ..|..+|+|+-+.+ +....+..|+++|..+.--++ .+++.|-. .++.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~ 90 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIR 90 (201)
T ss_pred hhhhhhhhhcccccEEEEee--ccCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEech------hhhh
Confidence 34567889999999999997 56779999986543 334567789999999976665 45544422 3456
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCC-CCCEEECCCCcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIK-GSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDik-p~NIll~~~~~~kl~DFGla~~~ 272 (348)
|||++|..+....... . +.-+..+++.---|-..||-|..|. |..++|..++.+.|+||..|..-
T Consensus 91 me~i~G~~L~~~~~~~----~--------rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 91 MEYIDGRPLGKLEIGG----D--------RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcCcchhhhhhcc----c--------HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9999984443332211 0 1123345555555667799999885 55555556669999999999843
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.1e-05 Score=66.97 Aligned_cols=72 Identities=17% Similarity=0.118 Sum_probs=46.4
Q ss_pred eeccCCc-eEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEEEEeecc
Q 018936 123 KIGQGTY-SNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYME 200 (348)
Q Consensus 123 ~LG~G~~-g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~~~ 200 (348)
.|-.|.+ ..||+... ++..+.+|...... ...+.+|+++++.+. +--+++++++.... ...+++|++++
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeC
Confidence 3445555 78999963 34678888764322 234567888888873 33455666655443 34688999998
Q ss_pred cCh
Q 018936 201 HDL 203 (348)
Q Consensus 201 ~~l 203 (348)
|..
T Consensus 76 G~~ 78 (244)
T cd05150 76 GVP 78 (244)
T ss_pred Ccc
Confidence 743
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.04 E-value=9.1e-05 Score=77.45 Aligned_cols=82 Identities=26% Similarity=0.340 Sum_probs=55.8
Q ss_pred eeeeeccCCceEEEEEEEccCC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCce--eeeeceEeecc-CceEE
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTG--KIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNV--IKLEGLVTSRM-SCSLY 193 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~~-~~~~~ 193 (348)
.++.|+.|.+..+|+......+ ..+++|+........ ....+.+|.++|+.+. |+++ ++++.++.+.. ....|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3578899999999998753322 467888754433211 2346778999999995 6665 67777665431 23468
Q ss_pred EEEeecccC
Q 018936 194 LVFHYMEHD 202 (348)
Q Consensus 194 lv~e~~~~~ 202 (348)
+||||+++.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.1e-05 Score=65.87 Aligned_cols=31 Identities=29% Similarity=0.422 Sum_probs=26.3
Q ss_pred CceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+++|+|+.+.||+++++...-|+||+.+..-
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 5899999999999987655679999987654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.4e-05 Score=63.84 Aligned_cols=129 Identities=18% Similarity=0.232 Sum_probs=83.1
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEeecCC--------------CChHHHHHHHHHHHHHHhcC------CCceeee
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN--------------LEPESVKFMAREILILRRLD------HPNVIKL 180 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~--------------~~~~~~~~~~~E~~~l~~l~------hpniv~l 180 (348)
...||+|+.=.||.- +.+....||++.... ..........+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999999964 555667899987765 11112344555665555554 7889999
Q ss_pred eceEeeccCceEEEEEeeccc-------ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 018936 181 EGLVTSRMSCSLYLVFHYMEH-------DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNL 253 (348)
Q Consensus 181 ~~~~~~~~~~~~~lv~e~~~~-------~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI 253 (348)
+|+.+...+ ..+|+|.+.. .+..++... .+.. .+...+-.-..||-+++|+.+|++|.||
T Consensus 83 ~G~veT~~G--~Glv~e~I~d~dG~~s~TL~~~l~~~-------~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 83 YGFVETNLG--LGLVVELIRDADGNISPTLEDYLKEG-------GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNI 149 (199)
T ss_pred eEEEecCCc--eEEEEEEEECCCCCcCccHHHHHHcC-------CccH----HHHHHHHHHHHHHHHcCCeecCCCcccE
Confidence 999988544 7888887743 122222111 1111 1223334555688889999999999999
Q ss_pred EECCCC----cEEEEe
Q 018936 254 LIDDDG----VLKIAD 265 (348)
Q Consensus 254 ll~~~~----~~kl~D 265 (348)
++..+. .+.|+|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 997432 477776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=5e-06 Score=87.92 Aligned_cols=206 Identities=13% Similarity=0.000 Sum_probs=127.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
+.++++.=-+|.|.++.--.-+.+.++ +.-+-|....+++.+...+-...|+.-++...|+++.....-.........|
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~ 1307 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEY 1307 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHH
Confidence 455655545555544432211112222 1112222333344444455555677777788999998776555555555667
Q ss_pred EEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-----CceecCCCCCCEEECCCCcEEEEeeC
Q 018936 194 LVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-----GVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
..++|+.++ ++..+......++.. ...-+.....+.+.+..-+|+. --+|+++|+.|.+|..+.++++.++|
T Consensus 1308 ~r~~~~~~g~~f~iIikg~ee~~~l--d~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1308 IRSLYVEFGKLFSIIIKGLEESPDL--DRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHhHHHHHHHhccccCCcc--hhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 888888754 334333322222221 1111333344546777777755 27999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
+.+...+. ........+++.|++|++... -.++.++|+|..|+.+|+...|.++|
T Consensus 1386 LdKIknp~-~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1386 LDKIKNPV-LSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccCch-HhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99943322 222345566888899986543 34777899999999999999998887
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=8.7e-05 Score=67.44 Aligned_cols=138 Identities=19% Similarity=0.209 Sum_probs=91.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-----------------hH---HHHHHHHHHHHHHhcC-C
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-----------------PE---SVKFMAREILILRRLD-H 174 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-----------------~~---~~~~~~~E~~~l~~l~-h 174 (348)
.-+.+.++||-|.-+.||.+-+ ..|.+.++|.-+..... .+ ..-...+|...|+.|. |
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 4578899999999999999985 77899999965442210 00 0112235777777773 2
Q ss_pred -CceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCE
Q 018936 175 -PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNL 253 (348)
Q Consensus 175 -pniv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI 253 (348)
--+++.+++ +..++||+++.+..+..... ... ...+...+..-+--|-.+|+||+|..-=||
T Consensus 171 gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~----v~d-------~~~ly~~lm~~Iv~la~~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 171 GFPVPKPIDH------NRHCVVMELVDGYPLRQVRH----VED-------PPTLYDDLMGLIVRLANHGLIHGDFNEFNI 233 (465)
T ss_pred CCCCCCcccc------cceeeHHHhhcccceeeeee----cCC-------hHHHHHHHHHHHHHHHHcCceecccchhee
Confidence 224444443 33578899887743332211 111 122233444555667789999999999999
Q ss_pred EECCCCcEEEEeeCCccc
Q 018936 254 LIDDDGVLKIADFGLASF 271 (348)
Q Consensus 254 ll~~~~~~kl~DFGla~~ 271 (348)
++++++.++++||--+..
T Consensus 234 mv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred EEecCCCEEEeechHhhc
Confidence 999999999999986653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0016 Score=55.50 Aligned_cols=100 Identities=26% Similarity=0.260 Sum_probs=73.9
Q ss_pred HHHHHHHhcCC-CceeeeeceEeeccCceEEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC
Q 018936 164 REILILRRLDH-PNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241 (348)
Q Consensus 164 ~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 241 (348)
.|.-+|+.+++ +++++++|.| ..+++.||.+.. +.+.... -..+ ...++.....++.+++..+.+|+..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C------G~~~v~E~~~~~~~~~~~~~-l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC------GRFYVVEYVGAGSLYGIYRP-LSQF--LQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC------CCEEEEEeecCccccccccc-cccc--cccCHHHHHHHHHHHHHHHHHHhcC
Confidence 47888888876 6999999976 346788998753 3211000 0000 1334555778999999999999983
Q ss_pred ---CceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 242 ---GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 242 ---~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
.+.-.|++|+|+-+++++++|++|...+...
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5888999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0017 Score=57.14 Aligned_cols=72 Identities=14% Similarity=0.156 Sum_probs=44.5
Q ss_pred eeeeccCCceEEEEEEEcc-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeeccCceEEEEEee
Q 018936 121 IDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN-VIKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~~lv~e~ 198 (348)
++.|..|-...+|++.... ++..|++|+...... ..-...+|+.+++.+.... .+++++.+. . .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEe
Confidence 4567888888999997422 257888997643211 1122346888888884333 344443322 1 379999
Q ss_pred ccc
Q 018936 199 MEH 201 (348)
Q Consensus 199 ~~~ 201 (348)
+++
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0015 Score=60.41 Aligned_cols=30 Identities=33% Similarity=0.522 Sum_probs=26.2
Q ss_pred CceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 799999999999998665568999998854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00052 Score=62.78 Aligned_cols=145 Identities=15% Similarity=0.159 Sum_probs=81.4
Q ss_pred eeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeece----EeeccCceEE
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGL----VTSRMSCSLY 193 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~----~~~~~~~~~~ 193 (348)
-.+.|..|....+|+... ++..+++|+... . ..+.+..|++++..+.+.. +++++.. .........+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 356788888889999863 445788998753 1 1344666888888874332 3444321 1111133468
Q ss_pred EEEeecccChhhh----------------hcC-CCCcCC--c-chhhHHH-H---------HHHHHHHHHHHHHHHH---
Q 018936 194 LVFHYMEHDLAGL----------------AAS-PEVKFT--E-PQFVYLK-V---------KCYMHQLLSGLEHCHN--- 240 (348)
Q Consensus 194 lv~e~~~~~l~~~----------------~~~-~~~~~~--~-~~~~~~~-~---------~~~~~qi~~aL~~LH~--- 240 (348)
+++++++|..... ... ...... . ....+.. . ......+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998642211 000 000000 0 0000000 0 0011122344445543
Q ss_pred ----CCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 241 ----NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 241 ----~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999887778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0016 Score=60.46 Aligned_cols=142 Identities=22% Similarity=0.250 Sum_probs=88.4
Q ss_pred eeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC----------------------ChHH--HHHHHHHHHHHHhcCCC
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----------------------EPES--VKFMAREILILRRLDHP 175 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~----------------------~~~~--~~~~~~E~~~l~~l~hp 175 (348)
+--+|..|.-+.||.|. ..+|..+|||+++-+.+ ++.. .-.-..|++.|+++..-
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 33568889999999998 58899999998754211 1111 11233577778887654
Q ss_pred ceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCCEE
Q 018936 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH-NNGVLHRDIKGSNLL 254 (348)
Q Consensus 176 niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~NIl 254 (348)
.|.-.--+.. ....|||++++..-...-..... .++...+..+-.|++.-+.-|- .+++||.||.-=|+|
T Consensus 227 GIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~-----~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDA-----SLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL 297 (520)
T ss_pred CCCCCCceee----ecceEeeeeccCCCCcCcccccc-----cCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence 4322111111 12579999997532221111122 2222235555556666665554 569999999999999
Q ss_pred ECCCCcEEEEeeCCcccc
Q 018936 255 IDDDGVLKIADFGLASFF 272 (348)
Q Consensus 255 l~~~~~~kl~DFGla~~~ 272 (348)
+ .+|.+.|+|.+-+...
T Consensus 298 y-hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 298 Y-HDGKLYIIDVSQSVEH 314 (520)
T ss_pred E-ECCEEEEEEccccccC
Confidence 8 5789999999988654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00073 Score=60.53 Aligned_cols=139 Identities=19% Similarity=0.167 Sum_probs=75.2
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeccCceEEEEEeecccC
Q 018936 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 124 LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
+..|-...+|+.. .++..+++|....... ...-...+|.++++.+....+ +++++... -++|++|+++.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK--ALGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc--cccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCc
Confidence 4567788899886 5677888887543211 110124568888888854333 34433321 26889999874
Q ss_pred hhhhh---------------c-CCCCcCCcchhh-HHHHHHHHHHH---------HHHHHHHHH--------CCceecCC
Q 018936 203 LAGLA---------------A-SPEVKFTEPQFV-YLKVKCYMHQL---------LSGLEHCHN--------NGVLHRDI 248 (348)
Q Consensus 203 l~~~~---------------~-~~~~~~~~~~~~-~~~~~~~~~qi---------~~aL~~LH~--------~~ivHrDi 248 (348)
..... . ..........+. ...+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 32210 0 000111111111 11111221111 111222221 14899999
Q ss_pred CCCCEEECCCCcEEEEeeCCccccC
Q 018936 249 KGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 249 kp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
.|.||++++++ +.|+||..|..-+
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCcCC
Confidence 99999999877 7899999887543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0036 Score=57.72 Aligned_cols=148 Identities=18% Similarity=0.157 Sum_probs=81.0
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeece----EeeccCce
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGL----VTSRMSCS 191 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~----~~~~~~~~ 191 (348)
...++.++.|....+|+... .+| .+++|+..... . .+.+..|.+++..|.... +++++.. ........
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 34467788888889999863 344 67889765421 1 223445677777774322 3333321 11111345
Q ss_pred EEEEEeecccChhh---------------hhcCCCCcCCcc------hhhHHH--HH----------HHHHHHHHHHHHH
Q 018936 192 LYLVFHYMEHDLAG---------------LAASPEVKFTEP------QFVYLK--VK----------CYMHQLLSGLEHC 238 (348)
Q Consensus 192 ~~lv~e~~~~~l~~---------------~~~~~~~~~~~~------~~~~~~--~~----------~~~~qi~~aL~~L 238 (348)
.+++++|++|.... .+......+..+ ...+.. .. .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 68999998763110 000000011000 000000 00 0112233455555
Q ss_pred HH-------CCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 239 HN-------NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 239 H~-------~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.. .+++|+|+.+.||+++.++...|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 43 4899999999999999887778999998854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0034 Score=59.76 Aligned_cols=76 Identities=20% Similarity=0.131 Sum_probs=51.9
Q ss_pred eeeeccCCceEEEEEEEccCC-cEEEEEEeecC-----CCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeccCce
Q 018936 121 IDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFD-----NLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g-~~vAvK~i~~~-----~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~ 191 (348)
.+.||.|.+..||++... +| +.++||.-... ...+...++...|.+.|+.+. -.++++++.+.. ..
T Consensus 31 ~~elggGn~N~VyrV~~~-~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDT-EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----EL 105 (401)
T ss_pred eeEcCCCceEEEEEEEeC-CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----CC
Confidence 468999999999999964 44 58999974321 111234566777888888762 345777766532 23
Q ss_pred EEEEEeeccc
Q 018936 192 LYLVFHYMEH 201 (348)
Q Consensus 192 ~~lv~e~~~~ 201 (348)
.++|||++++
T Consensus 106 ~~lVME~L~~ 115 (401)
T PRK09550 106 AVTVMEDLSD 115 (401)
T ss_pred CEEEEecCCC
Confidence 6899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0022 Score=58.92 Aligned_cols=32 Identities=28% Similarity=0.390 Sum_probs=28.1
Q ss_pred CceecCCCCCCEEECCC----CcEEEEeeCCccccC
Q 018936 242 GVLHRDIKGSNLLIDDD----GVLKIADFGLASFFD 273 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~----~~~kl~DFGla~~~~ 273 (348)
.++|+|+.|.|||++++ +.+.++||..|..-.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~ 215 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY 215 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence 58999999999999975 889999999987543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0037 Score=56.74 Aligned_cols=32 Identities=28% Similarity=0.427 Sum_probs=26.7
Q ss_pred CceecCCCCCCEEECCCCc-EEEEeeCCccccC
Q 018936 242 GVLHRDIKGSNLLIDDDGV-LKIADFGLASFFD 273 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~~~-~kl~DFGla~~~~ 273 (348)
.++|+|+.|.|||+++++. .-|+||+.+..-+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 4899999999999997565 4699999987654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0063 Score=55.87 Aligned_cols=79 Identities=14% Similarity=0.160 Sum_probs=53.6
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC---CceeeeeceEeecc-CceEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH---PNVIKLEGLVTSRM-SCSLY 193 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~~-~~~~~ 193 (348)
-.-.+.||.|..+.||.... .++ .+.+|..+ .. .....+..|.+.|+.+.. -.++++++++.... ....+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~-~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD-SQG-NPMPLMAR-SF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred hheeeecCCccceeEEEEEc-CCC-CEEEEEec-cc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34467899999999999863 334 56777743 21 123467789999998853 35777887765421 23479
Q ss_pred EEEeecccC
Q 018936 194 LVFHYMEHD 202 (348)
Q Consensus 194 lv~e~~~~~ 202 (348)
+|||++++.
T Consensus 90 LVmE~i~G~ 98 (297)
T PRK10593 90 LLLERLRGV 98 (297)
T ss_pred EEEeccCCE
Confidence 999998863
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.011 Score=54.44 Aligned_cols=154 Identities=19% Similarity=0.216 Sum_probs=84.7
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeeccCceEEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~lv 195 (348)
..+++.+-.|-.-.+|... .+++.++++ ...............+|..+|+.+.- --+...+++|..+.-...|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~--~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLG--DTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEe--cCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 4455555444444555554 337888888 33222233445667788999888743 223444566655432356889
Q ss_pred EeecccChhhhhcC-----------------------CCCcC---Ccch-hhHHHHHHHHHH--------------HHHH
Q 018936 196 FHYMEHDLAGLAAS-----------------------PEVKF---TEPQ-FVYLKVKCYMHQ--------------LLSG 234 (348)
Q Consensus 196 ~e~~~~~l~~~~~~-----------------------~~~~~---~~~~-~~~~~~~~~~~q--------------i~~a 234 (348)
|+++++........ ..... ..+. +...++..+..+ ...-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 99988721110000 00000 0000 000011111111 1233
Q ss_pred HHHHHHC--------CceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 235 LEHCHNN--------GVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 235 L~~LH~~--------~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
..+|+.+ .++|+|+.+.||+++.++-+=|.||+++..-++
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 4455543 489999999999999988899999999987554
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.01 Score=55.32 Aligned_cols=31 Identities=29% Similarity=0.565 Sum_probs=26.8
Q ss_pred ceecCCCCCCEEECC-CCcEEEEeeCCccccC
Q 018936 243 VLHRDIKGSNLLIDD-DGVLKIADFGLASFFD 273 (348)
Q Consensus 243 ivHrDikp~NIll~~-~~~~kl~DFGla~~~~ 273 (348)
+.|.|+-+.|||+++ ++.++++||..|..-.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 799999999999975 5789999999886543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.002 Score=67.41 Aligned_cols=158 Identities=21% Similarity=0.205 Sum_probs=97.4
Q ss_pred HHHHHHHHHHHHhcCCCceeeeeceEeeccCce--EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHH
Q 018936 159 VKFMAREILILRRLDHPNVIKLEGLVTSRMSCS--LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE 236 (348)
Q Consensus 159 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~--~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~ 236 (348)
......|.+.+.+..|+|++.+++|-..+.... +.+..+++...........-. ..+..+.+.+..+++.||.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-----~i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-----SIPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-----ccCHHHHHHHHHHHhhhHH
Confidence 334455788888999999999877754433211 112223443322222211111 3334457888999999999
Q ss_pred HHHHCCceecCCCCC---CEEECCCCcEEEE--eeCCccccCCCCCCCcccccccCcccccccccCcc-cCCccccHHHH
Q 018936 237 HCHNNGVLHRDIKGS---NLLIDDDGVLKIA--DFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSA 310 (348)
Q Consensus 237 ~LH~~~ivHrDikp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSl 310 (348)
|+|+....|.-+..+ +--.+.++...++ ||+.++.+..... ......+..+.+||...... +.....|+|.+
T Consensus 301 ~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 301 YLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred HHHHhccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHH
Confidence 999996666555554 4444556667776 9998887643322 22223355578888654321 12234799999
Q ss_pred HHHHHHHHhCCCC
Q 018936 311 GCILAELLAGKPI 323 (348)
Q Consensus 311 Gv~l~elltG~~p 323 (348)
|..+..+..|..+
T Consensus 379 gll~~~~~~~~~i 391 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHhhhhhcCcc
Confidence 9999999988754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.031 Score=51.54 Aligned_cols=31 Identities=26% Similarity=0.275 Sum_probs=28.5
Q ss_pred CceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+++|+|+.+.|+|+++++.+-++||..+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 7999999999999999999999999988754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.015 Score=54.52 Aligned_cols=75 Identities=19% Similarity=0.172 Sum_probs=46.7
Q ss_pred eeccCCceEEEEEEEccCCcEEEEEEee----c-CCCChHHHHHHHHHHHHHHhcC--CC-ceeeeeceEeeccCceEEE
Q 018936 123 KIGQGTYSNVYKAKDMLTGKIVALKKVR----F-DNLEPESVKFMAREILILRRLD--HP-NVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 123 ~LG~G~~g~Vy~~~~~~~g~~vAvK~i~----~-~~~~~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~~~l 194 (348)
.||.|....||++.+...++.|+||.-. . ....+-..++...|.+.|+... -| .+++++.+-. ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~----e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT----EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc----cccee
Confidence 5899999999999964333689999632 1 1122334455556888887663 23 4666654422 22468
Q ss_pred EEeeccc
Q 018936 195 VFHYMEH 201 (348)
Q Consensus 195 v~e~~~~ 201 (348)
+||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 8888853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.079 Score=49.71 Aligned_cols=146 Identities=14% Similarity=0.175 Sum_probs=78.9
Q ss_pred eeeeeeccCCceEEEEEEEcc----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeccCceEE
Q 018936 119 EKIDKIGQGTYSNVYKAKDML----TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IKLEGLVTSRMSCSLY 193 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~ 193 (348)
.-+..|-.|-.-.+|++.... .++.|++|+..... ....+ ..+|..+++.+..-++ .++++.+.. .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~------g 109 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN------G 109 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC------c
Confidence 334456558888999986422 24689999764432 22222 3568888888854333 355555432 1
Q ss_pred EEEeecccChhhhh------------------cCCCCcCCcchhhHHHHHHHHHHH-----------------HHHHHHH
Q 018936 194 LVFHYMEHDLAGLA------------------ASPEVKFTEPQFVYLKVKCYMHQL-----------------LSGLEHC 238 (348)
Q Consensus 194 lv~e~~~~~l~~~~------------------~~~~~~~~~~~~~~~~~~~~~~qi-----------------~~aL~~L 238 (348)
.+.+|+++..+... .............+.++..++.++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 46777765221110 000001111011122233333222 1112222
Q ss_pred ----H----HCCceecCCCCCCEEECC-CCcEEEEeeCCccccC
Q 018936 239 ----H----NNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFD 273 (348)
Q Consensus 239 ----H----~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~ 273 (348)
. ...++|+|+++.|||+++ ++.+.++||..+....
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 1 125899999999999986 4689999999887543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.025 Score=53.61 Aligned_cols=76 Identities=20% Similarity=0.162 Sum_probs=49.4
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEe----ecCCCChHHHHHHHHHHHHHHhcC--CC-ceeeeeceEeeccCceEE
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKV----RFDNLEPESVKFMAREILILRRLD--HP-NVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i----~~~~~~~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~~~ 193 (348)
.+.||.|.-.-||++.+...+..|+||.- +.....+-..++..-|.++|+... -| .+++++.+-.. ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e----~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV----MNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH----Hhh
Confidence 67899999999999986333567999963 322223445666667888888763 23 46667544222 245
Q ss_pred EEEeecc
Q 018936 194 LVFHYME 200 (348)
Q Consensus 194 lv~e~~~ 200 (348)
+|||+++
T Consensus 110 ~vMEdL~ 116 (409)
T PRK12396 110 CVMEDLS 116 (409)
T ss_pred HHHHhCc
Confidence 6777764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.094 Score=48.77 Aligned_cols=143 Identities=18% Similarity=0.238 Sum_probs=80.9
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc------eeeeeceEeeccC--ceEE
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN------VIKLEGLVTSRMS--CSLY 193 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~~--~~~~ 193 (348)
..|.+ .-..||+.+. .+|.. ++|+.+.. .. ...+.-|...|..|.-.. +..+-|-....-. +..+
T Consensus 32 ~~l~s-~eN~~f~~~~-~~g~~-iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 32 RGLNS-EENSNFRVQT-EDGRY-ILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccccc-ccCceEEEEe-cCCCe-EEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 34444 5567899873 45544 88988754 22 344556777887773221 3344343322222 3778
Q ss_pred EEEeecccChhhh----------------hc--CCCCc------CCcchhh----HHH-------HHHHHHHHHHHHHHH
Q 018936 194 LVFHYMEHDLAGL----------------AA--SPEVK------FTEPQFV----YLK-------VKCYMHQLLSGLEHC 238 (348)
Q Consensus 194 lv~e~~~~~l~~~----------------~~--~~~~~------~~~~~~~----~~~-------~~~~~~qi~~aL~~L 238 (348)
-+++|++|..... +. ..... ....... ... -.....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999998754331 00 00011 0000000 000 011334555666666
Q ss_pred HHC--------C--ceecCCCCCCEEECCCCc-EEEEeeCCccc
Q 018936 239 HNN--------G--VLHRDIKGSNLLIDDDGV-LKIADFGLASF 271 (348)
Q Consensus 239 H~~--------~--ivHrDikp~NIll~~~~~-~kl~DFGla~~ 271 (348)
.+. + +||+|+.|.||+++.+.. +-++||+-+..
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 653 4 999999999999998875 89999997753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.044 Score=52.24 Aligned_cols=76 Identities=18% Similarity=0.169 Sum_probs=50.0
Q ss_pred eeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-----ChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeccCce
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-----EPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~ 191 (348)
..+.||.|....||+..+ .+..++||.-..... .+...++...|.+.|+.+. -.++++++.++.+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 367899999999999985 345689997542111 1123444445677777663 2477888777653 2
Q ss_pred EEEEEeeccc
Q 018936 192 LYLVFHYMEH 201 (348)
Q Consensus 192 ~~lv~e~~~~ 201 (348)
.+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5778999965
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.05 Score=51.73 Aligned_cols=91 Identities=20% Similarity=0.216 Sum_probs=50.2
Q ss_pred hhhccccCcccCCCCCceeeeeeccCCceEEEEEEEccC-CcE-----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCC
Q 018936 102 VCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLT-GKI-----VALKKVRFDNLEPESVKFMAREILILRRLDHP 175 (348)
Q Consensus 102 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~-g~~-----vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hp 175 (348)
.|.+....|.....+..++. .|..|-...+|++..... +.. |.++.. .... +..-...+|+++++.+...
T Consensus 37 ~~~~~~p~w~~~~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~--g~~~-~l~IdR~~E~~i~~~Ls~~ 112 (383)
T PTZ00384 37 LCIRHVPFWNNVNPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS--STYN-SLVIDNDLQYNIAKLLGDN 112 (383)
T ss_pred HHHHHCCccccCCcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEec--cCCC-ceEeccHHHHHHHHHHHhC
Confidence 34444455543333445554 555599999999974322 223 333332 1111 1112235689999998655
Q ss_pred ce-eeeeceEeeccCceEEEEEeecccC
Q 018936 176 NV-IKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 176 ni-v~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
++ .++++.+. -+++.||+++.
T Consensus 113 glgP~l~~~f~------~g~l~efIeGr 134 (383)
T PTZ00384 113 NFGPKIIGRFG------DFTIQEWVEGN 134 (383)
T ss_pred CCCCeEEEecC------CEEEEEEeccc
Confidence 44 55666553 25788888764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.07 Score=48.68 Aligned_cols=76 Identities=16% Similarity=0.193 Sum_probs=45.8
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeccCceEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~l 194 (348)
.+-.+.++-|....+|+.. .+++.+.||+-.. .....+..|.+-|+.|. --.+++.+++...... -||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fL 89 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFL 89 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceE
Confidence 4556789999999999987 7788999998652 22345677888888883 3346677776655433 489
Q ss_pred EEeecccC
Q 018936 195 VFHYMEHD 202 (348)
Q Consensus 195 v~e~~~~~ 202 (348)
++||++..
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99998654
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.1 Score=50.61 Aligned_cols=95 Identities=13% Similarity=0.189 Sum_probs=55.5
Q ss_pred hhhhhhhccccCcccCCCCCceeeeeeccCCceEEEEEEEccC--------CcEEEEEEeecCCCChHHHHHHHHHHHHH
Q 018936 98 WLTAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLT--------GKIVALKKVRFDNLEPESVKFMAREILIL 169 (348)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~--------g~~vAvK~i~~~~~~~~~~~~~~~E~~~l 169 (348)
.....|.+....|.....++. -++.|..|-.-.+|++..... ++.|.+|+.-... .. .-...+|..++
T Consensus 88 ~~~~i~~~~vp~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--e~-lIdR~~E~~v~ 163 (442)
T PTZ00296 88 YIKKICLEKVPEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--DE-LYNPISEFEVY 163 (442)
T ss_pred HHHHHHHHHCCccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--cc-eeCHHHHHHHH
Confidence 344445555556654444555 667777788889999874311 4678888764321 11 12345588888
Q ss_pred HhcCCCce-eeeeceEeeccCceEEEEEeecccC
Q 018936 170 RRLDHPNV-IKLEGLVTSRMSCSLYLVFHYMEHD 202 (348)
Q Consensus 170 ~~l~hpni-v~l~~~~~~~~~~~~~lv~e~~~~~ 202 (348)
+.+....| .++++.+. -+.+.+|+++.
T Consensus 164 ~~ls~~gi~P~l~~~f~------gg~I~efi~g~ 191 (442)
T PTZ00296 164 KTMSKYRIAPQLLNTFS------GGRIEEWLYGD 191 (442)
T ss_pred HHHHHCCCCCceEEEeC------CCEEEEeeCCc
Confidence 87755444 34555442 13467887753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.057 Score=50.35 Aligned_cols=74 Identities=23% Similarity=0.292 Sum_probs=53.5
Q ss_pred cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEee
Q 018936 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADF 266 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DF 266 (348)
.+-+.|++|++-.+.+...-. ..+.++..++++.+..+.-+... .+=|||+.-.||||+ +|++.|+||
T Consensus 297 e~~y~yl~~kdhgt~is~ik~----------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 297 ETLYLYLHFKDHGTPISIIKA----------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred CceEEEEEEecCCceeeeeec----------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEe
Confidence 355678888876654332111 11223666777877777777655 799999999999999 999999999
Q ss_pred CCcccc
Q 018936 267 GLASFF 272 (348)
Q Consensus 267 Gla~~~ 272 (348)
-+++.-
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999943
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.5 Score=50.87 Aligned_cols=31 Identities=35% Similarity=0.597 Sum_probs=26.3
Q ss_pred CCceecCCCCCCEEECCCC--cEE-EEeeCCccc
Q 018936 241 NGVLHRDIKGSNLLIDDDG--VLK-IADFGLASF 271 (348)
Q Consensus 241 ~~ivHrDikp~NIll~~~~--~~k-l~DFGla~~ 271 (348)
.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3799999999999999775 565 999998754
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.84 Score=42.40 Aligned_cols=28 Identities=29% Similarity=0.258 Sum_probs=24.2
Q ss_pred CceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+++|+|+.+.|||++ + .+.|+||+-+..
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 689999999999995 4 578999998764
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.033 Score=51.13 Aligned_cols=51 Identities=24% Similarity=0.247 Sum_probs=35.9
Q ss_pred HHHHHHHHHHHHHHHHHC----CceecCCCCCCEEECCCC------------------cEEEEeeCCccccCC
Q 018936 224 VKCYMHQLLSGLEHCHNN----GVLHRDIKGSNLLIDDDG------------------VLKIADFGLASFFDP 274 (348)
Q Consensus 224 ~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~------------------~~kl~DFGla~~~~~ 274 (348)
++.+..||+.-.-.+-+. +++|-||||+|||+-+.. .++|.||.+++..+-
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~i 353 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVANI 353 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHccc
Confidence 566777877554344333 699999999999994332 467889998876543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.065 Score=49.22 Aligned_cols=30 Identities=27% Similarity=0.515 Sum_probs=26.1
Q ss_pred CCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 241 ~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.097 Score=50.94 Aligned_cols=122 Identities=27% Similarity=0.418 Sum_probs=73.2
Q ss_pred HHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH
Q 018936 161 FMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN 240 (348)
Q Consensus 161 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 240 (348)
++.-...+++.+.|+|..+.+++...... ...+|+|+++.++.+........ ..+++ .
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~-r~IVV~e~~~~Sled~~~~~~l~--------------~~s~~-------~ 85 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHE-RVIVVMEHYTMSLEDILKTGNLK--------------DESLL-------A 85 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccc-eEEEEehhhccchHHHHHhcccc--------------hhhhc-------c
Confidence 35556789999999999998876654433 37899999998877766543311 00111 1
Q ss_pred CCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC
Q 018936 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 320 (348)
Q Consensus 241 ~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG 320 (348)
+++.|- | .++++| ... |. | |- ..++|+||||+|.++.++.-|
T Consensus 86 ~~~~~~-----~-------~~~~td----~~~-------------t~-~--~~------~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 86 HGVLHL-----N-------IIYITD----HFL-------------TK-Y--PS------PIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred ccccee-----h-------hhhccc----ccc-------------cc-C--CC------CCCcchhhhhHHHHHHHHHHh
Confidence 222221 1 123333 000 00 1 11 123599999999999999999
Q ss_pred CCCCCCCChhHHHHHHHHHhccC
Q 018936 321 KPIMPGRTEVSATFCFVLNLIFD 343 (348)
Q Consensus 321 ~~pf~~~~~~~~~~~~i~~~~~~ 343 (348)
...+...++.+... +++....+
T Consensus 128 ~~l~~~~~~s~~l~-~i~k~~~~ 149 (725)
T KOG1093|consen 128 ISLEAELTESEYLE-ILLKYYTD 149 (725)
T ss_pred hHHHHHHHHHHHHH-HHHHhccC
Confidence 99988777655443 34443333
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.048 Score=50.34 Aligned_cols=52 Identities=25% Similarity=0.216 Sum_probs=34.7
Q ss_pred HHHHHHHHHHHHHHHHH----CCceecCCCCCCEEECCC------------------CcEEEEeeCCccccCCC
Q 018936 224 VKCYMHQLLSGLEHCHN----NGVLHRDIKGSNLLIDDD------------------GVLKIADFGLASFFDPN 275 (348)
Q Consensus 224 ~~~~~~qi~~aL~~LH~----~~ivHrDikp~NIll~~~------------------~~~kl~DFGla~~~~~~ 275 (348)
++.+..||+.-.--.-+ .+++|-||||+|||+-+. -.++|.||.+++..+-.
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~i~ 350 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVANII 350 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcccc
Confidence 45566676543311222 369999999999999432 24789999999876533
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.044 Score=46.51 Aligned_cols=31 Identities=32% Similarity=0.485 Sum_probs=26.9
Q ss_pred CceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
-.+|+|+.|.||++++++ ++|+||+.|..-+
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD 108 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGD 108 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence 369999999999998877 9999999987544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 348 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-50 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-50 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-49 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-49 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-47 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-47 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-47 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-47 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-47 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-47 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-47 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-47 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-47 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-47 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-47 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-47 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-47 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-47 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-47 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-47 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-47 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-47 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-46 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-46 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-46 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-46 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-46 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-46 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-46 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-46 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-46 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-46 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-46 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-46 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-46 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-46 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-46 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-46 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-46 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-46 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-46 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-44 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-42 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-42 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-41 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-41 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-40 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-40 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-40 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-40 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-36 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-36 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-36 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-36 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-36 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-36 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-36 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-36 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-35 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-35 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-35 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-35 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-35 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-35 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-35 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-35 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-35 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-35 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-35 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-35 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-35 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-35 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-35 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-35 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-35 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-35 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-35 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-35 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-34 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-34 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-34 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-34 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-34 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-34 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-33 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-33 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-33 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-33 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-33 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-33 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-33 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-33 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-33 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-33 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-33 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-33 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-32 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-32 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-32 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-32 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-32 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-32 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-32 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-32 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-32 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-32 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-32 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-32 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-32 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-32 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-32 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-32 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-32 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-32 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-32 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-32 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-32 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-32 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-32 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-32 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-32 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-32 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-32 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-32 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-32 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-32 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-32 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-32 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-32 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-32 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-32 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-32 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-32 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-32 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-32 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-32 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-32 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-32 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-32 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-32 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-32 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-32 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-32 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-32 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-32 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-32 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-32 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-32 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-32 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-32 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-32 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-32 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-32 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-32 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-32 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-31 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-31 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-31 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-31 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-31 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-31 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-31 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-31 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-31 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-31 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-31 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-31 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-31 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-31 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-31 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-31 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-30 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-29 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-29 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-29 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-28 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-27 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-27 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-27 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-27 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-27 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-27 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-27 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-27 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-27 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-27 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-26 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-26 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-26 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-26 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-26 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-26 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-26 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-26 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-26 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-26 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-26 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-26 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-26 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-26 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-26 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-26 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-26 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-26 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-26 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-26 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-26 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-26 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-26 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-25 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-25 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-24 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-23 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-23 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-23 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-23 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-22 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-22 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-22 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-22 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-22 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-22 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-22 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-22 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-22 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-21 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-21 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-21 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-21 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-21 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-21 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-21 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-21 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-21 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-21 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-21 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-21 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-21 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-21 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-21 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-20 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-20 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-19 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-19 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-19 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-19 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-19 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-19 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-19 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-19 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-19 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-19 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-19 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-19 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-19 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-19 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-18 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-18 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-18 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-18 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-137
Identities = 115/249 (46%), Positives = 147/249 (59%), Gaps = 21/249 (8%)
Query: 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA- 163
+++ +EK+ KIGQGT+ V+KA+ TG+ VALKKV +N E E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 164 REILILRRLDHPNVIKLEGLVTSRMS------CSLYLVFHYMEHDLAGLAASPEVKFTEP 217
REI IL+ L H NV+ L + ++ S S+YLVF + EHDLAGL ++ VKFT
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 218 QFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK 277
+ +K M LL+GL + H N +LHRD+K +N+LI DGVLK+ADFGLA F
Sbjct: 125 E-----IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 278 H---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
T+RVVTLWYRPPELLLG DYG +DLW AGCI+AE+ PIM G TE
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-- 237
Query: 335 CFVLNLIFD 343
L LI
Sbjct: 238 ---LALISQ 243
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-125
Identities = 102/236 (43%), Positives = 143/236 (60%), Gaps = 18/236 (7%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMA-REIL 167
+ RA +EK+D +G+G ++ VYKA+D T +IVA+KK++ + + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCY 227
+L+ L HPN+I L + + + LVF +ME DL + + T +K Y
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSH-----IKAY 117
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVT 286
M L GLE+ H + +LHRD+K +NLL+D++GVLK+ADFGLA SF PN T +VVT
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVT 175
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342
WYR PELL GA YGVGVD+W+ GCILAELL P +PG +++ L IF
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-----LTRIF 226
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 319 bits (821), Expect = e-109
Identities = 103/238 (43%), Positives = 143/238 (60%), Gaps = 18/238 (7%)
Query: 108 NGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REI 166
N + + ++K++K+G+GTY VYKAKD G+IVALK++R D E E + A REI
Sbjct: 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDA-EDEGIPSTAIREI 70
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKC 226
+L+ L HPN++ L ++ S L LVF +ME DL + + + Q +K
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDSQ-----IKI 123
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVV 285
Y++QLL G+ HCH + +LHRD+K NLLI+ DG LK+ADFGLA F P T VV
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVV 181
Query: 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
TLWYR P++L+G+ Y VD+WS GCI AE++ GKP+ PG T+ L IF
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-----LPKIFS 234
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-109
Identities = 89/241 (36%), Positives = 123/241 (51%), Gaps = 23/241 (9%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF---MAREILIL 169
+E + +IG G Y VYKA+D +G VALK VR N RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 170 RRL---DHPNVIKLEGLVTSR---MSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYL 222
RRL +HPNV++L + + + LVF +++ DL L +P
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAET---- 121
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
+K M Q L GL+ H N ++HRD+K N+L+ G +K+ADFGLA + +T
Sbjct: 122 -IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTP 178
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342
VVTLWYR PE+LL +T Y VD+WS GCI AE+ KP+ G +E L IF
Sbjct: 179 VVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-----LGKIF 232
Query: 343 D 343
D
Sbjct: 233 D 233
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 322 bits (826), Expect = e-108
Identities = 97/258 (37%), Positives = 131/258 (50%), Gaps = 30/258 (11%)
Query: 107 LNGWIPRRADSFEKID-KIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMA 163
L+ R D FE K+G+GTY +VYKA KD K ALK++ + +
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC---- 66
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL--------AASPEVKFT 215
REI +LR L HPNVI L+ + S ++L+F Y EHDL + A V+
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 216 EPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD----GVLKIADFGLASF 271
VK ++Q+L G+ + H N VLHRD+K +N+L+ + G +KIAD G A
Sbjct: 127 RGM-----VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 272 F-DPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
F P + VVT WYR PELLLGA Y +D+W+ GCI AELL +PI R E
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241
Query: 330 VSATFCFV----LNLIFD 343
T L+ IF+
Sbjct: 242 DIKTSNPYHHDQLDRIFN 259
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-108
Identities = 97/232 (41%), Positives = 137/232 (59%), Gaps = 13/232 (5%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRL 172
+ F++++K+G GTY+ VYK + TG VALK+V+ D+ E E A REI +++ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-E-EGTPSTAIREISLMKEL 60
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
H N+++L ++ + L LVF +M++DL S V T VK + QLL
Sbjct: 61 KHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRP 291
GL CH N +LHRD+K NLLI+ G LK+ DFGLA F P + +S VVTLWYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRA 176
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
P++L+G+ Y +D+WS GCILAE++ GKP+ PG + L LIFD
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-----LKLIFD 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-107
Identities = 92/228 (40%), Positives = 132/228 (57%), Gaps = 16/228 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+++ K+DK+G+GTY+ VYK K LT +VALK++R ++ E + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N++ L ++ + S L LVF Y++ DL VK ++ QLL GL
Sbjct: 61 NIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHN-----VKLFLFQLLRGL 113
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPPEL 294
+CH VLHRD+K NLLI++ G LK+ADFGLA P + VVTLWYRPP++
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDI 171
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342
LLG+TDY +D+W GCI E+ G+P+ PG T L+ IF
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-----LHFIF 214
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-107
Identities = 100/231 (43%), Positives = 135/231 (58%), Gaps = 18/231 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+EK++KIG+GTY V+KAK+ T +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKH 60
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N+++L ++ S L LVF + + DL S VK ++ QLL G
Sbjct: 61 KNIVRLHDVLHSDKK--LTLVFEFCDQDLKKYFDSCNGDLDPEI-----VKSFLFQLLKG 113
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPPE 293
L CH+ VLHRD+K NLLI+ +G LK+A+FGLA F P ++ VVTLWYRPP+
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPD 171
Query: 294 LLLGATDYGVGVDLWSAGCILAELL-AGKPIMPGRTEVSATFCFVLNLIFD 343
+L GA Y +D+WSAGCI AEL AG+P+ PG L IF
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-----LKRIFR 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-106
Identities = 92/230 (40%), Positives = 133/230 (57%), Gaps = 18/230 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+ + ++KIG+GTY VYKA++ G+ ALKK+R + E E + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKH 59
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++KL ++ ++ L LVF +++ DL L E K ++ QLL+G
Sbjct: 60 SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVT-----AKSFLLQLLNG 112
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTLWYRPPE 293
+ +CH+ VLHRD+K NLLI+ +G LKIADFGLA F P T +VTLWYR P+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPD 170
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
+L+G+ Y +D+WS GCI AE++ G P+ PG +E L IF
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-----LMRIFR 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-105
Identities = 90/240 (37%), Positives = 133/240 (55%), Gaps = 23/240 (9%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILI 168
D + +I K+G+GTY VYKA D +T + VA+K++R ++ E E V A RE+ +
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSL 86
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYM 228
L+ L H N+I+L+ ++ L+L+F Y E+DL + +K ++
Sbjct: 87 LKELQHRNIIELKSVIHHNHR--LHLIFEYAENDLKKYMDKN-PDVSMRV-----IKSFL 138
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLID-----DDGVLKIADFGLASFF-DPNHKHPMTS 282
+QL++G+ CH+ LHRD+K NLL+ + VLKI DFGLA F P T
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTH 196
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342
++TLWYRPPE+LLG+ Y VD+WS CI AE+L P+ PG +E+ L IF
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-----LFKIF 251
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 307 bits (790), Expect = e-104
Identities = 92/243 (37%), Positives = 132/243 (54%), Gaps = 23/243 (9%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMA-REIL 167
+ R +E + +IG+G Y V+KA+D+ G+ VALK+VR E + RE+
Sbjct: 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVA 63
Query: 168 ILRRL---DHPNVIKLEGLVTSRMS---CSLYLVFHYMEHDLAG-LAASPEVKFTEPQFV 220
+LR L +HPNV++L + T + L LVF +++ DL L PE
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-- 121
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
+K M QLL GL+ H++ V+HRD+K N+L+ G +K+ADFGLA + +
Sbjct: 122 ---IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--L 176
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340
TS VVTLWYR PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V L
Sbjct: 177 TSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-----LGK 230
Query: 341 IFD 343
I D
Sbjct: 231 ILD 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = e-103
Identities = 72/220 (32%), Positives = 124/220 (56%), Gaps = 12/220 (5%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRR 171
+ + +E + +G+G+Y V K ++ TG+IVA+KK + + + VK +A REI +L++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQ 80
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
L H N++ L + + YLVF +++H + V+ Y+ Q+
Sbjct: 81 LRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDLELFPNGLDYQV-----VQKYLFQI 133
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYR 290
++G+ CH++ ++HRDIK N+L+ GV+K+ DFG A + P V T WYR
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYR 191
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
PELL+G YG VD+W+ GC++ E+ G+P+ PG +++
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-102
Identities = 86/229 (37%), Positives = 125/229 (54%), Gaps = 17/229 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+ +EKI KIG+G+Y V+K ++ TG+IVA+KK + +K +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
PN++ L + R L+LVF Y +H + + E VK Q L
Sbjct: 62 PNLVNLLEVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL-----VKSITWQTLQA 114
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVVTLWYRPPE 293
+ CH + +HRD+K N+LI V+K+ DFG A P+ V T WYR PE
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPE 172
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342
LL+G T YG VD+W+ GC+ AELL+G P+ PG+++V L LI
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-----LYLIR 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 2e-88
Identities = 93/270 (34%), Positives = 134/270 (49%), Gaps = 16/270 (5%)
Query: 67 RGERKRSKSNPRLSNLPKHLRGEQVAAGWPP-WLTAVCGEALNGWIPRRADSFEKIDKIG 125
R + + P +V+ +T V G + S+ IG
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63
Query: 126 QGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVT 185
G++ VY+AK +G++VA+KKV D +F RE+ I+R+LDH N+++L
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 186 S----RMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN 241
S + L LV Y+ + +A +Y VK YM+QL L + H+
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRSLAYIHSF 175
Query: 242 GVLHRDIKGSNLLIDDD-GVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD 300
G+ HRDIK NLL+D D VLK+ DFG A P S + + +YR PEL+ GATD
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATD 233
Query: 301 YGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
Y +D+WSAGC+LAELL G+PI PG + V
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQPIFPGDSGV 263
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 3e-83
Identities = 80/224 (35%), Positives = 124/224 (55%), Gaps = 18/224 (8%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
+R ++ IG G++ V++AK + + + VA+KKV D +F RE+ I+R +
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIV 89
Query: 173 DHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAAS-PEVKFTEPQFVYLKVKCY 227
HPNV+ L+ S L LV Y+ + + ++K T P + +K Y
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL---IKLY 146
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
M+QLL L + H+ G+ HRDIK NLL+D GVLK+ DFG A P S + +
Sbjct: 147 MYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICS 204
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+YR PEL+ GAT+Y +D+WS GC++AEL+ G+P+ PG + +
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI 248
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-76
Identities = 75/255 (29%), Positives = 116/255 (45%), Gaps = 26/255 (10%)
Query: 100 TAVCGEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESV 159
+ A + + D F+ GQGT+ V K+ TG VA+KKV D
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------P 60
Query: 160 KFMAREILILRRL---DHPNVIKLEGLVTSRMSCS-----LYLVFHYMEHDLAGLAASPE 211
+F RE+ I++ L HPN+++L+ + L +V Y+ L +
Sbjct: 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY 120
Query: 212 VKFTEPQFVYLKVKCYMHQLLSGLEHCHNN--GVLHRDIKGSNLLID-DDGVLKIADFGL 268
+ P + +K ++ QL+ + H V HRDIK N+L++ DG LK+ DFG
Sbjct: 121 RRQVAPPPIL--IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328
A P+ P + + + +YR PEL+ G Y VD+WS GCI AE++ G+PI G
Sbjct: 179 AKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236
Query: 329 EVSATFCFVLNLIFD 343
L+ I
Sbjct: 237 SAGQ-----LHEIVR 246
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 1e-75
Identities = 71/256 (27%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
+ + +G G++ V + D+ +GK ALKKV D ++ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 172 LDHPNVIKLEGLVTSRMSCS------------------------------------LYLV 195
LDH N+IKL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI 255
Y+ L + S + Y++QL + H+ G+ HRDIK NLL+
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNL--ISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 256 D-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 314
+ D LK+ DFG A P+ P + + + +YR PEL+LGAT+Y +DLWS GC+
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 315 AELLAGKPIMPGRTEV 330
EL+ GKP+ G T +
Sbjct: 233 GELILGKPLFSGETSI 248
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 5e-73
Identities = 67/219 (30%), Positives = 114/219 (52%), Gaps = 20/219 (9%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DH 174
D ++ + K+G+G YS V++A ++ + V +K ++ P K + REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHY-MEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
PN+I L +V +S + LVF + D L ++ YM+++L
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILK 141
Query: 234 GLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
L++CH+ G++HRD+K N++ID + L++ D+GLA F+ P RV + +++ P
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGP 199
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEV 330
ELL+ Y +D+WS GC+LA ++ K P G
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 8e-71
Identities = 85/239 (35%), Positives = 124/239 (51%), Gaps = 23/239 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILIL 169
+ R + + IG+G Y V A D L VA+KK+ F++ + REI IL
Sbjct: 25 VGPR---YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKIL 79
Query: 170 RRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKC 226
R H N+I + ++ + +Y+V ME DL L + + Y
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYF---- 133
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTSRV 284
++Q+L GL++ H+ VLHRD+K SNLL++ LKI DFGLA DP+H H +T V
Sbjct: 134 -LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
T WYR PE++L + Y +D+WS GCILAE+L+ +PI PG+ + LN I
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNHILG 246
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-70
Identities = 90/248 (36%), Positives = 130/248 (52%), Gaps = 32/248 (12%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+ R + + +G G V+ A D K VA+KK+ + P+SVK REI I+R
Sbjct: 9 LGSR---YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIR 63
Query: 171 RLDHPNVIKLEGLVTSRMSCS------------LYLVFHYMEHDLAGLAASPEVKFTEPQ 218
RLDH N++K+ ++ S +Y+V YME DLA + E
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG--PLLEEH 121
Query: 219 FVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHK 277
M+QLL GL++ H+ VLHRD+K +NL I+ +D VLKI DFGLA DP++
Sbjct: 122 ARLF-----MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 278 HP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335
H ++ +VT WYR P LLL +Y +D+W+AGCI AE+L GK + G E+
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--- 233
Query: 336 FVLNLIFD 343
+ LI +
Sbjct: 234 --MQLILE 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-70
Identities = 85/259 (32%), Positives = 125/259 (48%), Gaps = 53/259 (20%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
IP R +E IG G+Y +V +A D L ++VA+KK+ F++ K + REI I
Sbjct: 51 IPDR---YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED--LIDCKRILREIAI 105
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVK 225
L RL+H +V+K+ +V + LY+V + D L +P V TE +K
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELH-----IK 159
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA---------------- 269
++ LL G+++ H+ G+LHRD+K +N L++ D +K+ DFGLA
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 270 ----------SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL- 318
N K +T VVT WYR PEL+L +Y +D+WS GCI AELL
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 319 ----------AGKPIMPGR 327
P+ PG
Sbjct: 280 MIKENVAYHADRGPLFPGS 298
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-69
Identities = 85/239 (35%), Positives = 124/239 (51%), Gaps = 28/239 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+P+ + +G G Y +V A D +G+ VA+KK+ F + K RE+L+
Sbjct: 22 LPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLL 76
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV 224
L+ + H NVI L + T S YLV +M+ DL + F+E + YL
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYL-- 131
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
++Q+L GL++ H+ GV+HRD+K NL +++D LKI DFGLA D MT V
Sbjct: 132 ---VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYV 184
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
VT WYR PE++L Y VD+WS GCI+AE+L GK + G+ + L I
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILK 238
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-69
Identities = 80/246 (32%), Positives = 118/246 (47%), Gaps = 30/246 (12%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILIL 169
I F+ +G+G Y V A TG+IVA+KK+ FD P REI IL
Sbjct: 9 ISSD---FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKIL 63
Query: 170 RRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKC 226
+ H N+I + + + +Y++ M+ DL + ++ ++ Y
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYF---- 117
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---------HK 277
++Q L ++ H + V+HRD+K SNLLI+ + LK+ DFGLA D + +
Sbjct: 118 -IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337
M V T WYR PE++L + Y +D+WS GCILAEL +PI PGR
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-----Q 231
Query: 338 LNLIFD 343
L LIF
Sbjct: 232 LLLIFG 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 4e-68
Identities = 69/247 (27%), Positives = 103/247 (41%), Gaps = 32/247 (12%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-----------FDNLEPESV 159
+ + I G+Y V D G VA+K+V +
Sbjct: 20 MQSP---YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSD--SFLC 73
Query: 160 KFMAREILILRRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTE 216
K + REI +L HPN++ L + + LYLV M DLA + + +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 217 PQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276
Y M+ +L GL H GV+HRD+ N+L+ D+ + I DF LA +
Sbjct: 134 QHIQYF-----MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336
T V WYR PEL++ + VD+WSAGC++AE+ K + G T +
Sbjct: 189 --NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN----- 241
Query: 337 VLNLIFD 343
LN I +
Sbjct: 242 QLNKIVE 248
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 5e-68
Identities = 81/239 (33%), Positives = 115/239 (48%), Gaps = 27/239 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ + + +G G Y V A D TG VA+KK+ F + K RE+ +
Sbjct: 23 VRAV---YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRL 77
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV 224
L+ + H NVI L + T + YLV +M DL L K E + +L
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFL-- 133
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
++Q+L GL + H G++HRD+K NL +++D LKI DFGLA D MT V
Sbjct: 134 ---VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYV 186
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
VT WYR PE++L Y VD+WS GCI+AE++ GK + G + L I
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-----QLKEIMK 240
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-67
Identities = 85/239 (35%), Positives = 122/239 (51%), Gaps = 27/239 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+P R ++ + +G G Y +V A D TG VA+KK+ F + K RE+ +
Sbjct: 27 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRL 81
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV 224
L+ + H NVI L + T S +YLV H M DL + K T+ +L
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFL-- 137
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
++Q+L GL++ H+ ++HRD+K SNL +++D LKI DFGLA MT V
Sbjct: 138 ---IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYV 190
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
T WYR PE++L Y VD+WS GCI+AELL G+ + PG + L LI
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-----QLKLILR 244
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-66
Identities = 85/256 (33%), Positives = 136/256 (53%), Gaps = 40/256 (15%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ R+ +E + K+G+G Y V+K+ D TG++VA+KK+ F N + REI+I
Sbjct: 7 VLRK---YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMI 61
Query: 169 LRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCY 227
L L H N++ L ++ + +YLVF YME DL + + Y+
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYV----- 114
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA------------------ 269
++QL+ +++ H+ G+LHRD+K SN+L++ + +K+ADFGL+
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 270 --SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327
+ + + +T V T WYR PE+LLG+T Y G+D+WS GCIL E+L GKPI PG
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
Query: 328 TEVSATFCFVLNLIFD 343
+ ++ L I
Sbjct: 235 STMNQ-----LERIIG 245
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 9e-66
Identities = 74/239 (30%), Positives = 123/239 (51%), Gaps = 27/239 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ +R ++ + IG G V A D + + VA+KK+ F N K RE+++
Sbjct: 60 VLKR---YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVL 114
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV 224
++ ++H N+I L + T + + +YLV M+ +L + + YL
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYL-- 169
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
++Q+L G++H H+ G++HRD+K SN+++ D LKI DFGLA + MT V
Sbjct: 170 ---LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYV 224
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
VT +YR PE++LG Y VD+WS GCI+ E++ K + PGR + N + +
Sbjct: 225 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-----QWNKVIE 277
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 9e-66
Identities = 73/239 (30%), Positives = 122/239 (51%), Gaps = 27/239 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+ +R ++ + IG G V A D + + VA+KK+ F N K RE+++
Sbjct: 23 VLKR---YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVL 77
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV 224
++ ++H N+I L + T + S +Y+V M+ +L + + YL
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYL-- 132
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
++Q+L G++H H+ G++HRD+K SN+++ D LKI DFGLA + MT V
Sbjct: 133 ---LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYV 187
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
VT +YR PE++LG Y VD+WS GCI+ E++ G + PG + N + +
Sbjct: 188 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-----QWNKVIE 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 6e-65
Identities = 85/282 (30%), Positives = 123/282 (43%), Gaps = 60/282 (21%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILI 168
+P + IG+G+Y VY A D T K VA+KKV F++ K + REI I
Sbjct: 24 VPDN---YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDCKRILREITI 78
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS---LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVK 225
L RL +I+L L+ LY+V + DL L +P + TE +
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTI--- 134
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP------ 279
++ LL G H +G++HRD+K +N L++ D +K+ DFGLA +
Sbjct: 135 --LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 280 ---------------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG---- 320
+TS VVT WYR PEL+L +Y +D+WS GCI AELL
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 321 -------KPIMPGRTEVSATFCFV------------LNLIFD 343
P+ PG + + LN+IF+
Sbjct: 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-59
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN- 176
+ + +IG G S V++ + +I A+K V + + +++ EI L +L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 177 -VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
+I+L + +Y+V DL + + K Y +L +
Sbjct: 89 KIIRLYDYEITDQY--IYMVMECGNIDLNSWLKK-KKSIDPWE-----RKSYWKNMLEAV 140
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-TSRVVTLWYRPPEL 294
H +G++H D+K +N LI DG+LK+ DFG+A+ P+ + S+V T+ Y PPE
Sbjct: 141 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 295 LLGA----------TDYGVGVDLWSAGCILAELLAGKP 322
+ + D+WS GCIL + GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-57
Identities = 59/233 (25%), Positives = 102/233 (43%), Gaps = 33/233 (14%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R A FE+I +GQG + V KA++ L + A+KK+R + ++ E+++L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 173 DHPNVIKL-----------EGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFV 220
+H V++ + + + +L++ Y E L L S + +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-- 117
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP- 279
Q+L L + H+ G++HRD+K N+ ID+ +KI DFGLA +
Sbjct: 118 ---YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 280 ------------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 320
+TS + T Y E+L G Y +D++S G I E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-57
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN- 176
+ + +IG G S V++ + +I A+K V + + +++ EI L +L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 177 -VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
+I+L + +Y+V DL + + K Y +L +
Sbjct: 70 KIIRLYDYEITDQY--IYMVMECGNIDLNSWLKK-KKSIDPWE-----RKSYWKNMLEAV 121
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-TSRVVTLWYRPPEL 294
H +G++H D+K +N LI DG+LK+ DFG+A+ P+ + S+V T+ Y PPE
Sbjct: 122 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 295 LLG----------ATDYGVGVDLWSAGCILAELLAGKP 322
+ + D+WS GCIL + GK
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-56
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN- 176
+ + +IG G S V++ + +I A+K V + + +++ EI L +L +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 177 -VIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
+I+L + +Y+V DL + + K Y +L +
Sbjct: 117 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKK-KKSIDPWE-----RKSYWKNMLEAV 168
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM-TSRVVTLWYRPPEL 294
H +G++H D+K +N LI DG+LK+ DFG+A+ P+ + S+V + Y PPE
Sbjct: 169 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 295 LLGATD----------YGVGVDLWSAGCILAELLAGKP 322
+ + D+WS GCIL + GK
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-55
Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
P RA+ +E + IG G+Y K + GKI+ K++ + ++ + + E+ +LR
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEH----DLAGL---AASPEVKFTEPQFVYLKV 224
L HPN+++ + R + +LY+V ME+ DLA + E V
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIV---MEYCEGGDLASVITKGTKERQYLDEEF-----V 113
Query: 225 KCYMHQLLSGLEHCH-----NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279
M QL L+ CH + VLHRD+K +N+ +D +K+ DFGLA + +
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF- 172
Query: 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
+ V T +Y PE + Y D+WS GC+L EL A P
Sbjct: 173 AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMP 214
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-55
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
R F++I+ IG G + V+KAK + GK +K+V+++N + RE+ L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAK 60
Query: 172 LDHPNVIKL--------------EGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFT 215
LDH N++ + + L++ + + L + K
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 216 EPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275
+ Q+ G+++ H+ +++RD+K SN+ + D +KI DFGL + +
Sbjct: 121 KVL-----ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
K T TL Y PE + DYG VDL++ G ILAELL
Sbjct: 176 GKR--TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCD 219
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-55
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 12/212 (5%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
SF+++ ++G G+Y V+K + G++ A+K+ P+ E+ +
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 172 L-DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
+ HP ++LE LYL L + E Q V Y+
Sbjct: 113 VGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQ-----VWGYLRD 165
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
L L H H+ G++H D+K +N+ + G K+ DFGL + Y
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYM 223
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PELL G YG D++S G + E+
Sbjct: 224 APELLQG--SYGTAADVFSLGLTILEVACNME 253
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-54
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 28/224 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ D +GQG +NV++ + TG + A+K + V RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHK 67
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH----DLAGLAASPE--VKFTEPQFVYLKVKCYMH 229
N++KL + + L+ ME L + P E +F +
Sbjct: 68 NIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEF-----LIVLR 119
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
++ G+ H NG++HR+IK N++ D V K+ DFG A + + + S
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYG 177
Query: 286 TLWYRPPELLLGATD-------YGVGVDLWSAGCILAELLAGKP 322
T Y P++ A YG VDLWS G G
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-54
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + ++ KIG+G++ K G+ +K++ + + + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 176 NVIK-LEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVKCYMHQLL 232
N+++ E + SLY+V Y E DL + A V F E Q + + Q+
Sbjct: 84 NIVQYRESFEENG---SLYIVMDYCEGGDLFKRINAQKGVLFQEDQ-----ILDWFVQIC 135
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRP 291
L+H H+ +LHRDIK N+ + DG +++ DFG+A N + + T +Y
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLS 193
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE+ Y D+W+ GC+L EL K
Sbjct: 194 PEICEN-KPYNNKSDIWALGCVLYELCTLKH 223
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 8e-54
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 28/224 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ D +GQG +NV++ + TG + A+K + V RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHK 67
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH----DLAGLAASPE--VKFTEPQFVYLKVKCYMH 229
N++KL + + L+ ME L + P E +F +
Sbjct: 68 NIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEF-----LIVLR 119
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
++ G+ H NG++HR+IK N++ D V K+ DFG A + + + S
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYG 177
Query: 286 TLWYRPPELLLGATD-------YGVGVDLWSAGCILAELLAGKP 322
T Y P++ A YG VDLWS G G
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-53
Identities = 73/212 (34%), Positives = 104/212 (49%), Gaps = 14/212 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
+F KIG+G +S VY+A +L G VALKKV+ +L + +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL---AASPEVKFTEPQFVYLKVKCYMHQ 230
PNVIK L +V + DL+ + + E V Y Q
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERT-----VWKYFVQ 144
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
L S LEH H+ V+HRDIK +N+ I GV+K+ D GL FF + S V T +Y
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYM 203
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE + Y D+WS GC+L E+ A +
Sbjct: 204 SPERIHE-NGYNFKSDIWSLGCLLYEMAALQS 234
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-52
Identities = 62/219 (28%), Positives = 116/219 (52%), Gaps = 11/219 (5%)
Query: 106 ALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAR 164
+L I + + F+ + +G+G+++ VY+A+ + TG VA+K + + + +
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLK 223
E+ I +L HP++++L +YLV + ++ + F+E +
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENE----- 113
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 283
+ +MHQ+++G+ + H++G+LHRD+ SNLL+ + +KIADFGLA+ H+ T
Sbjct: 114 ARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL- 172
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+ + +G+ D+WS GC+ LL G+P
Sbjct: 173 CGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRP 210
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 3e-52
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILR 170
PR + + +G+G ++ ++ D T ++ A K V L + M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYL 222
L H +V+ G +++V +E L + TEP+
Sbjct: 71 SLAHQHVVGFHGFFEDNDF--VFVV---LE-----LCRRRSLLELHKRRKALTEPE---- 116
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
+ Y+ Q++ G ++ H N V+HRD+K NL +++D +KI DFGLA+ + + +
Sbjct: 117 -ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 175
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L + VD+WS GCI+ LL GKP
Sbjct: 176 -CGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-52
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILR 170
PR + + +G+G ++ ++ D T ++ A K V L + M+ EI I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYL 222
L H +V+ G +++V +E L + TEP+
Sbjct: 97 SLAHQHVVGFHGFFEDNDF--VFVV---LE-----LCRRRSLLELHKRRKALTEPE---- 142
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
+ Y+ Q++ G ++ H N V+HRD+K NL +++D +KI DFGLA+ + + +
Sbjct: 143 -ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 201
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L + VD+WS GCI+ LL GKP
Sbjct: 202 -CGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-51
Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 23/221 (10%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+ I K+G+G +S V + + G ALK++ + + RE + R +HPN+
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNI 88
Query: 178 IKLEG--LVTSRMSCSLYLVFHYMEH-DLAGL---AASPEVKFTEPQFVYLKVKCYMHQL 231
++L L +L+ + + L TE Q + + +
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ-----ILWLLLGI 143
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV------ 285
GLE H G HRD+K +N+L+ D+G + D G + + + + +
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 286 --TLWYRPPELLLGATDYGVG--VDLWSAGCILAELLAGKP 322
T+ YR PEL + + D+WS GC+L ++ G+
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-51
Identities = 65/232 (28%), Positives = 101/232 (43%), Gaps = 35/232 (15%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R FE I +G+G + V++AK+ + A+K++R N E K M RE+ L +L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 60
Query: 173 DHPNVIK----------LEGLVTSRMSCSLYLVFHYMEH----DLAG-LAASPEVKFTEP 217
+HP +++ E L S LY+ M+ +L + ++ E
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQ---MQLCRKENLKDWMNGRCTIEERER 117
Query: 218 QFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD---- 273
Q+ +E H+ G++HRD+K SN+ D V+K+ DFGL + D
Sbjct: 118 SVCL----HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 274 -------PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
T +V T Y PE + G Y VD++S G IL ELL
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL 224
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 177 bits (449), Expect = 2e-50
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 19/229 (8%)
Query: 104 GEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA 163
G + +E +++G G + V + TG+ VA+K+ R + L P++ +
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC 60
Query: 164 REILILRRLDHPNVIKL----EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPE--VKFTE 216
EI I+++L+HPNV+ +GL + L Y E DL E E
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 217 PQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFFD 273
++ + + S L + H N ++HRD+K N+++ + KI D G A D
Sbjct: 121 GP-----IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T V TL Y PELL Y V VD WS G + E + G
Sbjct: 176 QGEL--CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFR 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 68/223 (30%), Positives = 115/223 (51%), Gaps = 26/223 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + + +G+G++ V K KD +T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQFVYLKVKCYMH 229
N++KL ++ S Y+V E G + +F+E +
Sbjct: 82 NIMKLFEILEDSS--SFYIV---GEL-YTGGELFDEIIK--RKRFSEHD-----AARIIK 128
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
Q+ SG+ + H + ++HRD+K N+L+ + D +KI DFGL++ F N K M R+ T
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGT 186
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+Y PE+L G Y D+WSAG IL LL+G P G+ E
Sbjct: 187 AYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 30/225 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++++ K+G G Y V +D +T A+K +R ++ S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYLKVKCY 227
N++KL + + YLV ME E+ KF E
Sbjct: 97 NIMKLYDFFEDKR--NYYLV---ME-----CYKGGELFDEIIHRMKFNEVD-----AAVI 141
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRV 284
+ Q+LSG+ + H + ++HRD+K NLL+ + D ++KI DFGL++ F+ K M R+
Sbjct: 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERL 199
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
T +Y PE+L Y D+WS G IL LLAG P G+T+
Sbjct: 200 GTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-49
Identities = 69/225 (30%), Positives = 115/225 (51%), Gaps = 30/225 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + + +G+G++ V K KD +T + A+K + + + + + RE+ +L++LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE--------VKFTEPQFVYLKVKCY 227
N++KL ++ S Y+V E L E +F+E
Sbjct: 82 NIMKLFEILEDSS--SFYIV---GE-----LYTGGELFDEIIKRKRFSEHD-----AARI 126
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRV 284
+ Q+ SG+ + H + ++HRD+K N+L+ + D +KI DFGL++ F N K M R+
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI 184
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
T +Y PE+L G Y D+WSAG IL LL+G P G+ E
Sbjct: 185 GTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNE 227
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 35/237 (14%), Positives = 66/237 (27%), Gaps = 31/237 (13%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREILILRR 171
+ + ++ + G S V+ +D+ + ALK S ++ + R
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 172 LDHPN------------------------VIKLEGLVTSRMSCSLYLVFHYMEHDLAGL- 206
L + +L + L+ DL L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 207 AASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266
+ V L + QL+ + + G++H NL I DG L + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAGKP 322
+ V + Y P E L + ++ W G + +
Sbjct: 239 SALWKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-48
Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 31/226 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDH 174
D ++ +G+G++ V KD +TG+ A+K + ++ + + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYLKVKC 226
PN++KL + YLV E + E+ +F+E
Sbjct: 86 PNIMKLYEFFEDKGY--FYLV---GE-----VYTGGELFDEIISRKRFSEVD-----AAR 130
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSR 283
+ Q+LSG+ + H N ++HRD+K NLL+ D ++I DFGL++ F+ + K M +
Sbjct: 131 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDK 188
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+ T +Y PE+L G Y D+WS G IL LL+G P G E
Sbjct: 189 IGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANE 232
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-48
Identities = 71/213 (33%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREILILRRLDH 174
+ FE +G+G + NVY A++ + I+ALK + LE + RE+ I L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
PN+++L G +YL+ Y + KF E + Y+ +L +
Sbjct: 69 PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQK-LSKFDEQ-----RTATYITELAN 120
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL----WY 289
L +CH+ V+HRDIK NLL+ G LKIADFG + H +SR L Y
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 173
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PPE++ G + VDLWS G + E L GKP
Sbjct: 174 LPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-47
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D+++ +++G+G +S V + TG A K + L + + RE I R+L HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE--------VKFTEPQFVYLKVKCY 227
N+++L + YLV + L E ++E
Sbjct: 66 NIVRLHDSIQEES--FHYLV---FD-----LVTGGELFEDIVAREFYSEA-----DASHC 110
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRV 284
+ Q+L + +CH+NG++HR++K NLL+ +K+ADFGLA + +
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFA 168
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L Y VD+W+ G IL LL G P
Sbjct: 169 GTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYP 205
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-47
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV------RFDNLEPESVKFMAREILIL 169
D + +G G V A + T K VA+K + E + + EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE--------VKFTEPQFVY 221
++L+HP +IK++ + Y+V +E L E + E
Sbjct: 70 KKLNHPCIIKIKNFFDAE---DYYIV---LE-----LMEGGELFDKVVGNKRLKEA---- 114
Query: 222 LKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKH 278
K Y +Q+L +++ H NG++HRD+K N+L+ ++D ++KI DFG +
Sbjct: 115 -TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172
Query: 279 PMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKP 322
M + T Y PE+L+ Y VD WS G IL L+G P
Sbjct: 173 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-47
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRL 172
D +E + IG+G +S V + + TG+ A+K +F + S + + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH----DLAGLAASPEVKFTEPQFVYLKVKCYM 228
HP++++L +S LY+VF +M+ A ++E YM
Sbjct: 84 KHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEA-----VASHYM 136
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Q+L L +CH+N ++HRD+K +L+ ++ +K+ FG+A + RV
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRVG 195
Query: 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T + PE++ YG VD+W G IL LL+G
Sbjct: 196 TPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCL 231
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-47
Identities = 54/217 (24%), Positives = 83/217 (38%), Gaps = 24/217 (11%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HP 175
SF D +G G + + M + VA+K++ PE F RE+ +LR D HP
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHP 78
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
NVI+ R Y+ L + + + Q SGL
Sbjct: 79 NVIRYFCTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLE-----PITLLQQTTSGL 131
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGLASFFDPNHK--HPMTSRVVTLW 288
H H+ ++HRD+K N+LI I+DFGL + T
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 289 YRPPELLLGATD--YGVGVDLWSAGCILAELLA-GKP 322
+ PE+L VD++SAGC+ +++ G
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-47
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D+++ +++G+G +S V + TG A K + L + + RE I R+L HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQFVYLKVKCYMH 229
N+++L + YLVF + G + A ++E +
Sbjct: 89 NIVRLHDSIQEES--FHYLVFDLVT----GGELFEDIVA--REFYSEA-----DASHCIQ 135
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
Q+L + +CH+NG++HR++K NLL+ +K+ADFGLA + + T
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGT 193
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
Y PE+L Y VD+W+ G IL LL G P
Sbjct: 194 PGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYP 228
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-47
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV------RFDNLEPESVKFMAREILIL 169
D + +G G V A + T K VA++ + E + + EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL------AGLAASPEVKFTEPQFVYL 222
++L+HP +IK++ + Y+V ME +L + E
Sbjct: 195 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEA----- 239
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHP 279
K Y +Q+L +++ H NG++HRD+K N+L+ ++D ++KI DFG +
Sbjct: 240 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 297
Query: 280 MTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKP 322
M + T Y PE+L+ Y VD WS G IL L+G P
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-47
Identities = 72/213 (33%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESV-KFMAREILILRRLDH 174
D F+ +G+G + NVY A++ I+ALK + LE E V + REI I L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-----LAASPEVKFTEPQFVYLKVKCYMH 229
PN++++ R +YL+ +E G L +F E + +M
Sbjct: 74 PNILRMYNYFHDRKR--IYLM---LEFAPRGELYKELQKHG--RFDEQ-----RSATFME 121
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 289
+L L +CH V+HRDIK NLL+ G LKIADFG + + M TL Y
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDY 178
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PPE++ G + VDLW AG + E L G P
Sbjct: 179 LPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-47
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVK----FMAREILI 168
+++E + +G+G S V + T K A+K + E V+ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 169 LRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE--------VKFTEPQF 219
LR++ HPN+I+L+ + +LV + L E V +E
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTF--FFLV---FD-----LMKKGELFDYLTEKVTLSEK-- 124
Query: 220 VYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279
+ + M LL + H ++HRD+K N+L+DDD +K+ DFG + DP K
Sbjct: 125 ---ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179
Query: 280 MTSRVVTLWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAGKP 322
+ T Y PE++ + + YG VD+WS G I+ LLAG P
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-46
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D F K+G G + +V+ ++ +G +K + D + ++ + EI +L+ LDHP
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHP 80
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
N+IK+ + + +Y+V E + A + +E V M Q+
Sbjct: 81 NIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGY-----VAELMKQM 133
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
++ L + H+ V+H+D+K N+L +KI DFGLA F + T+ T
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTAL 191
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
Y PE+ D D+WSAG ++ LL G
Sbjct: 192 YMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCL 223
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 41/236 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-----------FDNLEPESVKFMAR 164
+S+ K+ K+G G Y V K+ A+K ++ + + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 165 EILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTE 216
EI +L+ LDHPN+IKL + + YLV E E+ KF E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKY--FYLV---TE-----FYEGGELFEQIINRHKFDE 145
Query: 217 PQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFD 273
M Q+LSG+ + H + ++HRDIK N+L+ + +KI DFGL+SFF
Sbjct: 146 CD-----AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
++K + R+ T +Y PE+L Y D+WS G I+ LL G P G+ +
Sbjct: 201 KDYK--LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-46
Identities = 74/296 (25%), Positives = 111/296 (37%), Gaps = 41/296 (13%)
Query: 51 ESRKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGW 110
E R + + + S + G G
Sbjct: 25 EIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELP 84
Query: 111 IPRRADSFEKI----DKIGQGTYSNVYKAKDMLTGKIVALK-----KVRFDNLEPESVKF 161
A F + D IG+G S V + TG A+K R + E V+
Sbjct: 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 162 M-AREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPE-------- 211
RE ILR++ HP++I L S ++LV + L E
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSF--MFLV---FD-----LMRKGELFDYLTEK 194
Query: 212 VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271
V +E + + M LL + H N ++HRD+K N+L+DD+ ++++DFG +
Sbjct: 195 VALSEK-----ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 272 FDPNHKHPMTSRVVTLWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAGKP 322
+P K + T Y PE+L + D YG VDLW+ G IL LLAG P
Sbjct: 250 LEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-46
Identities = 70/218 (32%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + IG+G++ V A T A KK+ +E V +EI I++ LDHP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHP 66
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYLKVKCY 227
N+I+L +YLV ME L E+ F E
Sbjct: 67 NIIRLYETFEDNTD--IYLV---ME-----LCTGGELFERVVHKRVFRESD-----AARI 111
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRV 284
M +LS + +CH V HRD+K N L D LK+ DFGLA+ F P M ++V
Sbjct: 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV 169
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T +Y P++L G YG D WSAG ++ LL G P
Sbjct: 170 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYP 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++ +++G+G +S V + +L G+ A + L + + RE I R L HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYME-----HDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
N+++L ++ YL+F + D+ ++E + Q
Sbjct: 71 NIVRLHDSISEEGH--HYLIFDLVTGGELFEDIVA-----REYYSEA-----DASHCIQQ 118
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 287
+L + HCH GV+HR++K NLL+ +K+ADFGLA + + T
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTP 177
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
Y PE+L YG VDLW+ G IL LL G P
Sbjct: 178 GYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYP 211
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-45
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+F ++ +G G +S V+ K LTGK+ ALK ++ + + EI +L+++ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHE 66
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYLKVKCY 227
N++ LE + S YLV M+ L + E+ +TE
Sbjct: 67 NIVTLEDIYESTTH--YYLV---MQ-----LVSGGELFDRILERGVYTEK-----DASLV 111
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRV 284
+ Q+LS +++ H NG++HRD+K NLL +++ + I DFGL+ M++
Sbjct: 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTAC 168
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L Y VD WS G I LL G P
Sbjct: 169 GTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYP 205
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-45
Identities = 42/234 (17%), Positives = 77/234 (32%), Gaps = 36/234 (15%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R F +++KIG G + +V+K L G I A+K+ + + RE+ L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 173 -DHPNVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKCY 227
H +V++ + + Y D F E + +K
Sbjct: 68 GQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAE-----LKDL 120
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL-------------------KIADFGL 268
+ Q+ GL + H+ ++H DIK SN+ I + KI D G
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
+ + E+L + D+++ + +P
Sbjct: 181 VTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 5e-45
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 28/214 (13%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++G+G++ V++ KD TG A+KKVR + E E++ L P +
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 178 IKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
+ L G R + + +E L E + Y+ Q L
Sbjct: 113 VPLYG--AVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDR-----ALYYLGQALE 161
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVL-KIADFGLASFFDPNHKHPMTSRVVTL----W 288
GLE+ H +LH D+K N+L+ DG + DFG A P+ +
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
+ PE+++G VD+WS+ C++ +L G
Sbjct: 222 HMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-45
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALK------------------------KVRFDNLEP 156
D+IG+G+Y V A + A+K
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 157 ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFT 215
++ + +EI IL++LDHPNV+KL ++ LY+VF + + + +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLS 135
Query: 216 EPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275
E Q + Y L+ G+E+ H ++HRDIK SNLL+ +DG +KIADFG+++ F +
Sbjct: 136 EDQ-----ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 276 HKHPMTSRVVTLWYRPPELLLGAT-DY-GVGVDLWSAGCILAELLAGK 321
+ V T + PE L + G +D+W+ G L + G+
Sbjct: 191 DALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 48/232 (20%), Positives = 90/232 (38%), Gaps = 37/232 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMA--------- 163
+ + I + QG ++ + + K ALK K + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 164 ---REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYME--------HDLAGLAASPEV 212
E+ I+ + + + EG++T+ +Y+++ YME L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 213 KFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271
+KC + +L+ + HN + HRD+K SN+L+D +G +K++DFG + +
Sbjct: 147 FIPIQV-----IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDY-GVGVDLWSAGCILAELLAGKP 322
+ T + PPE + Y G VD+WS G L +
Sbjct: 202 MVDKK---IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 64/263 (24%), Positives = 102/263 (38%), Gaps = 56/263 (21%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRL 172
+ IGQG+Y V A + T I A+K K + + P+ V+ + E+ ++++L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYME-------------------------------- 200
HPN+ +L + + LV
Sbjct: 86 HHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 201 --------HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSN 252
+ G S + E + M Q+ S L + HN G+ HRDIK N
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKL-----ISNIMRQIFSALHYLHNQGICHRDIKPEN 198
Query: 253 LLI--DDDGVLKIADFGLASFFDPNHK---HPMTSRVVTLWYRPPELLLGATD-YGVGVD 306
L + +K+ DFGL+ F + + MT++ T ++ PE+L + YG D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 307 LWSAGCILAELLAGKPIMPGRTE 329
WSAG +L LL G PG +
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVND 281
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-44
Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK-----KVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+G+G+Y V + D T A+K K+R +VK +EI +LRRL H NVI
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNVI 69
Query: 179 KLEGLVTSRMSCSLYLVFHYMEHDLAGL-AASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
+L ++ + +Y+V Y + + + PE +F Q Y QL+ GLE+
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQ-----AHGYFCQLIDGLEY 124
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLL 296
H+ G++H+DIK NLL+ G LKI+ G+A P + + ++PPE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 297 GATDY-GVGVDLWSAGCILAELLAGK 321
G + G VD+WSAG L + G
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-44
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D +G+GTY VY +D+ +A+K++ + + + EI + + L H
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHK 79
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N+++ G + + + + + L+ L S + + + Y Q+L G
Sbjct: 80 NIVQYLG--SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IGFYTKQILEG 134
Query: 235 LEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYRPP 292
L++ H+N ++HRDIKG N+LI+ GVLKI+DFG + + T TL Y P
Sbjct: 135 LKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAP 192
Query: 293 ELLLGATD-YGVGVDLWSAGCILAELLAGKP 322
E++ YG D+WS GC + E+ GKP
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 53/233 (22%), Positives = 91/233 (39%), Gaps = 35/233 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-H 174
+ +G G+ V G+ VA+K+ + + EI +L D H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR-----MLIDFCDIALMEIKLLTESDDH 68
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVY--LKVKCYMHQLL 232
PNVI+ T+ LY+ +L L S E + + Q+
Sbjct: 69 PNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISLLRQIA 125
Query: 233 SGLEHCHNNGVLHRDIKGSNLLID-------------DDGVLKIADFGLASFFDPNH--- 276
SG+ H H+ ++HRD+K N+L+ ++ + I+DFGL D
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 277 KHPMTSRVVTLWYRPPELLLGATD------YGVGVDLWSAGCILAELL-AGKP 322
+ + + T +R PELL + + +D++S GC+ +L GK
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 17/207 (8%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE 181
+IG+G++ VYK D T VA +++ L + E +L+ L HPN+++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 182 G--LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE-- 236
T + + LV M L + ++ + Q+L GL+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKV-----LRSWCRQILKGLQFL 145
Query: 237 HCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
H ++HRD+K N+ I G +KI D GLA+ + + T + PE
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE-- 200
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKP 322
+ Y VD+++ G + E+ +
Sbjct: 201 MYEEKYDESVDVYAFGMCMLEMATSEY 227
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-43
Identities = 48/233 (20%), Positives = 91/233 (39%), Gaps = 21/233 (9%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + + +G+G + V++ + + K K V+ + VK +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++ L S L ++F ++ D+ + + E ++ Y+HQ+
Sbjct: 62 NILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNER-----EIVSYVHQVCEA 114
Query: 235 LEHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
L+ H++ + H DI+ N++ +KI +FG A P Y P
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAP 172
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMP--GRTEVSATFCFVLNLIFD 343
E+ D+WS G ++ LL+G P T ++N +
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGIN--PFLAETN-QQIIENIMNAEYT 221
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-43
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 27/207 (13%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL-EG 182
IG+G ++ V A+ +LTG+ VA+K + L P S++ + RE+ I++ L+HPN++KL E
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 183 LVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYLKVKCYMHQLLSG 234
+ T + LYL+ ME+ A+ EV + E + + Q++S
Sbjct: 83 IETEKT---LYLI---MEY-----ASGGEVFDYLVAHGRMKEKE-----ARSKFRQIVSA 126
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
+++CH ++HRD+K NLL+D D +KIADFG ++ F K + + Y PEL
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPEL 184
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGK 321
G G VD+WS G IL L++G
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-42
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 24/225 (10%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
D +E + IG G + V A + VA+K++ + + + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 172 LDHPNVIKLEG--LVTSRMSCSLYLVFHYME----HDL----AGLAASPEVKFTEPQFVY 221
HPN++ +V L+LV + D+ E
Sbjct: 70 CHHPNIVSYYTSFVVKD----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 222 LKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL-ASFFDPNHKHPM 280
+ + ++L GLE+ H NG +HRD+K N+L+ +DG ++IADFG+ A
Sbjct: 126 I-----LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 281 TSR---VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
R V T + PE++ Y D+WS G EL G
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 58/253 (22%), Positives = 108/253 (42%), Gaps = 35/253 (13%)
Query: 109 GWIPRRADSFEKI----DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVK 160
G P + E +++G G ++ V K ++ TG A K ++ S +
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 161 FMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKF 214
+ RE+ ILR++ H NVI L + +R + L+ + +G LA +
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENRTD--VVLILELV----SGGELFDFLAQ--KESL 112
Query: 215 TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLAS 270
+E + ++ Q+L G+ + H + H D+K N+++ +K+ DFGLA
Sbjct: 113 SEE-----EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+ + + T + PE++ G+ D+WS G I LL+G G T+
Sbjct: 168 EIEDGVE--FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK- 223
Query: 331 SATFCFVLNLIFD 343
T + ++ +D
Sbjct: 224 QETLANITSVSYD 236
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 58/244 (23%), Positives = 109/244 (44%), Gaps = 35/244 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
D ++ +++G G ++ V K ++ TG A K ++ S + + RE+ IL+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAA--------SPEVKFTEPQFVYLK 223
+ HPNVI L + ++ + L+ +E L A + + TE +
Sbjct: 71 IQHPNVITLHEVYENKTD--VILI---LE-----LVAGGELFDFLAEKESLTEE-----E 115
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHP 279
++ Q+L+G+ + H+ + H D+K N+++ +KI DFGLA D ++
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339
+ T + PE++ G+ D+WS G I LL+G G T+ T V
Sbjct: 174 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVSA 231
Query: 340 LIFD 343
+ ++
Sbjct: 232 VNYE 235
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 58/243 (23%), Positives = 109/243 (44%), Gaps = 33/243 (13%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
D +E +++G G ++ V K + TGK A K ++ L S + + RE+ ILR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYME-----HDLAGLAASPEVKFTEPQFVYLKVKC 226
+ HPN+I L + ++ + L+ + LA + TE +
Sbjct: 65 IRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLA-----EKESLTED-----EATQ 112
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTS 282
++ Q+L G+ + H+ + H D+K N+++ + +K+ DFG+A + ++ +
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKN 170
Query: 283 RVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP--GRTEVSATFCFVLNL 340
T + PE++ G+ D+WS G I LL+G P G T+ T + +
Sbjct: 171 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETK-QETLTNISAV 226
Query: 341 IFD 343
+D
Sbjct: 227 NYD 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 51/248 (20%), Positives = 92/248 (37%), Gaps = 30/248 (12%)
Query: 111 IPRRADSFEKI-----DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMARE 165
+ ++F ++G+G ++ V + TG+ A K ++ + + E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 166 ILILRRLDH-PNVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFV 220
I +L P VI L + + + L+ Y L +E
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTS--EIILILEYAAGGEIFSL--CLPELAEMVSEN--- 131
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHK 277
V + Q+L G+ + H N ++H D+K N+L+ G +KI DFG++ +
Sbjct: 132 --DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189
Query: 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP--GRTEVSATFC 335
+ + T Y PE+L D+W+ G I LL P G T+
Sbjct: 190 --LREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTS--PFVGEDN-QETYL 243
Query: 336 FVLNLIFD 343
+ + D
Sbjct: 244 NISQVNVD 251
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 35/211 (16%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+G+G Y V A + +T + VA+K R + PE++K +EI I + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 181 -EGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
+ YL F +E D + EP + HQ
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRIEPD---------IGMPEPDAQR-----FFHQ 113
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWY 289
L++G+ + H G+ HRDIK NLL+D+ LKI+DFGLA+ F N++ + +++ TL Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAG 320
PELL + VD+WS G +L +LAG
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 49/229 (21%), Positives = 91/229 (39%), Gaps = 31/229 (13%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPN 176
+ +G ++ VY+A+D+ +G+ ALK++ + E + + +E+ +++L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPN 87
Query: 177 VIKLEG---LVTSRMSCSLYLVFHYMEHDLAGL-----AASPEVKFTEPQFVYLKVKCYM 228
+++ + E L + V
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT-----VLKIF 142
Query: 229 HQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS---- 282
+Q ++H H ++HRD+K NLL+ + G +K+ DFG A+ + ++
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 283 -------RVVTLWYRPPEL--LLGATDYGVGVDLWSAGCILAELLAGKP 322
R T YR PE+ L G D+W+ GCIL L +
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 18/232 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDH 174
D ++ ++++G G + V++ + TG++ K + +VK EI I+ +L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
P +I L + + L+ ++ +L A+ + K +E +V YM Q
Sbjct: 108 PKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEA-----EVINYMRQACE 160
Query: 234 GLEHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
GL+H H + ++H DIK N++ +KI DFGLA+ +P+ + T +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAA 218
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
PE++ G D+W+ G + LL+G G + T V ++
Sbjct: 219 PEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWE 268
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 47/221 (21%), Positives = 87/221 (39%), Gaps = 22/221 (9%)
Query: 115 ADSFEKIDKIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
+E + IG+G V A+ TG+ V ++++ + E V F+ E+ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKCYM 228
+HPN++ + L++V +M DL + E + +
Sbjct: 84 NHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDL--ICTHFMDGMNELA-----IAYIL 134
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG-LASFFDPNHKH-----PMTS 282
+L L++ H+ G +HR +K S++LI DG + ++ S +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 283 RVVTLWYRPPELLL-GATDYGVGVDLWSAGCILAELLAGKP 322
V L + PE+L Y D++S G EL G
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 57/297 (19%), Positives = 108/297 (36%), Gaps = 23/297 (7%)
Query: 50 DESRKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNG 109
++ E+ + + + + P + + +
Sbjct: 98 APVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL- 156
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
D ++ +++G G + V++ + TG A K V + + + +EI +
Sbjct: 157 ------DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTM 208
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYM 228
L HP ++ L + +++ +M +L A K +E + YM
Sbjct: 209 SVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSE-----DEAVEYM 261
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
Q+ GL H H N +H D+K N++ LK+ DFGL + DP + T
Sbjct: 262 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGT 319
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
+ PE+ G G D+WS G + LL+G G + T V + ++
Sbjct: 320 AEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWN 374
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-42
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRLD-HPNV 177
+G+G++S K + + A+K K N + +EI L+ + HPN+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNI 68
Query: 178 IKLEGLVTSRMSCSLYLVFHYME------HDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
+KL + ++ +LV + + F+E + M +L
Sbjct: 69 VKLHEVFHDQLH--TFLVMELLNGGELFERIKK------KKHFSETE-----ASYIMRKL 115
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
+S + H H+ GV+HRD+K NLL +D+ +KI DFG A P+ P+ + TL
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLH 174
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
Y PE LL Y DLWS G IL +L+G+
Sbjct: 175 YAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-42
Identities = 69/230 (30%), Positives = 97/230 (42%), Gaps = 45/230 (19%)
Query: 112 PRRADSFEKI----DKIGQGTYSNVYKAKDMLTGKIVAL----KKVRFDNLEPESVKFMA 163
D+ ++G+G S VY+ K T K AL K V +
Sbjct: 45 GSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR-------- 96
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFT 215
EI +L RL HPN+IKL+ + + + LV +E L E+ ++
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTE--ISLV---LE-----LVTGGELFDRIVEKGYYS 146
Query: 216 EPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFF 272
E + Q+L + + H NG++HRD+K NLL D LKIADFGL+
Sbjct: 147 ER-----DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201
Query: 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
+ M + T Y PE+L G YG VD+WS G I LL G
Sbjct: 202 EHQVL--MKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFE 248
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-42
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 32/213 (15%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKL 180
+G G V + TG+ ALK + +E+ + P+++ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCI 87
Query: 181 EGLV--TSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQFVYLKVKCYMHQLL 232
+ L ++ ME G + + FTE + M +
Sbjct: 88 LDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTERE-----AAEIMRDIG 138
Query: 233 SGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 289
+ ++ H++ + HRD+K NLL + D VLK+ DFG A N + + T +Y
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYY 195
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE +LG Y D+WS G I+ LL G P
Sbjct: 196 VAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-42
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKL 180
D +G+G ++ V +++T + A+K + S + RE+ +L + H NV++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLEL 76
Query: 181 EGLVTSRMSCSLYLVFHYME------HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
YLVF M H F E L+ + + S
Sbjct: 77 IEFFEEEDR--FYLVFEKMRGGSILSHIHK------RRHFNE-----LEASVVVQDVASA 123
Query: 235 LEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKH------PMTSRVV 285
L+ HN G+ HRD+K N+L + +KI DF L S N + +
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 286 TLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKP 322
+ Y PE++ A+ Y DLWS G IL LL+G P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-42
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 35/211 (16%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
+G+G Y V A + +T + VA+K R + PE++K +EI I + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 181 -EGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
+ YL F +E D + EP + HQ
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRIEPD---------IGMPEPDAQR-----FFHQ 113
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWY 289
L++G+ + H G+ HRDIK NLL+D+ LKI+DFGLA+ F N++ + +++ TL Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAG 320
PELL + VD+WS G +L +LAG
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-42
Identities = 37/247 (14%), Positives = 77/247 (31%), Gaps = 42/247 (17%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRR 171
R + + +GQ +A D TG+ + F P ++K M E+L LR
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 172 L-------------------------DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL 206
L +I++ S + ++ M+ +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 207 AASPEVKFTEPQFVYLKVKCY-MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265
+ + + + Q++ L H+ G++H ++ ++++D G + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 266 FGLASFFDPNHKHPMTSRVVTLWYRPPELL----------LGATDYGVGVDLWSAGCILA 315
F V+ + PPEL T D W+ G ++
Sbjct: 250 FEHLVRDG-----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 316 ELLAGKP 322
+
Sbjct: 305 WIWCADL 311
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-41
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-ESVKFMAREILILRRLD 173
F + +IG G++ VY A+D+ ++VA+KK+ + + E + + +E+ L++L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 174 HPNVIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
HPN I+ G L +LV Y + L + E + + H
Sbjct: 113 HPNTIQYRGCYLREHT----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-----THGA 163
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLW 288
L GL + H++ ++HRD+K N+L+ + G++K+ DFG AS M V T +
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANSFVGTPY 215
Query: 289 YRPPELLLGATD--YGVGVDLWSAGCILA-ELLAGKP 322
+ PE++L + Y VD+WS G I EL KP
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP 251
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 16/230 (6%)
Query: 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
+ K + +G G + V+K ++ TG +A K ++ ++ + + EI ++ +LDH N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHAN 147
Query: 177 VIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
+I+L S+ + LV Y++ +L TE L +M Q+ G+
Sbjct: 148 LIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTE-----LDTILFMKQICEGI 200
Query: 236 EHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
H H +LH D+K N+L D +KI DFGLA + P K + T + PE
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPE 258
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343
++ D+WS G I LL+G G + + T +L +D
Sbjct: 259 VVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWD 306
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 56/244 (22%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
D ++ +++G G ++ V K ++ TG A K ++ + + RE+ ILR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQFVYLKVK 225
+ HPN+I L + +R + L+ + +G LA + +E +
Sbjct: 72 VLHPNIITLHDVYENRTD--VVLILELV----SGGELFDFLAQ--KESLSEE-----EAT 118
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMT 281
++ Q+L G+ + H + H D+K N+++ +K+ DFGLA + +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FK 176
Query: 282 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP--GRTEVSATFCFVLN 339
+ T + PE++ G+ D+WS G I LL+G P G T+ T +
Sbjct: 177 NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTK-QETLANITA 232
Query: 340 LIFD 343
+ +D
Sbjct: 233 VSYD 236
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 49/213 (23%), Positives = 87/213 (40%), Gaps = 31/213 (14%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKL 180
+G G V + + T + ALK + + RE+ + R P+++++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRI 120
Query: 181 EGLV--TSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQFVYLKVKCYMHQLL 232
+ L +V ++ G + + FTE + M +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTERE-----ASEIMKSIG 171
Query: 233 SGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 289
+++ H+ + HRD+K NLL + +LK+ DFG A + + +T+ T +Y
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYY 229
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE +LG Y D+WS G I+ LL G P
Sbjct: 230 VAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 60/270 (22%), Positives = 96/270 (35%), Gaps = 66/270 (24%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R FE I +G+G + V++AK+ + A+K++R N E K M RE+ L +L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 61
Query: 173 DHPNVIKLEG-----------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVY 221
+HP +++ + + A S +++ +P
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 222 LKVKCY------------------------------------------MHQLLSGLEHCH 239
V Q+ +E H
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLA-----------SFFDPNHKHPMTSRVVTLW 288
+ G++HRD+K SN+ D V+K+ DFGL T +V T
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELL 318
Y PE + G +Y VD++S G IL ELL
Sbjct: 242 YMSPEQIHG-NNYSHKVDIFSLGLILFELL 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-41
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK-----KVRFDNL-EPESVKFMARE 165
+ + + +G G + V+ A D K V +K KV D E + + E
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQF 219
I IL R++H N+IK+ + ++ LV ME +G + P + EP
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGF--FQLV---MEKHGSGLDLFAFIDRHP--RLDEPL- 131
Query: 220 VYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279
QL+S + + ++HRDIK N++I +D +K+ DFG A++ +
Sbjct: 132 ----ASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-- 185
Query: 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 320
+ T+ Y PE+L+G G +++WS G L L+
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-41
Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DH 174
D +E + IG G+YS + T A+K + +P EI IL R H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQH 75
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQFVYLKVKCYM 228
PN+I L+ + +Y+V M+ G + + F+E + + +
Sbjct: 76 PNIITLKDVYDDGKY--VYVVTELMK----GGELLDKILR--QKFFSEREASAV-----L 122
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLASFFDPNHKHPMTSRV 284
+ +E+ H GV+HRD+K SN+L + ++I DFG A + +
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPC 181
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T + PE+L Y D+WS G +L +L G
Sbjct: 182 YTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYT 218
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 32/221 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
I +D ++ + IG G + +D LT ++VA+K + E+V+ REI+ R
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHR 71
Query: 171 RLDHPNVIKL-EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVY 221
L HPN+++ E ++T L ++ ME+ A+ E+ +F+E +
Sbjct: 72 SLRHPNIVRFKEVILTPTH---LAII---MEY-----ASGGELYERICNAGRFSEDE--- 117
Query: 222 LKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--LKIADFGLASFFDPNHKHP 279
+ + QLLSG+ +CH+ + HRD+K N L+D LKI DFG + + + P
Sbjct: 118 --ARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 174
Query: 280 MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 320
++ V T Y PE+LL G D+WS G L +L G
Sbjct: 175 KST-VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 39/301 (12%), Positives = 88/301 (29%), Gaps = 46/301 (15%)
Query: 53 RKKEEKVVDGEKKPRGERKRSKSNPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIP 112
+ ++ + E +S ++ +S + W L
Sbjct: 30 EELFNRIPQANVRTTSEYMQSAADSLVS-----------TSLWNTGQPFRVESELGE--- 75
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-VKFMAREILILRR 171
R + + +GQ +A D TG+ + F P + +K M E+L LR
Sbjct: 76 -RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 172 L-------------------------DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGL 206
L +I++ S + ++ M+ +L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 207 AASPEVKFTEPQFVYLKVKCY-MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265
+ + + + Q++ L H+ G++H ++ ++++D G + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 266 FGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGK 321
F + P+ +L T D W+ G + +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 322 P 322
Sbjct: 315 L 315
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-40
Identities = 65/213 (30%), Positives = 113/213 (53%), Gaps = 21/213 (9%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ F K++KIG+G++ V+K D T K+VA+K + + E E ++ + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 175 PNVIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAASPEVK---FTEPQFVYLKVKCYMH 229
P V K G L ++ L+++ ME+ L G +A ++ E Q + +
Sbjct: 80 PYVTKYYGSYLKDTK----LWII---MEY-LGGGSALDLLEPGPLDETQIATI-----LR 126
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 289
++L GL++ H+ +HRDIK +N+L+ + G +K+ADFG+A T V T ++
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFW 185
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE++ + Y D+WS G EL G+P
Sbjct: 186 MAPEVIKQS-AYDSKADIWSLGITAIELARGEP 217
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-40
Identities = 54/239 (22%), Positives = 105/239 (43%), Gaps = 25/239 (10%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL 169
I R +D + +G+G + K TG+++ +K+ + E+ + +E+ ++
Sbjct: 5 RIFRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVM 61
Query: 170 RRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYM 228
R L+HPNV+K G++ L + Y++ L G+ S + ++ Q V
Sbjct: 62 RCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-----A 114
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--------- 279
+ SG+ + H+ ++HRD+ N L+ ++ + +ADFGLA P
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 280 ----MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
+ V ++ PE++ G Y VD++S G +L E++ P + F
Sbjct: 175 DRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILRRLDHPNVIKL-E 181
+G GT+ V + LTG VA+K + + V + REI L+ HP++IKL +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYLKVKCYMHQLLS 233
+ T ++V ME+ + E+ + E + + Q+LS
Sbjct: 79 VISTPTD---FFMV---MEY-----VSGGELFDYICKHGRVEEME-----ARRLFQQILS 122
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
+++CH + V+HRD+K N+L+D KIADFGL++ + + + Y PE
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPE 180
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGK 321
++ G G VD+WS G IL LL G
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-39
Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREIL 167
+ +G+G + V+ + VA+K + + + E+
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 168 ILRRLD----HPNVIKL-EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYL 222
+L ++ HP VI+L + T LV +E L ++ F Y+
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEG---FMLV---LERPLPAQ----DL------FDYI 130
Query: 223 KVK---------CYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFF 272
K C+ Q+++ ++HCH+ GV+HRDIK N+LID G K+ DFG +
Sbjct: 131 TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
Query: 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG 320
T Y PPE + + + +WS G +L +++ G
Sbjct: 191 HDEPYT--DF-DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ +E + ++G G + VYKAK+ TG + A K + + E ++ EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 175 PNVIKLEG--LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
P ++KL G + L+++ + + + + TEPQ + Q+
Sbjct: 76 PYIVKLLGAYYHDGK----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV-----CRQM 126
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
L L H+ ++HRD+K N+L+ +G +++ADFG+++ S + T ++
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSFIGTPYWMA 185
Query: 292 PELLLGAT----DYGVGVDLWSAGCILAELLAGKP 322
PE+++ T Y D+WS G L E+ +P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-39
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-D 173
A FE ++ +G GTY VYK + + TG++ A+K + ++ + + + +EI +L++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 174 HPNVIKLEG----LVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVK 225
H N+ G M L+LV + DL + + E Y+
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYI--- 134
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
++L GL H H + V+HRDIKG N+L+ ++ +K+ DFG+++ D + +
Sbjct: 135 --CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIG 191
Query: 286 TLWYRPPELLLGATD----YGVGVDLWSAGCILAELLAGKP 322
T ++ PE++ + Y DLWS G E+ G P
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-39
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 40/223 (17%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA----REILILRRLD 173
++ +G G + +VY + VA+K V D + E+++L+++
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 174 H--PNVIKL-EGLVTSRMSCSLYLVFHYMEHDLAGLAASP--EVKFTEPQFVYLKVK--- 225
VI+L + L+ +E P ++ F ++ +
Sbjct: 105 SGFSGVIRLLDWFERPDS---FVLI---LER------PEPVQDL------FDFITERGAL 146
Query: 226 ------CYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKH 278
+ Q+L + HCHN GVLHRDIK N+LID + G LK+ DFG +
Sbjct: 147 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 206
Query: 279 PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 321
T Y PPE + +G +WS G +L +++ G
Sbjct: 207 --DF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLE-PESVKFMAREILILRRLDHPNVIK 179
+G+G++ V A T + VALK + + V+ REI L+ L HP++IK
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRHPHIIK 73
Query: 180 L-EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYLKVKCYMHQ 230
L + + T + +V +E+ A E+ + TE + + + Q
Sbjct: 74 LYDVITTPTD---IVMV---IEY------AGGELFDYIVEKKRMTEDE-----GRRFFQQ 116
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK------HPMTSRV 284
++ +E+CH + ++HRD+K NLL+DD+ +KIADFGL++ + P
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN---- 172
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 321
Y PE++ G G VD+WS G +L +L G+
Sbjct: 173 ----YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 48/234 (20%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR----EILILRRL- 172
+E + IG+G++ V KA D + VALK VR + K R EI IL L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151
Query: 173 -----DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQ 218
+ NVI + + +S +LY +L + + F+ P
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLY--------EL--IKKNKFQGFSLPL 201
Query: 219 FVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG--VLKIADFGLASFFDPNH 276
V+ + H +L L+ H N ++H D+K N+L+ G +K+ DFG + +
Sbjct: 202 -----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256
Query: 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+ + + +YR PE++LGA YG+ +D+WS GCILAELL G P++PG E
Sbjct: 257 ----YTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ F+ ++K+G+G+Y +VYKA TG+IVA+K+V +E ++ + +EI I+++ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVE-SDLQEIIKEISIMQQCDSP 84
Query: 176 NVIKLEG--LVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
+V+K G + L++V Y D+ L TE + + +
Sbjct: 85 HVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATI-----LQ 132
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 289
L GLE+ H +HRDIK N+L++ +G K+ADFG+A + + T ++
Sbjct: 133 STLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFW 191
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE++ Y D+WS G E+ GKP
Sbjct: 192 MAPEVIQEI-GYNCVADIWSLGITAIEMAEGKP 223
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 118 FEKID---KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ ++ KIG G++ V++A+ G VA+K + + E V RE+ I++RL H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
PN++ G VT + L +V Y+ L L + + L + + +
Sbjct: 94 PNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM---AYDVAK 148
Query: 234 GLE--HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
G+ H N ++HR++K NLL+D +K+ DFGL+ + S T +
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMA 207
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGK 321
PE+L D++S G IL EL +
Sbjct: 208 PEVLRD-EPSNEKSDVYSFGVILWELATLQ 236
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + +KIGQG VY A D+ TG+ VA++++ + + EIL++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--NEILVMRENKNP 77
Query: 176 NVIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAAS---PEVKFTEPQFVYLKVKCYMHQ 230
N++ LV L++V Y+ G + + E E Q + +
Sbjct: 78 NIVNYLDSYLVGDE----LWVVMEYLA----GGSLTDVVTETCMDEGQIAAV-----CRE 124
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
L LE H+N V+HRDIK N+L+ DG +K+ DFG + P T V T ++
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWM 183
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE++ YG VD+WS G + E++ G+P
Sbjct: 184 APEVVTR-KAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 124 IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILRRLDHPNVIKL-E 181
+G GT+ V K LTG VA+K + + V + REI L+ HP++IKL +
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEV--------KFTEPQFVYLKVKCYMHQLLS 233
+ T +++V ME+ + E+ + E + + Q+LS
Sbjct: 84 VISTPSD---IFMV---MEY-----VSGGELFDYICKNGRLDEKE-----SRRLFQQILS 127
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
G+++CH + V+HRD+K N+L+D KIADFGL++ + + + Y PE
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPE 185
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGK 321
++ G G VD+WS+G IL LL G
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-37
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRL 172
R + F+ +G+G++S V A+++ T + A+K + + ++ V ++ RE ++ RL
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 173 DHPNVIKLEGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQFVYLK 223
DHP +KL T + LY Y+ F E
Sbjct: 88 DHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETC----- 131
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 283
+ Y +++S LE+ H G++HRD+K N+L+++D ++I DFG A P K +
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 284 VV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
V T Y PELL DLW+ GCI+ +L+AG P
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLP 230
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-37
Identities = 57/214 (26%), Positives = 106/214 (49%), Gaps = 26/214 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ KIG+G+ V A++ +G+ VA+K + D + + + + E++I+R H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 176 NVIKLEG--LVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
NV+++ LV L+++ +++ D+ +V+ E Q +
Sbjct: 103 NVVEMYKSYLVGEE----LWVLMEFLQGGALTDIV-----SQVRLNEEQIATV-----CE 148
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL-ASFFDPNHKHPMTSRVVTLW 288
+L L + H GV+HRDIK ++L+ DG +K++DFG A K S V T +
Sbjct: 149 AVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPY 206
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
+ PE++ + Y VD+WS G ++ E++ G+P
Sbjct: 207 WMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEP 239
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-37
Identities = 36/207 (17%), Positives = 73/207 (35%), Gaps = 23/207 (11%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEG 182
K+ + ++K + G + +K ++ + + E LR HPNV+ + G
Sbjct: 17 KLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 183 LVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLE-- 236
S + L+ H+M +++ L + Q V + G+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKF-----ALDMARGMAFL 127
Query: 237 HCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL 296
H + + +++ID+D +I+ + F R+ + PE L
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQ 181
Query: 297 G--ATDYGVGVDLWSAGCILAELLAGK 321
D+WS +L EL+ +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 67/248 (27%), Positives = 104/248 (41%), Gaps = 62/248 (25%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR----EILILRRL---- 172
+ K+G G +S V+ AKDM+ VA+K VR K EI +L+R+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDAD 76
Query: 173 -------DHPNVIKLEG-------------LVTSRMSCSLYLVFHYMEHDLAGLAASPEV 212
+++KL +V + +L L +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL--------AL--IKKYEHR 126
Query: 213 KFTEPQFVYLKVKCYMHQLLSGLEHCH-NNGVLHRDIKGSNLLIDD------DGVLKIAD 265
VK QLL GL++ H G++H DIK N+L++ +KIAD
Sbjct: 127 GIPLIY-----VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 266 FGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325
G A ++D ++ T+ + T YR PE+LLGA +G G D+WS C++ EL+ G +
Sbjct: 182 LGNACWYDEHY----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFE 236
Query: 326 GRTEVSAT 333
S T
Sbjct: 237 PDEGHSYT 244
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
W IP +IG G++ VYK K G VA+K + P+ ++ E+ +
Sbjct: 19 WEIPD--GQITVGQRIGSGSFGTVYKGK--WHGD-VAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCY 227
LR+ H N++ G T+ L +V + E L + E KF + + +
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDI----- 125
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP-NHKHPMTSRVVT 286
Q G+++ H ++HRD+K +N+ + +D +KI DFGLA+ + H +
Sbjct: 126 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 287 LWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGK 321
+ + PE++ Y D+++ G +L EL+ G+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 37/232 (15%), Positives = 75/232 (32%), Gaps = 36/232 (15%)
Query: 116 DSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+G+G ++ VY+A D + LK + N P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLK 122
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-----LAGLAASPEVKFTEPQFVYLKVK 225
+K + LV + + +PE + V
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGL-----VI 175
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLI-----------DDDGVLKIADFGLA---SF 271
+ ++L +E H+ ++H DIK N ++ D L + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPI 323
F T++ T ++ E+L + +D + + +L G +
Sbjct: 236 FPKGTI--FTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-36
Identities = 43/212 (20%), Positives = 75/212 (35%), Gaps = 52/212 (24%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLE 181
+G G V + + T + ALK + + RE+ + R P+++++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 182 GLV--TSRMSCSLYLVFHYMEHDLAG------LAASPEVKFTEPQFVYLKVKCYMHQLLS 233
+ L +V ++ G + + FTE + M +
Sbjct: 78 DVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTERE-----ASEIMKSIGE 128
Query: 234 GLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
+++ H+ + HRD+K NLL + +LK+ DFG A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------- 167
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
E Y D+WS G I+ LL G P
Sbjct: 168 -KETT--GEKYDKSCDMWSLGVIMYILLCGYP 196
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-----VKFMAREILILR 170
+ E +IG+G + V+K + + +VA+K + + E E+ + RE+ I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMH 229
L+HPN++KL GL+ + +V ++ DL + L M
Sbjct: 79 NLNHPNIVKLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-----ML 129
Query: 230 QLLSGLE--HCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGLASFFDPNHKHPMTS 282
+ G+E N ++HRD++ N+ + K+ADFGL+ H ++
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HSVSG 185
Query: 283 RVVTLWYRPPELLLGATD-YGVGVDLWSAGCILAELLAGK 321
+ + PE + + Y D +S IL +L G+
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
E + +G+G + V KAK K VA+K++ ++ F+ E+ L R++HP
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKA---FI-VELRQLSRVNHP 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++KL G + + LV Y E L + E + Q G
Sbjct: 62 NIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW---CLQCSQG 114
Query: 235 LEHCHN---NGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
+ + H+ ++HRD+K NLL+ G VLKI DFG A + MT+ + +
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWM 170
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGK 321
PE+ G ++Y D++S G IL E++ +
Sbjct: 171 APEVFEG-SNYSEKCDVFSWGIILWEVITRR 200
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 57/241 (23%), Positives = 100/241 (41%), Gaps = 56/241 (23%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR----EILILR 170
D +E IG+G++ V KA D + + VA+K ++ + K E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 171 RL------DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFT 215
+ ++ L+ LV +S +LY DL ++ T
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY--------DL--------LRNT 149
Query: 216 EPQFVYLK---VKCYMHQLLSGLEHCHNN--GVLHRDIKGSNLLIDDDG--VLKIADFGL 268
F + + + Q+ + L ++H D+K N+L+ + +KI DFG
Sbjct: 150 --NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207
Query: 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328
+ + + +YR PE+LLG Y + +D+WS GCIL E+ G+P+ G
Sbjct: 208 SCQLGQRI----YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGAN 262
Query: 329 E 329
E
Sbjct: 263 E 263
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 46/220 (20%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 118 FEKID---KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
FE+++ IG+G + VY + G+ VA++ + + + +K RE++ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGR--WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
NV+ G S L ++ + L + ++ + + +++
Sbjct: 89 ENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQI-----AQEIVK 141
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF----FDPNHKHPMTSRVVTLWY 289
G+ + H G+LH+D+K N+ D+G + I DFGL S + + + L +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 290 RPPELLLGATD--------YGVGVDLWSAGCILAELLAGK 321
PE++ + + D+++ G I EL A +
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 27/223 (12%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRL 172
+ D FE + IG+G +S V K TG++ A+K + + L+ V E +L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 173 DHPNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
D + +L + LYLV Y DL L + + +
Sbjct: 119 DRRWITQLH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-----AR 165
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y+ +++ ++ H G +HRDIK N+L+D G +++ADFG + V
Sbjct: 166 FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 286 TLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L YG D W+ G E+ G+
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-33
Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 16/227 (7%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
++ + ++ +G + V+KA L + VA+K F + +S + E+ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMK 76
Query: 174 HPNVIKLEGLVT--SRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC---Y 227
H N+++ G + + L+L+ + E L+ + V + E + + Y
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAY 136
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-T 286
+H+ + GL+ H + HRDIK N+L+ ++ IADFGLA F+ T V T
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 287 LWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
Y PE+L GA D + +D+++ G +L EL + G +
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 61/256 (23%), Positives = 100/256 (39%), Gaps = 70/256 (27%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAR----EILILRRL- 172
F I K+G GT+ V + + K A+K VR ++K R E IL+++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 173 ----DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQF 219
++ N++K G L+ + SLY ++ + + F
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY--------EI--ITRNNYNGFHIED- 138
Query: 220 VYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV------------------- 260
+K Y ++L L + + H D+K N+L+DD
Sbjct: 139 ----IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 261 ------LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCIL 314
+K+ DFG A+F H S + T YR PE++L + V D+WS GC+L
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVL 249
Query: 315 AELLAGKPIMPGRTEV 330
AEL G + +
Sbjct: 250 AELYTGSLLFRTHEHM 265
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ D FEKI ++G G V+K +G ++A K + + +P + RE+ +L +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN 89
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
P ++ G S + + +M+ L + + E + ++
Sbjct: 90 SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKV-----SIAVI 141
Query: 233 SGLEHCHNNG-VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
GL + ++HRD+K SN+L++ G +K+ DFG++ + + S V T Y
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMS 198
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE L G T Y V D+WS G L E+ G+
Sbjct: 199 PERLQG-THYSVQSDIWSMGLSLVEMAVGRY 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 31/225 (13%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A + + +IG+G Y V+ K G+ VA+K E+ F EI + H
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRH 90
Query: 175 PNVIKLEGLVT--SRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
N++ + LYL+ Y E+ L S + LK+ +
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKS----MLKL---AYSS 143
Query: 232 LSGLEHCH--------NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH---PM 280
+SGL H H + HRD+K N+L+ +G IAD GLA F + P
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 281 TSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAG 320
+RV T Y PPE+L + + D++S G IL E+
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP--ESVKFMAREILILRRLDHPNVIKL 180
IG G + VY+A G VA+K R D E ++++ + +E + L HPN+I L
Sbjct: 14 IIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYM-HQLLSGLEHC 238
G+ +L LV + L + + + + Q+ G+ +
Sbjct: 72 RGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIP--------PDILVNWAVQIARGMNYL 121
Query: 239 HNNG---VLHRDIKGSNLLID--------DDGVLKIADFGLASFFDPNHKHPMTSRVVTL 287
H+ ++HRD+K SN+LI + +LKI DFGLA + H+ S
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAY 178
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 321
+ PE++ + + G D+WS G +L ELL G+
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 46/223 (20%), Positives = 87/223 (39%), Gaps = 30/223 (13%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
A +E I G +Y A D + G+ V LK + + E+ E L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVV 137
Query: 174 HPNVIKLEGLV---TSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKC 226
HP+++++ V Y+V ME L + +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIV---MEYVGGQSLKRSKGQK---LPVAEAI-----A 186
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV- 285
Y+ ++L L + H+ G+++ D+K N+++ ++ + K+ D G S + +
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRIN------SFGYLYG 239
Query: 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328
T ++ PE++ V D+++ G LA L P GR
Sbjct: 240 TPGFQAPEIVRTGPT--VATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 54/225 (24%), Positives = 85/225 (37%), Gaps = 31/225 (13%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A ++ +G+G Y V++ G+ VA+K + E F E+ L H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRD---EKSWFRETELYNTVMLRH 61
Query: 175 PNVIKLEGLVTSRMSCS--LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
N++ + S L+L+ HY E L + L++ + +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS----CLRI---VLSI 114
Query: 232 LSGLEHCH--------NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH---PM 280
SGL H H + HRD+K N+L+ +G IAD GLA +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 281 TSRVVTLWYRPPELLLGATDYGVG-----VDLWSAGCILAELLAG 320
RV T Y PE+L VD+W+ G +L E+
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRL 172
+ FE + IG+G + V K K+ A+K + ++ L+ E +L
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 173 DHPNVIKLEGLVTSRMSCS------LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
D + L + LYLV Y DL L + E + E +
Sbjct: 132 DSKWITTLH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-----AR 178
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y+ +++ ++ H +HRDIK N+L+D +G +++ADFG + + V
Sbjct: 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 238
Query: 286 TLWYRPPELLLGATD----YGVGVDLWSAGCILAELLAGKP 322
T Y PE+L YG D WS G + E+L G+
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 28/227 (12%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA-REILILRRLDH 174
D+ + ++ IG+G Y VYK L + VA+K F ++ F+ + I + ++H
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKV--FSFANRQN--FINEKNIYRVPLMEH 66
Query: 175 PNVIKLEG---LVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC---Y 227
N+ + VT+ LV Y + L + + + V Y
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAY 126
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH-------KHPM 280
+H L +H + HRD+ N+L+ +DG I+DFGL+ N +
Sbjct: 127 LHTELPRGDHY-KPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 281 TSRVVTLWYRPPELLLGATD------YGVGVDLWSAGCILAELLAGK 321
S V T+ Y PE+L GA + VD+++ G I E+
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL- 172
A+ + + +IG+G Y +V K +G+I+A+K++R ++ + K + ++ ++ R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSS 78
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYM----EHDLAGLAASPEVKFTEPQFVYLKVKCYM 228
D P +++ G + ++ M + + + + E +
Sbjct: 79 DCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI-----T 131
Query: 229 HQLLSGLEHCHNNG-VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTL 287
+ L H N ++HRDIK SN+L+D G +K+ DFG++ T
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCR 189
Query: 288 WYRPPELLLGATD---YGVGVDLWSAGCILAELLAGKP 322
Y PE + + Y V D+WS G L EL G+
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 53/251 (21%), Positives = 93/251 (37%), Gaps = 66/251 (26%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLEPESVKFMAR----EILILRRL 172
+E +D +G+G + V + D G + VA+K V+ +V EI +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 173 ------DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEP 217
+++ +V + S Y D + + + F
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY--------DF--IKENGFLPFRLD 118
Query: 218 QFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV----------------- 260
++ +Q+ + H+N + H D+K N+L
Sbjct: 119 H-----IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 261 --LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
+K+ DFG A++ D +H ++ V T YR PE++L + D+WS GCIL E
Sbjct: 174 PDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYY 228
Query: 319 AGKPIMPGRTE 329
G + P
Sbjct: 229 LGFTVFPTHDS 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR-FDNLEPESVKFMAREILILRRL 172
+A+ +E + IG+G + V + T K+ A+K + F+ ++ F E I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
+ P V++L + LY+V YM DL L + E + Y ++
Sbjct: 127 NSPWVVQLFY--AFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKW-----ARFYTAEV 177
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
+ L+ H+ G +HRD+K N+L+D G LK+ADFG + + V T Y
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 292 PELLL---GATDYGVGVDLWSAGCILAELLAGKP 322
PE+L G YG D WS G L E+L G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-31
Identities = 55/254 (21%), Positives = 95/254 (37%), Gaps = 66/254 (25%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGK-IVALKKVRFDNLEPESVKFMAR----EILIL 169
+ +E + +G+GT+ V + D GK VALK +R +V EI +L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVL 70
Query: 170 RRL------DHPNVIKLEG---------LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKF 214
+++ + + + + + + + + L + +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF--------EF--LKENNFQPY 120
Query: 215 TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV-------------- 260
P V+ +QL L H N + H D+K N+L +
Sbjct: 121 PLPH-----VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 261 -----LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILA 315
+++ADFG A+F +H T+ V T YRPPE++L + D+WS GCIL
Sbjct: 176 VKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILF 230
Query: 316 ELLAGKPIMPGRTE 329
E G +
Sbjct: 231 EYYRGFTLFQTHEN 244
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-31
Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 17/223 (7%)
Query: 107 LNGW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMARE 165
+ G + E + ++G GT V+K + TG ++A+K++R E K + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMD 73
Query: 166 ILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV 224
+ ++ + D P +++ G + + +++ M L + E +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM-- 129
Query: 225 KCYMHQLLSGLEHCH-NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 283
++ L + +GV+HRD+K SN+L+D+ G +K+ DFG++
Sbjct: 130 ---TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRS 184
Query: 284 VVTLWYRPPE----LLLGATDYGVGVDLWSAGCILAELLAGKP 322
Y PE DY + D+WS G L EL G+
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 55/230 (23%), Positives = 81/230 (35%), Gaps = 31/230 (13%)
Query: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+ IG+G + V++ K G+ VA+K E F EI L H N++
Sbjct: 45 VLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENIL 99
Query: 179 KLEGLVTSRMSCS--LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
L+LV Y EH L V +K+ SGL
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG----MIKL---ALSTASGL 152
Query: 236 EHCH--------NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH---PMTSRV 284
H H + HRD+K N+L+ +G IAD GLA D RV
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 285 VTLWYRPPELLLGATDYGVG-----VDLWSAGCILAELLAGKPIMPGRTE 329
T Y PE+L + + D+++ G + E+ I +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
D FE + IG+G++ V + T K+ A+K + +E V+ + +E+ I++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 175 PNVIKLEGLVTSRMSCS------LYLVFHYME------HDLAGLAASPEVKFTEPQFVYL 222
P ++ L S +++V + H V F E
Sbjct: 75 PFLVNLW--------YSFQDEEDMFMVVDLLLGGDLRYH------LQQNVHFKEET---- 116
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
VK ++ +L+ L++ N ++HRD+K N+L+D+ G + I DF +A+ + T+
Sbjct: 117 -VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TT 173
Query: 283 RVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+ Y VD WS G ELL G+
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI-LRRL 172
+AD E I ++G+G Y V K + + +G+I+A+K++R + + K + ++ I +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTV 63
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYME---HDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
D P + G + +++ M+ E +
Sbjct: 64 DCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI-----AV 116
Query: 230 QLLSGLEHCHNNG-VLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
++ LEH H+ V+HRD+K SN+LI+ G +K+ DFG++ +
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKP 174
Query: 289 YRPPELLLGATD---YGVGVDLWSAGCILAELLAGKP 322
Y PE + + Y V D+WS G + EL +
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHPNVIK 179
+G+G +VY+A+D + +IVALK + + +P M RE RL P+V+
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 180 L------EGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
+ +G LY+ + DLA + + P+ V + + Q+
Sbjct: 99 IHDFGEIDGQ--------LYVDMRLINGVDLAAMLRR-QGPLAPPRAVAI-----VRQIG 144
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--RVV-TLWY 289
S L+ H G HRD+K N+L+ D + DFG+AS +T V TL+Y
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK---LTQLGNTVGTLYY 201
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
PE + D+++ C+L E L G P
Sbjct: 202 MAPERFSESH-ATYRADIYALTCVLYECLTGSP 233
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHPN 176
++ +DK+G G S VY A+D + VA+K + + E++K RE+ +L H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 177 VIKL------EGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
++ + + YLV Y+E L+ E + + +
Sbjct: 73 IVSMIDVDEEDDCY--------YLVMEYIEGPTLS------EYIESHGPLSVDTAINFTN 118
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLW 288
Q+L G++H H+ ++HRDIK N+LID + LKI DFG+A T+ V+ T+
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQ 177
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331
Y PE G D++S G +L E+L G+P G T VS
Sbjct: 178 YFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 21/224 (9%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-NLEPESVKFMAREILILRRLDHPN 176
+E + +G G S V+ A+D+ + VA+K +R D +P RE L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 177 VIKL--EGLVTSRMSCSLYLVFHYME----HDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
++ + G + Y+V ME L + + E T + + +
Sbjct: 74 IVAVYDTGEAETPAGPLPYIV---MEYVDGVTLRDIVHT-EGPMTPKRAIE-----VIAD 124
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT--SRVV-TL 287
L H NG++HRD+K +N++I +K+ DFG+A + + +T + V+ T
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTA 183
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331
Y PE G + D++S GC+L E+L G+P G + VS
Sbjct: 184 QYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
++F + +G+G + V + TGK+ A KK+ + + + E IL +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 175 PNVIKLEGLVTSRMSC-----SLYLVFHYME------HDLAGLAASPEVKFTEPQFVYLK 223
V+ L +L LV M H + + F E + V+
Sbjct: 244 RFVVSLA-------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVF-- 290
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 283
Y ++ GLE H +++RD+K N+L+DD G ++I+D GLA + R
Sbjct: 291 ---YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR 345
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
V T+ Y PE++ Y D W+ GC+L E++AG+
Sbjct: 346 VGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
D F +G+G + V+ + TGK+ A KK+ + + + E IL ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 175 PNVIKLEGLVTSRMSC-----SLYLVFHYMEH-DL---AGLAASPEVKFTEPQFVYLKVK 225
++ L L LV M D+ F EP+ ++
Sbjct: 245 RFIVSLA-------YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF---- 293
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y Q++SGLEH H +++RD+K N+L+DDDG ++I+D GLA +
Sbjct: 294 -YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAG 351
Query: 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T + PELLLG +Y VD ++ G L E++A +
Sbjct: 352 TPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARG 387
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA---REIL-ILRR 171
+ F IG+G + VY + TGK+ A+K + ++ + + +A R +L ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYME------HDLAGLAASPEVKFTEPQFVYLKVK 225
D P ++ + + L + M H S F+E ++
Sbjct: 249 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYH------LSQHGVFSEAD-----MR 295
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y +++ GLEH HN V++RD+K +N+L+D+ G ++I+D GLA F + V
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVG 352
Query: 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L Y D +S GC+L +LL G
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 39/221 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
D F++I +G G++ V K +G A+K + ++ + ++ E IL+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 175 PNVIKLEGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQFVYLKVK 225
P ++KLE + + + +LY+V F ++ +F+EP +
Sbjct: 101 PFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPH-----AR 144
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y Q++ E+ H+ +++RD+K NLLID G +++ DFG A R
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------GRTW 196
Query: 286 TL----WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
TL PE++L Y VD W+ G ++ E+ AG P
Sbjct: 197 TLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREI 166
+R ++I +G+G + V + G VA+K ++ ++ +EI
Sbjct: 18 FEKR--FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEI 74
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
ILR L H N++K +G+ T + L+ ++ L + K Q +
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK---- 130
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y Q+ G+++ + +HRD+ N+L++ + +KI DFGL + + ++
Sbjct: 131 -YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189
Query: 286 TL---WYRPPELLLGATDYGVGVDLWSAGCILAELL 318
WY PE L+ + + + D+WS G L ELL
Sbjct: 190 DSPVFWY-APECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
F+ + +G G++ V+ + G+ A+K ++ + + + V+ E L+L + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 175 PNVIKLEGLVTSRMSCSLYLV---------FHYMEHDLAGLAASPEVKFTEPQFVYLKVK 225
P +I++ G T + + ++++ F + +F P K
Sbjct: 66 PFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRK---------SQRFPNPV-----AK 109
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y ++ LE+ H+ +++RD+K N+L+D +G +KI DFG A +
Sbjct: 110 FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--------DVTY 161
Query: 286 TLW----YRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
TL Y PE++ Y +D WS G ++ E+LAG
Sbjct: 162 TLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 37/214 (17%), Positives = 63/214 (29%), Gaps = 41/214 (19%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF-MAREILILRRLDHPNVIK 179
+ G ++A D + VAL V + P+ V L L R+D P V +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 180 LEGLVTSRMSCSLYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238
+ +V +R +V ++ L +A + P M L + +
Sbjct: 96 VLDVVHTRAGG--LVVAEWIRGGSLQEVADTSP----SPVGAIR----AMQSLAAAADAA 145
Query: 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA 298
H GV S + + DG + +A +
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPATMP--------DANPQ--------------- 182
Query: 299 TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332
D+ G L LL + +P S
Sbjct: 183 ------DDIRGIGASLYALLVNRWPLPEAGVRSG 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 44/232 (18%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
+ F+ + +G+GT+ V ++ TG+ A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 175 PNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQFVYLK 223
P + L+ L V Y H S E FTE +
Sbjct: 65 PFLTALK-------YAFQTHDRLCFVMEYANGGELFFH------LSRERVFTEER----- 106
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 283
+ Y +++S LE+ H+ V++RDIK NL++D DG +KI DFGL K ++
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-------KEGISDG 159
Query: 284 VV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
T Y PE+L DYG VD W G ++ E++ G+ +
Sbjct: 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 36/160 (22%), Positives = 74/160 (46%), Gaps = 11/160 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+ + ++IG+G + V+ + +VA+K R KF+ +E IL+
Sbjct: 111 LNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILK 167
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMH 229
+ HPN+++L G+ T + +Y+V ++ D + + + +
Sbjct: 168 QYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQ-----MVG 220
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+G+E+ + +HRD+ N L+ + VLKI+DFG++
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREI 166
R + + ++G+G + +V + TG++VA+KK++ + E F REI
Sbjct: 38 FEER--HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REI 93
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
IL+ L H N++K +G+ S +L L+ Y+ + L + + + +
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ---- 149
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y Q+ G+E+ +HRD+ N+L++++ +KI DFGL + ++
Sbjct: 150 -YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208
Query: 286 TL---WYRPPELLLGATDYGVGVDLWSAGCILAELL 318
WY PE L + + V D+WS G +L EL
Sbjct: 209 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 242
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRRLDH 174
+ FE + +G+GT+ V K+ TG+ A+K ++ + + + V E +L+ H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 175 PNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQFVYLK 223
P + L+ L V Y H S E F+E +
Sbjct: 208 PFLTALK-------YSFQTHDRLCFVMEYANGGELFFH------LSRERVFSEDR----- 249
Query: 224 VKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
+ Y +++S L++ H+ V++RD+K NL++D DG +KI DFGL K +
Sbjct: 250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC-------KEGIKD 302
Query: 283 RVV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
T Y PE+L DYG VD W G ++ E++ G+ +
Sbjct: 303 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREI 166
R + + ++G+G + +V + TG++VA+KK++ + E F REI
Sbjct: 7 FEER--HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REI 62
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
IL+ L H N++K +G+ S +L L+ Y+ + L + + + +
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ---- 118
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y Q+ G+E+ +HRD+ N+L++++ +KI DFGL + +
Sbjct: 119 -YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 286 TL---WYRPPELLLGATDYGVGVDLWSAGCILAELL 318
WY PE L + + V D+WS G +L EL
Sbjct: 178 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 211
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 50/229 (21%)
Query: 116 DSFEKIDKIGQGTYSNVY---KAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRR 171
FE + +GQG++ V+ K ++ A+K ++ L + V+ E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 172 LDHPNVIKLEGLVTSRMSCS------LYLVFHY------MEHDLAGLAASPEVKFTEPQF 219
++HP ++KL + LYL+ + S EV FTE
Sbjct: 83 VNHPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTR------LSKEVMFTEED- 127
Query: 220 VYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279
VK Y+ +L L+H H+ G+++RD+K N+L+D++G +K+ DFGL+ K
Sbjct: 128 ----VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-------KES 176
Query: 280 MTSRVV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
+ T+ Y PE++ + D WS G ++ E+L G
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTL 224
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 54/232 (23%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNL--EPESVKFMAREILILR 170
+ FE + +G+G Y V++ + + TGKI A+K ++ + + E IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 171 RLDHPNVIKLEGLVTSRMSC-----SLYLV---------FHYMEHDLAGLAASPEVKFTE 216
+ HP ++ L + LYL+ F +E E F E
Sbjct: 77 EVKHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQLER---------EGIFME 120
Query: 217 PQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276
Y+ ++ L H H G+++RD+K N++++ G +K+ DFGL
Sbjct: 121 DT-----ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC------- 168
Query: 277 KHPMTSRVV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
K + V T+ Y PE+L+ + + VD WS G ++ ++L G P
Sbjct: 169 KESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
I + + IG+G + VY D KI A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
+I++ HPNV+ L G+ R S +V YM+H DL + T +
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---- 132
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ Q+ G+++ + +HRD+ N ++D+ +K+ADFGLA
Sbjct: 133 -FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREIL 167
I IG G V + + G+ VA+K ++ E + F+ E
Sbjct: 46 IEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEAS 102
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
I+ + DHPN+I+LEG+VT +V YME+ L + + +FT Q V
Sbjct: 103 IMGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG----- 155
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ + +G+ + + G +HRD+ N+L+D + V K++DFGL+
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 48/228 (21%), Positives = 96/228 (42%), Gaps = 18/228 (7%)
Query: 95 WPPWLTAVCGEALNGW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN 153
+ W + R K+G G Y VY+ VA+K ++ D
Sbjct: 200 RNKPTIYGVSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT 257
Query: 154 LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPE 211
+E E +F+ E +++ + HPN+++L G+ T Y++ +M + +L L
Sbjct: 258 MEVE--EFLK-EAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNR 312
Query: 212 VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271
+ + +Y Q+ S +E+ +HR++ N L+ ++ ++K+ADFGL+
Sbjct: 313 QEVSAVVLLY-----MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 272 F-DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
+ ++ W P L + + D+W+ G +L E+
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIA 413
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREIL 167
+ + +G G + V + L K VA+K ++ E + F+ E
Sbjct: 42 LDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEAS 98
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
I+ + DHPN+I+LEG+VT S + +V YME+ L + +FT Q V
Sbjct: 99 IMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG----- 151
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
+ + SG+++ + G +HRD+ N+LI+ + V K++DFGL + + + T+R
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 287 L---WYRPPELLLGATDYGV---GVDLWSAGCILAELL 318
+ W PE A Y D+WS G +L E++
Sbjct: 212 IPIRWT-SPE----AIAYRKFTSASDVWSYGIVLWEVM 244
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-24
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREI 166
+R +KI +G+G + V T +VA+K ++ D + +EI
Sbjct: 28 FHKR--YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEI 84
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
ILR L H ++IK +G + SL LV Y+ L P Q +
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLL---- 138
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ Q+ G+ + H +HRD+ N+L+D+D ++KI DFGLA
Sbjct: 139 -FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-24
Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 26/218 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK---DMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
+ F+KI +G G + VYK + KI VA+K++R + + + E
Sbjct: 12 LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEA 68
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
++ +D+P+V +L G+ + ++ L+ M L + +
Sbjct: 69 YVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN---- 121
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--R 283
+ Q+ G+ + + ++HRD+ N+L+ +KI DFGLA K +
Sbjct: 122 -WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 284 VVTLWYRPPELLLGATDYGV---GVDLWSAGCILAELL 318
V W E +L + + D+WS G + EL+
Sbjct: 181 VPIKWM-ALESIL----HRIYTHQSDVWSYGVTVWELM 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
I + + IG+G + VY D KI A+K + E +F+ E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 141
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
+I++ HPNV+ L G+ R S +V YM+H DL + T +
Sbjct: 142 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---- 196
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ Q+ G++ + +HRD+ N ++D+ +K+ADFGLA
Sbjct: 197 -FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
IP IG+G + VY D +I A+K + + F+ RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REG 73
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
L++R L+HPNV+ L G++ +++ YM H DL SP+ T +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS---- 128
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ Q+ G+E+ +HRD+ N ++D+ +K+ADFGLA
Sbjct: 129 -FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 41/164 (25%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI----VALKKVRFDNLEPESVKFMAREI 166
I + IG G + VYK + VA+K ++ E + V F+ E
Sbjct: 41 IHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEA 97
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
I+ + H N+I+LEG+++ + ++ YME+ L + +F+ Q V
Sbjct: 98 GIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVG---- 151
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ + +G+++ N +HRD+ N+L++ + V K++DFGL+
Sbjct: 152 -MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREI 166
R + I ++G+G + +V + TG +VA+K+++ P+ + REI
Sbjct: 20 FEER--HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREI 75
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
IL+ L ++K G+ SL LV Y+ L + + +
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL---- 131
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
Y Q+ G+E+ + +HRD+ N+L++ + +KIADFGLA + + +
Sbjct: 132 -YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 286 TL---WYRPPELLLGATDYGV---GVDLWSAGCILAELL 318
WY PE L + D+WS G +L EL
Sbjct: 191 QSPIFWY-APESLS----DNIFSRQSDVWSFGVVLYELF 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 36/162 (22%), Positives = 72/162 (44%), Gaps = 13/162 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILI 168
+ R I ++G G + +V + + K VA+K ++ + ++ + M RE I
Sbjct: 6 LKRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQI 63
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCY 227
+ +LD+P +++L G+ + +L LV L +
Sbjct: 64 MHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-----L 115
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+HQ+ G+++ +HRD+ N+L+ + KI+DFGL+
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 49/228 (21%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRR 171
F + IG+G++ V A+ A+K ++ + E + + R +L L+
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM-SERNVL-LKN 95
Query: 172 LDHPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQFV 220
+ HP ++ L LY V Y H E F EP+
Sbjct: 96 VKHPFLVGLH-------FSFQTADKLYFVLDYINGGELFYH------LQRERCFLEPR-- 140
Query: 221 YLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
+ Y ++ S L + H+ +++RD+K N+L+D G + + DFGL K +
Sbjct: 141 ---ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-------KENI 190
Query: 281 TSRVV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L Y VD W G +L E+L G P
Sbjct: 191 EHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-23
Identities = 39/163 (23%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI---VALKKVRFDNLEPESVKFMAREIL 167
I R + E IG+G + +V++ M VA+K + + KF+ +E L
Sbjct: 12 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEAL 68
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
+R+ DHP+++KL G++T ++++ +L + +
Sbjct: 69 TMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLIL----- 120
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
Y +QL + L + + +HRDI N+L+ + +K+ DFGL+
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 49/237 (20%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILIL 169
+ + F +G+G++ V+ A+ T + A+K ++ D + + E + + +L
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM-VEKRVL-S 72
Query: 170 RRLDHPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQ 218
+HP + + +L+ V Y M H KF +
Sbjct: 73 LAWEHPFLTHMF-------CTFQTKENLFFVMEYLNGGDLMYH------IQSCHKFDLSR 119
Query: 219 FVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 278
+ Y +++ GL+ H+ G+++RD+K N+L+D DG +KIADFG+ K
Sbjct: 120 ATF-----YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-------KE 167
Query: 279 PMTSRVVTLW------YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
M T Y PE+LLG Y VD WS G +L E+L G+ G+ E
Sbjct: 168 NMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRR-LD 173
F+ + IG+G+Y+ V + T +I A+K V+ + + E + ++ E + + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 174 HPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQFVYL 222
HP ++ L SC L+ V Y M H + K E
Sbjct: 69 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEH---- 111
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
+ Y ++ L + H G+++RD+K N+L+D +G +K+ D+G+ K +
Sbjct: 112 -ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRP 163
Query: 283 RVV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L G DYG VD W+ G ++ E++AG+
Sbjct: 164 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-23
Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 15/163 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
I R + +G+G + VY+ + KI VA+K + D KFM E +
Sbjct: 9 IAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAV 65
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
I++ LDHP+++KL G++ +++ + +L + V
Sbjct: 66 IMKNLDHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVL----- 117
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
Y Q+ + + + +HRDI N+L+ +K+ DFGL+
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 4e-23
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 96 PPWLTAVCGEALNGW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL 154
P G A + W IPR +S K+GQG + V+ T + VA+K ++ +
Sbjct: 248 PTSKPQTQGLAKDAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM 304
Query: 155 EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEV 212
PE F+ +E ++++L H +++L +V+ +Y+V YM L L
Sbjct: 305 SPE--AFL-QEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGK 358
Query: 213 KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272
PQ V Q+ SG+ + +HRD++ +N+L+ ++ V K+ADFGLA
Sbjct: 359 YLRLPQLVD-----MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413
Query: 273 -DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
D + ++ W P L G + + D+WS G +L EL
Sbjct: 414 EDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 458
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 4e-23
Identities = 61/295 (20%), Positives = 100/295 (33%), Gaps = 101/295 (34%)
Query: 104 GEALNGWIPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA 163
G+ NG + I K+G G +S V+ + D+ K VA+K V+ E+
Sbjct: 32 GDLFNG-------RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL--- 81
Query: 164 REILILRRL-----DHPN---VIKL------EG-------LVTSRMSCSLYLVFHYMEHD 202
EI +L+ + + PN V++L G +V + L
Sbjct: 82 DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKW------- 134
Query: 203 LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLI------ 255
+ S P VK + Q+L GL++ H ++H DIK N+L+
Sbjct: 135 ---IIKSNYQGLPLPC-----VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186
Query: 256 -------------------------------------------DDDGVLKIADFGLASFF 272
+ +KIAD G A +
Sbjct: 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV 246
Query: 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327
+ + +R YR E+L+G+ Y D+WS C+ EL G +
Sbjct: 247 HKHFTEDIQTRQ----YRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPH 296
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 39/232 (16%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILIL 169
+ F + +G+G++ V ++ T ++ A+K ++ D + + E + + +L L
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLAL 397
Query: 170 RRLDHPNVIKLEGLVTSRMSC-----SLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLK 223
P + +L SC LY V Y+ DL +F EP
Sbjct: 398 PG-KPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLM-YHIQQVGRFKEPH----- 443
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR 283
Y ++ GL + G+++RD+K N+++D +G +KIADFG+ K +
Sbjct: 444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDG 496
Query: 284 VV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
V T Y PE++ YG VD W+ G +L E+LAG+ G E
Sbjct: 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-23
Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 49/237 (20%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILIL 169
D+FE I +G+G++ V A+ TG + A+K ++ D + + E + IL L
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TEKRILSL 79
Query: 170 RRLDHPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQ 218
R +HP + +L C L+ V + M H +F E +
Sbjct: 80 AR-NHPFLTQLF-------CCFQTPDRLFFVMEFVNGGDLMFH------IQKSRRFDEAR 125
Query: 219 FVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 278
+ Y +++S L H+ G+++RD+K N+L+D +G K+ADFG+ K
Sbjct: 126 ARF-----YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KE 173
Query: 279 PMTSRVV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+ + V T Y PE+L YG VD W+ G +L E+L G E
Sbjct: 174 GICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-23
Identities = 37/163 (22%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
W I + ++G G + V K G+ VA+K ++ ++ + +F+ E
Sbjct: 19 WEIDP--KDLTFLKELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSED--EFI-EEAK 71
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
++ L H +++L G+ T + ++++ YM + L +F Q +
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLE----- 124
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ +E+ + LHRD+ N L++D GV+K++DFGL+
Sbjct: 125 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 7e-23
Identities = 38/163 (23%), Positives = 71/163 (43%), Gaps = 17/163 (10%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
W I + +IG G + V+ K VA+K +R + E F+ E
Sbjct: 3 WVIDP--SELTFVQEIGSGQFGLVHLGY--WLNKDKVAIKTIREGAMSEE--DFI-EEAE 55
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
++ +L HP +++L G+ + + LV +MEH L+ + F +
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAP--ICLVTEFMEHGCLSDYLRTQRGLFAAETLLG----- 108
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ G+ + V+HRD+ N L+ ++ V+K++DFG+
Sbjct: 109 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-23
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN-LEPESVKFMAREILILRR-LD 173
F+ + IG+G+Y+ V + T +I A++ V+ + + E + ++ E + + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 174 HPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQFVYL 222
HP ++ L SC L+ V Y M H + K E
Sbjct: 112 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEH---- 154
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS 282
+ Y ++ L + H G+++RD+K N+L+D +G +K+ D+G+ K +
Sbjct: 155 -ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRP 206
Query: 283 RVV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
T Y PE+L G DYG VD W+ G ++ E++AG+
Sbjct: 207 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 15/163 (9%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
W + R K+G G Y VY+ VA+K ++ D +E E +F+ +E +
Sbjct: 8 WEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFL-KEAAV 62
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVKC 226
++ + HPN+++L G+ T Y++ +M + +L L + + +Y
Sbjct: 63 MKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY----- 115
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
Q+ S +E+ +HRD+ N L+ ++ ++K+ADFGL+
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 109 GW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL 167
GW + + + IG+G + +V G VA+K ++ ++ + F+ E
Sbjct: 15 GWALNM--KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK-NDATAQ--AFL-AEAS 66
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVK 225
++ +L H N+++L G++ LY+V YM L L + +
Sbjct: 67 VMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK---- 121
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ + +E+ N +HRD+ N+L+ +D V K++DFGL
Sbjct: 122 -FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 26/218 (11%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK---DMLTGKI-VALKKVRFDNLEPESVKFMAREI 166
K+ +G G + V+K + + KI V +K + + +
Sbjct: 10 FKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHM 66
Query: 167 LILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVK 225
L + LDH ++++L GL SL LV Y+ L +
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN---- 119
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTS--R 283
+ Q+ G+ + +G++HR++ N+L+ +++ADFG+A P+ K + S +
Sbjct: 120 -WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 178
Query: 284 VVTLWYRPPELLLGATDYGV---GVDLWSAGCILAELL 318
W E + +G D+WS G + EL+
Sbjct: 179 TPIKWM-ALESIH----FGKYTHQSDVWSYGVTVWELM 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 42/191 (21%), Positives = 79/191 (41%), Gaps = 20/191 (10%)
Query: 92 AAGWPPWLTAVCGEALNGW-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALK 147
++G P + L I R + +G+G + +V + K + VA+K
Sbjct: 11 SSGLVPRGSEELQNKLEDVVIDR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK 68
Query: 148 KVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVT---SRMSCSLYLVFHYMEH-DL 203
++ DN ++ E ++ HPNVI+L G+ S+ ++ +M++ DL
Sbjct: 69 TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
Query: 204 -----AGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 258
+ + +M + G+E+ N LHRD+ N ++ DD
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLK-----FMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183
Query: 259 GVLKIADFGLA 269
+ +ADFGL+
Sbjct: 184 MTVCVADFGLS 194
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 49/237 (20%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILIL 169
+ F + +G+G++ V ++ T ++ A+K ++ D + + E + + +L L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLAL 76
Query: 170 RRLDHPNVIKLEGLVTSRMSC-----SLYLVFHY------MEHDLAGLAASPEVKFTEPQ 218
P + +L SC LY V Y M H +F EP
Sbjct: 77 PG-KPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLMYH------IQQVGRFKEPH 122
Query: 219 FVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH 278
Y ++ GL + G+++RD+K N+++D +G +KIADFG+ K
Sbjct: 123 -----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KE 170
Query: 279 PMTSRVV------TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+ V T Y PE++ YG VD W+ G +L E+LAG+ G E
Sbjct: 171 NIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 56/230 (24%), Positives = 104/230 (45%), Gaps = 46/230 (20%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNL--EPESVKFMAREILILR 170
++FE + +G G Y V+ + + TGK+ A+K ++ + + ++ + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 171 RLDH-PNVIKLEGLVTSRMSCS------LYLV---------FHYMEHDLAGLAASPEVKF 214
+ P ++ L + L+L+ F ++ +F
Sbjct: 114 HIRQSPFLVTLH--------YAFQTETKLHLILDYINGGELFTHLSQ---------RERF 156
Query: 215 TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274
TE + V+ Y+ +++ LEH H G+++RDIK N+L+D +G + + DFGL+ F
Sbjct: 157 TEHE-----VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211
Query: 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVG--VDLWSAGCILAELLAGKP 322
+ T+ Y P+++ G D G VD WS G ++ ELL G
Sbjct: 212 DETERAYDFCGTIEYMAPDIVRG-GDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 34/163 (20%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
+ R + + ++G G + V K G+ VA+K ++ ++ + +F +E
Sbjct: 3 MELKR--EEITLLKELGSGQFGVVKLGK--WKGQYDVAVKMIKEGSMSED--EFF-QEAQ 55
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
+ +L HP ++K G+ + +Y+V Y+ + L S Q +
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP--IYIVTEYISNGCLLNYLRSHGKGLEPSQLLE----- 108
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ + G+ ++ +HRD+ N L+D D +K++DFG+
Sbjct: 109 MCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S K+GQG + V+ T + VA+K ++ + PE F+ +E +++
Sbjct: 181 IPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMK 234
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVKCYM 228
+L H +++L +V+ +Y+V YM L L PQ V
Sbjct: 235 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MA 286
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF-DPNHKHPMTSRVVTL 287
Q+ SG+ + +HRD++ +N+L+ ++ V K+ADFGLA D + ++
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELL 318
W P L G + + D+WS G +L EL
Sbjct: 347 WTAPEAALYGR--FTIKSDVWSFGILLTELT 375
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 43/164 (26%), Positives = 83/164 (50%), Gaps = 19/164 (11%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-VALKKVRFDNLEPESVKFMAREIL 167
W +PR ++ + ++++G G + V+ G VA+K ++ ++ P+ F+A E
Sbjct: 8 WEVPR--ETLKLVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPD--AFLA-EAN 60
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVK 225
++++L H +++L +VT +Y++ YME+ L L +K T + +
Sbjct: 61 LMKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLD---- 113
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
Q+ G+ +HRD++ +N+L+ D KIADFGLA
Sbjct: 114 -MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-22
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 26/224 (11%)
Query: 105 EALNGWIPRRADSFEKIDKIGQGTYSNVYKAK---DMLTGKI-VALKKVRFDNLEPESVK 160
+AL + F+KI +G G + VYK + KI VA+K++R + +
Sbjct: 6 QALLRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 161 FMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQF 219
+ E ++ +D+P+V +L G+ + ++ L+ M L +
Sbjct: 64 IL-DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 220 VYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279
+ + Q+ G+ + + ++HRD+ N+L+ +KI DFGLA K
Sbjct: 120 LN-----WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 280 MTS--RVVTLWYRPPELLLGATDYGV---GVDLWSAGCILAELL 318
+V W E +L + + D+WS G + EL+
Sbjct: 175 HAEGGKVPIKWM-ALESIL----HRIYTHQSDVWSYGVTVWELM 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 48/219 (21%), Positives = 92/219 (42%), Gaps = 20/219 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI---VALKKVRFDNLEPESVKFMAREIL 167
I R + E IG+G + +V++ M VA+K + + KF+ +E L
Sbjct: 387 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEAL 443
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
+R+ DHP+++KL G++T ++++ +L + +
Sbjct: 444 TMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLIL----- 495
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKHPMTSRVV 285
Y +QL + L + + +HRDI N+L+ + +K+ DFGL+ D + ++
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
W P + + D+W G + E+ KP
Sbjct: 556 IKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKP 592
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 17/165 (10%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI---VALKKVRFDNLEPESV--KFMARE 165
I ++K+G G++ V + + VA+K ++ D L F+ RE
Sbjct: 15 IGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-RE 71
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKV 224
+ + LDH N+I+L G+V + + +V L + F
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--- 125
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
Y Q+ G+ + + +HRD+ NLL+ ++KI DFGL
Sbjct: 126 --YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-22
Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 21/179 (11%)
Query: 105 EALNGW-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKI-VALKKVRFDNLEPESVK 160
E L IP F +G+G + +V +A K + VA+K ++ D + ++
Sbjct: 13 EKLEDVLIPE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 161 FMAREILILRRLDHPNVIKLEGLVT----SRMSCSLYLVFHYMEH-DL-----AGLAASP 210
RE ++ DHP+V KL G+ ++ +M+H DL A
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 211 EVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
V +M + G+E+ + +HRD+ N ++ +D + +ADFGL+
Sbjct: 131 PFNLPLQTLVR-----FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 93.8 bits (232), Expect = 6e-22
Identities = 34/252 (13%), Positives = 81/252 (32%), Gaps = 55/252 (21%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE------PESVKFMAREILIL 169
+ ++ +KIG+G + V++ VA+K + + + ++ + + EI+I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 170 RRL---------DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFV 220
+ L I L + + S L+ + ++ +A+ F + +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 221 YL----------------------KVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDD 257
++ K +HQL + L + HRD+ N+L+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 258 DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317
+ K+ P V++ DY + + ++
Sbjct: 198 TSLKKLHYTLNGKSS----TIPSCGLQVSII-----------DYTLSRLERDGIVVFCDV 242
Query: 318 LAGKPIMPGRTE 329
+ + G +
Sbjct: 243 SMDEDLFTGDGD 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-22
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 31/180 (17%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
I A F + ++G+ + VYK G+ VA+K ++ P +F E
Sbjct: 6 ISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HE 62
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------AGLAAS 209
++ RL HPNV+ L G+VT L ++F Y H DL +
Sbjct: 63 AMLRARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 210 PEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ P FV+ + Q+ +G+E+ ++ V+H+D+ N+L+ D +KI+D GL
Sbjct: 121 VKSALEPPDFVH-----LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 36/169 (21%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
+ R + ++GQG++ VY+ AK ++ + VA+K V E ++F+ E
Sbjct: 22 VAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NE 78
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLK 223
+++ + +V++L G+V+ ++ M DL L + P
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 224 VK---CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ ++ G+ + + N +HRD+ N ++ +D +KI DFG+
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 109 GW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL 167
GW + + + IG+G + +V G VA+K ++ ++ + F+ E
Sbjct: 187 GWALNM--KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATAQ--AFL-AEAS 238
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVK 225
++ +L H N+++L G++ LY+V YM L L + +
Sbjct: 239 VMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK---- 293
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ + +E+ N +HRD+ N+L+ +D V K++DFGL
Sbjct: 294 -FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 58/261 (22%), Positives = 104/261 (39%), Gaps = 80/261 (30%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D+F + +G+G + VYK + + G +VA+K+++ + + ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 176 NVIKLEGLVTS---RMSCSLYLVFHYME--------HDLA-------------------- 204
N+++L G + R+ LV+ YM +
Sbjct: 88 NLLRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142
Query: 205 GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 264
GLA Y+H +HC ++HRD+K +N+L+D++ +
Sbjct: 143 GLA-------------------YLH------DHCDPK-IIHRDVKAANILLDEEFEAVVG 176
Query: 265 DFGLASFFDPNHKHPMTSRVV-TLWYRPPE-----LLLGATD-YGVGVDLWSAGCILAEL 317
DFGLA D H +T+ V T+ + PE TD +G GV +L EL
Sbjct: 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV-------MLLEL 228
Query: 318 LAG-KPIMPGRTEVSATFCFV 337
+ G + R +
Sbjct: 229 ITGQRAFDLARLANDDDVMLL 249
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 38/210 (18%), Positives = 81/210 (38%), Gaps = 13/210 (6%)
Query: 64 KKPRGERKRSKSNPRLSNLPKHLRGEQVA-AGWPPWLTAVCGEALNGWIPRRADSFEKID 122
+ P P R + + + + +R +
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342
Query: 123 KIGQGTYSNVYKAK-DMLTGKI-VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
++G G + +V + M +I VA+K ++ + ++ + M RE I+ +LD+P +++L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 401
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
G+ + +L LV L + +HQ+ G+++
Sbjct: 402 IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-----LLHQVSMGMKYLE 453
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+HR++ N+L+ + KI+DFGL+
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 9e-21
Identities = 64/247 (25%), Positives = 101/247 (40%), Gaps = 60/247 (24%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK----FMAREILI 168
+K+G+G + VYK + VA+KK+ ++ + + F EI +
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLA-AMVDITTEELKQQFDQ-EIKV 83
Query: 169 LRRLDHPNVIKLEGLVTSRMSCS----LYLVFHYM-----EHDLAGLAASPEVKFTEPQF 219
+ + H N+++L G S L LV+ YM L+ L +P
Sbjct: 84 MAKCQHENLVELLGF------SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP--------- 128
Query: 220 VYLKVKCYMHQLLS-------------GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266
LS G+ H N +HRDIK +N+L+D+ KI+DF
Sbjct: 129 -----------PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDF 177
Query: 267 GLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIM 324
GLA + + MTSR+V T Y PE L G + D++S G +L E++ G +
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 325 PGRTEVS 331
R
Sbjct: 236 EHREPQL 242
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S + K+G G + V+ A K VA+K ++ ++ E F+ E +++
Sbjct: 185 IPR--ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE--AFL-AEANVMK 238
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVKCYM 228
L H ++KL +VT +Y++ +M L L + K P+ + +
Sbjct: 239 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FS 290
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
Q+ G+ +HRD++ +N+L+ V KIADFGLA
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-20
Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 31/179 (17%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
I RR + ++G+G + V+ ++L + +VA+K ++ + E F RE
Sbjct: 38 IKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-RE 93
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL--------------AGLAASP 210
+L L H ++++ G+ T L +VF YM H DL AG
Sbjct: 94 AELLTMLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 211 EVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
Q + Q+ +G+ + +HRD+ N L+ V+KI DFG++
Sbjct: 152 PGPLGLGQLLA-----VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-20
Identities = 32/150 (21%), Positives = 68/150 (45%), Gaps = 12/150 (8%)
Query: 123 KIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKL 180
++G G + V K + + VA+K ++ + +P + E ++++LD+P ++++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH 239
G+ + S LV E L + + +HQ+ G+++
Sbjct: 84 IGICEAE---SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIE-----LVHQVSMGMKYLE 134
Query: 240 NNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ +HRD+ N+L+ KI+DFGL+
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-20
Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 32/180 (17%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
I RR ++ ++G+G + V+ ++ K +VA+K ++ D F RE
Sbjct: 12 IKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-RE 67
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------AGLAAS 209
+L L H +++K G+ L +VF YM+H DL G
Sbjct: 68 AELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 210 PEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ + Q +++ Q+ SG+ + + +HRD+ N L+ + ++KI DFG++
Sbjct: 126 AKGELGLSQMLHI-----ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 29/178 (16%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
+ + + D IG+G + V KA K A+K+++ + + F E+ +
Sbjct: 22 LDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEV 78
Query: 169 LRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------AGLAASPE 211
L +L HPN+I L G R LYL Y H +L +A S
Sbjct: 79 LCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 212 VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ Q + + + G+++ +HRD+ N+L+ ++ V KIADFGL+
Sbjct: 137 STLSSQQLL-----HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-20
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 22/178 (12%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMA 163
W PR D + +G+G + V +A T + VA+K ++ E M
Sbjct: 22 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM- 78
Query: 164 REILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL-------AGLAASPEVKF 214
E+ IL + H NV+ L G T + L ++ + + +L +V
Sbjct: 79 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 215 TEPQFVYLKVK---CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
+ +L ++ CY Q+ G+E + +HRD+ N+L+ + V+KI DFGLA
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 40/185 (21%), Positives = 76/185 (41%), Gaps = 30/185 (16%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK---IVALKKVRFDNLEPESVKFMA 163
W PR + +G+G + V KA + VA+K ++ + E +
Sbjct: 18 WEFPR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL- 74
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------AGLA 207
E +L++++HP+VIKL G + L L+ Y ++ L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 208 ASPEVKFTEPQFVYLKVK---CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 264
+ P L + + Q+ G+++ ++HRD+ N+L+ + +KI+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 265 DFGLA 269
DFGL+
Sbjct: 193 DFGLS 197
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
PR + + IG+G + V++ A +L + +VA+K ++ + F RE
Sbjct: 44 YPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 100
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------AGLAAS 209
++ D+PN++KL G+ + + L+F YM + DL + S
Sbjct: 101 AALMAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 210 PEVKFTEPQFVYLKVK---CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266
+ + P L C Q+ +G+ + +HRD+ N L+ ++ V+KIADF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 267 GLA 269
GL+
Sbjct: 219 GLS 221
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-19
Identities = 39/174 (22%), Positives = 69/174 (39%), Gaps = 25/174 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
+PR + I +G G + VY+ M VA+K + E + + F+ E
Sbjct: 27 VPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 83
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL------AGLAASPEVKFTEPQ 218
LI+ + +H N+++ G+ + +++ M DL S
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 219 FVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLA 269
+++ + G ++ N +HRDI N L+ G V KI DFG+A
Sbjct: 142 LLHV-----ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 37/226 (16%), Positives = 78/226 (34%), Gaps = 36/226 (15%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-------VALKKVRFDNLEPESVKFMA 163
I + + +GQGT++ ++K G V LK + + F
Sbjct: 5 IRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF- 60
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYL 222
++ +L H +++ G+ LV +++ L + +
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLE- 117
Query: 223 KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--------DDGVLKIADFGLASFFDP 274
QL + + N ++H ++ N+L+ + +K++D G++ P
Sbjct: 118 ----VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 275 N--HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELL 318
+ + W PPE + + + D WS G L E+
Sbjct: 174 KDILQERIP------WV-PPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 35/185 (18%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK-----IVALKKVRFDNLEPESVKF 161
W PR D +G+G + V A + K VA+K ++ D E +
Sbjct: 76 WEFPR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 133
Query: 162 MAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------A 204
+ E+ +++ + H N+I L G T LY++ Y +L
Sbjct: 134 V-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 205 GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 264
+ PE + T V +QL G+E+ + +HRD+ N+L+ ++ V+KIA
Sbjct: 191 DINRVPEEQMTFKDLV-----SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 265 DFGLA 269
DFGLA
Sbjct: 246 DFGLA 250
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 35/185 (18%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK-----IVALKKVRFDNLEPESVKF 161
W PR D +G+G + V A + K VA+K ++ D E +
Sbjct: 30 WEFPR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 162 MAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------A 204
+ E+ +++ + H N+I L G T LY++ Y +L
Sbjct: 88 V-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 205 GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 264
+ PE + T V +QL G+E+ + +HRD+ N+L+ ++ V+KIA
Sbjct: 145 DINRVPEEQMTFKDLV-----SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 265 DFGLA 269
DFGLA
Sbjct: 200 DFGLA 204
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 39/180 (21%), Positives = 72/180 (40%), Gaps = 25/180 (13%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK---IVALKKVRFDNLEPESVKFMA 163
W PR + +G G + V +A ++ VA+K ++ E M
Sbjct: 18 WEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM- 74
Query: 164 REILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------AGLAASPEV 212
E+ +L L +H N++ L G T ++ Y + DL + + +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 213 KFTEPQFVYLKVK---CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
E + L ++ + +Q+ G+ + +HRD+ N+L+ + KI DFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 38/174 (21%), Positives = 70/174 (40%), Gaps = 25/174 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK---IVALKKVRFDNLEPESVKFMARE 165
+PR+ + + +G G + VY+ M VA+K + E + + F+ E
Sbjct: 68 VPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 124
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL------AGLAASPEVKFTEPQ 218
LI+ + +H N+++ G+ + +++ M DL S
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 219 FVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLA 269
+++ + G ++ N +HRDI N L+ G V KI DFG+A
Sbjct: 183 LLHV-----ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 55/239 (23%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVK----FMAREILILRR 171
++F+ IG G + VYK + G VALK+ PES + F EI L
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-----RTPESSQGIEEFET-EIETLSF 91
Query: 172 LDHPNVIKLEGLVTSRMSCS----LYLVFHYMEHD-----LAGLAASPEVKFTEPQFVYL 222
HP+++ L G C + L++ YME+ L G ++ + +
Sbjct: 92 CRHPHLVSLIGF------CDERNEMILIYKYMENGNLKRHLYG---------SDLPTMSM 136
Query: 223 KVKCYMHQLL---SGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA-SFFDPNHKH 278
+ + + GL + H ++HRD+K N+L+D++ V KI DFG++ + + H
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 279 PMTSRVV-TLWYRPPE-----LLLGATD-YGVGVDLWSAGCILAELLAGK-PIMPGRTE 329
+++ V TL Y PE L +D Y GV +L E+L + I+
Sbjct: 197 -LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV-------VLFEVLCARSAIVQSLPR 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 35/185 (18%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYK--AKDMLTGK-----IVALKKVRFDNLEPESVKF 161
W +PR D +G+G + V A + K VA+K ++ D E +
Sbjct: 64 WELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 162 MAREILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL---------------A 204
+ E+ +++ + H N+I L G T LY++ Y +L
Sbjct: 122 I-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 205 GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 264
+ +PE + + V +Q+ G+E+ + +HRD+ N+L+ +D V+KIA
Sbjct: 179 NPSHNPEEQLSSKDLVS-----CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 233
Query: 265 DFGLA 269
DFGLA
Sbjct: 234 DFGLA 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 21/176 (11%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK-----IVALKKVRFDNLEPESVKFMA 163
W PR ++ + +G G + V +A GK VA+K ++ E M
Sbjct: 41 WEFPR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM- 97
Query: 164 REILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFV 220
E+ I+ L H N++ L G T + ++ Y + DL L V T+P F
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 221 YLKVKCYMHQLLS-------GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269
LL G+ + +HRD+ N+L+ + V KI DFGLA
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 60/236 (25%), Positives = 89/236 (37%), Gaps = 64/236 (27%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKF--MAREILILRRLDH- 174
F KIG G + + K++ T + VA+K LEP + + E ++L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 175 ---PNVIKL--EG----LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK-V 224
P V G +V + SL +F + F+ LK V
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR-----------TFS------LKTV 107
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGLASFF-DP-NHK 277
QL+S +E+ H+ +++RD+K N LI G V+ I DF LA + DP K
Sbjct: 108 LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK 167
Query: 278 H-PMTSRVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAGK 321
H P YR + L G Y +G DL + G + L G
Sbjct: 168 HIP---------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 45/185 (24%), Positives = 74/185 (40%), Gaps = 30/185 (16%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGK---IVALKKVRFDNLEPESVKFMA 163
W PR ++ E +G G + V A + VA+K ++ E M
Sbjct: 40 WEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM- 96
Query: 164 REILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DL--------------AGLA 207
E+ ++ +L H N++ L G T +YL+F Y + DL
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 208 ASPEVKFTEPQFVYLKVK---CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 264
+ + E L + C+ +Q+ G+E +HRD+ N+L+ V+KI
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214
Query: 265 DFGLA 269
DFGLA
Sbjct: 215 DFGLA 219
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 48/230 (20%), Positives = 83/230 (36%), Gaps = 47/230 (20%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE- 181
KIG G + +Y A + A V+ +E + + E+ +R+ + IK
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK---VEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 182 ----------------GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK-V 224
GL + ++V + DL ++ F V
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFK------KSTV 153
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNHKHPMTS 282
++L LE+ H N +H DIK +NLL+ + + +AD+GL+ + PN H
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH---- 209
Query: 283 RVVTLWYRPPELLLGATDY-------GVGV----DLWSAGCILAELLAGK 321
P + G ++ GV + D+ G + L GK
Sbjct: 210 --KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 48/230 (20%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ + KIG G++ ++Y D+ G+ VA+K P+ + E I + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 63
Query: 175 ----PNVIKL--EGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK-VKCY 227
P + EG +V + L L KF+ LK V
Sbjct: 64 GVGIPTIRWCGAEGDYN-------VMVMELLGPSLEDLFNFCSRKFS------LKTVLLL 110
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFF-DP-NHKHPMTS 282
Q++S +E+ H+ +HRD+K N L+ ++ I DFGLA + D H+H
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP-- 168
Query: 283 RVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAGK 321
YR + L G Y +G+ DL S G +L G
Sbjct: 169 ------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 52/237 (21%), Positives = 90/237 (37%), Gaps = 60/237 (25%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
++ +IG+G++ +++ ++L + VA+K + P+ + E + L
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 64
Query: 175 ----PNVIKL--EG----LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK- 223
PNV EG LV + SL + KF+ +K
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----------KFS------VKT 107
Query: 224 VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-----VLKIADFGLASFF-DP-NH 276
V Q+L+ ++ H +++RDIK N LI ++ + DFG+ F+ DP
Sbjct: 108 VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
Query: 277 KH-PMTSRVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAGK 321
+H P YR + L G Y +G DL + G + L G
Sbjct: 168 QHIP---------YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 65/238 (27%), Positives = 94/238 (39%), Gaps = 58/238 (24%)
Query: 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR 171
PR + F KIG G++ +Y ++ T + VA+K P+ + E I R
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRI 58
Query: 172 LDH----PNVIKL--EG----LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVY 221
L PNV EG LV + SL +F++ K +
Sbjct: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR-----------KLS------ 101
Query: 222 LK-VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFF-DPN- 275
LK V Q+++ +E H+ LHRDIK N L+ + I DFGLA + D +
Sbjct: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
Query: 276 HKH-PMTSRVVTLWYRPPELLLGATDYG-----VGV------DLWSAGCILAELLAGK 321
H+H P YR + L G Y +G+ DL S G +L L G
Sbjct: 162 HQHIP---------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 49/230 (21%), Positives = 81/230 (35%), Gaps = 44/230 (19%)
Query: 123 KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLE- 181
IGQG + +Y A DM + + V +EP + E+ +R P I+
Sbjct: 42 PIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 182 ----------------GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK-V 224
GL +++ DL + + +F+ K V
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFS------RKTV 154
Query: 225 KCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNHKHPMTS 282
++L LE+ H + +H DIK SNLL++ + + + D+GLA + P H
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH---- 210
Query: 283 RVVTLWYRPPELLLGATDY-------GVGV----DLWSAGCILAELLAGK 321
P G ++ GV DL G + + L G
Sbjct: 211 --KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 41/235 (17%), Positives = 74/235 (31%), Gaps = 54/235 (22%)
Query: 123 KIGQGTYSNVYKAKDMLTGKI--------VALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ +Y+A T +LK L+ + + + R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGRLFNEQNFFQRAAKP 102
Query: 175 PNVIKLEGLVTSRMSC--SLY-----------LVFHYMEHDLAGL-AASPEVKFTEPQFV 220
V K + L ++ + + LV + L SP+ +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS----- 157
Query: 221 YLK-VKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHK 277
+ V +LL LE H N +H ++ N+ + +D + +A +G A + P+ K
Sbjct: 158 -ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 278 HPMTSRVVTLWYRPPELLLGATDY-------GVGV----DLWSAGCILAELLAGK 321
H V G ++ G G DL S G + + L G
Sbjct: 217 H------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 2e-07
Identities = 34/272 (12%), Positives = 80/272 (29%), Gaps = 64/272 (23%)
Query: 14 VSESKEVSNFSVESSSRKVGNVSVKTIDGDVVEVQNDESRKKE--EKVVDGEKKPRGERK 71
V +K + F++ S + + + T V + + + + +
Sbjct: 253 VQNAKAWNAFNL--SCK----ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 72 RSKS-NPRLSNLPKHLRGEQVAAGWPPWLTAVCGEALNGWIPRRADSFEKIDKIGQGTYS 130
K + R +LP +V P ++ E++ D+++ ++
Sbjct: 307 LLKYLDCRPQDLP-----REVLTT-NPRRLSIIAESIRDG-LATWDNWKHVNC------- 352
Query: 131 NVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190
D LT I + + LEP + M + + P+ + + +
Sbjct: 353 ------DKLTTII----ESSLNVLEPAEYRKMFDRLSVFP----PSA-----HIPTILLS 393
Query: 191 SL--YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL-LSGLEHCHNNGVLHRD 247
+ ++ + + L V+ + + + L N LHR
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI-----SIPSIYLELKVKLENEYALHRS 448
Query: 248 IKGSNLLIDDDGVLKIADFGLASFFDPNHKHP 279
I + + + FD + P
Sbjct: 449 I--------------VDHYNIPKTFDSDDLIP 466
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 7e-05
Identities = 40/315 (12%), Positives = 91/315 (28%), Gaps = 80/315 (25%)
Query: 46 EVQNDESRKKEEKVVDGEKKPRGERKRSKSN-PR---LSNLPKHLRGEQVAAG------- 94
Q S + ++ + +K N R L + L + A
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 95 ----WPPWLTA-VC-----GEALNG---WIP-RRADSFEKIDKIGQGTYSNVYKAKDMLT 140
W+ VC ++ W+ + +S E + ++ Q + +
Sbjct: 160 GSGKT--WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 141 GKIVALKKVRFDNLEPESVKFMARE-----ILILRRLDHPNVIK-LEG----LVTSRMSC 190
+K +R +++ E + + + +L+L + + L+T+R
Sbjct: 218 DHSSNIK-LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 191 -----SLYLVFHY-MEHDLAGLAASPEVKFTEPQ----FV-YLKVK--------CYMHQL 231
S H ++H T + + YL + +
Sbjct: 277 VTDFLSAATTTHISLDHHSMT--------LTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328
Query: 232 LSGL-------EHCHNNGVLHRDIKGSNLLIDDD-GVLKIADF-----GLASFFDPNHKH 278
+ + H + +I+ VL+ A++ L+ F P H
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF--PPSAH 386
Query: 279 PMTSRVVTLWYRPPE 293
T + +W+ +
Sbjct: 387 IPTILLSLIWFDVIK 401
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA--SFFDPNHKHPMTSR 283
CY Q+ G+E + +HRD+ N+L+ + V+KI DFGLA + DP++ +R
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL--LAGKP 322
+ W PE + Y + D+WS G +L E+ L P
Sbjct: 257 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 9e-06
Identities = 22/99 (22%), Positives = 42/99 (42%), Gaps = 11/99 (11%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMA 163
W PR D + +G+G + V +A T + VA+K ++ + + +
Sbjct: 17 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALM 73
Query: 164 REILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEH 201
E+ IL + H NV+ L G T + L ++ + +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF 111
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 26/179 (14%), Positives = 55/179 (30%), Gaps = 46/179 (25%)
Query: 121 IDKIGQGTYSNVYKAKDMLTGKIVALK-------------------KVRFDNLEPESVKF 161
+G+G S V+ +K + F L S +
Sbjct: 95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR- 152
Query: 162 MAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVY 221
E L++L V K+ + ++ ++ L V+ P V
Sbjct: 153 --NEFRALQKLQGLAVPKVYAWEGN------AVLMELIDAK--EL---YRVRVENPDEVL 199
Query: 222 LKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280
+ + + ++ G++H D+ N+L+ ++G+ I DF +
Sbjct: 200 DMILEEVAKF-------YHRGIVHGDLSQYNVLVSEEGIWII-DFPQSV----EVGEEG 246
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 348 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.88 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.4 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.93 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.86 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.72 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.68 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.98 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 93.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.27 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=400.98 Aligned_cols=218 Identities=28% Similarity=0.439 Sum_probs=185.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+.++|||||+++++|.+ ...+|+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 689999999999999999999999999999999976533 22345678899999999999999999999987 456999
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ +|...+. ... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.+.
T Consensus 110 vmEy~~gG~L~~~i~-~~~-----~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 110 GLSYAKNGELLKYIR-KIG-----SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EECCCTTEEHHHHHH-HHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHH-HcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 9999987 4555443 222 34455589999999999999999999999999999999999999999999999875
Q ss_pred CCC-CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 274 PNH-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 274 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
... .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+...+|+...+.
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~ 252 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD 252 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 433 2335667999999999998864 4899999999999999999999999998887777777665443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-55 Score=403.73 Aligned_cols=219 Identities=24% Similarity=0.460 Sum_probs=181.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
+++|++++.||+|+||+||+|+++.+|+.||||++.+........+.+.+|+++|++++|||||++++++.++ ..+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEE
Confidence 4789999999999999999999999999999999988877777788899999999999999999999999874 56999
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ +|...+..... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 101 VmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 9999986 55555532221 123445588899999999999999999999999999999999999999999999764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
... ......+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+...+++....
T Consensus 177 ~~~-~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 242 (350)
T 4b9d_A 177 STV-ELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF 242 (350)
T ss_dssp HHH-HHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred CCc-ccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence 321 123456899999999998875 499999999999999999999999999988877777766543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-54 Score=387.87 Aligned_cols=214 Identities=28% Similarity=0.457 Sum_probs=168.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+++|+.++|||||++++++.+ ...+|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEE
Confidence 689999999999999999999999999999999987654 33446678899999999999999999999987 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+++++...+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 91 vmEy~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 91 VIEYAGNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EEECCCEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 99999988887765432 345556899999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.. ...+.+||+.|+|||++.+...++.++||||+||++|+|+||++||.+.+..+....+...
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~ 227 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 227 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 32 2456789999999999987664578999999999999999999999987765555555443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=395.17 Aligned_cols=212 Identities=26% Similarity=0.425 Sum_probs=180.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+++|+.++|||||+++++|.+. ..+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 5799999999999999999999999999999999765432 234578899999999999999999999884 569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+..+... . .+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 150 mEy~~gg~L~~~l~~-~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-T-----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp ECCCTTEEHHHHHHH-S-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EeCCCCCcHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999997544443322 2 3455568999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
. ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+....+..+
T Consensus 224 ~-~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 285 (346)
T 4fih_A 224 V-PRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 285 (346)
T ss_dssp S-CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred C-CcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 2 234667899999999988764 4999999999999999999999999998877766665543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=383.43 Aligned_cols=215 Identities=22% Similarity=0.299 Sum_probs=181.4
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--cCceEEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLYLV 195 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~lv 195 (348)
|++.++||+|+||+||+|++..++..||+|.+..........+.+.+|+++|++++|||||+++++|... ....+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4778899999999999999999999999999987777777788899999999999999999999998653 34568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEC-CCCcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLID-DDGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kl~DFGla~~~ 272 (348)
|||++++.+..+..... .+++..++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99998754443333222 3445558889999999999999998 99999999999998 4799999999999865
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
... ...+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.++....++.+.....
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred CCC---ccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC
Confidence 432 3456789999999998865 3999999999999999999999999988877777777665543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=392.46 Aligned_cols=219 Identities=26% Similarity=0.420 Sum_probs=175.4
Q ss_pred CCceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++++.||+|+||+||+|++. .+++.||||++++..........+.+|+++|++++|||||++++++.++ ..+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET--TEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence 67999999999999999999874 4678999999976544333344577899999999999999999999874 569
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++ |...+. ... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~-~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLS-KEV-----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHH-HHC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHH-hcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999874 444443 222 345556899999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
..... ....+.+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+...+++......|
T Consensus 176 ~~~~~-~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p 246 (304)
T 3ubd_A 176 SIDHE-KKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ccCCC-ccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence 54332 234567899999999998775 499999999999999999999999999988877777766544433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=394.93 Aligned_cols=222 Identities=37% Similarity=0.602 Sum_probs=190.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----cCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~ 191 (348)
++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+++|+.++|||||++++++... ....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 679999999999999999999999999999999987666666677888999999999999999999987643 2356
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+||||||+++++...+... . .+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~g~L~~~i~~~-~-----~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSS-Q-----PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCSEEHHHHHTSS-S-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCCCCHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 8999999999887776543 2 355556899999999999999999999999999999999999999999999987
Q ss_pred cCCC---CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccC
Q 018936 272 FDPN---HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343 (348)
Q Consensus 272 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~ 343 (348)
+... ......+.+||+.|+|||++.+...|+.++||||+||++|||++|++||.+.++.++...|+.....+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 6432 22334567999999999998887778999999999999999999999999999998888887655433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=396.83 Aligned_cols=212 Identities=26% Similarity=0.425 Sum_probs=181.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+. ..+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEEE
Confidence 5799999999999999999999999999999999876533 245678899999999999999999999884 569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
||||+++.+..+... . .+.+..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 227 mEy~~gG~L~~~i~~-~-----~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-T-----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EECCTTEEHHHHHHH-S-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EeCCCCCcHHHHHhc-c-----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 999997544443322 1 2455568899999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
. ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+....+..+
T Consensus 301 ~-~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 301 V-PRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 362 (423)
T ss_dssp C-CCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred C-ccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 2 235677899999999988764 4999999999999999999999999998887776666544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=379.48 Aligned_cols=218 Identities=23% Similarity=0.373 Sum_probs=178.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.++||+|+||+||+|++. ..||||+++......+..+.|.+|+++|++++|||||+++|++... .+|||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---~~~iV 109 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD---NLAIV 109 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC---eEEEE
Confidence 78999999999999999999743 3599999987766777788899999999999999999999988642 37999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++ +|...+..... .+++..+..++.||+.||+|||+++||||||||+||||++++++||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999986 45555544333 345555888999999999999999999999999999999999999999999987653
Q ss_pred CC-CCCcccccccCcccccccccCc--ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 275 NH-KHPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 275 ~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
.. .......+||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.++......++......|
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p 257 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP 257 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 22 2334567899999999998642 3489999999999999999999999999888887877777766555
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=386.53 Aligned_cols=209 Identities=25% Similarity=0.373 Sum_probs=173.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.+... .+|+.+|+.++|||||++++++.+ ...+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 36799999999999999999999999999999999865432 359999999999999999999987 456999
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-cEEEEeeCCcccc
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFF 272 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~ 272 (348)
||||++++ |...+. ... .+++..++.++.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+
T Consensus 128 vmEy~~gg~L~~~l~-~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 128 FMELLEGGSLGQLIK-QMG-----CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EECCCTTCBHHHHHH-HHS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHH-HcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 99999874 544443 222 345556889999999999999999999999999999999887 6999999999987
Q ss_pred CCCCCC----CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 273 DPNHKH----PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 273 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
...... .....+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+...++...
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 271 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE 271 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS
T ss_pred cCCCcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC
Confidence 543221 12345799999999999875 4999999999999999999999999988776666666553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=373.40 Aligned_cols=208 Identities=27% Similarity=0.423 Sum_probs=159.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC------
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS------ 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 189 (348)
++|++++.||+|+||+||+|+++.+|+.||||+++... .+...+.+.+|+++|++++|||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46999999999999999999999999999999997654 34456778899999999999999999999876432
Q ss_pred ----ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEe
Q 018936 190 ----CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265 (348)
Q Consensus 190 ----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~D 265 (348)
.++|++|||++++.+..+........ ......++.++.||+.||+|||++|||||||||+|||++.++++||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~--~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIE--ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGG--GSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCC--hhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 35799999998754443333222222 223344778999999999999999999999999999999999999999
Q ss_pred eCCccccCCCCCC-----------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 266 FGLASFFDPNHKH-----------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 266 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
||+|+.+...... ..++.+||+.|||||++.+. .|+.++|||||||++|||++ ||.+..+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQMER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCccHH
Confidence 9999987543221 12345799999999998875 49999999999999999996 78654443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=374.91 Aligned_cols=219 Identities=21% Similarity=0.355 Sum_probs=176.5
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|.+.++||+|+||+||+|++. .++..||||+++.. .....+.|.+|+++|++++|||||+++|++.+. .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--C
Confidence 68999999999999999999864 35789999998643 355567899999999999999999999999874 4
Q ss_pred eEEEEEeecccC-hhhhhcCCC-------CcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEE
Q 018936 191 SLYLVFHYMEHD-LAGLAASPE-------VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~-------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 262 (348)
.+|+|||||+++ |...+.... .......+++..+..++.||+.||+|||+++||||||||+||||+.++++|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 599999999864 444443211 011223466677899999999999999999999999999999999999999
Q ss_pred EEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHH
Q 018936 263 IADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 263 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~ 339 (348)
|+|||+|+........ ......||+.|||||++.+.. |+.++|||||||++|||+| |++||.+.+..+....+...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999876543322 223456899999999987654 9999999999999999999 99999998877766666554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=372.49 Aligned_cols=219 Identities=22% Similarity=0.342 Sum_probs=170.9
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|.+.++||+|+||+||+|++. .++..||||+++.. .....+.|.+|+++|++++|||||+++|++.+. .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--R 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 67999999999999999999854 36889999998643 455677899999999999999999999999874 4
Q ss_pred eEEEEEeecccC-hhhhhcCCCC---------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEV---------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 260 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~ 260 (348)
.+|||||||+++ |..++..... ......+++..+..++.||+.||+|||+++||||||||+||||+++++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 599999999875 4444433211 111234667778999999999999999999999999999999999999
Q ss_pred EEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 018936 261 LKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 261 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~ 338 (348)
+||+|||+|+....... ......+||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.++.+....+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999997654332 2334567899999999988754 9999999999999999999 9999999887776666554
Q ss_pred H
Q 018936 339 N 339 (348)
Q Consensus 339 ~ 339 (348)
.
T Consensus 276 g 276 (329)
T 4aoj_A 276 G 276 (329)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=370.07 Aligned_cols=218 Identities=22% Similarity=0.372 Sum_probs=175.9
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
+++++.++||+|+||+||+|+.. .+++.||||+++... .....+.|.+|+.+|++++|||||+++|++... .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--Q 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--C
Confidence 57899999999999999999853 467899999986543 334567789999999999999999999999874 3
Q ss_pred eEEEEEeeccc-ChhhhhcCCCCc----------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEVK----------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 259 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 259 (348)
.++||||||++ +|..++...... .....+++..+..++.||+.||+|||+++||||||||+||||++++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 48999999986 455554332110 1123466667889999999999999999999999999999999999
Q ss_pred cEEEEeeCCccccCCCC-CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 260 VLKIADFGLASFFDPNH-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 260 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
++||+|||+|+...... ....+..+||+.|||||++.+.. |+.++|||||||++|||+| |++||.+.++.+....+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999998764332 22345568899999999987654 9999999999999999999 899999988766555444
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=389.94 Aligned_cols=207 Identities=26% Similarity=0.380 Sum_probs=170.8
Q ss_pred cCCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHHhcCCCceeeeeceEeec
Q 018936 112 PRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILRRLDHPNVIKLEGLVTSR 187 (348)
Q Consensus 112 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 187 (348)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+... ..........++.+++.++|||||+++++|.+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~- 263 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 263 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-
Confidence 4456899999999999999999999999999999999976432 11222223334666777899999999999987
Q ss_pred cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
...+|+||||++++.+..+..... .+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFG 337 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccc
Confidence 456999999998754443333333 34455589999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
+|+.+.... ..+.+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+
T Consensus 338 lA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 338 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp TCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred eeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999875432 4567899999999998755569999999999999999999999997654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=366.18 Aligned_cols=224 Identities=23% Similarity=0.366 Sum_probs=180.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPESVKFMAREILILRRLDH-PNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~ 189 (348)
++|++.++||+|+||+||+|++..+ ++.||||.+.... .....+.+.+|+++|++++| ||||+++|+|... .
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-~ 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-T
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-C
Confidence 7899999999999999999987543 3689999986543 34456778899999999976 8999999998653 3
Q ss_pred ceEEEEEeecccC-hhhhhcCCCCc----------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC
Q 018936 190 CSLYLVFHYMEHD-LAGLAASPEVK----------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 258 (348)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~ 258 (348)
..+|+|||||+++ |...+...... .....+++..+..++.||+.||+|||+++||||||||+|||++++
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 4589999999864 44444322111 112346667788999999999999999999999999999999999
Q ss_pred CcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 259 GVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 259 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
+.+||+|||+|+.+...... .....+||+.|||||++.+.. |+.++|||||||++|||+| |++||.+.+..+...++
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~ 300 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 300 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999977544332 234567899999999988754 9999999999999999998 99999998766666666
Q ss_pred HHHhcc
Q 018936 337 VLNLIF 342 (348)
Q Consensus 337 i~~~~~ 342 (348)
+.....
T Consensus 301 i~~g~~ 306 (353)
T 4ase_A 301 LKEGTR 306 (353)
T ss_dssp HHHTCC
T ss_pred HHcCCC
Confidence 665443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=364.10 Aligned_cols=211 Identities=27% Similarity=0.434 Sum_probs=170.5
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecc
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 188 (348)
...++|++.++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+++|+.+ +|||||+++++|.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-- 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK-- 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--
Confidence 34478999999999999999999875 357899999986542 234577899999998 69999999999987
Q ss_pred CceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC-CcEEEEee
Q 018936 189 SCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADF 266 (348)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kl~DF 266 (348)
...+|+||||+++ ++...+. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCEEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 4569999999986 4554442 24555689999999999999999999999999999999876 79999999
Q ss_pred CCccccCCCC---------------------------CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh
Q 018936 267 GLASFFDPNH---------------------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 319 (348)
Q Consensus 267 Gla~~~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt 319 (348)
|+|+...... .....+.+||+.|+|||++.+...|+.++||||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 9998654321 1123456899999999999887679999999999999999999
Q ss_pred CCCCC-CCCChhHHHHHHHH
Q 018936 320 GKPIM-PGRTEVSATFCFVL 338 (348)
Q Consensus 320 G~~pf-~~~~~~~~~~~~i~ 338 (348)
|+.|| .+.++.+++..|+.
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~ 262 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMT 262 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHH
Confidence 99998 45556666655543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=377.90 Aligned_cols=214 Identities=24% Similarity=0.388 Sum_probs=183.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+++|+.++|||||+++++|.+ ...+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999997643 3446678899999999999999999999987 456999
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC--CcEEEEeeCCccc
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD--GVLKIADFGLASF 271 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~--~~~kl~DFGla~~ 271 (348)
+||||++ +|...+..... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 232 v~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 9999986 55555544333 34555689999999999999999999999999999999854 8999999999998
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
+.... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+...++....
T Consensus 307 ~~~~~--~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~ 372 (573)
T 3uto_A 307 LDPKQ--SVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372 (573)
T ss_dssp CCTTS--EEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred ccCCC--ceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC
Confidence 75432 24566899999999998875 49999999999999999999999999998887777766543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=353.02 Aligned_cols=198 Identities=27% Similarity=0.336 Sum_probs=155.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC--ceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS--CSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~~~ 193 (348)
.+|.+.++||+|+||+||+|++ +|+.||||++.... ........|+..+.+++|||||+++|++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4689999999999999999985 68999999986432 222233446666678999999999999977543 3689
Q ss_pred EEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEECCCCcEEEE
Q 018936 194 LVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN--------GVLHRDIKGSNLLIDDDGVLKIA 264 (348)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDikp~NIll~~~~~~kl~ 264 (348)
|||||++++ |...+... .+++..+..++.|++.||+|||++ +||||||||+||||+.++++||+
T Consensus 78 lV~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EEecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 999999864 44444322 344555778999999999999987 99999999999999999999999
Q ss_pred eeCCccccCCCCCC---CcccccccCcccccccccCcc-----cCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 265 DFGLASFFDPNHKH---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 265 DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
|||+|+........ .....+||+.|||||++.+.. .|+.++|||||||++|||+||.+||.
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 99999877543321 223457999999999986532 36779999999999999999987663
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.09 Aligned_cols=220 Identities=29% Similarity=0.496 Sum_probs=185.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+++|+.++||||+++++++.. ....|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEE
Confidence 368999999999999999999999999999999998776667777888899999999999999999999876 456999
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ .+...+... . .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH-G-----RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH-C-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999976 444444322 2 24455588899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
... .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.......|
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p 234 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 432 245668999999999998766445899999999999999999999999887766666655544434
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=341.25 Aligned_cols=216 Identities=37% Similarity=0.648 Sum_probs=176.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.+. ||||+++++++.......+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 6899999999999999999999999999999998765555666777889999999997 999999999998766667999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+++++...+... .+....++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 v~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 89 VFDYMETDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEECCSEEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EecccCcCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 9999998877766532 344455788999999999999999999999999999999999999999999987532
Q ss_pred C--------------------CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 275 N--------------------HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 275 ~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
. .....+..+||++|+|||++.+...++.++|||||||++|||++|++||.+.+..++..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 11123446789999999999876668999999999999999999999999999888888
Q ss_pred HHHH
Q 018936 335 CFVL 338 (348)
Q Consensus 335 ~~i~ 338 (348)
.++.
T Consensus 242 ~i~~ 245 (388)
T 3oz6_A 242 RIIG 245 (388)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=339.20 Aligned_cols=221 Identities=26% Similarity=0.393 Sum_probs=178.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+++++.+ +||||+++++++.+ ...+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 3789999999999999999999999999999999976432 223456677899999988 79999999999877 4569
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+||||++++.+........ .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999998754433332222 3455568889999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
... .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....++......|
T Consensus 175 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p 244 (353)
T 3txo_A 175 ICN-GVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 244 (353)
T ss_dssp CC----------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ccC-CccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 322 2234566899999999988764 489999999999999999999999999888777777766555444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=334.13 Aligned_cols=215 Identities=27% Similarity=0.411 Sum_probs=177.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++++.||+|+||+||+|++..+|+.||+|++++... .....+.+.+|+.+++.++||||+++++++... ..+|+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~l 82 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEEEE
Confidence 789999999999999999999999999999999975422 223356678899999999999999999999774 56999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........ .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus 83 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999998754433332222 344555888999999999999999999999999999999999999999999986432
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.. ......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....++..
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 220 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CC-CcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 22 234566899999999988765 4899999999999999999999999987766555555443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=323.21 Aligned_cols=215 Identities=42% Similarity=0.691 Sum_probs=181.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++.+ ....++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 67999999999999999999999999999999998776666666778899999999999999999999987 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++++...+...... ++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~l~~~~~~~~~~-----l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGD-----LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EECCSEEHHHHHHHTTTC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred EecCCCCHHHHHHhCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 999999888776554333 444558889999999999999999999999999999999999999999999877533
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPI-MPGRTEVSATFCFVL 338 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~p-f~~~~~~~~~~~~i~ 338 (348)
. .......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+....+..
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 2 2234567899999999988766689999999999999999987766 566555554444443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.54 Aligned_cols=216 Identities=44% Similarity=0.789 Sum_probs=180.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++++.||+|+||+||+|++ .+|+.||+|++............+.+|+++++.++||||+++++++... ...++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--RCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--SCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--CEEEE
Confidence 47899999999999999999997 5699999999976655555567788999999999999999999998764 45899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+++++...+...... ++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 v~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTG-----LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEECCSEEHHHHHHTCTTC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEcCCCCCHHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9999999888877654433 44455888999999999999999999999999999999999999999999987753
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.++.+....++..
T Consensus 172 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 235 (311)
T 3niz_A 172 PV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235 (311)
T ss_dssp CC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHH
T ss_pred Cc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 32 22345578999999999877666899999999999999999999999998887777766553
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=344.41 Aligned_cols=214 Identities=32% Similarity=0.559 Sum_probs=179.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----Cce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 191 (348)
++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... ...
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 6899999999999999999999999999999999765545666778889999999999999999999986542 246
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|+||||+++++...+.. .+....++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 142 ~~lv~E~~~~~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEEeCCCCCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 899999999988776643 244455888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
.... ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..++...++...
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~l 279 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cCCC--cccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 6543 224567899999999999875 49999999999999999999999999999888777776543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=346.07 Aligned_cols=218 Identities=25% Similarity=0.344 Sum_probs=180.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.++||+|+||+||+|++..+++.||+|++.+... .....+.+.+|+.++..++||||+++++++.+ ...+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~ 150 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNLY 150 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEEE
Confidence 4789999999999999999999999999999999975321 11122337789999999999999999999987 45699
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+||||+++ ++...+..... .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+..
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 99999976 55555543233 3445558889999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCcccccccCccccccccc----CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
...........+||+.|+|||++. +...|+.++|||||||++|||++|++||.+.+..+....++..
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 554444445568999999999986 2345899999999999999999999999998887777777643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.71 Aligned_cols=220 Identities=40% Similarity=0.721 Sum_probs=170.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++++.||+|+||.||+|++..+|+.||+|.++.... ....+.+.+|+++++.++||||+++++++.. ....|+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 81 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTLV 81 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEEE
Confidence 679999999999999999999989999999999976542 2234567789999999999999999999877 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++++...+...........+....++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 82 FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 99999887776643322222223556668889999999999999999999999999999999999999999999876533
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
. .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.++.+....++..
T Consensus 162 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 224 (317)
T 2pmi_A 162 V-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224 (317)
T ss_dssp C-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred c-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 2 22345578999999999877556899999999999999999999999998887776666543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.68 Aligned_cols=215 Identities=40% Similarity=0.731 Sum_probs=179.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++ .+|+.||+|++..........+.+.+|+++++.++||||+++++++... ...++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEEE
Confidence 5799999999999999999997 7899999999976554333446677899999999999999999999874 459999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++++...+...... ++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp EECCSEEHHHHHHTSTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EEecCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 999999887777654333 344558889999999999999999999999999999999999999999999876533
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.. ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.++.+....++..
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 216 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 22 2344578999999999877666899999999999999999999999998888777776654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=323.31 Aligned_cols=214 Identities=30% Similarity=0.470 Sum_probs=173.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..++..||+|.+..... .....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 88 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYYL 88 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEEE
Confidence 689999999999999999999999999999999876544 45566788999999999999999999999876 456899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ ++...+.. .. .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~~-~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES-HG-----PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHH-HC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999987 44444432 11 34555688899999999999999999999999999999999999999999998775
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
...........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..+...+.+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 226 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ 226 (294)
T ss_dssp ------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS
T ss_pred cccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh
Confidence 44433445567899999999988754 88999999999999999999999999887665555443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=343.64 Aligned_cols=217 Identities=27% Similarity=0.397 Sum_probs=178.6
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
..++|++.+.||+|+||+||+|++..+++.||+|++++... .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEE
Confidence 34789999999999999999999999999999999875321 11122346789999999999999999999987 4569
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||+++ ++...+... .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus 145 ~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 999999976 444444321 244555888999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCCcccccccCcccccccccCcc---cCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGAT---DYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
............+||+.|+|||++.+.. .++.++|||||||++|||++|++||.+.+..+...+++..
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc
Confidence 7544333345678999999999987532 2778999999999999999999999998877776666653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.90 Aligned_cols=213 Identities=24% Similarity=0.422 Sum_probs=178.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||+|++..+|+.||+|++++... .....+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~l 83 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFM 83 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEEE
Confidence 689999999999999999999999999999999975422 11235667789999999999999999999876 456999
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ .+...+. ... .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 84 v~e~~~gg~L~~~l~-~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLR-KSQ-----RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EECCCCSCBHHHHHH-HTS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEeCCCCCCHHHHHH-HcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 9999987 4444443 222 24445588899999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
.. ....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....++....
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC
T ss_pred Cc----cccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 32 3456899999999988764 489999999999999999999999998887776666665443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=330.53 Aligned_cols=216 Identities=26% Similarity=0.423 Sum_probs=177.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
.++|++.+.||+|+||.||+|+++.+|+.||+|++++... .....+.+..|..++..+ +||||+++++++.+ ...+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~~ 93 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 93 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCEE
Confidence 4789999999999999999999999999999999976422 122345677899999877 99999999999877 4569
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++ +...+. ... .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~-~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQ-SCH-----KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHH-HHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH-HcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999864 444433 222 244555888999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
..... ......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....+....
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~ 234 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccCC-CcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence 53222 224567899999999998775 48999999999999999999999999888766665555443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=341.09 Aligned_cols=217 Identities=26% Similarity=0.356 Sum_probs=179.6
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++... .....+.+.+|+.++..++||||+++++++.+ ...+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~ 137 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYLY 137 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEE
Confidence 4789999999999999999999999999999999975322 12233457789999999999999999999877 45699
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+||||+++ ++...+..... .++...++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 138 lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence 99999975 55554432221 3445558889999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCcccccccCcccccccccC------cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
...........+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.+.+..+...+++.
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 5544333345689999999998862 23489999999999999999999999999887777666664
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=339.45 Aligned_cols=207 Identities=38% Similarity=0.645 Sum_probs=163.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc---CceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~ 192 (348)
++|++.+.||+|+||+||+|++..+|+.||||++..........+.+.+|+++|+.++||||+++++++.... ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999999999999999999765556666778889999999999999999999985432 2568
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+||||+++++...+.... .++...++.++.||+.||.|||+.||+||||||+||||+.++++||+|||+|+..
T Consensus 133 ~lv~e~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEeccccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999999998887775432 3555568899999999999999999999999999999999999999999999876
Q ss_pred CCCCC--------------------------CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-------
Q 018936 273 DPNHK--------------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA------- 319 (348)
Q Consensus 273 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt------- 319 (348)
..... ...+..+||++|+|||++.....|+.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 43211 123456789999999987655669999999999999999999
Q ss_pred ----CCCCCCCCC
Q 018936 320 ----GKPIMPGRT 328 (348)
Q Consensus 320 ----G~~pf~~~~ 328 (348)
|+++|++.+
T Consensus 287 ~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 287 YHADRGPLFPGSS 299 (458)
T ss_dssp SGGGCCCSCC---
T ss_pred ccccccccCCCCc
Confidence 888898865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=326.13 Aligned_cols=220 Identities=49% Similarity=0.762 Sum_probs=185.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc------
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM------ 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 188 (348)
.++|++.+.||+|+||.||+|++..+|+.||+|++............+.+|+++++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 37899999999999999999999999999999998766554444556778999999999999999999987643
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
....|+||||+++++...+...... ++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCHHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 3468999999999888877665443 44455888999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 269 ASFFDPNH---KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 269 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
++...... ........||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 98765322 222345578999999999887666899999999999999999999999998877666665543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=327.11 Aligned_cols=215 Identities=27% Similarity=0.442 Sum_probs=181.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+ ....|+|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv 106 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 106 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998777666777889999999999999999999999887 4568999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC---CcEEEEeeCCccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~ 271 (348)
|||+.+ .+...+.. .. .++...++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~-~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA-RE-----FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT-CS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999987 44444432 22 34455588899999999999999999999999999999865 4599999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 247 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 247 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCCc--ccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 75332 23456789999999988764 489999999999999999999999998877665555555433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=327.48 Aligned_cols=211 Identities=24% Similarity=0.386 Sum_probs=177.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
+.|++.+.||+|+||+||+|++..+|+.||+|++....... ...+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~ 89 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RTD 89 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CCE
Confidence 67999999999999999999999999999999998765422 235678899999999999999999999977 456
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC----cEEEEee
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADF 266 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~----~~kl~DF 266 (348)
.|+||||+++ .+...+. ... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~-~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA-QKE-----SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT-TCS-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH-hcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999976 4544443 322 345556889999999999999999999999999999998777 7999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
|+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~ 231 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9998875432 23556799999999988764 48999999999999999999999999887666555544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=333.91 Aligned_cols=202 Identities=24% Similarity=0.451 Sum_probs=168.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 193 (348)
++|++++.||+|+||+||+|+++.+++.||+|++++... .....+.+.+|..++..+ +||||+++++++.. ...+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~ 129 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLF 129 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEEE
Confidence 689999999999999999999999999999999987544 233345677899999887 89999999999877 45699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||++++.+........ .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 130 lV~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999998754433332222 34555688899999999999999999999999999999999999999999998643
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
.. .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+
T Consensus 205 ~~-~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 205 RP-GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CT-TCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred cC-CCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 22 2234567899999999998875 489999999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=325.51 Aligned_cols=202 Identities=25% Similarity=0.455 Sum_probs=171.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
.++|++.+.||+|+||.||+|++..+|+.||+|++++... .....+.+.+|+.+++.+ +||||+++++++.. ....
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEE
Confidence 3789999999999999999999999999999999987654 445567788899999988 89999999999877 4569
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++ +...+. ... .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus 86 ~lv~e~~~gg~L~~~l~-~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQ-RQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEECCCCSCBHHHHHH-HHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEEeCCCCCcHHHHHH-HcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 9999999874 444333 222 345556888999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
..... ......+||+.|+|||++.+. .++.++|||||||++|||++|++||..
T Consensus 160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 160 GLRPG-DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp SCCTT-CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCC-CcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 43222 234566899999999988774 489999999999999999999999965
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=330.74 Aligned_cols=217 Identities=24% Similarity=0.354 Sum_probs=178.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
.++|++.+.||+|+||.||+|++..+|+.||+|++++... .....+.+.+|..++..+ +||||+++++++.. ...+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCEE
Confidence 3789999999999999999999988999999999976432 123355677899999987 89999999999877 4569
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||+++ ++...+. ... .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~-~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQ-QVG-----RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHH-HHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH-hcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999987 4444433 222 344555888999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
..... ......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....++....
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 238 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred cccCC-cccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC
Confidence 43222 224566899999999988764 489999999999999999999999999887666666655433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=331.77 Aligned_cols=216 Identities=24% Similarity=0.359 Sum_probs=169.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHH-HHhcCCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILI-LRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
.++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|..+ ++.++||||+++++++.. ...+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~ 114 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKL 114 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEE
Confidence 3789999999999999999999999999999999987654 22334456667776 567899999999999877 4569
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+||||++++.+........ .+....++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999998754433332222 2444558889999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
... .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....++..
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 254 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS
T ss_pred ccC-CCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 322 2234567899999999988764 4899999999999999999999999998877666666554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.40 Aligned_cols=217 Identities=27% Similarity=0.434 Sum_probs=181.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|.+..+|+.||+|++..........+.+.+|+++++.++||||+++++++.+ ....|+|
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv 88 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYLI 88 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEEE
Confidence 67999999999999999999999999999999998777666667788999999999999999999999876 4568999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC---CCCcEEEEeeCCccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID---DDGVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kl~DFGla~~ 271 (348)
|||+++ .+...+... . .++...+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~~-~-----~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-E-----YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC-S-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999987 444444322 2 244555888999999999999999999999999999998 567899999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+......
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 231 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD 231 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC
Confidence 65432 223456899999999988764 4899999999999999999999999998877666666655443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=329.08 Aligned_cols=214 Identities=25% Similarity=0.403 Sum_probs=178.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+ ....|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 117 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEE
Confidence 3789999999999999999999999999999999975432 12335667889999999999999999999877 45699
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+||||+++ .+...+.. .. .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus 118 lv~e~~~gg~L~~~l~~-~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRR-IG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEECCTTCBHHHHHHH-HC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCCcHHHHHHH-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceec
Confidence 99999976 44444432 12 2445558889999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+...++.....
T Consensus 192 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~ 255 (350)
T 1rdq_E 192 KGR----TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255 (350)
T ss_dssp SSC----BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred cCC----cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 432 3456899999999988765 489999999999999999999999998877666666655433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.38 Aligned_cols=214 Identities=35% Similarity=0.562 Sum_probs=178.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC----ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~ 191 (348)
++|++.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+++++.++||||+++++++..... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 68999999999999999999999999999999987655555667788899999999999999999999876422 35
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|+||||+++.+...+... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 6999999977777665432 244555888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
.... .....+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..++...++...
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 242 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 6432 3456789999999998875569999999999999999999999999999888877776544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=316.67 Aligned_cols=214 Identities=28% Similarity=0.434 Sum_probs=171.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHHh
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP------------------------ESVKFMAREILILRR 171 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~------------------------~~~~~~~~E~~~l~~ 171 (348)
++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+++++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 68999999999999999999999999999999997654311 123567889999999
Q ss_pred cCCCceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 018936 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGS 251 (348)
Q Consensus 172 l~hpniv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~ 251 (348)
++||||+++++++........|+||||++++.+..... ...++...++.++.||+.||.|||++||+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 99999999999998766678999999998754433221 124556668889999999999999999999999999
Q ss_pred CEEECCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCccc--CCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 252 NLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 252 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
|||++.++.+||+|||+++....... ......||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999987654322 2345578999999998875432 46789999999999999999999988765
Q ss_pred hHHHHHH
Q 018936 330 VSATFCF 336 (348)
Q Consensus 330 ~~~~~~~ 336 (348)
......+
T Consensus 246 ~~~~~~~ 252 (298)
T 2zv2_A 246 MCLHSKI 252 (298)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 5443333
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=317.16 Aligned_cols=212 Identities=28% Similarity=0.525 Sum_probs=178.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||+||+|++..+|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++... ...|+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG--DELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC--CEEEE
Confidence 36899999999999999999999999999999998765432 245678899999999999999999999874 45899
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||++++ +...+... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999764 44443321 24455588899999999999999999999999999999999999999999998775
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 231 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred Cccc-ccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 4432 234567899999999987754 899999999999999999999999988876666555544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=329.69 Aligned_cols=205 Identities=27% Similarity=0.436 Sum_probs=171.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+++|+.++|||||++++++.+. ...|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 91 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--EDMF 91 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEE
Confidence 3789999999999999999999999999999999875432 223356788899999999999999999999874 4699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||+.++.+........ .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 92 lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEECCCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999998754444433333 34455588899999999999999999999999999999999999999999999775
Q ss_pred CCCCCCcccccccCcccccccccCc--ccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 332 34567899999999998642 348899999999999999999999997543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=316.68 Aligned_cols=220 Identities=38% Similarity=0.632 Sum_probs=179.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhc---CCCceeeeeceEeecc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE---PESVKFMAREILILRRL---DHPNVIKLEGLVTSRM 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~ 188 (348)
.++|++.+.||+|+||+||+|++..+|+.||+|++...... ......+.+|+++++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 37899999999999999999999999999999998754321 11123455677777666 5999999999987643
Q ss_pred C---ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEe
Q 018936 189 S---CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265 (348)
Q Consensus 189 ~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~D 265 (348)
. ...+++|||+++++...+...... .++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 2 257999999999888777653321 255666889999999999999999999999999999999999999999
Q ss_pred eCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 266 FGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 266 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.++.+....++....
T Consensus 164 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 164 FGLARIYSYQM--ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp CSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CccccccCCCc--ccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99998764332 245667899999999987754 89999999999999999999999999998888777766543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=323.20 Aligned_cols=218 Identities=39% Similarity=0.729 Sum_probs=175.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||+||+|++..+|+.||||+++.........+.+.+|+++++.++||||+++++++.. ....|+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 110 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLHL 110 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEEE
Confidence 378999999999999999999999999999999997766555556677889999999999999999999987 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC-----CCCcEEEEeeCCc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-----DDGVLKIADFGLA 269 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-----~~~~~kl~DFGla 269 (348)
||||+++++...+.... .++...++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 111 v~e~~~~~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAENDLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCSEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999998777665332 345556888999999999999999999999999999994 5556999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
+...... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.++.+....++...-
T Consensus 185 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 185 RAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence 8775332 2234557799999999988766689999999999999999999999999998888888776543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=318.11 Aligned_cols=212 Identities=20% Similarity=0.327 Sum_probs=178.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+. ...|+|
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 79 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM--EELVMI 79 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEEEE
Confidence 6899999999999999999999999999999998643 34456688999999999999999999999874 569999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC--CCcEEEEeeCCcccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD--DGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~--~~~~kl~DFGla~~~ 272 (348)
|||+++ ++...+..... .++...++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 80 ~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 999987 55555543322 2445558889999999999999999999999999999987 789999999999887
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.++.+....+....
T Consensus 155 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 219 (321)
T 1tki_A 155 KPGD--NFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp CTTC--EEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred CCCC--ccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC
Confidence 5432 23456789999999988764 48899999999999999999999999988766665555443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=330.62 Aligned_cols=207 Identities=38% Similarity=0.608 Sum_probs=173.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC---ceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS---CSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~~ 192 (348)
++|++.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+++|+.++||||+++++++..... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 68999999999999999999999999999999997655556667788999999999999999999999876422 468
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+||||+++++...+.... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEECCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCcCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9999999998887775432 3455568899999999999999999999999999999999999999999999876
Q ss_pred CCCCC---------------------CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-----------C
Q 018936 273 DPNHK---------------------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-----------G 320 (348)
Q Consensus 273 ~~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-----------G 320 (348)
..... ...+..+||++|+|||++.....++.++|||||||++|||++ |
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 53321 123567889999999987665669999999999999999998 6
Q ss_pred CCCCCCCC
Q 018936 321 KPIMPGRT 328 (348)
Q Consensus 321 ~~pf~~~~ 328 (348)
.++|++.+
T Consensus 260 ~p~f~g~~ 267 (432)
T 3n9x_A 260 FPLFPGSS 267 (432)
T ss_dssp CCSCCCSC
T ss_pred cccCCCcc
Confidence 66776654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=315.11 Aligned_cols=215 Identities=37% Similarity=0.667 Sum_probs=177.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+|+.||+|++..........+.+.+|+++++.++||||+++++++.. ....++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEE
Confidence 67999999999999999999999999999999997766666667788899999999999999999999987 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+..+...... ++...++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRG-----VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EECCSEEHHHHHHHTSSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEeCCCchHHHHHhhhcC-----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999998776655433332 445558889999999999999999999999999999999999999999999876533
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
. .......+|+.|+|||.+.+...++.++||||||+++|+|++|++||.+.+..+....+..
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (311)
T 4agu_A 156 S-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK 217 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred c-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 2234557899999999987756689999999999999999999999999888776665544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=320.39 Aligned_cols=219 Identities=26% Similarity=0.402 Sum_probs=173.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC--ceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS--CSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~~ 192 (348)
++|++.+.||+|+||.||+|++..+++.||||+++.... .......+.+|+++++.++||||+++++++..... ...
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 689999999999999999999999999999999977544 44556778899999999999999999999876543 245
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||+++ .+...+.. .. .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~lv~e~~~g~~L~~~l~~-~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT-EG-----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHHH-HC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 999999976 44444432 11 344555888999999999999999999999999999999999999999999987
Q ss_pred cCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 272 FDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 272 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
...... .......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+...+++....
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC
Confidence 654322 123345689999999998775 489999999999999999999999999887776666655433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=324.90 Aligned_cols=204 Identities=28% Similarity=0.470 Sum_probs=172.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 47899999999999999999999999999999998753221 12234678899999999999999999999874 4699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||+++++...+.... .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 86 lv~E~~~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 86 MVIEYAGGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEEECCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999999888877664322 34555688899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
... .....+||+.|+|||++.+....++++|||||||++|+|++|+.||.+..
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 432 23556799999999998876645789999999999999999999997643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=319.04 Aligned_cols=216 Identities=25% Similarity=0.439 Sum_probs=166.7
Q ss_pred CCceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||.||+|++. .+|+.||+|+++.... .......+.+|+++++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 94 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG--G 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--C
Confidence 68999999999999999999975 6899999999976543 223445677899999999999999999999774 4
Q ss_pred eEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
..|+||||+++ .+...+.. .. .+....++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~-~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLER-EG-----IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHh-CC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 59999999986 44444332 12 2344558889999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
+...... ......+||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..+....++....
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 238 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 8653222 2234567899999999887644 89999999999999999999999999887766666655433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=320.49 Aligned_cols=219 Identities=44% Similarity=0.762 Sum_probs=178.1
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP---ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
..++|++.+.||+|+||.||+|++..+|+.||+|++....... .....+.+|+++++.++||||+++++++... .
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--S 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--T
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--C
Confidence 3478999999999999999999998899999999987543321 1224577899999999999999999999764 4
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
..++||||+++++...+......++... ++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~-----~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSH-----HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHH-----HHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 5899999999988777765544444443 78899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
...... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+....++...
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~ 229 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHc
Confidence 765332 223456789999999998766568899999999999999999999999999888877777654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=322.60 Aligned_cols=212 Identities=32% Similarity=0.567 Sum_probs=173.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC----ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~ 191 (348)
++|++.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++..... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 68999999999999999999999999999999998765566667788899999999999999999999876432 36
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|+||||+++++...+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEECCSEEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEEcCCCCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 899999999987776642 244455788999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++.
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 240 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240 (371)
T ss_dssp ---------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred ccccc--ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 64332 23456789999999998875 489999999999999999999999999887776665543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=315.81 Aligned_cols=211 Identities=26% Similarity=0.390 Sum_probs=176.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
+.|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 57999999999999999999999999999999998754321 235678899999999999999999999877 456
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC----cEEEEee
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADF 266 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~----~~kl~DF 266 (348)
.++||||+++ .+...+. ... .++...++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~-~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA-EKE-----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHT-TSS-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHH-hcC-----CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999976 4544443 222 345556888999999999999999999999999999999887 8999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 230 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence 9998875432 23456789999999988764 48999999999999999999999998877665554443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.91 Aligned_cols=217 Identities=32% Similarity=0.678 Sum_probs=181.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++..+|+.||+|++..........+.+.+|+++++.++||||+++++++.. ....|+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEEE
Confidence 478999999999999999999999999999999998776666667778899999999999999999999987 456899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++++..+..... .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 102 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEECCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEecCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999887766543332 244555888999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
... ......+|+.|+|||++.+...++.++||||||+++|+|++|++||.+.++.+....++..
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 240 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 322 2344578999999999887656899999999999999999999999999988877776643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=322.13 Aligned_cols=215 Identities=41% Similarity=0.742 Sum_probs=172.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|+++..... .....+.+|+++++.++||||+++++++... ...++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEEE
Confidence 6799999999999999999999999999999998654321 1122344699999999999999999999774 458999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++++...+..... .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp EECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred ecccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 99999988777654332 2444558889999999999999999999999999999999999999999999865433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
. .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....++..
T Consensus 154 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 216 (324)
T 3mtl_A 154 T-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred c-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 2 22344578999999999887666899999999999999999999999998887766666553
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=322.82 Aligned_cols=212 Identities=36% Similarity=0.585 Sum_probs=165.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----cCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~ 191 (348)
++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++... ....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 689999999999999999999999999999999876555556677788999999999999999999998653 1245
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|++++++++++...... ..++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CEEEEECCCEECC------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEEecccCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 799999998766655432 1345556888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.... .....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..++...++.
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5432 34567899999999988756689999999999999999999999999988777766654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=318.31 Aligned_cols=212 Identities=30% Similarity=0.466 Sum_probs=171.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv 83 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEEE
Confidence 7899999999999999999999999999999998755432 234567889999999999999999999876 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+........ .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99998744433333322 3455568889999999999999999999999999999999999999999999876422
Q ss_pred C-CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 276 H-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 276 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
. ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.......+.
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 219 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 2 22234567899999999988765457899999999999999999999987665544433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=319.09 Aligned_cols=212 Identities=30% Similarity=0.529 Sum_probs=179.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
+.|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+++++.++||||+++++++... ...++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEEE
Confidence 569999999999999999999999999999999976644 334456788999999999999999999999874 56899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+.+++...+..... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 132 v~e~~~g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 999999887776643322 344555888999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
. ....||+.|+|||++.+ ...++.++|||||||++|||++|++||.+.+..+....+..+
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 268 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 268 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence 2 34578999999998852 345889999999999999999999999988877766665544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.47 Aligned_cols=214 Identities=40% Similarity=0.632 Sum_probs=175.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----cCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~ 191 (348)
.+|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+++|+.++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 479999999999999999999999999999999865432 233699999999999999999988543 2335
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC-CcEEEEeeCCcc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-GVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kl~DFGla~ 270 (348)
+++||||+++.+........ .....++...++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeehhcccccHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 78999999987665543210 011234555688899999999999999999999999999999955 578999999999
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
....... .....+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..++...++..
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~ 272 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 7644322 345678999999999887656899999999999999999999999999988888777654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.56 Aligned_cols=218 Identities=21% Similarity=0.323 Sum_probs=179.8
Q ss_pred CCCceeeeeeccC--CceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQG--TYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G--~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
.++|++.+.||+| +||.||+|++..+|+.||||++..........+.+.+|+.+++.++|||||++++++... ...
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--CEE
Confidence 4789999999999 999999999999999999999988766677778899999999999999999999999874 469
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++ +...+..... ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999864 4444332211 1345556888999999999999999999999999999999999999999999865
Q ss_pred cCCCC------CCCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 272 FDPNH------KHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 272 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
..... ........||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+....++.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 42111 1112334789999999998763 4589999999999999999999999998877766665544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.14 Aligned_cols=218 Identities=27% Similarity=0.392 Sum_probs=169.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++... ..+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET--TEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEEE
Confidence 4789999999999999999999999999999999975422 233445677899999999999999999999874 4699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+||||++++.+........ .++...++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++..
T Consensus 225 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999998754433332222 34455688899999999999998 99999999999999999999999999999865
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
.... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....++....
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~ 366 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 366 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred cCCC-cccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence 3322 224556899999999998765 489999999999999999999999998877666555554433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=311.68 Aligned_cols=213 Identities=26% Similarity=0.354 Sum_probs=168.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||+||+|++ +|+.||+|++..........+.+.+|++++++++||||+++++++... ...++
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 111 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP--PNLSI 111 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--TCCEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CceEE
Confidence 37899999999999999999974 688999999987776777778899999999999999999999999774 34899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
||||+++ ++...+..... ...++...++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999987 55554443211 123556668889999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
..... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp --------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred ccccc-cccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54332 2234567899999999987754 899999999999999999999999887765544443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=320.49 Aligned_cols=215 Identities=33% Similarity=0.540 Sum_probs=176.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec-------
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR------- 187 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 187 (348)
.++|++.+.||+|+||+||+|++..+|+.||||++..+... ..+|+++++.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 36899999999999999999999999999999998754321 23699999999999999999998542
Q ss_pred -----------------------------cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHH
Q 018936 188 -----------------------------MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHC 238 (348)
Q Consensus 188 -----------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L 238 (348)
...+.++||||+++++...+.... .....++...++.++.||+.||.||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 234589999999987655543210 0111345556888999999999999
Q ss_pred HHCCceecCCCCCCEEEC-CCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHH
Q 018936 239 HNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAEL 317 (348)
Q Consensus 239 H~~~ivHrDikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~el 317 (348)
|+.||+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+...++.++||||+||++|+|
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 999999999999999998 688999999999997754332 34567899999999988766689999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHHH
Q 018936 318 LAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 318 ltG~~pf~~~~~~~~~~~~i~~ 339 (348)
++|++||.+.+..+....++..
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~ 257 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQI 257 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHH
T ss_pred HhCCCCCCCCChHHHHHHHHHH
Confidence 9999999999988888877754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=335.92 Aligned_cols=209 Identities=28% Similarity=0.418 Sum_probs=173.3
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+.... ....+.+.+|+++++.++||||+++++++.. ...+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 260 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTDL 260 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCEE
Confidence 457899999999999999999999999999999999754321 1234567889999999999999999999877 4569
Q ss_pred EEEEeecccChh-hhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLA-GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++.+ ..+.... .....++...++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~--~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVD--EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSS--TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHHhh--cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 999999986444 4433221 1122455666888999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
...... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+
T Consensus 339 ~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 339 LKAGQT-KTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CCTTCC-CBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred ccCCCc-ccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 754332 23456899999999998874 48999999999999999999999998764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=316.99 Aligned_cols=216 Identities=37% Similarity=0.612 Sum_probs=183.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc---Cce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~ 191 (348)
.++|++++.||+|+||.||+|++..++..||||++.... .....+.+.+|+++++.++||||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 368999999999999999999999999999999986433 3445577889999999999999999999986532 246
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|++|||+++++...+... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 105 ~~iv~e~~~~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccCcCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 8999999999877766432 244556888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 272 FDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 272 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
....... ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....++.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 7543221 134557899999999887666689999999999999999999999999888777766654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.47 Aligned_cols=216 Identities=28% Similarity=0.409 Sum_probs=178.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|.+.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++... ...|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDIF 92 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 3789999999999999999999999999999999975432 112356788999999999999999999998774 5699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||++++.+........ .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEECCSSEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999997644433333332 34555588899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
... .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 231 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG 231 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 432 2345679999999999887654578999999999999999999999987765555554443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=346.48 Aligned_cols=220 Identities=23% Similarity=0.333 Sum_probs=180.1
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCce
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 191 (348)
..++|++++.||+|+||.||+|++..+++.||||++++... .....+.+..|..++..+ +||||+++++++.+ ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 34789999999999999999999999999999999975422 223345677799999987 79999999998876 456
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|+||||++++.+........ .+.+..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999998754443333222 344555888999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
..... ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+....|+.....
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 560 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 560 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC
T ss_pred cccCC-cccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC
Confidence 43322 234567899999999988764 4899999999999999999999999998887776666654443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=316.86 Aligned_cols=212 Identities=37% Similarity=0.611 Sum_probs=178.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc----e
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC----S 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~----~ 191 (348)
++|.+.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++...... .
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 689999999999999999999999999999999987665666677888999999999999999999999764331 2
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|+||||+++++...... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCCEEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEEccccccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 499999999877665532 245556888999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....++..
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 257 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 6432 345678999999999887556899999999999999999999999998887777766553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=337.57 Aligned_cols=206 Identities=27% Similarity=0.449 Sum_probs=172.4
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+++|+.++||||+++++++.+ ...+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCEE
Confidence 45789999999999999999999999999999999975432 12234567789999999999999999999877 4569
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++ +...+.... ...++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 9999999764 444443321 11245566888999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..... .....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+
T Consensus 336 ~~~~~--~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 336 VPEGQ--TIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CCTTC--CEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cccCc--cccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 75432 23456899999999998774 48999999999999999999999998765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=315.07 Aligned_cols=210 Identities=24% Similarity=0.394 Sum_probs=173.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+++++.++||||+++++++........++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 6899999999999999999999999999999998754322 235567789999999999999999999987666678999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----CCCCcEEEEeeCCcc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLAS 270 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll----~~~~~~kl~DFGla~ 270 (348)
|||+++ ++...+...... ..++...++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999985 555554432211 125556688899999999999999999999999999999 778889999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccC-------cccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLG-------ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
....... .....||+.|+|||++.. ...++.++|||||||++|||++|+.||.......
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 230 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 8754432 345678999999998752 2458899999999999999999999997654433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.11 Aligned_cols=209 Identities=28% Similarity=0.414 Sum_probs=159.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||+||++++..+++.||+|++...... .+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEE
Confidence 37899999999999999999999999999999999765432 2457789999999999999999999987 456999
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc--EEEEeeCCccc
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--LKIADFGLASF 271 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kl~DFGla~~ 271 (348)
||||+++ .+...+.. .. .++...++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 94 v~e~~~~~~L~~~l~~-~~-----~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 94 IMEYASGGELYERICN-AG-----RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEECCCSCBHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEeCCCCCHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999976 44444322 12 3455568889999999999999999999999999999987765 99999999985
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
..... ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~ 230 (361)
T 3uc3_A 168 SVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT 230 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH
T ss_pred ccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 43222 2345578999999999877553344599999999999999999999886654433333
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=313.85 Aligned_cols=209 Identities=27% Similarity=0.427 Sum_probs=176.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----CCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-----HPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~~~~~~~~~~ 190 (348)
++|++.++||+|+||+||+|++..+++.||||+++. .......+..|+++++.+. ||||+++++++... .
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~ 109 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--D 109 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--T
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--C
Confidence 789999999999999999999999999999999863 2344556778999999996 99999999999874 5
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-------------
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD------------- 257 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~------------- 257 (348)
..++||||+++++...+...... .++...++.++.||+.||.|||++||+||||||+|||++.
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred eeEEEEcCCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 69999999987877776543211 2445558889999999999999999999999999999975
Q ss_pred ------------CCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 258 ------------DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 258 ------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
++.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCC
Confidence 789999999999875432 24567899999999988754 8999999999999999999999999
Q ss_pred CCChhHHHHHHHH
Q 018936 326 GRTEVSATFCFVL 338 (348)
Q Consensus 326 ~~~~~~~~~~~i~ 338 (348)
+.+..+....+..
T Consensus 261 ~~~~~~~~~~~~~ 273 (360)
T 3llt_A 261 THEHMEHLAMMES 273 (360)
T ss_dssp CSSHHHHHHHHHH
T ss_pred CCcHHHHHHHHHH
Confidence 9887666555543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=311.80 Aligned_cols=200 Identities=25% Similarity=0.406 Sum_probs=166.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.++||+|+||+||+|++..+|+.||||++...............|+..+..+ +||||+++++++.. ....|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 579999999999999999999988999999999876555555555555666666665 99999999999987 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+++++...+..... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 135 v~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECCCCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEeccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999999888777654332 345556888999999999999999999999999999999999999999999987754
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
... .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+
T Consensus 210 ~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 210 AGA--GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCC--CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322 345568999999998876 489999999999999999999777654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=303.59 Aligned_cols=215 Identities=27% Similarity=0.435 Sum_probs=180.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ....+++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 83 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 83 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEEE
Confidence 78999999999999999999999999999999998776666777888999999999999999999999876 4568999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc---EEEEeeCCccc
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kl~DFGla~~ 271 (348)
|||++++ +...+... . .++...+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~-~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-E-----FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH-S-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999874 43433321 1 3445558889999999999999999999999999999986655 99999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
..... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+.....
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 224 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 224 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc
Confidence 65332 234567899999999887654 89999999999999999999999988877666655555443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=317.59 Aligned_cols=212 Identities=24% Similarity=0.441 Sum_probs=176.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+++|+.++||||+++++++.+ ....++|
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv 126 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLI 126 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEEE
Confidence 67999999999999999999999999999999987543 3345578899999999999999999999977 4569999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC--CCcEEEEeeCCcccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD--DGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~--~~~~kl~DFGla~~~ 272 (348)
|||+++ ++...+..... .++...++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 127 ~E~~~gg~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 999986 45454443322 3445558889999999999999999999999999999974 478999999999987
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~ 265 (387)
T 1kob_A 202 NPDE--IVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265 (387)
T ss_dssp CTTS--CEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred CCCc--ceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 5432 23445789999999988764 4899999999999999999999999998876666555443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.31 Aligned_cols=207 Identities=29% Similarity=0.448 Sum_probs=168.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence 579999999999999999999999999999999864321 112356788999999999999999999999874 569
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc---EEEEeeCC
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFGL 268 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kl~DFGl 268 (348)
|+||||++++ +...+..... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999864 4333322110 0112445558889999999999999999999999999999986654 99999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
+........ .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 988754322 234567899999999887654 8999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=311.80 Aligned_cols=201 Identities=22% Similarity=0.251 Sum_probs=169.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+|+.||||++...... +.+.+|+++++.+ +||||+++++++.. ....++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~l 82 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAM 82 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEE
Confidence 6799999999999999999999999999999998755322 2467899999999 99999999999887 456899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc-----EEEEeeCCc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV-----LKIADFGLA 269 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~-----~kl~DFGla 269 (348)
||||+++++...+..... .++...++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 83 v~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 83 VLELLGPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EEEeCCCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999997777776654322 3455568889999999999999999999999999999998887 999999999
Q ss_pred cccCCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 270 SFFDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 270 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 876433221 12456789999999998874 48999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=307.49 Aligned_cols=202 Identities=24% Similarity=0.484 Sum_probs=169.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++..+++.||+|.+.. ......+.+.+|+++++.++||||+++++++.+. ...++|
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 85 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLNFI 85 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeEEE
Confidence 789999999999999999999999999999998853 3456677889999999999999999999999874 558999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ ++...+..... .++...+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999987 55554443222 345556888999999999999999999999999999999999999999999987643
Q ss_pred CCCCC-------------cccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 275 NHKHP-------------MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 275 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
..... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 32211 1245789999999998774 4899999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=316.89 Aligned_cols=213 Identities=25% Similarity=0.425 Sum_probs=172.7
Q ss_pred CCceeeeeeccCCceEEEEEEEc-------cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-------LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 187 (348)
++|++.+.||+|+||.||+|++. .++..||+|+++... .....+.+.+|+++++.+ +||||+++++++...
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 78999999999999999999864 345689999986543 445567788999999999 899999999998764
Q ss_pred cCceEEEEEeeccc-ChhhhhcCCC----------CcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 188 MSCSLYLVFHYMEH-DLAGLAASPE----------VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
..+|+||||+++ .+...+.... .......++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 160 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 160 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred --CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 458999999987 5555443321 122334566677889999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 257 DDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+.
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999987654322 2233445688999999987754 8999999999999999999 9999988765443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.99 Aligned_cols=213 Identities=31% Similarity=0.524 Sum_probs=175.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++..+|+.||||++............+.+|+++++.++||||+++++++.. ....|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 99 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIV 99 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEEE
Confidence 67999999999999999999999999999999987543323345678899999999999999999999887 4569999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC---CCCcEEEEeeCCccc
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID---DDGVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kl~DFGla~~ 271 (348)
|||+.++ +...+... . .++...++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~-~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-K-----RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH-S-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999864 44443321 2 344556888999999999999999999999999999995 556899999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 238 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 75432 2455678999999998876 38999999999999999999999999988877666665543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=310.78 Aligned_cols=204 Identities=27% Similarity=0.437 Sum_probs=165.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC------
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS------ 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 189 (348)
++|++.+.||+|+||.||+|++..+|+.||||+++... .....+.+.+|+++|++++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 57999999999999999999999999999999997654 33456778899999999999999999998865322
Q ss_pred -------------------------------------------------ceEEEEEeecccC-hhhhhcCCCCcCCcchh
Q 018936 190 -------------------------------------------------CSLYLVFHYMEHD-LAGLAASPEVKFTEPQF 219 (348)
Q Consensus 190 -------------------------------------------------~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~ 219 (348)
...+++|||++++ +...+... ... ...
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~--~~~ 161 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSL--EDR 161 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSG--GGS
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCc--cch
Confidence 2489999999874 44444332 221 223
Q ss_pred hHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC-----------CCcccccccCc
Q 018936 220 VYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-----------HPMTSRVVTLW 288 (348)
Q Consensus 220 ~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~ 288 (348)
....++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 3444778999999999999999999999999999999999999999999988754321 12344578999
Q ss_pred ccccccccCcccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 289 y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
|+|||++.+. .++.++||||||+++|+|++|..|+
T Consensus 242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCCh
Confidence 9999998775 4899999999999999999998776
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.13 Aligned_cols=207 Identities=25% Similarity=0.407 Sum_probs=173.3
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
.|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence 48888999999999999999988999999999976543 3356678899999999999999999999874 4699999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||++++.+..+.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 122 e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 122 EFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp CCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred ecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 999875554444321 34555688899999999999999999999999999999999999999999998765432
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
. ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 196 P-KRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred c-ccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 2 23456789999999988764 489999999999999999999999988766554433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=311.29 Aligned_cols=206 Identities=27% Similarity=0.467 Sum_probs=168.1
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeeccCce
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~ 191 (348)
..++|++.+.||+|+||.||++.+ .+++.||||++..........+.+.+|+.+|+.++| |||+++++++.. ...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCE
Confidence 347899999999999999999986 678999999998877777777889999999999987 999999999887 456
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|+|||+.++++...+.... .++...++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEECCCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99999988777777665422 344455888999999999999999999999999999997 67899999999987
Q ss_pred cCCCCCC-CcccccccCcccccccccC----------cccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 272 FDPNHKH-PMTSRVVTLWYRPPELLLG----------ATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 272 ~~~~~~~-~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
....... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+..+
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 225 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence 7543322 2345678999999998853 13478899999999999999999999987544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.07 Aligned_cols=212 Identities=34% Similarity=0.582 Sum_probs=179.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc------CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL------DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~~ 189 (348)
.+|++.+.||+|+||.||+|++..+++.||||+++.. ......+.+|+.+++.+ +|+||+++++++...
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-- 171 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-- 171 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--
Confidence 6799999999999999999999999999999998643 34455677788888887 577999999998874
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc--EEEEeeC
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV--LKIADFG 267 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kl~DFG 267 (348)
...+++|||+++++...+...... .++...++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccCCCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 569999999998887776543221 2455568889999999999999999999999999999999887 9999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.++.+...+++...-
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~ 316 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 99865432 34567899999999988754 89999999999999999999999999998888777765443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=318.44 Aligned_cols=203 Identities=17% Similarity=0.183 Sum_probs=162.4
Q ss_pred CCCceeeeeeccCCceEEEEE-----EEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEee
Q 018936 115 ADSFEKIDKIGQGTYSNVYKA-----KDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTS 186 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~-----~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~ 186 (348)
.++|++.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+++++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 478999999999999999999 467889999999986432 345667888888886 9999999999877
Q ss_pred ccCceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC--------
Q 018936 187 RMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-------- 257 (348)
Q Consensus 187 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-------- 257 (348)
. ...|+||||+++ ++...+.. ........+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 139 ~--~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 Q--NGSVLVGELYSYGTLLNAINL-YKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp S--SCEEEEECCCCSCBHHHHHHH-HHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred C--CCcEEEEeccCCCcHHHHHHH-hhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 4 458999999986 44444432 11112234566668999999999999999999999999999999998
Q ss_pred ---CCcEEEEeeCCccccCC-CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 258 ---DGVLKIADFGLASFFDP-NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 258 ---~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
++.+||+|||+|+.+.. .........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999976532 1222345567999999999988755 89999999999999999999999843
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=310.98 Aligned_cols=212 Identities=37% Similarity=0.612 Sum_probs=177.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC----ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS----CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~ 191 (348)
++|.+.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++..... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 67999999999999999999999999999999997665556667788899999999999999999999876432 23
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|++|||+++.+...... .++...++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCSEEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEeccccCCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 599999999866654421 245556888999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.... .....+|+.|+|||++.+...++.++||||||+++|+|++|+.||.+.+..+....++..
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~ 239 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHH
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 5432 344578999999999877556899999999999999999999999998877766666543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=312.94 Aligned_cols=224 Identities=27% Similarity=0.380 Sum_probs=176.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN---LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+.+|+++++.++||||+++++++.+ ....
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 103 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQYI 103 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCeE
Confidence 67999999999999999999999999999999986542 233456778899999999999999999999977 4569
Q ss_pred EEEEeecccChhhhhcCCC-----------------------------------CcCCcchhhHHHHHHHHHHHHHHHHH
Q 018936 193 YLVFHYMEHDLAGLAASPE-----------------------------------VKFTEPQFVYLKVKCYMHQLLSGLEH 237 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~~qi~~aL~~ 237 (348)
++||||++++.+....... .......++...++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999764443332100 00012234566688899999999999
Q ss_pred HHHCCceecCCCCCCEEECCCC--cEEEEeeCCccccCCCC---CCCcccccccCcccccccccCc-ccCCccccHHHHH
Q 018936 238 CHNNGVLHRDIKGSNLLIDDDG--VLKIADFGLASFFDPNH---KHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAG 311 (348)
Q Consensus 238 LH~~~ivHrDikp~NIll~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlG 311 (348)
||+.||+||||||+|||++.++ .+||+|||+++...... ........||+.|+|||.+.+. ..++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 89999999998753321 1123456789999999988642 4588999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 312 CILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 312 v~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
+++|+|++|+.||.+.+..+....++....
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 293 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKL 293 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhccc
Confidence 999999999999999888777766665543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=327.87 Aligned_cols=213 Identities=31% Similarity=0.525 Sum_probs=171.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++++.||+|+||+||+|++..++..||+|++............+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 114 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYLV 114 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998765544446678899999999999999999999987 4568999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC---CcEEEEeeCCccc
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~ 271 (348)
|||+.++ +...+... . .++...++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~-~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-M-----KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH-S-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999874 44433321 2 24455588899999999999999999999999999999764 5599999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
..... .....+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..+....+....
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK 253 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCCc--cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 75332 2455679999999998764 48999999999999999999999999988776666655543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=317.00 Aligned_cols=213 Identities=35% Similarity=0.603 Sum_probs=174.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----Cce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 191 (348)
.+|++.+.||+|+||+||+|++..++. ||+|++...... ..+|+++++.++||||+++++++.... ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 579999999999999999999866655 888887643321 225999999999999999999986533 234
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC-CCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~kl~DFGla~ 270 (348)
+++||||+++++......... ....++...++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 789999999876654432100 011345556888999999999999999999999999999999 79999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
....... .....+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..++...++..
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~ 257 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 7744332 345678999999999887666899999999999999999999999999988888877764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=312.22 Aligned_cols=210 Identities=34% Similarity=0.466 Sum_probs=158.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|++++++++||||+++++++.. ....++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 367999999999999999999999899999999997542 24557789999999999999999999977 456899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---CCcEEEEeeCCcc
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLAS 270 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kl~DFGla~ 270 (348)
||||+++ .+...+.. .. .++...++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~-~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE-KG-----YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTT-CS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 9999986 44444432 22 2445558889999999999999999999999999999975 8899999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+..+..+.+
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~ 265 (349)
T 2w4o_A 200 IVEHQV--LMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265 (349)
T ss_dssp ---------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred ccCccc--ccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence 764332 234567899999999987754 899999999999999999999999877765545544443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=312.84 Aligned_cols=217 Identities=30% Similarity=0.474 Sum_probs=173.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC---------ChHHHHHHHHHHHHHHhcCCCceeeeeceEe
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---------EPESVKFMAREILILRRLDHPNVIKLEGLVT 185 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 185 (348)
.++|++.+.||+|+||.||+|++ .+|..||||++..... .....+.+.+|+++++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEEC-TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEEC-CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 37899999999999999999997 4599999999865432 1223477889999999999999999999986
Q ss_pred ec---cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEE
Q 018936 186 SR---MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 186 ~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 262 (348)
.. .....|+||||+++++...+...... ++...++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIV-----ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 52 33478999999999888887754433 44455888999999999999999999999999999999999999
Q ss_pred EEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 263 IADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 263 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
|+|||++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....++..
T Consensus 175 l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 175 ICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249 (362)
T ss_dssp ECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999998654332 2345578999999999887556899999999999999999999999998887777666543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=316.66 Aligned_cols=207 Identities=21% Similarity=0.208 Sum_probs=162.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccC-----CcEEEEEEeecCCCChH---------HHHHHHHHHHHHHhcCCCceeeee
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT-----GKIVALKKVRFDNLEPE---------SVKFMAREILILRRLDHPNVIKLE 181 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~ 181 (348)
++|++.+.||+|+||.||+|++..+ ++.||||++........ .......|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 6899999999999999999988654 58899999875431100 011123355566777899999999
Q ss_pred ceEeeccC--ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC--C
Q 018936 182 GLVTSRMS--CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--D 257 (348)
Q Consensus 182 ~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~--~ 257 (348)
+++..... ...|+||||+++++...+..... .++...++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEETTEEEEEEEEECEEEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eeeeeccCCcceEEEEEeCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 99876432 56899999997677766654322 345556888999999999999999999999999999999 8
Q ss_pred CCcEEEEeeCCccccCCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 258 DGVLKIADFGLASFFDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 258 ~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
++.+||+|||+++.+...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+..
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 899999999999876432211 123445899999999888754 8999999999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.66 Aligned_cols=210 Identities=27% Similarity=0.410 Sum_probs=169.2
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEe
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e 197 (348)
|...+.||+|+||.||+|++..+|..||+|+++... ....+.+.+|+++|+.++||||+++++++... ...++|||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~E 166 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVME 166 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEe
Confidence 344678999999999999999999999999997643 34566788999999999999999999999874 46899999
Q ss_pred eccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE--CCCCcEEEEeeCCccccCC
Q 018936 198 YMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 198 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll--~~~~~~kl~DFGla~~~~~ 274 (348)
|+++ .+...+..... .++...++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++....
T Consensus 167 ~~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 167 YVDGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp CCTTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred CCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9986 44444432222 34555688899999999999999999999999999999 5678999999999998754
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++..
T Consensus 242 ~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 303 (373)
T 2x4f_A 242 REK--LKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303 (373)
T ss_dssp TCB--CCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred ccc--cccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 332 3445789999999988764 4899999999999999999999999998877766666654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.91 Aligned_cols=210 Identities=25% Similarity=0.379 Sum_probs=175.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RTD 89 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCE
Confidence 67999999999999999999999999999999997754322 135678899999999999999999999877 456
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC----cEEEEee
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADF 266 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~----~~kl~DF 266 (348)
.++||||+++ .+...+... . .++...++.++.||+.||.|||+.||+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-~-----~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-E-----SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-S-----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999976 555554432 1 355666888999999999999999999999999999999888 7999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
|++........ .....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 230 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99987754322 3455789999999988764 4899999999999999999999999887765554443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.56 Aligned_cols=214 Identities=25% Similarity=0.406 Sum_probs=171.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
.++|++.+.||+|+||.||+|++..+++ .||||.++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG--RL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG--GC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--Cc
Confidence 3789999999999999999999876554 59999986543 455567788999999999999999999999764 45
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.|+||||+++ ++...+..... .++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 8999999976 55555543332 34455588899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 271 FFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 271 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
........ ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||.+.+..+....+.
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 87543222 12233457789999988764 48999999999999999999 999998877665544443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.24 Aligned_cols=209 Identities=24% Similarity=0.380 Sum_probs=158.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++..+|+.||+|+++.........+.+.++...++.++||||+++++++... ...++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CCEEE
Confidence 3789999999999999999999999999999999976554444455555566668889999999999999874 45899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++++...+.... .....++...++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVI--DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEehhccchHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999987755543210 0111345556888999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccc---cCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 274 PNHKHPMTSRVVTLWYRPPELL---LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.... .....||+.|+|||++ .....++.++||||||+++|+|++|+.||.....
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc
Confidence 4322 2344689999999986 2344588999999999999999999999986443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=319.82 Aligned_cols=210 Identities=42% Similarity=0.672 Sum_probs=158.9
Q ss_pred CCcee-eeeeccCCceEEEEEEEc--cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEK-IDKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~-~~~LG~G~~g~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
+.|++ .++||+|+||.||+|++. .+++.||||++...... ..+.+|+.+|+.++||||+++++++........
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 45777 457999999999999965 56889999998754433 346689999999999999999999987667789
Q ss_pred EEEEeecccChhhhhcCCCC---cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----CCCCcEEEEe
Q 018936 193 YLVFHYMEHDLAGLAASPEV---KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIAD 265 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll----~~~~~~kl~D 265 (348)
|+||||+++++...+..... ......++...++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999999987766542111 0111135566689999999999999999999999999999999 6778999999
Q ss_pred eCCccccCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 266 FGLASFFDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 266 FGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
||+++....... ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+..+
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999987753321 2234567899999999988766689999999999999999999999987665
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=315.50 Aligned_cols=205 Identities=26% Similarity=0.456 Sum_probs=167.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD--HPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~~~ 193 (348)
++|++.+.||+|+||+||+|.+. +++.||||++..........+.+.+|+.+|+.++ ||||+++++++... ..+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIY 132 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEE
Confidence 57999999999999999999974 5999999999887767777788999999999996 59999999998774 4599
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+.++++...+.... .+....++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 133 lv~E~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 133 MVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEECCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999977777776665332 234445788999999999999999999999999999995 5899999999998775
Q ss_pred CCCCC-CcccccccCcccccccccCc----------ccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 274 PNHKH-PMTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 274 ~~~~~-~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
..... .....+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+..+.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 273 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence 43322 23456799999999998641 24888999999999999999999999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=326.60 Aligned_cols=213 Identities=31% Similarity=0.520 Sum_probs=179.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 103 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYL 103 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEE
Confidence 6799999999999999999999999999999999776542 3446778899999999999999999999987 456999
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---CCCCcEEEEeeCCcc
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLAS 270 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kl~DFGla~ 270 (348)
||||+.++ +...+... . .++...++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~-~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-K-----RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC-S-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999764 44444332 2 34555688899999999999999999999999999999 567899999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 243 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred Eccccc--ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 875432 2455678999999998876 38999999999999999999999999988877666665544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=303.60 Aligned_cols=220 Identities=30% Similarity=0.496 Sum_probs=180.0
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
..++|++.+.||+|+||.||+|++..+|+.||+|.+..........+.+.+|+++++.++||||+++++++........|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 44789999999999999999999999999999999988777777788899999999999999999999998776667899
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCCEEECCCCcEEEEeeC
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG-----VLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
++|||+++ .+...+..... ....++...++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999986 55554432110 0112455668889999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
++........ ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~ 229 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hheeeccccc-cccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh
Confidence 9987643321 12344689999999988765 48899999999999999999999998877655444433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=307.02 Aligned_cols=215 Identities=27% Similarity=0.410 Sum_probs=178.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|.+.+.||+|+||.||++++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ....|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 4689999999999999999999999999999999876543 44567788899999999999999999999987 45689
Q ss_pred EEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|||+++. +...... .. .+....++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 118 lv~e~~~~~~L~~~~~~-~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 118 VVLELCRRRSLLELHKR-RK-----ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEECCCTTCBHHHHHHH-HC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhc-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 999999864 4443322 11 3445558889999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
..... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+....+....+...
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 256 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred ccCcc-cccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC
Confidence 53322 234557899999999887644 889999999999999999999999887766555444433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=300.49 Aligned_cols=214 Identities=26% Similarity=0.384 Sum_probs=177.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEEE
Confidence 3689999999999999999999999999999999876543 44566788899999999999999999999976 45689
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
++|||++++.+........ .++...++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEEECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999998644333322211 34455588899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.... ......||+.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+....+....+.
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 228 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 228 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCcc-ccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 3322 23445789999999988764 48899999999999999999999998877655444433
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=298.58 Aligned_cols=211 Identities=32% Similarity=0.469 Sum_probs=175.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..++..||+|.+...... ..+.+.+|+++++.++||||+++++++.. ....++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEEE
Confidence 5799999999999999999999999999999998764432 35668889999999999999999999976 4568999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---CCCCcEEEEeeCCccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~ 271 (348)
|||+++ .+...+... . .++...++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~e~~~~~~L~~~~~~~-~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 85 MELCTGGELFERVVHK-R-----VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EECCCSCBHHHHHHHH-C-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeccCCCcHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 999986 444443321 1 24455588899999999999999999999999999999 7889999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
..... ......+|+.|+|||.+.+. ++.++||||||+++|+|++|+.||.+.+..+....+....
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (277)
T 3f3z_A 159 FKPGK--MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT 223 (277)
T ss_dssp CCTTS--CBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccCcc--chhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 75433 23455789999999988653 8999999999999999999999999887766655555443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=305.27 Aligned_cols=206 Identities=30% Similarity=0.568 Sum_probs=172.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+.+++.++ ||||+++++++........++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 7899999999999999999999999999999998643 2456888999999997 999999999998766677899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-cEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~ 273 (348)
+|||++++.+..... .+....++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 111 v~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999998755444332 244555888999999999999999999999999999999776 89999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC-CChhHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG-RTEVSATFCF 336 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~-~~~~~~~~~~ 336 (348)
.... .....+|..|+|||.+.+...++.++|||||||++|+|++|+.||.. ..+.+....+
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~ 244 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence 4332 34557899999999988756689999999999999999999999854 3444444433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=301.94 Aligned_cols=211 Identities=32% Similarity=0.485 Sum_probs=170.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||+|++..++..||+|++..... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 85 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVY 85 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEEE
Confidence 4789999999999999999999999999999999865332 112345688899999999999999999999774 5689
Q ss_pred EEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|||++++ +...+.. .. .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~~~l~~~l~~-~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK-LS-----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEECCCTTEEHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEEecCCCCcHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999864 4443322 11 2445558889999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.... .....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 220 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220 (279)
T ss_dssp -----------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred Cccc---ccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 4322 2455789999999988764 48899999999999999999999999877655544443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=307.55 Aligned_cols=216 Identities=33% Similarity=0.563 Sum_probs=178.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec---cCce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR---MSCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~~ 191 (348)
.++|++.+.||+|+||.||+|++..+|+.||||.+.... .......+.+|+++++.++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 378999999999999999999999999999999986433 344566778899999999999999999987653 1356
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|++|||+++++...+... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccCccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 8999999998877665432 345556888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCC---------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 272 FDPNHKH---------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 272 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
....... ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 6532211 123357899999999887655689999999999999999999999999887666655543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.92 Aligned_cols=210 Identities=28% Similarity=0.417 Sum_probs=161.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL------EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+++|++++||||+++++++..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--- 211 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 211 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES---
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 689999999999999999999999999999999876432 11223357789999999999999999999854
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC---cEEEEee
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADF 266 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~---~~kl~DF 266 (348)
...|+||||++++.+........ .++...++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred CceEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence 34799999998754433333222 345556888999999999999999999999999999997544 5999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
|+++..... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+.........
T Consensus 287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 355 (419)
T 3i6u_A 287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH
T ss_pred ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH
Confidence 999876533 22345678999999998853 34578899999999999999999999987654433333
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=313.42 Aligned_cols=202 Identities=24% Similarity=0.386 Sum_probs=169.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE------SVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++..+++.||||++........ ..+.+.+|+.+++.++||||+++++++.. .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~ 101 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN--Q 101 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--C
Confidence 679999999999999999999999999999999987643221 33456779999999999999999999976 4
Q ss_pred ceEEEEEeeccc--ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 190 CSLYLVFHYMEH--DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 190 ~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
...++||||+.. .+...+... . .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-P-----RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-C-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 568999999865 444444332 2 34455588899999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
+++....... .....||+.|+|||++.+...++.++||||||+++|+|++|+.||...
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 9988754332 345678999999999887664588999999999999999999999653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=298.56 Aligned_cols=210 Identities=22% Similarity=0.395 Sum_probs=172.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|++++++++||||+++++++.+. ...+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecC--CceEEE
Confidence 68999999999999999999974 6788999999765433 34678899999999999999999998774 448999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++ +...+..... .++...++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999874 5555443332 244555888999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
..........+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~ 221 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 221 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred cccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Confidence 3332334455678899999887544 8999999999999999999 999998877655544443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=323.70 Aligned_cols=212 Identities=31% Similarity=0.506 Sum_probs=173.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh-----------HHHHHHHHHHHHHHhcCCCceeeeeceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP-----------ESVKFMAREILILRRLDHPNVIKLEGLV 184 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~l~~~~ 184 (348)
++|++.++||+|+||+||+|++..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 68999999999999999999999999999999997654321 3356788999999999999999999999
Q ss_pred eeccCceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC---c
Q 018936 185 TSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---V 260 (348)
Q Consensus 185 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~---~ 260 (348)
.+ ....|+||||+++ .+...+... . .+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 116 ~~--~~~~~lv~e~~~gg~L~~~l~~~-~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 116 ED--KKYFYLVTEFYEGGELFEQIINR-H-----KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EC--SSEEEEEEECCTTCBHHHHHHHH-S-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred Ec--CCEEEEEEecCCCCcHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 87 4569999999987 444444321 1 345556888999999999999999999999999999998776 6
Q ss_pred EEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 261 LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 261 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..+....+...
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998875432 2455679999999998764 4899999999999999999999999998876665555544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=310.30 Aligned_cols=218 Identities=31% Similarity=0.492 Sum_probs=167.5
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc-----C
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM-----S 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~ 189 (348)
.++|++.+.||+|+||.||+|++..+|+.||||++...... .....++++.++.++||||+++++++.... .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 37899999999999999999999999999999998654322 223556888889999999999999986532 2
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCCEEECC-CCcEEEEee
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH--NNGVLHRDIKGSNLLIDD-DGVLKIADF 266 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~-~~~~kl~DF 266 (348)
.+.++||||+++++...+.... .....++...++.++.||+.||.||| +.||+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYY--RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred eeEEEEeecccccHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 3478999999988765443210 01113444557889999999999999 999999999999999996 899999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
|+++....... .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....++..
T Consensus 177 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 177 GSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp TTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 99987754332 345678999999999877666899999999999999999999999998887777776654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=298.29 Aligned_cols=213 Identities=23% Similarity=0.320 Sum_probs=177.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--cCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~ 193 (348)
..|++.+.||+|+||.||+|.+..++..||+|.+..........+.+.+|+.+++.++||||+++++++... ....++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 569999999999999999999999999999999987776777788899999999999999999999988653 345689
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEC-CCCcEEEEeeCCc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLID-DDGVLKIADFGLA 269 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kl~DFGla 269 (348)
+||||+++ .+...+.. .. .++...++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~-~~-----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR-FK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHH-cc-----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999977 44444432 11 3445558889999999999999999 99999999999998 7899999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
...... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.+..........+..
T Consensus 180 ~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 180 TLKRAS---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred cccccc---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence 765433 2345578999999998764 3899999999999999999999999886666555544443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=301.18 Aligned_cols=215 Identities=40% Similarity=0.675 Sum_probs=172.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--------
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR-------- 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-------- 187 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+... .....+.+.+|+++++.++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 6899999999999999999999999999999998754 345567788999999999999999999887432
Q ss_pred ----cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC-CCCcEE
Q 018936 188 ----MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLK 262 (348)
Q Consensus 188 ----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~k 262 (348)
.....|++|||+++++...+... .++...++.++.||+.||.|||++||+||||||+|||++ +++.+|
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccCceeEEeeccCCCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 23568999999998777766432 244555888999999999999999999999999999997 567999
Q ss_pred EEeeCCccccCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 263 IADFGLASFFDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 263 l~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
|+|||+++....... .......+|..|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+....++..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999987653321 12334567999999998876556899999999999999999999999998887766665543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=315.58 Aligned_cols=208 Identities=16% Similarity=0.179 Sum_probs=155.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc--CCCceeeee-------ceEe
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRL--DHPNVIKLE-------GLVT 185 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l--~hpniv~l~-------~~~~ 185 (348)
..|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 469999999999999999999999999999999987665 335566777886555555 699988754 3443
Q ss_pred eccC---------------ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHH-HHHHHHHHHHHHHHHHCCceecCCC
Q 018936 186 SRMS---------------CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKV-KCYMHQLLSGLEHCHNNGVLHRDIK 249 (348)
Q Consensus 186 ~~~~---------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~qi~~aL~~LH~~~ivHrDik 249 (348)
.... ...|+||||+++++...+................+ ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 3221 44899999999888777754322233333222222 4456999999999999999999999
Q ss_pred CCCEEECCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccC-cccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 250 GSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 250 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
|+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred HHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999876422 224566799999999875 235899999999999999999999999776
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.64 Aligned_cols=223 Identities=24% Similarity=0.386 Sum_probs=177.1
Q ss_pred CCCceeeeeeccCCceEEEEEE-----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 188 (348)
.++|++.+.||+|+||.||+|+ +..+++.||||+++... .....+.+.+|+++++++ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 3789999999999999999998 55677899999997543 344566788999999999 889999999998764
Q ss_pred CceEEEEEeeccc-ChhhhhcCCCCcC-----------------------------------------------------
Q 018936 189 SCSLYLVFHYMEH-DLAGLAASPEVKF----------------------------------------------------- 214 (348)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~~~~----------------------------------------------------- 214 (348)
....+++|||+++ ++...+.......
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 3457999999986 5555443322100
Q ss_pred -------CcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC-CCccccccc
Q 018936 215 -------TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVT 286 (348)
Q Consensus 215 -------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt 286 (348)
....++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......+|
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 011266677889999999999999999999999999999999999999999999987643322 223445678
Q ss_pred CcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHh
Q 018936 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 287 ~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~~ 340 (348)
+.|+|||++.+. .++.++||||||+++|+|++ |+.||.+....+.....+...
T Consensus 259 ~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 312 (359)
T 3vhe_A 259 LKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312 (359)
T ss_dssp GGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC
Confidence 999999988764 48999999999999999998 999998877665555555443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=307.07 Aligned_cols=221 Identities=20% Similarity=0.338 Sum_probs=158.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc--
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC-- 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-- 190 (348)
++|++.+.||+|+||.||+|++..++. .||+|+++.........+.+.+|+++++.++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 789999999999999999999776665 899999987655556678889999999999999999999998764331
Q ss_pred --eEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 191 --SLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 191 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
..+++|||+++ ++...+...........++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 24899999987 444444322111111235556688899999999999999999999999999999999999999999
Q ss_pred CccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 268 LASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 268 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
+++....... .......+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+..+....+.
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred ccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 9987643322 122334567889999988764 48999999999999999999 999998877665544443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=303.24 Aligned_cols=206 Identities=27% Similarity=0.409 Sum_probs=162.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence 4789999999999999999999989999999999875433 34456778899999999999999999999987 45689
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|||+++ .+...+... . .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~~-~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ-G-----PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHHH-C-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999987 554444321 1 3455568889999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
............+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp ------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred cccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 54433334456789999999988764 488999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=313.99 Aligned_cols=219 Identities=21% Similarity=0.332 Sum_probs=171.9
Q ss_pred CCceeeeeeccCCceEEEEEE-----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||+||+|+ +..++..||||.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 147 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--L 147 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--C
Confidence 789999999999999999999 44577899999986433 444556788899999999999999999998764 3
Q ss_pred eEEEEEeeccc-ChhhhhcCCCC-cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC---cEEEEe
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEV-KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIAD 265 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~---~~kl~D 265 (348)
..|+||||+++ ++...+..... ......+....++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 47999999976 55555433221 11123456666888999999999999999999999999999999555 599999
Q ss_pred eCCccccCCC-CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 018936 266 FGLASFFDPN-HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 266 FGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~ 338 (348)
||+++..... .........+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+..
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999865322 122234456789999999887644 8999999999999999998 9999998876655544443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=319.48 Aligned_cols=208 Identities=18% Similarity=0.253 Sum_probs=164.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHH---HHHHhcCCCceeeee-------ce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREI---LILRRLDHPNVIKLE-------GL 183 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~---~~l~~l~hpniv~l~-------~~ 183 (348)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+ ++++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4789999999999999999999888999999999986543 344567788999 555566899999998 44
Q ss_pred EeeccC---------------ceEEEEEeecccChhhhhcCCCCcCCc--chhhHHHHHHHHHHHHHHHHHHHHCCceec
Q 018936 184 VTSRMS---------------CSLYLVFHYMEHDLAGLAASPEVKFTE--PQFVYLKVKCYMHQLLSGLEHCHNNGVLHR 246 (348)
Q Consensus 184 ~~~~~~---------------~~~~lv~e~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 246 (348)
+..... ...|++|||+++++...+... ..+.+ ..+++..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 443211 037899999988777766532 11222 345556677899999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCc----------ccCCccccHHHHHHHHHH
Q 018936 247 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAE 316 (348)
Q Consensus 247 Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwSlGv~l~e 316 (348)
||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. ..++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986432 2345567 999999998765 258999999999999999
Q ss_pred HHhCCCCCCCCC
Q 018936 317 LLAGKPIMPGRT 328 (348)
Q Consensus 317 lltG~~pf~~~~ 328 (348)
|++|+.||.+.+
T Consensus 306 lltg~~Pf~~~~ 317 (377)
T 3byv_A 306 IWCADLPITKDA 317 (377)
T ss_dssp HHHSSCCC----
T ss_pred HHHCCCCCcccc
Confidence 999999997644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=295.75 Aligned_cols=211 Identities=19% Similarity=0.324 Sum_probs=172.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++ .++..||+|+++..... .+.+.+|+++++.++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccC--CceEE
Confidence 37899999999999999999986 46778999999765433 34578899999999999999999998764 45899
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||++++ +...+.... ..++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEEccCCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 99999765 555443221 134556688899999999999999999999999999999999999999999998775
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
...........+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 219 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred hhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH
Confidence 54333334445677899999887644 8899999999999999999 999998877665544433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=318.76 Aligned_cols=207 Identities=25% Similarity=0.406 Sum_probs=170.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+++++.++||||+++++++........++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 689999999999999999999999999999999875432 2235567789999999999999999999987666678999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE----CCCCcEEEEeeCCcc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI----DDDGVLKIADFGLAS 270 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll----~~~~~~kl~DFGla~ 270 (348)
|||+++ ++...+...... ..++...++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999986 444444332111 125566688899999999999999999999999999999 777889999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCc-------ccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGA-------TDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
...... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 775432 23456789999999987541 347789999999999999999999997543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.44 Aligned_cols=201 Identities=19% Similarity=0.249 Sum_probs=168.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+|+.||+|++..... .+.+.+|+.+++.+ +|+|++++++++.. ....++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~l 83 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 83 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEE
Confidence 689999999999999999999999999999999865432 23466799999999 89999999998876 456899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc-----EEEEeeCCc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV-----LKIADFGLA 269 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~-----~kl~DFGla 269 (348)
+|||+++++...+..... .++...++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 84 v~e~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 84 VIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEecCCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999997777776654322 2455568889999999999999999999999999999987776 999999999
Q ss_pred cccCCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 270 SFFDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 270 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
+........ ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 877543221 234557899999999887654 8999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=300.46 Aligned_cols=207 Identities=29% Similarity=0.514 Sum_probs=152.1
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
..++|++.+.||+|+||.||+|++..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeE
Confidence 44789999999999999999999989999999999865322 11224678889999999999999999999877 4568
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|++|||+++ .+...+..... .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVK-----PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 999999976 45444443322 344555888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
...... ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||...+.
T Consensus 162 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 162 LKMPHE-KHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred ccCCCC-cceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 653322 12345689999999988764 488999999999999999999999976543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=295.53 Aligned_cols=209 Identities=31% Similarity=0.492 Sum_probs=172.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.. ....|++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 5799999999999999999999889999999998755432 345678899999999999999999999877 4568999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ .+...+. ... .++...++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~-~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 84 LEYCSGGELFDRIE-PDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EECCTTEEGGGGSB-TTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEecCCCcHHHHHh-hcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 999987 4444332 222 345556888999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 275 NHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 275 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
... .......||+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 217 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 221 22345578999999999876554477999999999999999999999876654333
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=303.27 Aligned_cols=218 Identities=39% Similarity=0.667 Sum_probs=177.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEc-cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEee---c
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDM-LTGKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTS---R 187 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---~ 187 (348)
.++|++.+.||+|+||.||+|++. .+|+.||+|+++...........+.+|+.+++.+ +||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 378999999999999999999985 6789999999876543322223455677777666 89999999999863 1
Q ss_pred cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 188 MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
.....+++|||+++++...+..... ..++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCCCCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 3456899999999887776653221 124555688899999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
++....... ......+|+.|+|||++.+.. ++.++||||||+++|+|++|++||.+.++.+....++..
T Consensus 166 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 166 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccCCC--CccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 998764321 234567899999999887654 899999999999999999999999999888777776654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=315.46 Aligned_cols=205 Identities=26% Similarity=0.484 Sum_probs=165.6
Q ss_pred CCceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++. .+|+.||||+++.... .....+.+.+|+++++.+ +||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 131 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 131 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--
Confidence 68999999999999999999974 4889999999865332 112234466799999999 699999999998774
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...|+||||+++ .+...+.. .. .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~-~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQ-RE-----RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHH-HS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceEEEEeecCCCCCHHHHHHH-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 468999999987 44444432 11 344556888999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
++.............+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 987654333334456789999999998752 347889999999999999999999997644
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=303.26 Aligned_cols=203 Identities=26% Similarity=0.462 Sum_probs=164.7
Q ss_pred CCceeeeeeccCCceEEEEEE----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||+||+|+ +..+++.||+|++... .....+.+.+|+++++.++||||+++++++.......
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 689999999999999999998 5678999999998643 3555677889999999999999999999987655566
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.++||||+++ ++...+..... .++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 8999999976 55555443222 35555688899999999999999999999999999999999999999999998
Q ss_pred ccCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 271 FFDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 271 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
....... .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCC
Confidence 7654322 1123345677899999887654 89999999999999999999998854
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=308.15 Aligned_cols=196 Identities=28% Similarity=0.435 Sum_probs=162.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||+|+++.+|+.||+|++...... ..+|++++.++ +||||+++++++.+ ....|+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 93 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVYV 93 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEE
Confidence 6799999999999999999999999999999999765432 23588888888 79999999999976 456999
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC----CcEEEEeeCCc
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD----GVLKIADFGLA 269 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~----~~~kl~DFGla 269 (348)
||||+++ ++...+... . .++...++.++.||+.||.|||++||+||||||+|||+.++ +.+||+|||++
T Consensus 94 v~E~~~gg~L~~~i~~~-~-----~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ-K-----FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EECCCCSCBHHHHHHTC-T-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEeCCCCCcHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999986 555544432 2 34555688899999999999999999999999999998543 35999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
+...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.
T Consensus 168 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 168 KQLRAEN-GLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp EECBCTT-CCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccCcCCC-CceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 8765432 223456789999999988764 4889999999999999999999999763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=298.06 Aligned_cols=217 Identities=24% Similarity=0.375 Sum_probs=166.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++. ..||+|+++.........+.+.+|+++++.++||||++++++... ...+++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~lv 97 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIV 97 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---CccEEE
Confidence 78999999999999999999742 359999998777677777889999999999999999999996543 347899
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++ +...+..... .++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 9999864 4444433322 345555888999999999999999999999999999999999999999999986643
Q ss_pred C-CCCCcccccccCccccccccc--CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccC
Q 018936 275 N-HKHPMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343 (348)
Q Consensus 275 ~-~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~ 343 (348)
. .........||+.|+|||.+. ....++.++||||||+++|+|++|+.||.+..+.+....++......
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence 2 122234557899999999885 23447889999999999999999999999887777766666554433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.10 Aligned_cols=211 Identities=25% Similarity=0.418 Sum_probs=171.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++ .++..||||.++... ...+.+.+|+++|+.++||||+++++++.. ...|+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~~l 259 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 259 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred hHHeEEEEEcccCCceEEEEEEE-CCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC---CccEE
Confidence 37899999999999999999996 457889999997644 235678899999999999999999999863 34799
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+.+ ++...+..... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 260 v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999986 55555543211 123444578899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
...........+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~ 399 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 3322222334467889999988754 48999999999999999999 999999888766554443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.96 Aligned_cols=202 Identities=24% Similarity=0.368 Sum_probs=165.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc--CceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM--SCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~~ 192 (348)
.++|++.+.||+|+||+||+|++ .++.||||++.... .......+|+.++++++||||+++++++.... ...+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 37899999999999999999985 48999999986532 33445566899999999999999999997754 3457
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCCEEECCCCcE
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN----------GVLHRDIKGSNLLIDDDGVL 261 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----------~ivHrDikp~NIll~~~~~~ 261 (348)
++||||+++ ++...+... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 999999987 555554322 245556888999999999999999 99999999999999999999
Q ss_pred EEEeeCCccccCCCCC-CCcccccccCcccccccccCc----ccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 262 KIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGA----TDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 262 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
||+|||+++....... .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+..
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999987754332 223446789999999998763 335678999999999999999999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=306.36 Aligned_cols=198 Identities=29% Similarity=0.512 Sum_probs=146.2
Q ss_pred CCceee---eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCce
Q 018936 116 DSFEKI---DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~---~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 191 (348)
++|++. +.||+|+||.||+|++..+|+.||||++.. .....+.+|+.+++.+. ||||+++++++.+ ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCE
Confidence 356665 789999999999999999999999999864 23456778999999997 9999999999987 456
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC---cEEEEeeC
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFG 267 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~---~~kl~DFG 267 (348)
.|+||||+++ .+...+.. .. .++...++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKK-KK-----HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EEEEECCCCSCBHHHHHHH-CS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEEEEccCCCcHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 8999999987 44444432 22 345556888999999999999999999999999999998665 89999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
+++...... ......+||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+
T Consensus 155 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 155 FARLKPPDN-QPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp TCEECCC-----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cceecCCCC-CcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 998765432 223456789999999988764 48999999999999999999999997644
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=299.32 Aligned_cols=211 Identities=32% Similarity=0.483 Sum_probs=174.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||+|++..++..||+|++...... ....+.+.+|+++++.++||||+++++++.. ....|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEE
Confidence 37899999999999999999999899999999998653221 1224568889999999999999999999877 45689
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|||+++ .+...+... . .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~-~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH-G-----RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEECCCTTEEHHHHHHHH-S-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999976 554444322 1 2445558889999999999999999999999999999999999999999999766
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.... .....|++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+..+....+.
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 225 (284)
T 2vgo_A 165 PSLR---RRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225 (284)
T ss_dssp SSSC---BCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cccc---cccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence 4322 24457899999999887654 8899999999999999999999998877665554444
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=303.27 Aligned_cols=209 Identities=25% Similarity=0.365 Sum_probs=170.0
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
...++|++.+.||+|+||.||+|++ .+|+.||+|.+.... ....+.+.+|+++++.++||||+++++++... ...
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 110 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER--NEM 110 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--TCC
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CeE
Confidence 3457899999999999999999995 578999999876543 33466788999999999999999999998764 458
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++||||++++.+....... ......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEEEECCTTCBTGGGSSSS-CCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHhcc-CCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999864443333221 112224566668889999999999999999999999999999999999999999999875
Q ss_pred CCCC-CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 273 DPNH-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 273 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.... ........||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+..
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred ccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 4322 2223445689999999988764 48999999999999999999999997644
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.26 Aligned_cols=201 Identities=23% Similarity=0.360 Sum_probs=158.5
Q ss_pred CCCceee-eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHH-hcCCCceeeeeceEee--ccCc
Q 018936 115 ADSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR-RLDHPNVIKLEGLVTS--RMSC 190 (348)
Q Consensus 115 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~--~~~~ 190 (348)
.++|.+. +.||+|+||+||+|++..+|+.||||++... ..+.+|++++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3678887 7899999999999999999999999998632 24567888875 4589999999998865 2245
Q ss_pred eEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---CCcEEEEee
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADF 266 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kl~DF 266 (348)
.+|+||||+++ ++...+.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 68999999986 5555554321 123556668899999999999999999999999999999997 789999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
|+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 209 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp TTCEECC-------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ccccccCCCC--ccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9998764332 23566789999999988764 489999999999999999999999977654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.92 Aligned_cols=212 Identities=32% Similarity=0.513 Sum_probs=174.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC--Ch----HHHHHHHHHHHHHHhc-CCCceeeeeceEeecc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EP----ESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~--~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 188 (348)
++|++.+.||+|+||.||+|++..+|+.||||+++.... .. ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 579999999999999999999988999999999976542 11 2245678899999999 89999999999876
Q ss_pred CceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 189 SCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
....|+||||+++ .+...+.. .. .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~-~~-----~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTE-KV-----ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 4569999999987 44444432 11 34555688899999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccC-----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
++........ .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 246 FSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9988754332 345678999999998753 2247889999999999999999999998877655444443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=293.29 Aligned_cols=204 Identities=24% Similarity=0.363 Sum_probs=167.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHH-----HHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESV-----KFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
.++|++.+.||+|+||.||+|++..+++.||+|++.......... +.+.+|+++++.++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 378999999999999999999999999999999987654422211 6788999999999999999999988653
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEECCCCc-----E
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGV-----L 261 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~-----~ 261 (348)
.+++|||+++ ++...+..... .++...++.++.|++.||.|||++| |+||||||+|||++.++. +
T Consensus 96 --~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 --PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --TEEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --CeEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 2699999985 56565554433 3445558889999999999999999 999999999999988776 9
Q ss_pred EEEeeCCccccCCCCCCCcccccccCcccccccccC-cccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 262 KIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 262 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
||+|||+++.... ......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+..+
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 9999999985432 2345678999999998842 3347889999999999999999999998765443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=302.25 Aligned_cols=216 Identities=22% Similarity=0.296 Sum_probs=173.7
Q ss_pred CCceee-eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEE
Q 018936 116 DSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~-~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 193 (348)
+.|.+. +.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.+ .||||+++++++.. ....|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~~ 105 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEII 105 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeEE
Confidence 568887 899999999999999999999999999987655555567788999999999 56999999999876 45699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---CCcEEEEeeCCcc
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLAS 270 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kl~DFGla~ 270 (348)
+||||+.++.+....... ....++...++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 106 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred EEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 999999874443332221 1123555668889999999999999999999999999999997 7899999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 248 (327)
T 3lm5_A 183 KIGHACE--LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248 (327)
T ss_dssp EC-----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccCCccc--cccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence 7753322 3456789999999988764 4899999999999999999999999988876665555443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=295.66 Aligned_cols=209 Identities=26% Similarity=0.425 Sum_probs=170.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 57999999999999999999998899999999998764322 235678899999999999999999999877 456
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC----cEEEEee
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADF 266 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~----~~kl~DF 266 (348)
.+++|||+++ .+...+.. .. .++...++.++.||+.||.|||+.||+||||||+||+++.++ .+||+||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~-~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE-KE-----SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 8999999975 55444432 11 345556888999999999999999999999999999999877 8999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
|++........ .....+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 222 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTN 222 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence 99987654322 3445689999999988764 489999999999999999999999988776554433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=297.95 Aligned_cols=212 Identities=21% Similarity=0.354 Sum_probs=160.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
.++|++.+.||+|+||.||+|++..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Cc
Confidence 37899999999999999999997653 4579999886432 44556778899999999999999999998854 34
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.|+||||+++ .+...+..... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 7899999986 55554433222 34455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
..............+|+.|+|||.+.+. .++.++||||||+++|+|++ |.+||.+.+..+....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i 230 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230 (281)
T ss_dssp --------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred ccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH
Confidence 7754433333344567889999988754 48899999999999999997 99999887765544433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=300.55 Aligned_cols=216 Identities=30% Similarity=0.441 Sum_probs=174.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+++++.++||||+++++++........|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 689999999999999999999989999999999865432 123456788999999999999999999998665556789
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||+++++...+.... ...++...++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCGMQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEEHHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCCHHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999988666554321 1234555688899999999999999999999999999999999999999999998765
Q ss_pred CCCC-CCcccccccCcccccccccCcc-cCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 274 PNHK-HPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 274 ~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
.... .......||+.|+|||++.+.. .++.++||||||+++|+|++|+.||.+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 224 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Confidence 3322 2233456899999999886532 246799999999999999999999988765544333
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=309.12 Aligned_cols=201 Identities=27% Similarity=0.441 Sum_probs=171.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--------CCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD--------HPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~~~ 187 (348)
++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+++++.++ ||||+++++++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 6899999999999999999999999999999998643 345667888999999985 78899999988743
Q ss_pred --cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCC-----
Q 018936 188 --MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDG----- 259 (348)
Q Consensus 188 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~----- 259 (348)
.....|+||||++++++..+..... ..++...++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 3457899999999888877654321 1345556888999999999999998 999999999999999775
Q ss_pred --------------------------------------------cEEEEeeCCccccCCCCCCCcccccccCcccccccc
Q 018936 260 --------------------------------------------VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295 (348)
Q Consensus 260 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 295 (348)
.+||+|||++...... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876433 3455789999999998
Q ss_pred cCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 296 ~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.+.. ++.++|||||||++|+|++|+.||.+.+
T Consensus 266 ~~~~-~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 266 IGSG-YNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 8754 8999999999999999999999998755
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=314.56 Aligned_cols=208 Identities=24% Similarity=0.413 Sum_probs=170.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||||.++.. ......+.+.+|+++|+.++||||+++++++... ...|+|
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv 190 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIV 190 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSCEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCcEEE
Confidence 6899999999999999999999889999999998643 3445566788899999999999999999999764 348999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ ++...+..... .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999975 55555432211 344556888999999999999999999999999999999999999999999986543
Q ss_pred CCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 275 NHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 275 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
..... .....+++.|+|||.+.+. .++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~ 324 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 22111 1122357789999988754 48899999999999999998 9999988776543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=296.61 Aligned_cols=211 Identities=20% Similarity=0.368 Sum_probs=169.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++ .++..||+|++...... .+.+.+|+++++.++||||+++++++... ...++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEE-TTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEE-cCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecC--CCeEE
Confidence 37899999999999999999986 47788999999765433 34578899999999999999999998764 45899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ .+...+..... .++...++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999975 55555543222 34555688899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
...........+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 235 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred ccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh
Confidence 43322233445678899999887644 8999999999999999998 999998877665554443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=305.89 Aligned_cols=219 Identities=24% Similarity=0.425 Sum_probs=174.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
.++|++.+.||+|+||.||+|++. .+++.||+|.++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 122 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 122 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--
Confidence 378999999999999999999976 345899999987543 445567789999999999999999999999774
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCc------------------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVK------------------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKG 250 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp 250 (348)
...|+||||+++ ++...+...... .....++...++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 458999999987 555544321100 0013456667888999999999999999999999999
Q ss_pred CCEEECCCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 018936 251 SNLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 328 (348)
Q Consensus 251 ~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~ 328 (348)
+|||++.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999987643221 1233456788999999887644 8999999999999999999 999998877
Q ss_pred hhHHHHHHH
Q 018936 329 EVSATFCFV 337 (348)
Q Consensus 329 ~~~~~~~~i 337 (348)
..+....+.
T Consensus 282 ~~~~~~~~~ 290 (343)
T 1luf_A 282 HEEVIYYVR 290 (343)
T ss_dssp HHHHHHHHH
T ss_pred hHHHHHHHh
Confidence 655444443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=310.45 Aligned_cols=211 Identities=23% Similarity=0.420 Sum_probs=160.1
Q ss_pred CCceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||.||+|++. .++..||||.++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 121 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV 121 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--Cce
Confidence 68999999999999999999876 457789999986543 445567788999999999999999999999764 458
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
++||||+++ ++...+..... .++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 999999975 55555543322 344555888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCC--cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018936 272 FDPNHKHP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335 (348)
Q Consensus 272 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~ 335 (348)
........ .....+++.|+|||++.+. .++.++||||||+++|||++ |+.||.+.+..+....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~ 262 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262 (373)
T ss_dssp -----------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH
T ss_pred cccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 75432221 1222347789999988764 48999999999999999998 9999988776544433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.55 Aligned_cols=215 Identities=16% Similarity=0.233 Sum_probs=178.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++ ++..||+|++..........+.+.+|+.+++.++||||+++++++........++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 37899999999999999999986 4889999999887767777788999999999999999999999998765567899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|||+++ ++...+..... ..++...++.++.||+.||.|||++| |+||||||+||+++.++.++|+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999986 66665543221 13455568889999999999999999 99999999999999999999999998764
Q ss_pred cCCCCCCCcccccccCcccccccccCccc--CCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
.. .....+|+.|+|||.+.+... ++.++||||||+++|+|++|+.||.+.+..+....+.....
T Consensus 163 ~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 228 (271)
T 3kmu_A 163 FQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228 (271)
T ss_dssp TS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC
T ss_pred ec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC
Confidence 32 234467999999999876431 23379999999999999999999998887776666655543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=296.62 Aligned_cols=210 Identities=28% Similarity=0.424 Sum_probs=166.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..++..||+|.+...... ...+.+.+|+++++.++||||+++++++.. ....++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 98 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIV 98 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEEE
Confidence 6799999999999999999999999999999998765432 335678889999999999999999999976 4568999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---CCCCcEEEEeeCCccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~ 271 (348)
|||+++ .+...+..... ....++...++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++..
T Consensus 99 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 99 METCEGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp ECCCSCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999986 45444422100 00134455588899999999999999999999999999999 4567899999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
..... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.+.+..+...
T Consensus 177 ~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~ 235 (285)
T 3is5_A 177 FKSDE--HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235 (285)
T ss_dssp ------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cCCcc--cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence 64332 2345578999999998754 48899999999999999999999998876554443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=293.24 Aligned_cols=212 Identities=28% Similarity=0.439 Sum_probs=162.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE--PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
.++|++.+.||+|+||.||+|++ +|+.||+|+++..... ....+.+.+|+++++.++||||+++++++... ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PNL 81 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----C
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cce
Confidence 47899999999999999999985 4889999998765332 23356788999999999999999999998774 458
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCCEEECC--------CCcE
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG---VLHRDIKGSNLLIDD--------DGVL 261 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~--------~~~~ 261 (348)
+++|||++++.+....... .++...++.++.|++.||.|||++| |+||||||+|||++. ++.+
T Consensus 82 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EEEEECCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEEEEcCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 9999999865554443321 3445558889999999999999999 999999999999986 6789
Q ss_pred EEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 262 KIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 262 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
||+|||++....... .....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.......+..+.
T Consensus 156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred EEccCCccccccccc---ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 999999998764332 2345789999999988764 48999999999999999999999999887766655554443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.97 Aligned_cols=209 Identities=30% Similarity=0.451 Sum_probs=170.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....|++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEEE
Confidence 579999999999999999999999999999999975432 234567889999999999999999999876 4568999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---CCCCcEEEEeeCCccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~ 271 (348)
|||+++ .+...+... . .++...++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~e~~~~~~L~~~l~~~-~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 85 MQLVSGGELFDRILER-G-----VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp ECCCCSCBHHHHHHHH-S-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEcCCCccHHHHHHHc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 999976 554444321 1 24455588899999999999999999999999999999 7889999999999976
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.... ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (304)
T 2jam_A 159 EQNG---IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221 (304)
T ss_dssp CCCB---TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cCCC---ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 5332 23445689999999988764 489999999999999999999999988776554444443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=298.48 Aligned_cols=220 Identities=21% Similarity=0.300 Sum_probs=166.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEcc---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC--
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS-- 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-- 189 (348)
.++|++.+.||+|+||.||+|++.. ++..||+|.++.........+.+.+|+.+++.++||||+++++++.....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 3789999999999999999998765 45689999998776666777889999999999999999999999876433
Q ss_pred -ceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 190 -CSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 190 -~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
...+++|||+++ .+...+...........++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 246999999986 454444322222222345666789999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018936 268 LASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335 (348)
Q Consensus 268 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~ 335 (348)
++......... ......+++.|+|||.+.+. .++.++||||||+++|+|++ |.+||.+.+..+....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred cceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 99876433221 12334568889999988764 48999999999999999999 9999988776544433
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=295.34 Aligned_cols=210 Identities=28% Similarity=0.454 Sum_probs=164.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 88 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFFM 88 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEEE
Confidence 689999999999999999999988999999999865322 12235578889999999999999999999877 456899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+++ .+...+... . .++...++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~-~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH-G-----RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH-C-----SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999976 555544322 1 24455588899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
... ......+|+.|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+..+....
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 222 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK 222 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 432 233456899999999988755346899999999999999999999988765444333
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=302.39 Aligned_cols=207 Identities=29% Similarity=0.474 Sum_probs=164.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL------EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+++++.++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 679999999999999999999999999999999875432 122234577899999999999999999998653
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc---EEEEe
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIAD 265 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kl~D 265 (348)
..|+||||+++ .+...+.. .. .++...++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~-~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVG-NK-----RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -SEEEEEECCTTEETHHHHST-TC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -ceEEEEecCCCCcHHHHHhc-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 27999999986 44444432 22 3445558889999999999999999999999999999987654 99999
Q ss_pred eCCccccCCCCCCCcccccccCccccccccc--CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 266 FGLASFFDPNHKHPMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 266 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
||+++...... ......||+.|+|||++. +...++.++||||||+++|+|++|+.||.+.......
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 228 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence 99998764321 123456899999999874 2345889999999999999999999999776544333
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=302.34 Aligned_cols=209 Identities=22% Similarity=0.359 Sum_probs=165.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKI----VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||+||+|++..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 88 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---SS 88 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---SS
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---Cc
Confidence 6899999999999999999998888876 77777654322 2223456679999999999999999998864 34
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.++||||+.+ ++...+......++ ...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALG-----PQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSC-----TTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred cEEEEEeCCCCCHHHHHHHccccCC-----HHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 8899999985 55555544333333 33478899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 271 FFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 271 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
........ ......+|..|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 228 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH
T ss_pred ccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH
Confidence 87544332 234456788999999987644 8999999999999999999 999998876544433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=296.66 Aligned_cols=207 Identities=22% Similarity=0.408 Sum_probs=173.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++..++..||+|.+.... ...+.+.+|+++++.++||||+++++++... ...++
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 86 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYI 86 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCEEE
Confidence 378999999999999999999999999999999986543 3456788899999999999999999998764 45899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ .+...+.... ...++...++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHCC----TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhcc----cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999985 5555543221 1235555688899999999999999999999999999999999999999999998876
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
...........+|+.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.+..+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~ 220 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 5443334445668889999988764 48999999999999999999 999998866543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=305.67 Aligned_cols=213 Identities=25% Similarity=0.394 Sum_probs=173.2
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 187 (348)
++|++.+.||+|+||.||+|++.. ++..||+|+++.. ........+.+|+++++.+ +||||+++++++...
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 789999999999999999998653 3358999998654 3445567788999999999 999999999999774
Q ss_pred cCceEEEEEeeccc-ChhhhhcCCCC----------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 188 MSCSLYLVFHYMEH-DLAGLAASPEV----------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
...++||||+++ ++...+..... ......++...++.++.||+.||.|||+.||+||||||+|||++
T Consensus 148 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 148 --GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred --CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 448999999987 55555433221 11123466777899999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 257 DDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999987654322 2234446688999999988754 8999999999999999999 9999988765443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=320.12 Aligned_cols=207 Identities=22% Similarity=0.412 Sum_probs=171.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++..++..||||.++.... ..+.+.+|+.+|++++||||+++++++... ...|+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEE
Confidence 3679999999999999999999988899999999875443 356688899999999999999999999774 34899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ ++...+.... ...+....+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999985 5555554221 1234555688899999999999999999999999999999999999999999999775
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVS 331 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~ 331 (348)
...........+++.|+|||.+.+. .++.++|||||||++|||++ |+.||.+.+..+
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~ 427 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 4333223344567889999988764 48999999999999999999 999998876543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=292.39 Aligned_cols=215 Identities=29% Similarity=0.459 Sum_probs=176.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC---C----hHHHHHHHHHHHHHHhcC-CCceeeeeceEee
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---E----PESVKFMAREILILRRLD-HPNVIKLEGLVTS 186 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~---~----~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 186 (348)
.++|++.+.||+|+||.||+|++..+|+.||||++..... . ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 3789999999999999999999999999999999976542 1 233556788999999995 9999999999876
Q ss_pred ccCceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEe
Q 018936 187 RMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265 (348)
Q Consensus 187 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~D 265 (348)
....++||||+++ .+...+.. .. .++...++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~-~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTE-KV-----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred --CCeEEEEEeccCCCcHHHHHhc-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence 4569999999986 55554432 11 344556888999999999999999999999999999999999999999
Q ss_pred eCCccccCCCCCCCcccccccCccccccccc-----CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 266 FGLASFFDPNHKHPMTSRVVTLWYRPPELLL-----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 266 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
||++........ .....+|+.|+|||++. ....++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 999987754322 34557899999999875 2334788999999999999999999999887765555444443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=292.74 Aligned_cols=208 Identities=28% Similarity=0.500 Sum_probs=174.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++... ...|+|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 98 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWII 98 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence 6799999999999999999999999999999999765533 3466788999999999999999999999874 468999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++..+..+... . .++...+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 99 ~e~~~~~~L~~~~~~-~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-G-----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EECCTTEEHHHHHTT-S-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEeCCCCcHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999987444333322 1 3455568889999999999999999999999999999999999999999999876533
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
.. ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||......+...
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 229 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred cc-ccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH
Confidence 21 23455789999999988765 48899999999999999999999998876654443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.13 Aligned_cols=222 Identities=25% Similarity=0.420 Sum_probs=175.2
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 121 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 121 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--
Confidence 78999999999999999999963 456789999997543 333456788999999999 999999999998774
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCcCCc-----------------chhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVKFTE-----------------PQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGS 251 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~ 251 (348)
...++||||+++ ++...+......+.. ..++...++.++.||+.||.|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 458999999976 666655543322111 23566678889999999999999999999999999
Q ss_pred CEEECCCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCCh
Q 018936 252 NLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329 (348)
Q Consensus 252 NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~ 329 (348)
|||++.++.+||+|||++......... ......+|+.|+|||.+.+. .++.++||||||+++|+|+| |+.||.+...
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999876433222 12344568899999988764 48999999999999999998 9999998876
Q ss_pred hHHHHHHHHHhc
Q 018936 330 VSATFCFVLNLI 341 (348)
Q Consensus 330 ~~~~~~~i~~~~ 341 (348)
.+....++....
T Consensus 281 ~~~~~~~~~~~~ 292 (344)
T 1rjb_A 281 DANFYKLIQNGF 292 (344)
T ss_dssp SHHHHHHHHTTC
T ss_pred HHHHHHHHhcCC
Confidence 666666655543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=292.86 Aligned_cols=202 Identities=23% Similarity=0.273 Sum_probs=167.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+|+.||+|++...... +.+.+|+.+++.++|++++..+..+... ....+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEEE
Confidence 6899999999999999999999999999999998765432 2477899999999998877776665443 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC---CCCcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID---DDGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kl~DFGla~~~ 272 (348)
|||+++++...+..... .++...++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 84 ~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 84 MELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEecCCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99997777776653322 344555888999999999999999999999999999994 8889999999999876
Q ss_pred CCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 273 DPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 273 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
...... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 543321 134557899999999988754 8999999999999999999999998743
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=298.14 Aligned_cols=204 Identities=28% Similarity=0.423 Sum_probs=161.5
Q ss_pred CCCceee-eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 115 ADSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
.+.|++. +.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++.++ +||||+++++++... ...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEE
Confidence 3679995 78999999999999998999999999997653 23356678899999985 799999999999874 569
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc---EEEEeeCC
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFGL 268 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kl~DFGl 268 (348)
|+||||+++ .+...+... . .++...++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR-R-----HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH-S-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEcCCCCcHHHHHhcc-C-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 999999985 555444321 1 3445558889999999999999999999999999999998776 99999999
Q ss_pred ccccCCCCC------CCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 269 ASFFDPNHK------HPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 269 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
+........ .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 986542211 11234468999999998864 1347889999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=315.80 Aligned_cols=209 Identities=23% Similarity=0.400 Sum_probs=163.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++. .+..||||+++..... .+.+.+|+++|++++||||+++++++.. ...|+|
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv 256 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 256 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred hHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEE
Confidence 68999999999999999999974 4567999998765433 4568889999999999999999999865 347999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ ++...+.... ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999986 5555443211 11244556888999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
..........++..|+|||.+.+. .++.++||||||+++|||++ |+.||.+.+..+....+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 394 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394 (452)
T ss_dssp ----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 332223344567889999988764 48999999999999999999 99999988766554443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=304.78 Aligned_cols=213 Identities=27% Similarity=0.466 Sum_probs=177.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CC-----ceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HP-----NVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.++ |+ +|+++++++...
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-- 128 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-- 128 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--
Confidence 7899999999999999999999999999999998642 344566778999988885 55 489999988874
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCCEEEC--CCCcEEEEe
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH--NNGVLHRDIKGSNLLID--DDGVLKIAD 265 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~--~~~~~kl~D 265 (348)
...|+||||+++++...+..... ..++...++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCCCCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 56999999999988877654321 12445568889999999999999 46999999999999995 477899999
Q ss_pred eCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 266 FGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 266 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
||+++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+....++...-.
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc----cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999877432 34567899999999988754 899999999999999999999999999988888777765443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.68 Aligned_cols=204 Identities=26% Similarity=0.422 Sum_probs=171.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..++..||+|++.... .....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 109 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 109 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEEEEE
Confidence 68999999999999999999999999999999997653 455667888999999999999999999999874 569999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
|||+++ ++...+.. .. .++...+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 110 ~e~~~~~~L~~~l~~-~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK-AG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp ECCCTTCBHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EECCCCCCHHHHHHH-cC-----CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999987 55444432 11 244555888999999999999996 99999999999999999999999999997653
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...+..+.
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 184 DSM---ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp HHC-------CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred ccc---ccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 221 2345789999999998775 489999999999999999999999988765443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.82 Aligned_cols=201 Identities=18% Similarity=0.261 Sum_probs=164.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTG-------KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR 187 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g-------~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 187 (348)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... ....+.+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 378999999999999999999988777 479999986432 34466788999999999999999999999874
Q ss_pred cCceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc------
Q 018936 188 MSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV------ 260 (348)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~------ 260 (348)
...++||||+++ ++...+..... .++...++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 85 --~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 --DENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp --TCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred --CCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 347899999985 55555543221 2455558889999999999999999999999999999998887
Q ss_pred --EEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCCCh
Q 018936 261 --LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTE 329 (348)
Q Consensus 261 --~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~~~ 329 (348)
+||+|||++..... .....+|+.|+|||.+.+...++.++||||||+++|+|++| .+||.....
T Consensus 158 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp CEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 99999999875432 23445789999999988755689999999999999999995 555555443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=297.20 Aligned_cols=212 Identities=23% Similarity=0.383 Sum_probs=171.0
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||.||+|++. .++..||+|+++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 99 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD--G 99 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--C
Confidence 78999999999999999999873 456899999986443 455667788999999999999999999998764 4
Q ss_pred eEEEEEeeccc-ChhhhhcCCCCc------------------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEVK------------------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGS 251 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~------------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~ 251 (348)
..+++|||+++ .+...+...... .....++...++.++.||+.||.|||++||+||||||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 58999999985 555444322110 01123566678899999999999999999999999999
Q ss_pred CEEECCCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCCh
Q 018936 252 NLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329 (348)
Q Consensus 252 NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~ 329 (348)
|||++.++.+||+|||++......... ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+.
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876443221 22334568889999988764 48999999999999999999 9999988765
Q ss_pred hH
Q 018936 330 VS 331 (348)
Q Consensus 330 ~~ 331 (348)
.+
T Consensus 259 ~~ 260 (314)
T 2ivs_A 259 ER 260 (314)
T ss_dssp GG
T ss_pred HH
Confidence 43
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=304.67 Aligned_cols=204 Identities=21% Similarity=0.214 Sum_probs=160.1
Q ss_pred CCceeeeeeccCCceEEEEEEEcc---CCcEEEEEEeecCCCCh---------HHHHHHHHHHHHHHhcCCCceeeeece
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEP---------ESVKFMAREILILRRLDHPNVIKLEGL 183 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~---~g~~vAvK~i~~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~l~~~ 183 (348)
++|++.+.||+|+||.||+|++.. ++..||+|.+....... .....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 689999999999999999999876 78899999987653211 011235568888999999999999999
Q ss_pred Eeec--cCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC--
Q 018936 184 VTSR--MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-- 259 (348)
Q Consensus 184 ~~~~--~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-- 259 (348)
+... .....|+||||+++++...+.... .++...++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 8763 246789999999666666554322 345566889999999999999999999999999999999877
Q ss_pred cEEEEeeCCccccCCCCC------CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 260 VLKIADFGLASFFDPNHK------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 260 ~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
.+||+|||+++.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999987643221 112445789999999998875 489999999999999999999999965
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=296.55 Aligned_cols=221 Identities=21% Similarity=0.313 Sum_probs=177.5
Q ss_pred CCceeeeeeccCCceEEEEEEE-----ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++ ..+++.||+|.++... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 99 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-- 99 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC--
Confidence 6899999999999999999984 4567899999997543 344567788999999999 999999999999774
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCc------------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVK------------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
...+++|||+++ ++...+...... .....++...++.++.||+.||.|||++||+||||||+||+++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 458999999976 555554432211 0112356666889999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 257 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
.++.+||+|||++......... ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+....+...
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999877544322 12334568889999988764 48999999999999999999 999998877666665
Q ss_pred HHHHHh
Q 018936 335 CFVLNL 340 (348)
Q Consensus 335 ~~i~~~ 340 (348)
.++...
T Consensus 259 ~~~~~~ 264 (313)
T 1t46_A 259 KMIKEG 264 (313)
T ss_dssp HHHHHT
T ss_pred HHhccC
Confidence 555544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=292.60 Aligned_cols=202 Identities=22% Similarity=0.265 Sum_probs=165.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|++...... +.+.+|+++++.++|++++..++.+... ....+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEEE
Confidence 6899999999999999999999999999999987654332 2466799999999998888777666443 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---CCCCcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~~ 272 (348)
|||+++++...+..... .++...++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECCCCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEccCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99997777776653322 24455588899999999999999999999999999999 78899999999999876
Q ss_pred CCCCC------CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 273 DPNHK------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 273 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..... .......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 54322 1223557899999999988754 8999999999999999999999997744
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.68 Aligned_cols=207 Identities=25% Similarity=0.400 Sum_probs=160.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKI----VALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||+||+|++..+++. ||+|.++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---S
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---C
Confidence 6899999999999999999998878765 4777765432 334456788999999999999999999999863 2
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++++|+.+ .+...+..... .++...++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 6788888876 45554443332 24445588899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 271 FFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 271 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
........ ......+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 228 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH
Confidence 87543322 22334568899999998764 48999999999999999999 9999988765443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=292.30 Aligned_cols=203 Identities=20% Similarity=0.256 Sum_probs=167.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+++.||+|.+............+.+|+..+..+ +||||+++++++... ...++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~l 88 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHMLI 88 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 679999999999999999999988999999999987665555667788899999999 999999999999774 56899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC---------------
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD--------------- 258 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~--------------- 258 (348)
||||+++ ++...+..... ....++...++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEECCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999976 55555432110 00124555688899999999999999999999999999999844
Q ss_pred ----CcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 259 ----GVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 259 ----~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
..+||+|||++....... ...||+.|+|||.+.+...++.++||||||+++|+|++|.+|+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 479999999998765432 3358999999999887655778999999999999999999887543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=295.97 Aligned_cols=216 Identities=26% Similarity=0.471 Sum_probs=168.9
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecc----
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM---- 188 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~---- 188 (348)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 34789999999999999999999989999999999875542 235677899999999 8999999999997643
Q ss_pred CceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeC
Q 018936 189 SCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFG 267 (348)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFG 267 (348)
....|+||||+++ .+...+.... ...++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 4578999999987 5555443221 1234455588899999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
++........ ......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+.......+.
T Consensus 175 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 175 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 9987643221 2344578999999998862 2348899999999999999999999998877665554443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=296.49 Aligned_cols=207 Identities=24% Similarity=0.411 Sum_probs=172.3
Q ss_pred CCceeeeeeccCCceEEEEEEE-ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc------eeeeeceEeecc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKD-MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN------VIKLEGLVTSRM 188 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~ 188 (348)
++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+.+|+++++.++|++ ++++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~- 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH- 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-
Confidence 6899999999999999999998 568899999998642 345667888999999987654 99999998774
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-----------
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD----------- 257 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~----------- 257 (348)
...++||||+++++...+..... ..++...++.++.||+.||+|||++||+||||||+|||++.
T Consensus 90 -~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 -GHICIVFELLGLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp -TEEEEEEECCCCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred -CcEEEEEcCCCCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 46999999998888877654321 12445558889999999999999999999999999999987
Q ss_pred --------CCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 258 --------DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 258 --------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
++.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999875432 24557899999999987654 89999999999999999999999998877
Q ss_pred hHHHHHH
Q 018936 330 VSATFCF 336 (348)
Q Consensus 330 ~~~~~~~ 336 (348)
.+....+
T Consensus 240 ~~~~~~~ 246 (339)
T 1z57_A 240 KEHLAMM 246 (339)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6554443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=303.77 Aligned_cols=204 Identities=25% Similarity=0.429 Sum_probs=167.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++ .+|+.||+|++....... ....+.+|+++++.++||||+++++++... ...++
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 104 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 104 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS--SCCEE
T ss_pred hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecC--CceEE
Confidence 47899999999999999999984 578999999987654322 223578899999999999999999999774 44789
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN---GVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
||||+++ ++...+..... ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 105 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 9999987 45554443221 122355666888999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
..............||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCccc
Confidence 87655444445566899999999887644 8999999999999999999999995
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=295.33 Aligned_cols=198 Identities=28% Similarity=0.395 Sum_probs=159.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeec--cCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR--LDHPNVIKLEGLVTSR--MSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~--~~~~ 191 (348)
++|++.+.||+|+||+||+|++ +|+.||||++... ....+.+|.+++.. ++||||+++++++... ....
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 6899999999999999999985 7899999998642 23445567777776 7999999999987543 2356
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCCEEECCCCcEE
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH--------NNGVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--------~~~ivHrDikp~NIll~~~~~~k 262 (348)
.++||||+++ ++...+... .++...+..++.||+.||.||| +.||+||||||+|||++.++.+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred eEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 8999999987 555554321 3455568889999999999999 99999999999999999999999
Q ss_pred EEeeCCccccCCCCCC---CcccccccCcccccccccCcc-----cCCccccHHHHHHHHHHHHhC----------CCCC
Q 018936 263 IADFGLASFFDPNHKH---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAG----------KPIM 324 (348)
Q Consensus 263 l~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~elltG----------~~pf 324 (348)
|+|||+++........ ......||+.|+|||++.+.. .++.++||||||+++|||++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999999876433221 123447899999999987642 245789999999999999999 8898
Q ss_pred CCC
Q 018936 325 PGR 327 (348)
Q Consensus 325 ~~~ 327 (348)
...
T Consensus 234 ~~~ 236 (301)
T 3q4u_A 234 YDV 236 (301)
T ss_dssp TTT
T ss_pred ccc
Confidence 653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=295.75 Aligned_cols=203 Identities=24% Similarity=0.418 Sum_probs=164.7
Q ss_pred CCceeeeeeccCCceEEEEEE----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
+.|++.+.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+++++.++||||+++++++.......
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 569999999999999999998 56789999999987554 2334567889999999999999999999998866677
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++|||+++ ++...+..... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999977 55555433222 24455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 271 FFDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 271 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
....... .......+|..|+|||.+.+.. ++.++||||||+++|+|++|..|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCc
Confidence 8754432 1233456788899999887644 7889999999999999999998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=298.58 Aligned_cols=209 Identities=24% Similarity=0.415 Sum_probs=173.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc------eeeeeceEeecc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG-KIVALKKVRFDNLEPESVKFMAREILILRRLDHPN------VIKLEGLVTSRM 188 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~ 188 (348)
++|++.+.||+|+||+||+|++..++ ..||+|+++.. ....+.+.+|+++++.++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~- 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH- 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-
Confidence 68999999999999999999988776 69999998642 345667888999999997766 88888888764
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE-------------
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI------------- 255 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll------------- 255 (348)
...++||||++++++..+..... ..++...++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 -~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 -GHMCIAFELLGKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp -TEEEEEEECCCCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred -CeEEEEEeccCCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 46999999999888877654321 134455688899999999999999999999999999999
Q ss_pred ------CCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 256 ------DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 256 ------~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
+.++.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999875432 24557899999999987654 89999999999999999999999999887
Q ss_pred hHHHHHHHH
Q 018936 330 VSATFCFVL 338 (348)
Q Consensus 330 ~~~~~~~i~ 338 (348)
.+....+..
T Consensus 245 ~~~~~~~~~ 253 (355)
T 2eu9_A 245 REHLVMMEK 253 (355)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 665554443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=290.19 Aligned_cols=209 Identities=22% Similarity=0.378 Sum_probs=171.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++. +++.||+|.+...... .+.+.+|+++++.++||||+++++++... ...+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCeEEE
Confidence 68999999999999999999974 7789999999765433 35678899999999999999999998774 458999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ .+...+..... .++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp ECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999986 55555443222 244555888999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
..........+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i 218 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 322223344567889999988754 48899999999999999999 89999887765544443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=292.63 Aligned_cols=212 Identities=31% Similarity=0.534 Sum_probs=174.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|++..........+.+.+|++++++++||||+++++++.. ....+++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 99 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIV 99 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEEE
Confidence 67999999999999999999998899999999997655444456778899999999999999999999876 4568999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC---CcEEEEeeCCccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD---GVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~ 271 (348)
+||+++ .+...+... . .++...++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~~-~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-K-----RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHH-S-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999976 444443321 1 34455688899999999999999999999999999999754 4799999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
...... .....+|+.|+|||.+.+. ++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (287)
T 2wei_A 174 FQQNTK--MKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237 (287)
T ss_dssp BCCCSS--CSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ecCCCc--cccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 654322 3445689999999988753 889999999999999999999999887766555444443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=291.59 Aligned_cols=209 Identities=19% Similarity=0.329 Sum_probs=165.6
Q ss_pred CCCceeeeeeccCCceEEEEEEEcc---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
.++|++.+.||+|+||.||+|++.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---P 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---C
Confidence 3789999999999999999998643 33469999987543 445567788999999999999999999998653 3
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.|++|||+++ .+...+..... .++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 5899999986 45444432221 24455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
..............+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~ 224 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH
T ss_pred ccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH
Confidence 7754433333445568889999988654 48999999999999999998 99999876655443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=296.70 Aligned_cols=213 Identities=25% Similarity=0.427 Sum_probs=170.2
Q ss_pred CCceeeeeeccCCceEEEEEEEc-------cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-------LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 187 (348)
++|++.+.||+|+||.||+|++. .++..||+|+++... .....+.+.+|+++++.+ +||||+++++++...
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 78999999999999999999875 457789999986543 445567788999999999 999999999998764
Q ss_pred cCceEEEEEeeccc-ChhhhhcCCCC----------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 188 MSCSLYLVFHYMEH-DLAGLAASPEV----------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
...|+||||+++ ++...+..... ......++...++.++.||+.||.|||+.||+||||||+|||++
T Consensus 114 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 114 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp --SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 458999999986 55555543221 11223466667889999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 257 DDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+.
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 999999999999987654322 1223345688899999887644 8899999999999999999 9999988765443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=296.80 Aligned_cols=209 Identities=24% Similarity=0.391 Sum_probs=155.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEee------cc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTS------RM 188 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~------~~ 188 (348)
.+|++.+.||+|+||.||+|++..+|+.||+|++... .....+.+.+|+.+++++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 6899999999999999999999999999999998654 3455667888999999996 9999999998853 23
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEECCCCcEEEEee
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLIDDDGVLKIADF 266 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kl~DF 266 (348)
....+++|||+++++...+..... ...++...++.++.||+.||.|||+.| |+||||||+|||++.++.+||+||
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CceEEEEEEecCCCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 456899999999887776643110 113455568889999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCC-----------CcccccccCccccccccc--CcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 267 GLASFFDPNHKH-----------PMTSRVVTLWYRPPELLL--GATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 267 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
|+++........ ......+|+.|+|||++. ....++.++||||||+++|+|++|+.||.+...
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999876533221 112446899999999873 234478899999999999999999999976443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=292.75 Aligned_cols=208 Identities=35% Similarity=0.530 Sum_probs=158.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CcEE
Confidence 3689999999999999999999989999999999976443 455677888999999999999999999999874 4689
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|||+++ .+...+.... .....++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 109 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFK--KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEECCCSCBHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEecCCCCCHHHHHHHhc--ccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999987 4444332100 00112445558889999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..... ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+..
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp -------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cCCCc-cccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 43322 23345689999999988764 48999999999999999999999997643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=292.55 Aligned_cols=206 Identities=29% Similarity=0.518 Sum_probs=167.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.. ....|++
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 102 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWIV 102 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEE
Confidence 68999999999999999999998999999999997643 23457789999999999999999999887 4568999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ .+...+..... .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999987 44444432222 344555888999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~ 334 (348)
... ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+......
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 235 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred hcc-ccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 322 23445789999999988765 48999999999999999999999998876654443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=293.65 Aligned_cols=206 Identities=23% Similarity=0.382 Sum_probs=153.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++..+|+.||||++..........+.+..+..+++.++||||+++++++... ...++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEE
Confidence 4789999999999999999999988999999999987655444455555566678888999999999999874 56999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||++..+......... .++...++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 102 v~e~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 102 AMELMGTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EECCCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEeccCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999996554444332222 244555888999999999999995 99999999999999999999999999998764
Q ss_pred CCCCCCcccccccCccccccccc----CcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.... .....+|+.|+|||++. ....++.++||||||+++|+|++|+.||.....
T Consensus 177 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (318)
T 2dyl_A 177 DDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred CCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc
Confidence 3322 33456899999999885 234578899999999999999999999987443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=295.77 Aligned_cols=221 Identities=24% Similarity=0.400 Sum_probs=176.2
Q ss_pred CCceeeeeeccCCceEEEEEEE-----ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++ ..+++.||+|+++... .....+.+.+|+.+++.+ +||||+++++++... .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~ 104 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 104 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-T
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-C
Confidence 7899999999999999999984 3567899999997543 344566788999999999 799999999998764 3
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCcC----------CcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVKF----------TEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 258 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~ 258 (348)
...+++|||+++ ++...+....... ....++...++.++.||+.||.|||+.||+||||||+||+++.+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence 458999999986 5555554332110 01125666788999999999999999999999999999999999
Q ss_pred CcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 259 GVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 259 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
+.+||+|||+++........ ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||.+....+.....
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 99999999999876443221 223446788999999887644 8999999999999999998 99999887755555544
Q ss_pred HHH
Q 018936 337 VLN 339 (348)
Q Consensus 337 i~~ 339 (348)
+..
T Consensus 264 ~~~ 266 (316)
T 2xir_A 264 LKE 266 (316)
T ss_dssp HHH
T ss_pred hcc
Confidence 444
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=298.71 Aligned_cols=207 Identities=25% Similarity=0.393 Sum_probs=160.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEE----EEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIV----ALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~v----AvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||.||+|++..+++.| |+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 90 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 90 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS---
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC---
Confidence 78999999999999999999988888755 666664332 3344667888999999999999999999987642
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++++++.+ .+...+..... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 7788888876 45555443322 24445588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 271 FFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 271 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
....... .......+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+....+.
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 228 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp --------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 7643322 122334567889999998764 48999999999999999999 9999988765443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=289.46 Aligned_cols=207 Identities=23% Similarity=0.457 Sum_probs=168.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++ .++..||+|.+...... .+.+.+|+++++.++||||+++++++... ..+++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~v 85 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYII 85 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEE
T ss_pred HhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcCC---CcEEE
Confidence 7899999999999999999996 56778999998755432 45688899999999999999999988642 37899
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ ++...+.... ...++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999976 4444443211 11345556888999999999999999999999999999999999999999999988754
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
..........++..|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+..+...
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 221 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred cccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 433333444568889999988754 48899999999999999999 999998877654433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=287.14 Aligned_cols=208 Identities=23% Similarity=0.336 Sum_probs=168.7
Q ss_pred CCceeee-eeccCCceEEEEEEEc--cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKID-KIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~-~LG~G~~g~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|.+.+ .||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+++++.++||||+++++++.. ...
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 84 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 84 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CCc
Confidence 6788887 9999999999999853 467899999997543 45567788899999999999999999999843 348
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
++||||+++ .+...+..... .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhCCc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999987 44444433222 345556888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018936 272 FDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSAT 333 (348)
Q Consensus 272 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~ 333 (348)
....... ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 223 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred eccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 7543221 12333568899999988754 48899999999999999998 99999887665443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=293.32 Aligned_cols=207 Identities=21% Similarity=0.326 Sum_probs=165.2
Q ss_pred CCceeee-eeccCCceEEEEEE--EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKID-KIGQGTYSNVYKAK--DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~-~LG~G~~g~Vy~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+ .||+|+||.||+|. ...+++.||+|+++.........+.+.+|+++++.++||||+++++++.. ...
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 92 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESW 92 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---CCc
Confidence 6799998 99999999999994 45667899999997665555567789999999999999999999999843 348
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+++|||+++ .+...+.. .. .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~-~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ-NR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH-CT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh-Cc-----CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999986 44444432 22 244555888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 272 FDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 272 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 229 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred eccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 7543321 122234578899999887644 7889999999999999999 9999988765443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=298.75 Aligned_cols=204 Identities=25% Similarity=0.409 Sum_probs=170.3
Q ss_pred CCceeeeeeccCCceEEEEEE----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+++++.++||||+++++++.......
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 789999999999999999998 5678999999998754 3455677889999999999999999999988766778
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.|+||||+++ .+...+..... .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999965 45444432221 35556688899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 271 FFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 271 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
........ ......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 77543321 223345788899999887644 789999999999999999999998553
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=302.39 Aligned_cols=200 Identities=19% Similarity=0.194 Sum_probs=163.3
Q ss_pred CCceeeeeeccCCceEEEEEEEcc--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceee--------
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML--------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIK-------- 179 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-------- 179 (348)
++|++.+.||+|+||.||+|++.. +++.||+|.+... +.+.+|+++++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 689999999999999999999877 4889999998743 34678999999999999998
Q ss_pred -------eeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCC
Q 018936 180 -------LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSN 252 (348)
Q Consensus 180 -------l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~N 252 (348)
+++++.. .....|+||||++++|...+.... ...++...++.++.||+.||.|||++||+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred CccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 4455544 245789999999767777665321 1245566688999999999999999999999999999
Q ss_pred EEECCCC--cEEEEeeCCccccCCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 253 LLIDDDG--VLKIADFGLASFFDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 253 Ill~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
||++.++ .+||+|||+++........ ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999998 9999999999876532211 12345789999999988775 4899999999999999999999999
Q ss_pred CCCC
Q 018936 325 PGRT 328 (348)
Q Consensus 325 ~~~~ 328 (348)
.+..
T Consensus 269 ~~~~ 272 (352)
T 2jii_A 269 TNCL 272 (352)
T ss_dssp GGGT
T ss_pred ccCC
Confidence 8765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=294.62 Aligned_cols=210 Identities=21% Similarity=0.385 Sum_probs=162.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||.||+|++..++ ..||+|.++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 120 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KP 120 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--CC
Confidence 68999999999999999999876543 469999987543 445566788999999999999999999998764 45
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.++||||+++ .+...+..... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 8999999987 55554433222 34455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 271 FFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 271 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
........ ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+..+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 261 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 261 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred hhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 76543221 12223457789999988764 48999999999999999999 999998877654433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.18 Aligned_cols=216 Identities=24% Similarity=0.351 Sum_probs=167.5
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEccCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
....+|++.+.||+|+||.||+|++..++ ..||+|.+... ......+.+.+|+.++++++||||+++++++... .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 99 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-E 99 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-S
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-C
Confidence 33467999999999999999999865433 36899988643 3445567788999999999999999999986543 3
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...+++|||+++ ++...+..... .++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccc
Confidence 457899999987 55555544332 234445788999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 269 ASFFDPNHK---HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 269 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
++....... .......+|+.|+|||.+.+. .++.++||||||+++|+|++ |.+||.+.+..+....+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH
T ss_pred cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 987643221 122344568889999988764 48999999999999999999 67788776655444333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=286.87 Aligned_cols=210 Identities=25% Similarity=0.342 Sum_probs=165.5
Q ss_pred CCCCCceeeeeeccCCceEEEEEEEccCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 113 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
.....|.+.+.||+|+||.||+|++..++. .||+|.+... ......+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 95 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE- 95 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-
Confidence 333568888999999999999998755554 7999998643 34455678889999999999999999999987643
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...+++|||+.+ ++...+..... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 335899999965 55555544322 334455888999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCCChh
Q 018936 269 ASFFDPNH---KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEV 330 (348)
Q Consensus 269 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~~~~ 330 (348)
++...... ........+|+.|+|||.+.+.. ++.++||||||+++|+|++| .+||...+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHH
Confidence 98654321 12233456788999999887654 89999999999999999995 5555554443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=296.05 Aligned_cols=218 Identities=24% Similarity=0.397 Sum_probs=154.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++..+++.||||.+..... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--ELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS--CEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--CcEE
Confidence 3789999999999999999999888999999998865432 233556788999999999999999999998743 5899
Q ss_pred EEeeccc-ChhhhhcCC--CCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 195 VFHYMEH-DLAGLAASP--EVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
||||+++ .+...+... ........++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999976 444444310 0011112355666888999999999999999999999999999999999999999999987
Q ss_pred cCCCCC----CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018936 272 FDPNHK----HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFC 335 (348)
Q Consensus 272 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~ 335 (348)
...... .......||+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 238 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH
Confidence 643221 1123456899999999886544588999999999999999999999988766554433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=308.79 Aligned_cols=205 Identities=23% Similarity=0.389 Sum_probs=166.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++ +|+.||||+++... ..+.+.+|+++|++++||||+++++++.... ...|+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-CceEE
Confidence 47899999999999999999985 57899999997543 3456888999999999999999999987642 35899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ ++...+..... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999986 55555543211 123455578899999999999999999999999999999999999999999998653
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~ 335 (348)
... ....+++.|+|||.+.+.. ++.++||||||+++|||++ |+.||.+.+..+....
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~ 398 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH
T ss_pred ccc----cCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 221 2235688999999987654 8999999999999999998 9999988766554433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=298.85 Aligned_cols=222 Identities=23% Similarity=0.359 Sum_probs=176.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGK-----IVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRM 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 188 (348)
.++|++.+.||+|+||.||+|++..+++ .||+|.+.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-
Confidence 3789999999999999999999876654 79999986543 445567788999999999 899999999998764
Q ss_pred CceEEEEEeeccc-ChhhhhcCCC--------CcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC
Q 018936 189 SCSLYLVFHYMEH-DLAGLAASPE--------VKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 259 (348)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 259 (348)
...++||||+++ ++...+.... .......++...++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 123 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 123 -GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred -CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 458999999986 5554443211 001122345666888999999999999999999999999999999999
Q ss_pred cEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 260 VLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 260 ~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
.+||+|||++......... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+....+....++
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999866433221 123345688899999887644 8999999999999999999 999998877666655555
Q ss_pred HHh
Q 018936 338 LNL 340 (348)
Q Consensus 338 ~~~ 340 (348)
...
T Consensus 281 ~~~ 283 (333)
T 2i1m_A 281 KDG 283 (333)
T ss_dssp HHT
T ss_pred hcC
Confidence 544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=294.49 Aligned_cols=212 Identities=25% Similarity=0.414 Sum_probs=167.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+.+|+++++.++||||+++++++... ...++|
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 94 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIM 94 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--CeEEEE
Confidence 68999999999999999999999899999999986543 23456788899999999999999999999874 458999
Q ss_pred EeecccChhhhh-cCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLA-ASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++.+... ..... .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999987544433 22122 244555888999999999999999999999999999999999999999999764321
Q ss_pred CCCCCcccccccCccccccccc----CcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLL----GATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i 337 (348)
.. .......||+.|+|||.+. ....++.++||||||+++|+|++|+.||...+..+....+.
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 235 (302)
T 2j7t_A 170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 235 (302)
T ss_dssp HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh
Confidence 11 1123446899999999874 23458899999999999999999999998877665544443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.22 Aligned_cols=212 Identities=26% Similarity=0.385 Sum_probs=167.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEE--EEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIV--ALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~v--AvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 191 (348)
.++|++.+.||+|+||.||+|++..+|..+ |+|.++... .....+.+.+|+++++++ +||||+++++++... ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 100 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 100 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--Cc
Confidence 478999999999999999999998888865 999886432 334456688899999999 999999999999774 56
Q ss_pred EEEEEeeccc-ChhhhhcCCCCc----------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVK----------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 260 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~ 260 (348)
.|+||||+++ ++...+...... .....++...++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 9999999976 565555433210 11123556668899999999999999999999999999999999999
Q ss_pred EEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 261 LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 261 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
+||+|||+++...... ......+++.|+|||++.+. .++.++||||||+++|+|++ |+.||.+.+..+.
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~ 250 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence 9999999998543221 12334568889999988764 48899999999999999998 9999988765443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=301.99 Aligned_cols=216 Identities=24% Similarity=0.348 Sum_probs=160.8
Q ss_pred ccCCCCCceeeeeeccCCceEEEEEEEccCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec
Q 018936 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR 187 (348)
Q Consensus 111 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 187 (348)
++.....|++.+.||+|+||.||+|++..++ ..||+|.++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 3444457899999999999999999875443 468999886432 345567788999999999999999999987543
Q ss_pred cCceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEee
Q 018936 188 MSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266 (348)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DF 266 (348)
....++||||+++ ++...+..... .+....+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 163 -~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DF 236 (373)
T 3c1x_A 163 -EGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 236 (373)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred -CCCeEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeec
Confidence 3357899999987 55555543322 2344557889999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCC---CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 267 GLASFFDPNHKH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 267 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
|+++........ ......+|+.|+|||.+.+. .++.++||||||+++|||++ |.+||.+.+..+...
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~ 307 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH
Confidence 999876432211 12334567889999988764 48999999999999999999 788998766544433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=318.58 Aligned_cols=209 Identities=23% Similarity=0.396 Sum_probs=168.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++. .+..||||+++..... .+.+.+|+++|+.++||||+++++++.. ...|+|
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv 339 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 339 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred hhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEe
Confidence 68999999999999999999974 4567999999765433 4568889999999999999999999865 347999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ +|...+..... ..+....+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999986 55555432111 1244555888999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
..........++..|+|||.+.+. .++.++|||||||++|||++ |+.||.+....+....+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i 477 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred CceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 221122334567889999988764 48999999999999999999 99999988766554443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=295.02 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=165.5
Q ss_pred ceeeeeeccCCceEEEEEE----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 118 FEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
|++++.||+|+||+||++. +..+++.||||+++.. ......+.+.+|+++++.++||||+++++++.+.....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 4999999999999998875 3457899999999754 3445567788999999999999999999999887667899
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+||||+++ ++...+... .++...++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 112 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999986 555544322 2445568889999999999999999999999999999999999999999999987
Q ss_pred CCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 273 DPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 273 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
...... ......+|..|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 543321 123345688899999887644 789999999999999999999998653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=295.41 Aligned_cols=208 Identities=25% Similarity=0.384 Sum_probs=149.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHH-HHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL-ILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++.+.||+|+||.||+|++..+|+.||||++...... .....+..|+. +++.++||||+++++++... ...+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceE
Confidence 37899999999999999999999999999999999765433 33444555555 77778999999999999874 4689
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+||||+++++...+..... .....++...+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCSEEHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecCCChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9999999876665542100 0011344555888999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCccccccccc---CcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLL---GATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..... .....||+.|+|||++. ....++.++||||||+++|+|++|+.||.+..
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 43322 23447899999999883 23448899999999999999999999997643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=288.81 Aligned_cols=197 Identities=30% Similarity=0.491 Sum_probs=164.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee---------
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS--------- 186 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------- 186 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+.... +.+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999998899999999997543 235679999999999999999998854
Q ss_pred -----ccCceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc
Q 018936 187 -----RMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 260 (348)
Q Consensus 187 -----~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~ 260 (348)
......|++|||+++ .+...+.... ...++...++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 123458999999997 5555543221 113445568889999999999999999999999999999999999
Q ss_pred EEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 261 LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 261 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
+||+|||++........ .....+|+.|+|||.+.+. .++.++||||||+++|+|++|..||.
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999987754322 3445689999999988764 48999999999999999999998874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=287.86 Aligned_cols=196 Identities=30% Similarity=0.499 Sum_probs=158.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--------
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR-------- 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-------- 187 (348)
++|++.+.||+|+||.||+|++..+|+.||+|.+... ....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 5799999999999999999999899999999998642 35567788999999999999999999988653
Q ss_pred ---cCceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEE
Q 018936 188 ---MSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKI 263 (348)
Q Consensus 188 ---~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl 263 (348)
.....|++|||+++ ++...+..... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 24568999999976 55555543322 3344557889999999999999999999999999999999999999
Q ss_pred EeeCCccccCCCC-------------CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh
Q 018936 264 ADFGLASFFDPNH-------------KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA 319 (348)
Q Consensus 264 ~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt 319 (348)
+|||++....... ........||+.|+|||.+.+...++.++||||||+++|+|++
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999998764321 1123445689999999998765568999999999999999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=298.43 Aligned_cols=205 Identities=23% Similarity=0.440 Sum_probs=168.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChH---------------HHHHHHHHHHHHHhcCCCceeee
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE---------------SVKFMAREILILRRLDHPNVIKL 180 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~l 180 (348)
++|++.+.||+|+||.||+|++ +|+.||+|.+........ ..+.+.+|+.+++.++||||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 6899999999999999999997 899999999875432111 12678899999999999999999
Q ss_pred eceEeeccCceEEEEEeeccc-Chhhhh-----cCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCE
Q 018936 181 EGLVTSRMSCSLYLVFHYMEH-DLAGLA-----ASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNL 253 (348)
Q Consensus 181 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NI 253 (348)
++++... ...|+||||+++ ++.... ... .....++...++.++.||+.||.|||+ .||+||||||+||
T Consensus 109 ~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDK---NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp SEEEESS--SEEEEEEECCTTCBSSEESSSEESSCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred EEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 9999874 569999999987 444431 111 012345566688999999999999999 9999999999999
Q ss_pred EECCCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCc-cccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 254 LIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGV-GVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 254 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
+++.++.+||+|||++...... ......+|+.|+|||.+.+...++. ++||||||+++|+|++|+.||.+.+..
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 9999999999999999876433 2345678999999999887534655 999999999999999999999887763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=321.65 Aligned_cols=205 Identities=21% Similarity=0.325 Sum_probs=162.6
Q ss_pred eeeccCCceEEEEEEE--ccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEEeec
Q 018936 122 DKIGQGTYSNVYKAKD--MLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
++||+|+||.||+|.+ ..+++.||||+++.........+.+.+|+++|+.++|||||++++++..+ ..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEEcc
Confidence 4799999999999954 45678999999976655556677899999999999999999999998643 378999999
Q ss_pred ccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCC--
Q 018936 200 EHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-- 277 (348)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-- 277 (348)
+++.+..+..... .+....++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 452 ~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 452 ELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp TTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 8754433332222 344555888999999999999999999999999999999999999999999987754322
Q ss_pred CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018936 278 HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335 (348)
Q Consensus 278 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~ 335 (348)
.......+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~ 584 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 584 (635)
T ss_dssp --------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 122333567889999988764 48999999999999999998 9999998877554433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=292.84 Aligned_cols=215 Identities=20% Similarity=0.335 Sum_probs=165.5
Q ss_pred CCceeeeeeccCCceEEEEEE-----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||.||+|+ +..++..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 106 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--L 106 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC--C
Confidence 689999999999999999998 55678899999986433 445566788899999999999999999998774 3
Q ss_pred eEEEEEeeccc-ChhhhhcCCCCc-CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---CCcEEEEe
Q 018936 191 SLYLVFHYMEH-DLAGLAASPEVK-FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIAD 265 (348)
Q Consensus 191 ~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kl~D 265 (348)
..|+||||+++ ++...+...... .....+....++.++.||+.||.|||+.||+||||||+|||++. +..+||+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 47999999965 555555432211 11134566668889999999999999999999999999999984 44699999
Q ss_pred eCCccccCCCC-CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 266 FGLASFFDPNH-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 266 FGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
||++....... ........+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+..+...
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 256 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence 99998653322 1223345678899999988764 48999999999999999998 999998876654433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.51 Aligned_cols=201 Identities=33% Similarity=0.546 Sum_probs=165.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----------CCceeeeeceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-----------HPNVIKLEGLV 184 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~ 184 (348)
++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++ ||||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 6899999999999999999999999999999998643 344566788999999886 89999999998
Q ss_pred eecc--CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCCEEEC-----
Q 018936 185 TSRM--SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN-GVLHRDIKGSNLLID----- 256 (348)
Q Consensus 185 ~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~----- 256 (348)
.... ....+++||++++.+...+..... ..++...++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecCCCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 7643 336899999998777776653221 1244555888999999999999998 999999999999994
Q ss_pred -CCCcEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 257 -DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 257 -~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..+.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999876533 24457899999999988754 8999999999999999999999998655
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=294.31 Aligned_cols=218 Identities=19% Similarity=0.274 Sum_probs=171.3
Q ss_pred CCCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 189 (348)
.++|++.+.||+|+||.||+|++. .+++.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC--
Confidence 378999999999999999999876 357899999986443 344556788999999999999999999998764
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCC----cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEE
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEV----KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 264 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~ 264 (348)
...++||||+++ .+...+..... ......++...+..++.||+.||.|||++||+||||||+||+++.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 458999999986 55544432110 0001123455688899999999999999999999999999999999999999
Q ss_pred eeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 265 DFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 265 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
|||+++....... .......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 9999986643221 1123345688999999887644 8999999999999999999 89999887665444433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=316.62 Aligned_cols=211 Identities=21% Similarity=0.316 Sum_probs=164.8
Q ss_pred CCceeee-eeccCCceEEEEEEEc--cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKID-KIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~-~LG~G~~g~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
+++.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+++|+.++|||||++++++..+ ..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---AL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---Ce
Confidence 4566666 8999999999999765 356689999997653 334467788999999999999999999998752 38
Q ss_pred EEEEeecccChh-hhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLA-GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++.+ ..+..... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred EEEEEeCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 999999987544 44433222 345556888999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCc--ccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 272 FDPNHKHPM--TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 272 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
......... ....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 552 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552 (613)
T ss_dssp CC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 654322211 222346889999988754 48999999999999999998 99999988766544433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=291.43 Aligned_cols=207 Identities=23% Similarity=0.366 Sum_probs=165.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--cCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~ 193 (348)
++|++.+.||+|+||.||+|++..+|+.||+|++... .....+.+.+|+++++.++||||+++++++... .....+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 6899999999999999999999999999999998654 345567788999999999999999999998643 245689
Q ss_pred EEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 194 LVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 194 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|||+++ .+...+.... .....++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLK--DKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEECCTTCBHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEEeCCCCcHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999987 5544443210 01123455568889999999999999999999999999999999999999999998765
Q ss_pred CCCCCC--------CcccccccCcccccccccCcc--cCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 273 DPNHKH--------PMTSRVVTLWYRPPELLLGAT--DYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 273 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
...... ......||+.|+|||.+.+.. .++.++||||||+++|+|++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 321110 012235689999999886532 368899999999999999999999954
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=288.24 Aligned_cols=205 Identities=27% Similarity=0.462 Sum_probs=165.4
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCceeeeeceEeeccCceE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD--HPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~~ 192 (348)
.++|++.+.||+|+||.||++++ .+++.||+|++..........+.+.+|++++++++ ||||+++++++.. ....
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEE
T ss_pred cceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCEE
Confidence 36899999999999999999997 56899999999877667777888999999999997 5999999999877 4468
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|++||+.++++...+.... .++...++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 104 ~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp EEEECCCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred EEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 9999987777777665322 334455788999999999999999999999999999996 489999999999876
Q ss_pred CCCCCC-CcccccccCcccccccccCc----------ccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 273 DPNHKH-PMTSRVVTLWYRPPELLLGA----------TDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 273 ~~~~~~-~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
...... ......||+.|+|||.+.+. ..++.++||||||+++|+|++|+.||.+..+
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 543221 22345789999999988641 3478899999999999999999999977644
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=284.71 Aligned_cols=206 Identities=29% Similarity=0.457 Sum_probs=164.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...+++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEE
Confidence 45666679999999999999999999999999987653 33456788899999999999999999999774 468999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-CCcEEEEeeCCccccC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADFGLASFFD 273 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~ 273 (348)
|||+++ .+...+...... .......++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGP---LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCC---CTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccC---CCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999975 444444322111 12344557788999999999999999999999999999987 8999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCc-ccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.... ......||+.|+|||.+.+. ..++.++||||||+++|+|++|+.||.....
T Consensus 175 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 175 GINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp C------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred CCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 3321 23445789999999988643 2378899999999999999999999976544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=305.54 Aligned_cols=202 Identities=25% Similarity=0.301 Sum_probs=165.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCcee-eeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI-KLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~~l 194 (348)
++|++.++||+|+||.||+|++..+++.||||++....... .+.+|+++++.++|++.+ .+..++.. ....++
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~l 80 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVL 80 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEE
Confidence 78999999999999999999999999999999987654322 366799999999885544 44444433 456899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE---CCCCcEEEEeeCCccc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASF 271 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~ 271 (348)
||||+.+.+..++..... .+.+..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 81 vme~~g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEECCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999998777777653322 34555688999999999999999999999999999999 5889999999999987
Q ss_pred cCCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 272 FDPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 272 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 7543321 123567899999999988754 89999999999999999999999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=288.51 Aligned_cols=195 Identities=30% Similarity=0.450 Sum_probs=155.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++ +++.||+|.+... ...+.+.+|++++++++||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEEE
Confidence 6899999999999999999985 5789999998532 345678889999999999999999998764 26899
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCCEEECCCCc-EEEEeeCCcc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN---NGVLHRDIKGSNLLIDDDGV-LKIADFGLAS 270 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~-~kl~DFGla~ 270 (348)
|||+++ ++...+.... ....+....+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++.
T Consensus 78 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EECCTTCBHHHHHHCSS---SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEcCCCCCHHHHHhccC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 999986 5555544322 11234455578889999999999999 89999999999999998886 7999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
..... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus 155 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 155 DIQTH----MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp --------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccccc----cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 65432 2344689999999988764 48999999999999999999999997654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=288.86 Aligned_cols=213 Identities=26% Similarity=0.397 Sum_probs=161.2
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-CCc--EEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-TGK--IVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-~g~--~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||.||+|++.. ++. .||+|+++.... .....+.+.+|+++++.++||||+++++++....
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 94 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--- 94 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC---
Confidence 689999999999999999998543 333 699999876543 3455678889999999999999999999987642
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.++++||+++ .+...+.... ..++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 7899999985 5555443322 134555688899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 271 FFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 271 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
........ ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.+..+....+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 238 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred cccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence 87543321 12234567889999988764 37899999999999999999 999998877655544443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=286.85 Aligned_cols=205 Identities=28% Similarity=0.386 Sum_probs=165.6
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDN--LEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.|...+.||+|+||.||+|++ +++.||+|.+.... ......+.+.+|+.+++.++||||+++++++... ...++
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 107 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCL 107 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEE
Confidence 355569999999999999984 78899999986543 2344567788999999999999999999998764 45899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+++ .+...+..... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 184 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184 (307)
T ss_dssp EEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccc
Confidence 9999975 55554432211 1235556688899999999999999999999999999999999999999999998765
Q ss_pred CCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 274 PNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 274 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
..... ......||+.|+|||.+.+ .++.++||||||+++|+|++|++||.+....
T Consensus 185 ~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 185 KFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp SCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred cccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 43221 1234578999999998865 3789999999999999999999999875543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=292.60 Aligned_cols=203 Identities=26% Similarity=0.457 Sum_probs=165.7
Q ss_pred CCceeeeeeccCCceEEEEEE----EccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAK----DMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+++++.++||||+++++++.......
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 679999999999999999998 4568999999998653 3455677889999999999999999999987655556
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.++||||+++ ++...+..... .++...++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 8999999986 55555543322 24455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 271 FFDPNHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 271 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
........ ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 87543321 122335677899999887644 88999999999999999999998854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=300.08 Aligned_cols=200 Identities=25% Similarity=0.351 Sum_probs=156.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
.+|++.+.||+|+||+||.. ...+|+.||||++..... ....+|+++|+.+ +|||||++++++.+ ....|+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEE
Confidence 57999999999999996643 347899999999865432 2245699999999 89999999998876 456899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-----CCcEEEEeeCCc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-----DGVLKIADFGLA 269 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-----~~~~kl~DFGla 269 (348)
||||+++++...+........... +..++.||+.||.|||++||+||||||+|||++. ...+||+|||++
T Consensus 96 v~E~~~g~L~~~l~~~~~~~~~~~-----~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFAHLGLE-----PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCSEEHHHHHHSSSCCCCSSC-----HHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCCCCHHHHHHhcCCCccchh-----HHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999999988888776554443333 5678999999999999999999999999999953 236889999999
Q ss_pred cccCCCCC--CCcccccccCcccccccccC--cccCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 018936 270 SFFDPNHK--HPMTSRVVTLWYRPPELLLG--ATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 328 (348)
Q Consensus 270 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~ 328 (348)
+....... .......||+.|+|||++.+ ...++.++|||||||++|||++ |..||....
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 87753321 22345678999999999874 2346789999999999999999 999996543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=300.22 Aligned_cols=206 Identities=26% Similarity=0.381 Sum_probs=155.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 194 (348)
+.|...+.||+|+||+||.+. ..+|+.||||.+... ..+.+.+|+.+++.+ +||||+++++++.. ....|+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEE
Confidence 567778999999999998764 578999999998642 245567899999876 89999999988876 456999
Q ss_pred EEeecccChhhhhcCCCCcCCc-chhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC-------------Cc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTE-PQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD-------------GV 260 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-------------~~ 260 (348)
||||+++++...+......... .......++.++.||+.||+|||++||+||||||+|||++.+ +.
T Consensus 87 v~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 87 ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp EECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 9999998877776543321111 011122256789999999999999999999999999999754 48
Q ss_pred EEEEeeCCccccCCCCCC---CcccccccCcccccccccC------cccCCccccHHHHHHHHHHHHh-CCCCCCCCCh
Q 018936 261 LKIADFGLASFFDPNHKH---PMTSRVVTLWYRPPELLLG------ATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329 (348)
Q Consensus 261 ~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~ 329 (348)
+||+|||+++........ ......||+.|+|||++.+ ...++.++|||||||++|||++ |+.||.+...
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 999999999987543321 1234578999999998865 2348899999999999999999 9999976543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.21 Aligned_cols=201 Identities=27% Similarity=0.441 Sum_probs=165.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLD--HPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++..+++.||||.+....... ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-- 120 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-- 120 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC--
Confidence 68999999999999999999999999999999997654321 12234567999999996 59999999999874
Q ss_pred ceEEEEEeecc--cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC-CCCcEEEEee
Q 018936 190 CSLYLVFHYME--HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADF 266 (348)
Q Consensus 190 ~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~kl~DF 266 (348)
...++++|++. +.+...+... . .++...++.++.||+.||.|||+.||+||||||+|||++ .++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~-~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER-G-----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-C-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhcc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 46899999997 4555554321 1 344555888999999999999999999999999999999 7899999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
|+++...... .....||+.|+|||++.+...++.++||||||+++|+|++|+.||...
T Consensus 195 g~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 195 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 9998775332 345578999999998876554578899999999999999999999653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=288.13 Aligned_cols=197 Identities=28% Similarity=0.372 Sum_probs=155.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc--CCCceeeeeceEeeccC--ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL--DHPNVIKLEGLVTSRMS--CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~~--~~ 191 (348)
++|++.+.||+|+||.||+|++ +|+.||||++... ......+|.+++..+ +||||+++++++..... ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 6799999999999999999985 4899999998642 233344566666554 99999999999877533 57
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCCEEECCCCcEE
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN--------GVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~ivHrDikp~NIll~~~~~~k 262 (348)
.|+||||+++ ++...+... .++...++.++.|++.||.|||+. ||+||||||+|||++.++.+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred eEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 8999999987 555555322 345556888999999999999999 999999999999999999999
Q ss_pred EEeeCCccccCCCCCC---CcccccccCcccccccccCcccCCc------cccHHHHHHHHHHHHhC----------CCC
Q 018936 263 IADFGLASFFDPNHKH---PMTSRVVTLWYRPPELLLGATDYGV------GVDLWSAGCILAELLAG----------KPI 323 (348)
Q Consensus 263 l~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~------~~DvwSlGv~l~elltG----------~~p 323 (348)
|+|||+++........ ......||+.|+|||++.+.. ++. ++|||||||++|||++| +.|
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 9999999876433222 123457899999999987643 343 39999999999999999 777
Q ss_pred CCCC
Q 018936 324 MPGR 327 (348)
Q Consensus 324 f~~~ 327 (348)
|...
T Consensus 262 ~~~~ 265 (337)
T 3mdy_A 262 YHDL 265 (337)
T ss_dssp TTTT
T ss_pred Hhhh
Confidence 7553
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=292.97 Aligned_cols=197 Identities=26% Similarity=0.378 Sum_probs=152.4
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHH--HHhcCCCceeeeeceEee---cc
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI--LRRLDHPNVIKLEGLVTS---RM 188 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~---~~ 188 (348)
..++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.++ +..++||||+++++.+.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 347899999999999999999974 78999999987432 2333444444 445899999999876533 23
Q ss_pred CceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCCEEECCC
Q 018936 189 SCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNN---------GVLHRDIKGSNLLIDDD 258 (348)
Q Consensus 189 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---------~ivHrDikp~NIll~~~ 258 (348)
...+++||||+++ ++...+... ......+..++.||+.||.|||+. ||+||||||+|||++.+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred CceEEEEEecCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 3467899999976 555554322 123445778899999999999999 99999999999999999
Q ss_pred CcEEEEeeCCccccCCCC-------CCCcccccccCcccccccccCc------ccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 259 GVLKIADFGLASFFDPNH-------KHPMTSRVVTLWYRPPELLLGA------TDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 259 ~~~kl~DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
+.+||+|||+++.+.... ........||+.|+|||++.+. ..++.++|||||||++|||++|..||
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 999999999998764321 1122345789999999998762 23667899999999999999996554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=282.77 Aligned_cols=202 Identities=23% Similarity=0.412 Sum_probs=157.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++ +|+.||+|+++... ..+.+.+|+++++.++||||+++++++... ....|+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEE
Confidence 37899999999999999999985 58899999986432 355688899999999999999999987553 235799
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+++ ++...+.... ...++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999987 5555543211 1124555688899999999999999999999999999999999999999999998654
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSA 332 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~ 332 (348)
... ....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||...+..+.
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 223 (278)
T 1byg_A 169 STQ----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223 (278)
T ss_dssp -----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred ccc----cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 322 233568889999988754 48999999999999999998 9999987665443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.03 Aligned_cols=214 Identities=21% Similarity=0.344 Sum_probs=168.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
.++|++.+.||+|+||.||+|++..+ +..||+|.++.. ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 36899999999999999999987543 467999988643 244556778899999999999999999999854 34
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.|+||||+++ ++...+..... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 7999999986 55554433222 24455578899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~ 338 (348)
..............+|+.|+|||.+.+. .++.++||||||+++|||++ |.+||.+.+..+....+..
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~ 607 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence 7754433333444567899999988764 48999999999999999997 9999998877655544433
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=288.40 Aligned_cols=211 Identities=21% Similarity=0.327 Sum_probs=164.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||.||+|++.. .||+|.+..........+.+.+|+.+++.++||||+++++++... ...++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~i 106 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--PHLAI 106 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS--SCEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CceEE
Confidence 3789999999999999999998643 499999876654444455677899999999999999999999874 45899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+|||+++ .+...+...... ++...++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIV-----LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCC-----CCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999986 454444433222 33344888999999999999999999999999999998 6899999999987653
Q ss_pred CC----CCCCcccccccCcccccccccC--------cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018936 274 PN----HKHPMTSRVVTLWYRPPELLLG--------ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCF 336 (348)
Q Consensus 274 ~~----~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~ 336 (348)
.. .........||+.|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 21 1122334468999999998864 234788999999999999999999999887765544443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=287.15 Aligned_cols=200 Identities=25% Similarity=0.358 Sum_probs=141.3
Q ss_pred CCceeee-eeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--cCceE
Q 018936 116 DSFEKID-KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSL 192 (348)
Q Consensus 116 ~~y~~~~-~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~ 192 (348)
++|++.+ .||+|+||+||+|++..+|+.||||++... .. ........++.++||||+++++++... .....
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 6899965 599999999999999999999999998642 11 222233446778999999999998652 23458
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---CCcEEEEeeCC
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGL 268 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kl~DFGl 268 (348)
++||||+++ ++...+..... ..++...++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999987 55555543321 23555668899999999999999999999999999999986 45599999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
++...... .....+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+...
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp CEEC-------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ceeccccc---cccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 98764322 3455779999999988654 488999999999999999999999966554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=290.02 Aligned_cols=200 Identities=25% Similarity=0.435 Sum_probs=158.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhc----CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRL----DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~E~~~l~~l----~hpniv~l~~~~~~~ 187 (348)
++|++.+.||+|+||.||+|++..+++.||+|++....... .....+.+|+.++.++ +||||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 68999999999999999999998999999999997654322 1233455799999998 899999999998764
Q ss_pred cCceEEEEEee-ccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC-CCCcEEEE
Q 018936 188 MSCSLYLVFHY-MEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIA 264 (348)
Q Consensus 188 ~~~~~~lv~e~-~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-~~~~~kl~ 264 (348)
...++++|+ +.+ .+...+... . .++...++.++.||+.||.|||+.||+||||||+||+++ .++.+||+
T Consensus 111 --~~~~~v~e~~~~~~~L~~~l~~~-~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 111 --EGFMLVLERPLPAQDLFDYITEK-G-----PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHH-C-----SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred --CeEEEEEEecCCCCCHHHHHHhc-C-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence 447899998 554 555544321 1 245556888999999999999999999999999999999 88999999
Q ss_pred eeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 265 DFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 265 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
|||++....... .....||..|+|||++.+....+.++||||||+++|+|++|+.||.+
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999998775432 34556899999999887655345689999999999999999999965
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=285.05 Aligned_cols=198 Identities=26% Similarity=0.330 Sum_probs=161.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeeccC--ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRR--LDHPNVIKLEGLVTSRMS--CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~~--~~ 191 (348)
++|++.+.||+|+||.||+|++ +|+.||||++.. .....+.+|++++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 5799999999999999999985 689999999853 234556778999887 799999999999876542 26
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCCEEECCCCcEE
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH--------NNGVLHRDIKGSNLLIDDDGVLK 262 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--------~~~ivHrDikp~NIll~~~~~~k 262 (348)
.|++|||+++ ++...+... .++...++.++.||+.||.||| +.||+||||||+|||++.++.+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred eEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 8999999987 555555321 2445568889999999999999 89999999999999999999999
Q ss_pred EEeeCCccccCCCCCC---CcccccccCcccccccccCccc-----CCccccHHHHHHHHHHHHhC----------CCCC
Q 018936 263 IADFGLASFFDPNHKH---PMTSRVVTLWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAG----------KPIM 324 (348)
Q Consensus 263 l~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwSlGv~l~elltG----------~~pf 324 (348)
|+|||++......... ......||+.|+|||++.+... ++.++||||||+++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999876543321 2344578999999999876421 33689999999999999999 7888
Q ss_pred CCC
Q 018936 325 PGR 327 (348)
Q Consensus 325 ~~~ 327 (348)
...
T Consensus 268 ~~~ 270 (342)
T 1b6c_B 268 YDL 270 (342)
T ss_dssp TTT
T ss_pred ccc
Confidence 664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=288.85 Aligned_cols=194 Identities=18% Similarity=0.233 Sum_probs=155.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcC---------CCceeee
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL------EPESVKFMAREILILRRLD---------HPNVIKL 180 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~E~~~l~~l~---------hpniv~l 180 (348)
++|++.+.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.+++.++ ||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 6799999999999999999986 789999999987642 2233467888999999886 6666665
Q ss_pred eceE-----------------eec-----------cCceEEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHH
Q 018936 181 EGLV-----------------TSR-----------MSCSLYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQL 231 (348)
Q Consensus 181 ~~~~-----------------~~~-----------~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi 231 (348)
.+++ ... .....|+||||++++ ++..+.. ..++...++.++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHH
Confidence 5543 320 145799999999765 5554432 134556689999999
Q ss_pred HHHHHHHH-HCCceecCCCCCCEEECCCC--------------------cEEEEeeCCccccCCCCCCCcccccccCccc
Q 018936 232 LSGLEHCH-NNGVLHRDIKGSNLLIDDDG--------------------VLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290 (348)
Q Consensus 232 ~~aL~~LH-~~~ivHrDikp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 290 (348)
+.||.||| ++||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+
T Consensus 171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999999 99999999999999999887 8999999999976432 347899999
Q ss_pred ccccccCcccCCccccHHHHHHH-HHHHHhCCCCCCC
Q 018936 291 PPELLLGATDYGVGVDLWSAGCI-LAELLAGKPIMPG 326 (348)
Q Consensus 291 aPE~~~~~~~~~~~~DvwSlGv~-l~elltG~~pf~~ 326 (348)
|||++.+.. +.++||||++++ .+++++|..||.+
T Consensus 245 aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 245 DEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ChhhhcCCC--ccceehhhhhCCCCcccccccCCCcc
Confidence 999988643 789999998777 7778899999954
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=293.41 Aligned_cols=211 Identities=18% Similarity=0.197 Sum_probs=158.8
Q ss_pred CCCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCC-Cceeeee----------
Q 018936 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH-PNVIKLE---------- 181 (348)
Q Consensus 114 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~h-pniv~l~---------- 181 (348)
....|...+.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+++.++| +|...+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 33569999999999999999999999999999999874432 33346678899999999987 3221111
Q ss_pred -----------ceEeecc---CceEEEEEeecccChhhhhcCCCC-cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceec
Q 018936 182 -----------GLVTSRM---SCSLYLVFHYMEHDLAGLAASPEV-KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHR 246 (348)
Q Consensus 182 -----------~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 246 (348)
.++.... ...++++|+++.+++..++..... ......+++..+..++.||+.||+|||++||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 234688888888877766531100 1112356666788888999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccccCccccccccc---------CcccCCccccHHHHHHHHHHH
Q 018936 247 DIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLL---------GATDYGVGVDLWSAGCILAEL 317 (348)
Q Consensus 247 Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DvwSlGv~l~el 317 (348)
||||+|||++.++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999875433 345567 9999999883 334488899999999999999
Q ss_pred HhCCCCCCCCCh
Q 018936 318 LAGKPIMPGRTE 329 (348)
Q Consensus 318 ltG~~pf~~~~~ 329 (348)
++|+.||.+.+.
T Consensus 311 ltg~~Pf~~~~~ 322 (413)
T 3dzo_A 311 WCADLPNTDDAA 322 (413)
T ss_dssp HHSSCCCCTTGG
T ss_pred HHCCCCCCCcch
Confidence 999999977543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=310.60 Aligned_cols=195 Identities=22% Similarity=0.327 Sum_probs=162.9
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC---ce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS---CS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~ 191 (348)
++|++.+.||+|+||.||+|++.. +|+.||||++... ......+.+.+|+++++.++||||+++++++..... ..
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 789999999999999999999875 7899999998643 244556678899999999999999999999976533 22
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.|+||||+++..+...... .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999987544332221 35556688899999999999999999999999999999875 999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCC
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPG 326 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~ 326 (348)
.... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cccC-----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 6433 445789999999988653 58899999999999999999999865
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=304.86 Aligned_cols=206 Identities=29% Similarity=0.387 Sum_probs=166.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee----ccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS----RMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 191 (348)
++|++.+.||+|+||.||+|++..+|+.||||+++.. ......+.+.+|++++++++||||+++++++.. .....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6899999999999999999999899999999998654 345667778899999999999999999998754 12456
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc---EEEEeeC
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV---LKIADFG 267 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kl~DFG 267 (348)
.|+||||+++ ++...+...... ..++...++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999976 555554432211 11233347889999999999999999999999999999997765 9999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
++........ .....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+..
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~ 227 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNW 227 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cccccccccc--cccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence 9998754332 3456789999999988764 48999999999999999999999997653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=271.44 Aligned_cols=175 Identities=19% Similarity=0.182 Sum_probs=147.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++... ...|+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcEEE
Confidence 679999999999999999999988999999999976654 345567888999999999999999999999874 56899
Q ss_pred EEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||+++ ++...+ ... . ....+..++.||+.||.|||++||+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l-~~~--~-----~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVA-DTS--P-----SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEECCCEEEHHHHH-TTC--C-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEecCCCCHHHHH-hcC--C-----ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999986 444444 221 1 122367789999999999999999999999999999999999998443
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
|++| ++.++|||||||++|+|++|+.||.+.+.
T Consensus 175 ---------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ---------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ---------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ---------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3332 67899999999999999999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=262.67 Aligned_cols=178 Identities=23% Similarity=0.363 Sum_probs=145.4
Q ss_pred CCceee-eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHH-HhcCCCceeeeeceEee--ccCce
Q 018936 116 DSFEKI-DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILIL-RRLDHPNVIKLEGLVTS--RMSCS 191 (348)
Q Consensus 116 ~~y~~~-~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~--~~~~~ 191 (348)
++|.+. +.||+|+||.||+|++..+++.||+|++... ....+|++++ +.++||||+++++++.. .....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 578888 7899999999999999999999999998632 2456788887 56699999999999865 22456
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---CCcEEEEeeC
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFG 267 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kl~DFG 267 (348)
.++||||+++ ++...+.... ...++...++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 8999999986 5555554321 113556668899999999999999999999999999999998 7899999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
++..... ..++.++|||||||++|+|++|+.||.+.+
T Consensus 166 ~a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 166 FAKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp TCEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred ccccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 9875421 236789999999999999999999996543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=283.01 Aligned_cols=188 Identities=15% Similarity=0.071 Sum_probs=128.6
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCC--------ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCceE
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--------EPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 192 (348)
..++.|+.|.+..++....|+.||+|.+.+... .+...+.+.+|+++|+++ .|+||++++++++++ ...
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEE
Confidence 457788888888888788999999999976532 123456689999999999 799999999999884 559
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
||||||++|..+.........+. ...++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+..
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~--------~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEID--------REKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCC--------HHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEEEecCCCCcHHHHHHhCCCCC--------HHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999855544443333332 2347899999999999999999999999999999999999999999977
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCC
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~ 322 (348)
.... ....+.+||+.|+|||++.+. +..++|+||+|+++++|.++..
T Consensus 390 ~~~~-~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 390 PQDC-SWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp C----CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred CCCC-ccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence 5433 234567899999999998764 6678999999999887755543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-29 Score=246.13 Aligned_cols=187 Identities=17% Similarity=0.129 Sum_probs=139.0
Q ss_pred eeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE------SVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
...+.||+|+||.||+|+ ..+..+++|.......... ..+.+.+|++++++++||||+++..++.... ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--cc
Confidence 446789999999999994 6788999998755433211 2345789999999999999996555555433 36
Q ss_pred EEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||+++ ++...+.. +..++.||+.||.|||++||+||||||+|||++. ++||+|||+++.
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 999999985 45444432 3457999999999999999999999999999998 999999999998
Q ss_pred cCCCCCCC------cccccccCcccccccccC-cccCCccccHHHHHHHHHHHHhCCCCCC
Q 018936 272 FDPNHKHP------MTSRVVTLWYRPPELLLG-ATDYGVGVDLWSAGCILAELLAGKPIMP 325 (348)
Q Consensus 272 ~~~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwSlGv~l~elltG~~pf~ 325 (348)
........ .....||+.|+|||++.+ ...|+..+|+||..+-.++.+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 75432111 135678999999998864 1337788999999999999998887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=206.32 Aligned_cols=161 Identities=14% Similarity=0.109 Sum_probs=122.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh----------------HHHHHHHHHHHHHHhcCCCceee
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----------------ESVKFMAREILILRRLDHPNVIK 179 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~----------------~~~~~~~~E~~~l~~l~hpniv~ 179 (348)
..|++.+.||+|+||.||+|++ .+|+.||+|.++...... .....+.+|+++|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4677889999999999999998 889999999986543211 13566889999999999 5 66
Q ss_pred eeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC
Q 018936 180 LEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG 259 (348)
Q Consensus 180 l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 259 (348)
+.+++.. ...|+||||++++.+..+.. . . ...++.||+.||.|||++||+||||||+|||++ ++
T Consensus 166 v~~~~~~---~~~~lvmE~~~g~~L~~l~~-----~--~-----~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 166 VPKVYAW---EGNAVLMELIDAKELYRVRV-----E--N-----PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SCCEEEE---ETTEEEEECCCCEEGGGCCC-----S--C-----HHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT
T ss_pred cCeEEec---cceEEEEEecCCCcHHHcch-----h--h-----HHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC
Confidence 7666544 23599999998744333311 1 1 345899999999999999999999999999999 99
Q ss_pred cEEEEeeCCccccCCCCCCCcccccccCcccccccccCc---------ccCCccccHHHH
Q 018936 260 VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGA---------TDYGVGVDLWSA 310 (348)
Q Consensus 260 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~DvwSl 310 (348)
.+||+|||+|+.. ..+.|||++.+. ..|+..+|+|.+
T Consensus 230 ~vkl~DFG~a~~~--------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 230 GIWIIDFPQSVEV--------------GEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp EEEECCCTTCEET--------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred cEEEEECCCCeEC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 9999999999743 236889976420 225566677653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-22 Score=179.40 Aligned_cols=139 Identities=19% Similarity=0.266 Sum_probs=104.5
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcE--EEEEEeecCCCC----------------------hHHHHHHHHHHHHHHhc
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLE----------------------PESVKFMAREILILRRL 172 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~--vAvK~i~~~~~~----------------------~~~~~~~~~E~~~l~~l 172 (348)
-|++.+.||+|+||.||+|++..+|+. ||||+++..... ......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778999 999997654211 01123577899999999
Q ss_pred CCCce--eeeeceEeeccCceEEEEEeeccc------ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHH-HCCc
Q 018936 173 DHPNV--IKLEGLVTSRMSCSLYLVFHYMEH------DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCH-NNGV 243 (348)
Q Consensus 173 ~hpni--v~l~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~i 243 (348)
.|+++ +.+++. ...++||||+++ .+...... .+...+..++.||+.||.||| +.||
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~gi 192 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEAEL 192 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTSCE
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHCCE
Confidence 88864 333321 125899999953 23222111 011126678999999999999 9999
Q ss_pred eecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 244 LHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 244 vHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999988 9999999999865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.5e-19 Score=163.83 Aligned_cols=141 Identities=18% Similarity=0.224 Sum_probs=97.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC------------hHHHH--------HHHHHHHHHHhcCCC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE------------PESVK--------FMAREILILRRLDHP 175 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~------------~~~~~--------~~~~E~~~l~~l~hp 175 (348)
.-|++..+||+|+||.||+|.+ .+|+.||||+++..... ..... ...+|...|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 3499999999999999999996 67999999997643110 00011 112355666666444
Q ss_pred ceeeeeceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEE
Q 018936 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLI 255 (348)
Q Consensus 176 niv~l~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll 255 (348)
++.... .+... . .+|||||+++..+..+... . . ...++.||+.+|.+||++|||||||||.|||+
T Consensus 174 gv~vp~-p~~~~-~--~~LVME~i~G~~L~~l~~~----~--~-----~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 174 GFPVPE-PIAQS-R--HTIVMSLVDALPMRQVSSV----P--D-----PASLYADLIALILRLAKHGLIHGDFNEFNILI 238 (397)
T ss_dssp TCSCCC-EEEEE-T--TEEEEECCSCEEGGGCCCC----S--C-----HHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred CCCCCe-eeecc-C--ceEEEEecCCccHhhhccc----H--H-----HHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEE
Confidence 332111 11111 1 3799999987554332211 1 1 34568899999999999999999999999999
Q ss_pred CCCC----------cEEEEeeCCcccc
Q 018936 256 DDDG----------VLKIADFGLASFF 272 (348)
Q Consensus 256 ~~~~----------~~kl~DFGla~~~ 272 (348)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8776 3899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=4.7e-12 Score=112.51 Aligned_cols=140 Identities=16% Similarity=0.104 Sum_probs=105.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 194 (348)
+.|++...++.|+.+.||++. ..+..+++|........ ....+.+|+++++.+. +.+++++++++.. ....|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~--~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEE--CCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEE
Confidence 458899999999999999997 34789999998642111 1234778999999884 6778888888765 356899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN---------------------------------- 240 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---------------------------------- 240 (348)
+||+++|..+...... ... ...++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~~-----~~~-----~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-----EQS-----PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEECCSSEEHHHHCCT-----TTC-----HHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEecCCeehhhccCC-----ccc-----HHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 9999998654433110 001 23467899999999998
Q ss_pred -------------------------CCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 241 -------------------------NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 241 -------------------------~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
..++|+|++|.|||++++..+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 3489999999999998765567999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.2e-11 Score=109.30 Aligned_cols=136 Identities=11% Similarity=0.075 Sum_probs=95.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~ 193 (348)
..|.+....+.|..+.||++. ..+|..+++|...... ...+.+|+.+++.+.+.+ +++++++.... ...+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~ 91 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDW 91 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCE
Confidence 446665444566679999996 4667889999875431 234667999999886544 45677766543 4589
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG------------------------------- 242 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~------------------------------- 242 (348)
++|||+++..+. ... . . ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~-~~~----~---~-----~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 92 LLLGEVPGQDLL-SSH----L---A-----PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp EEEECCSSEETT-TSC----C---C-----HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred EEEEecCCcccC-cCc----C---C-----HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 999999985443 111 0 1 1235667777788888643
Q ss_pred ---------------------------ceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 243 ---------------------------VLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 243 ---------------------------ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
++|+|++|.||++++++.+.|+|||.+...
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987766679999987643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.6e-10 Score=107.50 Aligned_cols=144 Identities=14% Similarity=0.222 Sum_probs=99.3
Q ss_pred eeeeeeccCCceEEEEEEEccCCcEEEEEEee--cCCCChHHHHHHHHHHHHHHhcC--CCceeeeeceEeeccC-ceEE
Q 018936 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVR--FDNLEPESVKFMAREILILRRLD--HPNVIKLEGLVTSRMS-CSLY 193 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~--~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~-~~~~ 193 (348)
..++.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.+. +..++++++++.+... ...|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3467899999999999974 35678889765 32211 12346778999999997 4557788777765321 3478
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH---------------------------------
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN--------------------------------- 240 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--------------------------------- 240 (348)
+|||++++..+..... ..++......++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp EEEECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred EEEEecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 9999999754321100 112233356678899999999997
Q ss_pred -------------------------CCceecCCCCCCEEECCCCc--EEEEeeCCcccc
Q 018936 241 -------------------------NGVLHRDIKGSNLLIDDDGV--LKIADFGLASFF 272 (348)
Q Consensus 241 -------------------------~~ivHrDikp~NIll~~~~~--~kl~DFGla~~~ 272 (348)
..++|+|++|.|||++.++. +.|+||+.+..-
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 689999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=7.6e-11 Score=107.15 Aligned_cols=185 Identities=17% Similarity=0.164 Sum_probs=110.6
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCc--eeeeeceEeecc-CceEEEEE
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPN--VIKLEGLVTSRM-SCSLYLVF 196 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~-~~~~~lv~ 196 (348)
++.++.|....||++. ..+++|+... ......+.+|.++|+.+. +.. +.+++....... ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568999999999863 4688998542 244567889999999883 333 334433322211 12348899
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN------------------------------------ 240 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~------------------------------------ 240 (348)
++++|..+..... ..++......++.|++..|..||+
T Consensus 96 ~~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 96 TKIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp ECCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred cccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 9998743321100 011222234456666666666664
Q ss_pred ----------------------CCceecCCCCCCEEECC--CCcEEEEeeCCccccCCCCCCCcc-cc------------
Q 018936 241 ----------------------NGVLHRDIKGSNLLIDD--DGVLKIADFGLASFFDPNHKHPMT-SR------------ 283 (348)
Q Consensus 241 ----------------------~~ivHrDikp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~-~~------------ 283 (348)
..++|+|++|.||++++ +..+.|+||+.+...++...-... ..
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence 14799999999999998 456789999998765432100000 00
Q ss_pred cccCcccc-cccccCcccCCccccHHHHHHHHHHHHhCCCCC
Q 018936 284 VVTLWYRP-PELLLGATDYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 284 ~gt~~y~a-PE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
....+... |+.... .....+.|+++.++|.+.+|.++|
T Consensus 249 l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00001111 221111 112358999999999999999887
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=9e-07 Score=80.30 Aligned_cols=74 Identities=9% Similarity=0.131 Sum_probs=52.1
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---ceeeeeceEeeccCceEEEEEe
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP---NVIKLEGLVTSRMSCSLYLVFH 197 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~~~lv~e 197 (348)
++.++.|....||+. |..+++|+-. .......+.+|.++|+.+.+. .+.+.+.+... .....|++|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEe
Confidence 456888999999987 5678889742 234466788999999999753 24555555432 2345689999
Q ss_pred ecccChh
Q 018936 198 YMEHDLA 204 (348)
Q Consensus 198 ~~~~~l~ 204 (348)
+++|..+
T Consensus 94 ~i~G~~l 100 (306)
T 3tdw_A 94 KVQGQIL 100 (306)
T ss_dssp CCCSEEC
T ss_pred ccCCeEC
Confidence 9988543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.5e-06 Score=76.92 Aligned_cols=133 Identities=15% Similarity=0.119 Sum_probs=85.9
Q ss_pred eccCCce-EEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEEEEeeccc
Q 018936 124 IGQGTYS-NVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYLVFHYMEH 201 (348)
Q Consensus 124 LG~G~~g-~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~e~~~~ 201 (348)
+..|..+ .||+......+..+++|.-.. .....+.+|...|+.+. +-.+.++++++.+. ...|+||+++++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G 104 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPG 104 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCS
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCC
Confidence 4445544 699988666777899998652 33556888999998884 22356777777663 458999999987
Q ss_pred ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 018936 202 DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN----------------------------------------- 240 (348)
Q Consensus 202 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~----------------------------------------- 240 (348)
.......... ... ...+..++...|..||+
T Consensus 105 ~~~~~~~~~~----~~~-----~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 105 KTAFQVLEEY----PDS-----GENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp EEHHHHHHHC----GGG-----HHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred ccccccccCC----HHH-----HHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 4322211000 000 11223344444444442
Q ss_pred ----------C-------CceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 241 ----------N-------GVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 241 ----------~-------~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
. .++|+|+.+.|||+++++.+-|+||+.+...
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1 2799999999999998777779999988754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.1e-06 Score=79.47 Aligned_cols=78 Identities=18% Similarity=0.159 Sum_probs=48.2
Q ss_pred eeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC--C---hHHHHHHHHHHHHHHhcCC--C-ceeeeeceEeeccCce
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--E---PESVKFMAREILILRRLDH--P-NVIKLEGLVTSRMSCS 191 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~--~---~~~~~~~~~E~~~l~~l~h--p-niv~l~~~~~~~~~~~ 191 (348)
..+.||.|..+.||+++...++..+++|....... . ....+.+..|.++++.+.. | .+++++.+ +.. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~--~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE--M 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT--T
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC--c
Confidence 45789999999999997555678899998653211 0 1123345678888887742 3 34455543 222 2
Q ss_pred EEEEEeeccc
Q 018936 192 LYLVFHYMEH 201 (348)
Q Consensus 192 ~~lv~e~~~~ 201 (348)
.++|||++++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 4799999975
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=5.3e-05 Score=69.03 Aligned_cols=32 Identities=22% Similarity=0.349 Sum_probs=28.5
Q ss_pred CCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 241 NGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 241 ~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 47999999999999988889999999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=1.3e-05 Score=73.85 Aligned_cols=84 Identities=8% Similarity=0.035 Sum_probs=52.0
Q ss_pred eeeeee-ccCCceEEEEEEEc--c----CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCC---CceeeeeceEeec
Q 018936 119 EKIDKI-GQGTYSNVYKAKDM--L----TGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH---PNVIKLEGLVTSR 187 (348)
Q Consensus 119 ~~~~~L-G~G~~g~Vy~~~~~--~----~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~ 187 (348)
...+.| +.|....+|+.... . ++..+++|....... .......+.+|+.+++.+.. -.+.+++++..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445778 88999999998642 0 266889997543210 00001346678888887742 3466777665443
Q ss_pred c-CceEEEEEeecccC
Q 018936 188 M-SCSLYLVFHYMEHD 202 (348)
Q Consensus 188 ~-~~~~~lv~e~~~~~ 202 (348)
. ....|++||++++.
T Consensus 103 ~~~g~~~~v~e~l~G~ 118 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGV 118 (357)
T ss_dssp TTTSSCEEEEECCCCB
T ss_pred CccCCceEEEEecCCC
Confidence 1 12457899999873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00014 Score=68.67 Aligned_cols=80 Identities=8% Similarity=0.066 Sum_probs=47.3
Q ss_pred HHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCcccccc--cCcccccccccCccc--CCccccHHHHHHHH
Q 018936 239 HNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV--TLWYRPPELLLGATD--YGVGVDLWSAGCIL 314 (348)
Q Consensus 239 H~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~--~~~~~DvwSlGv~l 314 (348)
+...++|+|++|.|||++.++ +.|+||+.+..-.+... ...... ...|++|+....... -....++.+....+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 345799999999999998776 99999999876532211 011110 233566654421000 01124445777777
Q ss_pred HHHHhCC
Q 018936 315 AELLAGK 321 (348)
Q Consensus 315 ~elltG~ 321 (348)
|+.+++.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7776653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00068 Score=61.39 Aligned_cols=75 Identities=16% Similarity=0.136 Sum_probs=56.1
Q ss_pred eeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeeccCceEEEE
Q 018936 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD---HPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~lv 195 (348)
.-.+.|+.|....+|+.. .++..+++|..... ....+..|...|+.|. ...+++++++... ....|++
T Consensus 39 ~~~~~l~gG~~n~~y~v~--~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lv 109 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIN--DEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLL 109 (312)
T ss_dssp CEEEEECCSSSSEEEEEE--SSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEE
T ss_pred eeeEEeCCccceeeeEEE--ECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEE
Confidence 446789999999999997 35678899987532 3566788999998883 3557777776654 3458999
Q ss_pred EeecccC
Q 018936 196 FHYMEHD 202 (348)
Q Consensus 196 ~e~~~~~ 202 (348)
||++++.
T Consensus 110 me~l~G~ 116 (312)
T 3jr1_A 110 LEALNKS 116 (312)
T ss_dssp EECCCCC
T ss_pred EEeccCC
Confidence 9999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00033 Score=62.43 Aligned_cols=76 Identities=16% Similarity=0.239 Sum_probs=52.5
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---ceeeeeceEeeccCceEE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP---NVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~~~ 193 (348)
...-++.+|.|..+.||+.+ ..+|+.|++|+-..... .....+..|...|+.|.-- .+++++++ . . -+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~--~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--D--RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--T--TE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--C--ce
Confidence 45677899999999999998 47899999998653322 2234577899999888422 23444432 2 1 36
Q ss_pred EEEeeccc
Q 018936 194 LVFHYMEH 201 (348)
Q Consensus 194 lv~e~~~~ 201 (348)
++||+++.
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 88998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00069 Score=63.07 Aligned_cols=153 Identities=16% Similarity=0.258 Sum_probs=85.2
Q ss_pred cccCCCCCceeeeeeccCCceEEEEEEEcc-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeee
Q 018936 110 WIPRRADSFEKIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLE 181 (348)
Q Consensus 110 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~ 181 (348)
|.....+.+++ +.|..|-...+|++.... ++..|++|+... . ......+.+|..+++.+. +.-..+++
T Consensus 45 W~~~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~-~~~~~~~~rE~~vl~~L~~~gv~P~ll 120 (379)
T 3feg_A 45 WRRVQPEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--I-LQGVDSLVLESVMFAILAERSLGPQLY 120 (379)
T ss_dssp GGGCCGGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEE
T ss_pred CCCCCcCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--c-cchHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 43333344543 567778888999997521 357899998522 1 112445668999998874 32235666
Q ss_pred ceEeeccCceEEEEEeecccChhhh------------------hcCCCCcCCc-chhhHHHHHHHHHHHHH---------
Q 018936 182 GLVTSRMSCSLYLVFHYMEHDLAGL------------------AASPEVKFTE-PQFVYLKVKCYMHQLLS--------- 233 (348)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~~~l~~~------------------~~~~~~~~~~-~~~~~~~~~~~~~qi~~--------- 233 (348)
+.+.+ .+||+|+++..+.. +......+.. +...+.++..|+.++..
T Consensus 121 ~~~~~------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~ 194 (379)
T 3feg_A 121 GVFPE------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEM 194 (379)
T ss_dssp EEETT------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSC
T ss_pred EEcCC------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchh
Confidence 55432 28899998632110 0011111111 12133445556554422
Q ss_pred ----------HHHHHH----HC----CceecCCCCCCEEECCC----CcEEEEeeCCcccc
Q 018936 234 ----------GLEHCH----NN----GVLHRDIKGSNLLIDDD----GVLKIADFGLASFF 272 (348)
Q Consensus 234 ----------aL~~LH----~~----~ivHrDikp~NIll~~~----~~~kl~DFGla~~~ 272 (348)
.+..|. .. .++|+|+.+.||+++.+ +.+.|+||..+..-
T Consensus 195 ~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 195 NLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp CHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred hhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 233333 22 59999999999999876 78999999988643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0012 Score=59.61 Aligned_cols=147 Identities=11% Similarity=0.064 Sum_probs=77.0
Q ss_pred eeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeece----EeeccCceE
Q 018936 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGL----VTSRMSCSL 192 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~----~~~~~~~~~ 192 (348)
.-++.|+.|....+|+... .+| .+++|...... ..+.+..|+.++..+.... +++++.. .........
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 4457788899899999974 344 68899876421 1223455777777763222 3333321 000112346
Q ss_pred EEEEeecccChhh----------------hhc-CCCCcCCc----chhhHHH-HHH-----------HHHHHHHHHHHHH
Q 018936 193 YLVFHYMEHDLAG----------------LAA-SPEVKFTE----PQFVYLK-VKC-----------YMHQLLSGLEHCH 239 (348)
Q Consensus 193 ~lv~e~~~~~l~~----------------~~~-~~~~~~~~----~~~~~~~-~~~-----------~~~qi~~aL~~LH 239 (348)
+++++++++.... +.. ........ ....+.. ... +...+...+..|+
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8899999863210 010 00111010 0000110 000 0012344555555
Q ss_pred H-------CCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 240 N-------NGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 240 ~-------~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
. .+++|+|+.+.|||++++..+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3 2699999999999998776568999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00094 Score=59.87 Aligned_cols=31 Identities=26% Similarity=0.308 Sum_probs=26.2
Q ss_pred CceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
.++|+|+.|.||+ ..++.+.|+||..+..-.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 4899999999999 566788999999887543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0026 Score=60.18 Aligned_cols=72 Identities=17% Similarity=0.191 Sum_probs=47.4
Q ss_pred eeeeeccCCceEEEEEEEcc-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeccCce
Q 018936 120 KIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IKLEGLVTSRMSCS 191 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~ 191 (348)
.++.|+.|....||++.... ++..+++|+..... . .+.+.+|..+++.+...++ +++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence 45678889999999997532 25789999873211 1 1345578888888843333 566665432
Q ss_pred EEEEEeeccc
Q 018936 192 LYLVFHYMEH 201 (348)
Q Consensus 192 ~~lv~e~~~~ 201 (348)
.++++|+++
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 278899875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0056 Score=55.23 Aligned_cols=75 Identities=13% Similarity=0.091 Sum_probs=46.0
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeece---EeeccCceEEEEE
Q 018936 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN--VIKLEGL---VTSRMSCSLYLVF 196 (348)
Q Consensus 122 ~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~---~~~~~~~~~~lv~ 196 (348)
..|+ |....||++.. .+|+.+++|........ .+.+..|..+++.+.... +++++.. .........+++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4566 88889998863 46778999998643222 334566888887774222 3444432 0001134567899
Q ss_pred eeccc
Q 018936 197 HYMEH 201 (348)
Q Consensus 197 e~~~~ 201 (348)
+++++
T Consensus 107 ~~i~G 111 (328)
T 1zyl_A 107 PSVGG 111 (328)
T ss_dssp ECCCC
T ss_pred EecCC
Confidence 99986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0014 Score=60.57 Aligned_cols=73 Identities=7% Similarity=0.021 Sum_probs=41.5
Q ss_pred eeeeeccCCceEEEEEEEcc--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeeccCc
Q 018936 120 KIDKIGQGTYSNVYKAKDML--------TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN-VIKLEGLVTSRMSC 190 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~ 190 (348)
....|+.|....+|++.... .+..+++|+.... .........|..+++.+...+ .+++++.+ .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C---
Confidence 34678888889999997532 1267888876432 111112356888888774333 34565433 1
Q ss_pred eEEEEEeeccc
Q 018936 191 SLYLVFHYMEH 201 (348)
Q Consensus 191 ~~~lv~e~~~~ 201 (348)
-+++|+|+++
T Consensus 109 -~~~v~e~i~G 118 (369)
T 3c5i_A 109 -GGRIEEWLYG 118 (369)
T ss_dssp -TEEEEECCCS
T ss_pred -CcEEEEEecC
Confidence 2578999876
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0093 Score=56.85 Aligned_cols=73 Identities=21% Similarity=0.159 Sum_probs=45.8
Q ss_pred eeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeeccCceEEEEEee
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-IKLEGLVTSRMSCSLYLVFHY 198 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~lv~e~ 198 (348)
-++.|+.|-...+|++.....+..+++|+..... . ... ...+|..+++.|...++ +++++.+. + .++++|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EII-NREREKKISCILYNKNIAKKIYVFFT---N---GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCS-CHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEe
Confidence 4567888999999999853335788999864321 1 111 12468899998865444 56766652 2 248999
Q ss_pred ccc
Q 018936 199 MEH 201 (348)
Q Consensus 199 ~~~ 201 (348)
+++
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 876
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.011 Score=53.79 Aligned_cols=32 Identities=22% Similarity=0.379 Sum_probs=28.5
Q ss_pred CceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
.++|+|+.+.||++++++.+.|+||+.+....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 69999999999999988889999999887653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0046 Score=56.10 Aligned_cols=33 Identities=27% Similarity=0.305 Sum_probs=28.4
Q ss_pred CCceecCCCCCCEEECCC----CcEEEEeeCCccccC
Q 018936 241 NGVLHRDIKGSNLLIDDD----GVLKIADFGLASFFD 273 (348)
Q Consensus 241 ~~ivHrDikp~NIll~~~----~~~kl~DFGla~~~~ 273 (348)
..++|+|+.+.|||++.+ +.+.|+||+.+..-.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 369999999999999874 689999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.68 E-value=0.021 Score=53.84 Aligned_cols=74 Identities=7% Similarity=-0.004 Sum_probs=45.4
Q ss_pred eeeeeccCCceEEEEEEEccC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCce
Q 018936 120 KIDKIGQGTYSNVYKAKDMLT-------GKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 191 (348)
-++.|..|-...+|+...... +..|++|+..... +..-...+|..+++.+. +.-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~------ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP------ 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC------
Confidence 446677788899999985321 5789999853321 11112346888888774 322455554331
Q ss_pred EEEEEeecccC
Q 018936 192 LYLVFHYMEHD 202 (348)
Q Consensus 192 ~~lv~e~~~~~ 202 (348)
-++|++|+++.
T Consensus 145 ~~~I~efI~G~ 155 (424)
T 3mes_A 145 EGRIEEFIDGE 155 (424)
T ss_dssp TEEEEECCCSE
T ss_pred CCEEEEEeCCc
Confidence 26789999873
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.98 E-value=0.19 Score=46.79 Aligned_cols=30 Identities=27% Similarity=0.499 Sum_probs=25.5
Q ss_pred ceecCCCCCCEEE------CCCCcEEEEeeCCcccc
Q 018936 243 VLHRDIKGSNLLI------DDDGVLKIADFGLASFF 272 (348)
Q Consensus 243 ivHrDikp~NIll------~~~~~~kl~DFGla~~~ 272 (348)
++|+|+.+.|||+ +++..+.++||..|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6799999999999 45678999999988643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=93.33 E-value=0.0084 Score=57.26 Aligned_cols=65 Identities=11% Similarity=0.169 Sum_probs=19.2
Q ss_pred eeeeeeccCCceEEEEEEEccCCcEEEE------EEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 018936 119 EKIDKIGQGTYSNVYKAKDMLTGKIVAL------KKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTS 186 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~g~~vAv------K~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 186 (348)
.+.+.|| ||.||+|....+..+||+ |..+......+....+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4556676 999999987555568999 7765444444555667789999999999999999887643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.27 E-value=0.33 Score=41.13 Aligned_cols=108 Identities=13% Similarity=-0.032 Sum_probs=62.1
Q ss_pred ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCccccCCCCCCCc
Q 018936 202 DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPM 280 (348)
Q Consensus 202 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 280 (348)
+|...+...... +.+.++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|++-+.+ ..+.
T Consensus 34 SL~eIL~~~~~P-----lsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLYNQP-----INEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHHTSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcCCC-----cCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 344444444444 4444588889999998877621 1222344557899999999888764 2111
Q ss_pred ccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChh
Q 018936 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330 (348)
Q Consensus 281 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~ 330 (348)
.....+.|||... ...+.+.=|||||+++|..+-=..|-....+.
T Consensus 98 ---~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~eE~eL 142 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKENEEREL 142 (229)
T ss_dssp ------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECC
T ss_pred ---ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcccchhh
Confidence 0112257888653 22567889999999999999744443333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 348 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-63 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-58 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-57 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-56 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-55 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-54 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-52 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-50 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-50 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-47 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-47 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-37 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-36 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-27 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 5e-63
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 9/220 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++ + +G+G Y V A + +T + VA+K V + + + +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHE 63
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
NV+K G R YL Y P++ EP + + HQL++G+
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-----AQRFFHQLMAGV 116
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPEL 294
+ H G+ HRDIK NLL+D+ LKI+DFGLA+ F N++ + TL Y PEL
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
L + VD+WS G +L +LAG+ ++ +
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-62
Identities = 109/227 (48%), Positives = 140/227 (61%), Gaps = 14/227 (6%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
+EK+ KIGQGT+ V+KA+ TG+ VALKKV +N + REI IL+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 173 DHPNVIKLEGLVTSRMS------CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKC 226
H NV+ L + ++ S S+YLVF + EHDLAGL ++ VKFT + +K
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-----IKR 121
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---HKHPMTSR 283
M LL+GL + H N +LHRD+K +N+LI DGVLK+ADFGLA F + T+R
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
VVTLWYRPPELLLG DYG +DLW AGCI+AE+ PIM G TE
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 7e-60
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 16/226 (7%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
RA+ +E + IG G+Y K + GKI+ K++ + ++ + + E+ +LR L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGL---AASPEVKFTEPQFVYLKVKCYMH 229
HPN+++ + R + +LY+V Y E DLA + E V M
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF-----VLRVMT 116
Query: 230 QLLSGLEHCH-----NNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRV 284
QL L+ CH + VLHRD+K +N+ +D +K+ DFGLA + + + V
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFV 175
Query: 285 VTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
T +Y PE + Y D+WS GC+L EL A P ++
Sbjct: 176 GTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-59
Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 13/232 (5%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD 173
+ D FEKI ++G G V+K +G ++A K + + ++P + RE+ +L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECN 62
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
P ++ G S + + +M+ + E + ++
Sbjct: 63 SPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQI-----LGKVSIAVIK 115
Query: 234 GLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
GL + + ++HRD+K SN+L++ G +K+ DFG++ + S V T Y P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSP 172
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
E L G T Y V D+WS G L E+ G+ +P F + D
Sbjct: 173 ERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 6e-59
Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 15/222 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDH 174
F + +IG G++ VY A+D+ ++VA+KK+ + + E + + +E+ L++L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
PN I+ G + +LV Y + L + E + + H L G
Sbjct: 75 PNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQG 127
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
L + H++ ++HRD+K N+L+ + G++K+ DFG AS P S V T ++ PE+
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEV 182
Query: 295 LLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
+L + Y VD+WS G EL KP + +SA +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 8e-59
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D +E I ++G G + VYKA++ T + A K + + E ++ EI IL DHP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++KL + L+++ + + + E TE Q ++ Q L
Sbjct: 70 NIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQ-----IQVVCKQTLDA 122
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
L + H+N ++HRD+K N+L DG +K+ADFG+++ + S + T ++ PE+
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEV 181
Query: 295 LLGATD----YGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
++ T Y D+WS G L E+ +P +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 8e-58
Identities = 71/216 (32%), Positives = 104/216 (48%), Gaps = 12/216 (5%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESV-KFMAREILILRRLDH 174
+ FE +G+G + NVY A++ + I+ALK + LE V + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
PN+++L G + +YL+ Y KF E + Y+ +L +
Sbjct: 66 PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQR-----TATYITELANA 118
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
L +CH+ V+HRDIK NLL+ G LKIADFG + + + + TL Y PPE+
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEM 175
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+ G + VDLWS G + E L GKP T
Sbjct: 176 IEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-57
Identities = 93/215 (43%), Positives = 134/215 (62%), Gaps = 11/215 (5%)
Query: 119 EKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL---EPESVKFMAREILILRRLDHP 175
EK+D +G+G ++ VYKA+D T +IVA+KK++ + + + REI +L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N+I L + ++ LVF +ME DL + + T +K YM L GL
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGL 113
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
E+ H + +LHRD+K +NLL+D++GVLK+ADFGLA F ++ T +VVT WYR PELL
Sbjct: 114 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELL 172
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
GA YGVGVD+W+ GCILAELL P +PG +++
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-57
Identities = 56/240 (23%), Positives = 98/240 (40%), Gaps = 18/240 (7%)
Query: 110 W-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILI 168
W IP +IG G++ VYK K VA+K + P+ ++ E+ +
Sbjct: 3 WEIPD--GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGV 57
Query: 169 LRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCY 227
LR+ H N++ G T+ L +V + E L E KF + +
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDI 109
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP-NHKHPMTSRVVT 286
Q G+++ H ++HRD+K +N+ + +D +KI DFGLA+ + H +
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 287 LWYRPPELLLGATD--YGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
+ + PE++ Y D+++ G +L EL+ G+ V P
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 186 bits (474), Expect = 5e-57
Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 15/218 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D ++ ++++G G + V++ + TG++ K + P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHP 86
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
+I L + + L+ ++ +L A+ + K +E + V YM Q G
Sbjct: 87 KLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAE-----VINYMRQACEG 139
Query: 235 LEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
L+H H + ++H DIK N++ + +KI DFGLA+ +P+ +T T + P
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAP 197
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
E++ G D+W+ G + LL+G G ++
Sbjct: 198 EIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 9e-57
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 12/229 (5%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + +KIGQG VY A D+ TG+ VA++++ + + EIL++R +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNP 77
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N++ L++V Y+ E E Q + + L L
Sbjct: 78 NIVNYLDSYLV--GDELWVVMEYLAGGSL-TDVVTETCMDEGQ-----IAAVCRECLQAL 129
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
E H+N V+HRDIK N+L+ DG +K+ DFG + P ++ V T ++ PE++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVV 188
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
YG VD+WS G + E++ G+P + A + N +
Sbjct: 189 TR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 186 bits (472), Expect = 9e-57
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D ++ +++G G + V++ + TG A K V + + + +EI + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHP 83
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
++ L + +++ +M +L A K +E + YM Q+ G
Sbjct: 84 TLVNLHDAFEDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDE-----AVEYMRQVCKG 136
Query: 235 LEHCHNNGVLHRDIKGSNLLI--DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
L H H N +H D+K N++ LK+ DFGL + DP +T+ T + P
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAP 194
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
E+ G G D+WS G + LL+G G +
Sbjct: 195 EVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-56
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 10/219 (4%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRR 171
+R + F+ +G+G++S V A+++ T + A+K + ++ + V ++ RE ++ R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
LDHP +KL LY Y ++ F E + Y ++
Sbjct: 65 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTAEI 117
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWYR 290
+S LE+ H G++HRD+K N+L+++D ++I DFG A P K + V T Y
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
PELL + DLW+ GCI+ +L+AG P E
Sbjct: 178 SPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNE 215
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-55
Identities = 96/216 (44%), Positives = 136/216 (62%), Gaps = 9/216 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
++F+K++KIG+GTY VYKA++ LTG++VALKK+R D REI +L+ L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++KL ++ + LYLVF ++ DL + AS P +K Y+ QLL G
Sbjct: 62 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPL-----IKSYLFQLLQG 114
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
L CH++ VLHRD+K NLLI+ +G +K+ADFGLA F + T VVTLWYR PE+
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEI 173
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
LLG Y VD+WS GCI AE++ + + PG +E+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-54
Identities = 82/235 (34%), Positives = 124/235 (52%), Gaps = 14/235 (5%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
+ + IG+G Y V A D + VA+KK+ + + + REI IL R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 175 PNVIKLEGLV---TSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
N+I + ++ T +YLV H M DL L + + + +++Q+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDH-----ICYFLYQI 118
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHP--MTSRVVTLWY 289
L GL++ H+ VLHRD+K SNLL++ LKI DFGLA DP+H H +T V T WY
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
R PE++L + Y +D+WS GCILAE+L+ +PI PG+ + +L ++ P
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSP 232
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 175 bits (443), Expect = 3e-53
Identities = 85/215 (39%), Positives = 127/215 (59%), Gaps = 9/215 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + ++KIG+GTY VYKA++ G+ ALKK+R + + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N++KL ++ ++ L LVF +++ DL L E K ++ QLL+G+
Sbjct: 61 NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVT-----AKSFLLQLLNGI 113
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
+CH+ VLHRD+K NLLI+ +G LKIADFGLA F + +VTLWYR P++L
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVL 172
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+G+ Y +D+WS GCI AE++ G P+ PG +E
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-53
Identities = 51/233 (21%), Positives = 91/233 (39%), Gaps = 16/233 (6%)
Query: 118 FEKID-KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPN 176
F K D +IG+G++ VYK D T VA +++ L + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 177 VIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
+++ T + + LV M ++ + Q+L G
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV-----LRSWCRQILKG 124
Query: 235 LEHCHNNG--VLHRDIKGSNLLIDD-DGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
L+ H ++HRD+K N+ I G +KI D GLA+ + + T +
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMA 181
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
PE+ Y VD+++ G + E+ + + + V + +
Sbjct: 182 PEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 8e-53
Identities = 86/220 (39%), Positives = 121/220 (55%), Gaps = 15/220 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
S+ IG G++ VY+AK +G++VA+KKV D +F RE+ I+R+LDH
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHC 73
Query: 176 NVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
N+++L S L LV Y+ + +A + + VK YM+QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--HYSRAKQTLPVIYVKLYMYQL 131
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
L + H+ G+ HRDIK NLL+D D VLK+ DFG A P S + + +YR
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYR 189
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
PEL+ GATDY +D+WSAGC+LAELL G+PI PG + V
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (439), Expect = 1e-52
Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 24/229 (10%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPES-------VKFMAREILI 168
+++E + +G+G S V + T K A+K + S + +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 169 LRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
LR++ HPN+I+L+ + +LVF M+ +L +V +E + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTE-KVTLSEKE-----TRK 114
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
M LL + H ++HRD+K N+L+DDD +K+ DFG + DP K + T
Sbjct: 115 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGT 172
Query: 287 LWYRPPELLLGATD-----YGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
Y PE++ + + YG VD+WS G I+ LLAG P R ++
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-52
Identities = 86/217 (39%), Positives = 121/217 (55%), Gaps = 9/217 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+EK++KIG+GTY V+KAK+ T +IVALK+VR D+ + REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
N+++L ++ S +L F + VK ++ QLL GL
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLK-------KYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
CH+ VLHRD+K NLLI+ +G LK+A+FGLA F + ++ VVTLWYRPP++L
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVL 173
Query: 296 LGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVS 331
GA Y +D+WSAGCI AEL P+ PG
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (433), Expect = 2e-51
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 16/219 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
D ++ D +G G +S V A+D T K+VA+K + LE + EI +L ++ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++ L+ + S LYL+ + +L +TE + Q+L
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERD-----ASRLIFQVLDA 119
Query: 235 LEHCHNNGVLHRDIKGSNLLI---DDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
+++ H+ G++HRD+K NLL D+D + I+DFGL+ DP +++ T Y
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVA 177
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
PE+L Y VD WS G I LL G P +
Sbjct: 178 PEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 215
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-50
Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 16/217 (7%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + + +G+G + V++ + + K K V+ + VK +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
N++ L S L ++F ++ D+ + + E + + Y+HQ+
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNERE-----IVSYVHQVCEA 114
Query: 235 LEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
L+ H++ + H DI+ N++ +KI +FG A Y P
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAP 172
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
E+ D+WS G ++ LL+G T
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETN 208
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-50
Identities = 85/222 (38%), Positives = 122/222 (54%), Gaps = 8/222 (3%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLT-GKIVALKKVRFDNLEPESVKFMAREILILRR 171
R +E + +IG+G Y V+KA+D+ G+ VALK+VR E RE+ +LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 172 L---DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYM 228
L +HPNV++L + T + + EH + + K EP +K M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
QLL GL+ H++ V+HRD+K N+L+ G +K+ADFGLA + TS VVTLW
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 180
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
YR PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V
Sbjct: 181 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDV 221
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 6e-50
Identities = 79/236 (33%), Positives = 113/236 (47%), Gaps = 15/236 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ + +G G Y V A D TG VA+KK+ K RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 176 NVIKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
NVI L + T + YLV +M DL L K E + ++ ++Q+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDR-----IQFLVYQM 130
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
L GL + H G++HRD+K NL +++D LKI DFGLA D MT VVT WYR
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRA 186
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFVF 347
PE++L Y VD+WS GCI+AE++ GK + G + + P F
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-50
Identities = 72/215 (33%), Positives = 111/215 (51%), Gaps = 7/215 (3%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++ + +G G Y +V A D TG VA+KK+ K RE+ +L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGL 235
NVI L + T S + + + H + + + V+ ++Q+L GL
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGL 134
Query: 236 EHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELL 295
++ H+ ++HRD+K SNL +++D LKI DFGLA D MT V T WYR PE++
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIM 190
Query: 296 LGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
L Y VD+WS GCI+AELL G+ + PG +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 9e-50
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 11/235 (4%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLD 173
+D +E + +G G S V+ A+D+ + VA+K +R D +P RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 174 HPNVIKLEGLVTSR--MSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
HP ++ + + Y+V Y++ E T + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR-----AIEVIADA 120
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRVVTLWY 289
L H NG++HRD+K +N++I +K+ DFG+A N + + T Y
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
PE G + D++S GC+L E+L G+P G + VS + V P
Sbjct: 181 LSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 2e-49
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 14/233 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMA----REILILRR 171
+ F IG+G + VY + TGK+ A+K + ++ + + +A + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
D P ++ + + L + M S F+E ++ Y ++
Sbjct: 64 GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEAD-----MRFYAAEI 116
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRP 291
+ GLEH HN V++RD+K +N+L+D+ G ++I+D GLA F H T Y
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG---THGYMA 173
Query: 292 PELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
PE+L Y D +S GC+L +LL G + L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 7e-49
Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 11/231 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL--EPESVKFMAREILILRRLD 173
+ F +G+G++ V+ A+ T + A+K ++ D + + + M + ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 174 HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
HP + + ++ + L+ V Y+ KF + Y +++
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSR-----ATFYAAEIIL 114
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
GL+ H+ G+++RD+K N+L+D DG +KIADFG+ + T Y PE
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPE 173
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344
+LLG Y VD WS G +L E+L G+ G+ E ++ F P
Sbjct: 174 ILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 223
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-48
Identities = 52/222 (23%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+PR ++ + ++++G G + V+ VA+K ++ ++ P++ E +++
Sbjct: 10 VPR--ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFL---AEANLMK 63
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG--LAASPEVKFTEPQFVYLKVKCYM 228
+L H +++L +VT +Y++ YME+ L +K T + +
Sbjct: 64 QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINK-----LLDMA 115
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLW 288
Q+ G+ +HRD++ +N+L+ D KIADFGLA + N +
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
+ PE + T + + D+WS G +L E++ G+ PG T
Sbjct: 176 WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-48
Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPE----SVKFMAREILILRR 171
D ++ +++G G ++ V K ++ TG A K ++ + S + + RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
+ HPNVI L + ++ + L+ + + + TE + ++ Q+
Sbjct: 70 IQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQI 122
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGV----LKIADFGLASFFDPNHKHPMTSRVVTL 287
L+G+ + H+ + H D+K N+++ D V +KI DFGLA D ++ + T
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 180
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
+ PE++ G+ D+WS G I LL+G G T+
Sbjct: 181 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK 221
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-48
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 14/220 (6%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
IPR +S K+GQG + V+ T + VA+K ++ + PE+ +E +++
Sbjct: 14 IPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMK 67
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
+L H +++L +V+ +Y+V YM G T ++ Q
Sbjct: 68 KLRHEKLVQLYAVVSEE---PIYIVTEYMSK---GSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
+ SG+ + +HRD++ +N+L+ ++ V K+ADFGLA + N + +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
PE L + + D+WS G +L EL G+ PG
Sbjct: 182 APEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVN 220
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-47
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 10/215 (4%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
+ F+ + +G+GT+ V ++ TG+ A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
P + L+ + L V Y S E FTE + + Y +++S
Sbjct: 65 PFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
LE+ H+ V++RDIK NL++D DG +KI DFGL + M + T Y PE+
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329
L DYG VD W G ++ E++ G+ +
Sbjct: 177 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (408), Expect = 1e-47
Identities = 50/216 (23%), Positives = 97/216 (44%), Gaps = 13/216 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
F+ + +G G++ V+ + G+ A+K ++ + + + V+ E L+L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
P +I++ G ++++ Y+E +F P K Y ++
Sbjct: 64 PFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLA 116
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
LE+ H+ +++RD+K N+L+D +G +KI DFG A + + T Y PE+
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 172
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+ Y +D WS G ++ E+LAG +
Sbjct: 173 VSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-47
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 16/223 (7%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL----EPESVKFMAREILILR 170
++ +G G + +VY + VA+K V D + E + + E+++L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 171 RLD--HPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYM 228
++ VI+L S L L DL E + +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEEL-----ARSFF 116
Query: 229 HQLLSGLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTL 287
Q+L + HCHN GVLHRDIK N+LID + G LK+ DFG + T T
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTR 173
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
Y PPE + +G +WS G +L +++ G E+
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (408), Expect = 2e-47
Identities = 66/235 (28%), Positives = 124/235 (52%), Gaps = 19/235 (8%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DH 174
D ++ + K+G+G YS V++A ++ + V +K ++ P K + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
PN+I L +V +S + LVF ++ + D L T+ ++ YM+++L
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYD-----IRFYMYEILK 140
Query: 234 GLEHCHNNGVLHRDIKGSNLLID-DDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPP 292
L++CH+ G++HRD+K N++ID + L++ D+GLA F+ P ++ RV + +++ P
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 293 ELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFVF 347
ELL+ Y +D+WS GC+LA ++ K + + ++ ++
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-46
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ +IG G + V+ L VA+K +R + E E ++ +L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
+++L G+ + LVF +MEH L+ + F + + G
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAET-----LLGMCLDVCEG 113
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
+ + V+HRD+ N L+ ++ V+K++DFG+ F + T + + PE+
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173
Query: 295 LLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
+ Y D+WS G ++ E+ + GK R+
Sbjct: 174 FSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (398), Expect = 2e-46
Identities = 47/229 (20%), Positives = 93/229 (40%), Gaps = 11/229 (4%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILR 170
+ R K+G G Y VY+ VA+K ++ D +E E +E +++
Sbjct: 14 MER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMK 68
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
+ HPN+++L G+ T + F + L L + + +Y Q
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQ 123
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYR 290
+ S +E+ +HRD+ N L+ ++ ++K+ADFGL+ + + +
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 291 PPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339
PE L + + D+W+ G +L E+ ++S + +
Sbjct: 184 APESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (401), Expect = 3e-46
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 13/216 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDH 174
D F++I +G G++ V K +G A+K + + + + ++ E IL+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 175 PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
P ++KLE + + + + + L +F+EP + Y Q++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPH-----ARFYAAQIVLT 153
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
E+ H+ +++RD+K NLLID G +++ DFG A K + T PE+
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEI 209
Query: 295 LLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
+L Y VD W+ G ++ E+ AG P +
Sbjct: 210 ILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-46
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 15/222 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNL-EPESVKFMAREILILRR 171
++K+G G++ V + + VA+K ++ D L +PE++ RE+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
LDH N+I+L G+V + + +V L + F + Y Q
Sbjct: 68 LDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGT-----LSRYAVQ 119
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWY 289
+ G+ + + +HRD+ NLL+ ++KI DFGL N H M +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330
L + D W G L E+ G+ G
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-46
Identities = 48/225 (21%), Positives = 91/225 (40%), Gaps = 23/225 (10%)
Query: 109 GW-IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREIL 167
GW + + + IG+G + +V G VA+K ++ + + E
Sbjct: 1 GWALNM--KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK----NDATAQAFLAEAS 52
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVK 225
++ +L H N+++L G++ LY+V YM L L + +
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDC-----LL 106
Query: 226 CYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV 285
+ + +E+ N +HRD+ N+L+ +D V K++DFGL + +
Sbjct: 107 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKL 162
Query: 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
+ + PE L + D+WS G +L E+ + G+ P
Sbjct: 163 PVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-45
Identities = 44/216 (20%), Positives = 93/216 (43%), Gaps = 14/216 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHP 175
+ ++G G + V K VA+K ++ ++ + E ++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHE 59
Query: 176 NVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSG 234
+++L G+ T + ++++ YM + L +F Q + +
Sbjct: 60 KLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLE-----MCKDVCEA 112
Query: 235 LEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPEL 294
+E+ + LHRD+ N L++D GV+K++DFGL+ + + + + PPE+
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 295 LLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
L+ + + D+W+ G ++ E+ + GK T
Sbjct: 173 LMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 7e-45
Identities = 43/225 (19%), Positives = 93/225 (41%), Gaps = 15/225 (6%)
Query: 110 WIPRRADSFEKIDKIGQGTYSNVYKA--KDMLTGKIVALKKVRFDNLEPESVKFMAREIL 167
++ R+ + E ++G G + V K + K VA+K ++ + +P + E
Sbjct: 2 YLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCY 227
++++LD+P ++++ G+ + S LV E + +
Sbjct: 61 VMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKN-----IIEL 112
Query: 228 MHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-- 285
+HQ+ G+++ + +HRD+ N+L+ KI+DFGL+ + +
Sbjct: 113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 286 TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
+ + PE + + D+WS G ++ E + G+ G
Sbjct: 173 PVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-44
Identities = 48/224 (21%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLT---GKIVALKKVRFDNLEPESVKFMAREIL 167
I R + E IG+G + +V++ M VA+K + + KF+ +E L
Sbjct: 4 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEAL 60
Query: 168 ILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKC 226
+R+ DHP+++KL G++T ++++ +L + +
Sbjct: 61 TMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLAS-----LIL 112
Query: 227 YMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
Y +QL + L + + +HRDI N+L+ + +K+ DFGL+ + + + + + +
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
+ + PE + + D+W G + E+L G G
Sbjct: 173 IKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-44
Identities = 63/255 (24%), Positives = 105/255 (41%), Gaps = 32/255 (12%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGKI-----VALKKVRFDNLEPESVKFMARE 165
PR ++ E +G G + V A K VA+K ++ E M E
Sbjct: 34 FPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SE 90
Query: 166 ILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYL- 222
+ ++ +L H N++ L G T S +YL+F Y + DL S KF+E + Y
Sbjct: 91 LKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 223 ----------------KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266
+ C+ +Q+ G+E +HRD+ N+L+ V+KI DF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 267 GLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIM 324
GLA + + + + + + PE L Y + D+WS G +L E+ + G
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 325 PGRTEVSATFCFVLN 339
PG + + + N
Sbjct: 268 PGIPVDANFYKLIQN 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-44
Identities = 49/241 (20%), Positives = 96/241 (39%), Gaps = 24/241 (9%)
Query: 116 DSFEKIDK-IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-D 173
D ++ + +G G V + + T + ALK ++ RE+ + R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 174 HPNVIKLEGLVTSRMSC--SLYLVFHYMEH-DLAG-LAASPEVKFTEPQFVYLKVKCYMH 229
P+++++ + + + L +V ++ +L + + FTE + M
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE-----ASEIMK 118
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLID---DDGVLKIADFGLASFFDPNHKHPMTSRVVT 286
+ +++ H+ + HRD+K NLL + +LK+ DFG A ++ T
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--T 176
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFV 346
+Y PE+L Y D+WS G I+ LL G P ++ + + +
Sbjct: 177 PYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 347 F 347
F
Sbjct: 236 F 236
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (384), Expect = 3e-44
Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRL 172
+ IG G + V L GK VA+K ++ E + F+ E I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQF 84
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
DHPNVI LEG+VT S + ++ +ME+ L + +FT Q + + +
Sbjct: 85 DHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQ-----LVGMLRGI 137
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV----TL 287
+G+++ + +HRD+ N+L++ + V K++DFGL+ F + + P + + +
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 288 WYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
+ PE + + D+WS G ++ E+++ G+ T
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 3e-44
Identities = 47/222 (21%), Positives = 78/222 (35%), Gaps = 20/222 (9%)
Query: 113 RRADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL 172
R + + KIG G++ ++Y D+ G+ VA+K P+ + E I + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMM 59
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLL 232
I + +V + L L KF+ V Q++
Sbjct: 60 QGGVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKT-----VLLLADQMI 113
Query: 233 SGLEHCHNNGVLHRDIKGSNLLIDDDG---VLKIADFGLASFFDPN------HKHPMTSR 283
S +E+ H+ +HRD+K N L+ ++ I DFGLA + +
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 284 VVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMP 325
T Y LG + DL S G +L G
Sbjct: 174 TGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQ 214
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-44
Identities = 48/220 (21%), Positives = 92/220 (41%), Gaps = 17/220 (7%)
Query: 116 DSFEKID-KIGQGTYSNVYKAKDMLTGK--IVALKKVRFDNLEPESVKFMAREILILRRL 172
D+ D ++G G + +V + + K VA+K ++ E + M RE I+ +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQL 66
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
D+P +++L G+ + +L LV L + V +HQ+
Sbjct: 67 DNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSN-----VAELLHQV 118
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN--HKHPMTSRVVTLWY 289
G+++ +HRD+ N+L+ + KI+DFGL+ + + ++ L +
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRT 328
PE + + D+WS G + E L+ G+
Sbjct: 179 YAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 2e-43
Identities = 53/236 (22%), Positives = 102/236 (43%), Gaps = 31/236 (13%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAK-----DMLTGKIVALKKVRFDNLEPESVKFMARE 165
PR ++ E + IG+G + V++A+ +VA+K ++ + F RE
Sbjct: 10 YPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 66
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEH----------------DLAGLAAS 209
++ D+PN++KL G + + L+F YM + L+ S
Sbjct: 67 AALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 210 PEVKFTEPQFVYL---KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266
+ + P L + C Q+ +G+ + +HRD+ N L+ ++ V+KIADF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 267 GLASFFDP-NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK 321
GL+ ++ + + + + PPE + Y D+W+ G +L E+ +
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYG 239
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 5e-43
Identities = 67/217 (30%), Positives = 116/217 (53%), Gaps = 15/217 (6%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ + IG G V A D + + VA+KK+ K RE+++++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 178 IKLEGLVTSRMSCS----LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLS 233
I L + T + + +YLV M+ + + + + + ++ ++Q+L
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDAN--------LCQVIQMELDHERMSYLLYQMLC 130
Query: 234 GLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPE 293
G++H H+ G++HRD+K SN+++ D LKI DFGLA + MT VVT +YR PE
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPE 188
Query: 294 LLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEV 330
++LG Y VD+WS GCI+ E++ K + PGR +
Sbjct: 189 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 7e-43
Identities = 46/221 (20%), Positives = 85/221 (38%), Gaps = 13/221 (5%)
Query: 114 RADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALK---KVRFDNLEPESVKFMAREILILR 170
+ F+KI +G G + VYK + G+ V + K + P++ K + E ++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 171 RLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQ 230
+D+P+V +L G+ + + L + + + Q
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLN-----WCVQ 119
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVV-TLWY 289
+ G+ + + ++HRD+ N+L+ +KI DFGLA K + +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 290 RPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
E +L Y D+WS G + EL+ G G
Sbjct: 180 MALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 2e-42
Identities = 42/225 (18%), Positives = 78/225 (34%), Gaps = 22/225 (9%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
++ +IG+G++ +++ ++L + VA+K + P+ + E + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTG 62
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
I LV + L L KF+ V Q+L+ ++
Sbjct: 63 IPNVYYFGQEGLH-NVLVIDLLGPSLEDLLDLCGRKFSVKT-----VAMAAKQMLARVQS 116
Query: 238 CHNNGVLHRDIKGSNLLIDD-----DGVLKIADFGLASFFDPN------HKHPMTSRVVT 286
H +++RDIK N LI ++ + DFG+ F+ + T
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 287 LWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331
Y LG + DL + G + L G G +
Sbjct: 177 ARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-42
Identities = 56/239 (23%), Positives = 110/239 (46%), Gaps = 14/239 (5%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNL--EPESVKFMAREILILR 170
++FE + +G G Y V+ + + TGK+ A+K ++ + + ++ + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 171 RLDH-PNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMH 229
+ P ++ L + L+L+ Y+ S +FTE + V+ Y+
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVG 136
Query: 230 QLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSRVVTLWY 289
+++ LEH H G+++RDIK N+L+D +G + + DFGL+ F + T+ Y
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 290 RPPELLLGA-TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPFVF 347
P+++ G + + VD WS G ++ ELL G E ++ ++ +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-41
Identities = 52/237 (21%), Positives = 84/237 (35%), Gaps = 17/237 (7%)
Query: 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH 174
A + + IG+G + V++ K G+ VA+K + E F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIF---SSREERSWFREAEIYQTVMLRH 56
Query: 175 PNVIKLEGLVTSRMSC--SLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKV-KCYMHQ 230
N++ L+LV Y EH L V + L H
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKH---PMTSRVVTL 287
+ + + HRD+K N+L+ +G IAD GLA D RV T
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 288 WYRPPELLLGA-----TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339
Y PE+L + + D+++ G + E+ I + + ++
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 9e-40
Identities = 54/245 (22%), Positives = 95/245 (38%), Gaps = 19/245 (7%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMARE 165
PR D + +G+G + V +A T + VA+K ++ E M+
Sbjct: 10 FPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 67
Query: 166 ILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYL--- 222
+++ H NV+ L G T + +V +L+ S +F +
Sbjct: 68 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127
Query: 223 -------KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275
+ CY Q+ G+E + +HRD+ N+L+ + V+KI DFGLA +
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 276 HKHPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATF 334
+ L + PE + Y + D+WS G +L E+ + ++ F
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 335 CFVLN 339
C L
Sbjct: 247 CRRLK 251
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 4e-39
Identities = 48/237 (20%), Positives = 99/237 (41%), Gaps = 16/237 (6%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRR 171
+ IG G + VYK + VA+K ++ E + V F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 172 LDHPNVIKLEGLVTSRMSCSLYLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQ 230
H N+I+LEG+++ + ++ YME+ + +F+ Q + +
Sbjct: 66 FSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQ-----LVGMLRG 118
Query: 231 LLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF--DPNHKHPMTSRVVTLW 288
+ +G+++ N +HRD+ N+L++ + V K++DFGL+ DP + + + +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDPF 345
+ PE + D+WS G ++ E++ + + P
Sbjct: 179 WTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 234
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-38
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 16/217 (7%)
Query: 122 DKIGQGTYSNVYKAKDML---TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVI 178
+ IG+G + VY + A+K + E +F+ E +I++ HPNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 179 KLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEH 237
L G + R S +V YM+H DL + T + + Q+ G++
Sbjct: 92 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-----LIGFGLQVAKGMKF 145
Query: 238 CHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN---HKHPMTSRVVTLWYRPPEL 294
+ +HRD+ N ++D+ +K+ADFGLA H T + + + E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 295 LLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 330
L + D+WS G +L EL+ G P P
Sbjct: 206 LQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-38
Identities = 49/253 (19%), Positives = 87/253 (34%), Gaps = 37/253 (14%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMARE 165
PR + +G G + V +A VA+K ++ E M E
Sbjct: 20 FPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SE 76
Query: 166 ILILRRL-DHPNVIKLEGLVTSRMSCSLYLVFHYMEH------------------DLAGL 206
+ +L L +H N++ L G T ++ Y + +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 207 AASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266
E+ + + +Q+ G+ + +HRD+ N+L+ + KI DF
Sbjct: 135 MEDDELALDLED-----LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 267 GLASFFDPNHKHPMTSRVV-TLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIM 324
GLA + + + + + PE + Y D+WS G L EL + G
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPY 248
Query: 325 PGRTEVSATFCFV 337
PG S + +
Sbjct: 249 PGMPVDSKFYKMI 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-38
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 21/229 (9%)
Query: 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRL- 172
+ + D IG+G + V KA+ G A+K+++ + + + A E+ +L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 68
Query: 173 DHPNVIKLEGLVTSRMSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYL--------- 222
HPN+I L G LYL Y H +L V T+P F
Sbjct: 69 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 223 -KVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMT 281
++ + + G+++ +HRD+ N+L+ ++ V KIADFGL+ + K T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 282 SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
+ + + E L + Y D+WS G +L E+++ G G T
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 8e-37
Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 25/239 (10%)
Query: 111 IPRRADSFEKIDKIGQGTYSNVYKAKDMLTGK-------IVALKKVRFDNLEPESVKFMA 163
+PR D +G+G + V A+ + K VA+K ++ D E + ++
Sbjct: 10 LPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS 67
Query: 164 REILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-----------LAGLAASPEV 212
++ H N+I L G T LY++ Y +
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 213 KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272
E Q + +Q+ G+E+ + +HRD+ N+L+ +D V+KIADFGLA
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 273 DPNHKHPMT-SRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329
+ T + + + + PE L Y D+WS G +L E+ G PG
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 133 bits (334), Expect = 2e-36
Identities = 67/233 (28%), Positives = 113/233 (48%), Gaps = 26/233 (11%)
Query: 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV 177
+ + K+G G +S V+ AKDM+ VA+K VR D + E+ + EI +L+R++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 178 IKLEGLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLK----------VKCY 227
K + + + + L F++ + + EV + K VK
Sbjct: 72 TKEDSMGANHI-LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 228 MHQLLSGLEHC-HNNGVLHRDIKGSNLLIDDDGV------LKIADFGLASFFDPNHKHPM 280
QLL GL++ G++H DIK N+L++ +KIAD G A ++D ++ + +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 281 TSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333
+R YR PE+LLGA +G G D+WS C++ EL+ G + S T
Sbjct: 191 QTR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-36
Identities = 45/239 (18%), Positives = 95/239 (39%), Gaps = 18/239 (7%)
Query: 96 PPWLTAVCGEALNGW-IPRRADSFEKIDKIGQGTYSNVYKAKD-----MLTGKIVALKKV 149
P + +A + W + R + ++GQG++ VY+ VA+K V
Sbjct: 1 PEYFSAADVYVPDEWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 58
Query: 150 RFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVFHYMEHD-----LA 204
E ++F+ E +++ + +V++L G+V+ ++ M L
Sbjct: 59 NEAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLR 115
Query: 205 GLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIA 264
L + K+ ++ G+ + + N +HRD+ N ++ +D +KI
Sbjct: 116 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175
Query: 265 DFGLASFF-DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKP 322
DFG+ + ++ ++ + + PE L + D+WS G +L E+
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAE 233
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (256), Expect = 6e-27
Identities = 26/208 (12%), Positives = 65/208 (31%), Gaps = 35/208 (16%)
Query: 122 DKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFM--------AREILILRRLD 173
+G+G S V+ +K + + + VK + + R +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 174 HPNVIKLEG--LVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQL 231
+ KL+G + ++ ++ + + +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK------------ELYRVRVENPDEVLDMI 112
Query: 232 LSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNHKHPMTSR---VVTLW 288
L + ++ G++H D+ N+L+ ++G+ I DF + + R + +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITY 171
Query: 289 YRPPELLLGATDYGVGVDLWSAGCILAE 316
+ Y D+ SA + +
Sbjct: 172 FS--------RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 348 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.23 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.43 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=374.23 Aligned_cols=214 Identities=30% Similarity=0.470 Sum_probs=176.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|+++.+|+.||||++...... +..+.+.+|+++|++++|||||++++++.+. ...|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~iv 81 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLF 81 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeEEE
Confidence 6899999999999999999999999999999999765432 3345688999999999999999999999874 569999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ ++...+. ... .+++..++.++.||+.||+|||++||+||||||+|||+++++++||+|||+|+....
T Consensus 82 mEy~~gg~L~~~l~-~~~-----~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 82 LEYCSGGELFDRIE-PDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EECCTTEEGGGGSB-TTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EeccCCCcHHHHHh-cCC-----CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 999987 4444443 332 345556889999999999999999999999999999999999999999999997653
Q ss_pred CC-CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHH
Q 018936 275 NH-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 275 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~ 338 (348)
.. .......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.++....+..+.
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~ 220 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 32 22345668999999999988765456789999999999999999999988776555554443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=372.75 Aligned_cols=214 Identities=32% Similarity=0.468 Sum_probs=179.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+... .....+.+.+|+++++.++|||||++++++.+ ....|+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEEE
Confidence 689999999999999999999999999999999875432 22335668889999999999999999999987 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........ .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 84 vmEy~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EEeecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999998754433332222 344556889999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
.. .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+...++....
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 220 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 220 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred Cc---ccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 32 3556899999999999875 48999999999999999999999999988766665555443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=375.88 Aligned_cols=222 Identities=28% Similarity=0.459 Sum_probs=172.7
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++++.||+|+||+||+|+++.+|+.||+|.+......+...+.+.+|+++|++++|||||++++++.++....+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 37899999999999999999999999999999999888777777888999999999999999999999998766667899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG-----VLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
||||++++.+..+...... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999987444333211100 0113455568999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
+...... .......||+.|+|||++.+. .|+.++|||||||++|||+||++||.+.+..+...++...
T Consensus 162 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~ 229 (269)
T d2java1 162 RILNHDT-SFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 229 (269)
T ss_dssp HHC------------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred eecccCC-CccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 9875432 224557899999999988764 4899999999999999999999999998876655555444
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=372.31 Aligned_cols=213 Identities=27% Similarity=0.492 Sum_probs=183.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+.+|+++|+.++|||||++++++.+. ..+|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEEEE
Confidence 5799999999999999999999999999999999765432 346788999999999999999999999874 469999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+..+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+...
T Consensus 96 mEy~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 9999875554443221 3455568899999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
. ......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+....++.+.
T Consensus 170 ~-~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~ 232 (293)
T d1yhwa1 170 Q-SKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (293)
T ss_dssp T-CCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred c-ccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence 3 234566899999999998874 48999999999999999999999999988888887777664
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=375.07 Aligned_cols=216 Identities=29% Similarity=0.450 Sum_probs=178.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++.+.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++++|||||++++++.+. ..+|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEE
Confidence 679999999999999999999999999999999976432 223456788999999999999999999999874 56999
Q ss_pred EEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||++++ +..... ... .+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+.+.
T Consensus 86 vmEy~~gg~L~~~~~-~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIR-KIG-----SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EECCCTTEEHHHHHH-HHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEccCCCCHHHhhh-ccC-----CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999874 444433 222 34455588999999999999999999999999999999999999999999999875
Q ss_pred CCC-CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 274 PNH-KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 274 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
... .......+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+...+++...
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 226 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred cCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC
Confidence 432 22345568999999999988754 8999999999999999999999999988777666665543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=377.92 Aligned_cols=219 Identities=27% Similarity=0.398 Sum_probs=184.0
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccccc
Confidence 4789999999999999999999999999999999976532 22345678889999999999999999999987 45699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||++++.+......... +++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 82 iv~ey~~gg~L~~~~~~~~~-----~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred cceeccCCCchhhhhhcccC-----CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999997655444443333 3444588899999999999999999999999999999999999999999999764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
... ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+....+....+.
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~ 223 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cCC-cccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC
Confidence 332 234567899999999998875 4899999999999999999999999998876666666554443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-51 Score=372.44 Aligned_cols=214 Identities=29% Similarity=0.518 Sum_probs=183.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
..|+.+++||+|+||+||+|++..+|+.||||++...... ....+.+.+|+++|++++|||||++++++.+. ...|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEE
Confidence 3599999999999999999999999999999999876653 34566788999999999999999999999874 56999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||+.++.+........ .+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+....
T Consensus 93 v~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999877765544333 344555889999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcccccccCcccccccccCc--ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
.....||+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+.+..+....++.+..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~ 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 2456799999999998642 3488999999999999999999999999888877777766543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-51 Score=374.41 Aligned_cols=216 Identities=23% Similarity=0.377 Sum_probs=183.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
++|++++.||+|+||+||+|+++.+|+.||||+++++.. .....+.+.+|+.+|+.++|||||++++++.+ ...+|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeeee
Confidence 679999999999999999999999999999999975432 22345678899999999999999999999987 456999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+........... ...++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~-----~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFP-----NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCC-----HHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeeecCCcccccccccccccc-----ccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999866555544443333 334778999999999999999999999999999999999999999999998743
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFD 343 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~ 343 (348)
. ....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+...++.......
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~ 220 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF 220 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC
T ss_pred c----cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC
Confidence 3 3457899999999998775 48999999999999999999999999988877777776654433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=362.34 Aligned_cols=215 Identities=22% Similarity=0.299 Sum_probs=180.1
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--cCceEEEE
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR--MSCSLYLV 195 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~lv 195 (348)
|++.++||+|+||+||+|++..++..||+|.+..........+.+.+|+++|++++|||||++++++... ....+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4778899999999999999999999999999987766667778899999999999999999999998653 34568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCCEEEC-CCCcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNG--VLHRDIKGSNLLID-DDGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kl~DFGla~~~ 272 (348)
|||++++.+........ .++...++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99998755444333222 3445558889999999999999998 99999999999997 5789999999999875
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+..+....++.+.....
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred cCC---ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC
Confidence 433 2356789999999998865 3899999999999999999999999988777777766655443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=377.40 Aligned_cols=205 Identities=25% Similarity=0.405 Sum_probs=173.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|+++++||+|+||+||+|++..+|+.||+|+++... .....+.+.+|+.+|+.++|||||+++++|.+. ..+|+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 378999999999999999999999999999999997654 344466788999999999999999999999874 46999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
||||++++.+..+..... .+++..++.++.||+.||.|||+ +||+||||||+|||++.++++||+|||+|+...
T Consensus 82 VmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999754443332222 34555688999999999999997 599999999999999999999999999999764
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
... ..+.+||+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.+..+
T Consensus 157 ~~~---~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 157 DSM---ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp HHT---C---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred CCc---cccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 322 34568999999999998754 9999999999999999999999998866543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=368.11 Aligned_cols=214 Identities=26% Similarity=0.397 Sum_probs=179.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|++++.||+|+||+||+|++..+|..||||+++... ....+.+.+|+++|+.++|||||++++++.+. ...|+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CeEEEE
Confidence 57999999999999999999999999999999997653 33456788899999999999999999999874 469999
Q ss_pred EeecccChhhhh-cCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGLA-ASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++.+..+ ..... .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 88 mEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 999987555443 32222 244555889999999999999999999999999999999999999999999976532
Q ss_pred CCCCCcccccccCcccccccccC----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLG----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
.. .......||+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+...++...
T Consensus 163 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~ 230 (288)
T d2jfla1 163 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230 (288)
T ss_dssp HH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS
T ss_pred Cc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 21 11345678999999998742 344889999999999999999999999998888777777654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-50 Score=367.85 Aligned_cols=215 Identities=29% Similarity=0.443 Sum_probs=164.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
+.|++.+.||+|+||+||+|+++.+|+.||||++....... ..+.+.+|+++|+.++|||||++++++.+ ...+|+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 67999999999999999999999999999999998765433 24567789999999999999999999987 4569999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC---CCCcEEEEeeCCccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID---DDGVLKIADFGLASF 271 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kl~DFGla~~ 271 (348)
|||+++ +|...+.. .. .+++..++.++.||+.||+|||++||+||||||+|||+. +++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~-~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KG-----FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp ECCCCSCBHHHHHHT-CS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EeccCCCcHHHhhhc-cc-----CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999985 55555543 22 345556889999999999999999999999999999995 578999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+....+......
T Consensus 160 ~~~~~--~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~ 227 (307)
T d1a06a_ 160 EDPGS--VLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227 (307)
T ss_dssp ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC
T ss_pred ccCCC--eeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC
Confidence 65433 24556899999999998875 4899999999999999999999999998877766666655443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=361.65 Aligned_cols=218 Identities=24% Similarity=0.382 Sum_probs=177.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|+. +..||||+++.........+.+.+|+++|++++|||||+++|++.. ..+++|
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv 81 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIV 81 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEEE
Confidence 7899999999999999999974 2369999998776666778889999999999999999999998754 247999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||+++ ++...+..... .+++..+..++.||+.||+|||+++||||||||+|||++.++++||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999986 55555544333 344555888999999999999999999999999999999999999999999987653
Q ss_pred CC-CCCcccccccCcccccccccCc--ccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 275 NH-KHPMTSRVVTLWYRPPELLLGA--TDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 275 ~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
.. ........||+.|+|||++.+. ..|+.++|||||||++|||+||+.||.+.+........+......|
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p 229 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 32 2234556789999999998642 3478999999999999999999999999888888877777766555
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-50 Score=373.47 Aligned_cols=218 Identities=25% Similarity=0.375 Sum_probs=183.2
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+.++|||||++++++.. ....+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--ccccc
Confidence 3789999999999999999999999999999999875432 22345678899999999999999999999887 45689
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||+.++.+........ .+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cccccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 9999998765544433322 34455588999999999999999999999999999999999999999999999875
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
.. .....||+.|+|||++.+. .|+.++|||||||++|||+||++||.+.+......++.......|
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p 258 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred cc----cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC
Confidence 33 3456899999999998875 489999999999999999999999999887777777666554433
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=361.91 Aligned_cols=218 Identities=44% Similarity=0.816 Sum_probs=184.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++++.||+|+||+||+|++..+|+.||||+++.....+...+.+.+|+++|++++|||||++++++.+ ...+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence 68999999999999999999999999999999997765554556778899999999999999999999987 4569999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||+++++.......... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~e~~~~~~~~~~~~~~~~----~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSEEHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred EeecCCchhhhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 999998877665432211 3455569999999999999999999999999999999999999999999999887543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
. .......||+.|+|||.+.....++.++|+||+||++|+|++|+.||.+.++.+...+++...
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~ 219 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 2 234556789999999988776667899999999999999999999999999888888877654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-49 Score=367.17 Aligned_cols=215 Identities=24% Similarity=0.419 Sum_probs=183.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+++|+.++|||||+++++|.+ ...+|+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 104 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLI 104 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 67999999999999999999999999999999987643 3345678889999999999999999999987 4569999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC--CCCcEEEEeeCCcccc
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~--~~~~~kl~DFGla~~~ 272 (348)
|||++++ |...+...... +++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.+
T Consensus 105 mE~~~gg~L~~~~~~~~~~-----l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EECCCCCBHHHHTTCTTCC-----BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCChHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 9999865 44544443333 44555899999999999999999999999999999998 6789999999999987
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
.... ......||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+..+...++......
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 246 (352)
T d1koba_ 180 NPDE--IVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246 (352)
T ss_dssp CTTS--CEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC
T ss_pred CCCC--ceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 6543 24556789999999988775 4999999999999999999999999999888877777665543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-49 Score=366.76 Aligned_cols=214 Identities=24% Similarity=0.389 Sum_probs=181.7
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+. ..+|+|
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 101 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMI 101 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 68999999999999999999999999999999986543 44567788999999999999999999999874 569999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC--CCCcEEEEeeCCcccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID--DDGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~--~~~~~kl~DFGla~~~ 272 (348)
|||+++ ++...+...... +++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+.+
T Consensus 102 mE~~~gg~L~~~l~~~~~~-----l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSC-----BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999986 555555443333 45555889999999999999999999999999999996 4678999999999987
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
.... ......||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 177 ~~~~--~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 242 (350)
T d1koaa2 177 DPKQ--SVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 242 (350)
T ss_dssp CTTS--CEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccc--ccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 5433 245668899999999988754 89999999999999999999999999888777766665443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=361.12 Aligned_cols=213 Identities=44% Similarity=0.761 Sum_probs=178.7
Q ss_pred eeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEEE
Q 018936 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP---ESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLVF 196 (348)
Q Consensus 120 ~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 196 (348)
.++.||+|+||+||+|++..+|+.||||+++...... ...+.+.+|+++|+.++|||||++++++..+ ...|+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceeehh
Confidence 5689999999999999999999999999987654322 2234678899999999999999999999874 4589999
Q ss_pred eecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCCC
Q 018936 197 HYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPNH 276 (348)
Q Consensus 197 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 276 (348)
||+.+++...+......+++.. ++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~-----~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSH-----HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hhhcchHHhhhhhcccCCCHHH-----HHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9999988877766555555544 88899999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 277 KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 277 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
. .....+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.++.+...++....
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~ 217 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhc
Confidence 2 23456789999999998776668999999999999999999999999999988887776543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=358.37 Aligned_cols=213 Identities=25% Similarity=0.382 Sum_probs=179.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE----PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|++++|||||++++++.+. ..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--TD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 6799999999999999999999999999999999876442 22467788999999999999999999999874 56
Q ss_pred EEEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC----cEEEEee
Q 018936 192 LYLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG----VLKIADF 266 (348)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~----~~kl~DF 266 (348)
+|+||||++++ +...+.. .. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~-~~-----~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE-KE-----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhcc-cc-----ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 99999999874 4444432 22 355566899999999999999999999999999999998776 5999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
|+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~ 231 (293)
T d1jksa_ 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231 (293)
T ss_dssp TTCEECTTSCB--CSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred hhhhhcCCCcc--ccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 99998754432 3556789999999998764 4899999999999999999999999998877766665544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4e-49 Score=355.37 Aligned_cols=223 Identities=26% Similarity=0.373 Sum_probs=180.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC--ceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS--CSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~~ 192 (348)
++|++.+.||+|+||+||+|++..+|+.||||+++.+.. .....+.+.+|+++|+.++|||||++++++..... ...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 679999999999999999999999999999999987655 45566788999999999999999999999876533 458
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+||||++++.+........ .+++..++.++.||+.||+|||++||+||||||+|||++.++..+|+|||.+...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 99999999755443333222 3445568899999999999999999999999999999999999999999999866
Q ss_pred CCCC--CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 273 DPNH--KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 273 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
.... .......+||+.|+|||++.+. .+++++|||||||++|||+||++||.+.+..+...+++......|
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp C----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred ccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence 4332 2234556799999999998775 489999999999999999999999999998888888877655444
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=360.25 Aligned_cols=219 Identities=20% Similarity=0.345 Sum_probs=178.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.++||+|+||+||+|++..+|+.||||+++.+.. ..+.+.+|+++|++++|||||+++|++.+. ...|++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 91 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 91 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeC--CeeEEE
Confidence 689999999999999999999999999999999875543 345688999999999999999999999774 458999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++ +...+.... ...+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+....
T Consensus 92 ~E~~~~g~l~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eecccCcchHHHhhhcc----ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999864 444443221 12445555888999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhccCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
..........||+.|+|||++.+.. |+.++|||||||++|||++|..||....+....+.++......|
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~ 236 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 5444444556899999999887654 89999999999999999997666554455566666666554433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=360.15 Aligned_cols=216 Identities=26% Similarity=0.423 Sum_probs=178.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHH-hcCCCceeeeeceEeeccCceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNL-EPESVKFMAREILILR-RLDHPNVIKLEGLVTSRMSCSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~~~ 193 (348)
++|++.+.||+|+||+||+|+++.+|+.||||+++++.. .....+.+..|+.++. .++|||||++++++.++ ..+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 689999999999999999999999999999999975432 1223445666777665 68999999999999874 5699
Q ss_pred EEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccC
Q 018936 194 LVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFD 273 (348)
Q Consensus 194 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 273 (348)
+||||++++.+..+...... +++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++...
T Consensus 80 ivmEy~~~g~L~~~i~~~~~-----~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeecCCCcHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999987555444433333 3444588899999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
... .......||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 219 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 219 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 332 2345568999999999998754 9999999999999999999999999988777666665543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-48 Score=347.63 Aligned_cols=219 Identities=29% Similarity=0.430 Sum_probs=184.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC-------hHHHHHHHHHHHHHHhcC-CCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE-------PESVKFMAREILILRRLD-HPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 187 (348)
++|++.+.||+|+||+||+|++..+|+.||||++++.... ....+.+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 6899999999999999999999999999999999876542 223456788999999997 9999999999987
Q ss_pred cCceEEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEee
Q 018936 188 MSCSLYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADF 266 (348)
Q Consensus 188 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DF 266 (348)
+...|+||||+++ ++...+.. .. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~~-~~-----~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLTE-KV-----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHH-HS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred -CcceEEEEEcCCCchHHHHHHh-cC-----CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccc
Confidence 4569999999986 55555432 22 3455669999999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccC-----cccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLG-----ATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
|+++....... .....||+.|+|||.+.+ ...++.++||||+||++|+|++|+.||.+.+..+....++....
T Consensus 155 G~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 155 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred hheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 99998765433 355679999999998853 33478899999999999999999999999988877777776655
Q ss_pred cCC
Q 018936 342 FDP 344 (348)
Q Consensus 342 ~~p 344 (348)
..|
T Consensus 233 ~~~ 235 (277)
T d1phka_ 233 QFG 235 (277)
T ss_dssp CCC
T ss_pred CCC
Confidence 433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-48 Score=364.88 Aligned_cols=205 Identities=26% Similarity=0.391 Sum_probs=167.9
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE----PESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.... ........+|+.+++.++|||||++++++.+. .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--C
Confidence 37899999999999999999999999999999998754321 11122223456777778899999999999874 5
Q ss_pred eEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 191 SLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+|+||||++++.+..+..... .+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceee
Confidence 6999999998654443332222 23445588899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 271 FFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 271 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
...... ....+||+.|+|||++.+...|+.++|||||||++|||+||+.||.+.+.
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 775432 35568999999999987655689999999999999999999999987654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-48 Score=350.61 Aligned_cols=216 Identities=40% Similarity=0.731 Sum_probs=183.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|+++++||+|+||+||+|++ .+|+.||||++..........+.+.+|+.+|++++|||||++++++... ...+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--CceeEE
Confidence 6899999999999999999997 5889999999977655455567788999999999999999999999874 458999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
++++.++++......... ++...++.++.||+.||+|||+.|||||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~~~~~~~~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp EECCSEEHHHHHHTSTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EEeehhhhHHHHHhhcCC-----cchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 999999888877665544 445558999999999999999999999999999999999999999999999887543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
. .......+++.|+|||.+.+...++.++|+|||||++|||++|++||.+.++.+...++....
T Consensus 154 ~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~ 217 (286)
T d1ob3a_ 154 V-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred c-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 2 223455689999999999877778999999999999999999999999999888877776543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-48 Score=353.31 Aligned_cols=213 Identities=23% Similarity=0.416 Sum_probs=162.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK---IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~---~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||+||+|+++.+|+ .||||.+.... .....+.+.+|+++|++++|||||+++|++... ..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CEE
Confidence 679999999999999999999876664 68899876443 445567788999999999999999999999774 458
Q ss_pred EEEEeecccChhhh-hcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLAGL-AASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++.+.. ...... .+++..+..++.||+.||.|||+++|+||||||+||||+.++++||+|||+|+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 99999999765444 443332 345555888999999999999999999999999999999999999999999997
Q ss_pred cCCCCCC----CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 272 FDPNHKH----PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 272 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
....... ......||+.|+|||.+.+. .++.++|||||||++|||+| |++||.+.+..+....+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp ------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 7543221 12224578999999988765 48999999999999999998 899999988765554443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=344.87 Aligned_cols=210 Identities=22% Similarity=0.388 Sum_probs=161.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++ .+++.||||+++..... .+.+.+|++++++++|||||+++|++... ...|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEE-TTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEE-CCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccC--CceEEE
Confidence 6799999999999999999996 46788999998765433 35688899999999999999999999874 448999
Q ss_pred EeecccCh-hhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDL-AGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++. ...+..... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 99998754 444443332 234445788999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFV 337 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i 337 (348)
..........||+.|+|||++.+.. |+.++|||||||++|||+| |++||.+.+..+....+.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~ 216 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216 (263)
T ss_dssp -----------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH
T ss_pred CCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 5444445567899999999988754 9999999999999999999 577777766655444443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=351.91 Aligned_cols=212 Identities=20% Similarity=0.333 Sum_probs=179.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|+++.+|+.||||+++... .....+.+|+++|+.++|||||++++++.++ ..+|+|
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~lv 79 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM--EELVMI 79 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEE
Confidence 68999999999999999999999999999999997643 3345678899999999999999999999874 569999
Q ss_pred Eeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC--CcEEEEeeCCcccc
Q 018936 196 FHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD--GVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~--~~~kl~DFGla~~~ 272 (348)
|||+++ ++...+...... +++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 80 mE~~~gg~L~~~i~~~~~~-----l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999986 555555443333 4455589999999999999999999999999999999854 58999999999877
Q ss_pred CCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 273 DPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 273 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
.... ......+|+.|+|||.+.+.. |+.++||||+||++|+|++|++||.+.+..+...+++...
T Consensus 155 ~~~~--~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~ 219 (321)
T d1tkia_ 155 KPGD--NFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp CTTC--EEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred ccCC--cccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 5432 234567899999999887654 8999999999999999999999999988877776766543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=347.82 Aligned_cols=212 Identities=21% Similarity=0.384 Sum_probs=171.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++ .++..||||+++..... .+.+.+|+++|++++|||||+++|++... ..|+|
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~iv 85 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYII 85 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeeccC---CeEEE
Confidence 6899999999999999999996 46789999999765433 45688999999999999999999987642 36899
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+........ ...+++..+..++.||+.||.|||+++|+||||||+||||++++.+||+|||+|+.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 99999765544332211 123556668899999999999999999999999999999999999999999999987655
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~~~~~~~~~~i~~ 339 (348)
.........||+.|+|||++.+. .++.++|||||||++|||+|| ++||...+..+ ....+.+
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~ 225 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLER 225 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHT
T ss_pred ccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh
Confidence 44445566789999999988764 489999999999999999995 56666655444 3333433
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=342.95 Aligned_cols=211 Identities=20% Similarity=0.370 Sum_probs=177.8
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.++||+|+||+||+|++ .+++.||||.++..... .+.+.+|++++++++||||++++|++.++ ..+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEE
Confidence 6899999999999999999997 57889999999876544 35688999999999999999999999874 459999
Q ss_pred EeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++ +......... .+.+..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 9999865 4444443333 333445788999999999999999999999999999999999999999999988765
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~ 338 (348)
..........+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+....+..
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~ 216 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred CCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence 5554455667899999999887644 8999999999999999998 8999999887766555543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=351.41 Aligned_cols=218 Identities=39% Similarity=0.676 Sum_probs=177.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEeec---c
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLT-GKIVALKKVRFDNLEPESVKFMAREILILRRL---DHPNVIKLEGLVTSR---M 188 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~-g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~---~ 188 (348)
++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+++|+.+ +||||++++++|... .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 7899999999999999999998665 67899999976544333333455677777665 899999999998642 3
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...++++|||++++.+........ ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 457899999999876654432221 1344555888999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 269 ASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 269 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
++..... .......||+.|+|||++.+.. |+.++||||+||++|||++|++||.+.++.+...+++...
T Consensus 163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred hhhhccc--ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 9865432 2345668999999999988754 9999999999999999999999999999888777776543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=350.44 Aligned_cols=220 Identities=49% Similarity=0.762 Sum_probs=181.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc------
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM------ 188 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 188 (348)
.++|+++++||+|+||+||+|++..+|+.||||++......+...+.+.+|+++|++++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999999999999999998776655555667888999999999999999999885532
Q ss_pred CceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCC
Q 018936 189 SCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGL 268 (348)
Q Consensus 189 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGl 268 (348)
...+|++|||+++++..........+ ....++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~-----~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKF-----TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhccccc-----ccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 34589999999988887766554444 3344788999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 269 ASFFDPNH---KHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 269 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
++...... .......+||+.|+|||++.+...|++++||||+||++|||++|++||.+.++.+....+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 98765322 222344578999999999887667899999999999999999999999998877666655443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=353.24 Aligned_cols=225 Identities=25% Similarity=0.397 Sum_probs=179.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK-----IVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+|+++ +|||||++++++.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 689999999999999999999765543 699999865432 33455678899999998 899999999999874
Q ss_pred ceEEEEEeeccc-ChhhhhcCCCCcCC-----------------cchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 018936 190 CSLYLVFHYMEH-DLAGLAASPEVKFT-----------------EPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGS 251 (348)
Q Consensus 190 ~~~~lv~e~~~~-~l~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~ 251 (348)
...|+||||+++ ++...+......+. ...+++..++.++.||+.||+|||+++||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 458999999986 55555544332211 123566678899999999999999999999999999
Q ss_pred CEEECCCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCCh
Q 018936 252 NLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTE 329 (348)
Q Consensus 252 NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~ 329 (348)
|||++.++++||+|||+|+........ ......||+.|+|||++.+.. |+.++|||||||++|||+| |++||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876544332 223456799999999887644 8999999999999999998 8999999888
Q ss_pred hHHHHHHHHHhccCC
Q 018936 330 VSATFCFVLNLIFDP 344 (348)
Q Consensus 330 ~~~~~~~i~~~~~~p 344 (348)
.+...+++.+....|
T Consensus 273 ~~~~~~~~~~~~~~~ 287 (325)
T d1rjba_ 273 DANFYKLIQNGFKMD 287 (325)
T ss_dssp SHHHHHHHHTTCCCC
T ss_pred HHHHHHHHhcCCCCC
Confidence 777888877765443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=343.50 Aligned_cols=211 Identities=22% Similarity=0.340 Sum_probs=171.7
Q ss_pred CCceeeee-eccCCceEEEEEEEcc--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDK-IGQGTYSNVYKAKDML--TGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~-LG~G~~g~Vy~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|.+.+. ||+|+||+||+|.+.. ++..||||+++... .....+.+.+|+++|++++|||||+++|++..+ .+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---AL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eE
Confidence 67888884 9999999999997653 45589999996543 455677889999999999999999999998653 37
Q ss_pred EEEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++ +...+..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999975 4444433332 345555888999999999999999999999999999999999999999999998
Q ss_pred cCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 272 FDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 272 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
...... .......||+.|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+....+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i 225 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred ccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 754332 223345679999999988764 48999999999999999998 99999988765544443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=352.82 Aligned_cols=216 Identities=35% Similarity=0.539 Sum_probs=180.9
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc----Cce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM----SCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 191 (348)
++|+++++||+|+||+||+|+++.+|+.||||+++.........+.+.+|+++|+.++|||||+++++|.... ...
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 7899999999999999999999999999999999876666677778899999999999999999999987643 235
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|+||||++..+....... .++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 98 ~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecccccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 7999999977666554322 355566899999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
.... .+...||+.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+....+......
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence 6433 356678999999999987666899999999999999999999999999888777766655443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=346.93 Aligned_cols=210 Identities=20% Similarity=0.311 Sum_probs=165.2
Q ss_pred ceee-eeeccCCceEEEEEEEc--cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 118 FEKI-DKIGQGTYSNVYKAKDM--LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 118 y~~~-~~LG~G~~g~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
+.+. ++||+|+||+||+|.+. .+++.||||+++.....+...+.+.+|+++|++++|||||+++|++..+ ..++
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~l 84 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWML 84 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEE
Confidence 3443 47999999999999754 3457899999976655566677899999999999999999999998653 3789
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+..+..... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 85 vmE~~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 999998754443333222 345556888999999999999999999999999999999999999999999998754
Q ss_pred CCCC--CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018936 275 NHKH--PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCF 336 (348)
Q Consensus 275 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~ 336 (348)
.... ......||+.|+|||.+.+.. ++.++|||||||++|||+| |++||.+.+..+....+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred cccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence 4322 223346899999999887644 8999999999999999998 99999998765544333
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=340.93 Aligned_cols=219 Identities=20% Similarity=0.334 Sum_probs=164.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG----KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
+.|++.+.||+|+||+||+|.+..++ ..||||+++... .......+.+|+++|++++|||||+++|++... ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--Cc
Confidence 67999999999999999999876554 479999986543 445566788999999999999999999999774 44
Q ss_pred EEEEEeecccChhhhhc-CCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEHDLAGLAA-SPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++|||+.++.+.... .... .+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 89999999876554432 2222 34455588899999999999999999999999999999999999999999998
Q ss_pred ccCCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHHHhccCC
Q 018936 271 FFDPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGK-PIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 271 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~-~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|. +||.+.+. .+....+......|
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLP 233 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCCCC
T ss_pred cccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccCCCC
Confidence 8654322 223345679999999988765 4899999999999999999964 55555444 44455554443333
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=349.12 Aligned_cols=202 Identities=23% Similarity=0.379 Sum_probs=167.5
Q ss_pred CCceeee-eeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee--ccCce
Q 018936 116 DSFEKID-KIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTS--RMSCS 191 (348)
Q Consensus 116 ~~y~~~~-~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~~ 191 (348)
++|+++. .||+|+||+||+|++..+|+.||||+++. ...+.+|++++.++ +|||||+++++|.+ .....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 6899886 59999999999999999999999999863 23466799987655 89999999999875 23466
Q ss_pred EEEEEeeccc-ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---CCcEEEEeeC
Q 018936 192 LYLVFHYMEH-DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFG 267 (348)
Q Consensus 192 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kl~DFG 267 (348)
+|+||||+++ +|...+.... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 8999999986 5666554321 124666679999999999999999999999999999999985 5679999999
Q ss_pred CccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhH
Q 018936 268 LASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVS 331 (348)
Q Consensus 268 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~ 331 (348)
+|+....... ....+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+..+
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 9998754432 4566899999999988764 49999999999999999999999997765443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=347.08 Aligned_cols=213 Identities=40% Similarity=0.633 Sum_probs=177.5
Q ss_pred CceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----cCceE
Q 018936 117 SFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCSL 192 (348)
Q Consensus 117 ~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~~ 192 (348)
+|+.+++||+|+||+||+|++..+|+.||||++..+... ..+|+++|++++||||++++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999999999999999999765421 23699999999999999999998542 34568
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-cEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~ 271 (348)
|+||||+++++...+... ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~--~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHH--HHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhh--hhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999999998765554321 01112355556899999999999999999999999999999999775 899999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~ 339 (348)
..... ......||+.|+|||.+.+...|+.++||||+||++|||++|++||.+.++.+....++..
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~ 238 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHH
Confidence 75433 2455688999999999887667999999999999999999999999999988877776643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=339.69 Aligned_cols=218 Identities=23% Similarity=0.360 Sum_probs=164.8
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEE
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 194 (348)
.++|++.+.||+|+||+||+|++. ++..||||+++..... .+.+.+|+.+|++++|||||+++|++.++ ..++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEecC---CeEE
Confidence 378999999999999999999974 5567999999755433 35688999999999999999999998542 3789
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
||||++++.+....... ....+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+....
T Consensus 89 v~Ey~~~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999976544333221 111355566889999999999999999999999999999999999999999999988765
Q ss_pred CCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHHhccCC
Q 018936 275 NHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVSATFCFVLNLIFDP 344 (348)
Q Consensus 275 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~~~~~~~~~~i~~~~~~p 344 (348)
..........||+.|+|||++.+.. ++.++|||||||++|||++| ++||.+... .+....+......|
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMP 234 (285)
T ss_dssp ----------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCCC
T ss_pred CCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCCC
Confidence 5444445567899999999887644 89999999999999999995 555555554 44444444444333
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=337.43 Aligned_cols=213 Identities=20% Similarity=0.323 Sum_probs=162.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 192 (348)
++|++.+.||+|+||+||+|++..++ ..||||.++.. ......+.+.+|+++|++++|||||+++|++.+ ..+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeE
Confidence 68999999999999999999876543 46889887543 345556778899999999999999999999864 347
Q ss_pred EEEEeecccChhh-hhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 193 YLVFHYMEHDLAG-LAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 193 ~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||||++++.+. ....... .+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 9999999875443 3333332 344555888999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHH
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVL 338 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~ 338 (348)
.............||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~ 224 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224 (273)
T ss_dssp -------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred ccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 765544445566789999999998764 48999999999999999998 8999999887666555543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=342.73 Aligned_cols=217 Identities=36% Similarity=0.599 Sum_probs=179.2
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecc---CceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRM---SCSL 192 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~ 192 (348)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+++|+.++||||+++++++.... ...+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999999999999999997644 3455667888999999999999999999986532 2346
Q ss_pred EEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcccc
Q 018936 193 YLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFF 272 (348)
Q Consensus 193 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 272 (348)
|+++++.+++|...+... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 777777777777776432 3455668999999999999999999999999999999999999999999999876
Q ss_pred CCCCC--CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 273 DPNHK--HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 273 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
..... ......+||+.|+|||.+.....++.++||||+||++|+|++|++||.+.+..+....++...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~ 229 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhc
Confidence 44322 224556789999999998766668899999999999999999999999998877777665543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=342.30 Aligned_cols=215 Identities=24% Similarity=0.371 Sum_probs=166.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGK----IVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++++.||+|+||+||+|++..+|+ .||+|.++... .....+.+.+|+++|++++|||||+++|++.+. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 579999999999999999999888876 58888876433 333466788999999999999999999999763 2
Q ss_pred EEEEEeecc-cChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYME-HDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.+++++++. +++......... .+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+|+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 566677766 456555544333 34445588899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCC-cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhc
Q 018936 271 FFDPNHKHP-MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 271 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~~~ 341 (348)
......... .....||+.|+|||++.+.. |+.++|||||||++|||+| |++||.+.+..+ ...++.+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~~~i~~~~ 230 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGE 230 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-HHHHHHHTC
T ss_pred ecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHcCC
Confidence 875443322 33446899999999887654 8999999999999999998 899998877544 444444433
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=342.38 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=165.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEP----ESVKFMAREILILRRLD--HPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||+||+|++..+|+.||||++.+..... .....+.+|+.+|++++ |||||++++++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-- 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-- 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC--
Confidence 67999999999999999999999999999999997654321 11233567999999996 89999999999874
Q ss_pred ceEEEEEeeccc--ChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-CCcEEEEee
Q 018936 190 CSLYLVFHYMEH--DLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-DGVLKIADF 266 (348)
Q Consensus 190 ~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kl~DF 266 (348)
...|+||||+.+ .+...... .. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~-----~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RG-----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcc
Confidence 568999999975 33333322 22 3455568899999999999999999999999999999985 479999999
Q ss_pred CCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCC
Q 018936 267 GLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGR 327 (348)
Q Consensus 267 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~ 327 (348)
|+|+..... ......||+.|+|||++.+...++.++||||+||++|||++|+.||.+.
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 999876433 2356789999999999876665677899999999999999999999763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=333.91 Aligned_cols=213 Identities=42% Similarity=0.706 Sum_probs=179.4
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|+++++||+|+||+||+|++..+|+.||||+++.........+.+.+|+.+|+.++||||+++++++.+ ....+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 68999999999999999999999999999999998777666677889999999999999999999999987 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
++++.+..+.........+ ....++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~-----~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EECCSEEHHHHHHHTTTCC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eeecccccccccccccccc-----chhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999987776665544433 34458899999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCC-CCCChhHHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIM-PGRTEVSATFCF 336 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf-~~~~~~~~~~~~ 336 (348)
.. ......+++.|+|||.+.+...++.++||||+||++|||++|+.|| .+.+..+...++
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~ 215 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 32 2344456888999999887666799999999999999999998875 444444444333
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=342.98 Aligned_cols=215 Identities=32% Similarity=0.549 Sum_probs=177.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----cCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~ 191 (348)
++|+++++||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.++|||||+++++|... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999999999999999999987776777777889999999999999999999999654 2468
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
+|+||||+.++++..... .++...++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence 999999999988776642 244556899999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLI 341 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~ 341 (348)
..... .....++|+.|+|||++.+. .+++++||||+||++|+|++|++||.+.++.....+++....
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp --------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccc--ccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 64432 24556789999999998875 489999999999999999999999999988877777765544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=339.40 Aligned_cols=202 Identities=31% Similarity=0.579 Sum_probs=172.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 194 (348)
++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+++|+.++ ||||++++++|.......+++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 78999999999999999999999999999999986432 456788999999995 999999999998766677999
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCC-cEEEEeeCCccccC
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDG-VLKIADFGLASFFD 273 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~ 273 (348)
||||++++.+..... .++...++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 110 v~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEeecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999866543321 345556899999999999999999999999999999998655 69999999999875
Q ss_pred CCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHH
Q 018936 274 PNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSA 332 (348)
Q Consensus 274 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~ 332 (348)
.... .....+|+.|+|||.+.+...++.++|+||+||++|+|++|+.||....+...
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~ 238 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH
Confidence 4432 45667899999999988777789999999999999999999999976654433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=334.59 Aligned_cols=219 Identities=24% Similarity=0.346 Sum_probs=167.0
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-CC--cEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-TG--KIVALKKVRFDNL-EPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-~g--~~vAvK~i~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 191 (348)
++|++.+.||+|+||+||+|+... ++ ..||||++..... ..+..+.+.+|+++|++++|||||+++|++.+. .
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---P 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---c
Confidence 679999999999999999998543 33 3789999876544 345567789999999999999999999999753 3
Q ss_pred EEEEEeecccCh-hhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCcc
Q 018936 192 LYLVFHYMEHDL-AGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLAS 270 (348)
Q Consensus 192 ~~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 270 (348)
.++||||++++. ......... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred hheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhh
Confidence 689999998644 433332222 34555688999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCC--cccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHHHhccC
Q 018936 271 FFDPNHKHP--MTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFCFVLNLIFD 343 (348)
Q Consensus 271 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~~i~~~~~~ 343 (348)
......... .....+|..|+|||.+.+. .++.++|||||||++|||+| |++||.+.+..+....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC
Confidence 875443321 2234568899999988764 48999999999999999998 899999998888777766554433
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=337.22 Aligned_cols=216 Identities=36% Similarity=0.568 Sum_probs=178.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----cCce
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSR----MSCS 191 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~ 191 (348)
++|+++++||+|+||+||+|++..+|+.||||++++........+.+.+|+++|+.++|||||++++++... ....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 679999999999999999999999999999999987766666677888999999999999999999988643 1234
Q ss_pred EEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 192 LYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 192 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
.++++++.+++|...+... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++..
T Consensus 98 ~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred EEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 5565555555666655322 355566899999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHhcc
Q 018936 272 FDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNLIF 342 (348)
Q Consensus 272 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~~~ 342 (348)
... ......||+.|+|||.+.+...++.++|||||||++|+|++|++||.+.++.....+++.....
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 532 2345678999999999887766789999999999999999999999999988887777665443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-45 Score=333.43 Aligned_cols=220 Identities=23% Similarity=0.391 Sum_probs=175.0
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+++|++++||||+++++++... .
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~ 89 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--K 89 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--C
Confidence 78999999999999999999864 356799999986543 445567789999999999999999999999874 4
Q ss_pred eEEEEEeecccC-hhhhhcCCCC------------------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 018936 191 SLYLVFHYMEHD-LAGLAASPEV------------------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGS 251 (348)
Q Consensus 191 ~~~lv~e~~~~~-l~~~~~~~~~------------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~ 251 (348)
..+++|||++++ +...+..... ......+....+..++.||+.||+|||+++||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 589999999864 4443321110 011123566678899999999999999999999999999
Q ss_pred CEEECCCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCCCh
Q 018936 252 NLLIDDDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTE 329 (348)
Q Consensus 252 NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~~~ 329 (348)
|||++.++++||+|||+|+........ ..+...+|+.|+|||.+.+. .|+.++|||||||++|||++| .+||.+.++
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999876543322 23456788999999988764 499999999999999999998 578988887
Q ss_pred hHHHHHHHHH
Q 018936 330 VSATFCFVLN 339 (348)
Q Consensus 330 ~~~~~~~i~~ 339 (348)
.+....+...
T Consensus 249 ~e~~~~v~~~ 258 (301)
T d1lufa_ 249 EEVIYYVRDG 258 (301)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHHcC
Confidence 7766655443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=331.66 Aligned_cols=223 Identities=23% Similarity=0.355 Sum_probs=166.3
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-----TGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.++||+|+||+||+|++.. +++.||||+++.... ....+.+.+|..++.++ +||||+.+++++... .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence 789999999999999999998654 457899999865443 34455677788888777 689999998887654 3
Q ss_pred ceEEEEEeecccC-hhhhhcCCCCc----------CCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCC
Q 018936 190 CSLYLVFHYMEHD-LAGLAASPEVK----------FTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDD 258 (348)
Q Consensus 190 ~~~~lv~e~~~~~-l~~~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~ 258 (348)
..++++|||++++ +...+...... .....+++..+..++.||+.||+|||+++||||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 4589999999864 44443322110 112235667789999999999999999999999999999999999
Q ss_pred CcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCCChhHHHHHH
Q 018936 259 GVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVSATFCF 336 (348)
Q Consensus 259 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~~~~~~~~~~ 336 (348)
+++||+|||+|+........ ......||+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+....+....+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999876543332 23456789999999998764 489999999999999999996 6789887766666666
Q ss_pred HHHhc
Q 018936 337 VLNLI 341 (348)
Q Consensus 337 i~~~~ 341 (348)
+....
T Consensus 250 ~~~~~ 254 (299)
T d1ywna1 250 LKEGT 254 (299)
T ss_dssp HHHTC
T ss_pred HhcCC
Confidence 65543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4e-44 Score=324.97 Aligned_cols=202 Identities=20% Similarity=0.259 Sum_probs=168.3
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH-PNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~l 194 (348)
++|++.++||+|+||+||+|++..+|+.||||++...... ..+.+|++.++.+.| +|++.+++++.. ....++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEE
Confidence 6799999999999999999999999999999998654322 235678899999966 899999988876 456899
Q ss_pred EEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC-----CCcEEEEeeCCc
Q 018936 195 VFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD-----DGVLKIADFGLA 269 (348)
Q Consensus 195 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-----~~~~kl~DFGla 269 (348)
||||+++++.......... ++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 79 vme~~~~~l~~~~~~~~~~-----~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEECCCCBHHHHHHHTTTC-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEecCCCHHHHHHhhccc-----hhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 9999998887776544433 344558889999999999999999999999999999974 578999999999
Q ss_pred cccCCCCC------CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 270 SFFDPNHK------HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 270 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
+.+..... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 88643221 123456799999999998875 499999999999999999999999986543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-44 Score=326.56 Aligned_cols=207 Identities=23% Similarity=0.264 Sum_probs=166.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||+||+|++..+|+.||||++...... +.+.+|+++++.++|+|++..++.+... ....++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 5799999999999999999999999999999998765432 2366799999999888766665544332 4568999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECC---CCcEEEEeeCCcccc
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDD---DGVLKIADFGLASFF 272 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kl~DFGla~~~ 272 (348)
|||+++++.......... ++...+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+.+
T Consensus 82 me~~~~~l~~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EECCCCBHHHHHHHTTTC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEcCCchhhhhhhccCC-----CcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999998887766544443 444458889999999999999999999999999999863 457999999999987
Q ss_pred CCCCCC------CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018936 273 DPNHKH------PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTEVSAT 333 (348)
Q Consensus 273 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~ 333 (348)
...... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~ 222 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence 543221 234557999999999988754 899999999999999999999999876654433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=338.38 Aligned_cols=218 Identities=25% Similarity=0.436 Sum_probs=175.3
Q ss_pred CCceeeeeeccCCceEEEEEEEc---cCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCC-CceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM---LTGKIVALKKVRFDNL--EPESVKFMAREILILRRLDH-PNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~---~~g~~vAvK~i~~~~~--~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~ 189 (348)
++|++++.||+|+||+||+|++. .+|+.||||++++... .....+.+.+|+++|++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 78999999999999999999863 4689999999865432 12234557789999999977 8999999999884
Q ss_pred ceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCc
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLA 269 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla 269 (348)
...+++|||+.++.+.......... ....++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~-----~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERF-----TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCC-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred CceeeeeecccccHHHHHHHhcccc-----cHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 4699999999875554443332222 33447889999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCcccccccccCcc-cCCccccHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHHHh
Q 018936 270 SFFDPNHKHPMTSRVVTLWYRPPELLLGAT-DYGVGVDLWSAGCILAELLAGKPIMPGRTEVSATFCFVLNL 340 (348)
Q Consensus 270 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGv~l~elltG~~pf~~~~~~~~~~~~i~~~ 340 (348)
+..............|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+....
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~ 248 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 887554444455668899999999987543 46789999999999999999999998877666555555443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=326.99 Aligned_cols=225 Identities=20% Similarity=0.266 Sum_probs=180.8
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccC
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMS 189 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 189 (348)
++|++.+.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+++++ +|||||+++|++...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-- 99 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-- 99 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--
Confidence 78999999999999999999853 466799999997654 445566788999999999 699999999999874
Q ss_pred ceEEEEEeecccChhhhhcCCCC-------------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 190 CSLYLVFHYMEHDLAGLAASPEV-------------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 190 ~~~~lv~e~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
...+++|||++++.+..+..... ......+++..+..++.||+.||+|||+++||||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 44899999998754433322111 01112355666889999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 257 DDGVLKIADFGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
.++.+||+|||+++........ ......||+.|+|||.+.+. .++.++|||||||++|||+| |.+||.+.+..+...
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987544332 23446789999999988764 48999999999999999998 788888888777778
Q ss_pred HHHHHhccCC
Q 018936 335 CFVLNLIFDP 344 (348)
Q Consensus 335 ~~i~~~~~~p 344 (348)
.++......+
T Consensus 259 ~~i~~~~~~~ 268 (311)
T d1t46a_ 259 KMIKEGFRML 268 (311)
T ss_dssp HHHHHTCCCC
T ss_pred HHHhcCCCCC
Confidence 8877655443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=328.83 Aligned_cols=220 Identities=18% Similarity=0.236 Sum_probs=174.5
Q ss_pred CCceeeeeeccCCceEEEEEEEc-----cCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCc
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDM-----LTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSC 190 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 190 (348)
++|++.+.||+|+||+||+|++. .++..||||+++... .......+.+|++++++++|||||+++|++....
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-- 96 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-- 96 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--
Confidence 78999999999999999999864 245789999987543 4445567889999999999999999999997643
Q ss_pred eEEEEEeecccChhhh-hcCCCC----cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEe
Q 018936 191 SLYLVFHYMEHDLAGL-AASPEV----KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIAD 265 (348)
Q Consensus 191 ~~~lv~e~~~~~l~~~-~~~~~~----~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~D 265 (348)
..++||||++++.+.. +..... .......+...+..++.|++.||.|||+++|+||||||+|||++.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 4899999998654433 221100 00011234555788999999999999999999999999999999999999999
Q ss_pred eCCccccCCCCCC-CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHHH
Q 018936 266 FGLASFFDPNHKH-PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVSATFCFVLN 339 (348)
Q Consensus 266 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~~~~~~~~~~i~~ 339 (348)
||+|+.+...... ......+|+.|+|||.+.+.. ++.++||||||+++|||+|| ++||.+.+..+....+...
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 9999876443222 234446899999999887654 88999999999999999998 5889888877766655543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=321.87 Aligned_cols=205 Identities=22% Similarity=0.365 Sum_probs=159.5
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
++|++.+.||+|+||.||+|++ +|..||||+++.+. ..+.+.+|++++++++||||++++|++.+. ...+|+|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEE
Confidence 6899999999999999999985 58899999996543 345688999999999999999999988653 2347999
Q ss_pred EeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCCC
Q 018936 196 FHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDPN 275 (348)
Q Consensus 196 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 275 (348)
|||++++.+..+.... ....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999875444332211 1113455668899999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018936 276 HKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATFC 335 (348)
Q Consensus 276 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~~ 335 (348)
.....+|..|+|||.+.+. .+++++|||||||++|||+| |++||.+.+..+....
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~ 212 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212 (262)
T ss_dssp ---------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH
T ss_pred ----CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 2334678899999998764 48999999999999999998 7888888765544444
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=320.73 Aligned_cols=203 Identities=22% Similarity=0.290 Sum_probs=160.0
Q ss_pred eeeeeeccCCceEEEEEEEccCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccCceEEEE
Q 018936 119 EKIDKIGQGTYSNVYKAKDMLTG---KIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMSCSLYLV 195 (348)
Q Consensus 119 ~~~~~LG~G~~g~Vy~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 195 (348)
...++||+|+||+||+|++..++ ..||||.++.. ......+.+.+|+++|++++||||++++|++... ....++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEE
Confidence 33678999999999999976543 36999998643 3556677899999999999999999999998654 3468999
Q ss_pred EeecccChhhh-hcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcEEEEeeCCccccCC
Q 018936 196 FHYMEHDLAGL-AASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVLKIADFGLASFFDP 274 (348)
Q Consensus 196 ~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 274 (348)
|||++++.+.. ...... ......+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++....
T Consensus 108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 99999765544 333222 223344778999999999999999999999999999999999999999999997754
Q ss_pred CCCC---CcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCCh
Q 018936 275 NHKH---PMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRTE 329 (348)
Q Consensus 275 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~~ 329 (348)
.... ......||+.|+|||.+.+.. ++.++||||||+++|||+||..||.....
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~ 239 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVN 239 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred cccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence 3222 233456899999999887644 89999999999999999997766655443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=320.36 Aligned_cols=221 Identities=24% Similarity=0.366 Sum_probs=171.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTG-------KIVALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g-------~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 187 (348)
++|++.+.||+|+||.||+|+...++ ..||||+++.+. .......+.+|+..+.++ +|||||++++++.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 78999999999999999999865544 479999987554 444556778899999888 899999999999874
Q ss_pred cCceEEEEEeecccChh-hhhcCCCC----------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEEC
Q 018936 188 MSCSLYLVFHYMEHDLA-GLAASPEV----------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLID 256 (348)
Q Consensus 188 ~~~~~~lv~e~~~~~l~-~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~ 256 (348)
...++||||++++.+ ..+..... ......++...+..++.||+.||+|||+++||||||||+|||++
T Consensus 92 --~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 92 --GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp --SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred --CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 458999999987544 44432211 11223567777999999999999999999999999999999999
Q ss_pred CCCcEEEEeeCCccccCCCCC-CCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018936 257 DDGVLKIADFGLASFFDPNHK-HPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLA-GKPIMPGRTEVSATF 334 (348)
Q Consensus 257 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~ellt-G~~pf~~~~~~~~~~ 334 (348)
.++.+||+|||+++....... .......+|+.|+|||.+.+. .|+.++|||||||++|||++ |++||.+.+.. +.+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-~~~ 247 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELF 247 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-HHH
Confidence 999999999999997754332 234556789999999988764 49999999999999999998 79999877654 445
Q ss_pred HHHHHhc
Q 018936 335 CFVLNLI 341 (348)
Q Consensus 335 ~~i~~~~ 341 (348)
..+.+..
T Consensus 248 ~~i~~~~ 254 (299)
T d1fgka_ 248 KLLKEGH 254 (299)
T ss_dssp HHHHTTC
T ss_pred HHHHcCC
Confidence 5555443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=323.27 Aligned_cols=216 Identities=26% Similarity=0.360 Sum_probs=168.1
Q ss_pred CCCceeeeeeccCCceEEEEEEEccCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeeccCce
Q 018936 115 ADSFEKIDKIGQGTYSNVYKAKDMLTGKI--VALKKVRFDNLEPESVKFMAREILILRRL-DHPNVIKLEGLVTSRMSCS 191 (348)
Q Consensus 115 ~~~y~~~~~LG~G~~g~Vy~~~~~~~g~~--vAvK~i~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 191 (348)
.++|++.++||+|+||+||+|+++.+|.. ||||.++... ..+..+.+.+|+++|+++ +|||||+++|++.+. ..
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--Ce
Confidence 37899999999999999999999888874 6777765433 233456788999999998 799999999999874 56
Q ss_pred EEEEEeecccC-hhhhhcCCCC----------cCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCc
Q 018936 192 LYLVFHYMEHD-LAGLAASPEV----------KFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGV 260 (348)
Q Consensus 192 ~~lv~e~~~~~-l~~~~~~~~~----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~ 260 (348)
+|+||||++++ +...+..... ......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999964 4444432211 111234566678899999999999999999999999999999999999
Q ss_pred EEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhC-CCCCCCCChhHHHHHH
Q 018936 261 LKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAG-KPIMPGRTEVSATFCF 336 (348)
Q Consensus 261 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG-~~pf~~~~~~~~~~~~ 336 (348)
+||+|||+|+....... .....||..|+|||.+.+.. ++.++|||||||++|||++| .+||.+.+..+....+
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999987643322 23456899999999987654 89999999999999999996 5678887765554443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=320.62 Aligned_cols=197 Identities=27% Similarity=0.345 Sum_probs=154.1
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeeccC--ceEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNVIKLEGLVTSRMS--CSLY 193 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~~~ 193 (348)
.+|.+.+.||+|+||.||+|+ .+|+.||||+++.+. ........|+..+..++|||||++++++..+.. ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~--~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEE--ETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEE--ECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 579999999999999999998 478999999986432 222223345555567899999999999976543 4689
Q ss_pred EEEeecccC-hhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCCEEECCCCcEEEE
Q 018936 194 LVFHYMEHD-LAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN--------NGVLHRDIKGSNLLIDDDGVLKIA 264 (348)
Q Consensus 194 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--------~~ivHrDikp~NIll~~~~~~kl~ 264 (348)
+||||++++ +...+... .+++..+..++.|++.||+|||+ +|||||||||+||||+.++.+||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 999999874 44444322 24445577899999999999997 599999999999999999999999
Q ss_pred eeCCccccCCCCCC---CcccccccCcccccccccCcc-----cCCccccHHHHHHHHHHHHhCCCCC
Q 018936 265 DFGLASFFDPNHKH---PMTSRVVTLWYRPPELLLGAT-----DYGVGVDLWSAGCILAELLAGKPIM 324 (348)
Q Consensus 265 DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlGv~l~elltG~~pf 324 (348)
|||+++........ ......||+.|+|||++.+.. .++.++|||||||++|||+||.+||
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~ 218 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence 99999987543321 234567899999999876532 2567899999999999999998876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-39 Score=298.33 Aligned_cols=200 Identities=33% Similarity=0.517 Sum_probs=158.6
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----------CCceeeeeceE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-----------HPNVIKLEGLV 184 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~ 184 (348)
.+|+++++||+|+||+||+|+++.+|+.||||+++++ ....+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999999999999999999754 234456778999988875 57899999998
Q ss_pred eeccCceEEEEEeecccC--hhhhh-cCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCCEEECCCC-
Q 018936 185 TSRMSCSLYLVFHYMEHD--LAGLA-ASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHN-NGVLHRDIKGSNLLIDDDG- 259 (348)
Q Consensus 185 ~~~~~~~~~lv~e~~~~~--l~~~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~- 259 (348)
........++++.++... ..... ..... .+....++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHR-----GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred eeccccceeeeeeeccccccccccccccccc-----CCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence 876666777777766432 22222 11222 33445588999999999999998 8999999999999998655
Q ss_pred -----cEEEEeeCCccccCCCCCCCcccccccCcccccccccCcccCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 018936 260 -----VLKIADFGLASFFDPNHKHPMTSRVVTLWYRPPELLLGATDYGVGVDLWSAGCILAELLAGKPIMPGRT 328 (348)
Q Consensus 260 -----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGv~l~elltG~~pf~~~~ 328 (348)
.++++|||.+...... ....+||+.|+|||++.+.. ++.++|+||+||++++|++|+.||....
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccccceeeEeecccccccccc----cccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCc
Confidence 3999999999866432 34567899999999988654 8999999999999999999999996543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=3.5e-27 Score=199.50 Aligned_cols=166 Identities=14% Similarity=0.089 Sum_probs=118.5
Q ss_pred ceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCC----------------hHHHHHHHHHHHHHHhcCCCceeeee
Q 018936 118 FEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE----------------PESVKFMAREILILRRLDHPNVIKLE 181 (348)
Q Consensus 118 y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~----------------~~~~~~~~~E~~~l~~l~hpniv~l~ 181 (348)
+.+.++||+|+||+||+|++ .+|+.||||+++..... ........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46789999999999999997 67999999987643210 11123345688899999999999886
Q ss_pred ceEeeccCceEEEEEeecccChhhhhcCCCCcCCcchhhHHHHHHHHHHHHHHHHHHHHCCceecCCCCCCEEECCCCcE
Q 018936 182 GLVTSRMSCSLYLVFHYMEHDLAGLAASPEVKFTEPQFVYLKVKCYMHQLLSGLEHCHNNGVLHRDIKGSNLLIDDDGVL 261 (348)
Q Consensus 182 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~ 261 (348)
++.. .+++|||+++.....+. ... +..++.|++.+|.|||++||+||||||+|||++++ .+
T Consensus 81 ~~~~------~~lvme~~~~~~~~~l~-------~~~-----~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELYRVR-------VEN-----PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEET------TEEEEECCCCEEGGGCC-------CSC-----HHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EE
T ss_pred EecC------CEEEEEeeccccccchh-------hHH-----HHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CE
Confidence 5421 27899999875433221 112 55688999999999999999999999999999865 58
Q ss_pred EEEeeCCccccCCCCCCCcccccccCcccc------cccccCcccCCccccHHHHHHHH
Q 018936 262 KIADFGLASFFDPNHKHPMTSRVVTLWYRP------PELLLGATDYGVGVDLWSAGCIL 314 (348)
Q Consensus 262 kl~DFGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~DvwSlGv~l 314 (348)
+|+|||+|........ . .|.. .+.+. ..|+.++|+||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~----~-----~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGW----R-----EILERDVRNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTH----H-----HHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCc----H-----HHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence 9999999986542211 0 1111 12222 3488899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=2.3e-06 Score=73.17 Aligned_cols=83 Identities=14% Similarity=0.049 Sum_probs=54.0
Q ss_pred CCceeeeeeccCCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeeccCceEEE
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSRMSCSLYL 194 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 194 (348)
..|+..+..+-++.+.||+.. .++..+++|........ ....+.+|...+..+. +--+.+++.+... ....++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEE
Confidence 457777766556667999986 56667888887543221 1223567888887773 3335666666555 345799
Q ss_pred EEeecccChh
Q 018936 195 VFHYMEHDLA 204 (348)
Q Consensus 195 v~e~~~~~l~ 204 (348)
||+++++...
T Consensus 88 v~~~l~G~~~ 97 (263)
T d1j7la_ 88 LMSEADGVLC 97 (263)
T ss_dssp EEECCSSEEH
T ss_pred EEEecccccc
Confidence 9999987443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=3.4e-05 Score=65.26 Aligned_cols=72 Identities=14% Similarity=0.094 Sum_probs=46.3
Q ss_pred eeccCC-ceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeeccCceEEEEEeec
Q 018936 123 KIGQGT-YSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDH--PNVIKLEGLVTSRMSCSLYLVFHYM 199 (348)
Q Consensus 123 ~LG~G~-~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~lv~e~~ 199 (348)
.+..|. .+.||+.. ...+..+++|.-..... ..+..|...++.+.. -.+.+++++..+ ....+++|+++
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEee
Confidence 344454 36899997 35677788998654332 235667777777643 235666666554 34578999999
Q ss_pred ccC
Q 018936 200 EHD 202 (348)
Q Consensus 200 ~~~ 202 (348)
++.
T Consensus 89 ~G~ 91 (255)
T d1nd4a_ 89 PGQ 91 (255)
T ss_dssp SSE
T ss_pred ecc
Confidence 763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.84 E-value=2.3e-05 Score=71.22 Aligned_cols=77 Identities=18% Similarity=0.148 Sum_probs=46.7
Q ss_pred eeeeccCCceEEEEEEEccCCcEEEEEEeecC-----CCChHHHHHHHHHHHHHHhc-CC--CceeeeeceEeeccCceE
Q 018936 121 IDKIGQGTYSNVYKAKDMLTGKIVALKKVRFD-----NLEPESVKFMAREILILRRL-DH--PNVIKLEGLVTSRMSCSL 192 (348)
Q Consensus 121 ~~~LG~G~~g~Vy~~~~~~~g~~vAvK~i~~~-----~~~~~~~~~~~~E~~~l~~l-~h--pniv~l~~~~~~~~~~~~ 192 (348)
.+.||.|....||++.+..+++.+++|.-... ...+...++...|.+.|+.+ .+ ..+++++.+ +... .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~--~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--A 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC--C
Confidence 45789999999999987666788999964321 11112233455688888766 22 345666544 3222 4
Q ss_pred EEEEeeccc
Q 018936 193 YLVFHYMEH 201 (348)
Q Consensus 193 ~lv~e~~~~ 201 (348)
+++||++++
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 689999865
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.23 E-value=0.00081 Score=58.98 Aligned_cols=71 Identities=14% Similarity=0.111 Sum_probs=43.2
Q ss_pred CCceEEEEEEEccCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCce-----eeeeceEeeccCceEEEEEeeccc
Q 018936 127 GTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILILRRLDHPNV-----IKLEGLVTSRMSCSLYLVFHYMEH 201 (348)
Q Consensus 127 G~~g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~~~~~~~~~~~~~lv~e~~~~ 201 (348)
+.--.||+++ ..+|..|++|+.+..... .+.+..|...+..|....+ +...+-.........+.++++++|
T Consensus 33 s~EN~vy~v~-~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQ-DEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEEC-CTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEE-cCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 3346899998 478999999998755333 3456678888877743222 112111111124457888888865
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.74 E-value=0.0069 Score=54.25 Aligned_cols=75 Identities=16% Similarity=0.154 Sum_probs=48.8
Q ss_pred CCceeeeeeccCCceEEEEEEEcc-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeec
Q 018936 116 DSFEKIDKIGQGTYSNVYKAKDML-------TGKIVALKKVRFDNLEPESVKFMAREILILRRLD-HPNVIKLEGLVTSR 187 (348)
Q Consensus 116 ~~y~~~~~LG~G~~g~Vy~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 187 (348)
+++++ +.|+.|-.-.+|++.... .++.|.+++.- . ... .....+|..+++.+. +.-.+++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PET--ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 45555 578889999999998542 23567777754 2 211 234567999998884 4334577776642
Q ss_pred cCceEEEEEeeccc
Q 018936 188 MSCSLYLVFHYMEH 201 (348)
Q Consensus 188 ~~~~~~lv~e~~~~ 201 (348)
.+|++|+++
T Consensus 117 -----g~I~efi~g 125 (395)
T d1nw1a_ 117 -----GRLEEYIPS 125 (395)
T ss_dssp -----EEEECCCCE
T ss_pred -----ceEEEEecc
Confidence 578888876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.43 E-value=0.0043 Score=53.60 Aligned_cols=30 Identities=30% Similarity=0.448 Sum_probs=27.0
Q ss_pred CceecCCCCCCEEECCCCcEEEEeeCCccc
Q 018936 242 GVLHRDIKGSNLLIDDDGVLKIADFGLASF 271 (348)
Q Consensus 242 ~ivHrDikp~NIll~~~~~~kl~DFGla~~ 271 (348)
|+||+|+.++||+++.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 799999999999999887778999998854
|